PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Quigley, I				Quigley, Ian			How much are doctors worth: how much do doctors really earn?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					343	343		10.1136/bmj.39126.512836.47	http://dx.doi.org/10.1136/bmj.39126.512836.47			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303879	Green Published			2022-12-28	WOS:000244560400028
J	Gray-Schopfer, V; Wellbrock, C; Marais, R				Gray-Schopfer, Vanessa; Wellbrock, Claudia; Marais, Richard			Melanoma biology and new targeted therapy	NATURE			English	Review							KAPPA-B-KINASE; CUTANEOUS MALIGNANT-MELANOMA; ENDOTHELIAL GROWTH-FACTOR; PHASE-II; TRANSCRIPTION FACTOR; ANTITUMOR-ACTIVITY; BRAF MUTATIONS; METASTATIC MELANOMA; CELLULAR SENESCENCE; SIGNALING PATHWAYS	Melanoma is a cancer that arises from melanocytes, specialized pigmented cells that are found predominantly in the skin. The incidence of melanoma is rising steadily in western populations - the number of cases worldwide has doubled in the past 20 years. In its early stages malignant melanoma can be cured by surgical resection, but once it has progressed to the metastatic stage it is extremely difficult to treat and does not respond to current therapies. Recent discoveries in cell signalling have provided greater understanding of the biology that underlies melanoma, and these advances are being exploited to provide targeted drugs and new therapeutic approaches.	Canc Res UK, Inst Canc Res, Signal Transduct Team, Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Marais, R (corresponding author), Canc Res UK, Inst Canc Res, Signal Transduct Team, Ctr Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.marais@icr.ac.uk		Wellbrock, Claudia/0000-0002-3825-6381; Marais, Richard/0000-0001-7484-4183	Worldwide Cancer Research [06-0062] Funding Source: Medline	Worldwide Cancer Research		Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Amiri KI, 2004, CANCER RES, V64, P4912, DOI 10.1158/0008-5472.CAN-04-0673; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Boissy RE, 1997, PIGM CELL RES, V10, P12, DOI 10.1111/j.1600-0749.1997.tb00461.x; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Bush JA, 2003, CLIN EXP METASTAS, V20, P531, DOI 10.1023/A:1025874502181; Chen DH, 2003, CANCER RES, V63, P6626; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Collisson EA, 2003, CANCER RES, V63, P5669; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dancey JE, 2006, CANCER BIOL THER, V5, P1065, DOI 10.4161/cbt.5.9.3175; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Del Bufalo D, 2003, ONCOGENE, V22, P8441, DOI 10.1038/sj.onc.1206999; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Ellerhorst JA, 2006, ONCOGENE, V25, P3956, DOI 10.1038/sj.onc.1209419; End DW, 2001, CANCER RES, V61, P131; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Fry DW, 2004, MOL CANCER THER, V3, P1427; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Gray-Schopfer VC, 2007, CANCER RES, V67, P122, DOI 10.1158/0008-5472.CAN-06-1880; Gray-Schopfer VC, 2005, CANCER METAST REV, V24, P165, DOI 10.1007/s10555-005-5865-1; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Gupta PB, 2005, COLD SH Q B, V70, P291, DOI 10.1101/sqb.2005.70.033; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; Haass NK, 2004, J MOL HISTOL, V35, P309; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Ishihara Kazuyuki, 2001, International Journal of Clinical Oncology, V6, P109; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kirkwood JM, 2006, CLIN CANCER RES, V12, p2331S, DOI 10.1158/1078-0432.CCR-05-2538; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; Kuchelmeister C, 2000, BRIT J DERMATOL, V143, P275, DOI 10.1046/j.1365-2133.2000.03651.x; Lee Patrice, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P897; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; LYSSIKATOS J, 2004, P AM ASSOC CANC RES, V45, pB896; Margolin K, 2005, CANCER-AM CANCER SOC, V104, P1045, DOI 10.1002/cncr.21265; Markovic SN, 2005, CANCER-AM CANCER SOC, V103, P2584, DOI 10.1002/cncr.21108; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; ODONNELL A, 2003, P AM SOC CLIN ONCOL, V22; Omholt K, 2006, MELANOMA RES, V16, P197, DOI 10.1097/01.cmr.0000200488.77970.e3; Omholt K, 2001, INT J CANCER, V92, P839, DOI 10.1002/ijc.1270; Papp T, 2003, J Med Genet, V40, pE14, DOI 10.1136/jmg.40.2.e14; Peterson AC, 2004, CLIN CANCER RES, V10, P4048, DOI 10.1158/1078-0432.CCR-03-0766; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Polsky D, 2001, CANCER RES, V61, P6008; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Rofstad EK, 2000, CANCER RES, V60, P4932; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sauter ER, 2002, CANCER RES, V62, P3200; Selzer E, 2002, CANCER RES, V62, P2098; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Smalley KSM, 2003, INT J CANCER, V105, P165, DOI 10.1002/ijc.11064; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Straume O, 1997, INT J CANCER, V74, P535, DOI 10.1002/(SICI)1097-0215(19971021)74:5<535::AID-IJC10>3.0.CO;2-5; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tarhini AA, 2006, DERMATOL THER, V19, P19, DOI 10.1111/j.1529-8019.2005.00052.x; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wellbrock C, 2002, J BIOL CHEM, V277, P6443, DOI 10.1074/jbc.M110684200; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Willmore-Payne C, 2005, HUM PATHOL, V36, P486, DOI 10.1016/j.humpath.2005.03.015; Worm J, 2004, ONCOGENE, V23, P5215, DOI 10.1038/sj.onc.1207647; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; Wu M, 2000, GENE DEV, V14, P301; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; YEH T, 2004, P AM ASSOC CANC RES, V45, pC896	100	997	1047	7	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					851	857		10.1038/nature05661	http://dx.doi.org/10.1038/nature05661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314971				2022-12-28	WOS:000244341200035
J	Gegenwart, P; Westerkamp, T; Krellner, C; Tokiwa, Y; Paschen, S; Geibel, C; Steglich, F; Abrahams, E; Si, Q				Gegenwart, P.; Westerkamp, T.; Krellner, C.; Tokiwa, Y.; Paschen, S.; Geibel, C.; Steglich, F.; Abrahams, E.; Si, Q.			Multiple energy scales at a quantum critical point	SCIENCE			English	Article							PHASE-TRANSITIONS; FERMI-LIQUID; HEAVY; SYSTEMS; METALS	We report thermodynamic measurements in a magnetic-field-driven quantum critical point of a heavy fermion metal, YbRh2Si2. The data provide evidence for an energy scale in the equilibrium excitation spectrum that is in addition to the one expected from the slow fluctuations of the order parameter. Both energy scales approach zero as the quantum critical point is reached, thereby providing evidence for a new class of quantum criticality.	Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08855 USA; Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Max Planck Society; Rutgers State University New Brunswick; Rice University	Gegenwart, P (corresponding author), Univ Gottingen, Inst Phys 1, Bunsenstr 9, D-37077 Gottingen, Germany.	pgegenw@gwdg.de; qmsi@rice.edu	Tokiwa, Yoshifumi/P-6593-2015; Gegenwart, Philipp/A-7291-2017; Krellner, Cornelius/A-5389-2009; Paschen, Silke/C-3841-2014	Tokiwa, Yoshifumi/0000-0002-6294-7879; Gegenwart, Philipp/0000-0003-4180-3785; Krellner, Cornelius/0000-0002-0671-7729; Paschen, Silke/0000-0002-3796-0713				CHANDRASEKHAR BS, 1971, ADV PHYS, V20, P775, DOI 10.1080/00018737100101351; Coleman P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245111; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Gegenwart P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.076402; Gegenwart P, 2006, J PHYS SOC JPN, V75, P155, DOI 10.1143/JPSJS.75S.155; Gegenwart P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.056402; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Ishida K, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184401; Kuchler R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066405; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; MORIYA T, 1995, J PHYS SOC JPN, V64, P960, DOI 10.1143/JPSJ.64.960; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; Sachdev S., 1999, QUANTUM PHASE TRANSI; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2005, PHYSICA B, V359, P9, DOI 10.1016/j.physb.2004.12.041; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Si QM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115103; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; Tokiwa Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.226402; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; WILSON KG, 1983, REV MOD PHYS, V55, P583, DOI 10.1103/RevModPhys.55.583; Zhu LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066404	25	180	182	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					969	971		10.1126/science.1136020	http://dx.doi.org/10.1126/science.1136020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303749	Green Submitted			2022-12-28	WOS:000244229800036
J	Burns, JC				Burns, Jane C.			Focus on research: The riddle of Kawasaki disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Diego, Sch Med, Div Pediat Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Burns, JC (corresponding author), Univ Calif San Diego, Sch Med, Div Pediat Allergy Immunol & Rheumatol, La Jolla, CA 92093 USA.							Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334	5	40	51	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					659	661		10.1056/NEJMp068268	http://dx.doi.org/10.1056/NEJMp068268			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301296				2022-12-28	WOS:000244193300003
J	Dancer, SJ				Dancer, Stephanie J.			Attention prescribers: be careful with antibiotics	LANCET			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; RESISTANCE; MRSA		So Gen Hosp, Dept Microbiol, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Dancer, SJ (corresponding author), So Gen Hosp, Dept Microbiol, Glasgow G51 4TF, Lanark, Scotland.	stephanie.dancer@sgh.scot.nhs.uk		Dancer, Stephanie/0000-0002-8777-2614				Dancer SJ, 2006, J HOSP INFECT, V62, P200, DOI 10.1016/j.jhin.2005.06.033; Dancer SJ, 2004, LANCET INFECT DIS, V4, P611, DOI 10.1016/S1473-3099(04)01145-4; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Kummerer K, 2003, J ANTIMICROB CHEMOTH, V52, P5, DOI 10.1093/jac/dkg293; MacDougall C, 2005, CLIN INFECT DIS, V41, P435, DOI 10.1086/432056; Majeed A, 2002, BRIT MED J, V325, P340; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Meyer E, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P345; Muller A, 2006, J ANTIMICROB CHEMOTH, V58, P878, DOI 10.1093/jac/dkl343; *RIVM, 2004, EARSS ANN REP; Schentag JJ, 1998, CLIN INFECT DIS, V26, P1204, DOI 10.1086/520287; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Vardhan MS, 2003, J INFECTION, V46, P30, DOI 10.1053/jinf.2002.1087	13	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					442	443		10.1016/S0140-6736(07)60208-6	http://dx.doi.org/10.1016/S0140-6736(07)60208-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292745				2022-12-28	WOS:000244188300006
J	Laine, L; Curtis, SP; Cryer, B; Kaur, A; Cannon, CP				Laine, Loren; Curtis, Sean P.; Cryer, Byron; Kaur, Amarjot; Cannon, Christopher P.		MEDAL Steering Comm	Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; DOUBLE-BLIND; GASTRODUODENAL ULCERS; SELECTIVE-INHIBITION; RESOURCE UTILIZATION; CELECOXIB; NAPROXEN; VALDECOXIB; COMPLICATIONS	Background Upper gastrointestinal safety of cyclo-oxygenase (COX)-2 selective inhibitors versus traditional non-steroidal anti-inflammatory drugs (NSAIDs) has not been assessed in trials that simulate standard clinical practice. Our aim was to assess the effects of these drugs on gastrointestinal outcomes in a population that includes patients taking gastrointestinal protective therapy. Methods A prespecified pooled intent-to-treat analysis of three double-blind randomised comparisons of etoricoxib (60 or 90 mg daily) and diclofenac (150 mg daily) in 34701 patients with osteoarthritis or rheumatoid arthritis was done for upper gastrointestinal clinical events (bleeding, perforation, obstruction, or ulcer) and the subset of complicated events (perforation, obstruction, witnessed ulcer bleeding, or significant bleeding). We also assessed such outcomes in patients who were taking concomitant proton pump inhibitors (PPIs) or low-dose aspirin. These trials are registered with ClinicalTrials.gov, with the numbers NCT00092703, NCT00092742, and NCT00250445. Findings Overall upper gastrointestinal clinical events were significantly less common with etoricoxib than with diclofenac (hazard ratio [HR) 0.69, 95% CI 0.57-0.83; p=0.0001). There were significantly fewer uncomplicated gastrointestinal events with etoricoxib than there were with diclofenac (0.57, 0.45-0.74; p<0.0001); there was no difference in complicated events (0.91, 0.67-1.24; p=0.561). PPIs were used concomitantly for at least 75% of the study period by 13 862 (40%) and low-dose aspirin by 11418 (33%) patients; treatment effects did not differ significantly in these individuals. Interpretation There were significantly fewer upper gastrointestinal clinical events with the COX-2 selective inhibitor etoricoxib than with the traditional NSAID diclofenac due to a decrease in uncomplicated events, but not in the more serious complicated events. The reduction in uncomplicated events with etoricoxib is maintained in patients treated with PPIs and is also observed with regular low-dose aspirin use.	Univ So Calif, Keck Sch Med, Dept Med, Div Gastrointestinal & Liver Dis, Los Angeles, CA 90033 USA; Merck Res Labs, Rahway, NJ USA; Univ Texas, SW Med Sch, Dallas VA Med Ctr, Dept Med,Div Gastroenterol, Dallas, TX 75230 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Dept Med,Cardiovasc Div, Thrombolysis Myocardial Infarct Study Grp, Boston, MA 02115 USA	University of Southern California; Merck & Company; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Laine, L (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Div Gastrointestinal & Liver Dis, 2025 Zonal Ave, Los Angeles, CA 90033 USA.	llaine@usc.edu	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791				Allum WH, 2002, GUT, V50, P1; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bensen WG, 2000, J RHEUMATOL, V27, P1876; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Cannon CP, 2006, AM HEART J, V152, P237, DOI 10.1016/j.ahj.2006.05.024; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Chan FKL, 2001, NEW ENGL J MED, V344, P967, DOI 10.1056/NEJM200103293441304; Dubois RW, 2004, ALIMENT PHARM THER, V19, P197, DOI 10.1111/j.0269-2813.2004.01834.x; Eisen GM, 2005, ALIMENT PHARM THER, V21, P591, DOI 10.1111/j.1365-2036.2005.02383.x; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; *FDA ARTHR ADV COM, BRIEF INF NDA 209989; Goldstein JL, 2006, GASTROENTEROLOGY, V130, pA81; Goldstein JL, 2006, ALIMENT PHARM THER, V23, P1489, DOI 10.1111/j.1365-2036.2006.02912.x; Goldstein JL, 2002, ALIMENT PHARM THERAP, V16, P819, DOI 10.1046/j.1365-2036.2002.01219.x; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hawkey C, 2005, AM J GASTROENTEROL, V100, P1028, DOI 10.1111/j.1572-0241.2005.41465.x; Labenz J, 2002, GUT, V51, P329, DOI 10.1136/gut.51.3.329; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Laine L, 2004, GASTROENTEROLOGY, V127, P395, DOI 10.1053/j.gastro.2004.05.001; Laine L, 2004, GASTROENTEROLOGY, V126, pA36; Laine L, 2003, GASTROENTEROLOGY, V125, P389, DOI 10.1016/S0016-5085(03)00900-4; Laine L, 2002, GASTROENTEROLOGY, V123, P1006, DOI 10.1053/gast.2002.36013; Laine Loren, 2004, Rev Gastroenterol Disord, V4 Suppl 4, pS33; Lanes SF, 1997, ARTHRITIS RHEUM-US, V40, P1475, DOI 10.1002/art.1780400816; LARKAI EN, 1989, J CLIN GASTROENTEROL, V11, P158, DOI 10.1097/00004836-198904000-00009; Patrono C, 2001, J CLIN INVEST, V108, P7, DOI 10.1172/JCI13418; Pavelka K, 2003, RHEUMATOLOGY, V42, P1207, DOI 10.1093/rheumatology/keg359; Rabeneck L, 2005, AM J GASTROENTEROL, V100, P1043, DOI 10.1111/j.1572-0241.2005.40701.x; Rahme E, 2004, GASTROENTEROLOGY, V126, pA1; REILLY IAG, 1987, BLOOD, V69, P180; Scheiman JM, 2006, DRUGS, V66, P15; Schnitzer TJ, 2004, LANCET, V364, P665, DOI 10.1016/S0140-6736(04)16893-1; Sikes DH, 2002, EUR J GASTROEN HEPAT, V14, P1101, DOI 10.1097/00042737-200210000-00011; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; VANHECKEN A, 2000, J CLIN PHARMACOL, V40, P1; Watson DJ, 2000, ARCH INTERN MED, V160, P2998, DOI 10.1001/archinte.160.19.2998; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	40	153	186	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					465	473		10.1016/S0140-6736(07)60234-7	http://dx.doi.org/10.1016/S0140-6736(07)60234-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292766				2022-12-28	WOS:000244188300029
J	Brueckner, F; Hennecke, U; Carell, T; Cramer, P				Brueckner, Florian; Hennecke, Ulrich; Carell, Thomas; Cramer, Patrick			CPD damage recognition by transcribing RNA polymerase II	SCIENCE			English	Article							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; CYCLOBUTANE PYRIMIDINE DIMER; SYN THYMINE DIMER; ELONGATION COMPLEX; STRUCTURAL BASIS; DNA-DAMAGE; COCKAYNE-SYNDROME; YEAST; RESOLUTION	Cells use transcription-coupled repair (TCR) to efficiently eliminate DNA lesions such as ultraviolet light-induced cyclobutane pyrimidine dimers (CPDs). Here we present the structure-based mechanism for the first step in eukaryotic TCR, CPD-induced stalling of RNA polymerase (Pol)II. A CPD in the transcribed strand slowly passes a translocation barrier and enters the polymerase active site. The CPD 5'-thymine then directs uridine misincorporation into messenger RNA, which blocks translocation. Artificial replacement of the uridine by adenosine enables CPD bypass; thus, Pol II stalling requires CPD-directed misincorporation. In the stalled complex, the lesion is inaccessible, and the polymerase conformation is unchanged. This is consistent with nonallosteric recruitment of repair factors and excision of a lesion-containing DNA fragment in the presence of Pol II.	Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany; Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich	Carell, T (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, CiPSm, D-81377 Munich, Germany.	thomas.carell@cup.uni-muenchen.de; cramer@lmb.uni-muenchen.de	Carell, Thomas/G-4799-2012; Hennecke, Ulrich/A-7723-2010	Carell, Thomas/0000-0001-7898-2831; Hennecke, Ulrich/0000-0002-4904-6793				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kwei JSM, 2004, BIOCHEM BIOPH RES CO, V320, P1133, DOI 10.1016/j.bbrc.2004.06.066; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mitchell JR, 2003, CURR OPIN CELL BIOL, V15, P232, DOI 10.1016/S0955-0674(03)00018-8; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Tornaletti S, 1997, J BIOL CHEM, V272, P31719, DOI 10.1074/jbc.272.50.31719; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Verhage RA, 1997, MOL GEN GENET, V254, P284, DOI 10.1007/s004380050417; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	28	180	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					859	862		10.1126/science.1135400	http://dx.doi.org/10.1126/science.1135400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290000	Green Published			2022-12-28	WOS:000244069000073
J	Gamble, MJ; Kraus, WL				Gamble, Matthew J.; Kraus, W. Lee			Visualizing the histone code on LSD1	CELL			English	Editorial Material							DEMETHYLATION; METHYLATION; ACTIVATION		Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Gamble, MJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 465 Biotechnol Bldg, Ithaca, NY 14853 USA.	wlk5@cornell.edu						An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Daniel JA, 2005, CELL CYCLE, V4, P919, DOI 10.4161/cc.4.7.1824; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012	11	6	7	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					433	434		10.1016/j.cell.2007.01.017	http://dx.doi.org/10.1016/j.cell.2007.01.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289562	Bronze			2022-12-28	WOS:000244842700009
J	Himmel, ME; Ding, SY; Johnson, DK; Adney, WS; Nimlos, MR; Brady, JW; Foust, TD				Himmel, Michael E.; Ding, Shi-You; Johnson, David K.; Adney, William S.; Nimlos, Mark R.; Brady, John W.; Foust, Thomas D.			Biomass recalcitrance: Engineering plants and enzymes for biofuels production	SCIENCE			English	Editorial Material							DILUTE-SULFURIC-ACID; HYDROGEN-BONDING SYSTEM; SYNCHROTRON X-RAY; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; CORN STOVER; PRETREATMENT; HYDROLYSIS; XYLAN; CELLULOSOMES	Lignocellulosic biomass has long been recognized as a potential sustainable source of mixed sugars for fermentation to biofuels and other biomaterials. Several technologies have been developed during the past 80 years that allow this conversion process to occur, and the clear objective now is to make this process cost-competitive in today's markets. Here, we consider the natural resistance of plant cell walls to microbial and enzymatic deconstruction, collectively known as "biomass recalcitrance." It is this property of plants that is largely responsible for the high cost of lignocellulose conversion. To achieve sustainable energy production, it will be necessary to overcome the chemical and structural properties that have evolved in biomass to prevent its disassembly.	Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA; Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Cornell University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Himmel, ME (corresponding author), Natl Renewable Energy Lab, Chem & Biosci Ctr, Golden, CO 80401 USA.	mike_himmel@nrel.gov	Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021; Johnson, David K/G-4959-2011	DING, SHIYOU/0000-0002-1102-1507; Johnson, David K/0000-0003-4815-8782; Foust, Thomas/0000-0002-3995-8254				Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Esteghlalian A, 1997, BIORESOURCE TECHNOL, V59, P129, DOI 10.1016/S0960-8524(97)81606-9; European Commission, 2006, BIOF EUR UN VIS 2030; Faaij APC, 2006, ENERG POLICY, V34, P322, DOI 10.1016/j.enpol.2004.03.026; GAUSS W, 1976, Patent No. 39909444; Himmel ME, 1999, CURR OPIN BIOTECH, V10, P358, DOI 10.1016/S0958-1669(99)80065-2; Himmel ME, 1997, ACS SYM SER, V666, P2; HOUGHTON J, 2005, BREAKING BIOL BARRIE; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; KIM SB, 1987, BIOTECHNOL BIOENG S, V17, P71; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Liu CG, 2004, IND ENG CHEM RES, V43, P2781, DOI 10.1021/ie030754x; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16165, DOI 10.1073/pnas.0605381103; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MALONEY MT, 1985, BIOTECHNOL BIOENG, V27, P355, DOI 10.1002/bit.260270321; Matthews JF, 2006, CARBOHYD RES, V341, P138, DOI 10.1016/j.carres.2005.09.028; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Nonhebel S, 2005, RENEW SUST ENERG REV, V9, P191, DOI 10.1016/j.rser.2004.02.003; *OBP, 2005, MULT PROGR PLAN 2007; PERLACK RD, 2005, TM2005 ORNL; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; SHIANG M, 1991, BIOTECHNOL PROGR, V7, P315, DOI 10.1021/bp00010a005; SUN Y, IN PRESS BIORESOUR T; Teymouri F, 2005, BIORESOURCE TECHNOL, V96, P2014, DOI 10.1016/j.biortech.2005.01.016; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; TORGET R, 1992, APPL BIOCHEM BIOTECH, V34-5, P115, DOI 10.1007/BF02920538; TORGET R, 1991, BIORESOURCE TECHNOL, V35, P239, DOI 10.1016/0960-8524(91)90120-9; *US DEP EN OFF BIO, 2006, 30 X 30 WORKSH WASH; *USDA NAT RES CONS, 2003, NAT RES INV 2001 ANN; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043	39	3218	3399	36	1690	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					804	807		10.1126/science.1137016	http://dx.doi.org/10.1126/science.1137016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289988				2022-12-28	WOS:000244069000056
J	Lewis, NS				Lewis, Nathan S.			Toward cost-effective solar energy use	SCIENCE			English	Editorial Material							CELLS	At present, solar energy conversion technologies face cost and scalability hurdles in the technologies required for a complete energy system. To provide a truly widespread primary energy source, solar energy must be captured, converted, and stored in a cost-effective fashion. New developments in nanotechnology, biotechnology, and the materials and physical sciences may enable step-change approaches to cost-effective, globally scalable systems for solar energy use.	CALTECH, Beckman Inst, Noyes Lab 210, Pasadena, CA 91125 USA	California Institute of Technology	Lewis, NS (corresponding author), CALTECH, Beckman Inst, Noyes Lab 210, 127-72, Pasadena, CA 91125 USA.	nslewis@its.caltech.edu						Goldemberg J., 2004, WORLD ENERGY ASSESSM; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P137, DOI 10.1002/pip.368; GREEN MA, 2004, 3 GENERATION PHOTOVO; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Ivy J, 2004, SUMMARY ELECTROLYTIC; Kayes BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1901835; Lewis NS, 2005, INORG CHEM, V44, P6900, DOI 10.1021/ic051118p; Milliron DJ, 2005, MRS BULL, V30, P41, DOI 10.1557/mrs2005.8; Schaller RD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2142092; Smalley RE, 2005, MRS BULL, V30, P412, DOI 10.1557/mrs2005.124; *US DEP EN, 2005, BAS RES NEEDS SOL EN; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789	13	1817	1859	16	757	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					798	801		10.1126/science.1137014	http://dx.doi.org/10.1126/science.1137014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134FN	17289986	Green Published			2022-12-28	WOS:000244069000054
J	Dunser, MW; Rieder, J				Duenser, Martin W.; Rieder, Josef			Hydrofluoric acid burn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Univ Innsbruck, A-6020 Innsbruck, Austria	Medical University of Innsbruck	Dunser, MW (corresponding author), Med Univ Innsbruck, A-6020 Innsbruck, Austria.								0	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					E5	E5		10.1056/NEJMicm055763	http://dx.doi.org/10.1056/NEJMicm055763			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287472				2022-12-28	WOS:000244012700010
J	Marris, E				Marris, Emma			Carbon copies	NATURE			English	News Item																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					584	585		10.1038/445584a	http://dx.doi.org/10.1038/445584a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287785				2022-12-28	WOS:000244039400014
J	Turgeon, AF; Hutton, B; Fergusson, DA; McIntyre, L; Tinmouth, AA; Cameron, DW; Hebert, PC				Turgeon, Alexis F.; Hutton, Brian; Fergusson, Dean A.; McIntyre, Lauralyn; Tinmouth, Alan A.; Cameron, D. William; Hebert, Paul C.			Meta-analysis: Intravenous immunoglobulin in critically ill adult patients with sepsis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	10th Annual Toronto Critical Care Medicine Symposium	OCT 26-28, 2005	Toronto, CANADA				ENRICHED IMMUNOGLOBULIN; SEPTIC SHOCK; BACTERIAL-INFECTIONS; DOUBLE-BLIND; THERAPY; MULTICENTER; TRIAL; ANTIBIOTICS; GUIDELINES; MORTALITY	Background: Intravenous immunoglobulin therapy has been proposed as an adjuvant treatment for sepsis. Yet, its benefit remains unclear, and its use is not currently recommended. Purpose: To evaluate the effect of polyclonal intravenous immunoglobulin therapy on death in critically ill adult patients with sepsis. Data Sources: MEDLINE (1966 to May 2006) and the Cochrane Central Register of Controlled Trials (May 2006 edition). Study Selection: All randomized, controlled trials of critically ill adult patients with sepsis, severe sepsis, or septic shock who received polyclonal intravenous immunoglobulin therapy or placebo or no intervention were selected. No restrictions were made for study language or type of publication. Data extraction: Data were independently extracted by 2 investigators using a standardized form. Data Synthesis: The literature search identified 4096 articles, of which 33 were deemed to be potentially eligible. Twenty trials (n = 2621) met eligibility criteria and were included in the analysis. Polyclonal intravenous immunoglobulin therapy was associated with an overall survival benefit (risk ratio, 0.74 [95% CI, 0.62 to 0.89]) compared with placebo or no intervention. In sensitivity analyses, documented survival improved when the analysis was limited to published, peer-reviewed trials (risk ratio, 0.72 [CI, 0.58 to 0.89]) (17 trials [n = 1865]) and blinded trials (risk ratio, 0.61 [CI, 0.40 to 0.93) (7 trials [n = 896]). Severe sepsis or septic shock (risk ratio, 0.64 [CI, 0.52 to 0.79]) (11 trials [n = 689]), receiving a total dose regimen of 1 gram or more per kilogram of body weight (risk ratio, 0.61 [CI, 0.40 to 0.94]) (7 trials [n = 560]), and receiving therapy for longer than 2 days (risk ratio, 0.66 [CI, 0.53 to 0.82]) (17 trials [n = 1847]) were strongly associated with this survival benefit. Limitations: Most trials were published before new developments modifying the care and outcome of critically ill patients with sepsis including early goal-directed therapy and activated protein C treatment, were introduced. Conclusions: A survival benefit was observed for patients with sepsis who received polyclonal intravenous immunoglobulin therapy compared with those who received placebo or no intervention. A large, randomized, controlled trial of polyclonal intravenous immunoglobulin therapy should be performed on the basis of the methodological limitations of the current literature, the potential benefit from this therapy in more severely ill patients, and the potential effect of dosage and duration of this therapy.	Univ Ottawa, Ottawa Hlth Res Inst, Ctr Transfus & Crit Care Res, Clin Epidemiol Unit, Ottawa, ON K1H 8L6, Canada; Canadian Red Cross Blood Transfus Serv, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute	Turgeon, AF (corresponding author), Univ Ottawa, Ottawa Hlth Res Inst, Ctr Transfus & Crit Care Res, Clin Epidemiol Unit, 501 Smyth Rd,Box 208, Ottawa, ON K1H 8L6, Canada.	alexisturgeon@yahoo.ca	Cameron, Bill/E-9180-2010; McIntyre, Lauralyn/AAR-7710-2021	Cameron, Bill/0000-0002-0090-3539; McIntyre, Lauralyn/0000-0001-7421-1407; Hutton, Brian/0000-0001-5662-8647; Fergusson, Dean/0000-0002-3389-2485				ALEJANDRIA MM, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001090; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; [Anonymous], 1990, JAMA, V264, P3189; BEHRE G, 1995, ANTIINFECTIOUS DRUGS, V13, P12934; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BURNS ER, 1991, J CLIN IMMUNOL, V11, P363, DOI 10.1007/BF00918802; *CDC, 1970, OUTL SURV CONTR NOS; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P518; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chen C, 2000, ANN PHARMACOTHER, V34, P295, DOI 10.1345/aph.19252; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESIMONE C, 1988, CRIT CARE MED, V16, P23, DOI 10.1097/00003246-198801000-00005; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; DOMINIONI L, 1991, ARCH SURG-CHICAGO, V126, P236; Dominioni Lorenzo, 1996, Digestive Surgery, V13, P430, DOI 10.1159/000172479; ELEBUTE EA, 1983, BRIT J SURG, V70, P29, DOI 10.1002/bjs.1800700111; Go RS, 2000, MAYO CLIN PROC, V75, P83, DOI 10.4065/75.1.83; Grundmann R, 1988, Prog Clin Biol Res, V272, P339; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hentrich M, 2006, CRIT CARE MED, V34, P1319, DOI 10.1097/01.CCM.0000215452.84291.C6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JESDINSKY HJ, 1987, KLIN WOCHENSCHR, V65, P1132, DOI 10.1007/BF01734833; JUST HM, 1986, KLIN WOCHENSCHR, V64, P245, DOI 10.1007/BF01711930; Karatzas S, 2002, CRIT CARE, V6, P543, DOI 10.1186/cc1837; LINDQUIST L, 1981, VOX SANG, V40, P329, DOI 10.1111/j.1423-0410.1981.tb00717.x; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Masaoka T, 2000, JPN J CHEMOTHER, V48, P199; Norrby-Teglund A, 2003, SCAND J INFECT DIS, V35, P683, DOI 10.1080/00365540310015944; Pildal J, 2004, CLIN INFECT DIS, V39, P38, DOI 10.1086/421089; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; PILZ G, 1993, THEOR SURG, V8, P61; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rodriguez A, 2005, SHOCK, V23, P298, DOI 10.1097/01.shk.0000157302.69125.f8; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Spannbrucker N, 1987, INTENSIVMED, V6, P314; Stangel M, 1997, CLIN NEUROPHARMACOL, V20, P385, DOI 10.1097/00002826-199710000-00002; SVANBOM M, 1979, SCAND J INFECT DIS, V11, P187, DOI 10.3109/inf.1979.11.issue-3.03; Tugrul S, 2002, CRIT CARE, V6, P357, DOI 10.1186/cc1523; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; VOGEL F, 1988, KLIN ANGEW IMMUNOLOG, P130; Werdan K, 1999, CLIN CHEM LAB MED, V37, P341, DOI 10.1515/CCLM.1999.057; WERDEN K, 1997, SHOCK S, V7; WESOLY C, 1990, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V23, P213; [No title captured]	49	122	131	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					193	203		10.7326/0003-4819-146-3-200702060-00009	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	132QN	17283351				2022-12-28	WOS:000243957400006
J	Horton, R; Surnmerskill, W				Horton, Richard; Surnmerskill, William			Clarification: Human rights abuse and other criminal violations in Port-au-Prince, Haiti	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, London NW1 7BY, England.							CAMPBELL D, 2006, GUARDIAN        0908; DUFF L, 2004, PACIFIC NEWS SE 0302; *INT COMM MED J ED, 2006, UN REQ MAN SUBM BIOM; James A, 2003, LANCET, V361, P8, DOI 10.1016/S0140-6736(03)12184-8; Kolbe AR, 2006, LANCET, V368, P864, DOI 10.1016/S0140-6736(06)69211-8	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					355	356		10.1016/S0140-6736(07)60169-X	http://dx.doi.org/10.1016/S0140-6736(07)60169-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276760				2022-12-28	WOS:000243944400009
J	McGregor, HV; Dima, M; Fischer, HW; Mulitza, S				McGregor, H. V.; Dima, M.; Fischer, H. W.; Mulitza, S.			Rapid 20th-century increase in coastal upwelling off northwest Africa	SCIENCE			English	Article							VARIABILITY; CO2; TEMPERATURES; TRENDS; OCEAN; CYCLE; ICE; AIR	Near-shore waters along the northwest African margin are characterized by coastal upwelling and represent one of the world's major upwelling regions. Sea surface temperature (SST) records from Moroccan sediment cores, extending back 2500 years, reveal anomalous and unprecedented cooling during the 20th century, which is consistent with increased upwelling. Upwelling-driven SSTs also vary out of phase with millennial-scale changes in Northern Hemisphere temperature anomalies (NHTAs) and show relatively warm conditions during the Little Ice Age and relatively cool conditions during the Medieval Warm Period. Together, these results suggest that coastal upwelling varies with NHTAs and that upwelling off northwest Africa may continue to intensify as global warming and atmospheric CO(2) levels increase.	Univ Bremen, DFG Res Ctr Ocean Margins, D-28359 Bremen, Germany; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Univ Bucharest, Fac Phys, Bucharest 077125, Romania; Univ Bremen, Inst Environm Phys, D-28350 Bremen, Germany; Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany	German Research Foundation (DFG); University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bucharest; University of Bremen; University of Bremen	McGregor, HV (corresponding author), Australian Nucl Sci & Technol Org, PMB1, Menai, NSW 2234, Australia.	mcgregor@uni-bremen.de	Dima, Mihai/G-1370-2010; McGregor, Helen/I-1479-2013; Mulitza, Stefan/G-5357-2011; Fischer, Helmut W./K-6207-2012	McGregor, Helen/0000-0002-4031-2282; Mulitza, Stefan/0000-0002-3842-1447; Fischer, Helmut W./0000-0002-0593-5564				Anderson DM, 2002, SCIENCE, V297, P596, DOI 10.1126/science.1072881; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bauch D, 2000, DEEP-SEA RES PT II, V47, P1791, DOI 10.1016/S0967-0645(00)00007-2; Bohm F, 1996, EARTH PLANET SC LETT, V139, P291, DOI 10.1016/0012-821X(96)00006-4; Cohen J, 2005, J CLIMATE, V18, P4498, DOI 10.1175/JCLI3530.1; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Goes JI, 2005, SCIENCE, V308, P545, DOI 10.1126/science.1106610; Haarsma RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023232; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; Keeling CD, 1979, ENVIRON INT, V2, P229, DOI [10.1016/0160-4120(79)90005-9, DOI 10.1016/0160-4120(79)90005-9]; Knippertz P, 2003, METEOROL ATMOS PHYS, V83, P67, DOI 10.1007/s00703-002-0561-y; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Mendelssohn R, 2002, PROG OCEANOGR, V53, P141, DOI 10.1016/S0079-6611(02)00028-9; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pelegri JL, 2005, J MARINE SYST, V54, P39, DOI 10.1016/j.jmarsys.2004.07.001; Santos AMP, 2005, J MAR RES, V63, P359, DOI 10.1357/0022240053693671; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Slutz R.J., 1985, COMPREHENSIVE OCEAN, V1; Speth P., 1978, DTSCH HYDROGR Z, V31, P95, DOI [10.1007/BF02227007, DOI 10.1007/BF02227007]; Tomczak M., 2003, REGIONAL OCEANOGRAPH, V2; WOOSTER WS, 1976, J MAR RES, V34, P131	27	212	217	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					637	639		10.1126/science.1134839	http://dx.doi.org/10.1126/science.1134839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272719				2022-12-28	WOS:000243909400040
J	Worden, J; Noone, D; Bowman, K				Worden, John; Noone, David; Bowman, Kevin		Tropospheric Emission Spect	Importance of rain evaporation and continental convection in the tropical water cycle	NATURE			English	Article							ISOTOPE COMPOSITION; PRECIPITATION; BALANCE; CLOUDS; OXYGEN	Atmospheric moisture cycling is an important aspect of the Earth's climate system, yet the processes determining atmospheric humidity are poorly understood(1-4). For example, direct evaporation of rain contributes significantly to the heat and moisture budgets of clouds(5), but few observations of these processes are available(6). Similarly, the relative contributions to atmospheric moisture over land from local evaporation and humidity from oceanic sources are uncertain(3,7). Lighter isotopes of water vapour preferentially evaporate whereas heavier isotopes preferentially condense(8-10) and the isotopic composition of ocean water is known. Here we use this information combined with global measurements of the isotopic composition of tropospheric water vapour from the Tropospheric Emission Spectrometer (TES) aboard the Aura spacecraft(11,12), to investigate aspects of the atmospheric hydrological cycle that are not well constrained by observations of precipitation or atmospheric vapour content. Our measurements of the isotopic composition of water vapour near tropical clouds suggest that rainfall evaporation contributes significantly to lower troposphere humidity, with typically 20% and up to 50% of rainfall evaporating near convective clouds. Over the tropical continents the isotopic signature of tropospheric water vapour differs significantly from that of precipitation(8,10,13), suggesting that convection of vapour from both oceanic sources and evapotranspiration are the dominant moisture sources. Our measurements allow an assessment of the intensity of the present hydrological cycle and will help identify any future changes as they occur.	Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO USA; CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Noone, D (corresponding author), Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA.	david.noone@colorado.edu	Bowman, Kevin/L-8786-2019; Worden, John R/AAY-1002-2021	Bowman, Kevin/0000-0002-8659-1117; NOONE, DAVID/0000-0002-8642-7843				Araguas-Araguas L, 2000, HYDROL PROCESS, V14, P1341, DOI 10.1002/1099-1085(20000615)14:8&lt;1341::AID-HYP983&gt;3.0.CO;2-Z; ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; Beer R, 2001, APPL OPTICS, V40, P2356, DOI 10.1364/AO.40.002356; Bosilovich MG, 2005, J CLIMATE, V18, P1591, DOI 10.1175/JCLI3357.1; Boville BA, 2006, J CLIMATE, V19, P2184, DOI 10.1175/JCLI3749.1; DANSGAARD W, 1964, TELLUS, V16, P436; Ehhalt D. H., 1974, NCARTNSTR100; EMANUEL KA, 1994, Q J ROY METEOR SOC, V120, P1111, DOI 10.1256/smsqj.51901; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; GAMACHE JF, 1993, J ATMOS SCI, V50, P3221, DOI 10.1175/1520-0469(1993)050<3221:DAIOTI>2.0.CO;2; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Gat JR, 2000, HYDROL PROCESS, V14, P1357, DOI [10.1002/1099-1085(20000615)14:8<1357::AID-HYP986>3.0.CO;2-7, 10.1002/1099-1085(20000615)14:8&lt;1357::AID-HYP986&gt;3.0.CO;2-7]; GAT JR, 1991, J GEOPHYS RES-ATMOS, V96, P13179, DOI 10.1029/91JD00054; Hendricks MB, 2000, GLOBAL BIOGEOCHEM CY, V14, P851, DOI 10.1029/1999GB001198; Lawrence JR, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004046; Roderick ML, 2002, SCIENCE, V298, P1410; ROSENFELD D, 1988, J APPL METEOROL, V27, P209, DOI 10.1175/1520-0450(1988)027<0209:EORFFC>2.0.CO;2; Schmidt GA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005790; TAYLOR AB, 1972, INSR107 NZ DEP SCI I; Trenberth KE, 2002, SCIENCE, V296; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Worden J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004522; Worden J, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006606; Xue Y, 2006, J CLIMATE, V19, P741, DOI 10.1175/JCLI3667.1; Zhang GJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001005	25	309	322	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					528	532		10.1038/nature05508	http://dx.doi.org/10.1038/nature05508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268467				2022-12-28	WOS:000243867300041
J	Bunch, JS; van der Zande, AM; Verbridge, SS; Frank, IW; Tanenbaum, DM; Parpia, JM; Craighead, HG; McEuen, PL				Bunch, J. Scott; van der Zande, Arend M.; Verbridge, Scott S.; Frank, Ian W.; Tanenbaum, David M.; Parpia, Jeevak M.; Craighead, Harold G.; McEuen, Paul L.			Electromechanical resonators from graphene sheets	SCIENCE			English	Article								Nanoelectromechanical systems were fabricated from single- and multilayer graphene sheets by mechanically exfoliating thin sheets from graphite over trenches in silicon oxide. Vibrations with fundamental resonant frequencies in the megahertz range are actuated either optically or electrically and detected optically by interferometry. We demonstrate room-temperature charge sensitivities down to 8 x 10(-4) electrons per root hertz. The thinnest resonator consists of a single suspended layer of atoms and represents the ultimate limit of two-dimensional nanoelectromechanical systems.	Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA; Pomona Coll, Dept Phys, Claremont, CA 91711 USA	Cornell University; Claremont Colleges; Pomona College	McEuen, PL (corresponding author), Cornell Univ, Cornell Ctr Mat Res, Ithaca, NY 14853 USA.	mceuen@ccmr.cornell.edu	van der Zande, Arend M/C-1989-2016; Bunch, Joseph S/B-7555-2008	van der Zande, Arend M/0000-0001-5104-9646; Tanenbaum, David/0000-0002-6070-8882				Bunch JS, 2005, NANO LETT, V5, P287, DOI 10.1021/nl048111+; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; Ekinci KL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1927327; Ekinci KL, 2004, APPL PHYS LETT, V84, P4469, DOI 10.1063/1.1755417; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Gupta A, 2006, NANO LETT, V6, P2667, DOI 10.1021/nl061420a; Ilic B, 2004, J APPL PHYS, V95, P3694, DOI 10.1063/1.1650542; Kelly B.T., 1981, PHYS GRAPHITE; Kenny T, 2001, IEEE SENS J, V1, P148, DOI 10.1109/JSEN.2001.936932; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; LaHaye MD, 2004, SCIENCE, V304, P74, DOI 10.1126/science.1094419; Lavrik NV, 2003, APPL PHYS LETT, V82, P2697, DOI 10.1063/1.1569050; Li XX, 2003, APPL PHYS LETT, V83, P3081, DOI 10.1063/1.1618369; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Qian D., 2002, APPL MECH REV, V55, P495, DOI [DOI 10.1115/1.1490129, 10.1115/1.1490129]; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; Sekaric L, 2002, APPL PHYS LETT, V81, P4455, DOI 10.1063/1.1526941; Timoshenko S, 1974, VIBRATION PROBLEMS E, P425; Verbridge SS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2204829; Wilson M, 2006, PHYS TODAY, V59, P21, DOI 10.1063/1.2387079; Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	26	2421	2508	28	873	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					490	493		10.1126/science.1136836	http://dx.doi.org/10.1126/science.1136836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255506				2022-12-28	WOS:000243726600039
J	Moerke, NJ; Aktas, H; Chen, H; Cantel, S; Reibarkh, MY; Fahmy, A; Gross, JD; Degterev, A; Yuan, JY; Chorev, M; Halperin, JA; Wagner, G				Moerke, Nathan J.; Aktas, Huseyin; Chen, Han; Cantel, Sonia; Reibarkh, Mikhail Y.; Fahmy, Amr; Gross, John D.; Degterev, Alexei; Yuan, Junying; Chorev, Michael; Halperin, Jose A.; Wagner, Gerhard			Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G	CELL			English	Article							CAP-DEPENDENT TRANSLATION; BINDING PROTEIN EIF4E; MESSENGER-RNA CAP; FACTOR EIF-4E; MALIGNANT-TRANSFORMATION; MTOR INHIBITORS; CANCER; PHOSPHORYLATION; STIMULATION; REGULATORS	Assembly of the eIF4E/eIF4G complex has a central role in the regulation of gene expression at the level of translation initiation. This complex is regulated by the 4E-BPs, which compete with eIF4G for binding to eIF4E and which have tumor-suppressor activity. To pharmacologically mimic 4E-BP function we developed a high-throughput screening assay for identifying small-molecule inhibitors of the eIF4E/eIF4G interaction. The most potent compound identified, 4EGI-1, binds eIF4E, disrupts eIF4E/eIF4G association, and inhibits cap-dependent translation but not initiation factor-independent translation. While 4EGI-1 displaces eIF4G from eIF4E, it effectively enhances 4E-BP1 association both in vitro and in cells. 4EGI-1 inhibits cellular expression of oncogenic proteins encoded by weak mRNAs, exhibits activity against multiple cancer cell lines, and appears to have a preferential effect on transformed versus nontransformed cells. The identification of this compound provides a new tool for studying translational control and establishes a possible new strategy for cancer therapy.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lab Translat Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu	cantel, sonia/C-7121-2012	Reibarkh, Mikhail/0000-0002-6589-707X	NCI NIH HHS [CA87427, CA68262, CA078411] Funding Source: Medline; NIBIB NIH HHS [EB002026] Funding Source: Medline; NIGMS NIH HHS [P01 GM047467, GM47467] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068262, R01CA078411, U19CA087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DeFatta RJ, 2000, LARYNGOSCOPE, V110, P928, DOI 10.1097/00005537-200006000-00007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; EDERY I, 1988, GENE, V74, P517, DOI 10.1016/0378-1119(88)90184-9; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fan YH, 2004, BIOORG MED CHEM LETT, V14, P2547, DOI 10.1016/j.bmcl.2004.02.087; FukuchiShimogori T, 1997, CANCER RES, V57, P5041; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Herbert TP, 2000, CURR BIOL, V10, P793, DOI 10.1016/S0960-9822(00)00567-4; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LODISH HF, 1976, ANNU REV BIOCHEM, V45, P39, DOI 10.1146/annurev.bi.45.070176.000351; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miura T, 2003, J BIOMOL NMR, V27, P279, DOI 10.1023/A:1025442322316; Novac O, 2004, NUCLEIC ACIDS RES, V32, P902, DOI 10.1093/nar/gkh235; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Polunovsky VA, 2000, J BIOL CHEM, V275, P24776, DOI 10.1074/jbc.M001938200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rousseau D, 1996, ONCOGENE, V13, P2415; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Svitkin YV, 2001, RNA, V7, P1743; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tomoo K, 2006, J BIOCHEM, V140, P237, DOI 10.1093/jb/mvj143; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	58	402	418	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					257	267		10.1016/j.cell.2006.11.046	http://dx.doi.org/10.1016/j.cell.2006.11.046			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254965	Bronze			2022-12-28	WOS:000244420500012
J	van Gijn, J; Kerr, RS; Rinkel, GJE				van Gijn, Jan; Kerr, Richard S.; Rinkel, Gabriel J. E.			Subarachnoid haemorrhage	LANCET			English	Review							COMPUTERIZED-TOMOGRAPHY ANGIOGRAPHY; RUPTURED INTRACRANIAL ANEURYSMS; AUSTRALASIAN COOPERATIVE RESEARCH; EXTERNAL VENTRICULAR DRAIN; GOOD NEUROLOGICAL RECOVERY; DELAYED CEREBRAL-ISCHEMIA; ACUTE HYDROCEPHALUS; PERIMESENCEPHALIC HEMORRHAGE; LUMBAR PUNCTURE; CASE-FATALITY	Subarachnoid haemorrhage accounts for only 5% of strokes, but occurs at a fairly young age. Sudden headache is the cardinal feature, but patients might not report the mode of onset. CT brain scanning is normal in most patients with sudden headache, but to exclude subarachnoid haemorrhage or other serious disorders, a carefully planned lumbar puncture is also needed. Aneurysms are the cause of subarachnoid haemorrhage in 85% of cases. The case fatality after aneurysmal haemorrhage is 50%; one in eight patients with subarachnoid haemorrhage dies outside hospital. Rebleeding is the most imminent danger; a first aim is therefore occlusion of the aneurysm. Endovascular obliteration by means of platinum spirals (coiling) is the preferred mode of treatment, but some patients require a direct neurosurgical approach (clipping). Another complication is delayed cerebral ischaemia; the risk is reduced with oral nimodipine and probably by maintaining circulatory volume. Hydrocephalus might cause gradual obtundation in the first few hours or days; it can be treated by lumbar puncture or ventricular drainage, dependent on the site of obstruction.	Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; Radcliffe Infirm, Dept Neurosurg, Oxford OX2 6HE, England	Utrecht University; Utrecht University Medical Center; Radcliffe Infirmary	van Gijn, J (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands.	J.vanGijn@umcutrecht.nl	van Gijn, Jan/A-9444-2008					Anderson C, 2000, STROKE, V31, P1843; Anderson C, 2003, STROKE, V34, P1771, DOI 10.1161/01.STR.0000077015.90334.A7; Beetham R, 2004, J NEUROL NEUROSUR PS, V75, P528, DOI 10.1136/jnnp.2003.023176; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; Brilstra EH, 2000, NEUROLOGY, V55, P1656, DOI 10.1212/WNL.55.11.1656; Brilstra EH, 1997, J NEUROL NEUROSUR PS, V63, P382, DOI 10.1136/jnnp.63.3.382; Brilstra EH, 2002, J NEUROSURG, V97, P1036, DOI 10.3171/jns.2002.97.5.1036; BROMBERG JEC, 1995, BRIT MED J, V311, P288, DOI 10.1136/bmj.311.7000.288; BROUWERS PJAM, 1992, STROKE, V23, P374, DOI 10.1161/01.STR.23.3.374; Buczacki SJ, 2004, J NEUROL NEUROSUR PS, V75, P1620, DOI 10.1136/jnnp.2003.026856; BURUMA OJS, 1981, J NEUROL NEUROSUR PS, V44, P144, DOI 10.1136/jnnp.44.2.144; Butzkueven H, 2000, NEUROLOGY, V55, P1315, DOI 10.1212/WNL.55.9.1315; Byrne JV, 2003, NEUROSURGERY, V52, P545, DOI 10.1227/01.NEU.0000047672.25068.4A; Caeiro L, 2005, CEREBROVASC DIS, V19, P31, DOI 10.1159/000081909; Chang HS, 2000, J NEUROSURG, V92, P971, DOI 10.3171/jns.2000.92.6.0971; Chappell ET, 2003, NEUROSURGERY, V52, P624, DOI 10.1227/01.NEU.0000047895.82857.EB; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Cloft HJ, 1999, STROKE, V30, P317, DOI 10.1161/01.STR.30.2.317; de Gans K, 2002, NEUROSURGERY, V50, P336, DOI 10.1097/00006123-200202000-00018; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; Fann JR, 2000, J NEUROL NEUROSUR PS, V69, P768, DOI 10.1136/jnnp.69.6.768; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Fountas KN, 2006, NEUROSURG REV, V29, P14, DOI 10.1007/s10143-005-0423-4; Gieteling EW, 2003, J NEUROL, V250, P418, DOI 10.1007/s00415-003-0997-0; Given CA, 2003, AM J NEURORADIOL, V24, P254; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; HASAN D, 1991, STROKE, V22, P190, DOI 10.1161/01.STR.22.2.190; HASAN D, 1989, STROKE, V20, P747, DOI 10.1161/01.STR.20.6.747; Hellingman CA, 2007, STROKE, V38, P96, DOI 10.1161/01.STR.0000251841.51332.1d; HIJDRA A, 1986, NEUROLOGY, V36, P329, DOI 10.1212/WNL.36.3.329; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Hop JW, 1999, STROKE, V30, P2268, DOI 10.1161/01.STR.30.11.2268; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Inamasu J, 2002, RESUSCITATION, V52, P71, DOI 10.1016/S0300-9572(01)00433-6; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Khechinashvili G, 2002, CEREBROVASC DIS, V14, P67, DOI 10.1159/000064733; KOENIG GH, 1979, NEUROSURGERY, V5, P314, DOI 10.1227/00006123-197909000-00003; Korinek AM, 2005, ACTA NEUROCHIR, V147, P39, DOI 10.1007/s00701-004-0416-z; Linn FHH, 2005, J NEUROL NEUROSUR PS, V76, P1452, DOI 10.1136/jnnp.2004.051318; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; MANSCHOT WA, 1954, AM J OPHTHALMOL, V38, P501, DOI 10.1016/0002-9394(54)90700-X; MATSUDA M, 1993, CEREBROVASC DIS, V3, P285, DOI 10.1159/000108717; Mayer SA, 2002, NEUROLOGY, V59, P1750, DOI 10.1212/01.WNL.0000035748.91128.C2; McCarron MO, 2004, J NEUROL NEUROSUR PS, V75, P491, DOI 10.1136/jnnp.2003.016816; Mees SMD, 2003, STROKE, V34, P2285, DOI 10.1161/01.STR.0000083621.44269.3E; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Naff NJ, 2000, STROKE, V31, P841, DOI 10.1161/01.STR.31.4.841; Niemann DB, 2003, J NEUROSURG, V99, P843, DOI 10.3171/jns.2003.99.5.0843; Nieuwkamp DJ, 2000, J NEUROL, V247, P117, DOI 10.1007/PL00007792; O'Neill J, 2005, SCOT MED J, V50, P151, DOI 10.1177/003693300505000405; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; OHMAN J, 1989, J NEUROSURG, V70, P55, DOI 10.3171/jns.1989.70.1.0055; Ohno S, 2004, NEUROL SURG TOKYO, V32, P875; Olafsson E, 2000, EPILEPSIA, V41, P1201, DOI 10.1111/j.1528-1157.2000.tb00326.x; Phan TG, 2003, CEREBROVASC DIS, V15, P177, DOI 10.1159/000068823; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Pinto AN, 1996, J NEUROL, V243, P161, DOI 10.1007/BF02444009; PINTO AN, 1993, ACTA NEUROCHIR, V124, P79, DOI 10.1007/BF01401126; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Qureshi AI, 2000, CRIT CARE MED, V28, P824, DOI 10.1097/00003246-200003000-00035; Raaymakers TWM, 1999, NEUROLOGY, V53, P982, DOI 10.1212/WNL.53.5.982; Raaymakers TWM, 1999, NEW ENGL J MED, V341, P1344; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Rabinstein AA, 2004, AM J NEURORADIOL, V25, P1778; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Reijneveld JC, 2000, J NEUROL, V247, P112, DOI 10.1007/PL00007791; RINKEL GJ, 2005, COCHRANE DB SYST REV, V1; RINKEL GJ, 2004, COCHRANE DB SYST REV, V4; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; RINKEL GJE, 1990, NEUROLOGY, V40, P1130, DOI 10.1212/WNL.40.7.1130; RINKEL GJE, 1991, AM J NEURORADIOL, V12, P829; RINKEL GJE, 1992, NEUROLOGY, V42, P1805, DOI 10.1212/WNL.42.9.1805; RONKAINEN A, 1993, NEUROSURGERY, V33, P787; Roos Y, 2000, NEUROLOGY, V54, P77, DOI 10.1212/WNL.54.1.77; ROOS YBWEM, 1995, J NEUROL NEUROSUR PS, V58, P622, DOI 10.1136/jnnp.58.5.622; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Ruigrok YM, 2005, LANCET NEUROL, V4, P179, DOI 10.1016/S1474-4422(05)01015-X; Ruigrok YM, 2004, NEUROLOGY, V62, P891, DOI 10.1212/01.WNL.0000115104.19787.8E; Ruigrok YM, 2001, STROKE, V32, P1173, DOI 10.1161/01.STR.32.5.1173; Ruigrok YM, 2000, STROKE, V31, P2976, DOI 10.1161/01.STR.31.12.2976; Ruijs ACJ, 2005, ACTA NEUROCHIR, V147, P1157, DOI 10.1007/s00701-005-0584-5; SAITOH H, 1995, AM J NEURORADIOL, V16, P539; Sasaki T, 2004, SURG NEUROL, V62, P531, DOI 10.1016/j.surneu.2004.01.015; Schievink WI, 1997, STROKE, V28, P2572; SCHIEVINK WI, 1991, NEUROSURGERY, V29, P434, DOI 10.1227/00006123-199109000-00017; Schuiling WJ, 2005, NEUROSURGERY, V57, P230, DOI 10.1227/01.NEU.0000166536.42876.9C; Schwartz TH, 2003, CLIN NEUROL NEUROSUR, V105, P95, DOI 10.1016/S0303-8467(02)00112-9; Schwartz TH, 1996, NEUROSURGERY, V39, P433, DOI 10.1097/00006123-199609000-00001; Slob MJ, 2004, AM J NEURORADIOL, V25, P1373; Sluzewski M, 2005, AM J NEURORADIOL, V26, P2542; Sluzewski M, 2005, AM J NEURORADIOL, V26, P1739; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Smith WS, 2004, STROKE, V35, P2518, DOI 10.1161/01.STR.0000144682.00822.83; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Stiebel-Kalish H, 2004, RETINA-J RET VIT DIS, V24, P36, DOI 10.1097/00006982-200402000-00006; Teasdale GM, 2005, BRAIN, V128, P1677, DOI 10.1093/brain/awh497; Toussaint LG, 2005, NEUROSURGERY, V57, P25, DOI 10.1227/01.NEU.0000163086.23124.70; Tsutsumi K, 1998, STROKE, V29, P2511, DOI 10.1161/01.STR.29.12.2511; van den Bergh WM, 2006, STROKE, V37, P2326, DOI 10.1161/01.STR.0000236841.16055.0f; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; van der Schaaf I, 2006, STROKE, V37, P409, DOI 10.1161/01.STR.0000198831.69035.43; Van der Schaaf I, 2005, COCHRANE DB SYST REV, V4; van der Schaaf IC, 2004, STROKE, V35, P1614, DOI 10.1161/01.STR.0000131657.08655.ce; van der Schaaf IC, 2002, STROKE, V33, P2043, DOI 10.1161/01.STR.0000024110.82735.5A; VANCALENBERGH F, 1993, SURG NEUROL, V39, P320, DOI 10.1016/0090-3019(93)90014-R; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; VANGIJN J, 2005, PRACT NEUROL, V5, P362; Velthuis BK, 1999, J NEUROSURG, V91, P761, DOI 10.3171/jns.1999.91.5.0761; VERMEULEN M, 1990, J NEUROL NEUROSUR PS, V53, P365, DOI 10.1136/jnnp.53.5.365; Veyna RS, 2002, J NEUROSURG, V96, P510, DOI 10.3171/jns.2002.96.3.0510; Villablanca JP, 2002, J NEUROSURG, V97, P1322, DOI 10.3171/jns.2002.97.6.1322; Villablanca JP, 2000, J NEUROSURG, V93, P254, DOI 10.3171/jns.2000.93.2.0254; Wartenberg KE, 2006, CURR OPIN CRIT CARE, V12, P78, DOI 10.1097/01.ccx.0000216571.80944.65; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Wermer MJH, 2005, STROKE, V36, P2394, DOI 10.1161/01.STR.0000185686.28035.d2; Wermer MJH, 2005, STROKE, V36, P836, DOI 10.1161/01.STR.0000158906.79898.3a; Wermer MJH, 2005, NEUROSURGERY, V56, P197, DOI 10.1227/01.neu.0000148894.32031.39; Wermer MJH, 2003, STROKE, V34, P2788, DOI 10.1161/01.STR.0000099963.27578.75; White PM, 2001, J NEUROL NEUROSUR PS, V71, P322, DOI 10.1136/jnnp.71.3.322; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; WIJDICKS EFM, 1985, ANN NEUROL, V18, P211, DOI 10.1002/ana.410180208; Wintermark M, 2003, J NEUROSURG, V98, P828, DOI 10.3171/jns.2003.98.4.0828; Wong GKC, 2002, J NEUROL NEUROSUR PS, V73, P759, DOI 10.1136/jnnp.73.6.759; Zentner J, 1996, NEUROL RES, V18, P220; Zhang YJ, 2003, NEUROSURGERY, V52, P283, DOI 10.1227/01.NEU.0000043643.93767.86	138	1099	1116	7	128	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					306	318		10.1016/S0140-6736(07)60153-6	http://dx.doi.org/10.1016/S0140-6736(07)60153-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258671				2022-12-28	WOS:000243912000035
J	Nabi, G; Cook, J; N'Dow, J; McClinton, S				Nabi, Ghulam; Cook, J.; N'Dow, J.; McClinton, S.			Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis	BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; DISTAL URETERAL CALCULI; LITHOTRIPSY; MANAGEMENT; SYMPTOMS; STONES; LASER	Objective To investigate the potential beneficial and adverse effects of routine ureteric stent placement after ureteroscopy. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Cochrane controlled trials register (2006 issue 2), Embase, and Medline (1966 to 31 March 2006), without language restrictions. Review methods We included all randomised controlled trials that reported various outcomes with or without stenting after ureteroscopy. Two reviewers independently extracted data and assessed quality. Meta-analyses used both fixed and random effects models with dichotomous data reported as relative risk and continuous data as a weighted mean difference with 95% confidence intervals. Results Nine randomised controlled trials (reporting 831 participants) were identified. The incidence of lower urinary tract symptoms was significantly higher in participants who had a stent inserted (relative risk 2.25, 95% confidence interval 1.14 to 4.43, for dysuria; 2.00, 1.11 to 3.62, for frequency or urgency) after ureteroscopy. There was no significant difference in postoperative requirement for analgesia, urinary tract infections, stone free rate, and ureteric strictures in the two groups. Because of marked heterogeneity, formal pooling of data was not possible for some outcomes such as flank pain. A pooled analysis showed a reduced likelihood of unplanned medical visits or admission to hospital in the group with stents (0.53, 0.17 to 1.60), although this difference was not significant. None of the trials reported on health related quality of life. Cost reported in three randomised controlled trials favoured the group without stents. The overall quality of trials was poor and reporting of outcomes inconsistent. Conclusions Patients with stents after ureteroscopy have significantly higher morbidity in the form of irritative lower urinary symptoms with no influence on stone free rate, rate of urinary tract infection, requirement for analgesia, or tong term ureteric stricture formation. Because of the marked heterogeneity and poor quality of reporting of the included trials, the place of stenting in the management of patients after uncomplicated ureteroscopy remains unclear.	Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Nabi, G (corresponding author), Univ Aberdeen, Coll Life Sci & Med, Inst Appl Hlth Sci, Acad Urol Unit, Aberdeen AB25 2ZD, Scotland.	g.nabi@abdn.ac.uk	Cook, Jonathan/D-3648-2015; Cook, Jonathan/A-3474-2012	Cook, Jonathan/0000-0002-4156-6989; Nabi, Ghulam/0000-0002-4864-9445	Chief Scientist Office [HSRU1] Funding Source: Medline	Chief Scientist Office		Ali W, 2004, BAHRAIN MED B, V26, P3; BODDY SAM, 1988, BRIT J UROL, V61, P27, DOI 10.1111/j.1464-410X.1988.tb09156.x; Borboroglu PG, 2001, J UROLOGY, V166, P1651, DOI 10.1016/S0022-5347(05)65646-7; Byrne RR, 2002, J ENDOUROL, V16, P9, DOI 10.1089/089277902753483646; Chen YT, 2002, J UROLOGY, V167, P1977, DOI 10.1016/S0022-5347(05)65066-5; Cheung MC, 2003, J UROLOGY, V169, P1257, DOI 10.1097/01.ju.0000053763.30693.ef; Damiano R, 2004, EUR UROL, V46, P381, DOI 10.1016/j.eururo.2004.04.004; Denstedt JD, 2001, J UROLOGY, V165, P1419, DOI 10.1016/S0022-5347(05)66320-3; Duvdevani M, 2006, CURR OPIN UROL, V16, P77, DOI 10.1097/01.mou.0000193375.29942.0f; Gettman MT, 2005, BJU INT, V95, P85, DOI 10.1111/j.1464-410X.2005.05206.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jeong H, 2004, BJU INT, V93, P1032, DOI 10.1111/j.1464-410X.2004.4776a.x; Joshi HB, 2005, J UROLOGY, V174, P2303, DOI 10.1097/01.ju.0000181815.63998.5f; Joshi HB, 2003, J UROLOGY, V169, P1060, DOI 10.1097/01.ju.0000049198.53424.1d; Netto NR, 2001, J UROLOGY, V166, P1252, DOI 10.1016/S0022-5347(05)65747-3; OUVDEVANI M, 2006, CURR OPIN UROL, V16, P77; RYAN PC, 1994, BRIT J UROL, V74, P434, DOI 10.1111/j.1464-410X.1994.tb00418.x; Singh I, 2001, UROLOGY, V58, P526, DOI 10.1016/S0090-4295(01)01317-6; Srivastava A, 2003, J ENDOUROL, V17, P871, DOI 10.1089/089277903772036172; Teichman JMH, 1998, J UROLOGY, V159, P17, DOI 10.1016/S0022-5347(01)63998-3; Willis NS, 2003, COCHRANE LIB	21	119	131	1	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2007	334	7593					572	575		10.1136/bmj.39119.595081.55	http://dx.doi.org/10.1136/bmj.39119.595081.55			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AP	17311851	Bronze, Green Published			2022-12-28	WOS:000245404400035
J	Lee, MG; Norman, J; Shilatifard, A; Shiekhattar, R				Lee, Min Gyu; Norman, Jessica; Shilatifard, Ali; Shiekhattar, Ramin			Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein	CELL			English	Article							HISTONE LYSINE METHYLATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; ARGININE METHYLATION; PHD FINGER; COMPLEX; METHYLTRANSFERASE; DOMAIN; DEACETYLASE	Histone methylation is a posttranslational modification regulating chromatin structure and gene regulation. BHC110/LSD1 was the first histone demethylase described to reverse dimethyl histone H3 lysine 4 (H3K4). Here we show that JARID1 d, a JmjC-domain-containing protein, specifically demethylates trimethyl H3K4. Detailed mapping analysis revealed that besides the JmjC domain, the BRIGHT and zinc-finger-like C5HC2 domains are required for maximum catalytic activity. Importantly, iso-lation of native JARID1 d complexes from human cells revealed the association of the demethylase with a polycomb-like protein Ring6a/MBLR. Ring6a/MBLR not only directly interacts with JARID1d but also regulates its enzymatic activity. We show that JARID1d and Ring6a occupy human Engrailed 2 gene and regulate its expression and H3K4 methylation levels. Depletion of JARID1d enhanced recruitment of the chromatin remodeling complex, NURF, and the basal transcription machinery near the transcriptional start site, revealing a role for JARID1d in regulation of transcriptional initiation through H3K4 demethylation.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA	The Wistar Institute; Saint Louis University	Shiekhattar, R (corresponding author), Ctr Regulacio Genom, Dr Aiguader,88, Barcelona 08003, Spain.	ramin.shiekhattar@crg.es			NATIONAL CANCER INSTITUTE [R01CA090758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 090758] Funding Source: Medline; NIGMS NIH HHS [R01 GM069905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dong YS, 2003, MOL CELL, V12, P1087, DOI 10.1016/S1097-2765(03)00424-6; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Gregory Richard I., 2006, V342, P33, DOI 10.1385/1-59745-123-1:33; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, METHODS, V40, P327, DOI 10.1016/j.ymeth.2006.07.030; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	54	187	193	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					877	887		10.1016/j.cell.2007.02.004	http://dx.doi.org/10.1016/j.cell.2007.02.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320162	Bronze			2022-12-28	WOS:000245073400013
J	Lagerqvist, B; James, SK; Stenestrand, U; Lindback, J; Nilsson, T; Wallentin, L				Lagerqvist, Bo; James, Stefan K.; Stenestrand, Ulf; Lindback, Johan; Nilsson, Tage; Wallentin, Lars		SCAAR Study Grp	Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOLOGY-HOSPITAL RESEARCH; CORONARY-ARTERY-DISEASE; RANDOMIZED CLINICAL-TRIALS; RESEARCH REGISTRY; UNRESTRICTED USE; FOLLOW-UP; IMPLANTATION; THROMBOSIS; METAANALYSIS; PREDICTORS	BACKGROUND: Recent reports have indicated that there may be an increased risk of late stent thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. METHODS: We evaluated 6033 patients treated with drug-eluting stents and 13,738 patients treated with bare-metal stents in 2003 and 2004, using data from the Swedish Coronary Angiography and Angioplasty Registry. The outcome analysis covering a period of up to 3 years was based on 1424 deaths and 2463 myocardial infarctions and was adjusted for differences in baseline characteristics. RESULTS: The two study groups did not differ significantly in the composite of death and myocardial infarction during 3 years of follow-up. At 6 months, there was a trend toward a lower unadjusted event rate in patients with drug-eluting stents than in those with bare-metal stents, with 13.4 fewer such events per 1000 patients. However, after 6 months, patients with drug-eluting stents had a significantly higher event rate, with 12.7 more events per 1000 patients per year (adjusted relative risk, 1.20; 95% confidence interval [CI], 1.05 to 1.37). At 3 years, mortality was significantly higher in patients with drug-eluting stents (adjusted relative risk, 1.18; 95% CI, 1.04 to 1.35), and from 6 months to 3 years, the adjusted relative risk for death in this group was 1.32 (95% CI, 1.11 to 1.57). CONCLUSIONS: Drug-eluting stents were associated with an increased rate of death, as compared with bare-metal stents. This trend appeared after 6 months, when the risk of death was 0.5 percentage point higher and a composite of death or myocardial infarction was 0.5 to 1.0 percentage point higher per year. The long-term safety of drug-eluting stents needs to be ascertained in large, randomized trials.	Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; Linkoping Univ Hosp, S-58185 Linkoping, Sweden	Uppsala University; Uppsala University Hospital; Linkoping University	Lagerqvist, B (corresponding author), Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden.	bo.lagerqvist@ucr.uu.se	Lindbäck, Johan/R-2900-2017; James, Stefan K/J-4554-2014	Lindbäck, Johan/0000-0002-6473-8798; 				ANDERSON JR, 1983, J CLIN ONCOL, V1, P710, DOI 10.1200/JCO.1983.1.11.710; Aoki J, 2005, CIRCULATION, V112, P3876, DOI 10.1161/CIRCULATIONAHA.105.558601; Bavry AA, 2005, J AM COLL CARDIOL, V45, P941, DOI 10.1016/j.jacc.2004.11.064; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; DAEMEN J, IN PRESS LANCET; Daemen J, 2006, AM J CARDIOL, V98, P895, DOI 10.1016/j.amjcard.2006.04.031; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Flynn MR, 2005, EUR HEART J, V26, P308, DOI 10.1093/eurheartj/ehi079; Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kotani J, 2006, J AM COLL CARDIOL, V47, P2108, DOI 10.1016/j.jacc.2005.11.092; Lemos PA, 2004, CIRCULATION, V109, P1366, DOI 10.1161/01.CIR.0000121358.26097.06; Lemos PA, 2004, AM J CARDIOL, V93, P633, DOI 10.1016/j.amjcard.2003.11.037; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ong ATL, 2006, J AM COLL CARDIOL, V47, P1356, DOI 10.1016/j.jacc.2005.05.102; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; R Development Core Team, 2006, R LANG ENV STAT COMP; Rao SV, 2006, AM J CARDIOL, V97, P1478, DOI 10.1016/j.amjcard.2005.11.081; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4	26	974	1035	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1009	1019		10.1056/NEJMoa067722	http://dx.doi.org/10.1056/NEJMoa067722			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296822				2022-12-28	WOS:000244699200005
J	Loque, D; Lalonde, S; Looger, LL; von Wiren, N; Frommer, WB				Loque, D.; Lalonde, S.; Looger, L. L.; von Wiren, N.; Frommer, W. B.			A cytosolic trans-activation domain essential for ammonium uptake	NATURE			English	Article							TRANSPORTER AMTB; PLASMA-MEMBRANE; AUTOINHIBITORY DOMAIN; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; NH4+; IDENTIFICATION; PROTEIN; EXPRESSION; MECHANISM	Polytopic membrane proteins are essential for cellular uptake and release of nutrients. To prevent toxic accumulation, rapid shut-off mechanisms are required. Here we show that the soluble cytosolic carboxy terminus of an oligomeric ammonium transporter from Arabidopsis thaliana serves as an allosteric regulator essential for function; mutations in the C-terminal domain, conserved between bacteria, fungi and plants, led to loss of transport activity. When co-expressed with intact transporters, mutants inactivated functional subunits, but left their stability unaffected. Co-expression of two inactive transporters, one with a defective pore, the other with an ablated C terminus, reconstituted activity. The crystal structure of an Archaeoglobus fulgidus ammonium transporter (AMT)(1) suggests that the C terminus interacts physically with cytosolic loops of the neighbouring subunit. Phosphorylation of conserved sites in the C terminus(2) are proposed as the cognate control mechanism. Conformational coupling between monomers provides a mechanism for tight regulation, for increasing the dynamic range of sensing and memorizing prior events, and may be a general mechanism for transporter regulation.	Carnegie Inst Washington, Stanford, CA 94305 USA; Univ Hohenheim, Inst Plant Nutr, D-70593 Stuttgart, Germany	Carnegie Institution for Science; University Hohenheim	Frommer, WB (corresponding author), Carnegie Inst Washington, 290 Panama St, Stanford, CA 94305 USA.	wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Loque, Dominique/A-8153-2008; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; von Wiren, Nicolaus/0000-0002-4966-425X				Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Conroy MJ, 2004, EMBO REP, V5, P1153, DOI 10.1038/sj.embor.7400296; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; GRASBERGER B, 1986, P NATL ACAD SCI USA, V83, P6258, DOI 10.1073/pnas.83.17.6258; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Reinders A, 2002, STRUCTURE, V10, P763, DOI 10.1016/S0969-2126(02)00773-6; SCHULMAN H, 1992, CELL CALCIUM, V13, P401, DOI 10.1016/0143-4160(92)90053-U; Schulze Waltraud X, 2003, BMC Biochem, V4, P3, DOI 10.1186/1471-2091-4-3; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; ZEN KH, 1994, BIOCHEMISTRY-US, V33, P8198, DOI 10.1021/bi00193a005	30	205	219	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 8	2007	446	7132					195	198		10.1038/nature05579	http://dx.doi.org/10.1038/nature05579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17293878				2022-12-28	WOS:000244718100042
J	Schwickert, TA; Lindquist, RL; Shakhar, G; Livshits, G; Skokos, D; Kosco-Vilbois, MH; Dustin, ML; Nussenzweig, MC				Schwickert, Tanja A.; Lindquist, Randall L.; Shakhar, Guy; Livshits, Geulah; Skokos, Dimitris; Kosco-Vilbois, Marie H.; Dustin, Michael L.; Nussenzweig, Michel C.			In vivo imaging of germinal centres reveals a dynamic open structure	NATURE			English	Article							PRIMARY IMMUNE-RESPONSE; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; ANTIGEN; SELECTION; (4-HYDROXY-3-NITROPHENYL)ACETYL; ACTIVATION; MICROSCOPY; MECHANISM	Germinal centres are specialized structures wherein B lymphocytes undergo clonal expansion, class switch recombination, antibody gene diversification and affinity maturation. Three to four antigen-specific B cells colonize a follicle to establish a germinal centre and become rapidly dividing germinal-centre centroblasts that give rise to dark zones(1-4). Centroblasts produce non-proliferating centrocytes that are thought to migrate to the light zone of the germinal centre, which is rich in antigen-trapping follicular dendritic cells and CD4(+) T cells(5-7). It has been proposed that centrocytes are selected in the light zone on the basis of their ability to bind cognate antigen(5-8). However, there have been no studies of germinal-centre dynamics or the migratory behaviour of germinal-centre cells in vivo. Here we report the direct visualization of B cells in lymph node germinal centres by two-photon laser-scanning microscopy in mice. Nearly all antigen-specific B cells participating in a germinal-centre reaction were motile and physically restricted to the germinal centre but migrated bidirectionally between dark and light zones. Notably, follicular B cells were frequent visitors to the germinal-centre compartment, suggesting that all B cells scan antigen trapped in germinal centres. Consistent with this observation, we found that high-affinity antigen-specific B cells can be recruited to an ongoing germinal-centre reaction. We conclude that the open structure of germinal centres enhances competition and ensures that rare high-affinity B cells can participate in antibody responses.	NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, Dept Pathol, New York, NY 10016 USA; Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NovImmune SA, CH-1211 Geneva 4, Switzerland	New York University; New York University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; NovImmune SA	Dustin, ML (corresponding author), NYU, Sch Med, Program Mol Pathogenesis, New York, NY 10016 USA.	mikeroscope@nyc.rr.com; nussen@rockefeller.edu	Dustin, Michael/AAM-4611-2020; Nussenzweig, Michel/AAE-7292-2019	Dustin, Michael/0000-0003-4983-6389; Schwickert, Tanja/0000-0002-3371-2376				Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; FOSSUM S, 1983, SCAND J IMMUNOL, V17, P551; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; HANNA MG, 1964, LAB INVEST, V13, P95; JACOB J, 1993, J EXP MED, V178, P1293, DOI 10.1084/jem.178.4.1293; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1992, J EXP MED, V176, P679, DOI 10.1084/jem.176.3.679; KOSCO MH, 1992, J IMMUNOL, V148, P2331; KROESE FGM, 1987, EUR J IMMUNOL, V17, P1069, DOI 10.1002/eji.1830170726; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; NOSSAL GJV, 1965, IMMUNOLOGY, V9, P349; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Oprea M, 1997, J IMMUNOL, V158, P5155; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; SZAKAL AK, 1988, J IMMUNOL, V140, P341	30	349	351	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					83	87		10.1038/nature05573	http://dx.doi.org/10.1038/nature05573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17268470				2022-12-28	WOS:000244525600042
J	Bech, BH; Obel, C; Henriksen, TB; Olsen, J				Bech, Bodil Hammer; Obel, Carsten; Henriksen, Tine Brink; Olsen, Jorn			Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COFFEE CONSUMPTION; FETAL-GROWTH; PREGNANCY; ASSOCIATION; METABOLITES; TRIMESTER; COHORT; BLOOD; RISK	Objective To estimate the effect of reducing caffeine intake during pregnancy on birth weight and length of gestation. Design Randomised double blind controlled trial. Setting Denmark. Participants 1207 pregnant women drinking at least three cups of coffee a day, recruited before 20 weeks' gestation. Interventions Caffeinated instant coffee (568 women) or decaffeinated instant coffee (629 women). Main outcome measures Birth weight and length of gestation. Results Data on birth weight were obtained for 1150 liveborn singletons and on length of gestation for 1153 liveborn singletons. No significant differences were found for mean birth weight or mean length of gestation between women in the decaffeinated coffee group (whose mean caffeine intake was 182 mg lower than that of the other group) and women in the caffeinated coffee group. After adjustment for length of gestation, parity, prepregnancy body mass index, and smoking at entry to the study the mean birth weight of babies born to women in the decaffeinated group was 16 g (95% confidence interval -40 to 73) higher than those born to women in the caffeinated group. The adjusted difference (decaffeinated group-caffeinated group) of length of gestation was -1.31 days (-2.87 to 0.25). Conclusion A moderate reduction in caffeine intake in the second half of pregnancy has no effect on birth weight or length of gestation.	Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, DK-8000 Aarhus, Denmark; Aarhus Univ Hosp, Perinatal Epidemiol Res Unit, Skejby, Denmark; Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA	Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Bech, BH (corresponding author), Aarhus Univ, Inst Publ Hlth, Dept Epidemiol, DK-8000 Aarhus, Denmark.	bhb@soci.au.dk	Bech, Bodil Hammer/B-9646-2016; Olsen, Jørn/F-8801-2015; Obel, Carsten/H-9605-2016	Bech, Bodil Hammer/0000-0002-0287-3687; Olsen, Jørn/0000-0001-7462-5140; Obel, Carsten/0000-0001-5004-1933				ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447; ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; BEAULACBAILLARGEON L, 1987, AM J OBSTET GYNECOL, V157, P1236, DOI 10.1016/S0002-9378(87)80301-0; Bech BH, 2005, AM J EPIDEMIOL, V162, P983, DOI 10.1093/aje/kwi317; Bracken MB, 2003, AM J EPIDEMIOL, V157, P456, DOI 10.1093/aje/kwf220; Clausson B, 2002, AM J EPIDEMIOL, V155, P429, DOI 10.1093/aje/155.5.429; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; Eskenazi B, 1999, EPIDEMIOLOGY, V10, P242, DOI 10.1097/00001648-199905000-00009; FENSTER L, 1991, AM J PUBLIC HEALTH, V81, P458, DOI 10.2105/AJPH.81.4.458; Fenster L, 1997, EPIDEMIOLOGY, V8, P515, DOI 10.1097/00001648-199709000-00008; FORTIER I, 1993, AM J EPIDEMIOL, V137, P931, DOI 10.1093/oxfordjournals.aje.a116763; Grosso LM, 2006, AM J EPIDEMIOL, V163, P1035, DOI 10.1093/aje/kwj125; Grosso LM, 2001, EPIDEMIOLOGY, V12, P447, DOI 10.1097/00001648-200107000-00015; Juliano LM, 2004, PSYCHOPHARMACOLOGY, V176, P1, DOI 10.1007/s00213-004-2000-x; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Klebanoff MA, 2002, AM J EPIDEMIOL, V155, P32, DOI 10.1093/aje/155.1.32; Knight CA, 2004, FOOD CHEM TOXICOL, V42, P1923, DOI 10.1016/j.fct.2004.05.002; LINN S, 1982, NEW ENGL J MED, V306, P141, DOI 10.1056/NEJM198201213060304; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; MILLS JL, 1993, JAMA-J AM MED ASSOC, V269, P593, DOI 10.1001/jama.269.5.593; Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840; OLSEN J, 1991, EPIDEMIOLOGY, V2, P370, DOI 10.1097/00001648-199109000-00011; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; SHU XO, 1995, EPIDEMIOLOGY, V6, P115, DOI 10.1097/00001648-199503000-00005; Vik T, 2003, PAEDIATR PERINAT EP, V17, P324, DOI 10.1046/j.1365-3016.2003.00507.x; Vlajinac HD, 1997, AM J EPIDEMIOL, V145, P335, DOI 10.1093/oxfordjournals.aje.a009110; WEATHERSBEE PS, 1977, J REPROD MED, V19, P55	29	75	77	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2007	334	7590					409	412B		10.1136/bmj.39062.520648.BE	http://dx.doi.org/10.1136/bmj.39062.520648.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17259189	Bronze, Green Published			2022-12-28	WOS:000244654400033
J	Chandler, VL				Chandler, Vicki L.			Paramutation: From maize to mice	CELL			English	Article							PROCESSING CENTER; METHYLATION; HETEROCHROMATIN; MAINTENANCE; INHERITANCE; LOCUS; MOUSE		Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Chandler, VL (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.	chandler@ag.arizona.edu						Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Chan SWL, 2006, PLOS BIOL, V4, P1923, DOI 10.1371/journal.pbio.0040363; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Chandler VL, 2000, PLANT MOL BIOL, V43, P121, DOI 10.1023/A:1006499808317; COE EH, 1966, GENETICS, V53, P1035; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; McGinnis KM, 2006, GENETICS, V173, P1637, DOI 10.1534/genetics.106.058669; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339	19	190	204	3	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					641	645		10.1016/j.cell.2007.02.007	http://dx.doi.org/10.1016/j.cell.2007.02.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320501	Bronze			2022-12-28	WOS:000245098600006
J	Sladek, R; Rocheleau, G; Rung, J; Dina, C; Shen, L; Serre, D; Boutin, P; Vincent, D; Belisle, A; Hadjadj, S; Balkau, B; Heude, B; Charpentier, G; Hudson, TJ; Montpetit, A; Pshezhetsky, AV; Prentki, M; Posner, BI; Balding, DJ; Meyre, D; Polychronakos, C; Froguel, P				Sladek, Robert; Rocheleau, Ghislain; Rung, Johan; Dina, Christian; Shen, Lishuang; Serre, David; Boutin, Philippe; Vincent, Daniel; Belisle, Alexandre; Hadjadj, Samy; Balkau, Beverley; Heude, Barbara; Charpentier, Guillaume; Hudson, Thomas J.; Montpetit, Alexandre; Pshezhetsky, Alexey V.; Prentki, Marc; Posner, Barry I.; Balding, David J.; Meyre, David; Polychronakos, Constantin; Froguel, Philippe			A genome-wide association study identifies novel risk loci for type 2 diabetes	NATURE			English	Article							TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; NUCLEAR FACTOR-4-ALPHA GENE; ENZYME IDE GENE; POPULATION-STRUCTURE; INSULIN-SECRETION; LARGE-SCALE; SUSCEPTIBILITY; GLUCOSE; POLYMORPHISMS; VARIANTS	Type 2 diabetes mellitus results from the interaction of environmental factors with a combination of genetic variants, most of which were hitherto unknown. A systematic search for these variants was recently made possible by the development of high-density arrays that permit the genotyping of hundreds of thousands of polymorphisms. We tested 392,935 single-nucleotide polymorphisms in a French case - control cohort. Markers with the most significant difference in genotype frequencies between cases of type 2 diabetes and controls were fast-tracked for testing in a second cohort. This identified four loci containing variants that confer type 2 diabetes risk, in addition to confirming the known association with the TCF7L2 gene. These loci include a non-synonymous polymorphism in the zinc transporter SLC30A8, which is expressed exclusively in insulin-producing beta-cells, and two linkage disequilibrium blocks that contain genes potentially involved in beta-cell development or function (IDE - KIF11 - HHEX and EXT2 - ALX4). These associations explain a substantial portion of disease risk and constitute proof of principle for the genome-wide approach to the elucidation of complex genetic traits.	McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Med, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Dept Pediat, Fac Med, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; Univ Hosp, F-86021 Poitiers, France; INSERM, U780, IFR69, F-94807 Villejuif, France; Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, F-91100 Corbeil Essonnes, France; Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; Montreal Diabet Res Ctr, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Mol Nutr Unit, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; Univ Montreal, Ctr Hosp, Montreal, PQ H3C 3J7, Canada; Polypeptide Hormone Lab, Montreal, PQ H3A 2B2, Canada; Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ London Imperial Coll Sci & Technol, Sect Genom Med, London W12 0NN, England; Hammersmith Hosp, London W12 0HS, England	McGill University; McGill University; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Sud Francilien; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Imperial College London; Imperial College London; Imperial College London	Polychronakos, C (corresponding author), McGill Univ, Dept Human Genet, Fac Med, Montreal, PQ H3H 1P3, Canada.	Constantin.Polychronakos@McGill.ca	Balding, David/G-9898-2011; Heude, Barbara/G-3095-2016; FROGUEL, Philippe/O-6799-2017; Polychronakos, Constantin/B-8151-2008; Heude, Barbara/GLU-9626-2022; Dina, Christian R/D-3535-2015; Meyre, David/D-7315-2011; Sladek, Robert/R-2391-2019; Posner, Barry/B-6733-2008; Shen, Lishuang/B-3040-2013	Balding, David/0000-0002-1480-6115; Heude, Barbara/0000-0002-1565-1629; FROGUEL, Philippe/0000-0003-2972-0784; Heude, Barbara/0000-0002-1565-1629; Dina, Christian R/0000-0002-7722-7348; Meyre, David/0000-0003-4850-7444; Sladek, Robert/0000-0002-2730-1204; A, Pshezhetsky/0000-0002-6612-1062; Polychronakos, Constantin/0000-0002-7624-6635; Rung, Johan/0000-0001-5875-8429; Shen, Lishuang/0000-0002-0436-0199; Hudson, Thomas/0000-0002-1376-4849				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; Boras-Granic K, 2006, INT J DEV BIOL, V50, P601, DOI 10.1387/ijdb.062153kb; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cauchi S, 2006, DIABETES, V55, P3189, DOI 10.2337/db06-0692; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fingerlin TE, 2004, AM J HUM GENET, V74, P432, DOI 10.1086/381652; Florez JC, 2006, DIABETES, V55, P128, DOI 10.2337/diabetes.55.1.128; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Groves CJ, 2003, DIABETES, V52, P1300, DOI 10.2337/diabetes.52.5.1300; Hallaq H, 2004, DEVELOPMENT, V131, P5197, DOI 10.1242/dev.01393; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kohler K, 2006, ANN HUM GENET, V70, P98, DOI 10.1111/j.1529-8817.2005.00214.x; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Parton LE, 2006, AM J PHYSIOL-ENDOC M, V291, pE982, DOI 10.1152/ajpendo.00067.2006; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	50	2220	2346	0	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					881	885		10.1038/nature05616	http://dx.doi.org/10.1038/nature05616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17293876				2022-12-28	WOS:000244341200041
J	Woloshin, S; Schwartz, LM; Welch, HG				Woloshin, Steven; Schwartz, Lisa M.; Welch, H. Gilbert			The effectiveness of a primer to help people understand risk - Two randomized trials in distinct populations	ANNALS OF INTERNAL MEDICINE			English	Article								Background: People need basic data interpretation skills to understand health risks and to weigh the harms and benefits of actions meant to reduce those risks. Although many studies document problems with understanding risk information, few assess ways to teach interpretation skills. Objective: To see whether a general education primer improves patients' medical data interpretation skills. Design: Two randomized, controlled trials done in populations with high and low socioeconomic status (SES). Setting: The high SES trial included persons who attended a public lecture series at Dartmouth Medical School, Hanover, New Hampshire; and the low SES trial included veterans and their families from the waiting areas at the White River Junction Veterans Affairs Medical Center, White River Junction, Vermont. Participants: 334 adults in the high SES trial and 221 veterans and their families in the low SES trial were enrolled from October 2004 to August 2005. Completion rates for the primer and control groups in each trial were 95% versus 98% (high SES) and 85% versus 96% (low SES). Intervention: The intervention in the primer groups was an educational booklet specifically developed to teach people the skills needed to understand risk. The control groups received a general health booklet developed by the U.S. Department of Health and Human Services Agency for Health Care Research and Quality. Measurements: Score on a medical data interpretation test, a previously validated 100-point scale, in which 75 points or more is considered "passing." Secondary outcomes included 2 other 100-point validated scores (interest and confidence in interpreting medical statistics) and participants' ratings of the booklet's usefulness. Results: In the high SES trial, 74% of participants in the primer group received a "passing grade" on the medical data interpretation test versus 56% in the control group (P = 0.001). Mean scores were 81 and 75, respectively (P = 0.0006). In the low SES trial, 44% versus 26% "passed" (P = 0.010): Mean scores were 69 and 62 in the primer and control groups, respectively (P = 0.008). The primer also significantly increased interest in medical statistics by 6 points in the high SES trial (a 4-point increase vs. a 2-point decrease from baseline) (P = 0.004) and by 8 points in the low SES trial (a 6-point increase vs. a 2-point decrease from baseline) (P = 0.004) compared with the control booklet. The primer, however, did not improve participants' confidence in interpreting medical statistics beyond the control booklet (a 2-point vs. a 4-point increase in the high SES trial [P = 0.36] and a 2-point versus a 6-point increase in the low SES trial [P = 0.166]). The primer was rated highly: 91% of participants in the high SES trial found it "helpful" or "very helpful," as did 95% of participants in the low SES trial. Limitations: The primarily male low SES sample and the primarily female high SES sample limits generalizability. The authors did not assess whether better data interpretation skills improved decisionmaking. Conclusion: The primer improved medical data interpretation skills in people with high and low SES.	Dept Vet Affairs Med Ctr, VA Outcomes Grp 11Bg, White River Jct, VT 05009 USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA	VA Outcomes Group; Dartmouth College	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 11Bg, White River Jct, VT 05009 USA.	Lisa.schwartz@dartmouth.edu			NCI NIH HHS [R01CA104721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA104721] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG HEALTHC RES QU, 2006, POCK GUID GOOD HLTH; Edwards A, 2001, QUAL HEALTH CARE, V10, pI9; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488; KIRSCH IS, 1993, ADULT LIT AM 1 LOOK; KULIK JA, 1984, AM EDUC RES J, V21, P435, DOI 10.3102/00028312021002435; *MICR CORP, 1983, ICR WORD X FLESCH KI; Schwartz LM, 2005, MED DECIS MAKING, V25, P290, DOI 10.1177/0272989X05276860; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Thalheimer W, 2006, CALCULATE EFFECT SIZ; Valentine J., 2006, EFFECT SIZE SUBSTANT; Woloshin S, 2005, J GEN INTERN MED, V20, P996, DOI 10.1007/s11606-005-0245-7; 2006, DARTMOUTH COMMUNITY	13	37	37	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					256	265		10.7326/0003-4819-146-4-200702200-00004	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310049				2022-12-28	WOS:000244271000003
J	Coombes, R				Coombes, Rebecca			Hunting down the H5N1 virus	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					342	+		10.1136/bmj.39126.577488.59	http://dx.doi.org/10.1136/bmj.39126.577488.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303878	Green Published			2022-12-28	WOS:000244560400027
J	Gauderman, WJ; Vora, H; McConnell, R; Berhane, K; Gilliland, F; Thomas, D; Lurmann, F; Avol, E; Kunzli, N; Jerrett, M; Peters, J				Gauderman, W. James; Vora, Hita; McConnell, Rob; Berhane, Kiros; Gilliland, Frank; Thomas, Duncan; Lurmann, Fred; Avol, Edward; Kunzli, Nino; Jerrett, Michael; Peters, John			Effect of exposure to traffic on lung development from 10 to 18 years of age: a cohort study	LANCET			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; AMBIENT NITROGEN-DIOXIDE; OUTDOOR AIR-POLLUTION; PULMONARY-FUNCTION; RESPIRATORY HEALTH; FUNCTION GROWTH; CHILDHOOD ASTHMA; MAJOR HIGHWAY; PREADOLESCENT CHILDREN; ULTRAFINE PARTICLES	Background Whether local exposure to major roadways adversely affects lung-function growth during the period of rapid lung development that takes place between 10 and 18 years of age is unknown. This study investigated the association between residential exposure to traffic and 8-year lung-function growth. Methods In this prospective study, 3677 children (mean age 10 years [SD 0.44]) participated from 12 southern California communities that represent a wide range in regional air quality. Children were followed up for 8 years, with yearly lung-function measurements recorded. For each child, we identified several indicators of residential exposure to traffic from large roads. Regression analysis was used to establish whether 8-year growth in lung function was associated with local traffic exposure, and whether local traffic effects were independent of regional air quality Findings Children who lived within 500 m of a freeway (motorway) had substantial deficits in 8-year growth of forced expiratory volume in 1 s (FEV1-81 mL, p=0.01 [95% CI -143 to -18]) and maximum midexpiratory flow rate (MMEF, -127 mL/s, p=0.03 [-243 to -11), compared with children who lived at least 1500 m from a freeway. joint models showed that both local exposure to freeways and regional air pollution had detrimental, and independent, effects on lung-function growth. Pronounced deficits in attained lung function at age 18 years were recorded for those living within 500 m of a freeway, with mean percent-predicted 97.0% for FEV1 (p=0.013, relative to >1500 m [95% CI 94.6-99.4]) and 93.4% for MMEF (p=0.006 [95% CI 89.1-97.7]). Interpretation Local exposure to traffic on a freeway has adverse effects on children's lung development, which are independent of regional air quality, and which could result in important deficits in attained lung function in later life.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA; Sonoma Technol Inc, Petaluma, CA 94954 USA; Inst Municipal Invest Med, Resp & Environm Res Unit, E-08003 Barcelona, Spain; Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA	University of Southern California; University of California System; University of California Berkeley	Gauderman, WJ (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90033 USA.	jimg@usc.edu	Jerrett, Michael/CAA-2482-2022; Kuenzli, Nino/F-7195-2014	Kuenzli, Nino/0000-0001-8360-080X	NIEHS NIH HHS [P01ES11627, P30ES07048] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, P01ES011627] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Bascom R, 1996, AM J RESP CRIT CARE, V153, P477, DOI 10.1164/ajrccm.153.2.8564086; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; BENSEN P, 1989, CALINE4 DISPERSION M; Berhane K, 2004, STAT SCI, V19, P414, DOI 10.1214/088342304000000413; Brauer M, 2003, EPIDEMIOLOGY, V14, P228, DOI 10.1097/00001648-200303000-00019; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Brunekreef B, 1997, EPIDEMIOLOGY, V8, P298, DOI 10.1097/00001648-199705000-00012; Delfino RJ, 2002, ENVIRON HEALTH PERSP, V110, P573, DOI 10.1289/ehp.02110s4573; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; EDWARDS J, 1994, ARCH ENVIRON HEALTH, V49, P223, DOI 10.1080/00039896.1994.9937471; Fischer PH, 2000, ATMOS ENVIRON, V34, P3713, DOI 10.1016/S1352-2310(00)00067-4; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Frischer T, 1999, AM J RESP CRIT CARE, V160, P390, DOI 10.1164/ajrccm.160.2.9809075; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75; Gilbert NL, 2003, SCI TOTAL ENVIRON, V312, P43, DOI 10.1016/S0048-9697(03)00228-6; Gilbert NL, 2005, J AIR WASTE MANAGE, V55, P1059, DOI 10.1080/10473289.2005.10464708; Gonzales M, 2005, SCI TOTAL ENVIRON, V337, P163, DOI 10.1016/j.scitotenv.2004.07.010; Hirsch T, 1999, EUR RESPIR J, V14, P669, DOI 10.1034/j.1399-3003.1999.14c29.x; Hole DJ, 1996, BRIT MED J, V313, P711; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Jedrychowski W, 1999, ENVIRON HEALTH PERSP, V107, P669, DOI 10.2307/3434460; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Khan AJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006505; Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Kunzli N, 1997, ENVIRON RES, V72, P8, DOI 10.1006/enrs.1996.3687; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; Manchester-Neesvig JB, 2003, J AIR WASTE MANAGE, V53, P1065, DOI 10.1080/10473289.2003.10466265; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; RAIZENNE M, 1993, AM REV RESPIR DIS, V147, pA635; Roorda-Knape MC, 1998, ATMOS ENVIRON, V32, P1921, DOI 10.1016/S1352-2310(97)00496-2; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; SCHWARTZ J, 1989, ENVIRON RES, V50, P309, DOI 10.1016/S0013-9351(89)80012-X; Sugiri D, 2006, ENVIRON HEALTH PERSP, V114, P282, DOI 10.1289/ehp.8180; Tager IB, 2005, EPIDEMIOLOGY, V16, P751, DOI 10.1097/01.ede.0000183166.68809.b0; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Venn A, 2000, OCCUP ENVIRON MED, V57, P152, DOI 10.1136/oem.57.3.152; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502; WARE JH, 1986, AM REV RESPIR DIS, V133, P834; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zhu YF, 2006, ENVIRON SCI TECHNOL, V40, P2531, DOI 10.1021/es0516514; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842; Zmirou D, 2004, J EPIDEMIOL COMMUN H, V58, P18, DOI 10.1136/jech.58.1.18	54	528	540	1	115	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					571	577		10.1016/S0140-6736(07)60037-3	http://dx.doi.org/10.1016/S0140-6736(07)60037-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138MZ	17307103				2022-12-28	WOS:000244368000030
J	Blumenfeld, I; Clayton, CE; Decker, FJ; Hogan, MJ; Huang, CK; Ischebeck, R; Iverson, R; Joshi, C; Katsouleas, T; Kirby, N; Lu, W; Marsh, KA; Mori, WB; Muggli, P; Oz, E; Siemann, RH; Walz, D; Zhou, MM				Blumenfeld, Ian; Clayton, Christopher E.; Decker, Franz-Josef; Hogan, Mark J.; Huang, Chengkun; Ischebeck, Rasmus; Iverson, Richard; Joshi, Chandrashekhar; Katsouleas, Thomas; Kirby, Neil; Lu, Wei; Marsh, Kenneth A.; Mori, Warren B.; Muggli, Patric; Oz, Erdem; Siemann, Robert H.; Walz, Dieter; Zhou, Miaomiao			Energy doubling of 42 GeV electrons in a metre-scale plasma wakefield accelerator	NATURE			English	Article							BEAMS; CHANNEL; WAVES	The energy frontier of particle physics is several trillion electron volts, but colliders capable of reaching this regime ( such as the Large Hadron Collider and the International Linear Collider) are costly and time-consuming to build; it is therefore important to explore new methods of accelerating particles to high energies. Plasma-based accelerators are particularly attractive because they are capable of producing accelerating fields that are orders of magnitude larger than those used in conventional colliders(1-3). In these accelerators, a drive beam ( either laser or particle) produces a plasma wave (wakefield) that accelerates charged particles(4-11). The ultimate utility of plasma accelerators will depend on sustaining ultrahigh accelerating fields over a substantial length to achieve a significant energy gain. Here we show that an energy gain of more than 42 GeV is achieved in a plasma wakefield accelerator of 85 cm length, driven by a 42 GeV electron beam at the Stanford Linear Accelerator Center (SLAC). The results are in excellent agreement with the predictions of three-dimensional particle-in-cell simulations. Most of the beam electrons lose energy to the plasma wave, but some electrons in the back of the same beam pulse are accelerated with a field of similar to 52 GV m(-1). This effectively doubles their energy, producing the energy gain of the 3-km-long SLAC accelerator in less than a metre for a small fraction of the electrons in the injected bunch. This is an important step towards demonstrating the viability of plasma accelerators for high-energy physics applications.	Stanford Linear Accelerator Ctr, Menlo Pk, CA 94025 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA; Univ So Calif, Los Angeles, CA 90089 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Los Angeles; University of Southern California	Joshi, C (corresponding author), Stanford Linear Accelerator Ctr, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	joshi@ee.ucla.edu	Lu, Wei/F-2504-2016					Ammosov M. V., 1986, Soviet Physics - JETP, V64, P1191; BANE KLF, 2005, SLACPUB11038; Barov N, 1998, PHYS REV LETT, V80, P81, DOI 10.1103/PhysRevLett.80.81; Bruhwiler DL, 2003, PHYS PLASMAS, V10, P2022, DOI 10.1063/1.1566027; CHEN P, 1985, PHYS REV LETT, V54, P693, DOI 10.1103/PhysRevLett.54.693; Clayton CE, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.154801; Dodd ES, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.125001; Faure J, 2004, NATURE, V431, P541, DOI 10.1038/nature02963; Geddes CGR, 2004, NATURE, V431, P538, DOI 10.1038/nature02900; Gordon D, 1998, PHYS REV LETT, V80, P2133, DOI 10.1103/PhysRevLett.80.2133; Hogan MJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.054802; Huang C, 2006, J COMPUT PHYS, V217, P658, DOI 10.1016/j.jcp.2006.01.039; Johnson DK, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.175003; JOSHI C, 1984, NATURE, V311, P525, DOI 10.1038/311525a0; KATSOULEAS T, 1986, PHYS REV A, V33, P2056, DOI 10.1103/PhysRevA.33.2056; Krejcik P, 2003, PROCEEDINGS OF THE 2003 PARTICLE ACCELERATOR CONFERENCE, VOLS 1-5, P423, DOI 10.1109/PAC.2003.1288941; Mangles SPD, 2004, NATURE, V431, P535, DOI 10.1038/nature02939; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Muggli P, 1999, IEEE T PLASMA SCI, V27, P791, DOI 10.1109/27.774685; ROSENZWEIG JB, 1991, PHYS REV A, V44, pR6189, DOI 10.1103/PhysRevA.44.R6189; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Umstadter D, 1996, SCIENCE, V273, P472, DOI 10.1126/science.273.5274.472	22	566	570	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					741	744		10.1038/nature05538	http://dx.doi.org/10.1038/nature05538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301787				2022-12-28	WOS:000244205200039
J	Ridker, PM; Buring, JE; Rifai, N; Cook, NR				Ridker, Paul M.; Buring, Julie E.; Rifai, Nader; Cook, Nancy R.			Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BODY-MASS INDEX; FOLLOW-UP; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; A-I; PREDICTION; EVENTS; MEN	Context Despite improved understanding of atherothrombosis, cardiovascular prediction algorithms for women have largely relied on traditional risk factors. Objective To develop and validate cardiovascular risk algorithms for women based on a large panel of traditional and novel risk factors. Design, Setting, and Participants Thirty-five factors were assessed among 24 558 initially healthy US women 45 years or older who were followed up for a median of 10.2 years (through March 2004) for incident cardiovascular events (an adjudicated composite of myocardial infarction, ischemic stroke, coronary revascularization, and cardiovascular death). We used data among a random two thirds (derivation cohort, n = 16 400) to develop new risk algorithms that were then tested to compare observed and predicted outcomes in the remaining one third of women (validation cohort, n = 8158). Main Outcome Measure Minimization of the Bayes Information Criterion was used in the derivation cohort to develop the best-fitting parsimonious prediction models. In the validation cohort, we compared predicted vs actual 10-year cardiovascular event rates when the new algorithms were compared with models based on covariates included in the Adult Treatment Panel III risk score. Results In the derivation cohort, a best-fitting model (model A) and a clinically simplified model (model B, the Reynolds Risk Score) had lower Bayes Information Criterion scores than models based on covariates used in Adult Treatment Panel III. In the validation cohort, all measures of fit, discrimination, and calibration were improved when either model A or B was used. For example, among participants without diabetes with estimated 10-year risks according to the Adult Treatment Panel III of 5% to less than 10% (n = 603) or 10% to less than 20% (n = 156), model A reclassified 379 (50%) into higher- or lower-risk categories that in each instance more accurately matched actual event rates. Similar effects were achieved for clinically simplified model B limited to age, systolic blood pressure, hemoglobin A(1C) if diabetic, smoking, total and high-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and parental history of myocardial infarction before age 60 years. Neither new algorithm provided substantive information about women at very low risk based on the published Adult Treatment Panel III score. Conclusion We developed, validated, and demonstrated highly improved accuracy of 2 clinical algorithms for global cardiovascular risk prediction that reclassified 40% to 50% of women at intermediate risk into higher- or lower-risk categories.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiovasc Dis, Boston, MA 02215 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org						[Anonymous], 1997, P AM STAT ASS BIOM S; ASCHERIO A, 1992, CIRCULATION, V86, P1475, DOI 10.1161/01.CIR.86.5.1475; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COOK N, IN PRESS CIRCULATION; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; DAWBER TR, 1959, AM J PUBLIC HEALTH N, V49, P1349, DOI 10.2105/AJPH.49.10.1349; DOYLE JT, 1964, JAMA-J AM MED ASSOC, V190, P886; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Glynn RJ, 2002, HYPERTENSION, V39, P105, DOI 10.1161/hy1201.097199; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Grundy SM, 2005, J AM COLL CARDIOL, V46, P173, DOI 10.1016/j.jacc.2005.05.007; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Lamarche B, 1996, CIRCULATION, V94, P273, DOI 10.1161/01.CIR.94.3.273; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Michos ED, 2005, AM HEART J, V150, P1276, DOI 10.1016/j.ahj.2005.02.037; Mora S, 2006, JAMA-J AM MED ASSOC, V295, P1412, DOI 10.1001/jama.295.12.1412; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Voss R, 2002, INT J EPIDEMIOL, V31, P1253, DOI 10.1093/ije/31.6.1253; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Wang TJ, 2003, CIRCULATION, V108, P572, DOI 10.1161/01.CIR.0000081764.35431.DE; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Wilson PW, 2006, CIRCULATION, V114, P877; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	45	1270	1332	2	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					611	619		10.1001/jama.297.6.611	http://dx.doi.org/10.1001/jama.297.6.611			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135TU	17299196	Bronze			2022-12-28	WOS:000244177400024
J	Kao, G; Nordenson, C; Still, M; Ronnlund, A; Tuck, S; Naredi, P				Kao, Gautam; Nordenson, Cecilia; Still, Maria; Ronnlund, Agneta; Tuck, Simon; Naredi, Peter			ASNA-1 positively regulates insulin secretion in C-elegans and mammalian cells	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; TRANSCRIPTION FACTOR; DAF-16; ATPASE; LONGEVITY; ARREST; MEMBER; GENE; SUPERFAMILY	C. elegans worms hatching in the absence of food show growth arrest during the first larval stage (U). While much has been learned about the later diapause, dauer, which worms enter under adverse conditions, much less is known about the mechanisms governing L1 arrest. Here we show that worms lacking activity of the asna-1 gene arrest growth reversibly at the L1 stage even when food is abundant. asna-1 encodes an ATPase that functions nonautonomously to regulate growth. asna-1 is expressed in a restricted set of sensory neurons and in insulin-producing intestinal cells. asna-1 mutants are reduced in insulin secretion while overexpression of asna-1 mimics the effects of insulin overexpression. Human ASNA1 is highly expressed in pancreatic beta cells, but not in other pancreatic endocrine cell types, and regulates insulin secretion in cultured cells. We propose that ASNA1 is an evolutionarily conserved modulator of insulin signaling.	Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden; Umea Univ Hosp, Dept Surg, SE-90185 Umea, Sweden	Umea University; Umea University	Tuck, S (corresponding author), Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden.	simon.tuck@ucmp.umu.se; peter.naredi@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Naredi, Peter/0000-0002-5652-0422				Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; AVERY L, 1993, GENETICS, V133, P897; Avery Leon, 1993, Genetics, V134, P455; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Collet J, 1998, GENETICS, V148, P187; Fares H, 2001, GENETICS, V159, P133; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gems D, 1998, GENETICS, V150, P129; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hong Y, 1998, DEVELOPMENT, V125, P3585; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; KARKARIA CE, 1990, J BIOL CHEM, V265, P7832; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Kurdi-Haidar B, 1998, J HISTOCHEM CYTOCHEM, V46, P1243, DOI 10.1177/002215549804601104; KurdiHaidar B, 1996, GENOMICS, V36, P486, DOI 10.1006/geno.1996.0494; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mukhopadhyay R, 2006, FEBS LETT, V580, P3889, DOI 10.1016/j.febslet.2006.06.017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Priess J. R., 1997, C ELEGANS 2; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; THOMAS JH, 1993, GENETICS, V134, P1105; Tissenbaum HA, 2000, P NATL ACAD SCI USA, V97, P460, DOI 10.1073/pnas.97.1.460; VOGEL G, 1976, BIOCHEMISTRY-US, V15, P208, DOI 10.1021/bi00646a032	41	84	131	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					577	587		10.1016/j.cell.2006.12.031	http://dx.doi.org/10.1016/j.cell.2006.12.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289575	Bronze			2022-12-28	WOS:000244842700022
J	Mignot, T; Shaevitz, JW; Hartzell, PL; Zusman, DR				Mignot, Tam; Shaevitz, Joshua W.; Hartzell, Patricia L.; Zusman, David R.			Evidence that focal adhesion complexes power bacterial gliding motility	SCIENCE			English	Article								The bacterium Myxococcus xanthus has two motility systems: S motility, which is powered by type IV pilus retraction, and A motility, which is powered by unknown mechanism(s). We found that A motility involved transient adhesion complexes that remained at fixed positions relative to the substratum as cells moved forward. Complexes assembled at leading cell poles and dispersed at the rear of the cells. When cells reversed direction, the A-motility clusters relocalized to the new leading poles together with S-motility proteins. The Frz chemosensory system coordinated the two motility systems. The dynamics of protein cluster localization suggest that intracellular motors and force transmission by dynamic focal adhesions can power bacterial motility.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Idaho, Dept Microbiol Mol Biol & Biochem, Moscow, ID 83844 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Idaho; University of Idaho	Mignot, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	tmignot@berkeley.edu; zusman@berkeley.edu		Mignot, Tam/0000-0003-4338-9063	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020509, R01GM075242] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM075242-03, GM20509, R01 GM020509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; GODWIN SL, 1989, J BACTERIOL, V171, P4589, DOI 10.1128/jb.171.9.4589-4594.1989; Hoiczyk E, 1998, CURR BIOL, V8, P1161, DOI 10.1016/S0960-9822(07)00487-3; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wolgemuth CW, 2005, BIOPHYS J, V89, P945, DOI 10.1529/biophysj.105.062513; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004	13	172	176	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					853	856		10.1126/science.1137223	http://dx.doi.org/10.1126/science.1137223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289998	Green Accepted			2022-12-28	WOS:000244069000071
J	Smith, NL; Hindorff, LA; Heckbert, SR; Lemaitre, RN; Marciante, KD; Rice, K; Lumley, T; Bis, JC; Wiggins, KL; Rosendaal, FR; Psaty, BM				Smith, Nicholas L.; Hindorff, Lucia A.; Heckbert, Susan R.; Lemaitre, Rozenn N.; Marciante, Kristin D.; Rice, Kenneth; Lumley, Thomas; Bis, Joshua C.; Wiggins, Kerri L.; Rosendaal, Frits R.; Psaty, Bruce M.			Association of genetic variations with nonfatal venous thrombosis in postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FACTOR-V-LEIDEN; DEEP-VEIN-THROMBOSIS; ACTIVATED PROTEIN-C; MARBURG-I POLYMORPHISM; PATHWAY INHIBITOR GENE; BETA-FIBRINOGEN-GENE; FACTOR-XIII VA134LEU; FALSE DISCOVERY RATE; MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM	Context Although the roles of clotting proteins and enzymes that activate or inhibit fibrin production and lysis are well characterized, the underlying contribution of genetic variation in these constituents to risk of venous thrombosis (VT) has not been fully investigated. Objective To describe the association of common genetic variation in 24 coagulation, anticoagulation, fibrinolysis, and antifibrinolysis candidate genes with risk of incident nonfatal VT in postmenopausal women. Design, Setting, and Participants Population-based case-control study conducted in a large integrated health care system in Washington State. Participants were perimenopausal and postmenopausal women aged 30 to 89 years who sustained a first VT event between January 1995 and December 2002 ( n= 349) and 1680 controls matched on age, hypertension status, and calendar year ( n= 1680). Main Outcome Measure Risk of venous thrombosis associated with global variation within a gene as measured by common haplotypes and with individual haplotypes and single nucleotide polymorphisms ( SNPs). Significance of the associations was assessed by a .20 threshold of the false-discovery rate q value, which accounts for multiple testing. Results Only the tissue factor pathway inhibitor gene demonstrated global association with risk (q=. 13). Five significant SNP associations were identified across 3 of the candidate genes ( factors V, XI, and protein C) in SNP analyses. Two associations have been previously reported. Another 22 variants across 15 genes had P values less than .05 but q values between .20 and .35. Five of these confirm previously reported associations ( fibrinogen genes and protein C), 2 were inconsistent with earlier reports ( thrombomodulin and plasminogen activator inhibitor 1), and 15 were new discoveries. Conclusions After accounting for multiple testing, 5 SNPs associated with VT risk were identified, 3 of which have not been previously reported. Replication of these novel associations in other populations is necessary to corroborate these findings and identify which genetic factors may influence VT risk in postmenopausal women.	Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Smith, NL (corresponding author), Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.	nlsmith@u.washington.edu	Rice, Kenneth M/A-4150-2013; Rosendaal, Frits/Q-3842-2017	Rice, Kenneth M/0000-0001-5779-4495; Rosendaal, Frits/0000-0003-2558-7496; Wiggins, Kerri L/0000-0003-2749-1279	NHLBI NIH HHS [HL74745, HL73410, HL68986, HL60739, HL68639, HL43201] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074745, R01HL043201, R01HL060739, R01HL073410, R01HL068639, R01HL068986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aiach M, 1999, ARTERIOSCL THROM VAS, V19, P1573, DOI 10.1161/01.ATV.19.6.1573; Ameziane N, 2002, THROMB HAEMOSTASIS, V88, P195; Amini-Nekoo A, 2001, BRIT J HAEMATOL, V113, P537, DOI 10.1046/j.1365-2141.2001.02752.x; Arnaud E, 2000, ARTERIOSCL THROM VAS, V20, P892, DOI 10.1161/01.ATV.20.3.892; Arnaud E, 1999, THROMB HAEMOSTASIS, V82, P159, DOI 10.1055/s-0037-1614654; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertina RM, 2005, J THROMB HAEMOST, V3, P597, DOI 10.1111/j.1538-7836.2005.01198.x; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blake GJ, 2001, EUR HEART J, V22, P2262, DOI 10.1053/euhj.2001.2692; Camilleri RS, 2005, BLOOD COAGUL FIBRIN, V16, P193, DOI 10.1097/01.mbc.0000164428.13417.e2; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Carter AM, 2000, BLOOD, V96, P1177, DOI 10.1182/blood.V96.3.1177.015k25_1177_1179; Castaman G, 2003, HAEMATOLOGICA, V88, P1182; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; de Visser MCH, 2000, THROMB HAEMOSTASIS, V83, P577; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; Evans GD, 2000, THROMB HAEMOSTASIS, V83, P511, DOI 10.1055/s-0037-1613847; Franco RF, 2001, HAEMATOLOGICA, V86, P510; Franco RF, 2000, BRIT J HAEMATOL, V111, P118, DOI 10.1046/j.1365-2141.2000.02338.x; French B, 2006, GENET EPIDEMIOL, V30, P485, DOI 10.1002/gepi.20161; Heit JA, 2005, J THROMB HAEMOST, V3, P710, DOI 10.1111/j.1538-7836.2005.01187.x; Hoppe B, 2005, BLOOD, V105, P1549, DOI 10.1182/blood-2004-08-3328; Kleesiek K, 1999, THROMB HAEMOSTASIS, V82, P1; Ko YL, 2006, HUM GENET, V119, P84, DOI 10.1007/s00439-005-0102-0; Komanasin N, 2005, J THROMB HAEMOST, V3, P2487, DOI 10.1111/j.1538-7836.2005.01624.x; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PSATY BM, 1994, ARCH INTERN MED, V154, P1333, DOI 10.1001/archinte.154.12.1333; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Renner W, 2000, THROMB RES, V99, P35, DOI 10.1016/S0049-3848(00)00219-X; Renner W, 2002, EUR J CLIN INVEST, V32, P755, DOI 10.1046/j.1365-2362.2002.01070.x; Ridker PM, 1997, CIRCULATION, V95, P59, DOI 10.1161/01.CIR.95.1.59; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Scanavini D, 2005, THROMB HAEMOSTASIS, V93, P453, DOI 10.1160/TH04-09-0629; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SPEK CA, 1995, ARTERIOSCL THROM VAS, V15, P214, DOI 10.1161/01.ATV.15.2.214; Stegnar M, 1998, THROMB HAEMOSTASIS, V79, P975; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tirado I, 2004, THROMB HAEMOSTASIS, V91, P899, DOI 10.1160/TH03-10-0620; van Minkelen R, 2005, BLOOD, V105, P4898, DOI 10.1182/blood-2005-02-0576; Vlieg AV, 2002, BRIT J HAEMATOL, V119, P169; Nossent AY, 2006, THROMB HAEMOSTASIS, V95, P942, DOI 10.1160/TH06-01-0024; Zee RYL, 2006, CIRCULATION, V113, P2193, DOI 10.1161/CIRCULATIONAHA.106.615401; Zee RYL, 2005, J THROMB HAEMOST, V3, P2819, DOI 10.1111/j.1538-7836.2005.01665.x; Zidane M, 2003, THROMB HAEMOSTASIS, V90, P439, DOI 10.1160/TH03-01-0035	47	142	145	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					489	498		10.1001/jama.297.5.489	http://dx.doi.org/10.1001/jama.297.5.489			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284699	Bronze			2022-12-28	WOS:000243999100026
J	Saitz, R; Palfai, TP; Cheng, DM; Horton, NJ; Freedner, N; Dukes, K; Kraemer, KL; Roberts, MS; Guerriero, RT; Samet, JH				Saitz, Richard; Palfai, Tibor P.; Cheng, Debbie M.; Horton, Nicholas J.; Freedner, Naomi; Dukes, Kim; Kraemer, Kevin L.; Roberts, Mark S.; Guerriero, Rosanne T.; Samet, Jeffrey H.			Brief intervention for medical inpatients with unhealthy alcohol use - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							IDENTIFICATION TEST AUDIT; MINI-MENTAL-STATE; USE DISORDERS; MOTIVATIONAL INTERVENTION; PROBLEM DRINKING; PROBLEM DRINKERS; PRIMARY-CARE; SERVICES; VALIDATION; PHYSICIANS	Background: The efficacy of brief intervention in reducing alcohol consumption is well established for selected outpatients but not for medical inpatients. Objective: To determine whether brief intervention improves alcohol outcomes in medical inpatients who were identified by screening as having unhealthy alcohol use. Design: Randomized, controlled trial. Setting: Medical service of an urban hospital. Patients: 341 medical inpatients who were drinking risky amounts of alcohol (defined for eligibility as > 14 drinks/wk or >= 5 drinks/occasion for men and > 11 drinks/wk or >= 4 drinks/occasion for women and persons >= 66 y); 77% had alcohol dependence as determined by the Composite International Diagnostic Interview Alcohol Module. Intervention: A 30-minute session of motivational counseling given by trained counselors during a patient's hospitalization (n = 172) versus usual care (n = 169). Measurements: Self-reported primary outcomes were receipt of alcohol assistance (for example, alcohol disorders specialty treatment) by 3 months in dependent drinkers and change in the mean number of drinks per day from enrollment to 12 months in all patients. Results: The intervention was not significantly associated with receipt of alcohol assistance by 3 months among alcohol-dependent patients (adjusted proportions receiving assistance, 49% for the intervention group and 44% for the control group; intervention-control difference, 5% [95% CI, -8% to 19%]) or with drinks per day at 12 months among all patients (adjusted mean decreases, 1.5 for patients who received the intervention and 3.1 for patients who received usual care; adjusted mean group difference, -1.5 [CI, -3.7 to 0.6]). There was no significant interaction between the intervention and alcohol dependence in statistical models predicting drinks per day (P = 0.24). Limitations: Baseline imbalances existed between randomized groups. Patients who received usual care were assessed and advised that they could discuss their drinking with their physicians. Conclusions: Brief intervention is insufficient for linking medical inpatients with treatment for alcohol dependence and for changing alcohol consumption. Medical inpatients with unhealthy alcohol use require more extensive, tailored alcohol interventions.	Med Ctr, Boston, MA 02118 USA; Boston Univ, Boston, MA 02215 USA; Smith Coll, Northampton, MA 01063 USA; DM STAT, Malden, MA USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA	Boston University; Smith College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saitz, R (corresponding author), Med Ctr, 91 E Concord St,Suite 200, Boston, MA 02118 USA.	rsaitz@bu.edu	Horton, Nicholas/A-2493-2008	Horton, Nicholas/0000-0003-3332-4311; Samet, Jeffrey/0000-0002-0897-3400; Cheng, Debbie/0000-0002-2206-3059; /0000-0002-2535-1427	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00533] Funding Source: Medline; PHS HHS [R01 12617] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P1222, DOI 10.1001/jama.270.10.1222; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; ANTTIPOIKA I, 1988, ALCOHOL ALCOHOLISM, V23, P115; Beich A, 2003, BMJ-BRIT MED J, V327, P536, DOI 10.1136/bmj.327.7414.536; Berg AO, 2004, ANN INTERN MED, V140, P554, DOI 10.7326/0003-4819-140-7-200404060-00016; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BLONDELL RD, 2001, J FAM PRACTICE, V50, P447; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; BUCHSBAUM DG, 1992, J GEN INTERN MED, V7, P517, DOI 10.1007/BF02599456; CHICK J, 1985, BRIT MED J, V290, P965, DOI 10.1136/bmj.290.6473.965; Committee on Treatment of Alcohol Problems, 1990, BROAD BAS TREATM ALC; Del Boca FK, 2000, ADDICTION, V95, pS347; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dunn CW, 1997, AM J DRUG ALCOHOL AB, V23, P1, DOI 10.3109/00952999709001684; ELVY GA, 1988, BRIT J ADDICT, V83, P83; Emmen MJ, 2004, BMJ-BRIT MED J, V328, P318, DOI 10.1136/bmj.37956.562130.EE; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedmann PD, 2001, J STUD ALCOHOL, V62, P234, DOI 10.15288/jsa.2001.62.234; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Heather N, 1996, DRUG ALCOHOL REV, V15, P29, DOI 10.1080/09595239600185641; Hulse GK, 2002, DRUG ALCOHOL REV, V21, P105, DOI 10.1080/09595230220138993a; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; KUCHIPUDI V, 1990, J STUD ALCOHOL, V51, P356, DOI 10.15288/jsa.1990.51.356; Longabaugh R, 2001, J STUD ALCOHOL, V62, P806, DOI 10.15288/jsa.2001.62.806; Maisto SA, 2003, AM J ADDICTION, V12, pS12, DOI 10.1111/j.1521-0391.2003.tb00493.x; MCLELLAN AT, 1992, J NERV MENT DIS, V180, P101, DOI 10.1097/00005053-199202000-00007; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Miller, 1995, DRINKER INVENTORY CO, V4; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; MILLER WR, 1996, PROJECT MARCH MONOGR, V5; Mitka M, 1998, JAMA-J AM MED ASSOC, V279, P1767, DOI 10.1001/jama.279.22.1767; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; *NAT I ALC AB ALC, 2003, HELP PAT ALC PROBL H; National Institute on Alcohol Abuse and Alcoholism National Institute on Alcohol Abuse and Alcoholism, 2005, HELP PAT WHO DRINK T; Palfai TP, 2006, ALCOHOL CLIN EXP RES, V30, p210A; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Roche AM, 2006, DRUG ALCOHOL DEPEN, V83, P1, DOI 10.1016/j.drugalcdep.2005.10.011; Rowland N., 1993, HEALTH PROMOT INT, V8, P5; Saitz R, 2006, J GEN INTERN MED, V21, P381, DOI 10.1111/j.1525-1497.2006.00405.x; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Smith KL, 2006, DRUG ALCOHOL DEPEN, V82, P231, DOI 10.1016/j.drugalcdep.2005.09.012; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; WARE JE, 1998, SF 13 SCORE SF 12 PH; Watson HE, 1999, INT J NURS STUD, V36, P425, DOI 10.1016/S0020-7489(99)00028-0; Welte JW, 1998, ADDICTION, V93, P573, DOI 10.1046/j.1360-0443.1998.93457312.x; Wilk AI, 1997, J GEN INTERN MED, V12, P274; World Health Organization, 1996, COMP INT DIAGN INT C, VCIDI 2.0	58	108	108	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					167	176		10.7326/0003-4819-146-3-200702060-00005	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132QN	17283347				2022-12-28	WOS:000243957400002
J	Suttle, KB; Thomsen, MA; Power, ME				Suttle, K. B.; Thomsen, Meredith A.; Power, Mary E.			Species interactions reverse grassland responses to changing climate	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; CALIFORNIA; ECOSYSTEM; VEGETATION; MOUNTAIN; DIVERSITY; COMMUNITY; PATTERNS; RANGES; SHIFTS	Predictions of ecological response to climate change are based largely on direct climatic effects on species. We show that, in a California grassland, species interactions strongly influence responses to changing climate, overturning direct climatic effects within 5 years. We manipulated the seasonality and intensity of rainfall over large, replicate plots in accordance with projections of leading climate models and examined responses across several trophic levels. Changes in seasonal water availability had pronounced effects on individual species, but as precipitation regimes were sustained across years, feedbacks and species interactions overrode autecological responses to water and reversed community trajectories. Conditions that sharply increased production and diversity through 2 years caused simplification of the food web and deep reductions in consumer abundance after 5 years. Changes in these natural grassland communities suggest a prominent role for species interactions in ecosystem response to climate change.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of California System; University of California Berkeley; University of Wisconsin System	Suttle, KB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kbsuttle@socrates.berkeley.edu		Thomsen, Meredith/0000-0001-9843-5202				BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BENTLEY J. R., 1958, JOUR RANGE MANAGEMENT, V11, P133, DOI 10.2307/3893716; BENTLEY J. R., 1954, JOUR RANGE MANAGEMENT, V7, P25, DOI 10.2307/3894622; Burns CE, 2003, P NATL ACAD SCI USA, V100, P11474, DOI 10.1073/pnas.1635115100; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; FIELD CB, 1999, CONFRONTING GLOBAL C; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; HEADY HF, 1958, ECOLOGY, V39, P402, DOI 10.2307/1931750; HOBBS RJ, 1988, OECOLOGIA, V75, P291, DOI 10.1007/BF00378612; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; JACKSON LE, 1986, ACTA OECOL-OEC PLANT, V7, P191; JONES MB, 1990, J PROD AGRIC, V3, P534, DOI 10.2134/jpa1990.0534; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; *NAT ASS SYNTH TEA, 2002, CLIM CHANG IMP US PO; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; PITT MD, 1978, ECOLOGY, V59, P336, DOI 10.2307/1936378; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rothley KD, 2006, CAN J ZOOL, V84, P1053, DOI 10.1139/Z06-076; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Schmitz OJ, 2003, BIOSCIENCE, V53, P1199, DOI 10.1641/0006-3568(2003)053[1199:ERTGCC]2.0.CO;2; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	35	553	578	13	524	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					640	642		10.1126/science.1136401	http://dx.doi.org/10.1126/science.1136401			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272720				2022-12-28	WOS:000243909400041
J	Nagot, N; Ouedraogo, A; Foulongne, V; Konate, I; Weiss, HA; Vergne, L; Defer, M; Djagbare, D; Sanon, A; Andonaba, J; Becquart, P; Segondy, M; Vallo, R; Sawadogo, A; Van de Perre, P; Mayaud, P; Bahembera, E; Berthe, A; Coulibaly, M; Defer, MC; Diallo, R; Djagbare, D; Konate, I; Ky-Dama, F; M'Boutiki, GT; Meda, N; Millogo, I; Nagot, N; Ouedraogo, A; Ouedraogo, D; Rouet, F; Sanon, A; Sawadogo, H; Vallo, R; Vergne, L; Mayaud, P; Nagot, N; Weiss, HA; Becquart, P; Foulongne, V; Segondy, M; Van de Perre, P; Andonaba, JB; Sawadogo, A				Nagot, Nicolas; Ouedraogo, Abdoulaye; Foulongne, Vincent; Konate, Issouf; Weiss, Helen A.; Vergne, Laurence; Defer, Marie-Christine; Djagbare, Didier; Sanon, Anselme; Andonaba, Jean-Baptiste; Becquart, Pierre; Segondy, Michel; Vallo, Roselyne; Sawadogo, Adrien; Van de Perre, Philippe; Mayaud, Philippe; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M. -C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G. T.; Meda, N.; Millogo, I.; Nagot, N.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.; Sanon, A.; Sawadogo, H.; Vallo, R.; Vergne, L.; Mayaud, P.; Nagot, N.; Weiss, H. A.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P.; Andonaba, J. -B.; Sawadogo, A.		ANRS 1285 Study Grp	Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENITAL-TRACT; TYPE-1 INFECTION; CONTROLLED-TRIAL; AFRICAN WOMEN; SEX WORKERS; TRANSMISSION; ACQUISITION; MEN; COMPARTMENTALIZATION	Background: Epidemiologic data suggest that infection with herpes simplex virus type 2 (HSV-2) is associated with increased genital shedding of human immunodeficiency virus type 1 (HIV-1) RNA and HIV-1 transmissibility. Methods: We conducted a randomized, double-blind, placebo-controlled trial of HSV suppressive therapy with valacyclovir (at a dose of 500 mg twice daily) in Burkina Faso among women who were seropositive for HIV-1 and HSV-2; all were ineligible for highly active antiretroviral therapy. The patients were followed for 24 weeks (12 weeks before and 12 weeks after randomization). Regression models were used to assess the effect of valacyclovir on the presence and quantity of genital and plasma HIV-1 RNA and genital HSV-2 DNA during treatment, adjusting for baseline values, and to evaluate the effect over time. Results: A total of 140 women were randomly assigned to treatment groups; 136 were included in the analyses. At enrollment, the median CD4 cell count was 446 cells per cubic millimeter, and the mean plasma viral load was 4.44 log(sub 10) copies per milliliter. With the use of summary-measures analysis, valacyclovir therapy was found to be associated with a significant decrease in the frequency of genital HIV-1 RNA (odds ratio, 0.41; 95% confidence interval [CI], 0.21 to 0.80) and in the mean quantity of the virus (log(sub 10) copies per milliliter, -0.29; 95% CI, -0.44 to -0.15). However, there was no significant decrease in detection of HIV (risk ratio, 0.93; 95% CI, 0.81 to 1.07). HSV suppressive therapy also reduced the mean plasma HIV-1 RNA level by 0.53 log(sub 10) copy per milliliter (95% CI, -0.72 to -0.35). Repeated-measures analysis showed that these effects became significantly stronger during the 3 months of follow-up. Conclusions: HSV suppressive therapy significantly reduces genital and plasma HIV-1 RNA levels in dually infected women. This finding may have important implications for HIV control.	Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England; Ctr Muraz, Bobo Dioulasso, Burkina Faso; Univ Hosp, Bobo Dioulasso, Burkina Faso; Montpellier Univ Hosp, Montpellier, France; Res Unit 145, Montpellier, France	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; Universite de Montpellier; CHU de Montpellier	Nagot, N (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Res Unit, Keppel St, London WC1E 7HT, England.	n_nagot@hotmail.com	Van de Perre, Philippe/B-9692-2008; weiss, helen/ABC-7823-2021; Nagot, Nicolas/I-9467-2014; Becquart, Pierre/GLT-0845-2022	Van de Perre, Philippe/0000-0002-3912-0427; weiss, helen/0000-0003-3547-7936; MAYAUD, Philippe/0000-0001-5730-947X; Vallo, Roselyne/0000-0002-2447-6754; Nagot, Nicolas/0000-0002-3493-2821; Becquart, Pierre/0000-0002-0980-1678	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baeten JM, 2004, J INFECT DIS, V189, P1466, DOI 10.1086/383049; Celum CL, 2005, J INFECT DIS, V191, pS107, DOI 10.1086/425272; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Collier AC, 1998, ANTIVIR THER, V3, P25; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Cowan FF, 2006, AIDS, V20, P261, DOI 10.1097/01.aids.0000198086.39831.4a; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; DeJesus E, 2003, J INFECT DIS, V188, P1009, DOI 10.1086/378416; DeJesus E, 2003, J INFECT DIS, V188, P1404; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; *JOINT UN PROGR HI, 1997, WKLY EPIDEMIOL REC, V72, P81; Kemal KS, 2003, P NATL ACAD SCI USA, V100, P12972, DOI 10.1073/pnas.2134064100; Koelle DM, 2002, J CLIN INVEST, V110, P537, DOI [10.1172/JCI200215537, 10.1172/JCI0215537]; Kovacs A, 2002, LANCET, V359, P630; Kovacs A, 2001, LANCET, V358, P1593, DOI 10.1016/S0140-6736(01)06653-3; Legoff J, 2006, J CLIN MICROBIOL, V44, P423, DOI 10.1128/JCM.44.2.423-432.2006; Malkin Jean-Elie, 2004, Herpes, V11 Suppl 1, p2A; MARGOLIS DM, 1992, VIROLOGY, V186, P788, DOI 10.1016/0042-6822(92)90048-T; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P632; Nagot N, 2005, JAIDS-J ACQ IMM DEF, V39, P454, DOI 10.1097/01.qai.0000152399.54648.b9; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; PATEL R, 1995, INT J STD AIDS, V6, P320, DOI 10.1177/095646249500600503; Philpott S, 2005, J VIROL, V79, P353, DOI 10.1128/JVI.79.1.353-363.2005; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Van Dyck E, 2004, J CLIN MICROBIOL, V42, P2961, DOI 10.1128/JCM.42.7.2961-2965.2004; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; *WHO, 2000, SAF EFF US ANT TREAT; *WHO UNAIDS, 2001, WHO UNAIDS LSHTM WOR; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	45	260	274	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					790	799		10.1056/NEJMoa062607	http://dx.doi.org/10.1056/NEJMoa062607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314338	Green Accepted			2022-12-28	WOS:000244326700005
J	Sieving, PA; Collins, FS				Sieving, Paul A.; Collins, Francis S.			Genetic ophthalmology and the era of clinical care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CHILDHOOD BLINDNESS; CIGARETTE-SMOKING; UNITED-STATES; CANINE MODEL; RPE65; RISK; SUSCEPTIBILITY; PREVALENCE		NEI, NIH, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sieving, PA (corresponding author), NEI, NIH, Bldg 31,Room 6A03,31 Ctr Dr,MSC 2510, Bethesda, MD 20892 USA.	pas@nei.nih.gov			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000065] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; AGUIRRE GD, 1998, MOL VIS, V30, P4; Aldave AJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P177, DOI 10.1001/archopht.125.2.177; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; *AM MED ASS, 1998, SURV GEN TEST STUD C; Beby F, 2007, ARCH OPHTHALMOL-CHIC, V125, P213, DOI 10.1001/archopht.125.2.213; Blain D, 2007, ARCH OPHTHALMOL-CHIC, V125, P196, DOI 10.1001/archopht.125.2.196; Collins FS, 2006, AM J HUM GENET, V79, P421, DOI 10.1086/507611; Collins FS, 2003, SCIENCE, V302, P745, DOI 10.1126/science.302.5646.745; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Downs K, 2007, ARCH OPHTHALMOL-CHIC, V125, P252, DOI 10.1001/archopht.125.2.252; Duggal P, 2007, ARCH OPHTHALMOL-CHIC, V125, P74, DOI 10.1001/archopht.125.1.74; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GALLIE BL, IN PRESS PEDIAT BLOO; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gorin MB, 2007, ARCH OPHTHALMOL-CHIC, V125, P21, DOI 10.1001/archopht.125.1.21; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL PA, 1993, FASEB J, V7, P846, DOI 10.1096/fasebj.7.10.8344484; Ito YA, 2007, ARCH OPHTHALMOL-CHIC, V125, P128, DOI 10.1001/archopht.125.1.128; Iyengar SK, 2007, ARCH OPHTHALMOL-CHIC, V125, P11, DOI 10.1001/archopht.125.1.11; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; McKusick-Nathans Institute of Genetic Medicine Johns Hopkins Medicine, ONL MEND INH MAN OMI; *NINDS, PARK STUD; Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268; *REC DNA ADV COMM, PHAS 1 TRIAL OC SUBR; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; RetNetTM, RET INF NETW; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Shuler RK, 2007, ARCH OPHTHALMOL-CHIC, V125, P63, DOI 10.1001/archopht.125.1.63; Stone EM, 2007, ARCH OPHTHALMOL-CHIC, V125, P205, DOI 10.1001/archopht.125.2.205; Stone Edwin M, 2003, Trans Am Ophthalmol Soc, V101, P437; *U WASH, 1993, GENETESTS MED GEN IN; Waardenburg P.J., 1961, GENETICS OPHTHALMOLO, V1; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Wong WT, 2007, ARCH OPHTHALMOL-CHIC, V125, P239, DOI 10.1001/archopht.125.2.239; Wu WC, 2007, ARCH OPHTHALMOL-CHIC, V125, P225, DOI 10.1001/archopht.125.2.225; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	47	19	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					733	736		10.1001/jama.297.7.733	http://dx.doi.org/10.1001/jama.297.7.733			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17315303				2022-12-28	WOS:000244291100025
J	Scott, JF				Scott, J. F.			Applications of modern ferroelectrics	SCIENCE			English	Review							PHASE-TRANSITIONS; FILMS; SIZE; CAPACITORS	Long viewed as a topic in classical physics, ferroelectricity can be described by a quantum mechanical ab initio theory. Thin-film nanoscale device structures integrated onto Si chips have made inroads into the semiconductor industry. Recent prototype applications include ultrafast switching, cheap room-temperature magnetic-field detectors, piezoelectric nanotubes for microfluidic systems, electrocaloric coolers for computers, phased-array radar, and three-dimensional trenched capacitors for dynamic random access memories. Terabit-per-square-inch ferroelectric arrays of lead zirconate titanate have been reported on Pt nanowire interconnects and nanorings with 5-nanometer diameters. Finally, electron emission from ferroelectrics yields cheap, high-power microwave devices and miniature x-ray and neutron sources.	Univ Cambridge, Ctr Ferro, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Scott, JF (corresponding author), Univ Cambridge, Ctr Ferro, Dept Earth Sci, Cambridge CB2 3EQ, England.	jsco99@esc.cam.ac.uk	Ye, Shukai/A-2089-2009					Abrahams SC, 1999, ACTA CRYSTALLOGR B, V55, P494, DOI 10.1107/S0108768199003730; Alexe M, 2001, APPL PHYS LETT, V79, P242, DOI 10.1063/1.1385184; Auciello O, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337005; Catalan G, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177543; Catalan G, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/2/022201; Dawber M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177601; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Dawber M, 2003, J PHYS-CONDENS MAT, V15, pL667, DOI 10.1088/0953-8984/15/44/L03; Dawber M, 2003, J PHYS-CONDENS MAT, V15, pL393, DOI 10.1088/0953-8984/15/24/106; DAWBER M, COMMUNICATION; DEARAUJO CAP, 1995, NATURE, V374, P627, DOI 10.1038/374627a0; Dieguez O, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.144101; Ederer C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.020401; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fiebig M, 2005, J PHYS D APPL PHYS, V38, pR123, DOI 10.1088/0022-3727/38/8/R01; FOX DL, 1977, J PHYS C SOLID STATE, V10, pL329, DOI 10.1088/0022-3719/10/11/011; Gundel HW, 1996, FERROELECTRICS, V184, P89, DOI 10.1080/00150199608230248; Harrison RJ, 2002, P NATL ACAD SCI USA, V99, P16556, DOI 10.1073/pnas.262514499; Hemberger J, 2005, NATURE, V434, P364, DOI 10.1038/nature03348; Hill NA, 2000, J PHYS CHEM B, V104, P6694, DOI [10.1021/jp000114x, 10.1021/jpc00114x]; Isobe C, 1997, INTEGR FERROELECTR, V14, P95, DOI 10.1080/10584589708019981; Jiang AQ, 2003, J APPL PHYS, V93, P1180, DOI 10.1063/1.1533094; Johnston K, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.100103; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kawano K, 2006, ELECTROCHEM SOLID ST, V9, pC175, DOI 10.1149/1.2336992; Kim DC, 1997, INTEGR FERROELECTR, V18, P137, DOI 10.1080/10584589708221694; KITTEL C, 1946, PHYS REV, V70, P965, DOI 10.1103/PhysRev.70.965; Li YL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184112; Lines M.E., 2001, PRINCIPLES APPL FERR; Lou XJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.177601; MERMIN ND, 1979, REV MOD PHYS, V51, P591, DOI 10.1103/RevModPhys.51.591; MILLIKEN AD, IN PRESS APPL PHYS L; Mischenko AS, 2006, SCIENCE, V311, P1270, DOI 10.1126/science.1123811; MORALESCRUZ AL, 2005, INTEGR FERROELECTR, V77, P51; Morrison FD, 2003, J PHYS-CONDENS MAT, V15, pL527, DOI 10.1088/0953-8984/15/33/103; Naranjo B, 2005, NATURE, V434, P1115, DOI 10.1038/nature03575; Paruch P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197601; Pertsev NA, 1998, PHYS REV LETT, V80, P1988, DOI 10.1103/PhysRevLett.80.1988; Pertsev NA, 1999, FERROELECTRICS, V223, P79, DOI 10.1080/00150199908260556; POLLARD R, COMMUNICATION; Saad MM, 2004, J PHYS-CONDENS MAT, V16, pL451, DOI 10.1088/0953-8984/16/41/L04; Saad MM, 2006, IEEE T ULTRASON FERR, V53, P2208, DOI 10.1109/TUFFC.2006.168; Scott JF, 2006, J PHYS-CONDENS MAT, V18, pR361, DOI 10.1088/0953-8984/18/17/R02; Scott J.F., 2000, FERROELECTRIC MEMORI; SCOTT JF, 1989, SCIENCE, V246, P1400, DOI 10.1126/science.246.4936.1400; Stephanovich VA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047601; Tanaka M, 1998, FERROELECTRICS LETT, V24, P13, DOI 10.1080/07315179808204451; VONHIPPEL A, 1944, 300 US NAT DEF RES C; Walker D, 2005, J PHYS D APPL PHYS, V38, pA55, DOI 10.1088/0022-3727/38/10A/011; Wu X, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035105; Zheng H, 2004, SCIENCE, V303, P661, DOI 10.1126/science.1094207; Zhu XH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2347893	52	2298	2360	73	1833	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					954	959		10.1126/science.1129564	http://dx.doi.org/10.1126/science.1129564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303745				2022-12-28	WOS:000244229800032
J	Klauk, H; Zschieschang, U; Pflaum, J; Halik, M				Klauk, Hagen; Zschieschang, Ute; Pflaum, Jens; Halik, Marcus			Ultralow-power organic complementary circuits	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; LOW-VOLTAGE; MONOLAYERS; MOBILITY; ALUMINUM; ACIDS	The prospect of using low-temperature processable organic semiconductors to implement transistors, circuits, displays and sensors on arbitrary substrates, such as glass or plastics, offers enormous potential for a wide range of electronic products(1). Of particular interest are portable devices that can be powered by small batteries or by near-field radio-frequency coupling. The main problem with existing approaches is the large power consumption of conventional organic circuits, which makes battery-powered applications problematic, if not impossible. Here we demonstrate an organic circuit with very low power consumption that uses a self-assembled monolayer gate dielectric and two different air-stable molecular semiconductors (pentacene and hexadecafluorocopperphthalocyanine, F16CuPc). The monolayer dielectric is grown on patterned metal gates at room temperature and is optimized to provide a large gate capacitance and low gate leakage currents. By combining low-voltage p-channel and n-channel organic thin-film transistors in a complementary circuit design, the static currents are reduced to below 100 pA per logic gate. We have fabricated complementary inverters, NAND gates, and ring oscillators that operate with supply voltages between 1.5 and 3 V and have a static power consumption of less than 1 nW per logic gate. These organic circuits are thus well suited for battery-powered systems such as portable display devices 2 and large-surface sensor networks(3) as well as for radio-frequency identification tags with extended operating range(4).	Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; Univ Erlangen Nurnberg, Inst Polymer Mat, D-91058 Erlangen, Germany	Max Planck Society; University of Stuttgart; University of Erlangen Nuremberg	Klauk, H (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	h.klauk@fkf.mpg.de	Pflaum, Jens/G-2394-2010; Halik, Marcus/M-2556-2016	Pflaum, Jens/0000-0001-5326-8244; Halik, Marcus/0000-0001-5976-0862				Bao ZA, 1998, J AM CHEM SOC, V120, P207, DOI 10.1021/ja9727629; Baude PF, 2003, APPL PHYS LETT, V82, P3964, DOI 10.1063/1.1579554; Bram C, 1997, FRESEN J ANAL CHEM, V358, P108, DOI 10.1007/s002160050357; Collet J, 2000, APPL PHYS LETT, V76, P1941, DOI 10.1063/1.126219; Crone BK, 2001, J APPL PHYS, V89, P5125, DOI 10.1063/1.1362635; de Oteyza DG, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2117622; De Vusser S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197604; FOLKERS JP, 1995, LANGMUIR, V11, P813, DOI 10.1021/la00003a024; FONTAINE P, 1993, APPL PHYS LETT, V62, P2256, DOI 10.1063/1.109433; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Goetting LB, 1999, LANGMUIR, V15, P1182, DOI 10.1021/la981094h; Halik M, 2004, NATURE, V431, P963, DOI 10.1038/nature02987; Hulea IN, 2006, NAT MATER, V5, P982, DOI 10.1038/nmat1774; Jones BA, 2004, ANGEW CHEM INT EDIT, V43, P6363, DOI 10.1002/anie.200461324; Kim KD, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213010; Klauk H, 2003, APPL PHYS LETT, V82, P4175, DOI 10.1063/1.1579870; Ling MM, 2006, ORG ELECTRON, V7, P568, DOI 10.1016/j.orgel.2006.09.003; Park YD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2143113; Robertson J, 2004, EUR PHYS J-APPL PHYS, V28, P265, DOI 10.1051/epjap:2004206; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Ulman A., 1991, INTRO ULTRATHIN FILM; Wu CC, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P65, DOI 10.1109/IEDM.2002.1175780; Yang SY, 2005, ADV FUNCT MATER, V15, P1806, DOI 10.1002/adfm.200400486; Yoon MH, 2005, J AM CHEM SOC, V127, P10388, DOI 10.1021/JA052488f; Yoon MH, 2005, P NATL ACAD SCI USA, V102, P4678, DOI 10.1073/pnas.0501027102; Zhou LS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178213	26	1209	1223	6	513	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					745	748		10.1038/nature05533	http://dx.doi.org/10.1038/nature05533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301788				2022-12-28	WOS:000244205200040
J	Sugiyama, T; Cam, HP; Sugiyama, R; Noma, K; Zofall, M; Kobayashi, R; Grewal, SIS				Sugiyama, Tomoyasu; Cam, Hugh P.; Sugiyama, Rie; Noma, Ken-ichi; Zofall, Martin; Kobayashi, Ryuji; Grewal, Shiv I. S.			SHREC, an effector complex for heterochromatic transcriptional silencing	CELL			English	Article							DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; GENOME-WIDE ANALYSIS; MATING-TYPE LOCI; FISSION YEAST; HISTONE H3; SCHIZOSACCHAROMYCES-POMBE; DOMAIN PROTEIN; RNA-POLYMERASE; PERICENTRIC HETEROCHROMATIN	Transcriptional gene silencing (TGS) is the mechanism generally thought by which heterochromatin effects silencing. However, recent discovery in fission yeast of a cis-acting posttranscriptional gene-silencing (cis-PTGS) pathway operated by the RNAi machinery at heterochromatin challenges the role of TGS in heterochromatic silencing. Here, we describe a multienzyme effector complex (termed SHREC) that mediates heterochromatic TGS in fission yeast. SHREC consists of a core quartet of proteins-Clr1, Clr2, Clr3, and Mit1-which distribute throughout all major heterochromatin domains to effect TGS via distinct activities associated with the histone deacetylase Clr3 and the SNF2 chromatin-remodeling factor homolog Mit1. SHREG is also recruited to the telomeres by multiple independent mechanisms involving telomere binding protein Ccq1 cooperating with Taz1 and the RNAi machinery, and to euchromatic sites, via mechanism(s) distinct from its heterochromatin localization aided by Swi6/HP1. Our analyses suggest that SHREC regulates nucleosome positioning to assemble higher-order chromatin structures critical for heterochromatin functions.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Texas, MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Sugiyama, Tomoyasu/0000-0001-5704-6606; Grewal, Shiv/0000-0002-4552-9261	NATIONAL CANCER INSTITUTE [Z01BC010523] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bjerling P, 2004, NUCLEIC ACIDS RES, V32, P4421, DOI 10.1093/nar/gkh780; Bowen NJ, 2004, CELL MOL LIFE SCI, V61, P2163, DOI 10.1007/s00018-004-4177-x; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cryderman DE, 1998, CHROMOSOMA, V107, P277, DOI 10.1007/s004120050309; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Eissenberg JC, 2001, BIOESSAYS, V23, P767, DOI 10.1002/bies.1111; EKWALL K, 1994, GENETICS, V136, P53; Ekwall K, 2005, TRENDS GENET, V21, P608, DOI 10.1016/j.tig.2005.08.009; Feng Q, 2003, CURR TOP MICROBIOL, V274, P269; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; Freeman-Cook LL, 2005, GENETICS, V169, P1243, DOI 10.1534/genetics.104.032714; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanno T, 2005, EMBO REP, V6, P649, DOI 10.1038/sj.embor.7400446; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Partridge JF, 2000, GENE DEV, V14, P783; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schulte KM, 2001, THYROID, V11, P3, DOI 10.1089/10507250150500603; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thon G, 2000, GENETICS, V155, P551; THON G, 1992, GENETICS, V131, P287; THON G, 1994, GENETICS, V138, P29; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	71	234	243	1	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					491	504		10.1016/j.cell.2006.12.035	http://dx.doi.org/10.1016/j.cell.2006.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289569	Bronze			2022-12-28	WOS:000244842700016
J	Ginsberg, NS; Garner, SR; Hau, LV				Ginsberg, Naomi S.; Garner, Sean R.; Hau, Lene Vestergaard			Coherent control of optical information with matter wave dynamics	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; GROUP-VELOCITY; NOBEL LECTURE; ATOMIC VAPOR; LIGHT; GAS; AMPLIFICATION; FERMIONS; STORAGE; LASER	In recent years, significant progress has been achieved in manipulating matter with light, and light with matter(1). Resonant laser fields interacting with cold, dense atom clouds provide a particularly rich system(2-6). Such light fields interact strongly with the internal electrons of the atoms, and couple directly to external atomic motion through recoil momenta imparted when photons are absorbed and emitted. Ultraslow light propagation in Bose Einstein condensates(7) represents an extreme example of resonant light manipulation using cold atoms. Here we demonstrate that a slow light pulse can be stopped and stored in one Bose - Einstein condensate and subsequently revived from a totally different condensate, 160 mu m away; information is transferred through conversion of the optical pulse into a travelling matter wave. In the presence of an optical coupling field, a probe laser pulse is first injected into one of the condensates where it is spatially compressed to a length much shorter than the coherent extent of the condensate. The coupling field is then turned off, leaving the atoms in the first condensate in quantum superposition states that comprise a stationary component and a recoiling component in a different internal state. The amplitude and phase of the spatially localized light pulse are imprinted on the recoiling part of the wavefunction, which moves towards the second condensate. When this 'messenger' atom pulse is embedded in the second condensate, the system is re-illuminated with the coupling laser. The probe light is driven back on and the messenger pulse is coherently added to the matter field of the second condensate by way of slow-light-mediated atomic matter-wave amplification. The revived light pulse records the relative amplitude and phase between the recoiling atomic imprint and the revival condensate. Our results provide a dramatic demonstration of coherent optical information processing with matter wave dynamics. Such quantum control may find application in quantum information processing and wavefunction sculpting.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Hau, LV (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	hau@physics.harvard.edu						[Anonymous], 2003, BOSEEINSTEIN CONDENS; Arimondo E, 1996, PROG OPTICS, V35, P257, DOI 10.1016/S0079-6638(08)70531-6; Band YB, 2000, PHYS REV LETT, V84, P5462, DOI 10.1103/PhysRevLett.84.5462; BAYM G, 1974, LECT QUANTUM MECH, P425; Budker D, 1999, PHYS REV LETT, V83, P1767, DOI 10.1103/PhysRevLett.83.1767; Cohen-Tannoudji C., 1997, PHOTONS ATOMS; Cornell EA, 2002, REV MOD PHYS, V74, P875, DOI 10.1142/S0217979202014681; Deng L, 1999, NATURE, V398, P218, DOI 10.1038/18395; Dutton Z., 2004, Europhysics News, V35, P33, DOI 10.1051/epn:2004201; Dutton Z, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.053831; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Inouye S, 1999, NATURE, V402, P641, DOI 10.1038/45194; JAVANAINEN JH, 1994, PHYS REV LETT, V72, P2375, DOI 10.1103/PhysRevLett.72.2375; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Ketterle W, 2002, REV MOD PHYS, V74, P1131, DOI [10.1103/RevModPhys.74.1131, 10.1142/S0217979202014668]; Ketterle W, 2001, PHYS REV LETT, V86, P4203, DOI 10.1103/PhysRevLett.86.4203; KNIGHT PL, 1997, PHILOS T R SOC LON A, V355, P2215; Kozuma M, 1999, SCIENCE, V286, P2309, DOI 10.1126/science.286.5448.2309; Leggett AJ, 2001, REV MOD PHYS, V73, P307, DOI 10.1103/RevModPhys.73.307; LEWENSTEIN M, 1994, PHYS REV A, V50, P2207, DOI 10.1103/PhysRevA.50.2207; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Moore MG, 2001, PHYS REV LETT, V86, P4199, DOI 10.1103/PhysRevLett.86.4199; MORICE O, 1995, PHYS REV A, V51, P3896, DOI 10.1103/PhysRevA.51.3896; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; POLITZER HD, 1991, PHYS REV A, V43, P6444, DOI 10.1103/PhysRevA.43.6444; Southwell K, 2002, NATURE, V416, P205, DOI 10.1038/416205a; Svistunov B. V., 1990, Soviet Physics - JETP, V71, P71; YOU L, 1994, PHYS REV A, V50, pR3565, DOI 10.1103/PhysRevA.50.R3565	30	91	95	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					623	626		10.1038/nature05493	http://dx.doi.org/10.1038/nature05493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287804	Green Published			2022-12-28	WOS:000244039400038
J	Friedman, A; Perrimon, N				Friedman, Adam; Perrimon, Norbert			Genetic screening for signal transduction in the era of network biology	CELL			English	Article							NUMBER; ROBUSTNESS; RECEPTOR	In contrast to animal-based mutant phenotype assays, recent biochemical and quantitative genetic studies have identified hundreds of potential regulators of known signaling pathways. We discuss the discrepancy between previous models and new data, put forward a different signaling conceptual framework incorporating time-dependent quantitative contributions, and suggest how this new framework can impact our study of human disease.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02175 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02175 USA.	perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BUSTURIA A, 1994, NATURE, V370, P561, DOI 10.1038/370561a0; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Dworkin I, 2006, GENETICS, V173, P1417, DOI 10.1534/genetics.105.053868; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Norga KK, 2003, CURR BIOL, V13, P1388, DOI 10.1016/S0960-9822(03)00546-3; Noselli S, 2000, SCIENCE, V290, P68, DOI 10.1126/science.290.5489.68; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WAGNE A, 2005, ROBUSTNESS EVOLVABIL; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wieschaus E, 1996, GENETICS, V142, P5	25	133	135	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					225	231		10.1016/j.cell.2007.01.007	http://dx.doi.org/10.1016/j.cell.2007.01.007			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254958	Bronze			2022-12-28	WOS:000244420500005
J	Vohringer-Martinez, E; Hansmann, B; Hernandez, H; Francisco, JS; Troe, J; Abel, B				Voehringer-Martinez, E.; Hansmann, B.; Hernandez, H.; Francisco, J. S.; Troe, J.; Abel, B.			Water catalysis of a radical-molecule gas-phase reaction	SCIENCE			English	Article							BIMOLECULAR REACTIONS; CHLORINE DIOXIDE; COMPLEX; OH; DYNAMICS; KINETICS; VAPOR; ACETALDEHYDE; PHOTOLYSIS; DEPENDENCE	There has been considerable speculation about the role of water and water complexes in chemical gas-phase reactions, including the conjecture that water may act as a molecular catalyst through its ability to form hydrogen bonds. Here, we present kinetic studies in which the effect of water on the rate of the reaction between hydroxyl radicals and acetaldehyde has been measured directly in Laval nozzle expansions at low temperatures. An increasing enhancement of the reaction rate by added water was found with decreasing temperatures between 300 and 60 kelvin. Quantum chemical calculations and statistical rate theory support our conclusions that this observation is due to the reduction of an intrinsic reaction barrier caused by specific water aggregation. The results suggest that even single water molecules can act as catalysts in radical-molecule reactions.	Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	University of Gottingen; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Abel, B (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, D-37077 Gottingen, Germany.	babel@gwdg.de	Hernandez, Heriberto/D-9295-2012	Hernandez, Heriberto/0000-0001-6402-7331				Aloisio S, 2000, ACCOUNTS CHEM RES, V33, P825, DOI 10.1021/ar000097u; Alvarez-Idaboy JR, 2001, J AM CHEM SOC, V123, P2018, DOI 10.1021/ja003372g; ATKINSON R, 1994, J PHYS CHEM REF DATA, V2, P61; Chabinyc ML, 1998, SCIENCE, V279, P1882, DOI 10.1126/science.279.5358.1882; D'Anna B, 2003, PHYS CHEM CHEM PHYS, V5, P1790, DOI 10.1039/b211234p; DEMORE WB, 1979, J PHYS CHEM-US, V83, P1113, DOI 10.1021/j100472a001; DUNN RC, 1992, J AM CHEM SOC, V114, P4856, DOI 10.1021/ja00038a060; FROST G, 1995, J GEOPHYS RES-ATMOS, V100, P18803, DOI 10.1029/95JD01940; Garrett BC, 2004, SCIENCE, V303, P1146, DOI 10.1126/science.1089801; HAMILTON EJ, 1975, J CHEM PHYS, V63, P3682, DOI 10.1063/1.431772; Hansen JC, 2002, CHEMPHYSCHEM, V3, P833, DOI 10.1002/1439-7641(20021018)3:10<833::AID-CPHC833>3.0.CO;2-0; JOHNSSON K, 1992, J PHYS CHEM-US, V96, P5878; MICHAEL JV, 1985, J CHEM PHYS, V83, P1630, DOI 10.1063/1.449400; Miller Y, 2006, J AM CHEM SOC, V128, P9594, DOI 10.1021/ja062890+; SANDER SP, 1984, J PHYS CHEM-US, V88, P1566, DOI 10.1021/j150652a025; SINGLETON DL, 1976, J AM CHEM SOC, V98, P6812, DOI 10.1021/ja00438a006; Sivakumaran V, 2003, PHYS CHEM CHEM PHYS, V5, P106, DOI 10.1039/b209303k; Smith IWM, 2002, J PHYS CHEM A, V106, P4798, DOI 10.1021/jp014234w; Spangenberg T, 2004, J PHYS CHEM A, V108, P7527, DOI 10.1021/jp031228m; Suma K, 2006, SCIENCE, V311, P1278, DOI 10.1126/science.1124022; TAIT MJ, 1971, NATURE, V230, P91, DOI 10.1038/230091a0; Tanaka N, 1997, J PHYS CHEM A, V101, P507, DOI 10.1021/jp9619090; Tao FM, 1996, GEOPHYS RES LETT, V23, P1797, DOI 10.1029/96GL00947; TAYLOR PH, 1996, P COMBUST INST, V26, P497; TROE J, 1994, J CHEM SOC FARADAY T, V90, P2303, DOI 10.1039/ft9949002303; Vaida V, 2003, SCIENCE, V299, P1566, DOI 10.1126/science.1079297; VAIDA V, 1992, BER BUNSEN PHYS CHEM, V96, P391, DOI 10.1002/bbpc.19920960329; Wagner AF, 2002, P COMBUST INST, V29, P1173, DOI 10.1016/S1540-7489(02)80148-1	28	273	277	1	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					497	501		10.1126/science.1134494	http://dx.doi.org/10.1126/science.1134494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255507				2022-12-28	WOS:000243726600041
J	Candelise, L; Gattinoni, M; Bersano, A; Micieli, G; Sterzi, R; Morabito, A				Candelise, Livia; Gattinoni, Monica; Bersano, Anna; Micieli, Giuseppe; Sterzi, Roberto; Morabito, Alberto		PROSIT Study Grp	Stroke-unit care for acute stroke patients: an observational follow-up study	LANCET			English	Article							WARDS; CENTERS	Background Large numbers of stroke patients arrive at hospital at a very early stage, and effective treatments for the acute phase of the disease are available. However, evidence that patients with acute stroke benefit from stroke-unit care is scarce. Our aim was to determine whether admission to a stroke unit, rather than a conventional, ward, affected the outcome of patients with acute stroke. Methods We did an observational follow-up study of 11572 acute stroke patients hospitalised within 48 h of the onset of symptoms either in a stroke unit (n=4936) or in a conventional ward (6636). Patients were identified retrospectively from discharge records from 260 Italian hospitals. The primary outcome was mortality or disability (Rankin score greater than two), assessed prospectively by independent, masked assessors 2 years after admission. Analyses were adjusted for patient characteristics and clustered at the hospital level. Findings Overall, 1576 patients died in hospital; 2169 died during the follow-up period. 347 patients were lost to follow-up. Compared with conventional-ward care, stroke-unit care was associated with a reduced probability of death or being disabled at the end of follow-up (odds ratio 0.81, 95% CI 0.72-0.91; p=0.0001). The potential benefit was significant across all age ranges and clinical characteristics, except for unconsciousness. No specific elements of setting, organisation, or process of care were associated with outcome. Interpretation Admission to a stroke-unit ward with dedicated beds and staff within 48 h of onset should be recommended for all patients with acute stroke.	Univ Milan, OSped Maggiore Policlin IRCCS, Dipartimento Sci Neurol, Milan, Italy; ISt Neurol Mondino IRCCS, Stroke Unit, Pavia, Italy; Osped Niguarda Ca Granda, SC Neurol, Milan, Italy; Univ Milan, Fac Med & Chirurg, Cattedra Stat Med, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Milan	Candelise, L (corresponding author), Univ Milan, Osped Maggiore Policlin, Dipartimento Sci Neurol, Via F, I-20122 Milan, Italy.		Bersano, Anna/AAK-2888-2021; bersano, anna/J-8315-2018; Micieli, Giuseppe/Q-7725-2016	Bersano, Anna/0000-0002-2493-628X; bersano, anna/0000-0002-2493-628X; Micieli, Giuseppe/0000-0002-1746-478X				Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Brainin M, 2000, EUR J NEUROL, V7, P5, DOI 10.1046/j.1468-1331.2000.007001005.x; Cadilhac DA, 2004, STROKE, V35, P1035, DOI 10.1161/01.STR.0000125709.17337.5d; CANDELISE L, 1994, CEREBROVASC DIS, V4, P341, DOI 10.1159/000108505; Candelise L, 2005, NEUROL SCI, V26, P81, DOI 10.1007/s10072-005-0440-7; Cavallini A, 2003, STROKE, V34, P2599, DOI 10.1161/01.STR.0000094423.34841.BB; Dennis M, 2000, J ROY COLL PHYS LOND, V34, P92; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; Glader EL, 2001, STROKE, V32, P2124, DOI 10.1161/hs0901.095724; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Indredavik B, 1999, STROKE, V30, P1524, DOI 10.1161/01.STR.30.8.1524; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Kapral MK, 2004, STROKE, V35, P1756, DOI 10.1161/01.STR.0000130423.50191.9f; KASTE M, 1995, STROKE, V26, P249, DOI 10.1161/01.STR.26.2.249; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Norrving B, 2005, STROKE, V36, P1616, DOI 10.1161/01.STR.0000170643.59901.ae; ROINE RO, 2003, ACUTE STROKE TREATME, P261; Ronning OM, 1998, STROKE, V29, P586, DOI 10.1161/01.STR.29.3.586; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; Sterzi R, 2003, CEREBROVASC DIS, V15, P16, DOI 10.1159/000068210; Sulter G, 2003, STROKE, V34, P101, DOI 10.1161/01.STR.0000048148.09143.6C; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604	26	195	222	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					299	305		10.1016/S0140-6736(07)60152-4	http://dx.doi.org/10.1016/S0140-6736(07)60152-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258670	Green Submitted			2022-12-28	WOS:000243912000034
J	van Dijk, D; Spoor, M; Hijman, R; Nathoe, HM; Borst, C; Jansen, EWL; Grobbee, DE; de Jaegere, PPT; Kalkman, CJ				van Dijk, Diederik; Spoor, Monique; Hijman, Ron; Nathoe, Hendrik M.; Borst, Cornelius; Jansen, Erik W. L.; Grobbee, Diederick E.; de Jaegere, Peter P. T.; Kalkman, Cor J.		Octopus Study Grp	Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-SIGNIFICANCE; DYSFUNCTION; DECLINE; PATENCY; ANGINA; STROKE	Context Conventional coronary artery bypass graft surgery with use of cardiopulmonary bypass (on-pump CABG) is associated with excellent long-term cardiac outcomes but also with a high incidence of cognitive decline. The effect of avoiding cardiopulmonary bypass (off-pump CABG) on long-term cognitive and cardiac outcomes is unknown. Objective To compare the effect of off-pump CABG and on-pump CABG surgery on long-term cognitive and cardiac outcomes. Design, Setting, and Participants The Octopus Study, a multicenter randomized controlled trial conducted in the Netherlands, which enrolled 281 low-risk CABG patients between 1998 and 2000. Five years after their surgery, surviving patients were invited for a follow-up assessment. Intervention Patients were randomly assigned to receive either off-pump (n = 142) or on-pump (n = 139) CABG surgery. Main Outcome Measure The primary measure was cognitive status 5 years after surgery, which was determined by a psychologist blinded to treatment allocation who administered 10 standardized validated neuropsychological tests. Secondary measures were occurrence of cardiovascular events (all-cause mortality, stroke, myocardial infarction, and coronary reintervention), anginal status, and quality of life. Results After 5 years, 130 patients were alive in each group. Cognitive outcomes could be determined in 123 and 117 patients in the off-pump and on-pump groups, respectively. When using a standard definition of cognitive decline (20% decline in performance in 20% of the neuropsychological test variables), 62 (50.4%) of 123 in the off-pump group and 59 (50.4%) of 117 in the on-pump group had cognitive decline (absolute difference, 0%; 95% confidence interval [CI], -12.7% to 12.6%; P > .99). When a more conservative definition of cognitive decline was used, 41 (33.3%) in the off-pump group and 41 (35.0%) in the on-pump group had cognitive decline (absolute difference, -1.7%; 95% CI, -13.7% to 10.3%; P = .79). Thirty off-pump patients (21.1%) and 25 on-pump patients (18.0%) experienced a cardiovascular event (absolute difference, 3.1%; 95% CI, -6.1% to 12.4%; P = .55). No differences were observed in anginal status or quality of life. Conclusion In low-risk patients undergoing CABG surgery, avoiding the use of cardiopulmonary bypass had no effect on 5-year cognitive or cardiac outcomes.	Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, Dept Anesthesiol, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Psychiat, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Cardiothorac Surg, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Patient Oriented Res, NL-3508 GA Utrecht, Netherlands; Erasmus MC, Dept Cardiol, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	van Dijk, D (corresponding author), Univ Med Ctr Utrecht, Div Perioperat & Emergency Care, Dept Anesthesiol, Mail Stop Q004-2-313,POB 85500, NL-3508 GA Utrecht, Netherlands.	d.vandijk@umcutrecht.nl	Grobbee, Diederick/C-7651-2014; Kalkman, Cor/O-3215-2019	Grobbee, Diederick/0000-0003-4472-4468; Kalkman, Cor/0000-0002-8372-6960				Ascione R, 2005, CIRCULATION, V112, P3833, DOI 10.1161/CIRCULATIONAHA.105.557462; Blauw GJ, 2001, EUR HEART J SUPPL, V3, pN16, DOI 10.1016/S1520-765X(01)90133-6; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Cleveland JC, 2001, ANN THORAC SURG, V72, P1282, DOI 10.1016/S0003-4975(01)03006-5; HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F; Hartman GS, 1996, ANESTH ANALG, V83, P701, DOI 10.1097/00000539-199610000-00007; Hlatky MA, 1997, CIRCULATION, V96, P11; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931; Keenan TDL, 2005, CHEST, V128, P363, DOI 10.1378/chest.128.1.363; Keizer AMA, 2005, ACTA ANAESTH SCAND, V49, P1232, DOI 10.1111/j.1399-6576.2005.00835.x; Khan NE, 2004, NEW ENGL J MED, V350, P21, DOI 10.1056/NEJMoa031282; Lund C, 2003, ANN THORAC SURG, V76, P765, DOI 10.1016/S0003-4975(03)00679-9; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Nathoe HM, 2003, NEW ENGL J MED, V348, P394, DOI 10.1056/NEJMoa021775; Newman MF, 2006, LANCET, V368, P694, DOI 10.1016/S0140-6736(06)69254-4; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Puskas JD, 2004, JAMA-J AM MED ASSOC, V291, P1841, DOI 10.1001/jama.291.15.1841; Selnes OA, 2001, ARCH NEUROL-CHICAGO, V58, P598, DOI 10.1001/archneur.58.4.598; Selnes OA, 2006, ANN THORAC SURG, V82, P388, DOI 10.1016/j.athoracsur.2006.02.060; STUMP DA, 1995, ANN THORAC SURG, V59, P1340, DOI 10.1016/0003-4975(95)00108-W; Van Dijk D, 2002, JAMA-J AM MED ASSOC, V287, P1405, DOI 10.1001/jama.287.11.1405; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wahrborg P, 2004, CIRCULATION, V110, P3411, DOI 10.1161/01.CIR.0000148366.80443.2B; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Widimsky P, 2004, CIRCULATION, V110, P3418, DOI 10.1161/01.CIR.0000148139.79580.36; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	30	202	206	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					701	708		10.1001/jama.297.7.701	http://dx.doi.org/10.1001/jama.297.7.701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17312289	Bronze			2022-12-28	WOS:000244291100021
J	Fenton, AA				Fenton, Andre A.			Neuroscience - Where am I?	SCIENCE			English	Editorial Material							HIPPOCAMPUS; ENVIRONMENT; DYNAMICS; CELLS		SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Fenton, AA (corresponding author), SUNY Downstate Med Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	afenton@downstate.edu						Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; FYHN MH, 2006, SOC NEUR ABSTR, V68, P9; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hayman RMA, 2003, EUR J NEUROSCI, V18, P2825, DOI 10.1111/j.1460-9568.2003.03035.x; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; MULLER RU, 1987, J NEUROSCI, V7, P1951; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	14	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					947	949		10.1126/science.1139146	http://dx.doi.org/10.1126/science.1139146			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303741				2022-12-28	WOS:000244229800028
J	Iglehart, JK				Glehart, John K.			Medicaid revisited - Skirmishes over a vast public enterprise	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSONAL RESPONSIBILITY; HEALTH-INSURANCE; CARE					jiglehart@projecthope.org						ALKER J, 2006, 1 GEORG U HLTH POL I; Bishop G, 2006, NEW ENGL J MED, V355, P756, DOI 10.1056/NEJMp068170; BUSH J, 2006, STANFORD LAW POL REV, V17, P33; *C BUDG OFF, DEF RED ACT 2005 COS; Coughlin TA, 2006, HEALTH AFFAIR, V25, pW204, DOI 10.1377/hlthaff.25.w204; CROWLEY JS, 2006, MEDICAID LONG TERM S; Cunningham PJ, 2005, MED CARE RES REV, V62, P676, DOI 10.1177/1077558705281061; CUNNINGHAM PJ, 2006, 1L CTR STUD HLTH SYS; FOX W, 2006, PAYMENT LEVEL COMP P; FREUDENHEIM M, 2006, NY TIMES        0601, pC3; *GOV ACC OFF, 2006, MED FIN MAN STEPS TA; Holahan J, 2006, HEALTH AFFAIR, V25, pW432, DOI 10.1377/hlthaff.25.w432; HURLEY RE, 2006, UNDERSTANDING INFLUE; Iglehart JK, 2003, NEW ENGL J MED, V348, P2140, DOI 10.1056/NEJMhpr035376; IGLEHART JK, 2003, NEW ENGL J MED, V349, P100; JENKINS CL, 2006, WASHINGTON POST 1008, pC5; *KAIS FAM FDN, 2006, DAIL HLTH POL REP; *KAIS FAM FDN, LOW MED SPEND AM REB; MARTINEZ B, 2006, WALL STREET J   1006, pA1; Moran DW, 2005, HEALTH AFFAIR, V24, P1415, DOI 10.1377/hlthaff.24.6.1415; MORGAN D, 1994, WASHINGTON POST 0717, pA1; Newhouse JP, 1993, FREE ALL LESSONS RAN; Robinson JC, 2006, HEALTH AFFAIR, V25, P1475, DOI 10.1377/hlthaff.25.6.1475; Rosenbaum S, 2002, NEW ENGL J MED, V346, P635, DOI 10.1056/NEJM200202213460825; Rosenbaum Sara, 2006, DEFINED CONTRIBUTION; Rowland D, 2005, NEW ENGL J MED, V353, P1439, DOI 10.1056/NEJMp058063; RUDOWITZ R, 2006, NUTS BOLDS MAKING ME; SCHWARTZ S, 2006, MOVING TUG WAR IMPRO; SMITH V, 2006, LOW MED SPENDING GRO; SOLOMON J, 2006, W VIRGINIAS MEDICAID; Steinbrook R, 2006, NEW ENGL J MED, V355, P753, DOI 10.1056/NEJMp068141; Vladeck BC, 2003, HEALTH AFFAIR, V22, P90, DOI 10.1377/hlthaff.22.1.90; Weil A, 2003, HEALTH AFFAIR, V22, P13, DOI 10.1377/hlthaff.22.1.13; Wiener, 2003, FEDERALISM HLTH POLI; ZUCKERMAN S, 2004, HLTH AFF MILLWOOD S, V23	35	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					734	740		10.1056/NEJMhpr066650	http://dx.doi.org/10.1056/NEJMhpr066650			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135ZV	17301307				2022-12-28	WOS:000244193300015
J	Stranger, BE; Forrest, MS; Dunning, M; Ingle, CE; Beazley, C; Thorne, N; Redon, R; Bird, CP; de Grassi, A; Lee, C; Tyler-Smith, C; Carter, N; Scherer, SW; Tavare, S; Deloukas, P; Hurles, ME; Dermitzakis, ET				Stranger, Barbara E.; Forrest, Matthew S.; Dunning, Mark; Ingle, Catherine E.; Beazley, Claude; Thorne, Natalie; Redon, Richard; Bird, Christine P.; de Grassi, Anna; Lee, Charles; Tyler-Smith, Chris; Carter, Nigel; Scherer, Stephen W.; Tavare, Simon; Deloukas, Panagiotis; Hurles, Matthew E.; Dermitzakis, Emmanouil T.			Relative impact of nucleotide and copy number variation on gene expression phenotypes	SCIENCE			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; DELETION; POLYMORPHISMS; LANDSCAPE; DISEASE; LOCUS; YEAST	Extensive studies are currently being performed to associate disease susceptibility with one form of genetic variation, namely, single-nucleotide polymorphisms (SNPs). In recent years, another type of common genetic variation has been characterized, namely, structural variation, including copy number variants (CNVs). To determine the overall contribution of CNVs to complex phenotypes, we have performed association analyses of expression levels of 14,925 transcripts with SNPs and CNVs in individuals who are part of the International HapMap project. SNPs and CNVs captured 83.6% and 17.7% of the total detected genetic variation in gene expression, respectively, but the signals from the two types of variation had little overlap. Interrogation of the genome for both types of variants may be an effective way to elucidate the causes of complex phenotypes and disease in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Dept Oncol, Canc Res UK, Cambridge Res Inst,Li Ka Shing Ctr, Cambridge CB2 0RE, England; CNR, Ist Tecnol Biomed, Sez Bari, I-70126 Bari, Italy; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; Hosp Sick Children, Program Genet & Genom Biol, MaRS Ctr, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA	Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk; md4@sanger.ac.uk	Scherer, Stephen W./B-3785-2013; Dermitzakis, Emmanouil/B-7687-2013; Deloukas, Panos/B-2922-2013; De Grassi, Anna/AAE-6036-2020; Redon, Richard/F-3303-2014	Scherer, Stephen W./0000-0002-8326-1999; Deloukas, Panos/0000-0001-9251-070X; De Grassi, Anna/0000-0001-7273-4263; Redon, Richard/0000-0001-7751-2280; Dunning, Mark/0000-0002-8853-9435; Fosker, Christine/0000-0002-3799-9474; Forrest, Matthew/0000-0002-2141-0303; Stranger, Barbara/0000-0001-9021-7331	Wellcome Trust [077014, 076113, 065535, 077009, 077046] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dermitzakis ET, 2006, MAMM GENOME, V17, P503, DOI 10.1007/s00335-006-0005-y; Doerge RW, 1996, GENETICS, V142, P285; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Oleksiak MF, 2005, NAT GENET, V37, P67, DOI 10.1038/ng1483; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P357, DOI 10.1007/978-1-59745-039-3_25; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	28	1298	1376	0	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					848	853		10.1126/science.1136678	http://dx.doi.org/10.1126/science.1136678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289997	Green Accepted			2022-12-28	WOS:000244069000070
J	Strickfaden, SC; Winters, MJ; Ben-Ari, G; Lamson, RE; Tyers, M; Pryciak, PM				Strickfaden, Shelly C.; Winters, Matthew J.; Ben-Ari, Giora; Lamson, Rachel E.; Tyers, Mike; Pryciak, Peter M.			A mechanism for cell-cycle regulation of MAP kinase signaling in a yeast differentiation pathway	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MATING FACTOR; PHEROMONE RESPONSE; BUDDING YEAST; G-BETA; PROTEIN-KINASES; MEKK STE11; G1 CYCLIN; IN-VIVO; PHOSPHORYLATION	Yeast cells arrest in the G1 phase of the cell cycle upon exposure to mating pheromones. As cells commit to a new cycle, G1 CDK activity (Cln/CDK) inhibits signaling through the mating MAPK cascade. Here we show that the target of this inhibition is Ste5, the MAPK cascade scaffold protein. Cln/CDK disrupts Ste5 membrane localization by phosphorylating a cluster of sites that flank a small, basic, membrane-binding motif in Ste5. Effective inhibition of Ste5 signaling requires multiple phosphorylation sites and a substantial accumulation of negative charge, which suggests that Ste5 acts as a sensor for high G1 CDK activity. Thus, Ste5 is an integration point for both external and internal signals. When Ste5 cannot be phosphorylated, pheromone triggers an aberrant arrest of cells outside G1 either in the presence or absence of the CDK-inhibitor protein Far1. These findings define a mechanism and physiological benefit of restricting antiproliferative signaling to G1.	Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Massachusetts System; University of Massachusetts Worcester; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pryciak, PM (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA.	peter.pryciak@umassmed.edu	Tyers, Michael/ABE-3194-2021; Pryciak, Peter/P-7205-2019	Pryciak, Peter/0000-0001-9142-1369	NIGMS NIH HHS [R01 GM057769, GM57769] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057769] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHANG F, 1992, MOL BIOL CELL, V3, P445, DOI 10.1091/mbc.3.4.445; Cherkasova V, 1999, GENETICS, V151, P989; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; Flotho A, 2004, J BIOL CHEM, V279, P47391, DOI 10.1074/jbc.M405681200; Gartner A, 1998, MOL CELL BIOL, V18, P3681, DOI 10.1128/MCB.18.7.3681; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Jeoung DI, 1998, MOL CELL BIOL, V18, P433, DOI 10.1128/MCB.18.1.433; KRANZ JE, 1994, GENE DEV, V8, P313, DOI 10.1101/gad.8.3.313; Lamson RE, 2006, CURR BIOL, V16, P618, DOI 10.1016/j.cub.2006.02.060; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; MCKINNEY JD, 1993, GENE DEV, V7, P833, DOI 10.1101/gad.7.5.833; MCKINNEY JD, 1995, MOL CELL BIOL, V15, P2509; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Oehlen LJWM, 1998, MOL GEN GENET, V258, P183, DOI 10.1007/s004380050722; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Oehlen LJWM, 1998, J BIOL CHEM, V273, P25089, DOI 10.1074/jbc.273.39.25089; PETER M, 1994, SCIENCE, V265, P1228, DOI 10.1126/science.8066461; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; VALDIVIESO MH, 1993, MOL CELL BIOL, V13, P1013, DOI 10.1128/MCB.13.2.1013; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; Vidwans SJ, 2001, NAT CELL BIOL, V3, pE35, DOI 10.1038/35050681; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wu CL, 1998, J BIOL CHEM, V273, P28107, DOI 10.1074/jbc.273.43.28107	42	173	175	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					519	531		10.1016/j.cell.2006.12.032	http://dx.doi.org/10.1016/j.cell.2006.12.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289571	Green Accepted, Bronze			2022-12-28	WOS:000244842700018
J	Kitching, RP; Taylor, NM; Thrusfield, MV				Kitching, Richard P.; Taylor, Nicholas M.; Thrusfield, Michael V.			Vaccination strategies for foot-and-mouth disease	NATURE			English	Letter							EPIDEMIC		Natl Ctr Foreign Anim Dis, Winnipeg, MB R3E 3M4, Canada; Univ Reading, Vet Epidemiol & Econ Res Unit, Reading RG6 6AR, Berks, England; Univ Edinburgh, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland	University of Reading; University of Edinburgh	Kitching, RP (corresponding author), Natl Ctr Foreign Anim Dis, Winnipeg, MB R3E 3M4, Canada.	m.thrusfield@ed.ac.uk	Taylor, Nicholas/R-6665-2019	Thrusfield, Michael/0000-0003-1110-4094				DONALDSON AI, 1992, VET REC, V131, P114, DOI 10.1136/vr.131.6.114; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kitching RP, 2006, REV SCI TECH OIE, V25, P293, DOI 10.20506/rst.25.1.1665; Spedding C.R.W, 1988, INTRO AGR SYSTEMS; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; 1969, REPORT COMMITTE ENQU, V1; 1969, REPORT COMMITTE ENQU, V2	8	15	15	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					E12	E12		10.1038/nature05604	http://dx.doi.org/10.1038/nature05604			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287765	Bronze			2022-12-28	WOS:000244039400034
J	Kreitzer, AC; Malenka, RC				Kreitzer, Anatol C.; Malenka, Robert C.			Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models	NATURE			English	Article							TERM SYNAPTIC DEPRESSION; DOPAMINE D2 RECEPTORS; BASAL GANGLIA; GENE-EXPRESSION; PLASTICITY; NEURONS; HYDROLYSIS; MICE; INTERNEURONS; INHIBITION	The striatum is a major forebrain nucleus that integrates cortical and thalamic afferents and forms the input nucleus of the basal ganglia(1,2). Striatal projection neurons target the substantia nigra pars reticulata ( direct pathway) or the lateral globus pallidus ( indirect pathway). Imbalances between neural activity in these two pathways have been proposed to underlie the profound motor deficits observed in Parkinson's disease and Huntington's disease(3,4). However, little is known about differences in cellular and synaptic properties in these circuits. Indeed, current hypotheses suggest that these cells express similar forms of synaptic plasticity(5,6). Here we show that excitatory synapses onto indirect-pathway medium spiny neurons (MSNs) exhibit higher release probability and larger N-methyl-D-aspartate receptor currents than direct-pathway synapses. Moreover, indirect-pathway MSNs selectively express endocannabinoid-mediated long-term depression (eCB-LTD), which requires dopamine D2 receptor activation. In models of Parkinson's disease, indirect-pathway eCB-LTD is absent but is rescued by a D2 receptor agonist or inhibitors of endocannabinoid degradation. Administration of these drugs together in vivo reduces parkinsonian motor deficits, suggesting that endocannabinoid-mediated depression of indirect-pathway synapses has a critical role in the control of movement. These findings have implications for understanding the normal functions of the basal ganglia, and also suggest approaches for the development of therapeutic drugs for the treatment of striatal-based brain disorders.	Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Nancy Pritzker Lab, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	malenka@stanford.edu						ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Di Marzo V, 2000, FASEB J, V14, P1432, DOI 10.1096/fj.14.10.1432; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Makara JK, 2005, NAT NEUROSCI, V8, P1139, DOI 10.1038/nn1521; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Obeso JA, 2000, NEUROLOGY, V55, pS7; Saario SM, 2006, CHEM BIOL, V13, P811, DOI 10.1016/j.chembiol.2006.07.008; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	30	553	577	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					643	647		10.1038/nature05506	http://dx.doi.org/10.1038/nature05506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287809				2022-12-28	WOS:000244039400043
J	Reinhardt, UE				Reinhardt, Uwe E.			Is the president's plan dead before arrival? Bush's proposed health reforms would do little for the millions of low income, uninsured Americans	BRITISH MEDICAL JOURNAL			English	Editorial Material									Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Reinhardt, UE (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	reinhard@princeton.edu							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					238	238		10.1136/bmj.39112.449282.59	http://dx.doi.org/10.1136/bmj.39112.449282.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17272565	Green Published			2022-12-28	WOS:000244172400027
J	Schuster, DI; Houck, AA; Schreier, JA; Wallraff, A; Gambetta, JM; Blais, A; Frunzio, L; Majer, J; Johnson, B; Devoret, MH; Girvin, SM; Schoelkopf, RJ				Schuster, D. I.; Houck, A. A.; Schreier, J. A.; Wallraff, A.; Gambetta, J. M.; Blais, A.; Frunzio, L.; Majer, J.; Johnson, B.; Devoret, M. H.; Girvin, S. M.; Schoelkopf, R. J.			Resolving photon number states in a superconducting circuit	NATURE			English	Article							PHASE-SENSITIVE DETECTION; SINGLE QUANTUM-DOT; TRAPPED ATOM; CAVITY; ELECTRODYNAMICS; OSCILLATOR; COHERENCE; VACUUM	Electromagnetic signals are always composed of photons, although in the circuit domain those signals are carried as voltages and currents on wires, and the discreteness of the photon's energy is usually not evident. However, by coupling a superconducting quantum bit ( qubit) to signals on a microwave transmission line, it is possible to construct an integrated circuit in which the presence or absence of even a single photon can have a dramatic effect. Such a system(1) can be described by circuit quantum electrodynamics ( QED) - the circuit equivalent of cavity QED, where photons interact with atoms or quantum dots. Previously, circuit QED devices were shown to reach the resonant strong coupling regime, where a single qubit could absorb and re-emit a single photon many times(2). Here we report a circuit QED experiment in the strong dispersive limit, a new regime where a single photon has a large effect on the qubit without ever being absorbed. The hallmark of this strong dispersive regime is that the qubit transition energy can be resolved into a separate spectral line for each photon number state of the microwave field. The strength of each line is a measure of the probability of finding the corresponding photon number in the cavity. This effect is used to distinguish between coherent and thermal fields, and could be used to create a photon statistics analyser. As no photons are absorbed by this process, it should be possible to generate non-classical states of light by measurement and perform qubit - photon conditional logic, the basis of a logic bus for a quantum computer.	Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; Yale Univ, Dept Phys, New Haven, CT 06520 USA	Yale University; Yale University	Schoelkopf, RJ (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	Robert.Schoelkopf@yale.edu	Schoelkopf, Robert J/J-8178-2012; Wallraff, Andreas J/C-2130-2009; Frunzio, Luigi/O-1573-2019; Blais, Alexandre/E-3315-2010; Majer, Johannes B/C-1864-2008	Wallraff, Andreas J/0000-0002-3476-4485; Frunzio, Luigi/0000-0002-0272-5481; Blais, Alexandre/0000-0002-0591-2012; Majer, Johannes B/0000-0002-5192-1809; schuster, david/0000-0002-0012-3874				Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; BRUNE M, 1990, PHYS REV LETT, V65, P976, DOI 10.1103/PhysRevLett.65.976; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; BRUNE M, 1994, PHYS REV LETT, V72, P3339, DOI 10.1103/PhysRevLett.72.3339; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Dykman M. I., 1987, Soviet Physics - Solid State, V29, P210; Gambetta J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042318; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Irish EK, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155311; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Leibfried D, 1997, J MOD OPTIC, V44, P2485, DOI 10.1080/095003497152627; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Nogues G, 1999, NATURE, V400, P239, DOI 10.1038/22275; Ottl A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.090404; Peil S, 1999, PHYS REV LETT, V83, P1287, DOI 10.1103/PhysRevLett.83.1287; PURCELL EM, 1946, PHYS REV, V69, P681; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Siddiqi I, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054510; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Wallraff A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060501; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Walls D. F., 2006, QUANTUM OPTICS; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119	30	602	614	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					515	518		10.1038/nature05461	http://dx.doi.org/10.1038/nature05461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268464				2022-12-28	WOS:000243867300038
J	Aaron, SD; Vandemheen, KL; Fergusson, D; Maltais, F; Bourbeau, J; Goldstein, R; Balter, M; O'Donnell, D; McIvor, A; Sharma, S; Bishop, G; Anthony, J; Cowie, R; Field, S; Hirsch, A; Hernandez, P; Rivington, R; Road, J; Hoffstein, V; Hodder, R; Marciniuk, D; McCormack, D; Fox, G; Cox, G; Prins, HB; Ford, G; Bleskie, D; Doucette, S; Mayers, I; Chapman, K; Zamel, N; FitzGerald, M				Aaron, Shawn D.; Vandemheen, Katherine L.; Fergusson, Dean; Maltais, Francois; Bourbeau, Jean; Goldstein, Roger; Balter, Meyer; O'Donnell, Denis; McIvor, Andrew; Sharma, Sat; Bishop, Graham; Anthony, John; Cowie, Robert; Field, Stephen; Hirsch, Andrew; Hernandez, Paul; Rivington, Robert; Road, Jeremy; Hoffstein, Victor; Hodder, Richard; Marciniuk, Darcy; McCormack, David; Fox, George; Cox, Gerard; Prins, Henry B.; Ford, Gordon; Bleskie, Dominique; Doucette, Steve; Mayers, Irvin; Chapman, Kenneth; Zamel, Noe; FitzGerald, Mark			Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; COPD; PROPIONATE; EFFICACY; EXACERBATIONS; FORMOTEROL; XINAFOATE; SAFETY	Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD) with combinations of inhaled corticosteroids, long-acting beta-agonists, and long-acting anticholinergic bronchodilators is common but unstudied. Objective: To determine whether combining tiotropium with salmeterol or fluticasone-salmeterol improves clinical outcomes in adults with moderate to severe COPD compared with tiotropium alone. Design: Randomized, double-blind, placebo-controlled trial conducted from October 2003 to January 2006. Setting: 27 academic and community medical centers in Canada. Patients: 449 patients with moderate or severe COPD. Intervention: 1 year of treatment with tiotropium plus placebo, tiotropium plus salmeterol, or tiotropium plus fluticasone-salmeterol. Measurements: The primary end point was the proportion of patients who experienced an exacerbation of COPD that required treatment with systemic steroids or antibiotics. Results: The proportion of patients in the tiotropium plus placebo group who experienced an exacerbation (62.8%) did not differ from that in the tiotropium plus salmeterol group (64.8%; difference, -2.0 percentage points [95% CI, -12.8 to 8.8 percentage points]) or in the tiotropium plus fluticasone-salmeterol group (60.0%; difference, 2.8 percentage points [CI, -8.2 to 13.8 percentage points]). In sensitivity analyses, the point estimates and 95% confidence bounds shifted in the direction favoring tiotropium plus salmeterol and tiotropium plus fluticasone-salmeterol. Tiotropium plus fluticasone-salmeterol improved lung function (P = 0.049) and disease-specific quality of life (P = 0.01) and reduced the number of hospitalizations for COPD exacerbation (incidence rate ratio, 0.53 [CI, 0.33 to 0.86]) and all-cause hospitalizations (incidence rate ratio, 0.67 [CI, 0.45 to 0.99]) compared with tiotropium plus placebo. In contrast, tiotropium plus salmeterol did not statistically improve lung function or hospitalization rates compared with tiotropium plus placebo. Limitations: More than 40% of patients who received tiotropium plus placebo and tiotropium plus salmeterol discontinued therapy prematurely, and many crossed over to treatment with open-label inhaled steroids or long-acting beta-agonists. Conclusions: Addition of fluticasone-salmeterol to tiotropium therapy did not statistically influence rates of COPD exacerbation but did improve lung function, quality of life, and hospitalization rates in patients with moderate to severe COPD.	Ottawa Hosp, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Hlth Res Inst, Ottawa, ON K1N 6N5, Canada; Univ Toronto, Toronto, ON, Canada; McMaster Univ, Hamilton, ON L8S 4L8, Canada; Queens Univ, Kingston, ON K7L 3N6, Canada; Scarborough Centenary Hosp, Scarborough, ON, Canada; Univ Western Ontario, London, ON N6A 3K7, Canada; St Lawrence Med Clin, Morrisburg, ON, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Univ Laval, Hop Laval, Ctr Rech, Quebec City, PQ G1K 7P4, Canada; McGill Univ, Halifax, NS, Canada; Univ Manitoba, Winnipeg, MB R3T 2N2, Canada; Univ New Brunswick, St John, NB E2L 4L5, Canada; Univ Saskatchewan, Saskatoon, SK S7N 0W0, Canada; Univ Calgary, Calgary, AB T2N 1N4, Canada; Univ Alberta, Edmonton, AB T6G 2M7, Canada; Mem Univ Newfoundland, St John, NF, Canada; Woolcock Inst Med Res, Sydney, NSW, Australia	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; McMaster University; Queens University - Canada; Scarborough Hospital; Western University (University of Western Ontario); University of British Columbia; Laval University; McGill University; University of Manitoba; University of New Brunswick; University of Saskatchewan; University of Calgary; University of Alberta; Memorial University Newfoundland; University of Sydney; Woolcock Institute of Medical Research	Aaron, SD (corresponding author), Ottawa Hosp, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	saaron@ohri.ca	Mccormack, David/G-3331-2011; Willson, richard/AAD-4832-2019	Aaron, Shawn/0000-0002-4762-3542; Fergusson, Dean/0000-0002-3389-2485; Field, Stephen/0000-0002-6682-4155				Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161; Aaron Shawn D, 2004, Can Respir J, V11, P581; Alsaeedi A, 2002, AM J MED, V113, P59, DOI 10.1016/S0002-9343(02)01143-9; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2005, EUR RESPIR J, V26, P190, DOI 10.1183/09031936.05.00054905; Campbell S, 1999, ARCH INTERN MED, V159, P156, DOI 10.1001/archinte.159.2.156; *CAN THOR SOC, 2003, CAN RESP J SA, V10, pA11; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Donohue JF, 2002, CHEST, V122, P47, DOI 10.1378/chest.122.1.47; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Hanania NA, 2003, CHEST, V124, P834, DOI 10.1378/chest.124.3.834; Jackevicius CA, 1997, ANN PHARMACOTHER, V31, P160, DOI 10.1177/106002809703100204; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Moher D, 2001, ANN INTERN MED, V134, P657, DOI 10.7326/0003-4819-134-8-200104170-00011; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Pauwels R, 2002, AM J RESP CRIT CARE, V165, P1579, DOI 10.1164/rccm.2204029; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Scanlon PD, 2004, AM J RESP CRIT CARE, V170, P1302, DOI 10.1164/rccm.200310-1349OC; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; van Noord JA, 2006, CHEST, V129, P509, DOI 10.1378/chest.129.3.509; van Noord JA, 2005, EUR RESPIR J, V26, P214, DOI 10.1183/09031936.05.00140404; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702	30	495	525	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2007	146	8					545	U15		10.7326/0003-4819-146-8-200704170-00152	http://dx.doi.org/10.7326/0003-4819-146-8-200704170-00152			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	158FV	17310045				2022-12-28	WOS:000245778000001
J	Camici, PG; Crea, F				Camici, Paolo G.; Crea, Filippo			Medical progress - Coronary microvascular dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MYOCARDIAL BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; DISTAL EMBOLIC PROTECTION; NO-REFLOW PHENOMENON; HYPERTROPHIC CARDIOMYOPATHY; ANGINA-PECTORIS; VASODILATOR RESERVE; ARTERY-DISEASE; CHEST-PAIN; CARDIOVASCULAR-DISEASE		Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ Cattolica Sacro Cuore, Inst Cardiol, Rome, Italy	Imperial College London; Imperial College London; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Camici, PG (corresponding author), Hammersmith Hosp, MRC, Ctr Clin Sci, Du Cane Rd, London W12 0NN, England.	paolo.camici@csc.mrc.ac.uk	Camici, Paolo/AAN-1959-2020	Camici, Paolo/0000-0001-5584-0750; Weiss, Helen/0000-0003-3547-7936	Medical Research Council [MC_U120084164] Funding Source: Medline; MRC [MC_U120084164] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agati L, 2005, Eur J Echocardiogr, V6 Suppl 2, pS14, DOI 10.1016/S1525-2167(05)80724-3; [Anonymous], 2014, METABOLIC MOL BASES; Baim DS, 2002, CIRCULATION, V105, P1285, DOI 10.1161/01.CIR.0000012783.63093.0C; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; BRUSH JE, 1988, NEW ENGL J MED, V319, P1302, DOI 10.1056/NEJM198811173192002; Buffon A, 2000, AM J PHYSIOL-HEART C, V279, pH2627, DOI 10.1152/ajpheart.2000.279.6.H2627; Burzotta F, 2005, J AM COLL CARDIOL, V46, P371, DOI 10.1016/j.jacc.2005.04.057; CAMICI P, 1991, J AM COLL CARDIOL, V17, P879, DOI 10.1016/0735-1097(91)90869-B; CAMICI PG, 1991, CORONARY ARTERY DIS, V2, P837; CAMICI PG, 1991, J AM COLL CARDIOL, V17, P1461, DOI 10.1016/0735-1097(91)90632-J; Canetti M, 2003, AM J CARDIOL, V92, P1246, DOI 10.1016/j.amjcard.2003.08.002; CANNON RO, 1987, J AM COLL CARDIOL, V10, P53, DOI 10.1016/S0735-1097(87)80159-6; CANNON RO, 1992, CIRCULATION, V85, P883, DOI 10.1161/01.CIR.85.3.883; Carabello B A, 1995, J Heart Valve Dis, V4 Suppl 2, pS132; Cavallini C, 2005, EUR HEART J, V26, P1494, DOI 10.1093/eurheartj/ehi173; Cecchi F, 2003, NEW ENGL J MED, V349, P1027, DOI 10.1056/NEJMoa025050; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Chauhan A, 1997, EUR HEART J, V18, P60; Chilian WM, 1997, CIRCULATION, V95, P522; Choudhury L, 1997, EUR HEART J, V18, P108; Choudhury L, 1999, BASIC RES CARDIOL, V94, P49, DOI 10.1007/s003950050126; Crea F, 2004, HEART, V90, P457, DOI 10.1136/hrt.2003.020594; CREA F, 1989, LANCET, V1, P683; CREA F, 1994, AM HEART J, V127, P817, DOI 10.1016/0002-8703(94)90548-7; CREA F, 2006, ESC TXB CARDIOVASCUL, P391; CZERNIN J, 1995, CIRCULATION, V92, P197, DOI 10.1161/01.CIR.92.2.197; DAYANIKLI F, 1994, CIRCULATION, V90, P808, DOI 10.1161/01.CIR.90.2.808; DESILVA R, 1994, CARDIOVASC RES, V28, P1595; Di Carli MF, 2003, J AM COLL CARDIOL, V41, P1387, DOI 10.1016/S0735-1097(03)00166-9; ELTAMIMI H, 1991, CIRCULATION, V84, P2307, DOI 10.1161/01.CIR.84.6.2307; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; EPSTEIN SE, 1986, J AM COLL CARDIOL, V8, P459, DOI 10.1016/S0735-1097(86)80067-5; FEIGL EO, 1987, CIRCULATION, V76, P737, DOI 10.1161/01.CIR.76.4.737; Galiuto L, 2004, HEART, V90, P123, DOI 10.1136/hrt.2003.020800; GASPARDONE A, 1993, CIRCULATION, V88, P502, DOI 10.1161/01.CIR.88.2.502; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Gibson CM, 2002, CIRCULATION, V105, P1909, DOI 10.1161/01.CIR.0000014683.52177.B5; Gimelli A, 1998, J AM COLL CARDIOL, V31, P366, DOI 10.1016/S0735-1097(97)00503-2; GISTRI R, 1994, AM J CARDIOL, V74, P363, DOI 10.1016/0002-9149(94)90404-9; GOULD KL, 1994, CIRCULATION, V89, P1530, DOI 10.1161/01.CIR.89.4.1530; Gregorini L, 1999, CIRCULATION, V99, P482, DOI 10.1161/01.CIR.99.4.482; Gregorini L, 1998, J AM COLL CARDIOL, V31, P992, DOI 10.1016/S0735-1097(98)00055-2; HEUSCH G, 1985, J AUTONOM NERV SYST, V13, P311, DOI 10.1016/0165-1838(85)90020-7; Hozumi T, 1998, CIRCULATION, V97, P1557, DOI 10.1161/01.CIR.97.16.1557; Ikeda N, 2004, HEART, V90, P181, DOI 10.1136/hrt.2003.013789; Ito H, 1996, CIRCULATION, V93, P223, DOI 10.1161/01.CIR.93.2.223; Jagathesan R, 2005, J NUCL MED, V46, P212; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; JONAS MA, 1992, CIRCULATION, V86, P1664, DOI 10.1161/01.CIR.86.5.1664; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; Kaufmann PA, 2000, J AM COLL CARDIOL, V36, P103, DOI 10.1016/S0735-1097(00)00697-5; Kaufmann PA, 2000, CIRCULATION, V102, P1233, DOI 10.1161/01.CIR.102.11.1233; Kaufmann PA, 2005, J NUCL MED, V46, P75; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; KLONER RA, 1974, J CLIN INVEST, V54, P1496, DOI 10.1172/JCI107898; Kornowski R, 2003, CATHETER CARDIO INTE, V58, P364, DOI 10.1002/ccd.10447; KRUG A, 1966, CIRC RES, V19, P57, DOI 10.1161/01.RES.19.1.57; KUO L, 1990, CIRC RES, V66, P860, DOI 10.1161/01.RES.66.3.860; Lupi A, 1997, EUR HEART J, V18, P614; MARCUS ML, 1987, CIRCULATION, V75, P19; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; MARON BJ, 1979, AM J CARDIOL, V43, P1086, DOI 10.1016/0002-9149(79)90139-5; Marzilli M, 2002, J AM COLL CARDIOL, V40, P2102, DOI 10.1016/S0735-1097(02)02590-1; MASERI A, 1991, J AM COLL CARDIOL, V17, P499, DOI 10.1016/S0735-1097(10)80122-6; MERLET P, 1993, J NUCL MED, V34, P1899; Moon JC, 2005, HEART, V91, P1036, DOI 10.1136/hrt.2004.041384; Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119; NEGLIA D, 1995, CIRCULATION, V92, P796, DOI 10.1161/01.CIR.92.4.796; NITENBERG A, 1993, DIABETES, V42, P1017, DOI 10.2337/diabetes.42.7.1017; Olivotto I, 2006, J AM COLL CARDIOL, V47, P1043, DOI 10.1016/j.jacc.2005.10.050; Omran H, 1996, HEART, V75, P377, DOI 10.1136/hrt.75.4.377; OPHERK D, 1983, AM J CARDIOL, V51, P1657, DOI 10.1016/0002-9149(83)90205-9; OPHERK D, 1984, CIRCULATION, V69, P1, DOI 10.1161/01.CIR.69.1.1; Panza JA, 1997, J AM COLL CARDIOL, V29, P293, DOI 10.1016/S0735-1097(96)00481-0; PASTERNAC A, 1982, CIRCULATION, V65, P778, DOI 10.1161/01.CIR.65.4.778; Pitkanen OP, 1998, DIABETES, V47, P248, DOI 10.2337/diabetes.47.2.248; Prati F, 2003, CIRCULATION, V107, P2320, DOI 10.1161/01.CIR.0000066695.24697.07; PUPITA G, 1990, NEW ENGL J MED, V323, P514, DOI 10.1056/NEJM199008233230804; Rajappan K, 2002, CIRCULATION, V105, P470, DOI 10.1161/hc0402.102931; Rajappan K, 2003, CIRCULATION, V107, P3170, DOI 10.1161/01.CIR.0000074211.28917.31; Rimoldi O, 2000, J CARDIOVASC PHARM, V36, P310, DOI 10.1097/00005344-200009000-00005; Rosen SD, 2002, HEART, V87, P513, DOI 10.1136/heart.87.6.513; ROSEN SD, 1994, CIRCULATION, V90, P50, DOI 10.1161/01.CIR.90.1.50; SACKETT DL, 1968, NEW ENGL J MED, V279, P1413, DOI 10.1056/NEJM196812262792602; Sambuceti G, 2005, AM J PHYSIOL-HEART C, V288, pH2298, DOI 10.1152/ajpheart.00870.2004; SAMBUCETI G, 1993, AM J CARDIOL, V72, P990, DOI 10.1016/0002-9149(93)90850-C; SAMBUCETI G, 1994, CIRCULATION, V90, P1696, DOI 10.1161/01.CIR.90.4.1696; SCHWARTZKOPFF B, 1992, EUR HEART J, V13, P17, DOI 10.1093/eurheartj/13.suppl_D.17; Spyrou N, 2000, AM J PHYSIOL-HEART C, V279, pH2634, DOI 10.1152/ajpheart.2000.279.6.H2634; Stolen KQ, 2004, AM J CARDIOL, V93, P64, DOI 10.1016/j.amjcard.2003.08.074; STRAUER BE, 1979, AM J CARDIOL, V44, P999, DOI 10.1016/0002-9149(79)90235-2; Tomai F, 2005, EUR HEART J, V26, P2099, DOI 10.1093/eurheartj/ehi356; UREN NG, 1993, J AM COLL CARDIOL, V21, P612, DOI 10.1016/0735-1097(93)90092-F; UREN NG, 1993, J AM COLL CARDIOL, V22, P650, DOI 10.1016/0735-1097(93)90172-W; VOGT M, 1992, EUR HEART J, V13, P44, DOI 10.1093/eurheartj/13.suppl_D.44; WEISS MB, 1976, CIRCULATION, V54, P484, DOI 10.1161/01.CIR.54.3.484; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765; Yokoyama I, 1997, J AM COLL CARDIOL, V30, P1472, DOI 10.1016/S0735-1097(97)00327-6; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094	100	1136	1188	14	75	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					830	840		10.1056/NEJMra061889	http://dx.doi.org/10.1056/NEJMra061889			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314342				2022-12-28	WOS:000244326700009
J	Richardson, LJ; Deming, D; Horning, K; Seager, S; Harrington, J				Richardson, L. Jeremy; Deming, Drake; Horning, Karen; Seager, Sara; Harrington, Joseph			A spectrum of an extrasolar planet	NATURE			English	Article							SPITZER-SPACE-TELESCOPE; GIANT PLANETS; HD 209458B; INFRARED OBSERVATIONS; TRANSITING PLANET; SECONDARY ECLIPSE; THERMAL EMISSION; HOT JUPITERS; ATMOSPHERES; HD-209458B	Of the over 200 known extrasolar planets, 14 exhibit transits in front of their parent stars as seen from Earth. Spectroscopic observations of the transiting planets can probe the physical conditions of their atmospheres(1,2). One such technique(3,4) can be used to derive the planetary spectrum by subtracting the stellar spectrum measured during eclipse ( planet hidden behind star) from the combined-light spectrum measured outside eclipse ( star+planet). Although several attempts have been made from Earth-based observatories, no spectrum has yet been measured for any of the established extrasolar planets. Here we report a measurement of the infrared spectrum (7.5 - 13.2 mu m) of the transiting extrasolar planet HD 209458b. Our observations reveal a hot thermal continuum for the planetary spectrum, with an approximately constant ratio to the stellar flux over this wavelength range. Superposed on this continuum is a broad emission peak centred near 9.65 mu m that we attribute to emission by silicate clouds. We also find a narrow, unidentified emission feature at 7.78 mu m. Models of these 'hot Jupiter('5) planets predict a flux peak(6-9) near 10 mu m, where thermal emission from the deep atmosphere emerges relatively unimpeded by water absorption, but models dominated by water fit the observed spectrum poorly.	NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Planetary Syst Lab, Greenbelt, MD 20771 USA; Florida Inst Technol, Dept Phys & Space Sci, Melbourne, FL 32901 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Florida Institute of Technology; Carnegie Institution for Science; Massachusetts Institute of Technology (MIT); State University System of Florida; University of Central Florida	Richardson, LJ (corresponding author), NASA, Goddard Space Flight Ctr, Exoplanets & Stellar Astrophys Lab, Mail Code 667, Greenbelt, MD 20771 USA.	lee.richardson@colorado.edu	Harrington, Joseph/E-6250-2011	Harrington, Joseph/0000-0002-8955-8531				Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; Burrows A, 2005, NATURE, V433, P261, DOI 10.1038/nature03244; Burrows A, 1999, ASTROPHYS J, V512, P843, DOI 10.1086/306811; Charbonneau D, 2005, ASTROPHYS J, V626, P523, DOI 10.1086/429991; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Collier Cameron A, 2002, ASTRON GEOPHYS, V43, P21; Cushing MC, 2006, ASTROPHYS J, V648, P614, DOI 10.1086/505637; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Deming D, 2005, ASTROPHYS J, V622, P1149, DOI 10.1086/428376; Deming D, 2006, ASTROPHYS J, V644, P560, DOI 10.1086/503358; Dorschner J., 1971, ASTRON NACHR, V293, P53, DOI [10.1002/asna.19712930113, DOI 10.1002/ASNA.19712930113]; Fortney JJ, 2005, ASTROPHYS J, V627, pL69, DOI 10.1086/431952; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Hubeny I, 2003, ASTROPHYS J, V594, P1011, DOI 10.1086/377080; Kessler-Silacci J, 2006, ASTROPHYS J, V639, P275, DOI 10.1086/499330; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; MARLEY MS, 2006, ATMOSPHERES EXTRASOL; Richardson LJ, 2003, ASTROPHYS J, V597, P581, DOI 10.1086/378390; Richardson LJ, 2003, ASTROPHYS J, V584, P1053, DOI 10.1086/345813; Rothman LS, 2005, J QUANT SPECTROSC RA, V96, P139, DOI 10.1016/j.jqsrt.2004.10.008; Seager S, 2005, ASTROPHYS J, V632, P1122, DOI 10.1086/444411; Seager S, 2000, ASTROPHYS J, V540, P504, DOI 10.1086/309292; Sloan GC, 2005, ASTROPHYS J, V632, P956, DOI 10.1086/444371; Sudarsky D, 2003, ASTROPHYS J, V588, P1121, DOI 10.1086/374331; TARTER JC, 2006, HTTPARXIVORGASTROPH0; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; [No title captured]	30	154	155	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					892	895		10.1038/nature05636	http://dx.doi.org/10.1038/nature05636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314975	Green Submitted			2022-12-28	WOS:000244341200043
J	Boulware, LE; Marinopoulos, S; Phillips, KA; Hwang, CW; Maynor, K; Merenstein, D; Wilson, RF; Barnes, GJ; Bass, EB; Powe, NR; Daumit, GL				Boulware, L. Ebony; Marinopoulos, Spyridon; Phillips, Karran A.; Hwang, Constance W.; Maynor, Kenric; Merenstein, Dan; Wilson, Renee F.; Barnes, George J.; Bass, Eric B.; Powe, Neil R.; Daumit, Gail L.			Systematic review: The value of the periodic health evaluation	ANNALS OF INTERNAL MEDICINE			English	Review							PREVENTIVE-SERVICES; MEDICARE REIMBURSEMENT; PHYSICAL-EXAMINATION; PRIMARY-CARE; CANCER; WORRY; BEHAVIORS; DELIVERY; QUALITY; POPULATION	Background: The periodic health evaluation (PHE) has been a fundamental part of medical practice for decades despite a lack of consensus on its value. Purpose: To synthesize the evidence on benefits and harms of the PHE. Data Sources: Electronic searches of such databases as MEDLINE and the Cochrane Library, review of reference lists, and hand-searching of journals through September 2006. Study Selection: Studies (English-language only) assessing the delivery of preventive services, clinical outcomes, and costs among patients receiving the PHE versus those receiving usual care. Data Extraction: Study design and settings, descriptions of the PHE, and clinical outcomes associated with the PHE. Data Synthesis: The best available evidence assessing benefits or harms of the PHE consisted of 21 studies published from 1973 to 2004. The PHE had a consistently beneficial association with patient receipt of gynecologic examinations and Papanicolaou smears, cholesterol screening, and fecal occult blood testing. The PHE also had a beneficial effect on patient "worry" in 1 randomized, controlled trial but had mixed effects on other clinical outcomes and costs. Limitations: Descriptions of the PHE and outcomes were heterogeneous. Some trials were performed before U.S. Preventive Services Task Force guidelines were disseminated, limiting their applicability to modern practice. Conclusions: Evidence suggests that the PHE improves delivery of some recommended preventive services and may lessen patient worry. Although additional research is needed to clarify the long-term benefits, harms, and costs of receiving the PHE, evidence of benefits in this study justifies implementation of the PHE in clinical practice.	Johns Hopkins Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boulware, LE (corresponding author), 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	lboulwa@jhmi.edu	Marinopoulos, Spyridon/C-4541-2008	Boulware, Ebony/0000-0002-8650-4212; Bass, Eric/0000-0001-9106-527X				[Anonymous], 1995, BMJ, V310, P1099; [Anonymous], 1981, Ann Intern Med, V95, P729; BELCHER DW, 1990, ARCH INTERN MED, V150, P2533, DOI 10.1001/archinte.150.12.2533; BERNACKI EJ, 1988, J OCCUP ENVIRON MED, V30, P949; BOULWARE LE, 06E011 AHRQ; BURTON LC, 1995, PREV MED, V24, P492, DOI 10.1006/pmed.1995.1078; BURTON LC, 1995, AM J PUBLIC HEALTH, V85, P387, DOI 10.2105/AJPH.85.3.387; Burton LC, 1997, MED CARE, V35, P1149, DOI 10.1097/00005650-199711000-00006; Burton WN, 2002, J OCCUP ENVIRON MED, V44, P737, DOI 10.1097/00043764-200208000-00008; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Chiou CJ, 2002, PREV MED, V35, P264, DOI 10.1006/pmed.2002.1080; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Collen M F, 1973, Prev Med, V2, P236, DOI 10.1016/0091-7435(73)90067-4; CUTLER J L, 1973, Preventive Medicine, V2, P197, DOI 10.1016/0091-7435(73)90064-9; DALES LG, 1979, J CHRON DIS, V32, P385, DOI 10.1016/0021-9681(79)90080-8; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dijkstra A, 2003, BEHAV RES THER, V41, P1081, DOI 10.1016/S0005-7967(02)00244-9; Elder JP, 1995, AM J PREV MED, V11, P354, DOI 10.1016/S0749-3797(18)30412-4; Faulkner LA, 1997, AM J PREV MED, V13, P453, DOI 10.1016/S0749-3797(18)30141-7; Finkelstein MM, 2002, CAN FAM PHYSICIAN, V48, P1494; FLETCHER SW, 1977, JAMA-J AM MED ASSOC, V237, P887, DOI 10.1001/jama.237.9.887; Flocke SA, 2004, PREV MED, V38, P343, DOI 10.1016/j.ypmed.2003.11.004; Freedman A, 2000, CAN FAM PHYSICIAN, V46, P350; FRIEDMAN GD, 1986, J CHRON DIS, V39, P453, DOI 10.1016/0021-9681(86)90112-8; Geiger W J, 1993, Fam Med, V25, P447; GRIMALDI JV, 1965, J GNATHOL, V56, P365; Hahn DL, 1999, J FAM PRACTICE, V48, P785; Hama Y, 2001, MIL MED, V166, P721, DOI 10.1093/milmed/166.8.721; Harris R, 2003, ANN INTERN MED, V138, P215, DOI 10.7326/0003-4819-138-3-200302040-00015; Holland W., 1977, INT J EPIDEMIOL, V6, P357; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Hvas L, 2005, SCAND J PUBLIC HEALT, V33, P203, DOI 10.1080/14034940510005716; Kottke TE, 1997, MAYO CLIN PROC, V72, P515, DOI 10.4065/72.6.515; Kroll U, 2001, INT J EPIDEMIOL, V30, P935; Lin H, 2004, J ENVIRON SCI-CHINA, V16, P462; McCarthy BD, 1996, AM J PREV MED, V12, P91, DOI 10.1016/S0749-3797(18)30350-7; McCaul KD, 1996, HEALTH PSYCHOL, V15, P430, DOI 10.1037/0278-6133.15.6.430; Merenstein D, 2006, AM J PREV MED, V30, P521, DOI 10.1016/j.amepre.2006.02.003; MORRISSEY JP, 1995, MED CARE, V33, P315, DOI 10.1097/00005650-199504000-00001; Nakanishi N, 1996, SOC SCI MED, V43, P999, DOI 10.1016/0277-9536(96)00016-0; Nutting P A, 2001, J Am Board Fam Pract, V14, P352; Parchman M, 2001, J HEALTH CARE POOR U, V12, P404; Patrick DL, 1999, HEALTH CARE FINANC R, V20, P25; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; ROBERTS NJ, 1969, NEW ENGL J MED, V281, P20, DOI 10.1056/NEJM196907032810105; Schneider GW, 2003, AM J MED QUAL, V18, P82, DOI 10.1177/106286060301800206; Sheridan S, 2003, AM J PREV MED, V25, P151, DOI 10.1016/S0749-3797(03)00121-1; SLESINGER DP, 1976, MED CARE, V14, P392, DOI 10.1097/00005650-197605000-00002; Somkin CP, 2004, MED CARE, V42, P914, DOI 10.1097/01.mlr.0000135832.28672.61; Sox CH, 1997, ARCH FAM MED, V6, P223, DOI 10.1001/archfami.6.3.223; Stange KC, 2000, PREV MED, V31, P167, DOI 10.1006/pmed.2000.0700; STONE DH, 1981, ISRAEL J MED SCI, V17, P215; Tao GY, 2001, AM J PREV MED, V21, P291, DOI 10.1016/S0749-3797(01)00366-X; Theobald H, 1998, INT J EPIDEMIOL, V27, P194, DOI 10.1093/ije/27.2.194; *US DEP HLTH HUM S, 2006, PREV MAK COMM CENTS; Wilcox S, 2002, WOMEN HEALTH, V36, P83, DOI 10.1300/J013v36n03_06; Williams RB, 1998, ARCH FAM MED, V7, P338, DOI 10.1001/archfami.7.4.338; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635	58	118	119	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					289	300		10.7326/0003-4819-146-4-200702200-00008	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137CS	17310053				2022-12-28	WOS:000244271000007
J	Knapp, S				Knapp, Sandra			Anthropology - Some like it hot	SCIENCE			English	Editorial Material							SOLANACEAE		Nat Hist Museum, Dept Bot, London SW7 5BD, England	Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, Dept Bot, Cromwell Rd, London SW7 5BD, England.	s.knapp@nhm.ac.uk	Knapp, Sandra/A-4856-2011	Knapp, Sandra/0000-0001-7698-3945				Barboza GE, 2005, SYST BOT, V30, P863, DOI 10.1600/036364405775097905; DE AK, 2003, CAPSICUM; Knapp S, 2002, J EXP BOT, V53, P2001, DOI 10.1093/jxb/erf068; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; Pickersgill B., 1979, The biology and taxonomy of the Solanaceae, P679; SYMON DE, 1991, SOLANACEAE, V3, P197; Tewksbury JJ, 2006, J CHEM ECOL, V32, P547, DOI 10.1007/s10886-005-9017-4	8	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					946	947		10.1126/science.1138308	http://dx.doi.org/10.1126/science.1138308			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303740				2022-12-28	WOS:000244229800027
J	Sadlier, LG; Scheffer, IE				Sadleir, Lynette G.; Scheffer, Ingrid E.			Febrile seizures	BMJ-BRITISH MEDICAL JOURNAL			English	Review							UNPROVOKED SEIZURES; RECTAL DIAZEPAM; CHILDREN; EPILEPSY; CONVULSIONS; PREDICTORS; MIDAZOLAM; EFFICACY; RISK		Univ Melbourne, Austin Hlth & Royal Childrens Hosp, Dept Med, Melbourne, Vic, Australia; Univ Melbourne, Austin Hlth & Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; Univ Otago, Wellington Sch Med, Dept Paediat, Wellington, New Zealand	Austin Research Institute; University of Melbourne; Austin Research Institute; University of Melbourne; University of Otago	Scheffer, IE (corresponding author), Univ Melbourne, Austin Hlth & Royal Childrens Hosp, Dept Med, Melbourne, Vic, Australia.	scheffer@unimelb.edu.au	Scheffer, Ingrid E/G-1668-2013	Scheffer, Ingrid E/0000-0002-2311-2174; Sadleir, Lynette/0000-0002-5355-7115				American Academy of Pediatrics. Provisional Commit- tee on Quality Improvement Subcommittee on Febrile Seizures, 1996, PEDIATRICS, V97, P73; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; [Anonymous], 1999, Pediatrics, V103, P1307; Audenaert D, 2006, HUM MUTAT, V27, P391, DOI 10.1002/humu.20279; Berg AT, 1996, EPILEPSIA, V37, P126, DOI 10.1111/j.1528-1157.1996.tb00003.x; BERG AT, 1993, AM J DIS CHILD, V147, P1101, DOI 10.1001/archpedi.1993.02160340087020; Berg AT, 1997, ARCH PEDIAT ADOL MED, V151, P371, DOI 10.1001/archpedi.1997.02170410045006; Berg AT, 1996, NEUROLOGY, V47, P562, DOI 10.1212/WNL.47.2.562; Bergman DA, 1996, PEDIATRICS, V97, P769; Bhattacharyya M, 2006, PEDIATR NEUROL, V34, P355, DOI 10.1016/j.pediatrneurol.2005.09.006; Chang YC, 2001, NEUROLOGY, V57, P37, DOI 10.1212/WNL.57.1.37; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Gordon KE, 2001, PEDIATRICS, V108, P1080, DOI 10.1542/peds.108.5.1080; Kjeldsen MJ, 2002, EPILEPSY RES, V51, P167, DOI 10.1016/S0920-1211(02)00121-3; Lewis DV, 2005, EPILEPSIA, V46, P39, DOI 10.1111/j.1528-1167.2005.00306.x; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; Narula S, 2005, NEUROLOGY, V64, P169, DOI 10.1212/01.WNL.0000148721.26156.18; NELSON KB, 1976, NEW ENGL J MED, V295, P1029, DOI 10.1056/NEJM197611042951901; OFFRINGA M, 1994, J PEDIATR-US, V124, P574, DOI 10.1016/S0022-3476(05)83136-1; Scott RC, 2003, BRAIN, V126, P2551, DOI 10.1093/brain/awg262; Shinnar S, 2002, J CHILD NEUROL, V17, pS44, DOI 10.1177/08830738020170010601; Sloviter RS, 2004, EPILEPSY RES, V59, P123, DOI 10.1016/j.eplepsyres.2004.04.001; Teng D, 2006, PEDIATRICS, V117, P304, DOI 10.1542/peds.2005-0759; Uemura N, 2002, BRAIN DEV-JPN, V24, P745, DOI 10.1016/S0387-7604(02)00097-9; Waruiru C, 2004, ARCH DIS CHILD, V89, P751, DOI 10.1136/adc.2003.028449	26	105	114	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2007	334	7588					307	311		10.1136/bmj.39087.691817.AE	http://dx.doi.org/10.1136/bmj.39087.691817.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MN	17289734	Green Published			2022-12-28	WOS:000244654100040
J	Iwasaki, A				Iwasaki, Akiko			Division of labor by dendritic cells	CELL			English	Editorial Material							CROSS-PRESENTATION; LYMPH-NODE; T-CELLS; ANTIGEN; IMMUNITY; CD8(+)		Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856				Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; den Haan JMM, 2000, J EXP MED, V192, P1685, DOI 10.1084/jem.192.12.1685; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					435	436		10.1016/j.cell.2007.01.024	http://dx.doi.org/10.1016/j.cell.2007.01.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289563	Bronze			2022-12-28	WOS:000244842700010
J	Kearns, DB				Kearns, Daniel B.			Bright insight into bacterial gliding	SCIENCE			English	Editorial Material							MYXOCOCCUS-XANTHUS; MOTILITY	A tank tread-like motion of successive adhesions provides the force needed to propel a rod-shaped bacterium.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Kearns, DB (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dbkearns@indiana.edu		Kearns, Daniel/0000-0002-3460-8378				BURCHARD AC, 1977, J BACTERIOL, V132, P666, DOI 10.1128/JB.132.2.666-672.1977; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Freese A, 1997, J BACTERIOL, V179, P1246, DOI 10.1128/jb.179.4.1246-1252.1997; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052; Sun H, 1999, P NATL ACAD SCI USA, V96, P15178, DOI 10.1073/pnas.96.26.15178; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x	8	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					773	774		10.1126/science.1138995	http://dx.doi.org/10.1126/science.1138995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289965				2022-12-28	WOS:000244069000033
J	Jaglinski, T; Kochmann, D; Stone, D; Lakes, RS				Jaglinski, T.; Kochmann, D.; Stone, D.; Lakes, R. S.			Composite materials with viscoelastic stiffness greater than diamond	SCIENCE			English	Article							THERMAL-EXPANSION; INSTABILITY	We show that composite materials can exhibit a viscoelastic modulus (Young's modulus) that is far greater than that of either constituent. The modulus, but not the strength, of the composite was observed to be substantially greater than that of diamond. These composites contain barium-titanate inclusions, which undergo a volume-change phase transformation if they are not constrained. In the composite, the inclusions are partially constrained by the surrounding metal matrix. The constraint stabilizes the negative bulk modulus (inverse compressibility) of the inclusions. This negative modulus arises from stored elastic energy in the inclusions, in contrast to periodic composite metamaterials that exhibit negative refraction by inertial resonant effects. Conventional composites with positive-stiffness constituents have aggregate properties bounded by a weighted average of constituent properties; their modulus cannot exceed that of the stiffest constituent.	Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA; Washington State Univ, Inst Shock Phys, Pullman, WA 99163 USA; Ruhr Univ Bochum, Inst Mech, D-44780 Bochum, Germany; Univ Wisconsin, Dept Mat Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Washington State University; Ruhr University Bochum; University of Wisconsin System; University of Wisconsin Madison	Lakes, RS (corresponding author), Univ Wisconsin, Dept Engn Phys, 541 Engn Res Bldg,1500 Engn Dr, Madison, WI 53706 USA.	lakes@engr.wisc.edu	Kochmann, Dennis/A-6827-2012	Kochmann, Dennis/0000-0002-9112-6615; Stone, Donald/0000-0002-3388-2594				Baughman RH, 1998, NATURE, V392, P362, DOI 10.1038/32842; Cosserat E, 1898, CR HEBD ACAD SCI, V126, P1089; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; Hashin Z., 1962, J APPL MECH, V29, P143, DOI DOI 10.1115/1.3636446; Jaglinski T, 2004, PHIL MAG LETT, V84, P803, DOI 10.1080/09500830500040981; LAKES R, 1993, J MATER SCI, V28, P4667, DOI 10.1007/BF00414256; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Lakes RS, 2001, PHYS REV LETT, V86, P2897, DOI 10.1103/PhysRevLett.86.2897; Lakes RS, 2002, J MECH PHYS SOLIDS, V50, P979, DOI 10.1016/S0022-5096(01)00116-8; Lakes RS, 2001, PHIL MAG LETT, V81, P95, DOI 10.1080/09500830010015332; Lakes RS, 2001, NATURE, V410, P565, DOI 10.1038/35069035; Landau L.D., 1965, COLLECTED PAPERS LD, P193; Lee T, 2000, REV SCI INSTRUM, V71, P2855, DOI 10.1063/1.1150703; Moore B, 2006, PHIL MAG LETT, V86, P651, DOI 10.1080/09500830600957340; ROSEN BW, 1970, INT J ENG SCI, V8, P157, DOI 10.1016/0020-7225(70)90066-2; THOMPSON JMT, 1979, PHILOS T R SOC A, V292, P1, DOI 10.1098/rsta.1979.0043; VANDERWAALS J, 1988, THESIS U LEIDEN; Yang Y, 2004, MAT SCI ENG A-STRUCT, V380, P378, DOI 10.1016/j.msea.2004.03.073; YEGANEHHAERI A, 1992, SCIENCE, V257, P650, DOI 10.1126/science.257.5070.650; [No title captured]	21	139	141	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					620	622		10.1126/science.1135837	http://dx.doi.org/10.1126/science.1135837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272714				2022-12-28	WOS:000243909400035
J	Todd, JD; Rogers, R; Li, YG; Wexler, M; Bond, PL; Sun, L; Curson, ARJ; Malin, G; Steinke, M; Johnston, AWB				Todd, Jonathan D.; Rogers, Rachel; Li, You Guo; Wexler, Margaret; Bond, Philip L.; Sun, Lei; Curson, Andrew R. J.; Malin, Gill; Steinke, Michael; Johnston, Andrew W. B.			Structural and regulatory genes required to make the gas dimethyl sulfide in bacteria	SCIENCE			English	Article							HIGHER-PLANTS; DMSP; DIMETHYLSULFONIOPROPIONATE; DIMETHYLSULPHONIOPROPIONATE; ENVIRONMENT; METABOLISM; RHIZOBIUM; SULFUR; FLUX	Dimethyl sulfide (DMS) is a key compound in global sulfur and carbon cycles. DMS oxidation products cause cloud nucleation and may affect weather and climate. DMS is generated largely by bacterial catabolism of dimethylsulfoniopropionate (DMSP), a secondary metabolite made by marine algae. We demonstrate that the bacterial gene dddD is required for this process and that its transcription is induced by the DMSP substrate. Cloned dddD from the marine bacterium Marinomonas and from two bacterial strains that associate with higher plants, the N-2-fixing symbiont Rhizobium NGR234 and the root-colonizing Burkholderia cepacia AMMD, conferred to Escherichia coli the ability to make DMS from DMSP. The inferred enzymatic mechanism for DMS liberation involves an initial step in which DMSP is modified by addition of acyl coenzyme A, rather than the immediate release of DMS by a DMSP lyase, the previously suggested mechanism.	Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia; University of East Anglia	Johnston, AWB (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Curson, Andrew RJ/B-8964-2009; Todd, Jonathan/B-8967-2009; Bond, Philip/C-6046-2009; Bond, Philip/N-6649-2017; Wexler, Margaret/G-3423-2011; Rogers, Rachel/GVT-5579-2022; Malin, Gill/C-6985-2009; Johnston, Andrew W B/D-1859-2009; Steinke, Michael/A-6137-2012	Todd, Jonathan/0000-0003-0777-9312; Bond, Philip/0000-0002-9025-4797; Malin, Gill/0000-0002-3639-9215; Steinke, Michael/0000-0001-6820-0154	Natural Environment Research Council [NE/B501039/1, NER/T/S/2001/00253, NE/B500282/1] Funding Source: researchfish; BBSRC [BB/E01688X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01688X/1] Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ansede JH, 2001, APPL ENVIRON MICROB, V67, P1210, DOI 10.1128/AEM.67.3.1210-1217.2001; Ansede JH, 2001, APPL ENVIRON MICROB, V67, P3134, DOI 10.1128/AEM.67.7.3134-3139.2001; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; KIENE RP, 1990, APPL ENVIRON MICROB, V56, P3292, DOI 10.1128/AEM.56.11.3292-3297.1990; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Pueppke SG, 1999, MOL PLANT MICROBE IN, V12, P293, DOI 10.1094/MPMI.1999.12.4.293; Ramette A, 2005, APPL ENVIRON MICROB, V71, P1193, DOI 10.1128/AEM.71.3.1193-1201.2005; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; REED RH, 1983, MAR BIOL LETT, V4, P173; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; STEFELS J, IN PRESS BIOGEOCHEMI; Steinke M, 2006, LIMNOL OCEANOGR, V51, P1925, DOI 10.4319/lo.2006.51.4.1925; TRINICK MJ, 1973, NATURE, V244, P459, DOI 10.1038/244459a0; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002	21	200	209	2	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					666	669		10.1126/science.1135370	http://dx.doi.org/10.1126/science.1135370			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272727				2022-12-28	WOS:000243909400049
J	Sanderson, K				Sanderson, Katharine			Display of flexibility	NATURE			English	News Item																			0	10	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					473	473		10.1038/445473a	http://dx.doi.org/10.1038/445473a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268444	Bronze			2022-12-28	WOS:000243867300013
J	Kmietowicz, Z; Berwick, D; Pollock, A; Dixon, J; Ford, S; Carter, P; Ham, C				Kmietowicz, Zosia; Berwick, Donald; Pollock, Allyson; Dixon, Jennifer; Ford, Steven; Carter, Peter; Ham, Chris			One year to save the NHS: what would you do?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Healthcare Improvement, Cambridge, MA USA; Univ Edinburgh, Ctr Int Publ Hlth Policy, Edinburgh EH8 9YL, Midlothian, Scotland; Kings Fund, London, England; Haydon & Allen Valley Med Practice, Hexham, Northd, England; Royal Coll Nursing UK, London, England; Univ Birmingham, Birmingham B15 2TT, W Midlands, England	Institute for Healthcare Improvement; University of Edinburgh; University of Birmingham									0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					180	181		10.1136/bmj.39101.713704.47	http://dx.doi.org/10.1136/bmj.39101.713704.47			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255607	Green Published			2022-12-28	WOS:000244027600028
J	Fraser, C; Hanage, WP; Spratt, BG				Fraser, Christophe; Hanage, William P.; Spratt, Brian G.			Recombination and the nature of bacterial speciation	SCIENCE			English	Review							GENETIC EXCHANGE; HOMOLOGOUS RECOMBINATION; SEXUAL ISOLATION; SEQUENCE; POPULATIONS; DIVERGENCE; DIVERSITY; IDENTITY; BARRIERS	Genetic surveys reveal the diversity of bacteria and lead to the questioning of species concepts used to categorize bacteria. One difficulty in defining bacterial species arises from the high rates of recombination that results in the transfer of DNA between relatively distantly related bacteria. Barriers to this process, which could be used to define species naturally, are not apparent. Here, we review conceptual models of bacterial speciation and describe our computer simulations of speciation. Our findings suggest that the rate of recombination and its relation to genetic divergence have a strong influence on outcomes. We propose that a distinction be made between clonal divergence and sexual speciation. Hence, to make sense of bacterial diversity, we need data not only from genetic surveys but also from experimental determination of selection pressures and recombination rates and from theoretical models.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Fraser, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	c.fraser@imperial.ac.uk	Hanage, Bill/CAF-1813-2022; Spratt, Brian G/A-1676-2009; Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657	Wellcome Trust [030662] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; COHAN FM, 1994, AM NAT, V143, P965, DOI 10.1086/285644; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Datta A, 1997, P NATL ACAD SCI USA, V94, P9757, DOI 10.1073/pnas.94.18.9757; Drake JW, 1998, GENETICS, V148, P1667; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fraser C, 2005, P NATL ACAD SCI USA, V102, P1968, DOI 10.1073/pnas.0406993102; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Hanage WP, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-6; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; HANAGE WP, 2006, PHILOS T R SOC LON B, P361; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Majewski J, 1999, GENETICS, V153, P1525; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; MAYNARDSMITH J, 1991, P ROY SOC LOND B BIO, V245, P37; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mayr E, 1942, SYSTEMATICS ORIGIN S; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SHEN P, 1986, GENETICS, V112, P441; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Zahrt TC, 1997, P NATL ACAD SCI USA, V94, P9786, DOI 10.1073/pnas.94.18.9786; ZAWADZKI P, 1995, GENETICS, V140, P917	33	356	369	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					476	480		10.1126/science.1127573	http://dx.doi.org/10.1126/science.1127573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255503	Green Submitted, Green Accepted			2022-12-28	WOS:000243726600035
J	Wadman, M				Wadman, Meredith			Biomedical agency feels the pinch - again	NATURE			English	News Item																		2006, NATURE, V443, P894	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 11	2007	445	7124					130	130						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QF	17262926				2022-12-28	WOS:000243384300015
J	Lumpkin, EA; Caterina, MJ				Lumpkin, Ellen A.; Caterina, Michael J.			Mechanisms of sensory transduction in the skin	NATURE			English	Review							HAIR-CELL MECHANOTRANSDUCTION; ION-CHANNEL TRPA1; VANILLOID RECEPTOR; CATION CHANNEL; MICE LACKING; CAENORHABDITIS-ELEGANS; NOCICEPTIVE NEURONS; EPITHELIAL-CELLS; TOUCH SENSATION; NERVE-FIBERS	Sensory neurons innervating the skin encode the familiar sensations of temperature, touch and pain. An explosion of progress has revealed unanticipated cellular and molecular complexity in these senses. It is now clear that perception of a single stimulus, such as heat, requires several transduction mechanisms. Conversely, a given protein may contribute to multiple senses, such as heat and touch. Recent studies have also led to the surprising insight that skin cells might transduce temperature and touch. To break the code underlying somatosensation, we must therefore understand how the skin's sensory functions are divided among signalling molecules and cell types.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Human Genet, Houston, TX 77030 USA; Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Lumpkin, EA (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	lumpkin@bcm.edu; caterina@jhmi.edu		Lumpkin, Ellen/0000-0002-1166-3374	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR051219, R01 AR051219-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Biro T, 2006, J INVEST DERMATOL, V126, P1909, DOI 10.1038/sj.jid.5700321; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; Cahusac PMB, 2005, NEUROSCIENCE, V133, P763, DOI 10.1016/j.neuroscience.2005.03.018; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chateau Y, 2004, EXP DERMATOL, V13, P2, DOI 10.1111/j.0906-6705.2004.00158.x; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; Fagan BM, 2001, NEUROREPORT, V12, P341, DOI 10.1097/00001756-200102120-00032; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P430; Gopfert MC, 2006, NAT NEUROSCI, V9, P999, DOI 10.1038/nn1735; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kahn-Kirby AH, 2006, ANNU REV PHYSIOL, V68, P719, DOI 10.1146/annurev.physiol.68.040204.100715; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Khodorova A, 2003, NAT MED, V9, P1055, DOI 10.1038/nm885; Khodorova A, 2002, J NEUROSCI, V22, P7788; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2005, PFLUG ARCH EUR J PHY, V451, P176, DOI 10.1007/s00424-005-1449-8; Lumpkin EA, 2005, CURR OPIN NEUROBIOL, V15, P382, DOI 10.1016/j.conb.2005.06.005; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Muraki K, 2003, CIRC RES, V93, P829, DOI 10.1161/01.RES.0000097263.10220.0C; Naeini RS, 2006, NAT NEUROSCI, V9, P93, DOI 10.1038/nn1614; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Roper SD, 2006, CELL MOL LIFE SCI, V63, P1494, DOI 10.1007/s00018-006-6112-9; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sekerkova G, 2004, J NEUROSCI, V24, P5445, DOI 10.1523/JNEUROSCI.1279-04.2004; Shin JB, 2005, P NATL ACAD SCI USA, V102, P12572, DOI 10.1073/pnas.0502403102; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Szallasi A, 2006, TRENDS MOL MED, V12, P545, DOI 10.1016/j.molmed.2006.09.001; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wallis D, 2003, DEVELOPMENT, V130, P221, DOI 10.1242/dev.00190; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Zimmermann K, 2005, NEUROSCIENCE, V135, P1277, DOI 10.1016/j.neuroscience.2005.07.018; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	83	515	529	5	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					858	865		10.1038/nature05662	http://dx.doi.org/10.1038/nature05662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314972				2022-12-28	WOS:000244341200036
J	Mullan, F				Mullan, Fitzhugh			Responding to the global HIV/AIDS crisis - A peace corps for health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									George Washington Univ, Dept Hlth Policy, Washington, DC 20006 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Dept Hlth Policy, Suite 800,2021 K St NW, Washington, DC 20006 USA.	fmullan@gwu.edu						*AM INT HLTH ALL, WHAT IS TWINN; *ASS AM MED COLL, MED SCH GRAD QUEST 1; *BAYL INT PED AIDS, PED AIDS CORPS; *CTR GLOB DEV, COMM DEV IND 2006; *HJ KAIS FAM FDN, 2006, US FED FUND HIV AIDS; *I MED, 2005, HEAL ABROAD RESP HUM; *MED STUD ED, COST DEBT RES STIP F; PEPFAR, US PRES EM PLAN AIDS; Tuturu, 2020, COMM CONS HLTH ED; WHO, 2006, WORLD HLTH REP 20O6, P190; *WHO, 2006, AFR REG REP HLTH PEO; WOLK M, 2006, COST IRAQ WAR COULD	12	16	17	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					744	746		10.1001/jama.297.7.744	http://dx.doi.org/10.1001/jama.297.7.744			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312295				2022-12-28	WOS:000244291100028
J	Day, M				Day, Michael			Who's funding WHO? WHO guidelines state that it will not accept money from drug companies, but how rigorous is it in enforcing this?	BRITISH MEDICAL JOURNAL			English	Article																		Medawar C., 2004, MED OUT CONTROL ANTI; *WHO, 1996, RAT US BENZ	2	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					338	340		10.1136/bmj.39119.519664.BE	http://dx.doi.org/10.1136/bmj.39119.519664.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303876	Green Published			2022-12-28	WOS:000244560400025
J	Striemer, CC; Gaborski, TR; McGrath, JL; Fauchet, PM				Striemer, Christopher C.; Gaborski, Thomas R.; McGrath, James L.; Fauchet, Philippe M.			Charge- and size-based separation of macromolecules using ultrathin silicon membranes	NATURE			English	Article							MOLECULAR-TRANSPORT; ULTRAFILTRATION; CRYSTALLIZATION; NANOCOMPOSITE; DIFFUSION	Commercial ultrafiltration and dialysis membranes have broad pore size distributions and are over 1,000 times thicker than the molecules they are designed to separate, leading to poor size cutoff properties, filtrate loss within the membranes, and low transport rates(1,2). Nanofabricated membranes have great potential in molecular separation applications by offering more precise structural control(3,4), yet transport is also limited by micrometre-scale thicknesses(5). This limitation can be addressed by a new class of ultrathin nanostructured membranes where the membrane is roughly as thick (similar to 10 nm) as the molecules being separated, but membrane fragility and complex fabrication have prevented the use of ultrathin membranes for molecular separations(1). Here we report the development of an ultrathin porous nanocrystalline silicon (pnc-Si) membrane using straightforward silicon fabrication techniques that provide control over average pore sizes from approximately 5 nm to 25 nm. Our pnc-Si membranes can retain proteins while permitting the transport of small molecules at rates an order of magnitude faster than existing materials, separate differently sized proteins under physiological conditions, and separate similarly sized molecules carrying different charges. Despite being only 15 nm thick, pnc-Si membranes that are free-standing over 40,000 mu m(2) can support a full atmosphere of differential pressure without plastic deformation or fracture. By providing efficient, low-loss macromolecule separations, pnc-Si membranes are expected to enable a variety of new devices, including membrane-based chromatography systems and both analytical and preparative microfluidic systems that require highly efficient separations.	Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA; Univ Rochester, Dept Biomed Engn, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Striemer, CC (corresponding author), Univ Rochester, Dept Elect & Comp Engn, 601 Elmwood Ave, Rochester, NY 14627 USA.	striemer@ece.rochester.edu	Gaborski, Thomas/F-4306-2012	McGrath, James/0000-0003-2017-8335				BERG HC, 1993, RANDOM WALKS BIOL, P34; Grom GF, 2000, NATURE, V407, P358, DOI 10.1038/35030062; Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212; Karlsson D, 2002, BIOTECHNOL PROGR, V18, P1423, DOI 10.1021/bp0255659; Ku JR, 2004, LANGMUIR, V20, P2030, DOI 10.1021/la0357662; Kuiper S, 1998, J MEMBRANE SCI, V150, P1, DOI 10.1016/S0376-7388(98)00197-5; Lee SB, 2002, J AM CHEM SOC, V124, P11850, DOI 10.1021/ja027494f; Letant SE, 2003, NAT MATER, V2, P391, DOI 10.1038/nmat888; Li QY, 1997, J MEMBRANE SCI, V136, P181, DOI 10.1016/S0376-7388(97)00159-2; Mace CR, 2006, ANAL CHEM, V78, P5578, DOI 10.1021/ac060473+; Martin F, 2005, J CONTROL RELEASE, V102, P123, DOI 10.1016/j.jconrel.2004.09.024; Ouyang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196069; Palik E. D., 1985, HDB OPTICAL CONSTANT, DOI 10.1016/C2009-0-20920-2; Pujar NS, 1998, J CHROMATOGR A, V796, P229, DOI 10.1016/S0021-9673(97)01003-0; REISMAN A, 1979, J ELECTROCHEM SOC, V126, P1406, DOI 10.1149/1.2129289; Spinella C, 1998, J APPL PHYS, V84, P5383, DOI 10.1063/1.368873; Tong HD, 2004, NANO LETT, V4, P283, DOI 10.1021/nl0350175; Yamaguchi A, 2004, NAT MATER, V3, P337, DOI 10.1038/nmat1107; Zacharias M, 1999, APPL PHYS LETT, V74, P2614, DOI 10.1063/1.123914; Zacharias M, 2001, PHYSICA E, V11, P245, DOI 10.1016/S1386-9477(01)00212-0	20	598	628	10	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					749	753		10.1038/nature05532	http://dx.doi.org/10.1038/nature05532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301789				2022-12-28	WOS:000244205200041
J	Coombes, R				Coombes, Rebecca			FDA tightens its grip on drug regulation	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 10	2007	334	7588					290	291		10.1136/bmj.39119.546181.59	http://dx.doi.org/10.1136/bmj.39119.546181.59			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MN	17289729	Green Published			2022-12-28	WOS:000244654100028
J	Rees, PM; Fowler, CJ; Maas, CP				Rees, Peter M.; Fowler, Clare J.; Maas, Cornelis P.			Sexual Dysfunction 2 - Sexual function in men and women with neurological disorders	LANCET			English	Review							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MULTIPLE SYSTEM ATROPHY; QUALITY-OF-LIFE; TEMPORAL-LOBE EPILEPSY; ERECTILE DYSFUNCTION; PARKINSONS-DISEASE; RECTAL-CANCER; RADICAL HYSTERECTOMY; ANTIEPILEPTIC DRUGS	The advent of non-invasive functional brain imaging has clarified which regions of the brain are recruited during sexual arousal. Injuries to those regions, and to the spinal cord and peripheral nerves that link genitalia to limbic and cognitive centres, can profoundly influence sexual wellbeing. In epilepsy, expressions of hypersexuality and hyposexuality interact with the location of epileptogenic foci in the temporolimbic circuitry, and are tempered by the sexual effects of drug treatments. We outline the sexual consequences of epilepsy, stroke, multiple sclerosis, Parkinson's disease, and other common neurological disorders. Management of sexual dysfunction from both disease and treatment is discussed. Nerve-sparing techniques could mitigate the substantial sexual dysfunction in both men and women through surgical disruption of the autonomic nerves during radical pelvic surgery.	Burnaby Hosp, Dept Neurol, Burnaby, BC, Canada; Natl Hosp Neurol & Neurosurg, Neurol Inst, Univ Coll London, London WC1N 3BG, England; Leiden Univ, Med Ctr, Dept Anat, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Gynaecol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rees, PM (corresponding author), Vancouver Gen Hosp, Ctr Sexual Med, Vancouver, BC V5Z 1M9, Canada.	bassonrees@telus.net	Hibbert, Peter/T-7981-2019; Fowler, Clare J/B-2812-2009					Absher JR, 2000, NEUROPSY NEUROPSY BE, V13, P220; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALEXANDER CJ, 1993, ARCH SEX BEHAV, V22, P217, DOI 10.1007/BF01541767; Alves M, 1997, ACTA NEUROL SCAND, V96, P163; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Andersson KE, 2001, PHARMACOL REV, V53, P417; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Baird AD, 2004, ANN NEUROL, V55, P87, DOI 10.1002/ana.10997; Baird AD, 2003, EPILEPSY BEHAV, V4, P268, DOI 10.1016/S1525-5050(03)00085-4; Bakke A, 1996, SCAND J UROL NEPHROL, V30, P61; Bancroft J, 2005, J ENDOCRINOL, V186, P411, DOI 10.1677/joe.1.06233; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BECK RO, 1994, J UROLOGY, V151, P1336, DOI 10.1016/S0022-5347(17)35246-1; Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; BERIC A, 1993, J NEUROL NEUROSUR PS, V56, P548, DOI 10.1136/jnnp.56.5.548; BETTS CD, 1994, BRAIN, V117, P1303; BETTS T, 2005, MANAGING EPILEPSY WO; BHASIN S, IN PRESS LANCET; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; BOLDRINI P, 1991, ARCH PHYS MED REHAB, V72, P202; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bors E, 1960, UROL SURV, V10, P191; BROWN E, 1978, AM J PSYCHIAT, V135, P1552; BROWN RG, 1990, J NEUROL NEUROSUR PS, V53, P480, DOI 10.1136/jnnp.53.6.480; Burk K, 1998, N J Med, V95, P31; Carson Culley C 3rd, 2005, Curr Urol Rep, V6, P461, DOI 10.1007/s11934-005-0042-1; Castelli L, 2004, J NEUROL NEUROSUR PS, V75, P1260, DOI 10.1136/jnnp.2003.034579; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; Chandler BJ, 1998, J NEUROL NEUROSUR PS, V65, P877, DOI 10.1136/jnnp.65.6.877; Cheung RTF, 2002, CEREBROVASC DIS, V14, P122, DOI 10.1159/000064739; Chien GW, 2005, UROLOGY, V66, P419, DOI 10.1016/j.urology.2005.03.015; Clark JD, 1999, NEUROLOGY, V53, P2209, DOI 10.1212/WNL.53.9.2209; Colombo R, 2004, J UROLOGY, V171, P1819, DOI 10.1097/01.ju.0000123781.49896.fe; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DasGupta R, 2004, J UROLOGY, V171, P1189, DOI 10.1097/01.ju.0000113145.43174.24; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; De Carvalho M, 2000, MUSCLE NERVE, V23, P1016, DOI 10.1002/1097-4598(200007)23:7<1016::AID-MUS3>3.0.CO;2-W; De Souza EAP, 2000, ARQ NEURO-PSIQUIAT, V58, P214, DOI 10.1590/S0004-282X2000000200002; DeMarchi R, 2005, CAN J NEUROL SCI, V32, P4, DOI 10.1017/S0317167100016826; Derry FA, 1998, NEUROLOGY, V51, P1629, DOI 10.1212/WNL.51.6.1629; Dobesberger J, 2004, EPILEPSIA, V45, P777, DOI 10.1111/j.0013-9580.2004.44003.x; Duncan S, 1999, EPILEPSIA, V40, P197, DOI 10.1111/j.1528-1157.1999.tb02075.x; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; ENKER WE, 1992, ARCH SURG-CHICAGO, V127, P1396; Ferretti A, 2005, NEUROIMAGE, V26, P1086, DOI 10.1016/j.neuroimage.2005.03.025; FERRIERE G, 1992, J CHILD NEUROL, V7, P364, DOI 10.1177/088307389200700406; Forsythe E, 2006, SPINAL CORD, V44, P234, DOI 10.1038/sj.sc.3101844; Fowler CJ, 2005, J NEUROL NEUROSUR PS, V76, P700, DOI 10.1136/jnnp.2004.038695; Georgiadis JR, 2006, EUR J NEUROSCI, V24, P3305, DOI 10.1111/j.1460-9568.2006.05206.x; Ghezzi A, 1996, EUR J NEUROL, V3, P462, DOI 10.1111/j.1468-1331.1996.tb00250.x; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giaquinto S, 2003, J CLIN PSYCHIAT, V64, P302, DOI 10.4088/JCP.v64n0312; Glass C, 1999, BRIT MED J, V318, P518, DOI 10.1136/bmj.318.7182.518; Hai BGO, 2000, AM J PHYS MED REHAB, V79, P395, DOI 10.1097/00002060-200007000-00012; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; HAWTON K, 1984, J PSYCHOSOM RES, V28, P243, DOI 10.1016/0022-3999(84)90026-6; HEATH RG, 1964, ROLE PLEASURE BEHAV, P00219; HEATON JPW, 1995, UROLOGY, V45, P200, DOI 10.1016/0090-4295(95)80005-0; Heaton JPW, 2000, NEUROSCI BIOBEHAV R, V24, P561, DOI 10.1016/S0149-7634(00)00023-3; Hendren SK, 2005, ANN SURG, V242, P212, DOI 10.1097/01.sla.0000171299.43954.ce; Herzog AG, 2004, EPILEPSIA, V45, P764, DOI 10.1111/j.0013-9580.2004.60703.x; Herzog AG, 2005, NEUROLOGY, V65, P1016, DOI 10.1212/01.wnl.0000178988.78039.40; Herzog AG, 1998, NEUROLOGY, V50, P782, DOI 10.1212/WNL.50.3.782; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; HIRSCH IH, 1994, PARAPLEGIA, V32, P661, DOI 10.1038/sc.1994.106; Hockel M, 2005, LANCET ONCOL, V6, P751, DOI 10.1016/S1470-2045(05)70324-7; HOJO K, 1989, DIS COLON RECTUM, V32, P128, DOI 10.1007/BF02553825; Holstege G, 2003, J NEUROSCI, V23, P9185; HULTER BM, 1995, J NEUROL NEUROSUR PS, V59, P83, DOI 10.1136/jnnp.59.1.83; Hussain IF, 2001, J NEUROL NEUROSUR PS, V71, P371, DOI 10.1136/jnnp.71.3.371; Jacobs H, 2000, J NEUROL NEUROSUR PS, V69, P550, DOI 10.1136/jnnp.69.4.550; Jensen PT, 2004, CANCER, V100, P97, DOI 10.1002/cncr.11877; Kanovsky P, 2002, J NEUROL, V249, P112, DOI 10.1007/PL00007840; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kessler TM, 2004, J UROLOGY, V172, P1323, DOI 10.1097/01.ju.0000138249.31644.ec; Kimura M, 2001, COMPR PSYCHIAT, V42, P217, DOI 10.1053/comp.2001.23141; Kirchhof K, 2003, INT J IMPOT RES, V15, P293, DOI 10.1038/sj.ijir.3901014; KIRKEBY HJ, 1988, NEUROLOGY, V38, P1366, DOI 10.1212/WNL.38.9.1366; Komisaruk BR, 2004, BRAIN RES, V1024, P77, DOI 10.1016/j.brainres.2004.07.029; Korpelainen JT, 1999, STROKE, V30, P715, DOI 10.1161/01.STR.30.4.715; Korpelainen JT, 1998, ACTA NEUROL SCAND, V98, P400, DOI 10.1111/j.1600-0404.1998.tb07321.x; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LILIUS HG, 1999, MULT SCLER, V5, P428; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; LIPE H, 1990, NEUROLOGY, V40, P1347, DOI 10.1212/WNL.40.9.1347; Lundberg P O, 1981, Int Rehabil Med, V3, P32; Maas CP, 2004, BJOG-INT J OBSTET GY, V111, P456, DOI 10.1111/j.1471-0528.2004.00104.x; Maas CP, 1998, BRIT J SURG, V85, P92; Maas K, 1999, LANCET, V354, P772, DOI 10.1016/S0140-6736(05)76009-8; Marijnen CAM, 2005, J CLIN ONCOL, V23, P1847, DOI 10.1200/JCO.2005.05.256; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Mignot E, 2005, SLEEP, V28, P754, DOI 10.1093/sleep/28.6.754; Miller DC, 2005, J CLIN ONCOL, V23, P2772, DOI 10.1200/JCO.2005.07.116; Monga TN, 1995, PHYS MED REHABIL STA, V9, P345; Montorsi F, 2005, J SEX MED, V2, P658, DOI 10.1111/j.1743-6109.2005.00117.x; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Morrell MJ, 1996, EPILEPSIA, V37, P1204, DOI 10.1111/j.1528-1157.1996.tb00554.x; Morrell MJ, 2005, EPILEPSY BEHAV, V6, P360, DOI 10.1016/j.yebeh.2005.01.004; Morrell MJ, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s4.2.x; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Nehra A, 1996, J UROLOGY, V155, P554, DOI 10.1016/S0022-5347(01)66448-6; Newman LC, 2005, NEUROLOGY, V65, P1333, DOI 10.1212/01.wnl.0000180406.42944.6d; O'Sullivan JD, 1998, MOVEMENT DISORD, V13, P536, DOI 10.1002/mds.870130326; Oertel WH, 2003, MOVEMENT DISORD, V18, P430, DOI 10.1002/mds.10384; Park K, 2001, INT J IMPOT RES, V13, P73, DOI 10.1038/sj.ijir.3900649; Pieterse QD, 2006, INT J GYNECOL CANCER, V16, P1119, DOI 10.1111/j.1525-1438.2006.00461.x; Platell CFE, 2004, BRIT J SURG, V91, P465, DOI 10.1002/bjs.4471; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Podnar S, 2002, J NEUROL NEUROSUR PS, V73, P715, DOI 10.1136/jnnp.73.6.715; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Protogerou V, 2004, BJU INT, V94, P350, DOI 10.1111/j.1464-410X.2004.04932.x; Rattya J, 2001, NEUROLOGY, V56, P31, DOI 10.1212/WNL.56.1.31; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; REMILLARD GM, 1983, NEUROLOGY, V33, P323, DOI 10.1212/WNL.33.3.323; Romito LM, 2002, MOVEMENT DISORD, V17, P1371, DOI 10.1002/mds.10265; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Salonia A, 2005, HORM BEHAV, V47, P164, DOI 10.1016/j.yhbeh.2004.10.002; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Sipski ML, 2000, UROLOGY, V55, P812, DOI 10.1016/S0090-4295(00)00493-3; SIPSKI ML, 1995, ARCH PHYS MED REHAB, V76, P811, DOI 10.1016/S0003-9993(95)80544-3; Sipski ML, 2001, ANN NEUROL, V49, P35, DOI 10.1002/1531-8249(200101)49:1<35::AID-ANA8>3.0.CO;2-J; Sipski ML, 2001, CLIN AUTON RES, V11, P279, DOI 10.1007/BF02332972; Sjogren K, 1981, Int Rehabil Med, V3, P26; Staerman F, 1996, Int J Impot Res, V8, P241; Trimbos JB, 2001, INT J GYNECOL CANCER, V11, P180, DOI 10.1046/j.1525-1438.2001.01023.x; UITTI RJ, 1989, CLIN NEUROPHARMACOL, V12, P375, DOI 10.1097/00002826-198910000-00002; Villaplana GH, 1997, NEUROUROL URODYNAM, V16, P55, DOI 10.1002/(SICI)1520-6777(1997)16:1<55::AID-NAU7>3.0.CO;2-D; Welsh M, 1997, MOVEMENT DISORD, V12, P923, DOI 10.1002/mds.870120614; Wiygul JB, 2005, UROLOGY, V66, P582, DOI 10.1016/j.urology.2005.03.059; Yabuki Y, 1996, GYNECOL ONCOL, V62, P370, DOI 10.1006/gyno.1996.0251; Yang CC, 2000, J UROLOGY, V164, P2010, DOI 10.1016/S0022-5347(05)66941-8; Zippe CD, 2004, UROLOGY, V64, P682, DOI 10.1016/j.urology.2004.05.056; Zippe CD, 2004, UROLOGY, V63, P1153, DOI 10.1016/j.urology.2003.12.034; Zivadinov R, 1999, MULT SCLER J, V5, P428, DOI 10.1177/135245859900500i610; Zorzon M, 1999, MULT SCLER J, V5, P418, DOI 10.1191/135245899678846456	145	192	195	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					512	525		10.1016/S0140-6736(07)60238-4	http://dx.doi.org/10.1016/S0140-6736(07)60238-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292771				2022-12-28	WOS:000244188300034
J	Lathem, WW; Price, PA; Miller, VL; Goldman, WE				Lathem, Wyndham W.; Price, Paul A.; Miller, Virginia L.; Goldman, William E.			A plasminogen-activating protease specifically controls the development of primary pneumonic plague	SCIENCE			English	Article							YERSINIA-PESTIS; ESCHERICHIA-COLI; SURFACE PROTEASE; INFECTION; VIRULENCE; SEQUENCE; STRAINS; AGENT	Primary pneumonic plague is transmitted easily, progresses rapidly, and causes high mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely unknown. We show that the plasminogen activator Pla is essential for Y. pestis to cause primary pneumonic plague but is less important for dissemination during pneumonic plague than during bubonic plague. Experiments manipulating its temporal expression showed that Pla allows Y. pestis to replicate rapidly in the airways, causing a lethal fulminant pneumonia; if unexpressed, inflammation is aborted, and lung repair is activated. Inhibition of Pla expression prolonged the survival of animals with the disease, offering a therapeutic option to extend the period during which antibiotics are effective.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldman, WE (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	goldman@wustl.edu		Miller, Virginia/0000-0002-9522-1767; Goldman, William/0000-0002-1551-6718; Lathem, Wyndham/0000-0003-4347-089X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160, F32AI069688, R21AI053298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER; NIAID NIH HHS [F32 AI069688-01, AI53298, U54 AI057160] Funding Source: Medline; NIDDK NIH HHS [DK52574] Funding Source: Medline; NIGMS NIH HHS [NRSA T32 GM07067] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*APPL BIOS, 1977, ABI PRISM 7700 SEQ D; CELIS JE, 1987, FEBS LETT, V220, P1, DOI 10.1016/0014-5793(87)80865-7; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Huang XZ, 2006, CLIN MED RES, V4, P189, DOI 10.3121/cmr.4.3.189; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Kukkonen M, 2001, MOL MICROBIOL, V40, P1097, DOI 10.1046/j.1365-2958.2001.02451.x; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; LINDLER IE, 2004, ENCY MED GENOMICS PR, P1355; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SODEINDE OA, 1989, INFECT IMMUN, V57, P1517, DOI 10.1128/IAI.57.5.1517-1523.1989; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Welkos S, 2002, VACCINE, V20, P2206, DOI 10.1016/S0264-410X(02)00119-6; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; WU LT, 1926, TREATISE PNEUMONIC P, P466	22	227	237	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					509	513		10.1126/science.1137195	http://dx.doi.org/10.1126/science.1137195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255510				2022-12-28	WOS:000243726600045
J	Fricker, HA; Scambos, T; Bindschadler, R; Padman, L				Fricker, Helen Amanda; Scambos, Ted; Bindschadler, Robert; Padman, Laurie			An active subglacial water system in West Antarctica mapped from space	SCIENCE			English	Article							ICE STREAM-B; BENEATH; SHEET; JOKULHLAUP; DISCHARGE	Satellite laser altimeter elevation profiles from 2003 to 2006 collected over the lower parts of Whillans and Mercer ice streams, West Antarctica, reveal 14 regions of temporally varying elevation, which we interpret as the surface expression of subglacial water movement. Vertical motion and spatial extent of two of the largest regions are confirmed by satellite image differencing. A major, previously unknown subglacial lake near the grounding line of Whillans Ice Stream is observed to drain 2.0 cubic kilometers of water into the ocean over similar to 3 years, while elsewhere a similar volume of water is being stored subglacially. These observations reveal a widespread, dynamic subglacial water system that may exert an important control on ice flow and mass balance.	Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80302 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Earth & Space Res, Corvallis, OR 97333 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Fricker, HA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA.	hafricker@ucsd.edu	Padman, Laurence/AAH-3808-2021; Scambos, Ted A/B-1856-2009	Padman, Laurence/0000-0003-2010-642X; Fricker, Helen Amanda/0000-0002-0921-1432				ALLEY RB, 1994, ANN GLACIOL, V20, P187, DOI 10.3189/172756494794587032; ATRE SR, 1994, ANN GLACIOL, V20, P177, DOI 10.3189/172756494794587113; Bell RE, 2007, NATURE, V445, P904, DOI 10.1038/nature05554; BENTLEY CR, 1991, ANTARCT J US, V26, P62; Bindschadler R, 1998, SCIENCE, V279, P689, DOI 10.1126/science.279.5351.689; Bindschadler RA, 2003, SCIENCE, V301, P1087, DOI 10.1126/science.1087231; BINDSCHADLER RA, 1994, ANN GLACIOL, V20, P327, DOI 10.3189/172756494794587177; Bindschadler R, 2005, J GLACIOL, V51, P620, DOI 10.3189/172756505781829070; BLANKENSHIP DD, 1987, J GEOPHYS RES-SOLID, V92, P8903, DOI 10.1029/JB092iB09p08903; DIMARZIO J, 2007, DIGITAL MEDIA; Evatt GW, 2006, PHILOS T R SOC A, V364, P1769, DOI 10.1098/rsta.2006.1798; Flowers GE, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019088; Fricker HA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026907; GOODWIN ID, 1988, J GLACIOL, V34, P95, DOI 10.3189/S0022143000009114; Gray L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021387; IKEN A, 1986, J GLACIOL, V32, P101, DOI 10.3189/S0022143000006936; Jezek KC, 1999, ANN GLACIOL-SER, V29, P286, DOI 10.3189/172756499781820969; Joughin I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024319; Joughin I, 2004, J GLACIOL, V50, P96, DOI 10.3189/172756504781830295; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; Roberts MJ, 2005, REV GEOPHYS, V43, DOI 10.1029/2003RG000147; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Scambos TA, 1998, J GLACIOL, V44, P97, DOI 10.3189/S0022143000002392; Scambos TA, 1999, REMOTE SENS ENVIRON, V69, P56, DOI 10.1016/S0034-4257(99)00009-7; SCAMBOS TA, IN PRESS REMOTE SENS; Shuman CA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025227; Siegert MJ, 2005, ANTARCT SCI, V17, P453, DOI 10.1017/S0954102005002889; Siegert MJ, 2000, J GLACIOL, V46, P702, DOI 10.3189/172756500781832783; Smith AM, 2007, GEOLOGY, V35, P127, DOI 10.1130/G23036A.1; Vogel SW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022563; Wingham DJ, 2006, NATURE, V440, P1033, DOI 10.1038/nature04660; ZWALLY HJ, 1983, J GEOPHYS RES-OCEANS, V88, P1589, DOI 10.1029/JC088iC03p01589; [No title captured]	33	319	332	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1544	1548		10.1126/science.1136897	http://dx.doi.org/10.1126/science.1136897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17303716				2022-12-28	WOS:000244934800043
J	Maisel, WH				Maisel, William H.			Unanswered questions - Drug-eluting stents and the risk of late thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Maisel, WH (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							[Anonymous], 2003, CYPH SIR EL COR STEN; [Anonymous], 2004, TAX EXPR 2 PACL EL C; *FDA, 2007, FDA STAT COR DRUG EL; Food and Drug Administration, 2006, CIRC SYST DEV ADV PA; Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815	5	205	221	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					981	984		10.1056/NEJMp068305	http://dx.doi.org/10.1056/NEJMp068305			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296826				2022-12-28	WOS:000244699200001
J	Spaulding, C; Daemen, J; Boersma, E; Cutlip, DE; Serruys, PW				Spaulding, Christian; Daemen, Joost; Boersma, Eric; Cutlip, Donald E.; Serruys, Patrick W.			A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY REVASCULARIZATION; STANDARD STENT; FOLLOW-UP; THROMBOSIS; HYPERSENSITIVITY; IMPLANTATION; RAPAMYCIN; ARTERIES; REGISTRY; LESIONS	BACKGROUND: Although randomized studies have shown a beneficial effect of drug-eluting stents in reducing the risk of repeated revascularization, these trials were underpowered to compare rates of death and myocardial infarction. The long-term safety of drug-eluting stents has been questioned recently. METHODS: We performed a pooled analysis of 1748 patients in four randomized trials evaluating the safety of sirolimus-eluting stents as compared with bare-metal stents. Patient-level data were obtained and analyzed by independent statisticians at two academic institutions. The primary safety end point was survival at 4 years. We tested for heterogeneities in treatment effect in patient subgroups. RESULTS: The survival rate at 4 years was 93.3% in the sirolimus-stent group, as compared with 94.6% in the bare-metal-stent group (hazard ratio for death, 1.24; 95% confidence interval [CI], 0.84 to 1.83; P=0.28). In the 428 patients with diabetes, a significant difference in the survival rate was observed in favor of the bare-metal-stent group over the sirolimus-stent group (95.6% vs. 87.8%; hazard ratio for death in the sirolimus-stent group, 2.9; 95% CI, 1.38 to 6.10; P=0.008). The lower survival rate among patients with diabetes who were treated with sirolimus-eluting stents was due to increased numbers of deaths from both cardiovascular and noncardiovascular causes. No difference in survival rate was detected among the patients without diabetes. Rates of myocardial infarction and stent thrombosis were similar in the two groups. CONCLUSIONS: In a pooled analysis of data from four trials comparing sirolimus-eluting stents and bare-metal stents, no significant differences were found between the two treatments in rates of death, myocardial infarction, or stent thrombosis.	Univ Paris 05, Sch Med, Assistance Publ Hop Paris Cochin Hosp, INSERM,U780 Avenir, Paris, France; Erasmus MC, Rotterdam, Netherlands; Harvard Clin Res Inst, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School	Serruys, PW (corresponding author), Erasmus Univ, Thoraxctr, Dr Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands.	p.w.j.c.serruys@erasmusmc.nl						Babinska A, 1998, NEPHROL DIAL TRANSPL, V13, P3153, DOI 10.1093/ndt/13.12.3153; Camenzind E, 2006, EUR SOC CARD C NEWS; DAEMEN J, IN PRESS LANCET; Daemen J, 2007, EUR HEART J, V28, P26, DOI 10.1093/eurheartj/ehl412; Daemen J, 2006, AM J CARDIOL, V98, P895, DOI 10.1016/j.amjcard.2006.04.031; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; McFadden EP, 2004, LANCET, V364, P1519, DOI 10.1016/S0140-6736(04)17275-9; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Scheller B, 2005, Z KARDIOL, V94, P445, DOI 10.1007/s00392-005-0237-y; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Sianos G, 2004, CATHETER CARDIO INTE, V61, P111, DOI 10.1002/ccd.10709; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Urban P, 2006, CIRCULATION, V113, P1434, DOI 10.1161/CIRCULATIONAHA.104.532242; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4	22	554	598	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					989	997		10.1056/NEJMoa066633	http://dx.doi.org/10.1056/NEJMoa066633			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296825				2022-12-28	WOS:000244699200003
J	Mezard, M				Mezard, Marc			Computer science - Where are the exemplars?	SCIENCE			English	Editorial Material									Univ Paris 11, CNRS, F-91405 Orsay, France; Univ Paris 11, Lab Phys Theor & Modeles Stat, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Mezard, M (corresponding author), Univ Paris 11, CNRS, F-91405 Orsay, France.	mezard@lptms.u-psud.fr						DUBOIS O, 2001, THEOR COMP SCI, V265; FREY BJ, 2007, SCIENCE         0111, DOI DOI 10.1126/SCIENCE.1136800; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gallager R. G., 1963, LOW DENSITY PARITY C; LECAM L, 1967, P 5 BERK S MATH STAT, P281; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; MEZARD M, 2002, SCIENCE         0627, DOI DOI 10.1126/SCIENCE.1073287; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Yedidia JS, 2005, IEEE T INFORM THEORY, V51, P2282, DOI 10.1109/TIT.2005.850085	9	39	63	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					949	951		10.1126/science.1139678	http://dx.doi.org/10.1126/science.1139678			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303742				2022-12-28	WOS:000244229800029
J	Dauvilliers, Y; Amulf, I; Mignot, E				Dauvilliers, Yves; Amulf, Isabelle; Mignot, Emmanuel			Narcolepsy with cataplexy	LANCET			English	Review							EXCESSIVE DAYTIME SLEEPINESS; KLEINE-LEVIN-SYNDROME; LONG-TERM TREATMENT; QUALITY-OF-LIFE; HYPOCRETIN OREXIN; CANINE NARCOLEPSY; SODIUM OXYBATE; ETHNIC-GROUPS; DOUBLE-BLIND; REM-SLEEP	Narcolepsy with cataplexy is a disabling sleep disorder affecting 0.02% of adults worldwide. It is characterised by severe, irresistible daytime sleepiness and sudden loss of muscle tone (cataplexy), and can be associated with sleep-onset or sleep-offset paralysis and hallucinations, frequent movement and awakening during sleep, and weight gain. Sleep monitoring during night and day shows rapid sleep onset and abnormal, shortened rapid-eye-movement sleep latencies. The onset of narcolepsy with cataplexy is usually during teenage and young adulthood and persists throughout the lifetime. Pathophysiological studies have shown that the disease is caused by the early loss of neurons in the hypothalamus that produce hypocretin, a wakefulness-associated neurotransmitter present in cerebrospinal fluid. The cause of neural loss could be autoimmune since most patients have the HLA DQB1*0602 allele that predisposes individuals to the disorder. Treatment is with stimulant drugs to suppress daytime sleepiness, antidepressants for cataplexy, and gamma hydroxybutyrate for both symptoms. Because narcolepsy is an under-recognised disease, it is important that general practitioners and other primary health-care workers identify abnormal daytime sleepiness early.	CHU Montpellier, Hop Guidechauliac, Serv Neurol, F-34295 Montpellier 5, France; INSERM, U888, Montpellier, France; Assistance Publ Hop Paris, Federat Pathol Sommeil, Paris, France; Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; Stanford Univ, Ctr Narcolepsy, Palo Alto, CA 94304 USA	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Howard Hughes Medical Institute; Stanford University; Stanford University	Dauvilliers, Y (corresponding author), CHU Montpellier, Hop Guidechauliac, Serv Neurol, 80 Ave Augustin Fliche, F-34295 Montpellier 5, France.	ydauvilliers@yahoo.fr		Dauvilliers, yves/0000-0003-0683-6506; Arnulf, Isabelle/0000-0002-2240-2516				Abad Vivien C, 2004, Expert Opin Emerg Drugs, V9, P281, DOI 10.1517/14728214.9.2.281; ALVAREZ B, 1991, LANCET, V337, P1293, DOI 10.1016/0140-6736(91)92966-6; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Anic-Labat S, 1999, SLEEP, V22, P77; Arnulf I, 2005, BRAIN, V128, P2763, DOI 10.1093/brain/awh620; Arnulf I, 2002, NEUROLOGY, V58, P1019, DOI 10.1212/WNL.58.7.1019; Auger RR, 2005, SLEEP, V28, P667, DOI 10.1093/sleep/28.6.667; Bassetti C, 2003, SLEEP MED, V4, P7, DOI 10.1016/S1389-9457(02)00191-0; Bassetti CL, 2005, NEUROLOGY, V65, P1152, DOI 10.1212/01.wnl.0000186118.96509.94; Baumann CR, 2005, LANCET NEUROL, V4, P673, DOI 10.1016/S1474-4422(05)70196-4; Becker PM, 2000, NEUROLOGY, V54, P1166; Beuckmann CT, 2004, J NEUROSCI, V24, P4469, DOI 10.1523/JNEUROSCI.5560-03.2004; Beusterien KM, 1999, SLEEP, V22, P757, DOI 10.1093/sleep/22.6.757; Billiard M, 2001, Sleep Med Rev, V5, P349, DOI 10.1053/smrv.2001.0168; Billiard M, 2003, REV NEUROL-FRANCE, V159, P122; BILLIARD M, 1994, SLEEP, V17, pS54, DOI 10.1093/sleep/17.suppl_8.S54; BILLIARD M, 1985, LANCET, V1, P226; BILLIARD M, 1994, SLEEP, V17, pS107, DOI 10.1093/sleep/17.suppl_8.S107; Black J, 2004, SLEEP MED, V5, P119, DOI 10.1016/j.sleep.2003.11.002; Black J, 2002, SLEEP, V25, P42; Black J, 2006, SLEEP, V29, P939, DOI 10.1093/sleep/29.7.939; Black JL, 2005, SLEEP, V28, P1191; Black JL, 2005, SLEEP, V28, P427, DOI 10.1093/sleep/28.4.427; Blouin AM, 2005, NEUROLOGY, V65, P1189, DOI 10.1212/01.wnl.0000175219.01544.c8; BOIVIN DB, 1993, NEUROLOGY, V43, P2134, DOI 10.1212/WNL.43.10.2134; BROUGHTON R, 1981, CAN J NEUROL SCI, V8, P299, DOI 10.1017/S0317167100043419; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chabas D, 2003, ANNU REV GENOM HUM G, V4, P459, DOI 10.1146/annurev.genom.4.070802.110432; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen W, 2005, ANN NEUROL, V58, P489, DOI 10.1002/ana.20603; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; Daniels E, 2001, J SLEEP RES, V10, P75, DOI 10.1046/j.1365-2869.2001.00234.x; Dauvilliers Y, 2004, ANN NEUROL, V56, P905, DOI 10.1002/ana.20339; Dauvilliers Y, 2004, ANN NEUROL, V56, P382, DOI 10.1002/ana.20208; Dauvilliers Y, 2004, NEUROLOGY, V62, P2137, DOI 10.1212/WNL.62.11.2137; Dauvilliers Y, 2004, NEUROLOGY, V62, P46, DOI 10.1212/01.WNL.0000101725.34089.1E; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2003, CLIN NEUROPHYSIOL, V114, P2000, DOI 10.1016/S1388-2457(03)00203-7; Dauvilliers Y, 2003, SLEEP, V26, P663, DOI 10.1093/sleep/26.6.663; Dauvilliers Y., 2002, Pharmacogenomics Journal, V2, P65, DOI 10.1038/sj.tpj.6500088; Dauvilliers Y, 2001, MOL PSYCHIATR, V6, P367, DOI 10.1038/sj.mp.4000911; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Dauvilliers Y, 2006, CURR NEUROL NEUROSCI, V6, P156, DOI 10.1007/s11910-996-0039-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 2005, FEBS J, V272, P5675, DOI 10.1111/j.1742-4658.2005.04981.x; DEMENT WC, 1973, SLEEP RES, V2, P147; Fehr C, 2001, PROG NEURO-PSYCHOPH, V25, P965, DOI 10.1016/S0278-5846(01)00171-3; FINDLEY L, 1995, CHEST, V108, P619, DOI 10.1378/chest.108.3.619; Gallopin T, 2004, SLEEP, V27, P19; Gelineau J, 1880, GAZ HOPITAUX, V53, P735; Gencik M, 2001, BMC Med Genet, V2, P9, DOI 10.1186/1471-2350-2-9; Gibbs JW, 2002, SLEEP, V25, P672, DOI 10.1093/sleep/25.6.662; GUILLEMINAULT C, 1976, NARCOLEPSY, P125; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; HISHIKAWA Y, 1995, ADV NEUROL, V67, P245; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; Hohjoh H, 2000, TISSUE ANTIGENS, V56, P446, DOI 10.1034/j.1399-0039.2000.560508.x; HONDA Y, 1980, CURR THER RES CLIN E, V27, P429; HONDA Y, 1983, SLEEP RES, V12, P254; Honda Y., 1979, SLEEP RES, V8, P191; Hood Bernadette, 2002, Sleep Med, V3, P259, DOI 10.1016/S1389-9457(02)00005-9; Houghton WC, 2004, SLEEP MED REV, V8, P355, DOI 10.1016/j.smrv.2004.01.004; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Hungs M, 2001, NEUROLOGY, V57, P1893, DOI 10.1212/WNL.57.10.1893; IIJIMA S, 1986, SLEEP, V9, P265, DOI 10.1093/sleep/9.1.265; KALES A, 1982, ARCH NEUROL-CHICAGO, V39, P169, DOI 10.1001/archneur.1982.00510150039009; Khatami R, 2004, LANCET, V363, P1199, DOI 10.1016/S0140-6736(04)15951-5; Koch H, 1999, LANCET, V353, P645, DOI 10.1016/S0140-6736(98)05831-0; Kotagal S, 2004, SLEEP MED, V5, P147, DOI 10.1016/j.sleep.2003.10.006; KUPFER DJ, 1976, BIOL PSYCHIAT, V11, P159; LAMMERS GJ, 1993, SLEEP, V16, P216, DOI 10.1093/sleep/16.3.216; LANGDON N, 1986, SLEEP, V9, P371, DOI 10.1093/sleep/9.2.371; LAVIE P, 1987, SLEEP, V10, P608; Lecendreux M, 2003, J SLEEP RES, V12, P347, DOI 10.1046/j.1365-2869.2003.00380.x; LIN JS, 1992, BRAIN RES, V591, P319, DOI 10.1016/0006-8993(92)91713-O; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Maitre M, 1997, PROG NEUROBIOL, V51, P337, DOI 10.1016/S0301-0082(96)00064-0; MAYER G, 1995, CLIN NEUROPHARMACOL, V18, P306, DOI 10.1097/00002826-199508000-00002; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mignot E, 2005, SLEEP, V28, P754, DOI 10.1093/sleep/28.6.754; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; MIGNOT E, 1991, P NATL ACAD SCI USA, V88, P3475, DOI 10.1073/pnas.88.8.3475; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; MIGNOT E, 1992, SLEEP, V15, P415, DOI 10.1093/sleep/15.5.415; Mignot E, 2006, BRAIN, V129, P1609, DOI 10.1093/brain/awl079; MITLER MM, 1986, SLEEP, V9, P260, DOI 10.1093/sleep/9.1.260; Mitler MM, 1998, ANN NEUROL, V43, P88; Morrish E, 2004, SLEEP MED, V5, P37, DOI 10.1016/j.sleep.2003.06.002; MULLINGTON J, 1993, SLEEP, V16, P444, DOI 10.1093/sleep/16.5.444; Nakayama J, 2000, GENOMICS, V65, P84, DOI 10.1006/geno.2000.6143; Nightingale S, 2005, SLEEP MED, V6, P253, DOI 10.1016/j.sleep.2004.11.007; Nishino S, 2005, SLEEP MED REV, V9, P269, DOI 10.1016/j.smrv.2005.03.004; Nishino S, 2003, NEUROLOGY, V61, P823, DOI 10.1212/01.WNL.0000081049.14098.50; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Ohayon MM, 2000, PSYCHIAT RES, V97, P153, DOI 10.1016/S0165-1781(00)00227-4; Ohayon MM, 2002, NEUROLOGY, V58, P1826, DOI 10.1212/WNL.58.12.1826; Okun ML, 2002, SLEEP, V25, P27, DOI 10.1093/sleep/25.1.27; ORELLANA C, 1994, SLEEP, V17, pS50, DOI 10.1093/sleep/17.suppl_8.S50; Overeem S, 2006, J NEUROIMMUNOL, V174, P187, DOI 10.1016/j.jneuroim.2006.02.010; Overeem S, 2004, J SLEEP RES, V13, P257, DOI 10.1111/j.1365-2869.2004.00411.x; Overeem S, 2001, J CLIN NEUROPHYSIOL, V18, P78, DOI 10.1097/00004691-200103000-00002; PARKES JD, 1979, LANCET, V2, P1085; Pelin Z, 1998, TISSUE ANTIGENS, V51, P96, DOI 10.1111/j.1399-0039.1998.tb02952.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Picchioni D, 2004, SLEEP, V27, P1471, DOI 10.1093/sleep/27.8.1471; Poryazova R, 2005, NEUROLOGY, V65, P967, DOI 10.1212/01.wnl.0000175978.61048.62; Prinzmetal M, 1935, J AMER MED ASSOC, V105, P2051; Ripley B, 2001, NEUROBIOL DIS, V8, P525, DOI 10.1006/nbdi.2001.0389; ROEHRS T, 1986, SLEEP, V9, P194, DOI 10.1093/sleep/9.1.194; ROTH B, 1975, SCHWEIZ ARCH NEUROL, V116, P291; Ryan DH, 1999, OBES RES, V7, P313, DOI 10.1002/j.1550-8528.1999.tb00414.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2004, SLEEP, V27, P11; Scammell TE, 2003, ANN NEUROL, V53, P154, DOI 10.1002/ana.10444; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Smits M. G., 1996, Journal of Sleep Research, V5, P217; Tafti M, 2005, ANN MED, V37, P580, DOI 10.1080/07853890500372047; Taheri S, 2002, LANCET NEUROL, V1, P242, DOI 10.1016/S1474-4422(02)00103-5; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thorpy MJ, 2006, CNS DRUGS, V20, P43, DOI 10.2165/00023210-200620010-00004; Vandeputte M, 2003, SLEEP MED, V4, P343, DOI 10.1016/S1389-9457(03)00059-5; Vgontzas AN, 2000, PSYCHOSOM MED, V62, P220, DOI 10.1097/00006842-200003000-00013; Westphal C., 1877, ARCH PSYCHIAT NERVEN, V7, P631; Wieczorek S, 2004, J MOL MED-JMM, V82, P696, DOI 10.1007/s00109-004-0569-5; Wieczorek S, 2003, J MOL MED-JMM, V81, P87, DOI 10.1007/s00109-002-0405-8; Wieczorek S, 2003, TISSUE ANTIGENS, V61, P437, DOI 10.1034/j.1399-0039.2003.00068.x; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wing YK, 2002, ANN NEUROL, V51, P578, DOI 10.1002/ana.10162; Wisor JP, 2005, NEUROSCIENCE, V132, P1027, DOI 10.1016/j.neuroscience.2005.02.003; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	136	488	513	2	92	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					499	511		10.1016/S0140-6736(07)60237-2	http://dx.doi.org/10.1016/S0140-6736(07)60237-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292770				2022-12-28	WOS:000244188300033
J	Roche, S; Rey, FA; Gaudin, Y; Bressanelli, S				Roche, Stephane; Rey, Felix A.; Gaudin, Yves; Bressanelli, Stephane			Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G	SCIENCE			English	Article							FUSION-INACTIVE CONFORMATION; RABIES VIRUS; MEMBRANE-FUSION; LOW-PH; INFLUENZA HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; CRYSTAL-STRUCTURE; AMINO-ACIDS; PROTEIN; MUTATIONS	Glycoprotein G of the vesicular stomatitis virus triggers membrane fusion via a low pH-induced structural rearrangement. Despite the equilibrium between the pre- and postfusion states, the structure of the prefusion form, determined to 3.0 angstrom resolution, shows that the fusogenic transition entails an extensive structural reorganization of G. Comparison with the structure of the postfusion form suggests a pathway for the conformational change. In the prefusion form, G has the shape of a tripod with the fusion loops exposed, which point toward the viral membrane, and with the antigenic sites located at the distal end of the molecule. A large number of G glycoproteins, perhaps organized as in the crystals, act cooperatively to induce membrane merging.	CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; Universite Paris Saclay	Gaudin, Y (corresponding author), CNRS, UMR 2472, INRA,Lab Virol Mol & Struct, UMR 1157,Inst Fedaratif Rech 115, F-91198 Gif Sur Yvette, France.	gaudin@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Gaudin, Yves/0000-0002-0122-2954; Bressanelli, Stephane/0000-0002-0921-6727; Rey, Felix/0000-0002-9953-7988				BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; DeLano W.L, PYMOL MOL GRAPHICS S; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; Gaudin Y, 1997, J VIROL, V71, P3742, DOI 10.1128/JVI.71.5.3742-3750.1997; GAUDIN Y, 1995, J VIROL, V69, P5528, DOI 10.1128/JVI.69.9.5528-5534.1995; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; GAUDIN Y, 1992, VIROLOGY, V187, P627, DOI 10.1016/0042-6822(92)90465-2; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gaudin Y, 2000, Subcell Biochem, V34, P379; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Lafay F, 1996, J GEN VIROL, V77, P339, DOI 10.1099/0022-1317-77-2-339; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LUO LZ, 1988, VIROLOGY, V163, P341, DOI 10.1016/0042-6822(88)90274-7; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; Rao BL, 2004, LANCET, V364, P869, DOI 10.1016/S0140-6736(04)16982-1; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rose JK, 2001, FIELDS VIROLOGY, P1221; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	37	270	285	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					843	848		10.1126/science.1135710	http://dx.doi.org/10.1126/science.1135710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289996				2022-12-28	WOS:000244069000069
J	Verbiscer, A; French, R; Showalter, M; Helfenstein, P				Verbiscer, Anne; French, Richard; Showalter, Mark; Helfenstein, Paul			Enceladus: Cosmic graffiti artist caught in the act	SCIENCE			English	Article							SATURNS E-RING		Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; Wellesley Coll, Dept Astron, Wellesley, MA 02481 USA; Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	University of Virginia; Wellesley College; Cornell University	Verbiscer, A (corresponding author), Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA.	verbiscer@virginia.edu						Burns J.A., 1986, SATELLITES, P1; DOMINGUE DL, 1991, ICARUS, V90, P30, DOI 10.1016/0019-1035(91)90066-3; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; Hapke B, 2002, ICARUS, V157, P523, DOI 10.1006/icar.2002.6853; Hicks MD, 2004, ICARUS, V171, P210, DOI 10.1016/j.icarus.2004.02.012; Juhasz A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000182; Nicholson PD, 1996, SCIENCE, V272, P509, DOI 10.1126/science.272.5261.509; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Shkuratov YG, 2001, ICARUS, V152, P96, DOI 10.1006/icar.2001.6630	9	83	83	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					815	815		10.1126/science.1134681	http://dx.doi.org/10.1126/science.1134681			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289992				2022-12-28	WOS:000244069000060
J	Pielke, R; Prins, G; Rayner, S; Sarewitz, D				Pielke, Roger, Jr.; Prins, Gwyn; Rayner, Steve; Sarewitz, Daniel			Lifting the taboo on adaptation	NATURE			English	Editorial Material							CLIMATE-CHANGE		Univ Colorado, Boulder, CO 80309 USA; London Sch Econ, London, England; Columbia Univ, New York, NY 10027 USA; Univ Oxford, James Martin Inst, Oxford OX1 2JD, England; Arizona State Univ, Tempe, AZ 85287 USA	University of Colorado System; University of Colorado Boulder; University of London; London School Economics & Political Science; Columbia University; University of Oxford; Arizona State University; Arizona State University-Tempe	Pielke, R (corresponding author), Univ Colorado, Boulder, CO 80309 USA.	pielke@colorado.edu		rayner, steve/0000-0001-6779-9345				Bouwer LM, 2006, DISASTERS, V30, P49, DOI 10.1111/j.1467-9523.2006.00306.x; Burton I., 2005, POLICY OPTIONS, P33; Goklany IM, 2004, SCIENCE, V306, P55, DOI 10.1126/science.306.5693.55; Huq S, 2004, IDS BULL-I DEV STUD, V35, P15, DOI 10.1111/j.1759-5436.2004.tb00129.x; Pielke RA, 2005, ENVIRON SCI POLICY, V8, P548, DOI 10.1016/j.envsci.2005.06.013; Pielke RA, 2005, POPUL ENVIRON, V26, P255, DOI 10.1007/s11111-005-1877-6; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Stern N., 2006, EC CLIMATE CHANGE ST; THOMPSON M, 1998, HUMAN CHOICE CLIMATE, V1; *UNFCCC, 2002, DELH DECL CLIM CHANG	10	326	336	3	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					597	598		10.1038/445597a	http://dx.doi.org/10.1038/445597a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	133UM	17287795	Bronze			2022-12-28	WOS:000244039400024
J	Pogach, L; Engelgau, M; Aron, D				Pogach, Leonard; Engelgau, Michael; Aron, David			Measuring progress toward achieving hemoglobin A(1c) goals in diabetes care - Pass/fail or partial credit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLYCEMIC CONTROL		VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, E Orange, NJ 07018 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Case Western Reserve Univ, Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; Case Western Reserve Univ, Case Sch Med, Cleveland, OH 44106 USA	New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Pogach, L (corresponding author), VA New Jersey Healthcare Syst, HSR Ctr healthcare Knowledge Management, 385 Tremont Ave, E Orange, NJ 07018 USA.	Leonard.Pogach@va.gov						Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; [Anonymous], 1996, DIABETES, V45, P1289; Berlowitz DR, 2005, HEALTH SERV RES, V40, P1836, DOI 10.1111/j.1475-6773.2005.00436.x; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; *COLL AM PATH, 2006, GLYC SURV 2006 GH2 A; Engelgau MM, 2005, ANN INTERN MED, V143, P301, DOI 10.7326/0003-4819-143-4-200508160-00011; Gavin L A, 2000, Endocr Pract, V6, P305; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Huang ES, 2006, DIABETES CARE, V29, P259, DOI 10.2337/diacare.29.02.06.dc05-1443; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; Lohr K.N., 1990, MEDICARE STRATEGY QU, V1; *NAT COMM QUAL ASS, 2006, HEDIS 2007, V2; *NAT COMM QUAL ASS, BRIDG EXC; Pogach LM, 2006, DIABETES CARE, V29, P241, DOI 10.2337/diacare.29.02.06.dc05-1468; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Rosenstock J, 2005, DIABETES CARE, V28, P950, DOI 10.2337/diacare.28.4.950; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Vijan S, 1997, ANN INTERN MED, V127, P788, DOI 10.7326/0003-4819-127-9-199711010-00003; AMBULATORY CARE QUAL	22	37	39	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					520	523		10.1001/jama.297.5.520	http://dx.doi.org/10.1001/jama.297.5.520			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284702				2022-12-28	WOS:000243999100029
J	Hajnoczky, G				Hajnoczky, Gyoergy			Mitochondrial longevity pathways	SCIENCE			English	Editorial Material							LIFE-SPAN; CALORIE RESTRICTION; P66(SHC); AUTOPHAGY; DISEASE		Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Hajnoczky, G (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	gyorgy.hajnoczky@jefferson.edu		Hoek, Jan/0000-0001-7127-4218				Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Pandolfi S, 2005, MECH AGEING DEV, V126, P839, DOI 10.1016/j.mad.2005.03.004; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380	16	38	39	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					607	609		10.1126/science.1138825	http://dx.doi.org/10.1126/science.1138825			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272709				2022-12-28	WOS:000243909400030
J	Mullan, F				Mullan, Fitzhugh			Doctors and soccer players - African professionals on the move	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Washington, DC 20052 USA.							JOHNSON K, 2004, STALL MORTALITY DECL; Joint Learning Initiative, 2004, HUMAN RESOURCES HLTH; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; *WHO DEP REPROD HL, 2006, MONITORING EVALUATIO; 2007, 2006 REPORT GLOBAL A	5	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					440	443		10.1056/NEJMp068267	http://dx.doi.org/10.1056/NEJMp068267			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267902				2022-12-28	WOS:000243860700002
J	Dragert, H				Dragert, Herb			Mediating plate convergence	SCIENCE			English	Editorial Material							CASCADIA SUBDUCTION ZONE; SLOW EARTHQUAKES; SILENT SLIP; TREMORS		Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Dragert, H (corresponding author), Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada.	hdragert@nrcan.gc.ca						Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Lay T, 2005, SCIENCE, V308, P1127, DOI 10.1126/science.1112250; Mazzotti S, 2004, B SEISMOL SOC AM, V94, P1954, DOI 10.1785/012004032; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783	9	14	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					471	472		10.1126/science.1137171	http://dx.doi.org/10.1126/science.1137171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255502				2022-12-28	WOS:000243726600034
J	Sidorenko, A; Krupenkin, T; Taylor, A; Fratzl, P; Aizenberg, J				Sidorenko, Alexander; Krupenkin, Tom; Taylor, Ashley; Fratzl, Peter; Aizenberg, Joanna			Reversible switching of hydrogel-actuated nanostructures into complex micropatterns	SCIENCE			English	Article							SHAPE-MEMORY; PHOTONIC CRYSTALS; MICROSTRUCTURES; TENSEGRITY; SURFACES	Responsive behavior, which is intrinsic to natural systems, is becoming a key requirement for advanced artificial materials and devices, presenting a substantial scientific and engineering challenge. We designed dynamic actuation systems by integrating high-aspect-ratio silicon nanocolumns, either free-standing or substrate-attached, with a hydrogel layer. The nanocolumns were put in motion by the "muscle" of the hydrogel, which swells or contracts depending on the humidity level. This actuation resulted in a fast reversible reorientation of the nanocolumns from tilted to perpendicular to the surface. By further controlling the stress field in the hydrogel, the formation of a variety of elaborate reversibly actuated micropatterns was demonstrated. The mechanics of the actuation process have been assessed. Dynamic control over the movement and orientation of surface nanofeatures at the micron and submicron scales may have exciting applications in actuators, microfluidics, or responsive materials.	Bell Labs, Alcatel Lucent, Murray Hill, NJ 07974 USA; Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	Alcatel-Lucent; AT&T; Max Planck Society	Aizenberg, J (corresponding author), Bell Labs, Alcatel Lucent, 600 Mt Ave, Murray Hill, NJ 07974 USA.	jaizenberg@alcatel-lucent.com	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Sidorenko, Alexander/0000-0002-3109-7605				Asher SA, 2004, NAN SCI TEC, P145; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; BUCKMINSTERFULL.R, 1961, PORTFOLIO ART NEWS A, V4, P112; Chiellini F, 2001, MACROMOL RAPID COMM, V22, P1284, DOI 10.1002/1521-3927(20011001)22:15<1284::AID-MARC1284>3.0.CO;2-M; Defossez M, 2003, MECH RES COMMUN, V30, P311, DOI 10.1016/S0093-6413(03)00030-2; Delamarche E, 1997, ADV MATER, V9, P741, DOI 10.1002/adma.19970090914; Gates BD, 2004, ANGEW CHEM INT EDIT, V43, P2780, DOI 10.1002/anie.200353009; Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Iyer KS, 2003, MACROMOLECULES, V36, P6519, DOI 10.1021/ma034460z; Krupenkin TN, 2004, LANGMUIR, V20, P3824, DOI 10.1021/la036093q; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Lee SB, 2004, J AM CHEM SOC, V126, P13400, DOI 10.1021/ja048463i; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Maurer MK, 2005, ADV FUNCT MATER, V15, P1401, DOI 10.1002/adfm.200400070; Mayer M, 2004, PROTEOMICS, V4, P2366, DOI 10.1002/pmic.200300748; Minko S., 2006, RESPONSIVE POLYM MAT; OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park S, 2004, SCIENCE, V303, P348, DOI 10.1126/science.1093276; Ruppert EE, 2004, INVERTEBRATE ZOOLOGY; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; Zhai L, 2004, NANO LETT, V4, P1349, DOI 10.1021/nl049463j	26	471	485	16	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					487	490		10.1126/science.1135516	http://dx.doi.org/10.1126/science.1135516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255505	Green Submitted			2022-12-28	WOS:000243726600038
J	Li, W; Tu, DQ; Brunger, AT; Ye, YH				Li, Wei; Tu, Daqi; Brunger, Axel T.; Ye, Yihong			A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN LIGASE; DEGRADATION; DOMAIN; HERP; COMPLEX; CDC34; PATHWAY; LYSINE; GP78	In eukaryotic cells, many short-lived proteins are conjugated with Lys48-linked ubiquitin chains and degraded by the proteasome(1). Ubiquitination requires an activating enzyme (E1), a conjugating enzyme (E2) and a ligase (E3)(2). Most ubiquitin ligases use either a HECT (homologous to E6-associated protein C terminus) or a RING (really interesting new gene) domain to catalyse polyubiquitination(3), but the mechanism of E3 catalysis is poorly defined(4). Here we dissect this process using mouse Ube2g2 (E2; identical at the amino acid level to human Ube2g2) and human gp78 (E3), an endoplasmic reticulum (ER)-associated conjugating system essential for the degradation of misfolded ER proteins(5,6). We demonstrate by expressing recombinant proteins in Escherichia coli that Ube2g2/gp78-mediated polyubiquitination involves preassembly of Lys48-linked ubiquitin chains at the catalytic cysteine of Ube2g2. The growth of Ube2g2-anchored ubiquitin chains seems to be mediated by an aminolysis-based transfer reaction between two Ube2g2 molecules that each carries a ubiquitin moiety in its active site. Intriguingly, polyubiquitination of a substrate can be achieved by transferring preassembled ubiquitin chains from Ube2g2 to a lysine residue in a substrate.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Stanford Univ, Howard Hughes Med Inst, Dept Mol & Cellular Physiol Neurol & Neurol Sci S, Stanford, CA 94305 USA; Stanford Univ, SSRL, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Howard Hughes Medical Institute; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ye, YH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov		Brunger, Axel/0000-0001-5121-2036	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036137, Z01DK036137] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arai R, 2006, ACTA CRYSTALLOGR F, V62, P330, DOI 10.1107/S1744309106009006; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; CHEN JZ, 1993, J THERM SPRAY TECHN, V2, P357; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Huang HK, 2000, J BIOL CHEM, V275, P26661; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; VANNOCKER S, 1993, J BIOL CHEM, V268, P24766; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169	26	171	176	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 15	2007	446	7133					333	337		10.1038/nature05542	http://dx.doi.org/10.1038/nature05542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17310145				2022-12-28	WOS:000244892900049
J	Bodenheimer, T; Berenson, RA; Rudolf, P				Bodenheimer, Thomas; Berenson, Robert A.; Rudolf, Paul			The primary care-specialty income gap: Why it matters	ANNALS OF INTERNAL MEDICINE			English	Article							US MEDICAL-STUDENTS; HEALTH-CARE; LIFE-STYLE; PHYSICIANS; COSTS; QUALITY; CHOICE	A large, widening gap exists between the incomes of primary care physicians and those of many specialists. This disparity is important because noncompetitive primary care incomes discourage medical school graduates from choosing primary care careers. The Resource-Based Relative Value Scale, designed to reduce the inequality between fees for office visits and payment for procedures, failed to prevent the widening primary care-specialty income gap for 4 reasons: 1) The volume of diagnostic and imaging procedures has increased far more rapidly than the volume of office visits, which benefits specialists who perform those procedures; 2) the process of updating fees every 5 years is heavily influenced by the Relative Value Scale Update Committee, which is composed mainly of specialists; 3) Medicare's formula for controlling physician payments penalizes primary care physicians; and 4) private insurers tend to pay for procedures, but not for office visits, at higher levels than those paid by Medicare. Payment reform is essential to guarantee a healthy primary care base to the U.S. health care system.	Univ Calif San Francisco, San Francisco, CA 94143 USA; Urban Inst, Washington, DC 20037 USA; Arent Fox PLLC, Washington, DC USA	University of California System; University of California San Francisco; Urban Institute	Bodenheimer, T (corresponding author), San Francisco Gen Hosp, Bldg 80-83,1001 Potrero Ave, San Francisco, CA 94110 USA.	TBodenheimer@fcm.ucsf.edu						*AM MED ASS, 2005, RBRVS RES BAS REL VA; American College of Physicians, 2006, IMP COLL PRIM CAR ME; BAICKER K, 2004, MEDICARE SPENDING PH, P18497; BERENSON RA, 2003, HLTH AFF MILLWOOD, P33753; Bodenheimer T, 2005, ANN INTERN MED, V142, P996, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00009; Bodenheimer T, 2005, ANN INTERN MED, V143, P26, DOI 10.7326/0003-4819-143-1-200507050-00007; Casalino LP, 2004, HEALTH AFFAIR, V23, P82, DOI 10.1377/hlthaff.23.2.82; Crane M, 2001, Med Econ, V78, P74; *CTR MED MED SER, 2006, CMS1512PN; *CTR MED MED SERV, 2006, CMS ANNOUNCES PROPOS; *CTR MED MED SERV, 2006, CTR MED MED SERV HEA; *CTR STUD HLTH SYS, 1996, PHYS SURV; De Maeseneer Jan M, 2003, Ann Fam Med, V1, P144, DOI 10.1370/afm.75; *DIR RES LLC, 2003, MED PHYS PAYM RAT CO; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; *DYCKM ASS LLC, 2003, SURV HLTH PLANS CONC; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; GINSBURG PB, 2005, UNPUB PRICE ISNT RIG; Goodson JD, 2001, J GEN INTERN MED, V16, P250, DOI 10.1046/j.1525-1497.2001.016004250.x; GOROLL HA, 2007, IN PRESS J GEN INTER; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Grumbach K, 1999, JAMA-J AM MED ASSOC, V282, P261, DOI 10.1001/jama.282.3.261; HACKBARTH GM, 2005, MEDICARE PAYMENT PHY; HSIAO WC, 1988, NEW ENGL J MED, V319, P835, DOI 10.1056/NEJM198809293191305; Lowes Robert, 2005, Med Econ, V82, P58; MCCLELLAN M, 2006, COMMUNICATION; Mechanic D, 2003, JAMA-J AM MED ASSOC, V290, P941, DOI 10.1001/jama.290.7.941; *MED PAYM ADV COMM, 2004, REP C GROWTH VOL PHY; *MED PAYM ADV COMM, 2004, REP C IMP RES BAS PR; *MED PAYM ADV COMM, 2006, REP C IMP RES BAS PR; *MED PAYM ADV COMM, 2005, HEALTHC SPEND MED PR; *MED PAYM ADV COMM, 2006, CAR COORD FEE SERV M; Newton DA, 2005, ACAD MED, V80, P809, DOI 10.1097/00001888-200509000-00005; PARCHMAN ML, 1994, J FAM PRACTICE, V39, P123; Pugno PA, 2005, FAM MED, V37, P555; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; TU HT, 1995, LOSING GROUND PHYS I; *US DEP TREAS, 2006, ANN REP BOARDS TRUST; *US GOV ACC OFF, 2006, MED PHYS SERV; WEISS GG, 2005, MED ECON, V82, P86; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; West CP, 2006, ANN INTERN MED, V145, P774, DOI 10.7326/0003-4819-145-10-200611210-00010; Wetterneck TB, 2002, ARCH INTERN MED, V162, P649, DOI 10.1001/archinte.162.6.649; WOODWELL DA, 1993, NATL AMBULATORY MED, V6, P29; Zyzanski SJ, 1998, J FAM PRACTICE, V46, P397	49	177	179	3	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					301	306		10.7326/0003-4819-146-4-200702200-00011	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310054				2022-12-28	WOS:000244271000008
J	Ohlstein, B; Spradling, A				Ohlstein, Benjamin; Spradling, Allan			Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential Notch signaling	SCIENCE			English	Article							SELF-RENEWAL; NICHE; MAINTENANCE; DIVISION; EXOCYST	The adult Drosophila midgut contains multipotent intestinal stem cells (ISCs) scattered along its basement membrane that have been shown by lineage analysis to generate both enterocytes and enteroendocrine cells. ISCs containing high levels of cytoplasmic Delta-rich vesicles activate the canonical Notch pathway and down-regulate Delta within their daughters, a process that programs these daughters to become enterocytes. ISCs that express little vesiculate Delta, or are genetically impaired in Notch signaling, specify their daughters to become enteroendocrine cells. Thus, ISCs control daughter cell fate by modulating Notch signaling over time. Our studies suggest that ISCs actively coordinate cell production with local tissue requirements by this mechanism.	Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, A (corresponding author), Carnegie Inst Sci, Dept Embryol, Howard Hughes Med Inst, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090078] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R56 DK090078] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	21	463	473	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					988	992		10.1126/science.1136606	http://dx.doi.org/10.1126/science.1136606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303754				2022-12-28	WOS:000244229800042
J	Mayer, L; Kazantzidis, S; Mastropietro, C; Wadsley, J				Mayer, L.; Kazantzidis, S.; Mastropietro, C.; Wadsley, J.			Early gas stripping as the origin of the darkest galaxies in the Universe	NATURE			English	Article							DWARF GALAXIES; URSA-MINOR; MATTER; MASS; SUBSTRUCTURE; KINEMATICS; ABUNDANCE; PROFILES; CLUSTERS; DRACO	The known galaxies most dominated by dark matter ( Draco, Ursa Minor and Andromeda IX) are satellites of the Milky Way and the Andromeda galaxies(1-4). They are members of a class of faint galaxies, devoid of gas, known as dwarf spheroidals(3-5), and have by far the highest ratio of dark to luminous matter(3,6). None of the models proposed to unravel their origin(7-10) can simultaneously explain their exceptional dark matter content and their proximity to a much larger galaxy. Here we report simulations showing that the progenitors of these galaxies were probably gas-dominated dwarf galaxies that became satellites of a larger galaxy earlier than the other dwarf spheroidals. We find that a combination of tidal shocks and ram pressure swept away the entire gas content of such progenitors about ten billion years ago because heating by the cosmic ultraviolet background kept the gas loosely bound: a tiny stellar component embedded in a relatively massive dark halo survived until today. All luminous galaxies should be surrounded by a few extremely dark-matter-dominated dwarf spheroidal satellites, and these should have the shortest orbital periods among dwarf spheroidals because they were accreted early.	Univ Zurich, Inst Theoret Phys, CH-8057 Zurich, Switzerland; ETH, Inst Astron, Dept Phys, CH-8093 Zurich, Switzerland; Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Dept Phys, Stanford, CA 94309 USA; Univ Chicago, Kavli Inst Cosmol Phys, Dept Astron & Astrophys, Chicago, IL 60637 USA; Univ Sternwarte, D-81679 Munich, Germany; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Stanford University; University of Chicago; University of Munich; McMaster University	Mayer, L (corresponding author), Univ Zurich, Inst Theoret Phys, Winterthurestr 190, CH-8057 Zurich, Switzerland.	lucio@phys.ethz.ch; stelios@kicp.uchicago.edu	Bullock, James/K-1928-2015	Bullock, James/0000-0003-4298-5082				Bullock JS, 2000, ASTROPHYS J, V539, P517, DOI 10.1086/309279; Chapman SC, 2005, ASTROPHYS J, V632, pL87, DOI 10.1086/497686; deBlok WJG, 1997, MON NOT R ASTRON SOC, V290, P533, DOI 10.1093/mnras/290.3.533; Diemand J, 2005, MON NOT R ASTRON SOC, V364, P367, DOI 10.1111/j.1365-2966.2005.09604.x; EINASTO J, 1974, NATURE, V252, P111, DOI 10.1038/252111a0; Gallagher JS, 2003, ASTROPHYS J, V588, P326, DOI 10.1086/373951; Governato F, 2004, ASTROPHYS J, V607, P688, DOI 10.1086/383516; Grebel EK, 1999, IAU SYMP, P17; Haardt F, 1996, ASTROPHYS J, V461, P20, DOI 10.1086/177035; Kazantzidis S, 2004, ASTROPHYS J, V608, P663, DOI 10.1086/420840; Kleyna JT, 2005, ASTROPHYS J, V630, pL141, DOI 10.1086/491654; Kravtsov AV, 2004, ASTROPHYS J, V609, P482, DOI 10.1086/421322; LIN DNC, 1983, ASTROPHYS J, V266, pL21, DOI 10.1086/183971; Mac Low MM, 1999, ASTROPHYS J, V513, P142, DOI 10.1086/306832; Marcolini A, 2003, MON NOT R ASTRON SOC, V345, P1329, DOI 10.1046/j.1365-2966.2003.07054.x; Mateo M, 1998, ANNU REV ASTRON ASTR, V36, P435, DOI 10.1146/annurev.astro.36.1.435; Mayer L, 2004, MON NOT R ASTRON SOC, V354, P477, DOI 10.1111/j.1365-2966.2004.08203.x; Mayer L, 2001, ASTROPHYS J, V559, P754, DOI 10.1086/322356; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Mori M, 2000, ASTROPHYS J, V538, P559, DOI 10.1086/309140; Munoz RR, 2005, ASTROPHYS J, V631, pL137, DOI 10.1086/497396; Susa H, 2004, ASTROPHYS J, V600, P1, DOI 10.1086/379784; Verde L, 2002, MON NOT R ASTRON SOC, V336, P541, DOI 10.1046/j.1365-8711.2002.05771.x; Walker MG, 2006, ASTRON J, V131, P2114, DOI 10.1086/500193; Wilkinson MI, 2002, MON NOT R ASTRON SOC, V330, P778, DOI 10.1046/j.1365-8711.2002.05154.x; Willman B, 2004, MON NOT R ASTRON SOC, V353, P639, DOI 10.1111/j.1365-2966.2004.08095.x; Willman B, 2005, ASTROPHYS J, V626, pL85, DOI 10.1086/431760	29	115	115	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					738	740		10.1038/nature05552	http://dx.doi.org/10.1038/nature05552			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301786	Green Submitted			2022-12-28	WOS:000244205200038
J	Zacharski, LR; Chow, BK; Howes, PS; Shamayeva, G; Baron, JA; Dalman, RL; Malenka, DJ; Ozaki, CK; Lavori, PW				Zacharski, Leo R.; Chow, Bruce K.; Howes, Paula S.; Shamayeva, Galina; Baron, John A.; Dalman, Ronald L.; Malenka, David J.; Ozaki, C. Keith; Lavori, Philip W.			Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTIMA-MEDIA THICKNESS; BODY IRON; HEART-DISEASE; LIPID-PEROXIDATION; CAROTID ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; VASCULAR FUNCTION; SERUM FERRITIN; RISK-FACTORS; BLOOD	Context Accumulation of iron in excess of physiologic requirements has been implicated in risk of cardiovascular disease because of increased iron-catalyzed free radical mediated oxidative stress. Objective To test the hypothesis that reducing body iron stores through phlebotomy will influence clinical outcomes in a cohort of patients with symptomatic peripheral arterial disease (PAD). Design, Setting, and Patients Multicenter, randomized, controlled, single-blinded clinical trial based on the Iron (Fe) and Atherosclerosis Study (FeAST) (VA Cooperative Study #410) and conducted between May 1, 1999, and April 30, 2005, within the Department of Veterans Affairs Cooperative Studies Program and enrolling 1277 patients with symptomatic but stable PAD. Those with conditions likely to cause acute-phase increase of the ferritin level or with a diagnosis of visceral malignancy within the preceding 5 years were excluded. Analysis was by intent-to-treat. Intervention Patients were assigned to a control group (n = 641) or to a group undergoing reduction of iron stores by phlebotomy with removal of defined volumes of blood at 6-month intervals (avoiding iron deficiency) (n = 636), stratified by hospital, age, and baseline smoking status, diagnosis of diabetes mellitus, ratio of high-density to low-density lipoprotein cholesterol level, and ferritin level. Main Outcome Measures The primary end point was all-cause mortality; the secondary end point was death plus nonfatal myocardial infarction and stroke. Results There were no significant differences between treatment groups for the primary or secondary study end points. All-cause deaths occurred in 148 patients (23%) in the control group and in 125 (20%) in the iron-reduction group (hazard ratio (HR), 0.85; 95% confidence interval (CI), 0.67-1.08; P = .17). Death plus nonfatal myocardial infarction and stroke occurred in 205 patients (32%) in the control group and in 180 (28%) in the iron-reduction group (HR, 0.88; 95% CI, 0.72-1.07; P = .20). Conclusion Reduction of body iron stores in patients with symptomatic PAD did not significantly decrease all-cause mortality or death plus nonfatal myocardial infarction and stroke.	Dept Vet Affairs Med Ctr, VA Med Ctr, Res Serv 151, White River Jct, VT 05001 USA; Dept Vet Affairs Med Ctr, VA Palo Alto Hlth Care Syst, Res Serv, White River Jct, VT 05001 USA; Dartmouth Med Sch, Dept Med, Lebanon, NH USA; Stanford Univ, Sch Med, Dept Surg, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA; Univ Florida, Coll Med, Gainesville, FL USA; Dept Vet Affairs Med Ctr, Res Serv, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Dartmouth College; Stanford University; Stanford University; State University System of Florida; University of Florida	Zacharski, LR (corresponding author), Dept Vet Affairs Med Ctr, VA Med Ctr, Res Serv 151, 215 N Hartland Rd, White River Jct, VT 05001 USA.	leo.r.zacharski@dartmouth.edu	Ozaki, C Keith/A-4937-2013					Balducci Lodovico, 2003, Cancer Control, V10, P478; Berkman LF, 2005, CIRCULATION, V111, P3022, DOI 10.1161/CIRCULATIONAHA.104.509810; Chamoun AJ, 2006, NEW ENGL J MED, V354, P303; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; COX DR, 1972, J R STAT SOC B, V34, P187; Duffy SJ, 2001, CIRCULATION, V103, P2799; Ferrara DE, 2005, ARTERIOSCL THROM VAS, V25, P2235, DOI 10.1161/01.ATV.0000189303.45609.1f; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; Haidari M, 2001, CLIN CHEM, V47, P1666; Howard BV, 2005, CIRCULATION, V111, P1462, DOI 10.1161/01.CIR.0000159344.21672.FD; Jeziorska M, 1999, J PATHOL, V188, P189; Jiang R, 2004, AM J CLIN NUTR, V79, P70; Juonala M, 2005, CIRCULATION, V112, P1486, DOI 10.1161/CIRCULATIONAHA.104.502161; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kiechl S, 1997, CIRCULATION, V96, P3300; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Knoflach M, 2005, ANN NY ACAD SCI, V1051, P323, DOI 10.1196/annals.1361.074; LAKATOS E, 1986, CONTROL CLIN TRIALS, V7, P189, DOI 10.1016/0197-2456(86)90047-4; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lee DH, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.03.009; Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; McMahan CA, 2007, ATHEROSCLEROSIS, V190, P370, DOI 10.1016/j.atherosclerosis.2006.02.008; Meyers DG, 2002, TRANSFUSION, V42, P1135, DOI 10.1046/j.1537-2995.2002.00186.x; Nakamura YK, 2006, ARCH GERONTOL GERIAT, V42, P265, DOI 10.1016/j.archger.2005.08.002; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Papanikolaou G, 2005, TOXICOL APPL PHARM, V202, P199, DOI 10.1016/j.taap.2004.06.021; Paraskevaidis IA, 2005, EUR HEART J, V26, P263, DOI 10.1093/eurheartj/ehi028; Paul TK, 2005, AM J MED SCI, V330, P105, DOI 10.1097/00000441-200509000-00001; Qayyum R, 2005, CLIN CARDIOL, V28, P119; Ramakrishna G, 2003, VASC MED, V8, P203, DOI 10.1191/1358863x03vm493ra; Ramakrishnan U, 2002, AM J CLIN NUTR, V76, P1256, DOI 10.1093/ajcn/76.6.1256; Salonen JT, 1998, AM J EPIDEMIOL, V148, P445; SALONEN JT, 1995, J INTERN MED, V237, P161, DOI 10.1111/j.1365-2796.1995.tb01156.x; Samson FE, 2000, CELL MOL BIOL, V46, P699; Shah SV, 2003, AM J KIDNEY DIS, V41, pS80, DOI 10.1053/ajkd.2003.50091; Spiteller G, 2005, ANN NY ACAD SCI, V1043, P355, DOI 10.1196/annals.1333.042; Spiteller G, 2001, EXP GERONTOL, V36, P1425, DOI 10.1016/S0531-5565(01)00131-0; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; Sulieman M, 2004, DIABETES CARE, V27, P2730, DOI 10.2337/diacare.27.11.2730; SULLIVAN JL, 1981, LANCET, V1, P1293; *US CENS BUR, RAC ETHN CLASS US CE; Van Der A DL, 2006, CIRCULATION, V113, P1942, DOI 10.1161/CIRCULATIONAHA.105.545350; van der A DL, 2005, STROKE, V36, P1637, DOI 10.1161/01.STR.0000173172.82880.72; Vrtovec B, 1999, CORONARY ARTERY DIS, V10, P407, DOI 10.1097/00019501-199909000-00010; Weinberg ED, 1999, EMERG INFECT DIS, V5, P346, DOI 10.3201/eid0503.990305; Whincup PH, 2005, CIRCULATION, V112, P1789, DOI 10.1161/CIRCULATIONAHA.104.532663; Willeit J, 2000, ARTERIOSCL THROM VAS, V20, P529, DOI 10.1161/01.ATV.20.2.529; Wolff B, 2004, STROKE, V35, P453, DOI 10.1161/01.STR.0000114875.31599.1C; Wood RJ, 2004, AGEING RES REV, V3, P355, DOI 10.1016/j.arr.2004.04.002; You SA, 2005, CLIN CHIM ACTA, V357, P1, DOI 10.1016/j.cccn.2005.02.001; Yuan XM, 2003, ANN MED, V35, P578, DOI 10.1080/07853890310016342; Yuan XM, 1996, ATHEROSCLEROSIS, V124, P61, DOI 10.1016/0021-9150(96)05817-0; Yunker LM, 2006, VASC MED, V11, P85, DOI 10.1191/1358863x06vm656oa; Zacharski LR, 2004, AM HEART J, V148, P386, DOI 10.1016/j.ahj.2004.03.027; Zacharski LR, 2000, AM HEART J, V139, P337, DOI 10.1016/S0002-8703(00)90244-8; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646; Zheng HY, 2005, ARTERIOSCL THROM VAS, V25, P1577, DOI 10.1161/01.ATV.0000174126.28201.61	61	147	156	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					603	610		10.1001/jama.297.6.603	http://dx.doi.org/10.1001/jama.297.6.603			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135TU	17299195				2022-12-28	WOS:000244177400023
J	Drenth, JPH; Verheugt, FWA				Drenth, Joost P. H.; Verheugt, Freek W. A.			Do COX-2 inhibitors give enough gastrointestinal protection?	LANCET			English	Editorial Material							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON PUMP INHIBITORS		Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Heart Lung Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Drenth, JPH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands.	joostphdrenth@cs.com	Drenth, Joost/V-7436-2019; Drenth, J.P.H./H-8025-2014; Verheugt, F.W.A./H-8105-2014					Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Hawkey CJ, 2003, GUT, V52, P600, DOI 10.1136/gut.52.4.600; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Laine L, 2007, LANCET, V369, P465, DOI 10.1016/S0140-6736(07)60234-7; Moore RA, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-79; Rahme E, 2005, GASTROENTEROLOGY, V128, pA24; ROSTOM A, 2002, COCHRANE DB SYST REV, V2002, DOI [DOI 10.1002/14651858.CD002296, 10.1002/14651858.CD002296]	8	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					439	440		10.1016/S0140-6736(07)60206-2	http://dx.doi.org/10.1016/S0140-6736(07)60206-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292743				2022-12-28	WOS:000244188300004
J	Bagchi, A; Papazoglu, C; Wu, Y; Capurso, D; Brodt, M; Francis, D; Bredel, M; Vogel, H; Mills, AA				Bagchi, Anindya; Papazoglu, Cristian; Wu, Ying; Capurso, Daniel; Brodt, Michael; Francis, Dailia; Bredel, Markus; Vogel, Hannes; Mills, Alea A.			CHD5 is a tumor suppressor at human 1p36	CELL			English	Article							SUSCEPTIBILITY GENE; CELL-PROLIFERATION; BREAST-CANCER; IN-VIVO; IDENTIFICATION; DELETION; P53; SENESCENCE; SEQUENCE; REGIONS	Cancer gene discovery has relied extensively on analyzing tumors for gains and losses to reveal the location of oncogenes and tumor suppressor genes, respectively. Deletions of 1p36 are extremely common genetic lesions in human cancer, occurring in malignancies of epithelial, neural, and hematopoietic origin. Although this suggests that 1p36 harbors a gene that drives tumorigenesis when inactivated, the identity of this tumor suppressor has remained elusive. Here we use chromosome engineering to generate mouse models with gain and loss of a region corresponding to human 1p36. This approach functionally identifies chromodomain helicase DNA binding domain 5 (Chd5) as a tumor suppressor that controls proliferation, apoptosis, and senescence via the p19(Arf)/p53 pathway. We demonstrate that Chd5 functions as a tumor suppressor in vivo and implicate deletion of CHD5 in human cancer. Identification of this tumor suppressor provides new avenues for exploring innovative clinical interventions for cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Stanford Univ, Palo Alto, CA 94304 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Mills, AA (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mills@cshl.edu		Vogel, Otto Hannes/0000-0002-0960-3508	NCI NIH HHS [CA45508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLE SH, 1995, CLIN TRANSPL, V1, P19; BIECHE I, 1993, CANCER RES, V53, P1990; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chen W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-85; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Esteller M, 2001, CANCER RES, V61, P3225; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Gonzalez S, 2006, CELL CYCLE, V5, P1382, DOI 10.4161/cc.5.13.2901; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kleer CG, 2000, ENDOCR PATHOL, V11, P137, DOI 10.1385/EP:11:2:137; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Melendez B, 2003, LEUKEMIA RES, V27, P627, DOI 10.1016/S0145-2126(02)00278-3; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; MOLEY JF, 1992, CANCER RES, V52, P770; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Piaskowski S, 2005, CANCER GENET CYTOGEN, V162, P63, DOI 10.1016/j.cancergencyto.2005.02.009; Poetsch M, 2003, MELANOMA RES, V13, P29, DOI 10.1097/00008390-200302000-00006; PRAML C, 1995, ONCOGENE, V11, P1357; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	53	255	280	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					459	475		10.1016/j.cell.2006.11.052	http://dx.doi.org/10.1016/j.cell.2006.11.052			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289567	Bronze			2022-12-28	WOS:000244842700014
J	Schrag, DP				Schrag, Daniel P.			Preparing to capture carbon	SCIENCE			English	Editorial Material							STORAGE	Carbon sequestration from large sources of fossil fuel combustion, particularly coal, is an essential component of any serious plan to avoid catastrophic impacts of human-induced climate change. Scientific and economic challenges still exist, but none are serious enough to suggest that carbon capture and storage will not work at the scale required to offset trillions of tons of carbon dioxide emissions over the next century. The challenge is whether the technology will be ready when society decides that it is time to get going.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Schrag, DP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	schrag@eps.harvard.edu						Anderson S, 2004, ANNU REV ENV RESOUR, V29, P109, DOI 10.1146/annurev.energy.29.082703.145619; BRADSHAW J, 2004, STORAGE RETENTION TI; *BRIT PETR, 2006, BP STAT REV WORLD EN; House KZ, 2006, P NATL ACAD SCI USA, V103, P12291, DOI 10.1073/pnas.0605318103; IPCC, 2005, IPCC SPECIAL REPORT	5	292	298	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					812	813		10.1126/science.1137632	http://dx.doi.org/10.1126/science.1137632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134FN	17289991				2022-12-28	WOS:000244069000059
J	Roger, M; Morris, DJP; Tennant, DA; Gutmann, MJ; Goff, JP; Hoffmann, JU; Feyerherm, R; Dudzik, E; Prabhakaran, D; Boothroyd, AT; Shannon, N; Lake, B; Deen, PP				Roger, M.; Morris, D. J. P.; Tennant, D. A.; Gutmann, M. J.; Goff, J. P.; Hoffmann, J. -U.; Feyerherm, R.; Dudzik, E.; Prabhakaran, D.; Boothroyd, A. T.; Shannon, N.; Lake, B.; Deen, P. P.			Patterning of sodium ions and the control of electrons in sodium cobaltate	NATURE			English	Article							PHASE-TRANSITIONS; NAXCOO2; THERMOPOWER; NA0.5COO2; COO2	Sodium cobaltate (NaxCoO2) has emerged as a material of exceptional scientific interest due to the potential for thermoelectric applications(1,2), and because the strong interplay between the magnetic and superconducting properties has led to close comparisons with the physics of the superconducting copper oxides(3). The density x of the sodium in the intercalation layers can be altered electrochemically, directly changing the number of conduction electrons on the triangular Co layers(4). Recent electron diffraction measurements reveal a kaleidoscope of Na+ ion patterns as a function of concentration(5). Here we use single-crystal neutron diffraction supported by numerical simulations to determine the long-range three-dimensional superstructures of these ions. We show that the sodium ordering and its associated distortion field are governed by pure electrostatics, and that the organizational principle is the stabilization of charge droplets that order long range at some simple fractional fillings. Our results provide a good starting point to understand the electronic properties in terms of a Hubbard hamiltonian(6) that takes into account the electrostatic potential from the Na superstructures. The resulting depth of potential wells in the Co layer is greater than the single-particle hopping kinetic energy and as a consequence, holes preferentially occupy the lowest potential regions. Thus we conclude that the Na+ ion patterning has a decisive role in the transport and magnetic properties.	CEA Saclay, CNRS,URA 2464, MIPPU,DSM,DRECAM,SPEC, Serv Phys Etat Condense, F-91191 Gif Sur Yvette, France; Univ Liverpool, Oliver Lodge Lab, Dept Phys, Liverpool L69 7ZE, Merseyside, England; Hahn Meitner Inst Berlin GmbH, D-14109 Berlin, Germany; Tech Univ Berlin, Inst Festkorperphys, D-10623 Berlin, Germany; Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; European Synchrotron Radiat Facil, F-38043 Grenoble, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Liverpool; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Technical University of Berlin; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; University of Bristol; European Synchrotron Radiation Facility (ESRF)	Roger, M (corresponding author), CEA Saclay, CNRS,URA 2464, MIPPU,DSM,DRECAM,SPEC, Serv Phys Etat Condense, PC 135, F-91191 Gif Sur Yvette, France.	roger@drecam.saclay.cea.fr	Hoffmann, Jens-Uwe/J-6035-2013; Lake, Bella/A-6264-2011; Morris, David Jonathan Pryce/D-9183-2011; Boothroyd, Andrew/AAA-7883-2021; Hoffmann, Jens-Uwe/U-9858-2019; Shannon, Nic/N-3874-2014; Feyerherm, Ralf/F-5487-2013; Feyerherm, Ralf/I-4050-2013; Tennant, David A/Q-2497-2015; Deen, Pascale/C-6557-2015	Hoffmann, Jens-Uwe/0000-0002-3651-958X; Lake, Bella/0000-0003-0034-0964; Morris, David Jonathan Pryce/0000-0002-4785-7541; Boothroyd, Andrew/0000-0002-3575-7471; Hoffmann, Jens-Uwe/0000-0002-3651-958X; Shannon, Nic/0000-0001-9258-1583; Feyerherm, Ralf/0000-0003-3034-4210; Feyerherm, Ralf/0000-0003-3034-4210; Tennant, David A/0000-0002-9575-3368; Deen, Pascale/0000-0002-0204-0802	EPSRC [EP/E034993/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E034993/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; BALSYS RJ, 1996, SOLID STATE IONICS, V93, P279; Bayrakci SP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157205; de Vaulx C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.186405; DELMAS C, 1981, SOLID STATE IONICS, V3-4, P165, DOI 10.1016/0167-2738(81)90076-X; FUMI FG, 1964, J PHYS CHEM SOLIDS, V25, P31, DOI 10.1016/0022-3697(64)90159-3; Hasan MZ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246402; Helme LM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.157206; Huang Q, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184110; Huang Q, 2004, J PHYS-CONDENS MAT, V16, P5803, DOI 10.1088/0953-8984/16/32/016; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; Lee M, 2006, NAT MATER, V5, P537, DOI 10.1038/nmat1669; Mukhamedshin IR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.167601; Mukhamedshin IR, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.247602; Nolas GS, 1998, APPL PHYS LETT, V73, P178, DOI 10.1063/1.121747; Nolas GS, 1998, PHYS REV B, V58, P164, DOI 10.1103/PhysRevB.58.164; Prabhakaran D, 2004, J CRYST GROWTH, V271, P74, DOI 10.1016/j.jcrysgro.2004.07.033; Sakurai H, 2004, PHYSICA C, V412, P182, DOI 10.1016/j.physc.2003.12.033; SLACK GA, 1994, J APPL PHYS, V76, P1665, DOI 10.1063/1.357750; Sperb R, 1998, MOL SIMULAT, V20, P179, DOI 10.1080/08927029808024176; Takada K, 2003, NATURE, V422, P53, DOI 10.1038/nature01450; TERASAKI I, 1997, PHYS REV B, V56, P12687; Wang YY, 2003, NATURE, V423, P425, DOI 10.1038/nature01639; Yokoi M, 2005, J PHYS SOC JPN, V74, P3046, DOI 10.1143/JPSJ.74.3046; Zandbergen HW, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024101; Zhang PH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.153102	27	192	196	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					631	634		10.1038/nature05531	http://dx.doi.org/10.1038/nature05531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287806	Green Submitted			2022-12-28	WOS:000244039400040
J	Ahmad, J; Beattie, GC; Kennedy, R; Clements, WDB; Kennedy, JA				Ahmad, J.; Beattie, G. C.; Kennedy, R.; Clements, W. D. B.; Kennedy, J. A.			Lesson of the week - Penetrating trauma to the junctional zone needs aggressive management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LAPAROSCOPY; DIAPHRAGM; INJURIES; WOUNDS		Royal Victoria Hosp, Upper Gastrointestinal Unit, Belfast BT12 6BA, Antrim, North Ireland		Ahmad, J (corresponding author), Royal Victoria Hosp, Upper Gastrointestinal Unit, Belfast BT12 6BA, Antrim, North Ireland.	surgeonjawad@hotmail.com						Ahmed N, 2005, J AM COLL SURGEONS, V201, P213, DOI 10.1016/j.jamcollsurg.2005.04.021; Degiannis E, 1996, BRIT J SURG, V83, P88, DOI 10.1002/bjs.1800830128; Exadaktylos A, 2003, UNFALLCHIRURG, V106, P215, DOI 10.1007/s00113-002-0543-z; Friese RS, 2005, J TRAUMA, V58, P789, DOI 10.1097/01.TA.0000158243.78299.B5; GRIMES OF, 1974, AM J SURG, V128, P175; Leppaniemi A, 2003, J TRAUMA, V55, P646, DOI 10.1097/01.TA.0000092592.63261.7E; Manlulu AV, 2004, EUR J CARDIO-THORAC, V25, P1048, DOI 10.1016/j.ejcts.2004.02.017; Shanmuganathan K, 2004, RADIOLOGY, V231, P775, DOI 10.1148/radiol.2313030126; Stagnitti F, 2004, G Chir, V25, P276	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					257	258		10.1136/bmj.39055.459248.80	http://dx.doi.org/10.1136/bmj.39055.459248.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272569	Green Published			2022-12-28	WOS:000244172400033
J	Day, M				Day, Michael			So how much do doctors really earn?	BRITISH MEDICAL JOURNAL			English	Editorial Material												miday@f2s.com							0	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					236	237		10.1136/bmj.39112.426481.59	http://dx.doi.org/10.1136/bmj.39112.426481.59			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272564	Green Published			2022-12-28	WOS:000244172400026
J	Albers, GW; Olivot, JM				Albers, Gregory W.; Olivot, Jean-Marc			Intravenous alteplase for ischaemic stroke	LANCET			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; AGED 80 YEARS; CANADIAN ALTEPLASE; THROMBOLYSIS; ECASS; OLDER		Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford Stroke Ctr, Stanford, CA 94305 USA	Stanford University	Albers, GW (corresponding author), Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford Stroke Ctr, Stanford, CA 94305 USA.	albers@stanford.edu		Albers, Gregory/0000-0003-0263-4632				Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Berrouschot J, 2005, STROKE, V36, P2421, DOI 10.1161/01.STR.0000185696.73938.e0; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Dzialowski I, 2007, STROKE, V38, P75, DOI 10.1161/01.STR.0000251644.76546.62; Engelter ST, 2005, NEUROLOGY, V65, P1795, DOI 10.1212/01.wnl.0000183702.04080.27; Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280; Hacke W, 2004, LANCET, V363, P768; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Sylaja PN, 2006, J NEUROL NEUROSUR PS, V77, P826, DOI 10.1136/jnnp.2005.086595; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Tanne D, 2000, STROKE, V31, P370, DOI 10.1161/01.STR.31.2.370; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	14	49	50	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					249	250		10.1016/S0140-6736(07)60120-2	http://dx.doi.org/10.1016/S0140-6736(07)60120-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258646				2022-12-28	WOS:000243912000004
J	Ford, PA; Barnes, PJ; Usmani, OS				Ford, Paul A.; Barnes, Peter J.; Usmani, Omar S.			Chronic cough and Holmes-Adie syndrome	LANCET			English	Editorial Material									Royal Brompton Hosp, Cough Clin, London SW3 6LY, England	Royal Brompton Hospital	Ford, PA (corresponding author), Royal Brompton Hosp, Cough Clin, Sydney St, London SW3 6LY, England.	p.ford@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018				Baloh RH, 2004, NEUROLOGY, V62, P1905, DOI 10.1212/01.WNL.0000125287.98456.23; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Kimber J, 1998, J NEUROL NEUROSUR PS, V65, P583, DOI 10.1136/jnnp.65.4.583; Martinelli P, 2000, LANCET, V356, P1760, DOI 10.1016/S0140-6736(00)03216-5	4	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					342	342		10.1016/S0140-6736(07)60156-1	http://dx.doi.org/10.1016/S0140-6736(07)60156-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258674				2022-12-28	WOS:000243912000038
J	Kernan, WN				Kernan, Walter N.			Stroke after transient ischaemic attack: dealing in futures	LANCET			English	Editorial Material							MINOR STROKE; EARLY RISK; PROGNOSIS; TIA		Yale Univ, Sch Med, New Haven, CT 06519 USA	Yale University	Kernan, WN (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06519 USA.	walter.kernan@yale.edu						Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; DENNIS M, 1990, STROKE, V21, P848, DOI 10.1161/01.STR.21.6.848; Eliasziw M, 2004, CAN MED ASSOC J, V170, P1105, DOI 10.1503/cmaj.1030460; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; KERNAN WN, 1991, STROKE, V22, P1108, DOI 10.1161/01.STR.22.9.1108; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lindley RI, 2006, STROKE, V37, P1139, DOI 10.1161/01.STR.0000209329.67467.a0; Martin PJ, 1997, QJM-INT J MED, V90, P759; MCDERMOTT W, 1982, ANN INTERN MED, V96, P512, DOI 10.7326/0003-4819-96-4-512; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5	13	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					251	252		10.1016/S0140-6736(07)60121-4	http://dx.doi.org/10.1016/S0140-6736(07)60121-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258647				2022-12-28	WOS:000243912000005
J	Guy, J; Gan, J; Selfridge, J; Cobb, S; Bird, A				Guy, Jacky; Gan, Jian; Selfridge, Jim; Cobb, Stuart; Bird, Adrian			Reversal of neurological defects in a mouse model of Rett syndrome	SCIENCE			English	Article							CPG-BINDING PROTEIN-2; MECP2; NEURONS; MICE; DISORDER; DNA	Rett syndrome is an autism spectrum disorder caused by mosaic expression of mutant copies of the X-linked MECP2 gene in neurons. However, neurons do not die, which suggests that this is not a neurodegenerative disorder. An important question for future therapeutic approaches to this and related disorders concerns phenotypic reversibility. Can viable but defective neurons be repaired, or is the damage done during development without normal MeCP2 irrevocable? Using a mouse model, we demonstrate robust phenotypic reversal, as activation of MeCP2 expression leads to striking loss of advanced neurological symptoms in both immature and mature adult animals.	Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Edinburgh; University of Glasgow	Bird, A (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	a.bird@ed.ac.uk		Guy, Jacky/0000-0002-8440-5667; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Gan, Jian/0000-0002-0155-6241	Wellcome Trust [077224] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dragatsis I, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e10; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995	15	825	854	2	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1143	1147		10.1126/science.1138389	http://dx.doi.org/10.1126/science.1138389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17289941	Green Accepted			2022-12-28	WOS:000244387600042
J	Okeoma, CM; Lovsin, N; Peterlin, BM; Ross, SR				Okeoma, Chioma M.; Lovsin, Nika; Peterlin, B. Matija; Ross, Susan R.			APOBEC3 inhibits mouse mammary tumour virus replication in vivo	NATURE			English	Article							HIV-1 INFECTION; T-CELLS; B-CELLS; PROTEIN; MICE; DNA; RETROVIRUSES; RECEPTOR; GENE	Genomes of all mammals encode apobec3 genes, which are thought to have a function in intrinsic cellular immunity to several viruses including human immunodeficiency virus type 1 (HIV-1)(1). APOBEC3 (A3) proteins are packaged into virions and inhibit retroviral replication in newly infected cells, at least in part by deaminating cytidines on the negative strand DNA intermediates(2). However, the role of A3 in innate resistance to mouse retroviruses is not understood. Here we show that A3 functions during retroviral infection in vivo and provides partial protection to mice against infection with mouse mammary tumour virus ( MMTV). Both mouse A3 and human A3G proteins interacted with the MMTV nucleocapsid in an RNA-dependent fashion and were packaged into virions. In addition, mouse A3-containing and human A3G-containing virions showed a marked decrease in titre. Last, A3(-/-) mice were more susceptible to MMTV infection, because virus spread was more rapid and extensive than in their wild-type littermates.	Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Ctr, Philadelphia, PA 19104 USA; Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, SI-1000 Ljubljana, Slovenia; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Rosalinf Russell Med Res Ctr, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Ljubljana; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ross, SR (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.	rosss@mail.med.upenn.edu		Ross, Susan R/0000-0002-3094-3769; Okeoma, Chioma/0000-0001-7737-6493	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baillie GJ, 2004, J VIROL, V78, P5784, DOI 10.1128/JVI.78.11.5784-5798.2004; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Dzuris JL, 1997, J VIROL, V71, P6044, DOI 10.1128/JVI.71.8.6044-6048.1997; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; GOLOVKINA TV, 1995, P NATL ACAD SCI USA, V92, P4828, DOI 10.1073/pnas.92.11.4828; Golovkina TV, 1998, J VIROL, V72, P3066, DOI 10.1128/JVI.72.4.3066-3071.1998; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Indik S, 2005, CANCER RES, V65, P6651, DOI 10.1158/0008-5472.CAN-04-2609; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; MORRIS VL, 1977, J MOL BIOL, V114, P73, DOI 10.1016/0022-2836(77)90284-4; NANDI S, 1973, ADV CANCER RES, V17, P353; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Ross SR, 2000, MICROBES INFECT, V2, P1215, DOI 10.1016/S1286-4579(00)01275-2; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Uz-Zaman T, 2003, VIROLOGY, V314, P294, DOI 10.1016/S0042-6822(03)00429-X; Zhang YM, 2003, J VIROL, V77, P10468, DOI 10.1128/JVI.77.19.10468-10478.2003; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	29	156	160	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					927	930		10.1038/nature05540	http://dx.doi.org/10.1038/nature05540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259974				2022-12-28	WOS:000244341200052
J	Forest, F; Grenyer, R; Rouget, M; Davies, TJ; Cowling, RM; Faith, DP; Balmford, A; Manning, JC; Proches, S; van der Bank, M; Reeves, G; Hedderson, TAJ; Savolainen, V				Forest, Felix; Grenyer, Richard; Rouget, Mathieu; Davies, T. Jonathan; Cowling, Richard M.; Faith, Daniel P.; Balmford, Andrew; Manning, John C.; Proches, Serban; van der Bank, Michelle; Reeves, Gail; Hedderson, Terry A. J.; Savolainen, Vincent			Preserving the evolutionary potential of floras in biodiversity hotspots	NATURE			English	Article							CAPE FLORA; PLANT DIVERSITY; CONSERVATION; RADIATION; RICHNESS; HISTORY	One of the biggest challenges for conservation biology is to provide conservation planners with ways to prioritize effort. Much attention has been focused on biodiversity hotspots(1). However, the conservation of evolutionary process is now also acknowledged as a priority in the face of global change(2). Phylogenetic diversity (PD) is a biodiversity index that measures the length of evolutionary pathways that connect a given set of taxa(3,4). PD therefore identifies sets of taxa that maximize the accumulation of 'feature diversity'. Recent studies, however, concluded that taxon richness is a good surrogate for PD5-9. Here we show taxon richness to be decoupled from PD, using a biome-wide phylogenetic analysis of the flora of an undisputed biodiversity hotspot - the Cape of South Africa. We demonstrate that this decoupling has real-world importance for conservation planning. Finally, using a database of medicinal and economic plant use(10), we demonstrate that PD protection is the best strategy for preserving feature diversity in the Cape. We should be able to use PD to identify those key regions that maximize future options, both for the continuing evolution of life on Earth and for the benefit of society.	Kirstenbosch Res Ctr, S African Natl Biodivers Inst, ZA-7735 Claremont, South Africa; Univ Cape Town, Dept Bot, ZA-7700 Rondebosch, South Africa; Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; S African Natl Biodivers Inst, Biodivers Planning Unit, ZA-0001 Pretoria, South Africa; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Nelson Mandela Metropolitan Univ, Dept Bot, ZA-6031 Port Elizabeth, South Africa; Australian Museum, Sydney, NSW 2010, Australia; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Ctr Invas Biol, ZA-7602 Matieland, South Africa; Univ Johannesburg, Dept Bot & Plant Biotechnol, ZA-2006 Auckland Pk, South Africa	South African National Biodiversity Institute; University of Cape Town; Royal Botanic Gardens, Kew; South African National Biodiversity Institute; University of Virginia; University System of Georgia; University of Georgia; Nelson Mandela University; Australian Museum; University of Cambridge; Stellenbosch University; University of Johannesburg	Forest, F (corresponding author), Kirstenbosch Res Ctr, S African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa.	f.forest@kew.org; v.savolainen@kew.org	Cowling, Richard/AFU-6261-2022; Hedderson, Terry/AAD-8614-2021; Procheş, Şerban/A-2044-2008; Rouget, Mathieu/B-7249-2008	Procheş, Şerban/0000-0002-3415-6930; Rouget, Mathieu/0000-0003-1836-7727; Balmford, Andrew/0000-0002-0144-3589; Savolainen, Vincent/0000-0001-5350-9984; Rouget, Mathieu/0000-0002-6172-3152				Angiosperm Phylogeny Group, 2003, BOT J LINN SOC, V141, P399, DOI [10.1046/j.1095-8339.2003.t01-1-00158.x, DOI 10.1046/J.1095-8339.2003.T01-1-00158.X]; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cowling R. M., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P273; Cowling RM, 2002, DIVERS DISTRIB, V8, P163, DOI 10.1046/j.1472-4642.2002.00143.x; Cowling RM, 1999, J BIOGEOGR, V26, P367, DOI 10.1046/j.1365-2699.1999.00275.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Goldblatt P, 2002, ANN MO BOT GARD, V89, P281, DOI 10.2307/3298566; Goldblatt P, 2002, MOL PHYLOGENET EVOL, V25, P341, DOI 10.1016/S1055-7903(02)00235-X; GOLDBLATT P, 2000, CONSPECTUS CAPE FLOR; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, TRENDS PLANT SCI, V10, P536, DOI 10.1016/j.tplants.2005.09.006; LINDER HP, 1994, S AFR J SCI, V90, P329; Mace GM, 2003, SCIENCE, V300, P1707, DOI 10.1126/science.1085510; Midley G. F., 2001, J MEDITERRANEAN ECOL, V2, P137, DOI DOI 10.1111/EVO.12573; MOOERS AO, 2005, PHYLOGENY CONSERVATI; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Polasky S, 2001, BIOL CONSERV, V97, P99, DOI 10.1016/S0006-3207(00)00103-8; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Rodrigues ASL, 2005, CONSERV BIOL SER, V8, P101; Rodrigues ASL, 2002, BIOL CONSERV, V105, P103, DOI 10.1016/S0006-3207(01)00208-7; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; *SURV EC PLANTS AR, 1999, SEPASAL DAT; Torres NM, 2004, GENET MOL BIOL, V27, P511, DOI 10.1590/S1415-47572004000400008; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	30	643	675	11	393	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					757	760		10.1038/nature05587	http://dx.doi.org/10.1038/nature05587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301791				2022-12-28	WOS:000244205200043
J	Lieberman, D; Tooby, J; Cosmides, L				Lieberman, Debra; Tooby, John; Cosmides, Leda			The architecture of human kin detection	NATURE			English	Article							INBREEDING DEPRESSION; SIBLING INCEST; SELECTION; EVOLUTION; SEX; PREFERENCES; HYPOTHESES; HISTORY	Evolved mechanisms for assessing genetic relatedness have been found in many species, but their existence in humans has been a matter of controversy. Here we report three converging lines of evidence, drawn from siblings, that support the hypothesis that kin detection mechanisms exist in humans. These operate by computing, for each familiar individual, a unitary regulatory variable ( the kinship index) that corresponds to a pairwise estimate of genetic relatedness between self and other. The cues that the system uses were identified by quantitatively matching individual exposure to potential cues of relatedness to variation in three outputs relevant to the system's evolved functions: sibling altruism, aversion to personally engaging in sibling incest, and moral opposition to third party sibling incest. As predicted, the kin detection system uses two distinct, ancestrally valid cues to compute relatedness: the familiar other's perinatal association with the individual's biological mother, and duration of sibling coresidence.	Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA; Univ Hawaii, Dept Psychol, Honolulu, HI 96822 USA	University of California System; University of California Santa Barbara; University of Hawaii System	Lieberman, D (corresponding author), Univ Calif Santa Barbara, Ctr Evolut Psychol, Santa Barbara, CA 93106 USA.	debra@debralieberman.com			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000516] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000516-02, DP1 OD000516] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		[Anonymous], 1995, SEXUAL ATTRACTION CH; Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Bernstein I.S., 1991, P6; Bevc I, 2000, EVOL HUM BEHAV, V21, P151, DOI 10.1016/S1090-5138(99)00041-0; BITTLES AH, 1994, NAT GENET, V8, P117, DOI 10.1038/ng1094-117; Buchan JC, 2003, NATURE, V425, P179, DOI 10.1038/nature01866; Cade B.S., 2005, USER MANUAL BLOSSOM; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Chapuisat M, 1999, HEREDITY, V82, P473, DOI 10.1038/sj.hdy.6885340; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crozier R.H., 1996, EVOLUTION SOCIAL INS; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Fessler DMT, 2004, EVOL HUM BEHAV, V25, P277, DOI 10.1016/j.evolhumbehav.2004.05.004; Fletcher DJ., 1987, KIN RECOGNITION ANIM; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hepper PG., 1991, KIN RECOGNITION; Hewlett B. S., 2005, HUNTER GATHERER CHIL; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOWELL N, 2000, DEMOGRAPHY DOBEL KUN; ITO Y, 1989, TRENDS ECOL EVOL, V4, P69, DOI 10.1016/0169-5347(89)90151-1; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Lee Richard, 1968, MAN HUNTER; Lieberman D, 2003, P ROY SOC B-BIOL SCI, V270, P819, DOI 10.1098/rspb.2002.2290; Mielke P. W., 2001, PERMUTATION METHODS; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; Queller D. C., 1989, Oxford Surveys in Evolutionary Biology, V6, P73; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; SHEPHER J, 1971, ARCH SEX BEHAV, V1, P293, DOI 10.1007/BF01638058; SHERMAN PW, 1977, SCIENCE, V197, P1246, DOI 10.1126/science.197.4310.1246; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TOOBY J, 1982, J THEOR BIOL, V97, P557, DOI 10.1016/0022-5193(82)90358-7; Walters J.R., 1987, P359; Wedekind C, 1997, P ROY SOC B-BIOL SCI, V264, P1471, DOI 10.1098/rspb.1997.0204; Westermarck E, 1891, HIST HUMAN MARRIAGE; WILLIAMS GC, 1957, EVOLUTION, V11, P32, DOI 10.2307/2405809	43	340	350	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					727	731		10.1038/nature05510	http://dx.doi.org/10.1038/nature05510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301784	Green Accepted			2022-12-28	WOS:000244205200036
J	Shuchman, M				Shuchman, Miriam			Improving global health - Margaret Chan at the WHO	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		[Anonymous], 2006, WHO BRIEF MAL TREATM; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; JACK A., 2006, FINANCIAL TIMES 0515, P4; *SARS EXP COMM, SARS HONG KONG EXP A; Vogel G, 2006, SCIENCE, V313, P1554	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					653	656		10.1056/NEJMp068299	http://dx.doi.org/10.1056/NEJMp068299			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301294				2022-12-28	WOS:000244193300001
J	Staudt, LM				Staudt, Louis M.			A closer look at follicular lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTHY-INDIVIDUALS; B-CELLS		NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.		Staudt, Louis/AAC-5324-2019					Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Giannelli F, 2003, BLOOD, V102, P1196, DOI 10.1182/blood-2002-05-1537; Roulland S, 2006, J EXP MED, V203, P2425, DOI 10.1084/jem.20061292	4	41	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					741	742		10.1056/NEJMcibr067155	http://dx.doi.org/10.1056/NEJMcibr067155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301308				2022-12-28	WOS:000244193300016
J	Zongo, I; Dorsey, G; Rouamba, N; Tinto, H; Dokomajilar, C; T Guiguemde, R; Rosenthal, PJ; Ouedraogo, JB				Zongo, Issaka; Dorsey, Grant; Rouamba, Noel; Tinto, Halidou; Dokomajilar, Christian; T Guiguemde, Robert; Rosenthal, Philip J.; Ouedraogo, Jean Bosco			Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM; COMBINATION THERAPY; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; MOLECULAR MARKER; CHLOROQUINE; RESISTANCE; DRUG; ARTESUNATE; MUTATIONS	Background Artemisinin-based combination regimens are widely advocated for malarial treatment, but other effective regimens might be cheaper and more readily available. Our aim was to compare the risk of recurrent parasitaemia in patients given artemether-lumefantrine with that in those given amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated malaria. Methods We enrolled 521 patients aged 6 months or older with uncomplicated falciparum malaria in Bobo-Dioulasso, Burkina Faso. Patients were randomly assigned to receive standard doses of either artemether-lumefantrine (261) or amodiaquine plus sulfadoxine-pyrimethamine (260) for 3 days. Primary endpoints were the risks of treatment failure within 28 days, either unadjusted or adjusted by genotyping to distinguish recrudescence from new infection. The study is registered at controlled-trials.gov with the identifier ISRCTN54261005. Findings Of enrolled patients, 478 (92%) completed the 28-day study. The risk of recurrent symptomatic malaria was lowest in the group given amodiaquine plus sulfadoxine-pyrimethamine (1.7% vs 10.2%; risk difference 8.5%; 95% CI 4.3-12.6; p=0.0001); as was the risk of recurrent parasitaemia (4.7% vs 15.1%; 10.4%; 5.1-15.6; p=0.0002). Nearly all recurrences were due to new infections. Recrudescences were four late treatment failures with artemetherlumefantrine and one early treatment failure with amodiaquine plus sulfadoxine-pyrimethamine. Both regimens were safe and well tolerated, with pruritus more common with amodiaquine plus sulfadoxine-pyrimethamine than with artemether-lumefantrine. Each regimen selected for new isolates with mutations that have been associated with decreased drug susceptibility. Interpretation Amodiaquine plus sulfadoxine-pyrimethamine was more effective than was artemether-lumefantrine for the treatment of uncomplicated malaria. For regions of Africa where amodiaquine plus sulfadoxine-pyrimethamine continues to be effective, this less expensive and more available regimen should be considered as an alternative to blanket recommendations for artemisinin-based combination treatment for malaria.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; Ctr Muraz, Bobo Dioulasso, Burkina Faso	University of California System; University of California San Francisco; Centre Muraz	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, Dept Med, Box 0811, San Francisco, CA 94143 USA.	prosenthal@medsfgh.ucsf.edu		Tinto, Halidou/0000-0002-0472-3586; Ouedraogo, Jean Bosco/0000-0003-0412-8733	FOGARTY INTERNATIONAL CENTER [D43TW001506] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW01506] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Bukirwa H, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010007; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Djimde A, 2001, LANCET, V358, P890, DOI 10.1016/S0140-6736(01)06040-8; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2004, AM J TROP MED HYG, V71, P758, DOI 10.4269/ajtmh.2004.71.758; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Duraisingh MT, 1997, PARASITOLOGY, V114, P205, DOI 10.1017/S0031182096008487; Falade C, 2005, T ROY SOC TROP MED H, V99, P459, DOI 10.1016/j.trstmh.2004.09.013; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Holmgren G, 2006, INFECT GENET EVOL, V6, P309, DOI 10.1016/j.meegid.2005.09.001; Jima D, 2005, East Afr Med J, V82, P387; Koram KA, 2005, ACTA TROP, V95, P194, DOI 10.1016/j.actatropica.2005.06.018; Kyabayinze D, 2003, AM J TROP MED HYG, V69, P247, DOI 10.4269/ajtmh.2003.69.247; Marks F, 2005, ANTIMICROB AGENTS CH, V49, P1101, DOI 10.1128/AAC.49.3.1101-1105.2005; Mockenhaupt FP, 2005, TROP MED INT HEALTH, V10, P512, DOI 10.1111/j.1365-3156.2005.01427.x; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Ochong EO, 2003, AM J TROP MED HYG, V69, P184, DOI 10.4269/ajtmh.2003.69.184; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Rwagacondo CE, 2003, AM J TROP MED HYG, V68, P743, DOI 10.4269/ajtmh.2003.68.743; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; Sowunmi A, 2002, ANN TROP MED PARASIT, V96, P227, DOI 10.1179/000349802125000763; Staedke SG, 2004, LANCET, V364, P1950, DOI 10.1016/S0140-6736(04)17478-3; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; WHO, 2003, ASS MON ANT DRUG EFF; *WHO, GLOB ANT DRUG POL DA; *WHO UNICEF, 1999, STRAT INT MAN CHILDH; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2005, AM J TROP MED HYG, V73, P826, DOI 10.4269/ajtmh.2005.73.826	38	99	99	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					491	498		10.1016/S0140-6736(07)60236-0	http://dx.doi.org/10.1016/S0140-6736(07)60236-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292769				2022-12-28	WOS:000244188300032
J	Sinha, A; Levine, O; Knoll, MD; Muhib, F; Lieu, TA				Sinha, Anushua; Levine, Orin; Knoll, Maria D.; Muhib, Farzona; Lieu, Tracy A.			Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis	LANCET			English	Article; Proceedings Paper	42nd Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 30-OCT 03, 2004	Boston, MA	Infect Dis Soc Amer			INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; EFFICACY; DISEASE; IMMUNIZATION; SAFETY; GAMBIA	Background Routine vaccination of infants against Streptococcus pneumoniae (pneumococcus) needs substantial investment by governments and charitable organisations. Policymakers need information about the projected health benefits, costs, and cost-effectiveness of vaccination when considering these investments. Our aim was to incorporate these data into an economic analysis of pneumococcal vaccination of infants in countries eligible for financial support from the Global Alliance for Vaccines & immunization (GAVI). Methods We constructed a decision analysis model to compare pneumococcal vaccination of infants aged 6, 10, and 14 weeks with no vaccination in the 72 countries that were eligible as of 2005. We used published and unpublished data to estimate child mortality, effectiveness of pneumococcal conjugate vaccine, and immunisation. rates. Findings Pneumococcal vaccination at the rate of diptheria-tetanus-pertussis vaccine coverage was projected to prevent 262000 deaths per year (7%) in children aged 3-29 months in the 72 developing countries studied, thus averting 8.34 million disability-adjusted life years (DALYs) yearly. If every child could be reached, up to 407 000 deaths per year would be prevented. At a vaccine cost of International $5 per dose, vaccination would have a net cost of $838 million, a cost of $100 per DALY averted. Vaccination at this price was projected to be highly cost-effective in 68 of 72 countries when each country's per head gross domestic product per DALY averted was used as a benchmark. Interpretation At a vaccine cost of between $1 and $5 per dose, purchase and accelerated uptake of pneumococcal vaccine in the world's poorest countries is projected to substantially reduce childhood mortality and to be highly cost-effective.	Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07101 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Ctr Child Hlth Care Studies, Boston, MA USA; Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Boston Children's Hospital	Sinha, A (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, MSB F506,185 S Orange Ave, Newark, NJ 07101 USA.	sinhaan1@umdnj.edu		Deloria Knoll, Maria/0000-0001-9041-2671				Berndt ER, 2005, HEALTH AFFAIR, V24, P653, DOI 10.1377/hlthaff.24.3.653; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DRUMMOND M, 2000, METHODS EC EVALUATIO; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; *FIN TASK FORC, IMM PROGR EXP FIN FU; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; Hinman AR, 2004, AM J PREV MED, V26, P84, DOI 10.1016/j.amepre.2003.09.008; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kuntz KM, 2001, EC EVALUATION HLTH C, P141; Levine OS, 2004, J HEALTH POPUL NUTR, V22, P268; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lieu TA, 2005, HEALTH AFFAIR, V24, P666, DOI 10.1377/hlthaff.24.3.666; LOPEZ AD, 2001, LIFE TABLES 191 COUN, P1; Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C; Murray C. J. L., 1996, GLOBAL BURDEN DIS; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; O'Brien KL, 2003, VACCINE, V21, P1815, DOI 10.1016/S0264-410X(02)00807-1; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Saving Newborn Lives, 2001, SAV NEWB LIV STAT WO, P1; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; SHEPARD DS, 1995, VACCINE, V13, P707, DOI 10.1016/0264-410X(94)00063-S; TREMONTI G, 2005, 0127 G8 FIN MIN; *UNICEF, 2005 VACC PROJ QUANT; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2005, 01229 WHO; WHO, UN COSTS PAT SERV; *WHO, 2002, 01230 WHO; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; *WORLD BANK, WDI ONL; World Health Organization, 1991, TECHN BAS WHO REC MA	34	102	112	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					389	396		10.1016/S0140-6736(07)60195-0	http://dx.doi.org/10.1016/S0140-6736(07)60195-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	132LN	17276779				2022-12-28	WOS:000243944400033
J	Calfee, CS; Shah, SJ; Wolters, PJ; Saint, S; King, TE				Calfee, Carolyn S.; Shah, Sanjiv J.; Wolters, Paul J.; Saint, Sanjay; King, Talmadge E., Jr.			Anchors away	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LYMPHOMATOID GRANULOMATOSIS		Univ Calif San Francisco, Div Pulm & Crit Care, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Univ Michigan, Sch Med, Vet Affairs Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Calfee, CS (corresponding author), Univ Calif San Francisco, Div Pulm & Crit Care, 505 Parnassus Ave, San Francisco, CA 94143 USA.	carolyn.calfee@ucsf.edu	Shah, Sanjiv J./AFQ-9480-2022; Saint, Sanjay/AAF-5126-2019		AHRQ HHS [P20-HS11540] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Beaty MW, 2001, AM J SURG PATHOL, V25, P1111, DOI 10.1097/00000478-200109000-00001; FAUCI AS, 1982, NEW ENGL J MED, V306, P68, DOI 10.1056/NEJM198201143060203; KASSIRER JP, 1989, AM J MED, V86, P433, DOI 10.1016/0002-9343(89)90342-2; Kassirer JP., 2009, LEARNING CLIN REASON; Lee JS, 2000, AM J ROENTGENOL, V175, P1335, DOI 10.2214/ajr.175.5.1751335; LIEBOW AA, 1972, HUM PATHOL, V3, P457, DOI 10.1016/S0046-8177(72)80005-4; Smith JR, 2000, BIODRUGS, V13, P9, DOI 10.2165/00063030-200013010-00002; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wilson WH, 1996, BLOOD, V87, P4531, DOI 10.1182/blood.V87.11.4531.bloodjournal87114531	9	9	9	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					504	509		10.1056/NEJMcps052993	http://dx.doi.org/10.1056/NEJMcps052993			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267911				2022-12-28	WOS:000243860700012
J	Donnan, GA; Dewey, HM; Davis, SM				Donnan, Geoffrey A.; Dewey, Helen M.; Davis, Stephen M.			MRI and stroke: why has it taken so long?	LANCET			English	Editorial Material							COMPUTED-TOMOGRAPHY; THERAPY; CT		Univ Melbourne, Austin Hosp, Natl Stroke Res Inst, Melbourne, Vic 3081, Australia; Univ Melbourne, Royal Melbourne Hosp, Dept Neurosci, Melbourne, Vic 3050, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Donnan, GA (corresponding author), Univ Melbourne, Austin Hosp, Natl Stroke Res Inst, Melbourne, Vic 3081, Australia.	gdonnan@unimelb.edu.au	Davis, Stephen M/L-5260-2013	Davis, Stephen M/0000-0003-0962-2300; Donnan, Geoffrey/0000-0001-6324-3403				Baird AE, 2000, NEUROLOGY, V54, P674, DOI 10.1212/WNL.54.3.674; Barber PA, 1999, STROKE, V30, P2059, DOI 10.1161/01.STR.30.10.2059; Caplan LR, 2002, ARCH NEUROL-CHICAGO, V59, P703, DOI 10.1001/archneur.59.5.703; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Davis SM, 2005, CURR OPIN NEUROL, V18, P47, DOI 10.1097/00019052-200502000-00010; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hacke W, 2004, LANCET, V363, P768; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Kumral E, 2004, CEREBROVASC DIS, V17, P287, DOI 10.1159/000077339; Muir KW, 2006, LANCET NEUROL, V5, P755, DOI 10.1016/S1474-4422(06)70545-2; Staaf G, 2004, CEREBROVASC DIS, V17, P1, DOI 10.1159/000073891; Stroke Unit Trialists' Collaboration, 2000, COCHRANE DB SYST REV, V2; U-King-Im JM, 2005, J NEUROL NEUROSUR PS, V76, P1002, DOI 10.1136/jnnp.2004.046201; Wardlaw JM, 2004, STROKE, V35, P2477, DOI 10.1161/01.STR.0000143453.78005.44	14	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					252	254		10.1016/S0140-6736(07)60122-6	http://dx.doi.org/10.1016/S0140-6736(07)60122-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258648				2022-12-28	WOS:000243912000006
J	Stone, GW; Moses, JW; Ellis, SG; Schofer, J; Dawkins, KD; Morice, M; Colombo, A; Schampaert, E; Grube, E; Kirtane, AJ; Cutlip, DE; Fahy, M; Pocock, SJ; Mehran, R; Leon, MB				Stone, Gregg W.; Moses, Jeffrey W.; Ellis, Stephen G.; Schofer, Joachim; Dawkins, Keith D.; Morice, Marie-Claude; Colombo, Antonio; Schampaert, Erick; Grube, Eberhard; Kirtane, Ajay J.; Cutlip, Donald E.; Fahy, Martin; Pocock, Stuart J.; Mehran, Roxana; Leon, Martin B.			Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BARE METAL STENT; ARTERY-DISEASE; FOLLOW-UP; SLOW-RELEASE; DOUBLE-BLIND; RESTENOSIS; LESIONS; THROMBOSIS; REVASCULARIZATION	BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death. Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data. METHODS: We performed a pooled analysis of data from four double-blind trials in which 1748 patients were randomly assigned to receive either sirolimus-eluting stents or bare-metal stents and five double-blind trials in which 3513 patients were randomly assigned to receive either paclitaxel-eluting stents or bare-metal stents; we then analyzed the major clinical end points of the trials. RESULTS: The 4-year rates of stent thrombosis were 1.2% in the sirolimus-stent group versus 0.6% in the bare-metal-stent group (P=0.20) and 1.3% in the paclitaxel-stent group versus 0.9% in the bare-metal-stent group (P=0.30). However, after 1 year, there were five episodes of stent thrombosis in patients with sirolimus-eluting stents versus none in patients with bare-metal stents (P=0.025) and nine episodes in patients with paclitaxel-eluting stents versus two in patients with bare-metal stents (P=0.028). The 4-year rates of target-lesion revascularization were markedly reduced in both the sirolimus-stent group and the paclitaxel-stent group, as compared with the bare-metal-stent groups. The rates of death or myocardial infarction did not differ significantly between the groups with drug-eluting stents and those with bare-metal stents. CONCLUSIONS: Stent thrombosis after 1 year was more common with both sirolimus-eluting stents and paclitaxel-eluting stents than with bare-metal stents. Both drug-eluting stents were associated with a marked reduction in target-lesion revascularization. There were no significant differences in the cumulative rates of death or myocardial infarction at 4 years.	Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; Cleveland Clin, Cleveland, OH 44106 USA; Univ Hamburg, Ctr Cardiovasc, Hamburg, Germany; Southampton Univ Hosp, Southampton, Hants, England; Inst Cardiovasc Paris Sud, Massy, France; Hosp San Raffaele, I-20132 Milan, Italy; Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; Heart Ctr Siegburg, Siegburg, Germany; Harvard Clin Res Inst, Boston, MA USA; London Sch Hyg & Trop Med, London WC1, England	Cardiovascular Research Foundation (CRF); Columbia University; Cleveland Clinic Foundation; University of Hamburg; University of Southampton; UDICE-French Research Universities; Universite Paris Saclay; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universite de Montreal; Harvard University; Harvard Medical School; University of London; London School of Hygiene & Tropical Medicine	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu	Colombo, Antonio/N-2960-2015; Mehran, Roxana/ABF-4160-2021	Colombo, Antonio/0000-0002-2940-2455; Schampaert, Erick/0000-0002-7607-1214				Baierl V, 2005, AM J CARDIOL, V96, P1399, DOI 10.1016/j.amjcard.2005.06.087; Bossi I, 2000, J AM COLL CARDIOL, V35, P1569, DOI 10.1016/S0735-1097(00)00584-2; CAMENZIND E, 2006, EUR SOC CARD 2006 WO; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; CUTLIP D, 2006, TRANSC CARD THER S W; Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190; Feres F, 2006, CATHETER CARDIO INTE, V68, P83, DOI 10.1002/ccd.20692; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Guagliumi G, 2003, CIRCULATION, V107, P1340, DOI 10.1161/01.CIR.0000062700.42060.6F; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Lee MS, 2006, AM J CARDIOL, V98, p180M; Leon MB, 2004, CIRCULATION, V110, P405; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nayak AK, 2006, CIRC J, V70, P1026, DOI 10.1253/circj.70.1026; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Ong ATL, 2005, J AM COLL CARDIOL, V45, P947, DOI 10.1016/j.jacc.2004.09.079; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Pinto DS, 2006, J AM COLL CARDIOL, V48, P32, DOI 10.1016/j.jacc.2006.02.060; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Walters DL, 2002, AM J CARDIOL, V89, P491, DOI 10.1016/S0002-9149(01)02285-8	29	1301	1416	2	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					998	1008		10.1056/NEJMoa067193	http://dx.doi.org/10.1056/NEJMoa067193			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296824	Green Accepted			2022-12-28	WOS:000244699200004
J	Radoshitzky, SR; Abraham, J; Spiropoulou, CF; Kuhn, JH; Nguyen, D; Li, WH; Nagel, J; Schmidt, PJ; Nunberg, JH; Andrews, NC; Farzan, M; Choe, H				Radoshitzky, Sheli R.; Abraham, Jonathan; Spiropoulou, Christina F.; Kuhn, Jens H.; Nguyen, Dan; Li, Wenhui; Nagel, Jane; Schmidt, Paul J.; Nunberg, Jack H.; Andrews, Nancy C.; Farzan, Michael; Choe, Hyeryun			Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses	NATURE			English	Article							ALPHA-DYSTROGLYCAN; ENDOTHELIUM; VIRUSES; CELLS; JUNIN; ANTIBODIES; BIOLOGY; BINDING; ENTRY	At least five arenaviruses cause viral haemorrhagic fevers in humans. Lassa virus, an Old World arenavirus, uses the cellular receptor alpha-dystroglycan to infect cells(1). Machupo, Guanarito, Junin and Sabia viruses are New World haemorrhagic fever viruses that do not use alpha-dystroglycan(2). Here we show a specific, high-affinity association between transferrin receptor 1 (TfR1) and the entry glycoprotein ( GP) of Machupo virus. Expression of human TfR1, but not human transferrin receptor 2, in hamster cell lines markedly enhanced the infection of viruses pseudotyped with the GP of Machupo, Guanarito and Junin viruses, but not with those of Lassa or lymphocytic choriomeningitis viruses. An anti-TfR1 antibody efficiently inhibited the replication of Machupo, Guanarito, Junin and Sabia viruses, but not that of Lassa virus. Iron depletion of culture medium enhanced, and iron supplementation decreased, the efficiency of infection by Junin and Machupo but not Lassa pseudoviruses. These data indicate that TfR1 is a cellular receptor for New World haemorrhagic fever arenaviruses.	Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA; Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany; Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Div Hematol Oncol, Boston, MA 02115 USA; Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Centers for Disease Control & Prevention - USA; Free University of Berlin; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Montana System; University of Montana	Choe, H (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Pulm Div, Boston, MA 02115 USA.	hyeryun.choe@childrens.harvard.edu	Radoshitzky, Sheli S/F-2766-2019; Kuhn, Jens H./B-7615-2011; Radoshitzky, Sheli/L-8410-2019	Kuhn, Jens H./0000-0002-7800-6045; Radoshitzky, Sheli/0000-0001-8976-8056; Li, Wenhui/0000-0003-1305-7404; Andrews, Nancy/0000-0003-0243-4462; Farzan, Michael/0000-0002-2990-5319	NIAID NIH HHS [R01 AI074879] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON GJ, 1990, GASTROENTEROLOGY, V98, P576, DOI 10.1016/0016-5085(90)90276-7; Andrews N C, 1999, Curr Opin Hematol, V6, P61, DOI 10.1097/00062752-199903000-00001; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; BUCHMEIER MJ, 1987, J VIROL, V61, P982, DOI 10.1128/JVI.61.4.982-985.1987; BURNS JW, 1991, VIROLOGY, V183, P620, DOI 10.1016/0042-6822(91)90991-J; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Castilla V, 1996, ARCH VIROL, V141, P1307, DOI 10.1007/BF01718832; Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kasvosve I, 2002, CLIN CHEM LAB MED, V40, P1014, DOI 10.1515/CCLM.2002.176; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2002, CURR TOP MICROBIOL, V262, P111; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; MATTIA E, 1984, J BIOL CHEM, V259, P2689; MCGRAW TE, 1987, J CELL BIOL, V105, P207, DOI 10.1083/jcb.105.1.207; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, pV; Oldstone MBA, 2002, CURR TOP MICROBIOL, V262, pV; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; Peters CJ, 2002, CRIT CARE MED, V30, pS268, DOI 10.1097/00003246-200205001-00016; Raya G, 2001, CLIN CHEM LAB MED, V39, P1162, DOI 10.1515/CCLM.2001.183; Reignier T, 2006, VIROLOGY, V353, P111, DOI 10.1016/j.virol.2006.05.018; Rojek JM, 2006, VIROLOGY, V349, P476, DOI 10.1016/j.virol.2006.02.033; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; SODA R, 1984, BLOOD, V63, P270; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; Templeton DM, 2003, BBA-GEN SUBJECTS, V1619, P113, DOI 10.1016/S0304-4165(02)00497-X; WARD JH, 1982, J BIOL CHEM, V257, P317; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06	30	300	313	0	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					92	96		10.1038/nature05539	http://dx.doi.org/10.1038/nature05539			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287727	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000244525600044
J	Groth, A; Rocha, W; Verreault, A; Almouzni, G				Groth, Anja; Rocha, Walter; Verreault, Alain; Almouzni, Genevieve			Chromatin challenges during DNA replication and repair	CELL			English	Review							DOUBLE-STRAND BREAKS; HISTONE DEACETYLASE ACTIVITY; NEWLY SYNTHESIZED HISTONES; H3 LYSINE-56 ACETYLATION; CELL NUCLEAR ANTIGEN; ASSEMBLY FACTOR-1; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME CORE; EPIGENETIC INHERITANCE; DAMAGE CHECKPOINT		Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; Inst Curie, Lab Nucl Dynam & Genome Plast, UMR 218, CNRS, F-75248 Paris 5, France	Universite de Montreal; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Verreault, A (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128,Succarsale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	alain.verreault@umontreal.ca; genevieve.almouzni@curie.fr	Almouzni, Genevieve/ABG-1029-2021; Groth, Anja/AAH-5386-2019	Almouzni, Genevieve/0000-0001-5570-0723; Groth, Anja/0000-0003-0577-1771				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ANNUNZIATO AT, 1983, J BIOL CHEM, V258, P2675; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Benson LJ, 2006, J BIOL CHEM, V281, P9287, DOI 10.1074/jbc.M512956200; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chua S, 1997, DIABETES REV, V5, P2; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Downs JA, 2004, MOL CELL, V16, P979, DOI 10.1016/j.molcel.2004.12.003; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fisher D, 2003, EMBO J, V22, P3737, DOI 10.1093/emboj/cdg352; Forlani S, 1998, DEVELOPMENT, V125, P3153; Formosa T, 2003, CURR TOP MICROBIOL, V274, P171; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Glowczewski L, 2004, MOL CELL BIOL, V24, P10180, DOI 10.1128/MCB.24.23.10180-10192.2004; Green CM, 2003, EMBO J, V22, P5163, DOI 10.1093/emboj/cdg478; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2003, EMBO J, V22, P1676, DOI 10.1093/emboj/cdg151; GRUSS C, 1993, EMBO J, V12, P4533, DOI 10.1002/j.1460-2075.1993.tb06142.x; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JACKSON V, 1988, BIOCHEMISTRY-US, V27, P2109, DOI 10.1021/bi00406a044; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krause DR, 2003, ONCOGENE, V22, P5927, DOI 10.1038/sj.onc.1206691; KRUDE T, 1995, EXP CELL RES, V220, P304, DOI 10.1006/excr.1995.1320; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Little JB, 2003, ONCOGENE, V22, P6978, DOI 10.1038/sj.onc.1206988; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; MOUSSON F, 2006, IN PRESS CHROMO 1219; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; Okuwaki M, 2004, J BIOL CHEM, V279, P2904, DOI 10.1074/jbc.M310111200; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Poot RA, 2004, NAT CELL BIOL, V6, P1236, DOI 10.1038/ncb1196; PRIOR CP, 1980, CELL, V20, P597, DOI 10.1016/0092-8674(80)90306-2; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; RANDALL SK, 1992, J BIOL CHEM, V267, P14259; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; Robertson AK, 2004, BIOCHEM BIOPH RES CO, V322, P110, DOI 10.1016/j.bbrc.2004.07.083; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wurtele H, 2006, CURR OPIN CELL BIOL, V18, P137, DOI 10.1016/j.ceb.2006.02.008; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	112	559	573	0	63	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					721	733		10.1016/j.cell.2007.01.030	http://dx.doi.org/10.1016/j.cell.2007.01.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320509	Bronze			2022-12-28	WOS:000245098600014
J	Fuchs, E				Fuchs, Elaine			Scratching the surface of skin development	NATURE			English	Review							HAIR FOLLICLE MORPHOGENESIS; NF-KAPPA-B; SQUAMOUS-CELL CARCINOMA; STEM-CELLS; BETA-CATENIN; GENE-EXPRESSION; MOUSE EPIDERMIS; CONDITIONAL ABLATION; TRANSIENT ACTIVATION; SONIC HEDGEHOG	The epidermis and its appendages develop from a single layer of multipotent embryonic progenitor keratinocytes. Embryonic stem cells receive cues from their environment that instruct them to commit to a particular differentiation programme and generate a stratified epidermis, hair follicles or sebaceous glands. Exciting recent developments have focused on how adult skin epithelia maintain populations of stem cells for use in the natural cycles of hair follicle regeneration and for re-epithelialization in response to wounding.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave,Box 300, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR027883-28] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Atit R, 2003, DEV CELL, V4, P231, DOI 10.1016/S1534-5807(03)00021-2; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; BONEKO VM, 1988, ACTA ANAT, V133, P325; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Brakebusch C, 2005, CANCER METAST REV, V24, P403, DOI 10.1007/s10555-005-5132-5; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chang DH, 2000, NAT IMMUNOL, V1, P169, DOI 10.1038/77861; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DAVIDSON D, 1983, J EMBRYOL EXP MORPH, V74, P261; DE SB, 1999, NATURE, V398, P518; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; GREEN H, 1991, Scientific American, V265, P96; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hu YL, 2001, NATURE, V410, P710, DOI 10.1038/35070605; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Kwan KM, 2004, GENESIS, V39, P10, DOI 10.1002/gene.20021; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; LI J, IN PRESS P NATL ACAD; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Niemann C, 2002, DEVELOPMENT, V129, P95; Noramly S, 1999, DEVELOPMENT, V126, P3509; Noramly S, 1998, DEVELOPMENT, V125, P3775; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P93, DOI 10.1387/ijdb.15272374; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Panteleyev AA, 2000, AM J PATHOL, V157, P1071, DOI 10.1016/S0002-9440(10)64621-4; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Potten C S, 1981, Int Rev Cytol, V69, P271; Potter GB, 2001, GENE DEV, V15, P2687, DOI 10.1101/gad.916701; Raghavan S, 2003, DEV CELL, V5, P415, DOI 10.1016/S1534-5807(03)00261-2; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Schmidt-Ullrich R, 2006, DEVELOPMENT, V133, P1045, DOI 10.1242/dev.02278; SMART IHM, 1970, BRIT J DERMATOL, V82, P276, DOI 10.1111/j.1365-2133.1970.tb12437.x; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Takeda H, 2006, NAT MED, V12, P395, DOI 10.1038/nm1386; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; van Roy FM, 2005, NAT REV CANCER, V5, P956, DOI 10.1038/nrc1752; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904; Zhang WT, 2006, J CELL SCI, V119, P283, DOI 10.1242/jcs.02738	100	604	632	3	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					834	842		10.1038/nature05659	http://dx.doi.org/10.1038/nature05659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314969	Green Accepted			2022-12-28	WOS:000244341200033
J	Hoffman, JI; Forcada, J; Trathan, PN; Amos, W				Hoffman, J. I.; Forcada, J.; Trathan, P. N.; Amos, W.			Female fur seals show active choice for males that are heterozygous and unrelated	NATURE			English	Article							ARCTOCEPHALUS-GAZELLA; LEK PARADOX; PARENTAL RELATEDNESS; MATE CHOICE; GREY SEAL; PATERNITY; SELECTION; EVOLUTION; FITNESS; CAPTURE	Much debate surrounds the exact rules that influence mating behaviour, and in particular the selective forces that explain the evolution of female preferences. A key example is the lek paradox, in which female choice is expected rapidly to become ineffective owing to loss of additive genetic variability for the preferred traits(1-3). Here we exploit a remarkable system in which female fur seals exert choice by moving across a crowded breeding colony to visit largely static males. We show that females move further to maximize the balance between male high multilocus heterozygosity and low relatedness. Such a system shows that female choice can be important even in a strongly polygynous species, and at the same time may help to resolve the lek paradox because heterozygosity has low heritability and inbreeding avoidance means there is no single 'best' male for all females.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; British Antarctic Survey, NERC, Cambridge CB3 0ET, England	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hoffman, JI (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	jih24@cam.ac.uk	Forcada, Jaume/GYU-0677-2022; Hoffman, Joseph i/K-7725-2012	Hoffman, Joseph i/0000-0001-5895-8949	NERC [bas010017] Funding Source: UKRI; Natural Environment Research Council [bas010017] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Arnould JPY, 1997, J ZOOL, V241, P649, DOI 10.1111/j.1469-7998.1997.tb05739.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BIRKHEAD T, 1993, TRENDS ECOL EVOL, V8, P100, DOI 10.1016/0169-5347(93)90060-3; Borgia G., 1979, SEXUAL SELECTION REP, P19; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; Goldsworthy SD, 1999, BEHAV ECOL SOCIOBIOL, V45, P253, DOI 10.1007/s002650050560; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hoffman JI, 2006, MOL ECOL, V15, P3841, DOI 10.1111/j.1365-294X.2006.03053.x; Hoffman JI, 2006, MOL ECOL, V15, P1995, DOI 10.1111/j.1365-294X.2006.02894.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffman JI, 2003, EVOLUTION, V57, P1917; Hoffman JI, 2004, EVOLUTION, V58, P2087; Irwin AJ, 2000, EVOL ECOL RES, V2, P119; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Lidgard DC, 2004, MOL ECOL, V13, P3543, DOI 10.1111/j.1365-294X.2004.02334.x; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; PARTRIDGE L, 1983, MATE CHOICE, P227; Pujolar JM, 2005, EVOLUTION, V59, P189; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, 10.1111/j.1558-5646.1989.tb04226.x]; Qvarnstrom A, 2006, NATURE, V441, P84, DOI 10.1038/nature04564; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Seddon N, 2004, P ROY SOC B-BIOL SCI, V271, P1823, DOI 10.1098/rspb.2004.2805; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Tiira K, 2006, BEHAV ECOL SOCIOBIOL, V59, P657, DOI 10.1007/s00265-005-0094-8; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wilmer JW, 1999, MOL ECOL, V8, P1417, DOI 10.1046/j.1365-294x.1999.00705.x	30	153	156	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					912	914		10.1038/nature05558	http://dx.doi.org/10.1038/nature05558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287726				2022-12-28	WOS:000244341200048
J	Raby, CR; Alexis, DM; Dickinson, A; Clayton, NS				Raby, C. R.; Alexis, D. M.; Dickinson, A.; Clayton, N. S.			Planning for the future by western scrub-jays	NATURE			English	Article							MENTAL TIME-TRAVEL; HUMAN MIND; MEMORY; EVOLUTION; RECOVERY; ABILITY; MAZE	Knowledge of and planning for the future is a complex skill that is considered by many to be uniquely human. We are not born with it; children develop a sense of the future at around the age of two and some planning ability by only the age of four to five(1-3). According to the Bischof-Kohler hypothesis(4), only humans can dissociate themselves from their current motivation and take action for future needs: other animals are incapable of anticipating future needs, and any future-oriented behaviours they exhibit are either fixed action patterns or cued by their current motivational state. The experiments described here test whether a member of the corvid family, the western scrub-jay (Aphelocoma californica), plans for the future. We show that the jays make provision for a future need, both by preferentially caching food in a place in which they have learned that they will be hungry the following morning and by differentially storing a particular food in a place in which that type of food will not be available the next morning. Previous studies have shown that, in accord with the Bischof-Kohler hypothesis, rats(5) and pigeons(6) may solve tasks by encoding the future but only over very short time scales. Although some primates and corvids(7-9) take actions now that are based on their future consequences, these have not been shown to be selected with reference to future motivational states(10), or without extensive reinforcement of the anticipatory act(11). The results described here suggest that the jays can spontaneously plan for tomorrow without reference to their current motivational state, thereby challenging the idea that this is a uniquely human ability.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X	Biotechnology and Biological Sciences Research Council [BB/D000335/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Atance CM, 2005, COGNITIVE DEV, V20, P341, DOI 10.1016/j.cogdev.2005.05.001; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Clayton NS, 2005, J EXP PSYCHOL-ANIM B, V31, P115, DOI 10.1037/0097-7403.31.2.115; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Clayton NS, 1999, ANIM BEHAV, V57, P435, DOI 10.1006/anbe.1998.0989; COOK RG, 1985, J EXP PSYCHOL ANIM B, V11, P453, DOI 10.1037/0097-7403.11.3.453; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Klein SB, 2002, SOC COGNITION, V20, P353, DOI 10.1521/soco.20.5.353.21125; Mulcahy NJ, 2006, SCIENCE, V312, P1038, DOI 10.1126/science.1125456; Naqshbandi M, 2006, J COMP PSYCHOL, V120, P345, DOI 10.1037/0735-7036.120.4.345; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; PETROVICH GD, IN PRESS PHYSL BEHAV; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Roitman MF, 2001, BEHAV BRAIN RES, V122, P193, DOI 10.1016/S0166-4328(01)00189-9; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2006, SCIENCE, V312, P1006, DOI 10.1126/science.1129217; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; ZENTALL TR, 1990, J EXP PSYCHOL ANIM B, V16, P358, DOI 10.1037/0097-7403.16.4.358	20	379	393	11	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					919	921		10.1038/nature05575	http://dx.doi.org/10.1038/nature05575			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314979				2022-12-28	WOS:000244341200050
J	Gureje, O; Jenkins, R				Gureje, Oye; Jenkins, Rachel			Mental health in development: re-emphasising the link	LANCET			English	Editorial Material									Univ Ibadan, Univ Coll Hosp, Dept Psychiat, Ibadan, Nigeria; WHO Collaborating Ctr, Inst Psychiat, London, England	University of Ibadan; University College Hospital, Ibadan; University of London; King's College London; World Health Organization	Gureje, O (corresponding author), Univ Ibadan, Univ Coll Hosp, Dept Psychiat, Ibadan, Nigeria.	ogureje@comui.edu.ng	Jenkins, Rachel/H-2953-2019; Adewuya, Abiodun/N-4997-2017; Jenkins, Rachel/E-4287-2010; Gureje, Oye/J-1183-2014	Jenkins, Rachel/0000-0002-2958-0331; Adewuya, Abiodun/0000-0002-7611-6953; Jenkins, Rachel/0000-0002-2958-0331; Gureje, Oye/0000-0003-0094-5947				CATALAN J, 1999, MENTAL HLTH HIV INFE; Gureje O, 2006, SOC PSYCH PSYCH EPID, V41, P44, DOI 10.1007/s00127-005-0001-7; Gureje O, 2000, B WORLD HEALTH ORGAN, V78, P475; Islam M Kamrul, 2006, Int J Equity Health, V5, P3, DOI 10.1186/1475-9276-5-3; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; RANIS G, 916 YAL U EC GROWTH; Shah A, 1999, ACTA PSYCHIAT SCAND, V100, P1; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *WHO, 2001, ATL COUNTR PROF  MEN; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591; World Health Organization, 2001, WORLD HLTH REP	11	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					447	449		10.1016/S0140-6736(07)60211-6	http://dx.doi.org/10.1016/S0140-6736(07)60211-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292748				2022-12-28	WOS:000244188300009
J	Alexander, RM				Alexander, R. McNeill			Antennae as gyroscopes	SCIENCE			English	Editorial Material								Moths use their antennae as part of a motion sensing system that ensures stable flight.	Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Alexander, RM (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	r.m.alexander@leeds.ac.uk						Muller M, 2000, NETH J ZOOL, V50, P279, DOI 10.1163/156854200505874; NALBACH G, 1993, J COMP PHYSIOL A, V173, P293, DOI 10.1007/BF00212693; PIX W, 1993, NATURWISSENSCHAFTEN, V80, P371, DOI 10.1007/BF01138795; PRINGLE JWS, 1948, PHILOS T ROY SOC B, V233, P347, DOI 10.1098/rstb.1948.0007; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598	5	5	8	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					771	772		10.1126/science.1136840	http://dx.doi.org/10.1126/science.1136840			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289963				2022-12-28	WOS:000244069000031
J	Monje-Casas, F; Prabhu, VR; Lee, BH; Boselli, M; Amon, A				Monje-Casas, Fernando; Prabhu, Vineet R.; Lee, Brian H.; Boselli, Monica; Amon, Angelika			Kinetochore orientation during meiosis is controlled by Aurora B and the monopolin complex	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; CENTROMERIC COHESION; PROTEIN-KINASE; CHROMOSOME SEGREGATION; BUDDING YEAST; MEIOTIC RECOMBINATION; SPINDLE; AIR-2; PHOSPHORYLATION	Kinetochores of sister chromatids attach to microtubules emanating from the same pole (coorientation) during meiosis I and microtubules emanating from opposite poles (biorientation) during meiosis II. We find that the Aurora B kinase IpI1 regulates kinetochore-microtubule attachment during both meiotic divisions and that a complex known as the monopolin complex ensures that the protein kinase coorients sister chromatids during meiosis I. Furthermore, the defining of conditions sufficient to induce sister kinetochore coorientation during mitosis provides insight into monopolin complex function. The monopolin complex joins sister kinetochores independently of cohesins, the proteins that hold sister chromatids together. We propose that this function of the monopolin complex helps Aurora B coorient sister chromatids during meiosis I.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Monje-Casas, Fernando/M-3062-2014	Monje-Casas, Fernando/0000-0002-3587-2373; Amon, Angelika/0000-0001-9837-0314; Lee, Brian/0000-0003-2497-5139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062207, GM62207] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dewar H, 2004, NATURE, V428, P93, DOI 10.1038/nature02328; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; GOLDSTEIN LSB, 1981, CELL, V25, P591, DOI 10.1016/0092-8674(81)90167-7; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; KLAPHOLZ S, 1985, GENETICS, V110, P187; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2004, CURR BIOL, V14, P2168, DOI 10.1016/j.cub.2004.12.033; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; Moore DP, 1998, CURR TOP DEV BIOL, V37, P263; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Parra MT, 2004, J CELL SCI, V117, P1221, DOI 10.1242/jcs.00947; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Schumacher JM, 1998, J CELL BIOL, V143, P1635, DOI 10.1083/jcb.143.6.1635; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; XU L, 1998, MOL CELL BIOL, V12, P6572; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	45	101	103	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					477	490		10.1016/j.cell.2006.12.040	http://dx.doi.org/10.1016/j.cell.2006.12.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289568	Bronze, Green Accepted			2022-12-28	WOS:000244842700015
J	Diddams, SA; Hollberg, L; Mbele, V				Diddams, Scott A.; Hollberg, Leo; Mbele, Vela			Molecular fingerprinting with the resolved modes of a femtosecond laser frequency comb	NATURE			English	Article							BROAD-BAND CONTINUUM; WAVELENGTH DEMULTIPLEXER; SPECTROSCOPY; OSCILLATOR; PULSES	The control of the broadband frequency comb(1) emitted from a mode-locked femtosecond laser has permitted a wide range of scientific and technological advances - ranging from the counting of optical cycles for next-generation atomic clocks(1,2) to measurements of phase-sensitive high-field processes(3). Aunique advantage of the stabilized frequency comb is that it provides, in a single laser beam, about a million optical modes with very narrow linewidths(4) and absolute frequency positions known to better than one part in 10(15) (ref. 5). One important application of this vast array of highly coherent optical fields is precision spectroscopy, in which a large number of modes can be used to map internal atomic energy structure and dynamics(6,7). However, an efficient means of simultaneously identifying, addressing and measuring the amplitude or relative phase of individual modes has not existed. Here we use a high-resolution disperser(8,9) to separate the individual modes of a stabilized frequency comb into a two-dimensional array in the image plane of the spectrometer. We illustrate the power of this technique for high-resolution spectral fingerprinting of molecular iodine vapour, acquiring in a few milliseconds absorption images covering over 6 THz of bandwidth with high frequency resolution. Our technique for direct and parallel accessing of stabilized frequency comb modes could find application in high-bandwidth spread-spectrum communications with increased security, high-resolution coherent quantum control, and arbitrary optical waveform synthesis(10) with control at the optical radian level.	Natl Inst Stand & Technol, Time & Frequency Div, Boulder, CO 80305 USA; CSIR, NML, ZA-0001 Pretoria, South Africa; Univ Witwatersrand, Sch Phys, ZA-2050 Wits, South Africa	National Institute of Standards & Technology (NIST) - USA; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Witwatersrand	Diddams, SA (corresponding author), Natl Inst Stand & Technol, Time & Frequency Div, 325 Broadway, Boulder, CO 80305 USA.	sdiddams@boulder.nist.gov	Diddams, Scott A/L-2819-2013	Diddams, Scott A/0000-0002-2144-0764				BAKLANOV YV, 1977, APPL PHYS, V12, P97, DOI 10.1007/BF00900075; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bartels A, 2004, OPT LETT, V29, P1081, DOI 10.1364/OL.29.001081; Bartels A, 2002, OPT LETT, V27, P1839, DOI 10.1364/OL.27.001839; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Gerginov V, 2005, OPT LETT, V30, P1734, DOI 10.1364/OL.30.001734; JENKINS FA, 1976, FUNDAMENALS OPTICS; Jiang Z, 2005, OPT LETT, V30, P1557, DOI 10.1364/OL.30.001557; Jones DJ, 2000, SCIENCE, V288, P635, DOI 10.1126/science.288.5466.635; KATO H, 2000, DOPPLER FREE HIGH RE; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Marian A, 2004, SCIENCE, V306, P2063, DOI 10.1126/science.1105660; OSAKAY WH, 2006, PHYS REV LETT, V97; Quinn TJ, 2003, METROLOGIA, V40, P103, DOI 10.1088/0026-1394/40/2/316; Ramond TM, 2002, OPT LETT, V27, P1842, DOI 10.1364/OL.27.001842; Shirasaki M, 1996, OPT LETT, V21, P366, DOI 10.1364/OL.21.000366; Simonsen HR, 2000, METROLOGIA, V37, P651, DOI 10.1088/0026-1394/37/6/2; TEETS R, 1977, PHYS REV LETT, V38, P760, DOI 10.1103/PhysRevLett.38.760; Thorpe MJ, 2006, SCIENCE, V311, P1595, DOI 10.1126/science.1123921; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Wang SX, 2005, OPT EXPRESS, V13, P9374, DOI 10.1364/OPEX.13.009374; Xiao SJ, 2004, OPT EXPRESS, V12, P2895, DOI 10.1364/OPEX.12.002895	22	537	560	7	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					627	630		10.1038/nature05524	http://dx.doi.org/10.1038/nature05524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287805				2022-12-28	WOS:000244039400039
J	Ala, A; Walker, AP; Ashkan, K; Dooley, JS; Schilsky, ML				Ala, Aftab; Walker, Ann P.; Ashkan, Keyoumars; Dooley, James S.; Schilsky, Michael L.			Wilson's disease	LANCET			English	Review							COPPER-TRANSPORTING ATPASE; P-TYPE ATPASE; LIVER-TRANSPLANTATION; HEPATIC COPPER; ATP7B GENE; HEPATOLENTICULAR DEGENERATION; AMMONIUM TETRATHIOMOLYBDATE; NEUROLOGIC PRESENTATION; PSYCHIATRIC-SYMPTOMS; CLINICAL CORRELATION	Progressive hepatolenticular degeneration, or Wilson's disease, is a genetic disorder of copper metabolism. Knowledge of the clinical presentations and treatment of the disease are important both to the generalist and to specialists in gastroenterology and hepatology, neurology, psychiatry, and paediatrics. Wilson's disease invariably results in severe disability and death if untreated. The diagnosis is easily overlooked but if discovered early, effective treatments are available that will prevent or reverse many manifestations of this disorder. Studies have identified the role of copper in disease pathogenesis and clinical, biochemical, and genetic markers that can be useful in diagnosis. There are several chelating agents and zinc salts for medical therapy. Liver transplantation corrects the underlying pathophysiology and can be lifesaving. The discovery of the Wison's disease gene has opened up a new molecular diagnostic approach, and could form the basis of future gene therapy.	Frimley Pk Hosp NHS Fdn Trust, Dept Med, Ctr Gastroenterol & Hepatol, Surrey GU16 7UJ, England; UCL, Royal Free & Univ Coll Med Sch, Div Med, UCL Inst Hepatol, London, England; Natl Hosp Neurol & Neurosurg, Inst Neurol, Sobell Dept Neurosci, London WC1N 3BG, England; New York Weill Cornell Med Ctr, Ctr Liver Dis & Transplantat, New York, NY USA	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ala, A (corresponding author), Frimley Pk Hosp NHS Fdn Trust, Dept Med, Ctr Gastroenterol & Hepatol, Surrey GU16 7UJ, England.	aftab.ala@fph-tr.nhs.uk	Dening, Tom/E-1335-2013; Walker, Ann P/C-1628-2008; Leggio, Lorenzo/M-2972-2016	Dening, Tom/0000-0003-3387-4241; ALA, AFTAB/0000-0001-6257-3160				Al Jumah M, 2004, EUR J NEUROL, V11, P121, DOI 10.1046/j.1351-5101.2003.00729.x; Ala A, 2005, HEPATOLOGY, V41, P668, DOI 10.1002/hep.20601; Alt E R, 1990, Int Rev Exp Pathol, V31, P165; Askari FK, 2003, J LAB CLIN MED, V142, P385, DOI 10.1016/S0022-2143(03)00157-4; Barthel H, 2003, AM J NEURORADIOL, V24, P234; Bax RT, 1998, NEUROLOGY, V51, P863, DOI 10.1212/WNL.51.3.863; Bobba A, 2003, MOL CELL PROBE, V17, P271, DOI 10.1016/S0890-8508(03)00065-3; Brewer GJ, 2006, ARCH NEUROL-CHICAGO, V63, P521, DOI 10.1001/archneur.63.4.521; Brewer GJ, 2005, CNS DRUGS, V19, P185, DOI 10.2165/00023210-200519030-00001; Brewer GJ, 1998, J LAB CLIN MED, V132, P264, DOI 10.1016/S0022-2143(98)90039-7; BREWER GJ, 1987, ARCH NEUROL-CHICAGO, V44, P490, DOI 10.1001/archneur.1987.00520170020016; Brewer GJ, 2003, ARCH NEUROL-CHICAGO, V60, P379, DOI 10.1001/archneur.60.3.379; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Butler P, 2001, MOL GENET METAB, V72, P223, DOI 10.1006/mgme.2000.3143; CAIRNS JE, 1969, BRIT MED J, V3, P95, DOI 10.1136/bmj.3.5662.95; CARPENTER TO, 1983, NEW ENGL J MED, V309, P873, DOI 10.1056/NEJM198310133091501; CHU NS, 1991, J NEUROL SCI, V106, P1, DOI 10.1016/0022-510X(91)90186-B; CHU NS, 1989, CLIN NEUROL NEUROSUR, V91, P45, DOI 10.1016/S0303-8467(89)80007-1; Coronado VA, 2005, CLIN GENET, V68, P548, DOI 10.1111/j.1399-0004.2005.00524.x; Czlonkowska A, 1996, J NEUROL, V243, P269, DOI 10.1007/BF00868525; DACOSTA CM, 1992, HEPATOLOGY, V15, P609, DOI 10.1002/hep.1840150410; DAVIS EJB, 1993, BRIT J PSYCHIAT, V162, P256, DOI 10.1192/bjp.162.2.256; del Rosario MAF, 1998, LANCET, V351, P336, DOI 10.1016/S0140-6736(97)10254-9; DENING TR, 1989, ARCH GEN PSYCHIAT, V46, P1126; DENING TR, 1990, BIOL PSYCHIAT, V28, P255, DOI 10.1016/0006-3223(90)90581-L; EDWARDS CQ, 1979, CLIN GENET, V15, P311; Emre S, 2001, TRANSPLANTATION, V72, P1232, DOI 10.1097/00007890-200110150-00008; Esmaeli B, 1996, CORNEA, V15, P582; FACTOR SM, 1982, VIRCHOWS ARCH A, V397, P301, DOI 10.1007/BF00496571; Ferenci P, 2005, CLIN GASTROENTEROL H, V3, P811, DOI 10.1016/S1542-3565(05)00181-3; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2004, ALIMENT PHARM THER, V19, P157, DOI 10.1046/j.1365-2036.2003.01813.x; FLEMING CR, 1977, ANN INTERN MED, V86, P285, DOI 10.7326/0003-4819-86-3-285; FROMMER D, 1977, GASTROENTEROLOGY, V72, P1331; FROMMER DJ, 1981, DIGESTION, V21, P169, DOI 10.1159/000198559; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; FRYDMAN M, 1991, J ANDROL, V12, P180; GIBBS K, 1966, LANCET, V1, P175; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; GOLDING DN, 1977, ANN RHEUM DIS, V36, P99, DOI 10.1136/ard.36.2.99; Gow PJ, 2000, GUT, V46, P415, DOI 10.1136/gut.46.3.415; Gu YH, 2003, CLIN GENET, V64, P479, DOI 10.1046/j.1399-0004.2003.00179.x; GUARINO M, 1995, ACTA NEUROL SCAND, V92, P405; Ha-Hao D, 2002, Z GASTROENTEROL, V40, P209, DOI 10.1055/s-2002-25151; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Irani AN, 2001, MOL THER, V3, P302, DOI 10.1006/mthe.2001.0271; Jeon B, 1998, J NEUROL NEUROSUR PS, V65, P60, DOI 10.1136/jnnp.65.1.60; Kalra V, 2004, INT UROL NEPHROL, V36, P289, DOI 10.1023/B:UROL.0000034630.73124.36; KAUSHANSKY A, 1987, FERTIL STERIL, V47, P270; King AD, 1996, AM J ROENTGENOL, V167, P1579, DOI 10.2214/ajr.167.6.8956601; Kozic D, 2003, EUR J NEUROL, V10, P587, DOI 10.1046/j.1468-1331.2003.00661.x; KUAN P, 1987, CHEST, V91, P579, DOI 10.1378/chest.91.4.579; Kumar S, 2005, CLIN GENET, V67, P443, DOI 10.1111/j.1399-0004.2005.00440.x; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee LW, 2001, P NATL ACAD SCI USA, V98, P6842, DOI 10.1073/pnas.111058698; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MEDALIA A, 1992, BIOL PSYCHIAT, V31, P823, DOI 10.1016/0006-3223(92)90313-O; Medici V, 2005, LIVER TRANSPLANT, V11, P1056, DOI 10.1002/lt.20486; Menkes J H, 1999, Eur J Paediatr Neurol, V3, P147, DOI 10.1016/S1090-3798(99)90048-X; Muller T, 2004, HEPATOLOGY, V39, P963, DOI 10.1002/hep.20108; ODER W, 1991, J NEUROL, V238, P281; Opalski A, 1930, Z GESAMTE NEUROL PSY, V124, P420, DOI 10.1007/BF02865108; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Page RA, 2004, NEUROLOGY, V63, P638, DOI 10.1212/01.WNL.0000134793.50831.C1; Perri RE, 2005, HEPATOLOGY, V42, P974, DOI 10.1002/hep.20893; Podgaetz Eitan, 2003, Ann Hepatol, V2, P131; Prashanth LK, 2005, QJM-INT J MED, V98, P557, DOI 10.1093/qjmed/hci095; RICHARD JM, 1983, PEDIATR CLIN N AM, V30, P1123; Roberts EA, 2003, HEPATOLOGY, V37, P1475, DOI 10.1053/jhep.2003.50252; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Safaei R, 2005, CRIT REV ONCOL HEMAT, V53, P13, DOI 10.1016/j.critrevonc.2004.09.007; SAITO T, 1987, EUR J PEDIATR, V146, P261, DOI 10.1007/BF00716470; SALLIE R, 1992, HEPATOLOGY, V16, P1206, DOI 10.1016/0270-9139(92)90016-3; Santos RG, 2005, PEDIATR TRANSPLANT, V9, P112, DOI 10.1111/j.1399-3046.2005.00254.x; Schaefer M, 1999, GASTROENTEROLOGY, V117, P1380, DOI 10.1016/S0016-5085(99)70288-X; Scheinberg IH, 1984, MAJOR PROBLEMS INTER, VXXIII; Scheinberg IH., 1984, WILSONS DIS; Schilsky M L, 2001, Curr Gastroenterol Rep, V3, P54, DOI 10.1007/s11894-001-0041-4; Schilsky Michael L, 2005, Curr Gastroenterol Rep, V7, P26, DOI 10.1007/s11894-005-0062-5; SCHILSKY ML, 1991, GASTROENTEROLOGY, V100, P762, DOI 10.1016/0016-5085(91)80023-3; SCHILSKY ML, 1994, HEPATOLOGY, V19, P583, DOI 10.1002/hep.1840190307; Schmidt HHJ, 2003, TRANSPLANT P, V35, P2078, DOI 10.1016/S0041-1345(03)00671-7; Sen S, 2002, LIVER TRANSPLANT, V8, P962, DOI 10.1053/jlts.2002.35546; Siesling S, 1997, MOVEMENT DISORD, V12, P229, DOI 10.1002/mds.870120214; Sinha S, 2006, NEURORADIOLOGY, V48, P613, DOI 10.1007/s00234-006-0101-4; Sinha S, 2005, J NEUROL SCI, V228, P121, DOI 10.1016/j.jns.2004.10.017; Sinha S, 2004, J NEUROL SCI, V217, P37, DOI 10.1016/j.jns.2003.08.007; Sozeri E, 1997, PEDIATR NEPHROL, V11, P307, DOI 10.1007/s004670050282; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; Steindl P, 1997, GASTROENTEROLOGY, V113, P212, DOI 10.1016/S0016-5085(97)70097-0; STERNLIE.I, 1968, GASTROENTEROLOGY, V55, P354; STERNLIEB I, 1968, NEW ENGL J MED, V278, P352, DOI 10.1056/NEJM196802152780702; Stracciari A, 2000, ARCH NEUROL-CHICAGO, V57, P384, DOI 10.1001/archneur.57.3.384; Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588; Svetel M, 2001, MOVEMENT DISORD, V16, P719, DOI 10.1002/mds.1118; Tamura S, 2005, CLIN TRANSPLANT, V19, P483, DOI 10.1111/j.1399-0012.2005.00371.x; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Terada K, 1999, FEBS LETT, V448, P53, DOI 10.1016/S0014-5793(99)00319-1; Tissieres Pierre, 2003, Pediatr Crit Care Med, V4, P338, DOI 10.1097/01.PCC.0000074268.77622.DE; Tsivkovskii R, 2003, J BIOL CHEM, V278, P13302, DOI 10.1074/jbc.M300034200; TU JB, 1967, METABOLISM, V16, P507, DOI 10.1016/0026-0495(67)90079-0; van Dongen EMWM, 2004, BIOCHEM BIOPH RES CO, V323, P789, DOI 10.1016/j.bbrc.2004.08.160; Vrabelova S, 2005, MOL GENET METAB, V86, P277, DOI 10.1016/j.ymgme.2005.05.004; WALSHE JM, 1956, LANCET, V270, P25; Walshe JM, 2003, QJM-INT J MED, V96, P657, DOI 10.1093/qjmed/hcg114; WALSHE JM, 1962, ARCH DIS CHILD, V37, P253, DOI 10.1136/adc.37.193.253; WALSHE JM, 1969, LANCET, V2, P1401; WALSHE JM, 1993, Q J MED, V86, P197; Walter G, 1997, AUST NZ J PSYCHIAT, V31, P880, DOI 10.3109/00048679709065517; WIEBERS DO, 1977, MAYO CLIN PROC, V52, P409; WILKINSON ML, 1983, GUT, V24, P767, DOI 10.1136/gut.24.8.767; Wilson DC, 2000, J PEDIATR-US, V137, P719, DOI 10.1067/mpd.2000.108569; Wilson SAK, 1912, BRAIN, V34, P20, DOI DOI 10.1093/BRAIN/34.4.295; Wu ZY, 2001, ARCH NEUROL-CHICAGO, V58, P971, DOI 10.1001/archneur.58.6.971; XIE YZ, 1985, SKELETAL RADIOL, V13, P114; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; YUZBASIYANGURKAN V, 1989, J LAB CLIN MED, V114, P520	118	729	799	5	172	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					397	408		10.1016/S0140-6736(07)60196-2	http://dx.doi.org/10.1016/S0140-6736(07)60196-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276780				2022-12-28	WOS:000243944400034
J	Han, JH; Zhou, H; Horazdovsky, B; Zhang, KL; Xu, RM; Zhang, ZG				Han, Junhong; Zhou, Hui; Horazdovsky, Bruce; Zhang, Kangling; Xu, Rui-Ming; Zhang, Zhiguo			Rtt109 acetylates histone H3 lysine 56 and functions in DNA replication	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; REPAIR; MAINTENANCE; COMPLEXES; INTEGRITY; NETWORK; HST3	Acetylation of histone H3 lysine 56 (H3-K56) occurs in S phase, and cells lacking H3-K56 acetylation are sensitive to DNA-damaging agents. However, the histone acetyltransferase (HAT) that catalyzes global H3-K56 acetylation has not been found. Here we show that regulation of Ty1 transposition gene product 109 (Rtt109) is an H3-K56 HAT. Cells lacking Rtt109 or expressing rtt109 mutants with alterations at a conserved aspartate residue lose H3-K56 acetylation and exhibit increased sensitivity toward genotoxic agents, as well as elevated levels of spontaneous chromosome breaks. Thus, Rtt109, which shares no sequence homology with any other known HATs, is a unique HAT that acetylates H3-K56.	Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Univ Calif Riverside, Mass Spectrometry Facil, Riverside, CA 92521 USA; NYU, Sch Med, Struct Biol Program,Skirball Inst Biomed, Helen L & Martin S Kimmel Ctr Biol & Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	Mayo Clinic; University of California System; University of California Riverside; New York University; New York University	Zhang, ZG (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, 200 1st St SW, Rochester, MN 55905 USA.	Zhang.Zhiguo@mayo.edu	Han, Junhong/L-5264-2013; xu, rui/GRX-5734-2022	Han, Junhong/0000-0002-3371-8698				Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Eissenberg JC, 1997, MOL CELL BIOL, V17, P6367, DOI 10.1128/MCB.17.11.6367; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Marmorstein Ronen, 2004, Novartis Found Symp, V259, P78; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Sutton A, 2003, J BIOL CHEM, V278, P16887, DOI 10.1074/jbc.M210709200; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	26	327	331	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					653	655		10.1126/science.1133234	http://dx.doi.org/10.1126/science.1133234			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272723				2022-12-28	WOS:000243909400045
J	Kicheva, A; Pantazis, P; Bollenbach, T; Kalaidzidis, Y; Bittig, T; Julicher, F; Gonzalez-Gaitan, M				Kicheva, Anna; Pantazis, Periklis; Bollenbach, Tobias; Kalaidzidis, Yannis; Bittig, Thomas; Juelicher, Frank; Gonzalez-Gaitan, Marcos			Kinetics of morphogen gradient formation	SCIENCE			English	Article							WING IMAGINAL DISC; FLUORESCENT PROTEIN; PHOTOBLEACHING RECOVERY; DROSOPHILA DPP; CELLS; ENDOCYTOSIS; DIFFUSION; TRAFFICKING; RECEPTORS; MOBILITY	In the developing fly wing, secreted morphogens such as Decapentaplegic (Dpp) and Wingless (Wg) form gradients of concentration providing positional information. Dpp forms a longer-range gradient than Wg. To understand how the range is controlled, we measured the four key kinetic parameters governing morphogen spreading: the production rate, the effective diffusion coefficient, the degradation rate, and the immobile fraction. The four parameters had different values for Dpp versus Wg. In addition, Dynamin-dependent endocytosis was required for spreading of Dpp, but not Wg. Thus, the cellular mechanisms of Dpp and Wingless spreading are different: Dpp spreading requires endocytic, intracellular trafficking.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Max Planck Inst Phys Complex Syst, D-01187 Dresden, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; University of Geneva; University of Geneva; Max Planck Society; Lomonosov Moscow State University	Julicher, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauer Str 109, D-01307 Dresden, Germany.	julicher@pks.mpg.de; marcos.gonzalez@biochem.unige.ch	Julicher, Frank/B-1828-2009; Kalaidzidis, Yannis/H-3094-2016; Bollenbach, Tobias/AAK-3206-2020; Pantazis, Periklis/AAR-1795-2021	Julicher, Frank/0000-0003-4731-9185; Kalaidzidis, Yannis/0000-0002-6137-1193; Bollenbach, Tobias/0000-0003-4398-476X; Pantazis, Periklis (Laki)/0000-0002-8367-9332; Gonzalez-Gaitan, Marcos/0000-0002-6295-7321				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; BASLER K, 1994, TRENDS GENET, V10, P187; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Charpilienne A, 2001, J BIOL CHEM, V276, P29361, DOI 10.1074/jbc.M101935200; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Groppe J, 1998, J BIOL CHEM, V273, P29052, DOI 10.1074/jbc.273.44.29052; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lippincott-Schwartz J, 2003, NAT CELL BIOL, pS7, DOI 10.1038/ncb1032; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Rives AF, 2006, DEV BIOL, V293, P268, DOI 10.1016/j.ydbio.2006.02.006; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	23	285	288	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					521	525		10.1126/science.1135774	http://dx.doi.org/10.1126/science.1135774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255514				2022-12-28	WOS:000243726600049
J	Lander, AD				Lander, Arthur D.			Morpheus unbound: Reimagining the morphogen gradient	CELL			English	Review							BMP ACTIVITY GRADIENT; POSITIONAL INFORMATION; TWISTED-GASTRULATION; DROSOPHILA EMBRYOS; PATTERN-FORMATION; DPP; RECEPTOR; ROBUSTNESS; ENDOCYTOSIS; ACTIVATION	The theory that the spatial organization of cell fate is orchestrated by gradients of diffusing molecules was a major contribution to 20(th) century developmental biology. Although the existence of morphogens is no longer in doubt, studies on the formation and function of their gradients have yielded far more puzzles than answers. On close inspection, every morphogen gradient seems to use a rich array of regulatory mechanisms, suggesting that the tasks carried out by such systems are far more extensive than previously thought.	Univ Calif Irvine, Ctr Dev Biol, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lander, AD (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	adlander@uci.edu	Lander, Arthur/L-2827-2019; Lander, Arthur D/C-9008-2011	Lander, Arthur/0000-0002-4380-5525; Lander, Arthur D/0000-0002-4380-5525	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247, P20GM066051] Funding Source: NIH RePORTER; NICHD NIH HHS [HD38761] Funding Source: Medline; NIGMS NIH HHS [GM66051, GM067247, R01 GM067247] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Ayala FJ, 1999, HIST PHIL LIFE SCI, V21, P3; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Berg, 2018, RANDOM WALKS BIOL; Bollenbach T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018103; Burz DS, 2001, J MOL BIOL, V305, P219, DOI 10.1006/jmbi.2000.4287; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Dorfman R, 2001, DEVELOPMENT, V128, P965; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dyson S, 1998, CELL, V93, P557, DOI 10.1016/S0092-8674(00)81185-X; Eaton S, 2006, CURR OPIN GENET DEV, V16, P17, DOI 10.1016/j.gde.2005.12.006; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Goentoro LA, 2006, DEV CELL, V11, P263, DOI 10.1016/j.devcel.2006.07.004; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Green J, 2002, DEV DYNAM, V225, P392, DOI 10.1002/dvdy.10170; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gursky VV, 2004, PHYSICA D, V197, P286, DOI 10.1016/j.physd.2004.07.003; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Iglesias Pablo A, 2002, Sci STKE, V2002, pre12, DOI 10.1126/stke.2002.148.re12; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jazwinska A, 1999, DEVELOPMENT, V126, P3323; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kerszberg M, 1996, J THEOR BIOL, V183, P95, DOI 10.1006/jtbi.1996.0205; Kirkbride KC, 2005, TRENDS BIOCHEM SCI, V30, P611, DOI 10.1016/j.tibs.2005.09.003; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335; Lai K, 2004, BIOPHYS J, V86, P2748, DOI 10.1016/S0006-3495(04)74328-3; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander AD, 2004, PLOS BIOL, V2, P712, DOI 10.1371/journal.pbio.0020164; Lander AD, 2005, STUD APPL MATH, V114, P343, DOI 10.1111/j.0022-2526.2005.01556.x; Lawrence PA, 2001, NAT CELL BIOL, V3, pE151, DOI 10.1038/35083096; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Mizutani CM, 2005, DEV CELL, V8, P915, DOI 10.1016/j.devcel.2005.04.009; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Pages F, 2000, TRENDS GENET, V16, P40, DOI 10.1016/S0168-9525(99)01880-6; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Pfeiffer S, 1999, SEMIN CELL DEV BIOL, V10, P303, DOI 10.1006/scdb.1999.0306; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reas PG, 2004, RIV BIOL-BIOL FORUM, V97, P443; Reeves GT, 2006, DEV CELL, V11, P289, DOI 10.1016/j.devcel.2006.08.006; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Rusakov DA, 1998, P NATL ACAD SCI USA, V95, P8975, DOI 10.1073/pnas.95.15.8975; Saha K, 2006, DEVELOPMENT, V133, P889, DOI 10.1242/dev.02254; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; SCHRODINGER E, 1944, WHAT LIFE; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; Vilmos P, 2005, EMBO REP, V6, P262, DOI 10.1038/sj.embor.7400347; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Von Dassow G, 2002, J EXP ZOOL, V294, P179, DOI 10.1002/jez.10144; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yu K, 1996, DEVELOPMENT, V122, P4033	93	242	248	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					245	256		10.1016/j.cell.2007.01.004	http://dx.doi.org/10.1016/j.cell.2007.01.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254964	Bronze, Green Published			2022-12-28	WOS:000244420500011
J	Marquez, LM; Redman, RS; Rodriguez, RJ; Roossinck, MJ				Marquez, Luis M.; Redman, Regina S.; Rodriguez, Russell J.; Roossinck, Marilyn J.			A virus in a fungus in a plant: Three-way symbiosis required for thermal tolerance	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; HYPOVIRULENCE; DISRUPTION; CONVERSION; VIRULENCE	A mutualistic association between a fungal endophyte and a tropical panic grass allows both organisms to grow at high soil temperatures. We characterized a virus from this fungus that is involved in the mutualistic interaction. Fungal isolates cured of the virus are unable to confer heat tolerance, but heat tolerance is restored after the virus is reintroduced. The virus-infected fungus confers heat tolerance not only to its native monocot host but also to a eudicot host, which suggests that the underlying mechanism involves pathways conserved between these two groups of plants.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; Univ Washington, Dept Bot, Seattle, WA 98195 USA; Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; US Geol Survey, Seattle, WA 98115 USA	Noble Research Institute; University of Washington; University of Washington Seattle; Montana State University System; Montana State University Bozeman; United States Department of the Interior; United States Geological Survey	Roossinck, MJ (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	mroossinck@noble.org						Ahn IP, 2001, MOL PLANT MICROBE IN, V14, P496, DOI 10.1094/MPMI.2001.14.4.496; ANAGNOSTAKIS SL, 1979, PHYTOPATHOLOGY, V69, P1226, DOI 10.1094/Phyto-69-1226; Bordenstein SR, 2004, MOL BIOL EVOL, V21, P1981, DOI 10.1093/molbev/msh211; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Dawe AL, 2001, ANNU REV GENET, V35, P1, DOI 10.1146/annurev.genet.35.102401.085929; GHABRIAL SA, 1994, ADV VIRUS RES, V43, P303, DOI 10.1016/S0065-3527(08)60052-4; Kuznetsov YG, 2006, VIROLOGY, V352, P329, DOI 10.1016/j.virol.2006.04.008; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Redman RS, 1999, MOL PLANT MICROBE IN, V12, P969, DOI 10.1094/MPMI.1999.12.11.969; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Zabalgogeazcoa I, 1998, MYCOL RES, V102, P914, DOI 10.1017/S0953756297005819; Zhou T, 1997, PHYTOPATHOLOGY, V87, P147, DOI 10.1094/PHYTO.1997.87.2.147; [No title captured]	16	505	570	13	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					513	515		10.1126/science.1136237	http://dx.doi.org/10.1126/science.1136237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255511				2022-12-28	WOS:000243726600046
J	Settleman, J				Settleman, Jeffrey			PAK-in' up cGMP for the move	CELL			English	Editorial Material							CHEMOTAXIS; RECEPTOR	Although guanylyl cyclases have been implicated in cell migration, how they are activated to promote cell motility is unknown. In this issue, Guo et al. (2007) report direct communication between guanylyl cyclases and the Rac-p21-activated kinase (PAK) signaling pathway-which is essential for cell migration-to promote cell motility, through allosteric activation of guanylyl cyclases by autophosphorylated PAK.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu						Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Dumas JJ, 1998, STRUCT FOLD DES, V6, P407, DOI 10.1016/S0969-2126(98)00042-2; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; GUO D, 2007, CELL; Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	9	8	10	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					237	238		10.1016/j.cell.2007.01.002	http://dx.doi.org/10.1016/j.cell.2007.01.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254961	Bronze			2022-12-28	WOS:000244420500008
J	Chalela, JA; Kidwell, CS; Nentwich, LM; Luby, M; Butman, JA; Demchuk, AM; Hill, MD; Patronas, N; Latour, L; Warach, S				Chalela, Julio A.; Kidwell, Chelsea S.; Nentwich, Lauren M.; Luby, Marie; Butman, John A.; Demchuk, Andrew M.; Hill, Michael D.; Patronas, Nicholas; Latour, Lawrence; Warach, Steven			Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison	LANCET			English	Article							DIFFUSION-WEIGHTED MR; INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; SYMPTOM ONSET; CT; BRAIN; INFARCTION; DIAGNOSIS; VARIABILITY; ACCURACY	Background Although the use of magnetic resonance imaging (MRI) for the diagnosis of acute stroke is increasing, this method has not proved more effective than computed tomography (CT) in the emergency setting. We aimed to prospectively compare CT and MRI for emergency diagnosis of acute stroke. Methods We did a single-centre, prospective, blind comparison of non-contrast CT and MRI (with diffusion-weighted and susceptibility weighted images) in a consecutive series of patients referred for emergency assessment of suspected acute stroke. Scans were independently interpreted by four experts, who were unaware of clinical information, MRI-CT pairings, and follow-up imaging. Results 356 patients, 217 of whom had a final clinical diagnosis of acute stroke, were assessed. MRI detected acute stroke (ischaemic or haemorrhagic), acute ischaemic stroke, and chronic haemorrhage more frequently than did CT (p<0.0001, for all comparisons). MRI was similar to CT for the detection of acute intracranial haemorrhage. MRI detected acute ischaemic stroke in 164 of 356 patients (46%; 95% CI 41-51%), compared with CT in 35 of 356 patients (10%; 7-14%). In the subset of patients scanned within 3 h of symptom onset, MRI detected acute ischaemic stroke in 41 of 90 patients (46%; 35-56%); CT in 6 of 90 (7%; 3-14%). Relative to the final clinical diagnosis, MRI had a sensitivity of 83% (181 of 217; 78-88%) and CT of 26% (56 of 217; 20-32%) for the diagnosis of any acute stroke. Interpretation MRI is better than CT for detection of acute ischaemia, and can detect acute and chronic haemorrhage; therefore it should be the preferred test for accurate diagnosis of patients with suspected acute stroke. Because our patient sample encompassed the range of disease that is likely to be encountered in emergency cases of suspected stroke, our results are directly applicable to clinical practice.	NINDS, Sect Stroke Diagnost & Therapeut, NIH, Bethesda, MD 20892 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Georgetown Univ, Washington Hosp Ctr, Washington, DC USA; Boston Med Ctr, Boston, MA USA; NIH, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Medical University of South Carolina; Georgetown University; MedStar Washington Hospital Center; Boston Medical Center; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Warach, S (corresponding author), NINDS, Sect Stroke Diagnost & Therapeut, NIH, 10 Ctr Dr,Rm B1D733,MSC 1063, Bethesda, MD 20892 USA.	warachs@ninds.nih.gov	Demchuk, Andrew M/E-1103-2012; Latour, Larry/AAH-5663-2021; Butman, John/J-2780-2013; Butman, John A/A-2694-2008; Hill, Michael D/C-9073-2012; Warach, Steven/R-5074-2019; Luby, Marie/AEX-9494-2022	Demchuk, Andrew M/0000-0002-4930-7789; Latour, Larry/0000-0001-6160-5263; Butman, John/0000-0002-1547-9195; Hill, Michael D/0000-0002-6269-1543; Nentwich, Lauren/0000-0001-8263-4119	Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [Z01 NS002975-07] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002975, Z01NS003043, Z01NS003042] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; BRYAN RN, 1991, AM J NEURORADIOL, V12, P611; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Fiebach JB, 2002, STROKE, V33, P2206, DOI 10.1161/01.STR.0000026864.20339.CB; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hjort N, 2005, STROKE, V36, P388, DOI 10.1161/01.STR.0000152268.47919.be; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kang DW, 2005, STROKE, V36, P1939, DOI 10.1161/01.STR.0000177539.72071.f0; Kelly PJ, 2001, NEUROLOGY, V56, P914, DOI 10.1212/WNL.56.7.914; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Lansberg MG, 2000, NEUROLOGY, V54, P1557, DOI 10.1212/WNL.54.8.1557; LIBMAN RB, 1995, ARCH NEUROL-CHICAGO, V52, P1119, DOI 10.1001/archneur.1995.00540350113023; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Linfante I, 1999, STROKE, V30, P2263, DOI 10.1161/01.STR.30.11.2263; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; MOHR JP, 1995, STROKE, V26, P807, DOI 10.1161/01.STR.26.5.807; Mullins ME, 2002, RADIOLOGY, V224, P353, DOI 10.1148/radiol.2242010873; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Urbach H, 2000, NEURORADIOLOGY, V42, P722, DOI 10.1007/s002340000401; WARACH S, 1992, NEUROLOGY, V42, P1717, DOI 10.1212/WNL.42.9.1717; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Wardlaw JM, 2005, RADIOLOGY, V235, P444, DOI 10.1148/radiol.2352040262; Wardlaw JM, 2004, STROKE, V35, P2477, DOI 10.1161/01.STR.0000143453.78005.44	28	748	794	3	64	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					293	298		10.1016/S0140-6736(07)60151-2	http://dx.doi.org/10.1016/S0140-6736(07)60151-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258669	Green Accepted			2022-12-28	WOS:000243912000033
J	Townley, R; Shapiro, L				Townley, Robert; Shapiro, Lawrence			Crystal structures of the adenylate sensor from fission yeast AMP-activated protein kinase	SCIENCE			English	Article							PARKINSON-WHITE-SYNDROME; FATTY-ACID OXIDATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; CYTOPLASMIC DOMAIN; GAMMA(2) SUBUNIT; SKELETAL-MUSCLE; BETA-SUBUNITS; SNF1; MUTATIONS	The 5'-AMP (adenosine monophosphate)-activated protein kinase (AMPK) coordinates metabolic function with energy availability by responding to changes in intracellular ATP (adenosine triphosphate) and AMP concentrations. Here, we report crystal structures at 2.9 and 2.6 angstrom resolution for ATP- and AMP-bound forms of a core alpha beta gamma adenylate-binding domain from the fission yeast AMPK homolog. ATP and AMP bind competitively to a single site in the g subunit, with their respective phosphate groups positioned near function-impairing mutants. Unexpectedly, ATP binds without counterions, amplifying its electrostatic effects on a critical regulatory region where all three subunits converge.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Shapiro, L (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	LSS8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Townley, Robert/0000-0002-9347-2431				Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Gollob MH, 2001, CIRCULATION, V104, P3030, DOI 10.1161/hc5001.102111; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Leff T, 2003, BIOCHEM SOC T, V31, P224; Lumbreras V, 2001, EMBO REP, V2, P55, DOI 10.1093/embo-reports/kve001; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Musi N, 2003, BIOCHEM SOC T, V31, P191, DOI 10.1042/bst0310191; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; WOODS A, 1994, J BIOL CHEM, V269, P19509; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	34	149	156	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 23	2007	315	5819					1726	1729		10.1126/science.1137503	http://dx.doi.org/10.1126/science.1137503			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148WA	17289942				2022-12-28	WOS:000245106900044
J	Kohsaka, Y; Taylor, C; Fujita, K; Schmidt, A; Lupien, C; Hanaguri, T; Azuma, M; Takano, M; Eisaki, H; Takagi, H; Uchida, S; Davis, JC				Kohsaka, Y.; Taylor, C.; Fujita, K.; Schmidt, A.; Lupien, C.; Hanaguri, T.; Azuma, M.; Takano, M.; Eisaki, H.; Takagi, H.; Uchida, S.; Davis, J. C.			An intrinsic bond-centered electronic glass with unidirectional domains in underdoped cuprates	SCIENCE			English	Article							PHASE-DIAGRAM; STRIPED PHASE; SPIN; LA2-XSRXCUO4; CHARGE; STATES; PLANE	Removing electrons from the CuO2 plane of cuprates alters the electronic correlations sufficiently to produce high-temperature superconductivity. Associated with these changes are spectral-weight transfers from the high-energy states of the insulator to low energies. In theory, these should be detectable as an imbalance between the tunneling rate for electron injection and extraction - a tunneling asymmetry. We introduce atomic-resolution tunneling-asymmetry imaging, finding virtually identical phenomena in two lightly hole-doped cuprates: Ca1.88Na0.12CuO2Cl2 and Bi2Sr2Dy0.2Ca0.8Cu2O8+delta. Intense spatial variations in tunneling asymmetry occur primarily at the planar oxygen sites; their spatial arrangement forms a Cu-O-Cu bond-centered electronic pattern without long-range order but with 4a(0)-wide unidirectional electronic domains dispersed throughout (a(0): the Cu-O-Cu distance). The emerging picture is then of a partial hole localization within an intrinsic electronic glass evolving, at higher hole densities, into complete delocalization and highest-temperature superconductivity.	Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA; Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778651, Japan; Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	Cornell University; University of Tokyo; University of Sherbrooke; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; United States Department of Energy (DOE); Brookhaven National Laboratory	Davis, JC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA.	jcdavis@ccmr.cornell.edu	Kohsaka, Yuhki/A-4428-2009; Lupien, Christian/C-2148-2008; Azuma, Masaki/C-2945-2009; Eisaki, Hiroshi/F-6317-2018; TAKAGI, HIDENORI/Q-1041-2019; Takagi, Hidenori/B-2935-2010; Hanaguri, Tetsuo/I-6710-2012	Kohsaka, Yuhki/0000-0002-6459-2661; Lupien, Christian/0000-0003-1767-8603; Azuma, Masaki/0000-0002-8378-321X; Eisaki, Hiroshi/0000-0002-8299-6416; TAKAGI, HIDENORI/0000-0001-5700-3761; Hanaguri, Tetsuo/0000-0003-2896-0081				Abbamonte P, 2005, NAT PHYS, V1, P155, DOI 10.1038/nphys178; Alvarez G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014514; Anderson PW, 2006, J PHYS CHEM SOLIDS, V67, P1, DOI 10.1016/j.jpcs.2005.10.132; ANDO Y, 1995, PHYS REV LETT, V75, P4662, DOI 10.1103/PhysRevLett.75.4662; Balakirev FF, 2003, NATURE, V424, P912, DOI 10.1038/nature01890; Bozin ES, 2000, PHYS REV LETT, V84, P5856, DOI 10.1103/PhysRevLett.84.5856; Brown SE, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.224512; Capriotti L, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.014508; CHEN CT, 1991, PHYS REV LETT, V66, P104, DOI 10.1103/PhysRevLett.66.104; Chen Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237004; CHO JH, 1992, PHYS REV B, V46, P3179, DOI 10.1103/PhysRevB.46.3179; CHOU FC, 1993, PHYS REV LETT, V71, P2323, DOI 10.1103/PhysRevLett.71.2323; Grafe HJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017002; Haase J, 2002, J SUPERCOND, V15, P339, DOI 10.1023/A:1021014028677; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; HARSHMAN DR, 1988, PHYS REV B, V38, P852, DOI 10.1103/PhysRevB.38.852; Hasselmann N, 1999, PHYS REV LETT, V82, P2135, DOI 10.1103/PhysRevLett.82.2135; Julien MH, 1999, PHYS REV LETT, V83, P604, DOI 10.1103/PhysRevLett.83.604; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; LI L, 2006, J MAGN MAGN MATER, DOI DOI 10.1016/J.JRNRNRN.2006.10.535; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; MEINDERS MBJ, 1993, PHYS REV B, V48, P3916, DOI 10.1103/PhysRevB.48.3916; Niedermayer C, 1998, PHYS REV LETT, V80, P3843, DOI 10.1103/PhysRevLett.80.3843; Ofer R, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.012503; Padilla WJ, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205101; Panagopoulos C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.064501; Parcollet O, 1999, PHYS REV B, V59, P5341, DOI 10.1103/PhysRevB.59.5341; Randeria M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.137001; READ N, 1989, PHYS REV LETT, V62, P1694, DOI 10.1103/PhysRevLett.62.1694; Sanna S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207001; Savici AT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.014524; Schmalian J, 2000, PHYS REV LETT, V85, P836, DOI 10.1103/PhysRevLett.85.836; Singer PM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047602; Smadici S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.075104; TAKAGI H, 1992, PHYS REV LETT, V69, P2975, DOI 10.1103/PhysRevLett.69.2975; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Tranquada JM, 1999, PHYS REV B, V59, P14712, DOI 10.1103/PhysRevB.59.14712; UEMURA YJ, 1988, J PHYS-PARIS, V49, P2087, DOI 10.1051/jphyscol:19888943; White SR, 1998, PHYS REV LETT, V80, P1272, DOI 10.1103/PhysRevLett.80.1272; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418	45	511	515	2	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1380	1385		10.1126/science.1138584	http://dx.doi.org/10.1126/science.1138584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17289939	Green Submitted			2022-12-28	WOS:000244752200024
J	Farb, A; Boam, AB				Farb, Andrew; Boam, Ashley B.			Stent thrombosis redux - The FDA perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Farb, A (corresponding author), US FDA, Intervent Cardiol Devices Branch, Off Device Evaluat, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.							American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; CAMENZIND E, 2006, WORLD C CARD 2006 BA; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Muni NI, 2004, NEW ENGL J MED, V351, P1593, DOI 10.1056/NEJMp048262; Wenaweser P., 2006, WORLD C CARD 2006 BA	5	210	220	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					984	987		10.1056/NEJMp068304	http://dx.doi.org/10.1056/NEJMp068304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296827				2022-12-28	WOS:000244699200002
J	Jin, D; Liu, HX; Hirai, H; Torashima, T; Nagai, T; Lopatina, O; Shnayder, NA; Yamada, K; Noda, M; Seike, T; Fujita, K; Takasawa, S; Yokoyama, S; Koizumi, K; Shiraishi, Y; Tanaka, S; Hashii, M; Yoshihara, T; Higashida, K; Islam, MS; Yamada, N; Hayashi, K; Noguchi, N; Kato, I; Okamoto, H; Matsushima, A; Salmina, A; Munesue, T; Shimizu, N; Mochida, S; Asano, M; Higashida, H				Jin, Duo; Liu, Hong-Xiang; Hirai, Hirokazu; Torashima, Takashi; Nagai, Taku; Lopatina, Olga; Shnayder, Natalia A.; Yamada, Kiyofumi; Noda, Mami; Seike, Toshihiro; Fujita, Kyota; Takasawa, Shin; Yokoyama, Shigeru; Koizumi, Keita; Shiraishi, Yoshitake; Tanaka, Shigenori; Hashii, Minako; Yoshihara, Toru; Higashida, Kazuhiro; Islam, Mohammad Saharul; Yamada, Nobuaki; Hayashi, Kenshi; Noguchi, Naoya; Kato, Ichiro; Okamoto, Hiroshi; Matsushima, Akihiro; Salmina, Alla; Munesue, Toshio; Shimizu, Nobuaki; Mochida, Sumiko; Asano, Masahide; Higashida, Haruhiro			CD38 is critical for social behaviour by regulating oxytocin secretion	NATURE			English	Article							CYCLIC-ADP-RIBOSE; ADENINE-DINUCLEOTIDE PHOSPHATE; RELEASE; CA2+; RECOGNITION; BRAIN; NEUROPEPTIDES; NEUROBIOLOGY; TRANSDUCTION; VASOPRESSIN	CD38, a transmembrane glycoprotein with ADP-ribosyl cyclase activity, catalyses the formation of Ca2+ signalling molecules, but its role in the neuroendocrine system is unknown. Here we show that adult CD38 knockout (CD38(-/-)) female and male mice show marked defects in maternal nurturing and social behaviour, respectively, with higher locomotor activity. Consistently, the plasma level of oxytocin (OT), but not vasopressin, was strongly decreased in CD38(-/-) mice. Replacement of OT by subcutaneous injection or lentiviral-vector-mediated delivery of human CD38 in the hypothalamus rescued social memory and maternal care in CD38(-/-) mice. Depolarization-induced OT secretion and Ca2+ elevation in oxytocinergic neurohypophysial axon terminals were disrupted in CD38(-/-) mice; this was mimicked by CD38 metabolite antagonists in CD38(+/+) mice. These results reveal that CD38 has a key role in neuropeptide release, thereby critically regulating maternal and social behaviours, and may be an element in neurodevelopmental disorders.	Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Cellular Neurophysiol, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Biophys Genet, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Grad Sch Med, Dept Anat, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa 9208640, Japan; Japan Sci & Technol Agcy, SORST, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Nat Sci & Technol, Lab Neuropsychopharmacol, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Inst Nat & Environm Technol, Kanazawa, Ishikawa 9201192, Japan; Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Pathophysiol, Fukuoka 8128582, Japan; Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Adv Biol Sci Regenerat, Sendai, Miyagi 9808575, Japan; Kanazawa Univ Hosp, Cent Clin Lab, Kanazawa, Ishikawa 9208641, Japan; Kanazawa Univ Hosp, Dept Psychiat, Kanazawa, Ishikawa 9208641, Japan; Toyama Univ, Sch Med, Dept Biochem, Toyama 9300194, Japan; Nanao Natl Hosp, Nanao 9208531, Japan; Krasnoyarsk State Med Acad, Dept Med Chem & Biochem, Krasnoyarsk 660022, Russia; Tokyo Med Univ, Dept Physiol, Tokyo, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Kyushu University; Tohoku University; Tohoku University; Kanazawa University; Kanazawa University; University of Toyama; Krasnoyarsk State Medical University; Tokyo Medical University	Higashida, H (corresponding author), Kanazawa Univ, 21st Century COE Program Innovat Brain Sci & Dev, Kanazawa, Ishikawa 9208640, Japan.	haruhiro@med.kanazawa-u.ac.jp	Salmina, Alla B./L-7977-2013; Hirai, Hirokazu/ABP-1143-2022; Lopatina, Olga/I-9610-2014; Noda, Mami/AAC-3949-2020; Yamada, Kiyofumi/I-7487-2014; Nagai, Taku/I-7507-2014; Shnayder, Natalia/M-7084-2014; Sokabe, Masahiro/I-1565-2012; higashida, haruhiro/L-3773-2015	Lopatina, Olga/0000-0002-7884-2721; Yamada, Kiyofumi/0000-0002-5280-5180; Nagai, Taku/0000-0001-5050-7748; Shnayder, Natalia/0000-0002-2840-837X; Hirai, Hirokazu/0000-0002-0721-4293; higashida, haruhiro/0000-0002-1779-0606				Argiolas A, 2005, PROG NEUROBIOL, V76, P1, DOI 10.1016/j.pneurobio.2005.06.002; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BELIN V, 1986, J PHYSIOL-LONDON, V377, P369, DOI 10.1113/jphysiol.1986.sp016192; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Chini EN, 2002, BIOCHEM J, V362, P125, DOI 10.1042/0264-6021:3620125; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; De Flora A, 2004, ANN NY ACAD SCI, V1028, P176, DOI 10.1196/annals.1322.021; Deaglio S, 2006, BLOOD, V108, P1135, DOI 10.1182/blood-2006-01-013003; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gerasimenko JV, 2006, J CELL SCI, V119, P226, DOI 10.1242/jcs.02721; HATTON GI, 1990, PROG NEUROBIOL, V34, P437, DOI 10.1016/0301-0082(90)90017-B; Higashida H, 2001, PHARMACOL THERAPEUT, V90, P283, DOI 10.1016/S0163-7258(01)00142-5; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; Kirsch P, 2005, J NEUROSCI, V25, P11489, DOI 10.1523/JNEUROSCI.3984-05.2005; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; KOSHIYAMA H, 1991, J BIOL CHEM, V266, P16985; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lee HC, 2005, J BIOL CHEM, V280, P33693, DOI 10.1074/jbc.R500012200; Lim MM, 2005, INT J DEV NEUROSCI, V23, P235, DOI 10.1016/j.ijdevneu.2004.05.006; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; OuYang W, 2004, BRAIN RES, V1024, P203, DOI 10.1016/j.brainres.2004.07.068; POPIK P, 1992, PSYCHOPHARMACOLOGY, V106, P71, DOI 10.1007/BF02253591; Russell JA, 2003, FRONT NEUROENDOCRIN, V24, P27, DOI 10.1016/S0091-3022(02)00104-8; Sasaki N, 2005, CELL CALCIUM, V37, P45, DOI 10.1016/j.ceca.2004.06.007; Soares SM, 2005, ENDOCRINOLOGY, V146, P2186, DOI 10.1210/en.2004-1298; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yamashita M, 2002, ENDOCRINOLOGY, V143, P4464, DOI 10.1210/en.2002-220516; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	44	478	485	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					41	45		10.1038/nature05526	http://dx.doi.org/10.1038/nature05526			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17287729				2022-12-28	WOS:000244525600032
J	Coombes, RC; Kilburn, LS; Snowdon, CF; Paridaens, R; Coleman, RE; Jones, SE; Jassem, J; Van de Velde, CJH; Delozier, T; Alvarez, I; Del Mastro, L; Ortmann, O; Diedrich, K; Coates, AS; Bajetta, E; Holmberg, SB; Dodwell, D; Mickiewicz, E; Andersen, J; Lonning, PE; Cocconi, G; Forbes, J; Castiglione, M; Stuart, N; Stewart, A; Fallowfield, LJ; Bertelli, G; Hall, E; Bogle, RG; Carpentieri, M; Colajori, E; Subar, M; Ireland, E; Bliss, JM				Coombes, R. C.; Kilburn, L. S.; Snowdon, C. F.; Paridaens, R.; Coleman, R. E.; Jones, S. E.; Jassem, J.; Van de Velde, C. J. H.; Delozier, T.; Alvarez, I.; Del Mastro, L.; Ortmann, O.; Diedrich, K.; Coates, A. S.; Bajetta, E.; Holmberg, S. B.; Dodwell, D.; Mickiewicz, E.; Andersen, J.; Lonning, P. E.; Cocconi, G.; Forbes, J.; Castiglione, M.; Stuart, N.; Stewart, A.; Fallowfield, L. J.; Bertelli, G.; Hall, E.; Bogle, R. G.; Carpentieri, M.; Colajori, E.; Subar, M.; Ireland, E.; Bliss, J. M.		Intergroup Exemestane Study	Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial	LANCET			English	Article							EARLY BREAST-CANCER; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CONTINUED TAMOXIFEN; ADJUVANT TAMOXIFEN; 1ST-LINE THERAPY; ANASTROZOLE; BIOMARKERS; LETROZOLE; SUPERIOR	Background Early improvements in disease-free survival have been noted when an aromatase inhibitor is given either instead of or sequentially after tamoxifen in postmenopausal women with oestrogen-receptor-positive early breast cancer. However, little information exists on the long-term effects of aromatase inhibitors after treatment, and whether these early improvements lead to real gains in survival. Methods 4724 postmenopausal patients with unilateral invasive, oestrogen-receptor-positive or oestrogen-receptor-unknown breast cancer who were disease-free on 2-3 years of tamoxifen, were randomly assigned to switch to exemestane (n=2352) or to continue tamoxifen (n=2372) for the remainder of a 5-year endocrine treatment period. The primary endpoint was disease-free survival; overall survival was a secondary endpoint. Efficacy analyses were intention-to-treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN11883920. Results After a median follow-up of 55.7 months (range 0-89.7), 809 events contributing to the analysis of disease-free survival had been reported (354 exemestane, 455 tamoxifen); unadjusted hazard ratio 0.76 (95% CI 0.66-0.88, p=0.0001) in favour of exemestane, absolute benefit 3.3% (95% CI 1.6-4.9) by end of treatment (ie, 2.5 years after randomisation). 222 deaths occurred in the exemestane group compared with 261 deaths in the tamoxifen group; unadjusted hazard ratio 0.85 (95% CI 0.71-1.02, p=0.08), 0.83 (0.69-1.00, p=0.05) when 122 patients with oestrogen-receptor-negative disease were excluded. Conclusions Our results suggest that early improvements in disease-free survival noted in patients who switch to exemestane after 2-3 years on tamoxifen persist after treatment, and translate into a modest improvement in overall survival.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Hammersmith Hosp Trust, Canc Res UK,Dept Canc Med,Div Surg Oncol, London W12 0NN, England; Inst Canc Res, Clin Trials & Stat Unit, Sutton, Surrey, England; Univ Ziekenhuis Gasthuisberg, Louvain, Belgium; Weston Pk Hosp, Res Ctr, Sheffield, S Yorkshire, England; US Oncol Res, Houston, TX USA; Med Univ Gdansk, Gdansk, Poland; Leiden Univ, Med Ctr, Leiden, Netherlands; Ctr Francois Baclesse, F-14021 Caen, France; Hosp Nuestra Senora de Aranzazu, San Sebastian, Spain; Natl Inst Canc Res, Genoa, Italy; Univ Regensburg, D-8400 Regensburg, Germany; Univ Med Ctr Schleswig Holstein, Lubeck, Germany; Int Breast Canc Study Grp, Bern, Switzerland; Ist Nazl Studio & Cura Tumori, I-20133 Milan, Italy; Sahlgrenska Univ Hosp Molndal, Molndal, Sweden; Cookridge Hosp, Leeds LS16 6QB, W Yorkshire, England; Inst Angel Roffo, Buenos Aires, DF, Argentina; Aarhus Univ Hosp, DK-8000 Aarhus, Denmark; Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway; Haukeland Hosp, Dept Oncol, Bergen, Norway; Univ Hosp, Parma, Italy; Univ Newcastle, Newcastle Mater Hosp, ANZ Breast Canc Trials Grp, Newcastle, NSW 2308, Australia; Ysbyty Gwynedd, Bangor, Gwynedd, Wales; Christie Hosp, Manchester, Lancs, England; Univ Sussex, Canc Res UK Psychosocial Oncol Grp, Brighton, E Sussex, England; Singleton Hosp, SW Wales Canc Inst, Swansea SA2 8QA, W Glam, Wales; Univ London Imperial Coll Sci Technol & Med, Fac Med, London, England; Pfizer Italia Srl, Clin Oncol R&D, Rome, Italy; Pfizer, Worldwide Med Oncol, New York, NY USA	Cancer Research UK; Imperial College London; University of London; Institute of Cancer Research - UK; KU Leuven; University Hospital Leuven; Weston Park Hospital; US Oncology Network; Fahrenheit Universities; Medical University Gdansk; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UNICANCER; Centre Francois Baclesse; University of Genoa; IRCCS AOU San Martino IST; University of Regensburg; University of Kiel; Schleswig Holstein University Hospital; International Breast Cancer Study Group; Fondazione IRCCS Istituto Nazionale Tumori Milan; Sahlgrenska University Hospital; Cookridge Hospital; Aarhus University; University of Bergen; University of Bergen; Haukeland University Hospital; University of Parma; University Hospital of Parma; Calvary Mater Newcastle Hospital; University of Newcastle; Christie NHS Foundation Trust; Christie Hospital; Cancer Research UK; University of Sussex; Singleton Hospital; Swansea University; Imperial College London; Pfizer; Pfizer	Coombes, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Hammersmith Hosp Trust, Canc Res UK,Dept Canc Med,Div Surg Oncol, London W12 0NN, England.	c.coombes@imperial.ac.uk	Del Mastro, Lucia/J-6163-2016	Del Mastro, Lucia/0000-0002-9546-5841; Lonning, Per Eystein/0000-0002-8890-6303; Hall, Emma/0000-0001-5999-5020; Bogle, Richard/0000-0002-8300-3367; Coombes, Raoul Charles/0000-0002-4811-1100; Bliss, Judith/0000-0001-7957-7424; Kilburn, Lucy/0000-0002-1987-7545				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Bonneterre J, 2001, CANCER, V92, P2247, DOI 10.1002/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coleman RE, 2007, LANCET ONCOL, V8, P119, DOI 10.1016/S1470-2045(07)70003-7; *COMB TRIAL GROUP, 2006, LANCET ONCOL, V7, P633; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cuzick J, 2006, BRIT J CANCER, V94, P460, DOI 10.1038/sj.bjc.6602964; Fallowfield LJ, 2006, J CLIN ONCOL, V24, P910, DOI 10.1200/JCO.2005.03.3654; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Ingle JN, 2006, J CLIN ONCOL, V24, P1052, DOI 10.1200/JCO.2005.04.1053; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; Lonning PE, 2005, J CLIN ONCOL, V23, P5126, DOI 10.1200/JCO.2005.07.097; Mamounas EP, 2001, ONCOLOGY-NY, V15, P35; Milla-Santos A, 2003, AM J CLIN ONCOL-CANC, V26, P317, DOI 10.1097/00000421-200306000-00022; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Paridaens R, 2003, ANN ONCOL, V14, P1391, DOI 10.1093/annonc/mdg362; Piccart-Gebhart MJ, 2004, NEW ENGL J MED, V350, P1140, DOI 10.1056/NEJMe048037; Punglia RS, 2005, J CLIN ONCOL, V23, P5178, DOI 10.1200/JCO.2005.02.964; REA D, PHASE 3 RANDOMIZED S	23	663	687	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					559	570		10.1016/S0140-6736(07)60200-1	http://dx.doi.org/10.1016/S0140-6736(07)60200-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138MZ	17307102				2022-12-28	WOS:000244368000029
J	Heath, I				Heath, Iona			Out of hours primary care - a shambles?	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					341	341		10.1136/bmj.39125.448287.59	http://dx.doi.org/10.1136/bmj.39125.448287.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303877	Green Published			2022-12-28	WOS:000244560400026
J	Cahen, DL; Gouma, DJ; Nio, Y; Rauws, EAJ; Boermeester, MA; Busch, OR; Stoker, J; Lameris, JS; Dijkgraaf, MGW; Huibregtse, K; Bruno, MJ				Cahen, Djuna L.; Gouma, Dirk J.; Nio, Yung; Rauws, Erik A. J.; Boermeester, Marja A.; Busch, Olivier R.; Stoker, Jaap; Lameris, Johan S.; Dijkgraaf, Marcel G. W.; Huibregtse, Kees; Bruno, Marco J.			Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERM-FOLLOW-UP; DUODENUM-PRESERVING RESECTION; LATERAL PANCREATICOJEJUNOSTOMY; LONGITUDINAL PANCREATICOJEJUNOSTOMY; LOCAL RESECTION; CLASSIFICATION; HEAD; IMMEDIATE; THERAPY; DISEASE	BACKGROUND For patients with chronic pancreatitis and a dilated pancreatic duct, ductal decompression is recommended. We conducted a randomized trial to compare endoscopic and surgical drainage of the pancreatic duct. METHODS All symptomatic patients with chronic pancreatitis and a distal obstruction of the pancreatic duct but without an inflammatory mass were eligible for the study. We randomly assigned patients to undergo endoscopic transampullary drainage of the pancreatic duct or operative pancreaticojejunostomy. The primary end point was the average Izbicki pain score during 2 years of follow-up. The secondary end points were pain relief at the end of follow-up, physical and mental health, morbidity, mortality, length of hospital stay, number of procedures undergone, and changes in pancreatic function. RESULTS Thirty-nine patients underwent randomization: 19 to endoscopic treatment (16 of whom underwent lithotripsy) and 20 to operative pancreaticojejunostomy. During the 24 months of follow-up, patients who underwent surgery, as compared with those who were treated endoscopically, had lower Izbicki pain scores (25 vs. 51, P<0.001) and better physical health summary scores on the Medical Outcomes Study 36-Item Short-Form General Health Survey questionnaire (P=0.003). At the end of follow-up, complete or partial pain relief was achieved in 32% of patients assigned to endoscopic drainage as compared with 75% of patients assigned to surgical drainage (P=0.007). Rates of complications, length of hospital stay, and changes in pancreatic function were similar in the two treatment groups, but patients receiving endoscopic treatment required more procedures than did patients in the surgery group (a median of eight vs. three, P<0.001). CONCLUSIONS Surgical drainage of the pancreatic duct was more effective than endoscopic treatment in patients with obstruction of the pancreatic duct due to chronic pancreatitis.	Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Biostat, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cahen, DL (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	djca@zha.nl	cahen, djuna/AAC-4037-2020; Dijkgraaf, Marcel GW/G-6663-2011; Stoker, Jaap/AAH-7597-2019; Busch, Olivier/AAC-3650-2020	Stoker, Jaap/0000-0002-9822-3784; 				ADAMS DB, 1994, ANN SURG, V219, P481, DOI 10.1097/00000658-199405000-00006; Binmoeller KF, 1995, ENDOSCOPY, V27, P638, DOI 10.1055/s-2007-1005780; BLOECHLE C, 1995, PANCREAS, V11, P77, DOI 10.1097/00006676-199507000-00008; Boerma D, 2002, EUR J SURG, V168, P223, DOI 10.1080/11024150260102834; CREMER M, 1991, ENDOSCOPY, V23, P171, DOI 10.1055/s-2007-1010649; DELHAYE M, 1992, GASTROENTEROLOGY, V102, P610, DOI 10.1016/0016-5085(92)90110-K; Delhaye Myriam, 2003, Gastrointest Endosc Clin N Am, V13, P717, DOI 10.1016/S1052-5157(03)00070-9; Deviere J, 1998, Gastrointest Endosc Clin N Am, V8, P163; Dite P, 2003, ENDOSCOPY, V35, P553; Dumonceau JM, 1996, GASTROINTEST ENDOSC, V43, P547, DOI 10.1016/S0016-5107(96)81583-5; Eleftheriadis N, 2005, ENDOSCOPY, V37, P223, DOI 10.1055/s-2005-860988; FREY CF, 1994, ANN SURG, V220, P492, DOI 10.1097/00000658-199410000-00008; Frey CF, 2003, WORLD J SURG, V27, P1217, DOI 10.1007/s00268-003-7241-z; Gabbrielli A, 2005, GASTROINTEST ENDOSC, V61, P576, DOI 10.1016/S0016-5107(05)00295-6; Gabbrielli A, 2002, GASTROINTEST ENDOSC, V55, P488, DOI 10.1067/mge.2002.122651; Hammarstrom LE, 1997, EUR J SURG, V163, P577; Izbicki JR, 1998, ANN SURG, V227, P213, DOI 10.1097/00000658-199802000-00010; Kalady MF, 2001, AM SURGEON, V67, P478; Lucas CE, 1999, SURGERY, V126, P790, DOI 10.1016/S0039-6060(99)70137-6; Madura JA, 2003, ARCH SURG-CHICAGO, V138, P644, DOI 10.1001/archsurg.138.6.644; Morgan DE, 2003, AM J GASTROENTEROL, V98, P821, DOI 10.1016/S0002-9270(03)00045-5; PARTINGTON PF, 1960, ANN SURG, V152, P1037, DOI 10.1097/00000658-196012000-00015; PONCHON T, 1995, GASTROINTEST ENDOSC, V42, P452, DOI 10.1016/S0016-5107(95)70049-8; Renou C, 2000, INT J PANCREATOL, V27, P143, DOI 10.1385/IJGC:27:2:143; Rios G A, 1998, J Gastrointest Surg, V2, P223, DOI 10.1016/S1091-255X(98)80016-4; Rosch T, 2002, ENDOSCOPY, V34, P765, DOI 10.1055/s-2002-34256; SARNER M, 1984, GUT, V25, P756, DOI 10.1136/gut.25.7.756; Schnelldorfer T, 2003, AM SURGEON, V69, P1041; Sielezneff I, 2000, EUR J SURG, V166, P58; SINGER MV, 1985, GASTROENTEROLOGY, V89, P683, DOI 10.1016/0016-5085(85)90468-8; SMITS ME, 1995, GASTROINTEST ENDOSC, V42, P461, DOI 10.1016/S0016-5107(95)70051-X; Strate T, 2005, ANN SURG, V241, P591, DOI 10.1097/01.sla.0000157268.78543.03; Tantia O, 2004, SURG ENDOSC, V18, P1054, DOI 10.1007/s00464-003-9210-x; Vitale GC, 2004, SURG ENDOSC, V18, P1431, DOI 10.1007/s00464-003-8933-z; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wolters U, 1996, BRIT J ANAESTH, V77, P217, DOI 10.1093/bja/77.2.217	36	479	523	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					676	684		10.1056/NEJMoa060610	http://dx.doi.org/10.1056/NEJMoa060610			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301298	Bronze			2022-12-28	WOS:000244193300005
J	Siekmann, AF; Lawson, ND				Siekmann, Arndt F.; Lawson, Nathan D.			Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries	NATURE			English	Article							EMBRYONIC VASCULAR DEVELOPMENT; ENDOTHELIAL-GROWTH-FACTOR; EXPRESSION; ACTIVATION; PATHWAY; DIFFERENTIATION; SUPPRESSOR; RECEPTORS; HAIRLESS	Recent evidence indicates that growing blood-vessel sprouts consist of endothelial cells with distinct cell fates and behaviours(1,2); however, it is not clear what signals determine these sprout cell characteristics. Here we show that Notch signalling is necessary to restrict angiogenic cell behaviour to tip cells in developing segmental arteries in the zebrafish embryo. In the absence of the Notch signalling component Rbpsuh ( recombining binding protein suppressor of hairless) we observed excessive sprouting of segmental arteries, whereas Notch activation suppresses angiogenesis. Through mosaic analysis we find that cells lacking Rbpsuh preferentially localize to the terminal position in developing sprouts. In contrast, cells in which Notch signalling has been activated are excluded from the tip-cell position. In vivo time-lapse analysis reveals that endothelial tip cells undergo a stereotypical pattern of proliferation and migration during sprouting. In the absence of Notch, nearly all sprouting endothelial cells exhibit tip-cell behaviour, leading to excessive numbers of cells within segmental arteries. Furthermore, we find that flt4 (fms-related tyrosine kinase 4, also called vegfr3) is expressed in segmental artery tip cells and becomes ectopically expressed throughout the sprout in the absence of Notch. Loss of flt4 can partially restore normal endothelial cell number in Rbpsuh-deficient segmental arteries. Finally, loss of the Notch ligand dll4 (delta-like 4) also leads to an increased number of endothelial cells within segmental arteries. Together, these studies indicate that proper specification of cell identity, position and behaviour in a developing blood-vessel sprout is required for normal angiogenesis, and implicate the Notch signalling pathway in this process.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Lawson, ND (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Lazare Res Bldg,364 Plantat St, Worcester, MA 01605 USA.	nathan.lawson@umassmed.edu	Siekmann, Arndt/AAE-4769-2021	Lawson, Nathan/0000-0001-7788-9619; Siekmann, Arndt/0000-0001-6972-2173				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Childs S, 2002, DEVELOPMENT, V129, P973; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Roman BL, 2002, DEVELOPMENT, V129, P3009; Salameh A, 2005, BLOOD, V106, P3423, DOI 10.1182/blood-2005-04-1388; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Shutter JR, 2000, GENE DEV, V14, P1313; Sieger D, 2003, MECH DEVELOP, V120, P1083, DOI 10.1016/S0925-4773(03)00154-0; Smithers L, 2000, MECH DEVELOP, V90, P119, DOI 10.1016/S0925-4773(99)00231-2; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Westerfield M, 1993, ZEBRAFISH BOOK; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000	24	498	533	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					781	784		10.1038/nature05577	http://dx.doi.org/10.1038/nature05577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259972				2022-12-28	WOS:000244205200048
J	Shuster, E				Shuster, Evelyne			Microarray genetic screening: a prenatal roadblock for life?	LANCET			English	Article							DIAGNOSIS; DNA		Philadelphia Vet Affairs Med Ctr, Off Med Eth, Philadelphia, PA USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania	Shuster, E (corresponding author), Philadelphia Dept Vet Affairs, Univ & Woodland Ave, Philadelphia, PA 19104 USA.	Evelyn.shuster@med.va.gov						American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Annas G., 1998, SOME CHOICE LAW MED; ANNAS GJ, 1975, FAM LAW QUART, V9, P463; Asch A, 1999, AM J PUBLIC HEALTH, V89, P1649, DOI 10.2105/AJPH.89.11.1649; ASCH A, 2006, 7 ANN JOINT APPL URB; ASCH A, 2003, FLORIDA STATE U L RE, V315, P47; *BAYL COLL MED, CHROM MICR AN; BOTKIN JR, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3562793; Buchanan Allen, 2001, CHANCE CHOICE GENETI; Canguilhem G., 2012, NORMAL PATHOLOGICAL, V3; Check E, 2005, NATURE, V438, P733, DOI 10.1038/438733a; *COMM STUD INB ERR, 1975, GEN SCREEN PROGR PRI; Cremonesi L, 2004, ANN NY ACAD SCI, V1022, P105, DOI 10.1196/annals.1318.017; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Haddow JE, 1993, ESSENTIALS PRENATAL, P185; HARMON A, 2004, NY TIMES NEW YO 0620; Henn W, 1999, J MED ETHICS, V25, P200, DOI 10.1136/jme.25.2.200; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Larrabee PB, 2004, AM J HUM GENET, V75, P485, DOI 10.1086/423288; NELSON JP, 2006, BMJ-BRIT MED J, V332, P443; NISAND MI, 2000, P INT S BIOETH RIGHT, P31; Rawls J., 1971, THEORY JUSTICE; REGALADO A, 2006, WALL STREET J N 0414; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; SHUSTER E, 2001, J LAW MED ETHICS, V29, P35; SHUSTER E, 1992, GENE MAPPING USING L, P115; Stone JH, 2006, NEW ENGL J MED, V354, P2748, DOI 10.1056/NEJMp058264; Suter SM, 2002, AM J LAW MED, V28, P233; TESTART J, 2004, VONT VALEURS, P365; WADE N, 2006, NY TIMES NEW YO 0718	31	53	53	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					526	529		10.1016/S0140-6736(07)60239-6	http://dx.doi.org/10.1016/S0140-6736(07)60239-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292772				2022-12-28	WOS:000244188300035
J	Stephanopoulos, G				Stephanopoulos, Gregory			Challenges in engineering microbes for biofuels production	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; ETHANOL; PATHWAY	Economic and geopolitical factors ( high oil prices, environmental concerns, and supply instability) have been prompting policy-makers to put added emphasis on renewable energy sources. For the scientific community, recent advances, embodied in new insights into basic biology and technology that can be applied to metabolic engineering, are generating considerable excitement. There is justified optimism that the full potential of biofuel production from cellulosic biomass will be obtainable in the next 10 to 15 years.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Stephanopoulos, G (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	gregstep@mit.edu						Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; BAILEY JE, 1991, SCIENCE, V252, P1668, DOI 10.1126/science.2047876; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; *DEP EN, 2005, BIOM BIOF ROADM EN F; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; Kuyper M, 2003, FEMS YEAST RES, V4, P69, DOI 10.1016/S1567-1356(03)00141-7; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MCFARLAND KC, 2006, WORLD C IND BIOT BIO; PATNAIK R, 1995, BIOTECHNOL BIOENG, V46, P361, DOI 10.1002/bit.260460409; STEPHANOPOULOS G, 1993, TRENDS BIOTECHNOL, V11, P392, DOI 10.1016/0167-7799(93)90099-U; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Stephanopoulos G, 2002, AICHE J, V48, P920, DOI 10.1002/aic.690480502; Takagi M, 1977, P BIOCONVERSION S, P551; ZHANG M, 1995, SCIENCE, V267, P240, DOI 10.1126/science.267.5195.240	16	540	583	3	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					801	804		10.1126/science.1139612	http://dx.doi.org/10.1126/science.1139612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289987				2022-12-28	WOS:000244069000055
J	Doerschuk, CM				Doerschuk, Claire M.			Pulmonary alveolar proteinosis - Is host defense awry?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLONY-STIMULATING FACTOR		Rainbow Babies & Childrens Hosp, Dept Pediat, Div Integrat Biol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	Doerschuk, CM (corresponding author), Rainbow Babies & Childrens Hosp, Dept Pediat, Div Integrat Biol, 2101 Adelbert Rd, Cleveland, OH 44106 USA.							DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Kato T, 2006, INT J HEMATOL, V84, P205, DOI 10.1532/IJH97.06141; Nakata K, 2006, RESPIROLOGY, V11, pS65, DOI 10.1111/j.1440-1843.2006.00812.x; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592	5	12	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					547	549		10.1056/NEJMp068259	http://dx.doi.org/10.1056/NEJMp068259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287475	Green Published			2022-12-28	WOS:000244012700003
J	Snow, V; Qaseem, A; Barry, P; Hornbake, ER; Rodnick, JE; Tobolic, T; Ireland, B; Segal, JB; Bass, EB; Weiss, KB; Green, L; Owens, DK				Snow, Vincenza; Qaseem, Amir; Barry, Patricia; Hornbake, E. Rodney; Rodnick, Jonathan E.; Tobolic, Timothy; Ireland, Belinda; Segal, Jodi B.; Bass, Eric B.; Weiss, Kevin B.; Green, Lee; Owens, Douglas K.		Joint Amer Acad Family Phys	Management of venous thromboembolism: A clinical practice guideline from the American college of physicians and the American academy of family physicians	ANNALS OF INTERNAL MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; CATHETER-DIRECTED THROMBOLYSIS; ORAL ANTICOAGULANT-THERAPY; LONG-TERM TREATMENT; VENA-CAVAL FILTERS; UNFRACTIONATED HEPARIN; OUTPATIENT TREATMENT; HOME TREATMENT; PULMONARY-EMBOLISM	Venous thromboembolism is a common condition affecting 7.1 persons per 10 000 person-years among community residents. Incidence rates for venous thromboembolism are higher in men and African Americans and increase substantially with age. It is critical to treat deep venous thrombosis at an early stage to avoid development of further complications, such as pulmonary embolism or recurrent deep venous thrombosis. The target audience for this guideline is all clinicians caring for patients who have been given a diagnosis of deep venous thrombosis or pulmonary embolism. The target patient population is patients receiving a diagnosis of pulmonary embolism or lower-extremity deep venous thrombosis.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Merck Inst Aging & Hlth, Gloucester Point, VA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Amer Acad Family Physicians, Leawood, KS USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; Northwestern Univ, Chicago, IL 60611 USA; Hines Vet Affairs Hosp, Chicago, IL USA; Univ Michigan, Ann Arbor, MI 48109 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA; Stanford Univ, Stanford, CA 94305 USA	American College of Physicians; Merck & Company; University of California System; University of California San Francisco; Johns Hopkins University; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.		; Casey, Donald/AFM-6658-2022	Bass, Eric/0000-0001-9106-527X; Peterson, Kevin/0000-0002-6914-8586; Casey, Donald/0000-0002-3820-598X				Aburahma A F, 1993, W V Med J, V89, P445; AbuRahma AF, 2001, J VASC SURG, V33, P375, DOI 10.1067/mva.2001.111488; AbuRahma AF, 1999, AM SURGEON, V65, P164; Ageno W, 2002, HAEMATOLOGICA, V87, P286; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Barbour L A, 2001, Int J Gynaecol Obstet, V75, P203; Belcaro G, 1999, ANGIOLOGY, V50, P781; Bjarnason H, 1997, J VASC INTERV RADIOL, V8, P405, DOI 10.1016/S1051-0443(97)70581-5; Boccalon H, 2000, ARCH INTERN MED, V160, P1769, DOI 10.1001/archinte.160.12.1769; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brewer D, 1998, J FAM PRACTICE, V47, P185; Castaneda F, 2002, J VASC INTERV RADIOL, V13, P577, DOI 10.1016/S1051-0443(07)61650-9; Comerota AJ, 2000, J VASC SURG, V32, P130, DOI 10.1067/mva.2000.105664; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Dolovich M, 1997, PEDIATR PULM, P184; Ebell MH, 2004, AM FAM PHYSICIAN, V69, P548; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; *EX LOW INT ANT TH, 2003, NEW ENGL J MED, V349, P631; Ginsberg JS, 2001, ARCH INTERN MED, V161, P2105, DOI 10.1001/archinte.161.17.2105; Gonzalez-Fajardo JA, 1999, J VASC SURG, V30, P283, DOI 10.1016/S0741-5214(99)70139-4; Gould MK, 1999, ANN INTERN MED, V130, P789, DOI 10.7326/0003-4819-130-10-199905180-00002; Grau E, 2001, AM J HEMATOL, V67, P10, DOI 10.1002/ajh.1069; GREEN D, 1994, PHARMACOL REV, V46, P89; Grunwald MR, 2004, J VASC INTERV RADIOL, V15, P347, DOI 10.1097/01.RVI.0000121407.46920.15; Hann CL, 2005, BLOOD REV, V19, P179, DOI 10.1016/j.blre.2004.08.002; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Hettiarachchi R J, 1998, Curr Opin Pulm Med, V4, P220, DOI 10.1097/00063198-199807000-00007; HIRSH J, 1995, THROMB HAEMOSTASIS, V74, P360; Howard PA, 1997, ANN PHARMACOTHER, V31, P192, DOI 10.1177/106002809703100212; Huse DM, 2002, AM J MANAG CARE, V8, pS10; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kakkar VV, 2003, THROMB HAEMOSTASIS, V89, P674; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Lapidus L, 2002, PATHOPHYSIOL HAEMO T, V32, P59, DOI 10.1159/000065077; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lepercq J, 2001, BRIT J OBSTET GYNAEC, V108, P1134, DOI 10.1111/j.1471-0528.2003.00272.x; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Lopez-Beret P, 2001, J VASC SURG, V33, P77, DOI 10.1067/mva.2001.109336; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Monreal M, 1998, HAEMOSTASIS, V28, P236; O'Brien JA, 2002, PHARMACOECONOMICS, V20, P603, DOI 10.2165/00019053-200220090-00004; Ouriel K, 2000, J VASC INTERV RADIOL, V11, P849, DOI 10.1016/S1051-0443(07)61799-0; Pearson S D, 1999, Eff Clin Pract, V2, P210; Pinede L, 2001, CIRCULATION, V103, P2453; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; QASEEM A, 2007, IN PRESS ANN FAM MED; Raju S, 1998, J Miss State Med Assoc, V39, P81; Raschke R, 2003, ANN INTERN MED, V138, P720, DOI 10.7326/0003-4819-138-9-200305060-00008; Razavi MK, 2002, J ENDOVASC THER, V9, P593, DOI 10.1583/1545-1550(2002)009<0593:ICROTT>2.0.CO;2; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rocha E, 2000, HAEMATOLOGICA, V85, P935; Rodger MA, 2003, THROMB RES, V112, P13, DOI 10.1016/j.thromres.2003.09.027; Rymes NL, 2002, CLIN LAB HAEMATOL, V24, P165, DOI 10.1046/j.1365-2257.2002.00440.x; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Segal J B, 2003, Evid Rep Technol Assess (Summ), P1; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Smith BJ, 2002, INTERN MED J, V32, P29, DOI 10.1046/j.1445-5994.2002.00146.x; Smith MP, 2004, AM J OBSTET GYNECOL, V190, P495, DOI 10.1016/S0002-9378(03)00953-0; Spyropoulos AC, 2002, CHEST, V122, P108, DOI 10.1378/chest.122.1.108; Sugimoto K, 2003, J VASC SURG, V37, P512, DOI 10.1067/mva.2003.41; van Den Belt AG, 2000, COCHRANE DB SYST REV; van der Heijden JF, 2000, THROMB RES, V100, pV121; Veiga F, 2000, THROMB HAEMOSTASIS, V84, P559; Vinson DR, 2001, ANN EMERG MED, V37, P251, DOI 10.1067/mem.2001.113703; White RH, 2000, ARCH INTERN MED, V160, P2033, DOI 10.1001/archinte.160.13.2033	77	125	142	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					204	210		10.7326/0003-4819-146-3-200702060-00149	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00149			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17261857				2022-12-28	WOS:000243957400007
J	Both, C				Both, Christiaan			Comment on "Rapid advance of spring arrival dates in long-distance migratory birds"	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; MIGRANT		Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolut Studies, NL-9750 AA Haren, Netherlands	University of Groningen	Both, C (corresponding author), Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolut Studies, POB 14, NL-9750 AA Haren, Netherlands.	c.both@rug.nl	Both, Christiaan/E-6459-2011	Both, Christiaan/0000-0001-7099-9831				Both C, 2005, J AVIAN BIOL, V36, P368, DOI 10.1111/j.0908-8857.2005.03484.x; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Hagemeijer E.J.M., 1997, EBCC ATLAS EUROPEAN; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Moller AP, 2005, J EVOLUTION BIOL, V18, P481, DOI 10.1111/j.1420-9101.2004.00807.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; ZINK G, 1973, EUROPAISCHER SINGVOG	13	28	28	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812								10.1126/science.1136148	http://dx.doi.org/10.1126/science.1136148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272705	Green Submitted			2022-12-28	WOS:000243909400022
J	Kaldis, P				Kaldis, Philipp			Another piece of the p27(Kip1) puzzle	CELL			English	Review							KINASE INHIBITOR P27; SUBCELLULAR-LOCALIZATION; DEPENDENT DEGRADATION; CDK INHIBITORS; MICE LACKING; HYPERPLASIA; COMPLEXES; PATHWAY; PHASE; G1	How extracellular signals communicate with the cell cycle is poorly understood. In this issue, two papers (Grimmler et al., 2007; Chu et al., 2007) address this problem by reporting phosphorylation of the cyclin-dependent kinase inhibitor p27(Kip1) on a tyrosine residue by nonreceptor tyrosine kinases, which decreases p27 stability. This new mechanism could explain how cells enter the cell cycle from a quiescent state.	NCI, Mouse Canc Genet Program, Canc Res Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kaldis, P (corresponding author), NCI, Mouse Canc Genet Program, Canc Res Ctr, Bldg 560-22-56,1050 Boyles St, Frederick, MD 21702 USA.	kaldis@ncifcrf.gov	Kaldis, Philipp/G-2714-2010	Kaldis, Philipp/0000-0002-7247-7591	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01SC010367] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; CHU I, 2007, CELL; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; GRIMMLER M, 2007, CELL; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Loda M, 1997, NAT MED, V3, P231, DOI 10.1038/nm0297-231; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Timmerbeul I, 2006, P NATL ACAD SCI USA, V103, P14009, DOI 10.1073/pnas.0606316103; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334	21	55	57	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					241	244		10.1016/j.cell.2007.01.006	http://dx.doi.org/10.1016/j.cell.2007.01.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254963	Bronze			2022-12-28	WOS:000244420500010
J	Erkko, H; Xia, B; Nikkilae, J; Schleutker, J; Syrjaekoski, K; Mannermaa, A; Kallioniemi, A; Pylkas, K; Karppinen, SM; Rapakko, K; Miron, A; Sheng, Q; Li, GL; Mattila, H; Bell, DW; Haber, DA; Grip, M; Reiman, M; Jukkola-Vuorinen, A; Mustonen, A; Kere, J; Aaltonen, LA; Kosma, VM; Kataja, V; Soini, Y; Drapkin, RI; Livingston, DM; Winqvist, R				Erkko, Hannele; Xia, Bing; Nikkilae, Jenni; Schleutker, Johanna; Syrjaekoski, Kirsi; Mannermaa, Arto; Kallioniemi, Anne; Pylkas, Katri; Karppinen, Sanna-Maria; Rapakko, Katrin; Miron, Alexander; Sheng, Qing; Li, Guilan; Mattila, Henna; Bell, Daphne W.; Haber, Daniel A.; Grip, Mervi; Reiman, Mervi; Jukkola-Vuorinen, Arja; Mustonen, Aki; Kere, Juha; Aaltonen, Lauri A.; Kosma, Veli-Matti; Kataja, Vesa; Soini, Ylermi; Drapkin, Ronny I.; Livingston, David M.; Winqvist, Robert			A recurrent mutation in PALB2 in Finnish cancer families	NATURE			English	Article							SENSITIVE GEL-ELECTROPHORESIS; BREAST; BRCA2	BRCA1, BRCA2 and other known susceptibility genes account for less than half of the detectable hereditary predisposition to breast cancer(1-3). Other relevant genes therefore remain to be discovered. Recently a new BRCA2-binding protein, PALB2, was identified(4). The BRCA2-PALB2 interaction is crucial for certain key BRCA2 DNA damage response functions as well as its tumour suppression activity(4). Here we show, by screening for PALB2 mutations in Finland that a frameshift mutation, c.1592delT, is present at significantly elevated frequency in familial breast cancer cases compared with ancestry-matched population controls. The truncated PALB2 protein caused by this mutation retained little BRCA2-binding capacity and was deficient in homologous recombination and crosslink repair. Further screening of c.1592delT in unselected breast cancer individuals revealed a roughly fourfold enrichment of this mutation in patients compared with controls. Most of the mutation-positive unselected cases had a familial pattern of disease development. In addition, one multigenerational prostate cancer family that segregated the c.1592delT truncation allele was observed. These results indicate that PALB2 is a breast cancer susceptibility gene that, in a suitably mutant form, may also contribute to familial prostate cancer development.	Univ Kuopio, Inst Clin Med, FIN-70211 Kuopio, Finland; Karolinska Inst, Dept Biosci, SE-17177 Huddinge, Sweden; Karolinska Inst, Clin Res Ctr, SE-17177 Huddinge, Sweden; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Biomedicum Helsinki, FIN-00014 Helsinki, Finland; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Kuopio Univ Hosp, Dept Clin Pathol, FIN-70211 Kuopio, Finland; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FIN-70211 Kuopio, Finland; Univ Tampere, Inst Med technol, Canc Genet Lab, FIN-33520 Tampere, Finland; Tampere Univ Hosp, Tampere, Finland; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Oulu Univ Hosp, FIN-90029 OYS, Finland; Univ Oulu, Dept Pathol, Oulu, Finland; Univ Oulu, Dept Oncol, Oulu, Finland; Univ Oulu, Dept Surg, Oulu, Finland; Univ Oulu, Dept Clin Genet, Oulu, Finland	University of Eastern Finland; Karolinska Institutet; Karolinska Institutet; University of Helsinki; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; Tampere University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Winqvist, R (corresponding author), Kuopio Univ Hosp, Dept Oncol, FIN-70211 Kuopio, Finland.	david_livingston@dfci.harvard.edu; robert.winqvist@oulu.fi	Aaltonen, Lauri/A-5375-2010; Drapkin, Ronny/E-9944-2016; Kere, Juha/AAX-9117-2021; xin, xp/C-7350-2009; Kere, Juha/A-9179-2008	Aaltonen, Lauri/0000-0001-6839-4286; Drapkin, Ronny/0000-0002-6912-6977; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Kataja, Vesa/0000-0003-4846-4843; Winqvist, Robert/0000-0003-0932-9104; Schleutker, Johanna/0000-0002-1863-0305; Pylkas, Katri/0000-0002-2449-0521; Kallioniemi, Anne/0000-0003-3552-8158; Karppinen, Sanna/0000-0001-6233-9075				Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Borg A, 2001, SEMIN CANCER BIOL, V11, P375, DOI 10.1006/scbi.2001.0393; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Hedenfalk I, 2003, P NATL ACAD SCI USA, V100, P2532, DOI 10.1073/pnas.0533805100; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sarantaus L, 2000, EUR J HUM GENET, V8, P757, DOI 10.1038/sj.ejhg.5200529; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Syrjakoski K, 2000, J NATL CANCER I, V92, P1529, DOI 10.1093/jnci/92.18.1529; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	16	339	348	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					316	319		10.1038/nature05609	http://dx.doi.org/10.1038/nature05609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17287723				2022-12-28	WOS:000244892900045
J	Novoselov, KS; Jiang, Z; Zhang, Y; Morozov, SV; Stormer, HL; Zeitler, U; Maan, JC; Boebinger, GS; Kim, P; Geim, AK				Novoselov, K. S.; Jiang, Z.; Zhang, Y.; Morozov, S. V.; Stormer, H. L.; Zeitler, U.; Maan, J. C.; Boebinger, G. S.; Kim, P.; Geim, A. K.			Room-temperature quantum hall effect in graphene	SCIENCE			English	Article									Univ Manchester, Dept Phys, Manchester M13 9PL, Lancs, England; Columbia Univ, Dept Phys, New York, NY 10027 USA; Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; Univ Nijmegen St Radboud Hosp, High Field Magnet Lab, NL-6525 ED Nijmegen, Netherlands	University of Manchester; Columbia University; State University System of Florida; Florida State University; Radboud University Nijmegen	Kim, P (corresponding author), Univ Manchester, Dept Phys, Manchester M13 9PL, Lancs, England.	pkim@phys.columbia.edu; geim@man.ac.uk	Zeitler, Uli/P-5607-2019; Geim, Andre K/J-7888-2012; Kim, Philip/N-1886-2013; Zeitler, Uli/D-4344-2012; Morozov, Sergey V/H-3171-2014; Novoselov, Kostya S/G-9581-2014; Maan, Jan Cornelis/D-4952-2012	Geim, Andre K/0000-0003-2861-8331; Kim, Philip/0000-0002-8255-0086; Zeitler, Uli/0000-0002-5293-2673; Morozov, Sergey V/0000-0003-3075-7787; Novoselov, Kostya S/0000-0003-4972-5371; hai yan, he/0000-0003-0366-6185	Engineering and Physical Sciences Research Council [EP/C511875/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Jeckelmann B, 2001, REP PROG PHYS, V64, P1603, DOI 10.1088/0034-4885/64/12/201; Landwehr G, 2000, PHYSICA E, V6, P713, DOI 10.1016/S1386-9477(99)00179-4; Murphy SQ, 2000, PHYSICA E, V6, P293, DOI 10.1016/S1386-9477(99)00157-5; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Sarma Sankar Das, 1997, PERSPECTIVES QUANTUM; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	6	2397	2534	40	1304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1379	1379		10.1126/science.1137201	http://dx.doi.org/10.1126/science.1137201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17303717	Green Submitted			2022-12-28	WOS:000244752200023
J	Morris, CA; Moazed, D				Morris, Corey A.; Moazed, Danesh			Centromere assembly and propagation	CELL			English	Review							HETEROCHROMATIN; CHROMATIN; LOCALIZATION; DROSOPHILA		Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Morris, CA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	cmorris@hms.harvard.edu; danesh@hms.harvard.edu						Annunziato AT, 2005, J BIOL CHEM, V280, P12065, DOI 10.1074/jbc.R400039200; Baum M, 2006, P NATL ACAD SCI USA, V103, P14877, DOI 10.1073/pnas.0606958103; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083	19	53	57	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					647	650		10.1016/j.cell.2007.02.002	http://dx.doi.org/10.1016/j.cell.2007.02.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320502	Bronze			2022-12-28	WOS:000245098600007
J	Schuettengruber, B; Chourrout, D; Vervoort, M; Leblanc, B; Cavalli, G				Schuettengruber, Bernd; Chourrout, Daniel; Vervoort, Michel; Leblanc, Benjamin; Cavalli, Giacomo			Genome regulation by polycomb and trithorax proteins	CELL			English	Review							DNA-BINDING PROTEIN; RESPONSE ELEMENTS; DEVELOPMENTAL REGULATORS; NONCODING RNAS; PCG PROTEINS; HISTONE H2A; PHD FINGER; HOX GENES; CELL FATE; METHYLATION		CNRS, Inst Human Genet, F-34396 Montpellier 5, France; Univ Bergen, Sars Int Ctr Marine Mol Biol, N-5008 Bergen, Norway; CNRS, Ctr Mol Genet, UPR 2167, F-91198 Gif Sur Yvette, France; Univ Paris 07, UFR Biol & Sci Nat, F-75251 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Bergen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Cavalli, G (corresponding author), CNRS, Inst Human Genet, 141,Rue Cardonille, F-34396 Montpellier 5, France.	giacomo.cavalli@igh.cnrs.fr	Cavalli, Giacomo/A-7958-2008; Vervoort, Michel/S-1448-2019; cavalli, giacomo/Z-2754-2019	Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469; Schuettengruber, Bernd/0000-0001-7338-4648; Leblanc, Benjamin/0000-0002-8657-2821				Aboobaker A, 2003, CURR OPIN GENET DEV, V13, P593, DOI 10.1016/j.gde.2003.10.009; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Cleard F, 2006, NAT GENET, V38, P931, DOI 10.1038/ng1833; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dejardin J, 2004, EMBO J, V23, P857, DOI 10.1038/sj.emboj.7600108; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Guitton AE, 2005, INT J DEV BIOL, V49, P707, DOI 10.1387/ijdb.051990ag; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Mohd-Sarip A, 2002, MOL CELL BIOL, V22, P7473, DOI 10.1128/MCB.22.21.7473-7483.2002; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pierce RJ, 2005, MOL BIOL EVOL, V22, P2491, DOI 10.1093/molbev/msi239; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Spagnuolo A, 2003, GENE, V309, P71, DOI 10.1016/S0378-1119(03)00488-8; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Springer NM, 2002, PLANT PHYSIOL, V128, P1332, DOI 10.1104/pp.010742; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	78	1068	1115	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					735	745		10.1016/j.cell.2007.02.009	http://dx.doi.org/10.1016/j.cell.2007.02.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320510	Bronze			2022-12-28	WOS:000245098600015
J	Hinson, JT; Fantin, VR; Schonberger, J; Breivik, N; Siem, G; McDonough, B; Sharma, P; Keogh, I; Godinho, R; Santos, F; Esparza, A; Nicolau, Y; Selvaag, E; Cohen, BH; Hoppel, CL; Tranebjaerg, L; Eavey, RD; Seidman, JG; Seidman, CE				Hinson, J. Travis; Fantin, Valeria R.; Schoenberger, Jost; Breivik, Noralv; Siem, Geir; McDonough, Barbara; Sharma, Pankaj; Keogh, Ivan; Godinho, Ricardo; Santos, Felipe; Esparza, Alfonso; Nicolau, Yamileth; Selvaag, Edgar; Cohen, Bruce H.; Hoppel, Charles L.; Tranebjaerg, Lisbeth; Eavey, Roland D.; Seidman, J. G.; Seidman, Christine E.			Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MITOCHONDRIAL RESPIRATORY-CHAIN; SENSORINEURAL HEARING-LOSS; LETHAL METABOLIC-DISORDER; PILI TORTI; GRACILE SYNDROME; IRON OVERLOAD; PROTEIN; COMPLEX; MEMBRANE; DISEASE	Background: The Bjornstad syndrome, an autosomal recessive disorder associated with sensorineural hearing loss and pili torti, is caused by mutation of a previously unidentified gene on chromosome 2q34-36. Methods: Refined genetic mapping and DNA sequencing of 44 genes between D2S2210 and D2S2244 revealed BCS1L mutations. Functional analyses elucidated how BCS1L mutations cause the Bjornstad syndrome. Results: BCS1L encodes a member of the AAA family of ATPases that is necessary for the assembly of complex III in the mitochondria. In addition to the Bjornstad syndrome, BCS1L mutations cause complex III deficiency and the GRACILE syndrome, which in neonates are lethal conditions that have multisystem and neurologic manifestations typifying severe mitochondrial disorders. Patients with the Bjornstad syndrome have mutations that alter residues involved in protein-protein interactions, whereas mutations in patients with complex III deficiency alter ATP-binding residues, as deduced from the crystal structure of a related AAA-family ATPase. Biochemical studies provided evidence to support this model: complex III deficiency mutations prevented ATP-dependent assembly of BCS1L-associated complexes. All mutant BCS1L proteins disrupted the assembly of complex III, reduced the activity of the mitochondrial electron-transport chain, and increased the production of reactive oxygen species. However, only mutations associated with complex III deficiency increased mitochondrial content, which further increased the production of reactive oxygen species. Conclusions: BCS1L mutations cause disease phenotypes ranging from highly restricted pili torti and sensorineural hearing loss (the Bjornstad syndrome) to profound multisystem organ failure (complex III deficiency and the GRACILE syndrome). All BCS1L mutations disrupted the assembly of mitochondrial respirasomes (the basic unit for respiration in human mitochondria), but the clinical expression of the mutations was correlated with the production of reactive oxygen species. Mutations that cause the Bjornstad syndrome illustrate the exquisite sensitivity of ear and hair tissues to mitochondrial function, particularly to the production of reactive oxygen species.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Wurzburg, Wurzburg, Germany; Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; Aalesund Hosp, Alesund, Norway; Hammersmith Hosp, London, England; Univ London Imperial Coll Sci Technol & Med, London, England; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Pontificia Univ Catholica Minas Gerais, Belo Horizonte, MG, Brazil; Univ Washington, Seattle, WA 98195 USA; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Cleveland Clin, Brain Tumor Inst, Cleveland, OH 44106 USA; Louis Stokes Vet Affairs Med Ctr, Cleveland, OH USA; Univ Copenhagen, Inst Med Biochem & Genet, Copenhagen, Denmark; Univ Tromso Hosp, N-9012 Tromso, Norway	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wurzburg; Imperial College London; Imperial College London; Harvard University; Massachusetts Eye & Ear Infirmary; Pontificia Universidade Catolica de Minas Gerais; University of Washington; University of Washington Seattle; University of Copenhagen; Bispebjerg Hospital; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Copenhagen; UiT The Arctic University of Tromso; University Hospital of North Norway	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Room 256 NRB,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	sharma, pankaj/HGE-4423-2022; KEOGH, IVAN J/M-2704-2016	KEOGH, IVAN J/0000-0001-6358-6377; Santos, Felipe/0000-0002-3523-665X				Armstrong JS, 2004, J BIOL CHEM, V279, P50420, DOI 10.1074/jbc.M408882200; Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428; *CEL GEN, 2005, CEL DISC SYST; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Fellman V, 2002, BLOOD CELL MOL DIS, V29, P444, DOI 10.1006/bcmd.2002.0582; Folsch H, 1996, EMBO J, V15, P479, DOI 10.1002/j.1460-2075.1996.tb00380.x; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; HILL JE, 1986, YEAST, V2, P13; KREGEL KC, IN PRESS AM J PHYSL; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; *NAT HUM GEN RES I, 2005, DBSNP DAT SINGL NUCL; Neto JFL, 1998, AM J HUM GENET, V62, P1107, DOI 10.1086/301837; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Ronchese F, 1932, ARCH DERMATOL SYPH, V26, P98, DOI 10.1001/archderm.1932.01450030101015; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Selvaag E, 2000, EUR J DERMATOL, V10, P91; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Stan T, 2003, MOL CELL BIOL, V23, P2239, DOI 10.1128/MCB.23.7.2239-2250.2003; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; WALKER B, 1994, PROTEIN ENG, V7, P91, DOI 10.1093/protein/7.1.91; Wenchich L, 2003, PHYSIOL RES, V52, P781; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	33	135	143	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					809	819		10.1056/NEJMoa055262	http://dx.doi.org/10.1056/NEJMoa055262			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314340				2022-12-28	WOS:000244326700007
J	Tyson, JJ				Tyson, John J.			Bringing cartoons to life	NATURE			English	Editorial Material									Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Tyson, JJ (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.		Tyson, John J/A-2942-2014	Tyson, John J/0000-0001-7560-6013				Goldbeter A., 1996, BIOCH OSCILLATIONS C; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016	4	21	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					823	823		10.1038/445823a	http://dx.doi.org/10.1038/445823a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	138CR	17314960				2022-12-28	WOS:000244341200024
J	Sandstrom, T; Brunekreef, B				Sandstrom, Thomas; Brunekreef, Bert			Traffic-related pollution and lung development in children	LANCET			English	Editorial Material							DIESEL EXHAUST; AIR-POLLUTION; DYSFUNCTION; AIRWAYS; HEALTH		Univ Hosp, Dept Resp Med & Allergy, SE-90185 Umea, Sweden; Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Umea University; Utrecht University; Utrecht University Medical Center	Sandstrom, T (corresponding author), Univ Hosp, Dept Resp Med & Allergy, SE-90185 Umea, Sweden.	thomas.sandstrom@lung.umu.se		brunekreef, bert/0000-0001-9908-0060				Brunekreef B, 1997, EPIDEMIOLOGY, V8, P298, DOI 10.1097/00001648-199705000-00012; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Green RS, 2004, ENVIRON HEALTH PERSP, V112, P61, DOI 10.1289/ehp.6566; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Kelly FJ, 2004, P NUTR SOC, V63, P579, DOI 10.1079/PNS2004388; Kunzli N, 2000, LANCET, V356, P795, DOI 10.1016/S0140-6736(00)02653-2; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Nordenhall C, 2001, EUR RESPIR J, V17, P909, DOI 10.1183/09031936.01.17509090; Pourazar J, 2005, AM J PHYSIOL-LUNG C, V289, pL724, DOI 10.1152/ajplung.00055.2005; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Xia T, 2004, ENVIRON HEALTH PERSP, V112, P1347, DOI 10.1289/ehp.7167	12	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					535	537		10.1016/S0140-6736(07)60038-5	http://dx.doi.org/10.1016/S0140-6736(07)60038-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307083				2022-12-28	WOS:000244368000005
J	Okubo, CH; McEwen, AS				Okubo, Chris H.; McEwen, Alfred S.			Fracture-controlled paleo-fluid flow in Candor Chasma, Mars	SCIENCE			English	Article							JURASSIC NAVAJO SANDSTONE; SURFACE MATERIALS; MERIDIANI; HEMATITE; HISTORY	Color observations from the High Resolution Imaging Science Experiment on board the Mars Reconnaissance Orbiter reveal zones of localized fluid alteration ( cementation and bleaching) along joints within layered deposits in western Candor Chasma, Mars. This fluid alteration occurred within the subsurface in the geologic past and has been exposed at the surface through subsequent erosion. These findings demonstrate that fluid flow along fractures was a mechanism by which subsurface fluids migrated through these layered deposits. Fractured layered deposits are thus promising sites for investigating the geologic history of water on Mars.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Okubo, CH (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	chriso@lpl.arizona.edu		Okubo, Chris/0000-0001-9776-8128				Beitler B, 2005, J SEDIMENT RES, V75, P547, DOI 10.2110/jsr.2005.045; Beitler B, 2003, GEOLOGY, V31, P1041, DOI 10.1130/G19794.1; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Chan M. A., 2005, GSA TODAY, V15, P4, DOI [10.1130/1052-5173(2005)015[4:RRARPD]2.0.CO;2, DOI 10.1130/1052-5173(2005)015[4:RRARPD]2.0.CO;2, 10.1130/1052-5173(2005)015[4: RRARPD]2.0.CO;2]; Chan MA, 2000, AAPG BULL, V84, P1281; Chan MA, 2004, NATURE, V429, P731, DOI 10.1038/nature02600; Chapman MG, 2002, ICARUS, V155, P324, DOI 10.1006/icar.2001.6735; Clark BC, 2005, EARTH PLANET SC LETT, V240, P73, DOI 10.1016/j.epsl.2005.09.040; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Jamtveit B, 1997, FLUID FLOW TRANSPORT; LUCCHITTA BK, 1992, MARS, P423; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; MCCAFFREY KJW, 1999, SPECIAL PUBLICATION, V155; MCEWEN AS, IN PRESS J GEOPHYS R; McLennan SM, 2005, EARTH PLANET SC LETT, V240, P95, DOI 10.1016/j.epsl.2005.09.041; Murchie S, 2000, ICARUS, V147, P444, DOI 10.1006/icar.2000.6446; National Research Council, 1996, ROCK FRACT FLUID FLO, P551, DOI 10.17226/2309; Parry WT, 2004, AAPG BULL, V88, P175, DOI 10.1306/09090303034; Shipton Z.K., 2004, GEOL SOC LOND SPEC P, V233, P43, DOI [DOI 10.1144/GSL.SP.2004.233.01.05, 10.1144/gsl.Sp.2004.233.01.05]; Tosca NJ, 2005, EARTH PLANET SC LETT, V240, P122, DOI 10.1016/j.epsl.2005.09.042; Wong TF, 1997, J GEOPHYS RES-SOL EA, V102, P3009, DOI 10.1029/96JB03281	21	72	72	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					983	985		10.1126/science.1136855	http://dx.doi.org/10.1126/science.1136855			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303752				2022-12-28	WOS:000244229800040
J	Krueger, GG; Langley, RG; Leonardi, C; Yeilding, N; Guzzo, C; Wang, YH; Dooley, LT; Lebwohl, M				Krueger, Gerald G.; Langley, Richard G.; Leonardi, Craig; Yeilding, Newman; Guzzo, Cynthia; Wang, Yuhua; Dooley, Lisa T.; Lebwohl, Mark		CNTO 1275 Paoriasis Study Grp	A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; INFLIXIMAB INDUCTION; EXPRESSION; IL-23; SKIN; THERAPY; PROMOTES; DISTINCT; LESIONS; IL-12	BACKGROUND: Skin-infiltrating lymphocytes expressing type 1 cytokines have been linked to the pathophysiology of psoriasis. We evaluated the safety and efficacy of a human interleukin-12/23 monoclonal antibody in treating psoriasis. METHODS: In this double-blind, placebo-controlled trial, 320 patients with moderate-to-severe plaque psoriasis underwent randomization to treatment with the interleukin-12/23 monoclonal antibody (one 45-mg dose, one 90-mg dose, four weekly 45-mg doses, or four weekly 90-mg doses) or placebo; 64 patients were randomly assigned to each group. Patients assigned to the interleukin-12/23 monoclonal antibody received one additional dose at week 16 if needed. Patients assigned to placebo crossed over to receive one 90-mg dose of interleukin-12/23 monoclonal antibody at week 20. RESULTS: There was at least 75% improvement in the psoriasis area-and-severity index at week 12 (the primary end point) in 52% of patients who received 45 mg of the interleukin-12/23 monoclonal antibody, in 59% of those who received 90 mg, in 67% of those who received four weekly 45-mg doses, and in 81% of those who received four weekly 90-mg doses, as compared with 2% of those who received placebo (P<0.001 for each comparison), and there was at least 90% improvement in 23%, 30%, 44%, and 52%, respectively, of patients who received the monoclonal antibody as compared with 2% of patients who received placebo (P<0.001 for each comparison). Adverse events occurred in 79% of patients treated with the interleukin-12/23 monoclonal antibody as compared with 72% of patients in the placebo group (P=0.19). Serious adverse events occurred in 4% of patients who received the monoclonal antibody and in 1% of those who received placebo (P=0.69). CONCLUSIONS: This study demonstrates the therapeutic efficacy of an interleukin-12/23 monoclonal antibody in psoriasis and provides further evidence of a role of the interleukin-12/23 p40 cytokines in the pathophysiology of psoriasis. Larger studies are needed to determine whether serious adverse events might limit the clinical usefulness of this new therapeutic target.	Univ Utah, Salt Lake City, UT USA; Dalhousie Univ, Halifax, NS, Canada; St Louis Univ, St Louis, MO 63103 USA; Centocor Inc, Malvern, PA 19355 USA; Mt Sinai Sch Med, New York, NY USA	Utah System of Higher Education; University of Utah; Dalhousie University; Saint Louis University; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Icahn School of Medicine at Mount Sinai	Krueger, GG (corresponding author), 30 N 1900 E,Suite 4B-454, Salt Lake City, UT 84132 USA.	gerald.krueger@derm.med.utah.edu						Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Barrie MA, 2005, CLIN APPL IMMUNOL, V5, P225; BruchGerharz D, 1996, J EXP MED, V184, P2007, DOI 10.1084/jem.184.5.2007; Carlin CS, 2004, J AM ACAD DERMATOL, V50, P859, DOI 10.1016/j.jaad.2003.09.014; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Conover WJ, 1980, PRACTICAL NONPARAMET, P318; de Jong R, 1998, SCIENCE, V280, P1435; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Gottlieb A, 2005, J AM ACAD DERMATOL, V52, pP172; Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021; Hong K, 1999, J IMMUNOL, V162, P7480; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kim YK, 2002, MOL PSYCHIATR, V7, P1107, DOI 10.1038/sj.mp.4001084; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Lebwohl M, 2003, ARCH DERMATOL, V139, P719, DOI 10.1001/archderm.139.6.719; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Overwijk WW, 2006, J IMMUNOL, V176, P5213, DOI 10.4049/jimmunol.176.9.5213; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Schon MP, 1997, NAT MED, V3, P183, DOI 10.1038/nm0297-183; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Tada Y, 2006, BRIT J DERMATOL, V154, P1180, DOI 10.1111/j.1365-2133.2006.07180.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x	33	616	696	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					580	592		10.1056/NEJMoa062382	http://dx.doi.org/10.1056/NEJMoa062382			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287478				2022-12-28	WOS:000244012700006
J	Wara, M				Wara, Michael			Is the global carbon market working?	NATURE			English	Editorial Material									Stanford Univ, Program Energy & Sustainable Dev, Stanford, CA 94305 USA	Stanford University	Wara, M (corresponding author), Holland & Knight LLP, 50 Calif St, San Francisco, CA 94111 USA.							Heller T.C., 2003, DEV CLIMATE ENGAGING; International Energy Outlook, 2006, INT EN OUTL 2006; JACKSON M, 2006, GREENHOUSE GAS IMPLI; *UK NAT ALL PLAN, 2006, DEFRA EU EM TRAD SCH; Victor DG, 2005, SCIENCE, V309, P1820, DOI 10.1126/science.1113180; Wara M., 2006, MEASURING CLEAN DEV	6	225	231	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 8	2007	445	7128					595	596		10.1038/445595a	http://dx.doi.org/10.1038/445595a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	133UM	17287794				2022-12-28	WOS:000244039400023
J	Prytkova, TR; Kurnikov, IV; Beratan, DN				Prytkova, Tatiana R.; Kurnikov, Igor V.; Beratan, David N.			Coupling coherence distinguishes structure sensitivity in protein electron transfer	SCIENCE			English	Article							TRANSFER RATES; BIOLOGICAL MOLECULES; TRANSFER PATHWAYS; DYNAMICS; INTERFERENCE; INTERFACE; MEDIA	Quantum mechanical analysis of electron tunneling in nine thermally fluctuating cytochrome b(562) derivatives reveals two distinct protein-mediated coupling limits. A structure-insensitive regime arises for redox partners coupled through dynamically averaged multiple-coupling pathways (in seven of the nine derivatives) where heme-edge coupling leads to the multiple-pathway regime. A structure-dependent limit governs redox partners coupled through a dominant pathway (in two of the nine derivatives) where axial-ligand coupling generates the single-pathway limit and slower rates. This two-regime paradigm provides a unified description of electron transfer rates in 26 ruthenium-modified heme and blue-copper proteins, as well as in numerous photosynthetic proteins.	Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA	Duke University	Beratan, DN (corresponding author), Duke Univ, Dept Chem & Biochem, Durham, NC 27708 USA.	david.beratan@duke.edu	Beratan, David N/C-5098-2011	Beratan, David N/0000-0003-4758-8676	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048043] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM048043] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antony J, 2000, J AM CHEM SOC, V122, P1057, DOI 10.1021/ja993784t; Babini E, 2000, J AM CHEM SOC, V122, P4532, DOI 10.1021/ja994472t; Balabin IA, 2000, SCIENCE, V290, P114, DOI 10.1126/science.290.5489.114; BERATAN DN, 1991, SCIENCE, V252, P1285, DOI 10.1126/science.1656523; Daizadeh I, 1997, P NATL ACAD SCI USA, V94, P3703, DOI 10.1073/pnas.94.8.3703; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; Hoffman BM, 2005, P NATL ACAD SCI USA, V102, P3564, DOI 10.1073/pnas.0408767102; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P3640, DOI 10.1073/pnas.71.9.3640; Improta R, 2006, CHEMPHYSCHEM, V7, P1211, DOI 10.1002/cphc.200600069; Jones ML, 2002, J PHYS CHEM A, V106, P2002, DOI 10.1021/jp0133743; Kang SA, 2005, P NATL ACAD SCI USA, V102, P15465, DOI 10.1073/pnas.0505176102; Kawatsu T, 2002, J PHYS CHEM B, V106, P11356, DOI 10.1021/jp026035y; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCLENDON G, 1992, CHEM REV, V92, P481, DOI 10.1021/cr00011a007; Nishioka H, 2005, J PHYS CHEM B, V109, P1978, DOI 10.1021/jp046282x; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Prytkova TR, 2007, P NATL ACAD SCI USA, V104, P802, DOI 10.1073/pnas.0605319104; Prytkova TR, 2005, J PHYS CHEM B, V109, P1618, DOI 10.1021/jp0457491; Ramirez BE, 1995, P NATL ACAD SCI USA, V92, P11949, DOI 10.1073/pnas.92.26.11949; Regan JJ, 1999, ADV CHEM PHYS, V107, P497; Skourtis SS, 1999, ADV CHEM PHYS, V106, P377, DOI 10.1002/9780470141656.ch8; Skourtis SS, 2005, P NATL ACAD SCI USA, V102, P3552, DOI 10.1073/pnas.0409047102; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; STUCHEBRUKHOV AA, 1995, J PHYS CHEM-US, V99, P7581, DOI 10.1021/j100019a044; Tan ML, 2004, BIOPHYS J, V86, P1813, DOI 10.1016/S0006-3495(04)74248-4; Troisi A, 2003, J CHEM PHYS, V119, P5782, DOI 10.1063/1.1601600; van Amsterdam IMC, 2002, NAT STRUCT BIOL, V9, P48, DOI 10.1038/nsb736; Winkler JR, 1999, PURE APPL CHEM, V71, P1753, DOI 10.1351/pac199971091753; Zheng YJ, 2003, J PHYS CHEM B, V107, P7288, DOI 10.1021/jp027092u; [No title captured]	33	158	159	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					622	625		10.1126/science.1134862	http://dx.doi.org/10.1126/science.1134862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272715	Green Accepted, Green Published			2022-12-28	WOS:000243909400036
J	Richards, T				Richards, Tessa			Time to tune into Europe - Clarifying the legal framework for cross border care is in everyone's interests	BRITISH MEDICAL JOURNAL			English	Editorial Material												trichards@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					185	185		10.1136/bmj.39105.430058.59	http://dx.doi.org/10.1136/bmj.39105.430058.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255609	Green Published			2022-12-28	WOS:000244027600030
J	Watts, G				Watts, Geoff			Animal testing: is it worth it?	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*AC MED SCI, US NONH PRIM RES; *EUR UN, PROP REG EUR PARL CO; *NUFF COUNC BIOET, 2005, ETH RES INV AN; *RES DEF SOC, AN RES FACTS; ROBINSON S, 2004, P 9 FELASA S, P10; Rowland M, 2006, MICRODOSING 3RS	6	6	7	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					182	184		10.1136/bmj.39058.469491.68	http://dx.doi.org/10.1136/bmj.39058.469491.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255608	Green Published			2022-12-28	WOS:000244027600029
J	Guo, DG; Tan, YC; Wang, DW; Madhusoodanan, KS; Zheng, Y; Maack, T; Zhang, JJ; Huang, XY				Guo, Dagang; Tan, Ying-cai; Wang, Dawei; Madhusoodanan, K. S.; Zheng, Yi; Maack, Thomas; Zhang, J. Jillian; Huang, Xin-Yun			A Rac-cGMP signaling pathway	CELL			English	Article							GUANYLATE-CYCLASE ACTIVITY; CYCLIC-GMP; KINASE; ACTIVATION; GROWTH; PAK1; MEMBRANE; RECEPTOR; COMPLEX; ORGANIZATION	The small GTPase Rac and the second messenger cGMP (guanosine 3',5'-cyclic monophosphate) are critical regulators of diverse cell functions. When activated by extracellular signals via membrane signaling receptors, Rac executes its functions through engaging downstream effectors such as p21-activated kinase (PAK), a serine/threonine protein kinase. However, the molecular mechanism by which membrane signaling receptors regulate cGMP levels is not known. Here we have uncovered a signaling pathway linking Rac to the increase of cellular cGMP. We show that Rac uses PAK to directly activate transmembrane guanylyl cyclases (GCs), leading to increased cellular cGMP levels. This Rac/PAK/GC/cGMP pathway is involved in platelet-derived growth factor-induced fibroblast cell migration and lamellipodium formation. Our findings connect two important regulators of cellular physiological functions and provide a general mechanism for diverse receptors to modulate physiological responses through elevating cellular cGMP levels.	Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA; Univ Cincinnati, Childrens Hosp, Res Fdn, Div Expt Hematol, Cincinnati, OH 45229 USA	Cornell University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Huang, XY (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	xyhuang@med.cornell.edu	Maack, Thomas/AAN-7878-2020; Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074	NIA NIH HHS [AG23202, R01 AG023202, AG14563, R01 AG014563] Funding Source: Medline; NIGMS NIH HHS [R01 GM084191, R01 GM056904, GM56904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056904, R01GM084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023202, R01AG014563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; BENTLEY JK, 1986, CELL, V45, P281, DOI 10.1016/0092-8674(86)90392-2; Birnby DA, 2000, GENETICS, V155, P85; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Carter JH, 2004, CLIN CANCER RES, V10, P3448, DOI 10.1158/1078-0432.CCR-03-0210; COFFEY RG, 1988, J IMMUNOL, V140, P2695; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; ESTENSEN RD, 1973, NATURE, V245, P458, DOI 10.1038/245458a0; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hou YL, 2004, CELL SIGNAL, V16, P1061, DOI 10.1016/j.cellsig.2004.03.002; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lowry WE, 2002, DEV CELL, V2, P733, DOI 10.1016/S1534-5807(02)00175-2; Lucas KA, 2000, PHARMACOL REV, V52, P375; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MANEER E, 1997, MOL CELL BIOL, V17, P1129; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; SCHEVING LA, 1985, ENDOCRINOLOGY, V116, P332, DOI 10.1210/endo-116-1-332; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schmidt H, 2002, J CELL BIOL, V159, P489, DOI 10.1083/jcb.200207058; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	81	87	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					341	355		10.1016/j.cell.2006.11.048	http://dx.doi.org/10.1016/j.cell.2006.11.048			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254971	Green Accepted, Bronze			2022-12-28	WOS:000244420500018
J	Natsume, R; Eitoku, M; Akai, Y; Sano, N; Horikoshi, M; Senda, T				Natsume, Ryo; Eitoku, Masamitsu; Akai, Yusuke; Sano, Norihiko; Horikoshi, Masami; Senda, Toshiya			Structure and function of the histone chaperone CIA/ASF1 complexed with histones H3 and H4	NATURE			English	Article							CHROMATIN; ASF1; TRANSCRIPTION; DEPOSITION; IDENTIFICATION; REPLICATION; HISTORIES; GENES; RAD53	CIA(CCG1-interacting factor A)/ASF1, which is the most conserved histone chaperone among the eukaryotes, was genetically identified as a factor for an anti-silencing function (Asf1)(1) by yeast genetic screening. Shortly after that, the CIA-histone-H3-H4 complex was isolated from Drosophila as a histone chaperone CAF-1 stimulator(2). Human CIA-I/II (ASF1a/b) was identified as a histone chaperone that interacts with the bromodomain - an acetylated-histone-recognizing domain - of CCG1, in the general transcription initiation factor TFIID3-5. Intensive studies have revealed that CIA/ASF1 mediates nucleosome assembly by forming a complex with another histone chaperone in human cells 6 and yeast 7, and is involved in DNA replication 1,2, transcription 4,8 - 10, DNA repair 1,2,11,12 and silencing/ anti-silencing(1,2,8,13-15) in yeast. CIA/ASF1 was shown as a major storage chaperone for soluble histones in proliferating human cells(6,16). Despite all these biochemical and biological functional analyses, the structure - function relationship of the nucleosome assembly/disassembly activity of CIA/ASF1 has remained elusive. Here we report the crystal structure, at 2.7 angstrom resolution, of CIA-I in complex with histones H3 and H4. The structure shows the histone H3 - H4 dimer's mutually exclusive interactions with another histone H3 - H4 dimer and CIA-I. The carboxy-terminal beta-strand of histone H4 changes its partner from the beta-strand in histone H2A to that of CIA-I through large conformational change. In vitro functional analysis demonstrated that CIA-I has a histone H3 - H4 tetramer-disrupting activity. Mutants with weak histone H3-H4 dimer binding activity showed critical functional effects on cellular processes related to transcription. The histone H3-H4 tetramer-disrupting activity of CIA/ASF1 and the crystal structure of the CIA/ASF1-histone-H3-H4 dimer complex should give insights into mechanisms of both nucleosome assembly/disassembly and nucleosome semi-conservative replication.	Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; JST, ERATO, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan; JBIC, JBIRC, Koto Ku, Tokyo 1350064, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tokyo	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Koto Ku, 2-42 Aomi, Tokyo 1350064, Japan.	horikosh@iam.u-tokyo.ac.jp; tsenda@jbirc.aist.go.jp		Senda, Toshiya/0000-0002-5153-928X				Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chimura T, 2002, P NATL ACAD SCI USA, V99, P9334, DOI 10.1073/pnas.142627899; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; DeLano W., 2006, PYMOL MOL GRAPHICS S; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; English CM, 2005, BIOCHEMISTRY-US, V44, P13673, DOI 10.1021/bi051333h; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; Meijsing SH, 2001, GENE DEV, V15, P3169, DOI 10.1101/gad.929001; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Osada S, 2001, GENE DEV, V15, P3155, DOI 10.1101/gad.907201; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Sillje HHW, 2001, CURR BIOL, V11, P1068, DOI 10.1016/S0960-9822(01)00298-6; SILVERMAN SJ, 1984, MOL CELL BIOL, V4, P1246, DOI 10.1128/MCB.4.7.1246; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2003, J BIOL CHEM, V278, P35660, DOI 10.1074/jbc.M303549200; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; Yamaguchi Y, 2001, J BIOCHEM, V129, P185, DOI 10.1093/oxfordjournals.jbchem.a002842	30	229	232	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2007	446	7133					338	341		10.1038/nature05613	http://dx.doi.org/10.1038/nature05613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145VC	17293877				2022-12-28	WOS:000244892900050
J	Eldrett, JS; Harding, IC; Wilson, PA; Butler, E; Roberts, AP				Eldrett, James S.; Harding, Ian C.; Wilson, Paul A.; Butler, Emily; Roberts, Andrew P.			Continental ice in Greenland during the Eocene and Oligocene	NATURE			English	Article							GLACIATION; HISTORY; ONSET; MA	The Eocene and Oligocene epochs (similar to 55 to 23 million years ago) comprise a critical phase in Earth history. An array of geological records(1-5) supported by climate modelling(6) indicates a profound shift in global climate during this interval, from a state that was largely free of polar ice caps to one in which ice sheets on Antarctica approached their modern size. However, the early glaciation history of the Northern Hemisphere is a subject of controversy(3,7-9). Here we report stratigraphically extensive ice-rafted debris, including macroscopic dropstones, in late Eocene to early Oligocene sediments from the Norwegian - Greenland Sea that were deposited between about 38 and 30 million years ago. Our data indicate sediment rafting by glacial ice, rather than sea ice, and point to East Greenland as the likely source. Records of this type from one site alone cannot be used to determine the extent of ice involved. However, our data suggest the existence of ( at least) isolated glaciers on Greenland about 20 million years earlier than previously documented(10), at a time when temperatures and atmospheric carbon dioxide concentrations were substantially higher.	Univ Southampton, Natl Oceanog Ctr Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England	NERC National Oceanography Centre; University of Southampton	Harding, IC (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	ich@noc.soton.ac.uk	Roberts, Andrew P/E-6422-2010; Harding, Ian C/K-3320-2012	Roberts, Andrew P/0000-0003-0566-8117; Wilson, Paul/0000-0001-6425-8906; eldrett, james/0000-0001-5196-3112; Harding, Ian/0000-0003-4281-0581				BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Clark D., 1983, GLACIAL MARINE SEDIM, P301, DOI DOI 10.1007/978-1-4613-3793-5_7; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DECONTO RM, 2005, AGU FALL M 2005; Eldrett JS, 2004, MAR GEOL, V204, P91, DOI 10.1016/S0025-3227(03)00357-8; Firth John V., 1996, Proceedings of the Ocean Drilling Program Scientific Results, V151, P203; Harland W. B., 1997, GEOLOGICAL SOC MEMOI, V17, P363; Helland PE, 1997, PALAEOGEOGR PALAEOCL, V135, P109, DOI 10.1016/S0031-0182(97)00025-4; Hinrichs J, 2001, MAR GEOL, V177, P79, DOI 10.1016/S0025-3227(01)00125-6; KARLIN R, 1983, NATURE, V303, P327, DOI 10.1038/303327a0; Krinsley D. H., 2011, ATLAS QUARTZ SAND SU; LARSEN M, 2004, PETROLEUM GEOLOGY NW, P923; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; MARGOLIS SV, 1971, AM J SCI, V271, P1, DOI 10.2475/ajs.271.1.1; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Myhre A., 1995, P OCEAN DRILL PROGRA, P345, DOI DOI 10.2973/ODP.PROC.IR.151.111.1995; NURNBERG D, 1994, MAR GEOL, V119, P185, DOI 10.1016/0025-3227(94)90181-3; Olivarez Lyle A., 2002, P OCEAN DRILL PROGRA, P199, DOI [10.2973/odp.procir.199.106.2002, DOI 10.2973/ODP.PROC.IR.199.106.2002]; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pekar SF, 2005, GEOL SOC AM BULL, V117, P1081, DOI 10.1130/B25486.1; Richter TO, 2001, MAR GEOL, V173, P37, DOI 10.1016/S0025-3227(00)00165-1; Soper N.J., 1976, J GEOLOGICAL SOC LON, V132, P85, DOI DOI 10.1144/GSJGS.132.1.0085; Strand K, 2003, PALAEOGEOGR PALAEOCL, V198, P101, DOI 10.1016/S0031-0182(03)00396-1; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; UPTON BGJ, 1984, J PETROL, V25, P151, DOI 10.1093/petrology/25.1.151; Winkler A, 2002, INT J EARTH SCI, V91, P133, DOI 10.1007/s005310100199; Wolf-Welling Thomas C.W., 1996, Proceedings of the Ocean Drilling Program Scientific Results, V151, P515; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	175	181	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 8	2007	446	7132					176	179		10.1038/nature05591	http://dx.doi.org/10.1038/nature05591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143JS	17287724				2022-12-28	WOS:000244718100038
J	Curtis, MA; Kam, M; Nannmark, U; Anderson, MF; Axell, MZ; Wikkelso, C; Holtas, S; van Roon-Mom, WMC; Bjork-Eriksson, T; Nordborg, C; Frisen, J; Dragunow, M; Faull, RLM; Eriksson, PS				Curtis, Maurice A.; Kam, Monica; Nannmark, Ulf; Anderson, Michelle F.; Axell, Mathilda Zetterstrom; Wikkelso, Carsten; Holtas, Stig; van Roon-Mom, Willeke M. C.; Bjork-Eriksson, Thomas; Nordborg, Claes; Frisen, Jonas; Dragunow, Michael; Faull, Richard L. M.; Eriksson, Peter S.			Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension	SCIENCE			English	Article							PRECURSOR CELL-PROLIFERATION; SUBVENTRICULAR ZONE; DIAGNOSTIC-TOOL; ADULT; NEURONS; DOUBLECORTIN; BROMODEOXYURIDINE; PLASTICITY; MEDICINE; BIOLOGY	The rostral migratory stream (RMS) is the main pathway by which newly born subventricular zone cells reach the olfactory bulb ( OB) in rodents. However, the RMS in the adult human brain has been elusive. We demonstrate the presence of a human RMS, which is unexpectedly organized around a lateral ventricular extension reaching the OB, and illustrate the neuroblasts in it. The RMS ensheathing the lateral olfactory ventricular extension, as seen by magnetic resonance imaging, cell-specific markers, and electron microscopy, contains progenitor cells with migratory characteristics and cells that incorporate 5-bromo-2'-deoxyuridine and become mature neurons in the OB.	Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Auckland 1, New Zealand; Sahlgrens Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, SE-40530 Gothenburg, Sweden; Sahlgrens Acad, Inst Biomed, SE-40530 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, SE-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Univ Auckland, Fac Med & Hlth Sci, Dept Pharmacol, Auckland, New Zealand; Sahlgrens Univ Hosp, Dept Oncol, SE-41345 Gothenburg, Sweden	University of Auckland; University of Gothenburg; University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital; Karolinska Institutet; University of Auckland; Sahlgrenska University Hospital	Eriksson, PS (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Anat & Radiol, Private Bag 92019, Auckland 1, New Zealand.	rlm.faull@auckland.ac.nz; per@neuro.gu.se	van Roon-Mom, Willeke/Y-3039-2018	van Roon-Mom, Willeke/0000-0002-3035-0533; Faull, Richard/0000-0003-3385-9498; Curtis, Maurice/0000-0003-4496-0233; Bjork-Eriksson, Thomas/0000-0003-3680-5196				Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; BERNARD A, 2004, DEV BRAIN RES, V19, P159; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chazal G, 2000, J NEUROSCI, V20, P1446; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Doetsch F, 1997, J NEUROSCI, V17, P5046; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dolbeare F, 1996, HISTOCHEM J, V28, P531, DOI 10.1007/BF02331377; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lee A, 2003, ANN NEUROL, V53, P668, DOI 10.1002/ana.10579; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; RAE ASL, 1994, CLIN NEUROPATHOL, V13, P17; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Tomasevic G, 1998, MOL BRAIN RES, V60, P168, DOI 10.1016/S0169-328X(98)00173-9; BRAIN ATLAS DOMESTIC	25	644	685	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1243	1249		10.1126/science.1136281	http://dx.doi.org/10.1126/science.1136281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17303719				2022-12-28	WOS:000244564700041
J	Mitchell, GF; Vasan, RS; Keyes, MJ; Parise, H; Wang, TJ; Larson, MG; D'Agostino, RB; Kannel, WB; Levy, D; Benjamin, EJ				Mitchell, Gary F.; Vasan, Ramachandran S.; Keyes, Michelle J.; Parise, Helen; Wang, Thomas J.; Larson, Martin G.; D'Agostino, Ralph B., Sr.; Kannel, William B.; Levy, Daniel; Benjamin, Emelia J.			Pulse pressure and risk of new-onset atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATRIURETIC PEPTIDE LEVELS; SYSTOLIC HYPERTENSION; DIASTOLIC DYSFUNCTION; BLOOD-PRESSURE; HEART-FAILURE; HEALTHY-MEN; FRAMINGHAM; POPULATION; ADULTS; AGE	Context Atrial fibrillation (AF) is responsible for considerable morbidity and mortality, making identification of modifiable risk factors a priority. Increased pulse pressure, a reflection of aortic stiffness, increases cardiac load and may increase AF risk. Objective To examine relations between pulse pressure and incident AF. Design, Setting, and Participants Prospective, community-based observational cohort in Framingham, Mass, including 5331 Framingham Heart Study participants aged 35 years and older and initially free from AF (median age, 57 years; 55% women). Main Outcome Measures Incident AF. Results AF developed in 698 participants (13.1%) a median of 12 years after pulse pressure assessment. Cumulative 20-year AF incidence rates were 5.6% for pulse pressure of 40 mm Hg or less (25th percentile) and 23.3% for pulse pressure greater than 61 mm Hg (75th percentile). In models adjusted for age, sex, baseline and time-dependent change in mean arterial pressure, and clinical risk factors for AF (body mass index, smoking, valvular disease, diabetes, electrocardiographic left ventricular hypertrophy, hypertension treatment, and prevalent myocardial infarction or heart failure), pulse pressure was associated with increased risk for AF (adjusted hazard ratio [HR], 1.26 per 20-mm Hg increment; 95% confidence interval [CI], 1.12-1.43; P < .001). In contrast, mean arterial pressure was unrelated to incident AF (adjusted HR, 0.96 per 10-mm Hg increment; 95% CI, 0.88-1.05; P = .39). Systolic pressure was related to AF (HR, 1.14 per 20-mm Hg increment; 95% CI, 1.04-1.25; P = .006); however, if diastolic pressure was added, model fit improved and the diastolic relation was inverse (adjusted HR, 0.87 per 10-mm Hg increment; 95% CI, 0.78-0.96; P = .01), consistent with a pulse pressure effect. Among patients with interpretable echocardiographic images, the association between pulse pressure and AF persisted in models that adjusted for baseline left atrial dimension, left ventricular mass, and left ventricular fractional shortening (adjusted HR, 1.23; 95% CI, 1.09-1.39; P = .001). Conclusion Pulse pressure is an important risk factor for incident AF in a community-based sample. Further research is needed to determine whether interventions that reduce pulse pressure will limit the growing incidence of AF.	Cardiovasc Engn Inc, Waltham, MA 02453 USA; Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; Boston Univ, Sch Med, Sect Prevent Med, Boston, MA 02118 USA; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Natl Heart Lung & Blood Inst Framingham Study, Framingham, MA USA; NHLBI, Bethesda, MD 20892 USA	Cardiovascular Engineering; Boston University; Boston University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mitchell, GF (corresponding author), Cardiovasc Engn Inc, 51 Sawyer Rd,Suite 100, Waltham, MA 02453 USA.	garyfmitchell@mindspring.com	Levy, Daniel/ABB-2752-2021; Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; Parise, Helen/0000-0001-7761-4973; Benjamin, Emelia/0000-0003-4076-2336	NHLBI NIH HHS [N01-HC-25195, K24-HL-04334, R01-HL60040, R01-HL70100] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004334, R01HL060040, R01HL070100] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; COX DR, 1972, J R STAT SOC B, V34, P187; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Eijsbouts SCM, 2003, J CARDIOVASC ELECTR, V14, P269, DOI 10.1046/j.1540-8167.2003.02280.x; Gardin JM, 1997, HYPERTENSION, V29, P1095, DOI 10.1161/01.HYP.29.5.1095; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Huang JL, 2003, BASIC RES CARDIOL, V98, P16, DOI 10.1007/s00395-003-0385-z; Hundley WG, 2001, J AM COLL CARDIOL, V38, P796, DOI 10.1016/S0735-1097(01)01447-4; Kannel W., 1987, FRAMINGHAM HEART STU; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; KANNEL WB, 1969, ANN INTERN MED, V71, P89, DOI 10.7326/0003-4819-71-1-89; Kato J, 2002, HYPERTENS RES, V25, P887; Leite-Moreira AF, 1999, CARDIOVASC RES, V43, P344, DOI 10.1016/S0008-6363(99)00099-1; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Mitchell GF, 1997, CIRCULATION, V96, P4254; Mitchell GF, 2002, CIRCULATION, V105, P2955, DOI 10.1161/01.CIR.0000020500.77568.3C; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; OKIN PM, 2006, JAMA-J AM MED ASSOC, V26, P1242; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Psaty BM, 1997, CIRCULATION, V96, P2455; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SAS Institute Inc, 1999, SAS STAT US GUID VER; SAVAGE DD, 1987, HYPERTENSION, V9, P40; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Tsang TSM, 2002, J AM COLL CARDIOL, V40, P1636, DOI 10.1016/S0735-1097(02)02373-2; Vasan RS, 2003, AM J CARDIOL, V91, P1079, DOI 10.1016/S0002-9149(03)00152-8; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yasmin, 2004, ARTERIOSCL THROM VAS, V24, P969, DOI 10.1161/01.ATV.zhq0504.0173; ZILE MR, 1990, PROG CARDIOVASC DIS, V32, P333, DOI 10.1016/0033-0620(90)90020-3	42	253	260	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					709	715		10.1001/jama.297.7.709	http://dx.doi.org/10.1001/jama.297.7.709			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17312290				2022-12-28	WOS:000244291100022
J	Glasziou, P; Chalmers, I; Rawlins, M; McCulloch, P				Glasziou, Paul; Chalmers, Iain; Rawlins, Michael; McCulloch, Peter			When are randomised trials unnecessary? Picking signal from noise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Ctr Evidence Based Med, Dept Primary Hlth Care, Oxford OX3 7LF, England; James Lind Lib, James Lind Initiat, Oxford OX2 7LG, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Glasziou, P (corresponding author), Univ Oxford, Ctr Evidence Based Med, Dept Primary Hlth Care, Oxford OX3 7LF, England.	paul.glasziou@dphpc.ox.ac.uk	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; McCulloch, Peter/0000-0002-3210-8273				Bloomston Mark, 2003, JSLS, V7, P211; Botma P, 2000, J LARYNGOL OTOL, V114, P598; Colebrook L, 1936, LANCET, V2, P1319; CUSCHIERI A, 1993, SURG ENDOSC-ULTRAS, V7, P505, DOI 10.1007/BF00316690; DJULBEGOVIC B, NONRANDOMIZED TRIALS; Donaldson I., AMBROISE PARES ACCOU; Goh C. L., 2000, SMJ, V41, P24; JENICEK M, 1995, EPIDEMIOLOGY LOGIC M, P36; LOUDON I, USE HIST CONTROLS CO; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Vandenbroucke JP, 1999, J ROY SOC MED, V92, P159, DOI 10.1177/014107689909200401; WILLIAMS HC, SUCCESSFUL USE TOPIC	12	419	433	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2007	334	7589					349	351		10.1136/bmj.39070.527986.68	http://dx.doi.org/10.1136/bmj.39070.527986.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303884	Green Published, Green Submitted			2022-12-28	WOS:000244560400031
J	Mwaluko, G; Wringe, A; Todd, J; Glynn, JR; Crampin, AC; Jaffar, S; Kalluvya, S; Zaba, B				Mwaluko, Gabriel; Wringe, Alison; Todd, James; Glynn, Judith R.; Crampin, Amelia C.; Jaffar, Shabbar; Kalluvya, Samuel; Zaba, Basia			Use of data from HIV counselling and testing services for HIV surveillance in Africa	LANCET			English	Article									Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, London WC1E 7HT, England; Tanzania Netherlands Project Support HIV AIDS Con, Mwanza, Tanzania; Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Karonga Prevent Study, London WC1E 7HT, England; Uganda Virus Res Inst, MRC Programme AIDS, Entebbe, Uganda; Bugando Univ, Coll Hlth Sci, HIV AIDS Unit, Mwanza, Tanzania; Natl Inst Med Res, TAZAMA Project, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Uganda Virus Research Institute; National Institute of Medical Research	Wringe, A (corresponding author), Univ London London Sch Hyg & Trop Med, Ctr Populat Studies, Keppel St, London WC1E 7HT, England.	alison.wringe@lshtm.ac.uk		Jaffar, Shabbar/0000-0002-9615-1588; Crampin, Amelia/0000-0002-1513-4330; Todd, Jim/0000-0001-5918-4914	Medical Research Council [G0700837] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baryarama F, 2004, JAIDS-J ACQ IMM DEF, V37, P1180, DOI 10.1097/01.qai.0000127063.76701.bb; Diaz T, 2005, AIDS, V19, pS1, DOI 10.1097/01.aids.0000172871.80723.3e; Global Fund to Fight AIDS Tuberculosis and Malaria, 2006, MON EV TOOLK HIV AID; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P13, DOI 10.1136/sti.2004.011635; *UN REP TANZ MIN H, 2003, HIV AIDS CAR TREATM	6	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					612	613		10.1016/S0140-6736(07)60281-5	http://dx.doi.org/10.1016/S0140-6736(07)60281-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307108				2022-12-28	WOS:000244368000035
J	Ghany, RA; de Marchena, E				Ghany, Reyan A.; de Marchena, Eduardo			Two hearts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Ghany, RA (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	rghany@med.miami.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					E6	E6		10.1056/NEJMicm066635	http://dx.doi.org/10.1056/NEJMicm066635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301293				2022-12-28	WOS:000244193300010
J	Ziegler, S; Bosshard, G				Ziegler, Stephen; Bosshard, Georg			Role of non-governmental organisations in physician assisted suicide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SWITZERLAND		Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Ft Wayne, IN 46805 USA; Univ Zurich, Inst Legal Med, Zurich, Switzerland	Purdue University System; Indiana University Purdue University Fort Wayne; University of Zurich	Ziegler, S (corresponding author), Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Ft Wayne, IN 46805 USA.	zieglers@ipfw.edu						BARNETT EH, 1999, OREGONIAN       0311, pD1; Battin M., 2005, ENDING LIFE ETHICS W; Bosshard G, 2003, SWISS MED WKLY, V133, P310; Bosshard G, 2003, INT J LEGAL MED, V117, P106, DOI 10.1007/s00414-002-0346-3; Bosshard G, 2002, SWISS MED WKLY, V132, P527; CHRISTIE T, 2006, REGISTER GUARD  1023; Dyer C, 2006, BRIT MED J, V332, P1169, DOI 10.1136/bmj.332.7551.1169; Faber-Langendoen K, 2000, ANN INTERN MED, V132, P482, DOI 10.7326/0003-4819-132-6-200003210-00010; Hurst SA, 2003, BRIT MED J, V326, P271, DOI 10.1136/bmj.326.7383.271; LEE BC, 2004, PHYS ASSISTED DYING, P190; LEE BC, 1997, OREGON HLTH LAW MANU, V2, P1; MINELLI L, 2000, AKTUELLE JURISTISCHE, V9, P474; Ogden RD, 2001, DEATH STUD, V25, P387, DOI 10.1080/074811801750257491; *OR DEP HUM SERV, 2006, 8 ANN REP OR DEATH D; RIPPE KP, 2003, QUALITATSSICHERUNG F; *SWISS NAT ADV COM, 2006, 13 SWISS NAT ADV COM; *TASK FORC IMPR CA, 2005, OREG DEATH DIGN ACT; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; Werth JL, 2000, PSYCHOL PUBLIC POL L, V6, P348, DOI 10.1037//1076-8971.6.2.348; *WORLD FED RIGHT D, OUR MEMB	20	26	26	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2007	334	7588					295	298		10.1136/bmj.39100.417072.BE	http://dx.doi.org/10.1136/bmj.39100.417072.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MN	17289733	Green Published			2022-12-28	WOS:000244654100032
J	Kawaguchi, R; Yu, JM; Honda, J; Hu, J; Whitelegge, J; Ping, PP; Wiita, P; Bok, D; Sun, H				Kawaguchi, Riki; Yu, Jiamei; Honda, Jane; Hu, Jane; Whitelegge, Julian; Ping, Peipei; Wiita, Patrick; Bok, Dean; Sun, Hui			A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A	SCIENCE			English	Article							EPITHELIAL-CELLS; ESTER FORMATION; MICE LACKING; ACID; TRANSPORT; LECITHIN; GENE; ACYLTRANSFERASE; ACCUMULATION; LESSONS	Vitamin A has diverse biological functions. It is transported in the blood as a complex with retinol binding protein ( RBP), but the molecular mechanism by which vitamin A is absorbed by cells from the vitamin A-RBP complex is not clearly understood. We identified in bovine retinal pigment epithelium cells STRA6, a multitransmembrane domain protein, as a specific membrane receptor for RBP. STRA6 binds to RBP with high affinity and has robust vitamin A uptake activity from the vitamin A-RBP complex. It is widely expressed in embryonic development and in adult organ systems. The RBP receptor represents a major physiological mediator of cellular vitamin A uptake.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Pasarow Mass Spectrometry Lab, Semel Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sun, H (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	hsun@mednet.ucla.edu	Kawaguchi, Riki/AAV-6090-2020	Ping, Peipei/0000-0003-3583-3881	NATIONAL EYE INSTITUTE [T32EY007026] Funding Source: NIH RePORTER; NEI NIH HHS [5T32EY07026] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Biesalski HK, 2003, MOL ASPECTS MED, V24, P431, DOI 10.1016/S0098-2997(03)00039-6; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; CHEN CC, 1977, J BIOL CHEM, V252, P5216; DOWLING JE, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1066-78; DRAGER UC, 2006, SCI STKE, pPE10; Evans R M, 1994, Harvey Lect, V90, P105; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Goodman DS, 1984, RETINOIDS, P41, DOI DOI 10.1016/B978-0-12-658102-7.50008-7; Hagen E, 1999, J NUTR BIOCHEM, V10, P345, DOI 10.1016/S0955-2863(99)00013-3; HELLER J, 1975, J BIOL CHEM, V250, P3613; KANAI N, 1995, SCIENCE, V268, P866, DOI 10.1126/science.7754369; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; MACDONALD PN, 1990, P NATL ACAD SCI USA, V87, P4265, DOI 10.1073/pnas.87.11.4265; Maret S, 2005, SCIENCE, V310, P111, DOI 10.1126/science.1117623; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; OTTONELLO S, 1987, J BIOL CHEM, V262, P3975; PASUTTO F, IN PRESS AM J HUM GE; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2000, J INFECT DIS, V182, pS97, DOI 10.1086/315920; RASK L, 1976, J BIOL CHEM, V251, P6360; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SHINGLETON JL, 1989, BIOCHEMISTRY-US, V28, P9641, DOI 10.1021/bi00451a015; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; SIVAPRASADARAO A, 1994, BIOCHEM J, V300, P437, DOI 10.1042/bj3000437; Sivaprasadarao A., 1994, Vitamin A in health and disease., P87; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; Sommer A, 1997, NAT MED, V3, P1061, DOI 10.1038/nm1097-1061; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Sundaram M, 1998, J BIOL CHEM, V273, P3336, DOI 10.1074/jbc.273.6.3336; Szeto W, 2001, CANCER RES, V61, P4197; Vahlquist A., 1994, Vitamin A in health and disease., P365; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	41	574	595	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					820	825		10.1126/science.1136244	http://dx.doi.org/10.1126/science.1136244			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17255476				2022-12-28	WOS:000244069000062
J	Shaw, RM; Fay, AJ; Puthenveedu, MA; von Zastrow, M; Jan, YN; Jan, LY				Shaw, Robin M.; Fay, Alex J.; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Jan, Yuh-Nung; Jan, Lily Y.			Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions	CELL			English	Article							ADULT-RAT CARDIOMYOCYTES; N-CADHERIN; PLASMA-MEMBRANE; HUMAN-FIBROBLASTS; BETA-CATENIN; BORDER ZONE; CONNEXIN43; ADHESION; DYNEIN; EB1	Gap junctions are intercellular channels that connect the cytoplasms of adjacent cells. For gap junctions to properly control organ formation and electrical synchronization in the heart and the brain, connexin-based hemichannels must be correctly targeted to cell-cell borders. While it is generally accepted that gap junctions form via lateral diffusion of hemichannels following microtubule-mediated delivery to the plasma membrane, we provide evidence for direct targeting of hemichannels to cell-cell junctions through a pathway that is dependent on microtubules; through the adherens-junction proteins N-cadherin and beta-catenin through the microtubule plus-end-tracking protein (+TIP) EB1; and through its interacting protein p150(Glued). Based on live cell microscopy that includes fluorescence recovery after photobleaching (FRAP), total internal reflection fluorescence (TIRF), deconvolution, and siRNA knockdown, we propose that preferential tethering of microtubule plus ends at the adherens junction promotes delivery of connexin hemichannels directly to the cell-cell border. These findings support an unanticipated mechanism for protein delivery to points of cell-cell contact.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231; Shaw, Robin/0000-0001-7429-6092; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL075449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R29DA010711, P01DA010154, R01DA010711, R37DA010711] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08 HL075449-01A1, K08 HL075449, HL 075449, K08 HL075449-02] Funding Source: Medline; NIDA NIH HHS [DA 10154, DA 10711] Funding Source: Medline; NIMH NIH HHS [MH 065334] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Angst BD, 1997, CIRC RES, V80, P88, DOI 10.1161/01.RES.80.1.88; Askham JM, 2002, MOL BIOL CELL, V13, P3627, DOI 10.1091/mbc.E02-01-0061; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Berrueta L, 1999, CURR BIOL, V9, P425, DOI 10.1016/S0960-9822(99)80190-0; Chausovsky A, 2000, NAT CELL BIOL, V2, P797, DOI 10.1038/35041037; DAVIDSON JS, 1984, EXP CELL RES, V155, P406, DOI 10.1016/0014-4827(84)90201-5; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Frenzel EM, 1996, DEV BIOL, V179, P1, DOI 10.1006/dbio.1996.0237; Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gros DB, 1996, BIOESSAYS, V18, P719, DOI 10.1002/bies.950180907; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hertig CM, 1996, J CELL SCI, V109, P11; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Ko KS, 2001, J CELL SCI, V114, P1155; Koonce MP, 2004, TRENDS CELL BIOL, V14, P612, DOI 10.1016/j.tcb.2004.09.013; Kostin S, 1999, CIRC RES, V85, P154, DOI 10.1161/01.RES.85.2.154; Krutovskikh V, 2002, SEMIN CANCER BIOL, V12, P267, DOI 10.1016/S1044-579X(02)00013-5; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; Matsushita T, 1999, CIRC RES, V85, P1046; MEGE RM, 1988, P NATL ACAD SCI USA, V85, P7274, DOI 10.1073/pnas.85.19.7274; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Musil LS, 1990, CURR OPIN CELL BIOL, V2, P875, DOI 10.1016/0955-0674(90)90086-T; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oliveira R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-7; Peters NS, 1997, CIRCULATION, V95, P988; Reinecke H, 2004, HUM GENE THER, V15, P627, DOI 10.1089/1043034041361253; Schuyler SC, 2001, J CELL SCI, V114, P247; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Shaw RM, 1997, CIRC RES, V81, P727; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Waterman-Storer CM, 2000, MOL BIOL CELL, V11, P2471, DOI 10.1091/mbc.11.7.2471; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Williams EJ, 2000, MOL CELL NEUROSCI, V15, P456, DOI 10.1006/mcne.2000.0847	54	343	357	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					547	560		10.1016/j.cell.2006.12.037	http://dx.doi.org/10.1016/j.cell.2006.12.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289573	Green Accepted, Bronze			2022-12-28	WOS:000244842700020
J	Willis, SN; Fletcher, JI; Kaufmann, T; van Delft, MF; Chen, L; Czabotar, PE; Ierino, H; Lee, EF; Fairlie, WD; Bouillet, P; Strasser, A; Kluck, RM; Adams, JM; Huang, DCS				Willis, Simon N.; Fletcher, Jamie I.; Kaufmann, Thomas; van Delft, Mark F.; Chen, Lin; Czabotar, Peter E.; Ierino, Helen; Lee, Erinna F.; Fairlie, W. Douglas; Bouillet, Philippe; Strasser, Andreas; Kluck, Ruth M.; Adams, Jerry M.; Huang, David C. S.			Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak	SCIENCE			English	Article							BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; FAMILY-MEMBERS; CELL-DEATH; X-L; BIM; PUMA; RESPONSES; DOMAINS; HELIX	A central issue in the regulation of apoptosis by the Bcl-2 family is whether its BH3-only members initiate apoptosis by directly binding to the essential cell-death mediators Bax and Bak, or whether they can act indirectly, by engaging their pro-survival Bcl-2-like relatives. Contrary to the direct-activation model, we show that Bax and Bak can mediate apoptosis without discernable association with the putative BH3-only activators (Bim, Bid, and Puma), even in cells with no Bim or Bid and reduced Puma. Our results indicate that BH3-only proteins induce apoptosis at least primarily by engaging the multiple pro-survival relatives guarding Bax and Bak.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Huang, DCS (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Melbourne, Vic 3050, Australia.	huang_d@wehi.edu.au	Adams, Jerry M/E-1199-2013; Fletcher, Jamie/V-4667-2019; Strasser, Andreas/C-7581-2013; Huang, David C. S./C-7586-2013; Bouillet, Philippe/E-1241-2013; Lee, Erinna/N-1523-2015; Fairlie, Walter/M-8401-2015; Kluck, Ruth M/C-8413-2013	Strasser, Andreas/0000-0002-5020-4891; Huang, David C. S./0000-0002-3101-4873; Bouillet, Philippe/0000-0002-9012-6058; Lee, Erinna/0000-0003-1255-9808; Fairlie, Walter/0000-0002-2498-1160; Kluck, Ruth M/0000-0002-7101-1925; Adams, Jerry/0000-0002-4360-8628; Fletcher, Jamie/0000-0003-2949-9469; van Delft, Mark/0000-0002-3866-4318; Czabotar, Peter/0000-0002-2594-496X; Kaufmann, Thomas/0000-0001-9906-874X	NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER; NCI NIH HHS [CA80188, CA43540] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cuconati A, 2002, J VIROL, V76, P4547, DOI 10.1128/JVI.76.9.4547-4558.2002; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Shindler KS, 1997, J NEUROSCI, V17, P3112; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhu YN, 2004, P NATL ACAD SCI USA, V101, P7681, DOI 10.1073/pnas.0402293101	24	901	942	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					856	859		10.1126/science.1133289	http://dx.doi.org/10.1126/science.1133289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289999				2022-12-28	WOS:000244069000072
J	Curlin, FA; Lawrence, RE; Chin, MH; Lantos, JD				Curlin, Farr A.; Lawrence, Ryan E.; Chin, Marshall H.; Lantos, John D.			Religion, conscience, and controversial clinical practices	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHYSICIAN-PATIENT RELATIONSHIP; OBJECTION; ENCOUNTER; MEDICINE; AUTONOMY; MODEL; CARE	BACKGROUND: There is a heated debate about whether health professionals may refuse to provide treatments to which they object on moral grounds. It is important to understand how physicians think about their ethical rights and obligations when such conflicts emerge in clinical practice. METHODS: We conducted a cross-sectional survey of a stratified, random sample of 2000 practicing U.S. physicians from all specialties by mail. The primary criterion variables were physicians' judgments about their ethical rights and obligations when patients request a legal medical procedure to which the physician objects for religious or moral reasons. These procedures included administering terminal sedation in dying patients, providing abortion for failed contraception, and prescribing birth control to adolescents without parental approval. RESULTS: A total of 1144 of 1820 physicians (63%) responded to our survey. On the basis of our results, we estimate that most physicians believe that it is ethically permissible for doctors to explain their moral objections to patients (63%). Most also believe that physicians are obligated to present all options (86%) and to refer the patient to another clinician who does not object to the requested procedure (71%). Physicians who were male, those who were religious, and those who had personal objections to morally controversial clinical practices were less likely to report that doctors must disclose information about or refer patients for medical procedures to which the physician objected on moral grounds (multivariate odds ratios, 0.3 to 0.5). CONCLUSIONS: Many physicians do not consider themselves obligated to disclose information about or refer patients for legal but morally controversial medical procedures. Patients who want information about and access to such procedures may need to inquire proactively to determine whether their physicians would accommodate such requests.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Curlin, FA (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	fcurlin@medicine.bsd.uchicago.edu			NCCIH NIH HHS [K23 AT002749, K23 AT002749-02, 1 K23 AT002749] Funding Source: Medline; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002749] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		ALLPORT GW, 1967, J PERS SOC PSYCHOL, V5, P432, DOI 10.1037/h0021212; Cantor J, 2004, NEW ENGL J MED, V351, P2008, DOI 10.1056/NEJMsb042263; Charo RA, 2005, NEW ENGL J MED, V352, P2471, DOI 10.1056/NEJMp058112; Childress J F, 1984, Theor Med, V5, P17, DOI 10.1007/BF00489243; Curlin FA, 2006, MED CARE, V44, P446, DOI 10.1097/01.mlr.0000207434.12450.ef; Curlin FA, 2005, J GEN INTERN MED, V20, P629, DOI 10.1111/j.1525-1497.2005.0119.x; Dana L, 2006, WASH POST; ELLISON CG, 1989, SOC FORCES, V68, P100, DOI 10.2307/2579222; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; Fetzer Institute/National Institute on Aging Working Group, 1999, MULT MEAS REL SPIR U; GORSUCH RL, 1989, J SCI STUD RELIG, V28, P348, DOI 10.2307/1386745; Groves RM., 2011, SURV METHODOL; HOGE DR, 1972, J SCI STUD RELIG, V11, P369; Koenig H, 1997, AM J PSYCHIAT, V154, P885; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Savulescu J, 2006, BRIT MED J, V332, P294, DOI 10.1136/bmj.332.7536.294; SIEGLER M, 1981, B NEW YORK ACAD MED, V57, P56; Stein Rob, 2006, WASH POST, pA06; THOMASMA DC, 1983, ANN INTERN MED, V98, P243, DOI 10.7326/0003-4819-98-2-243; Vischer Robert K, 2006, Stanford Law Pol Rev, V17, P83; White KA, 1999, STANFORD LAW REV, V51, P1703, DOI 10.2307/1229534	21	226	232	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					593	600		10.1056/NEJMsa065316	http://dx.doi.org/10.1056/NEJMsa065316			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	133KV	17287479	Bronze, Green Accepted			2022-12-28	WOS:000244012700007
J	Maynard, A; Buckman, L				Maynard, Alan; Buckman, Laurence			Is doctors' self interest undermining the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ York, York YO10 5DD, N Yorkshire, England; Temple Fortune Hlth Ctr, London NW11 7TE, England	University of York - UK	Maynard, A (corresponding author), Univ York, York YO10 5DD, N Yorkshire, England.	akm3@ayork.ac.uk; l.buckman@ntlworld.com							0	7	7	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					234	235		10.1136/bmj.39066.452847.68	http://dx.doi.org/10.1136/bmj.39066.452847.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272562	Green Published			2022-12-28	WOS:000244172400025
J	Serreli, V; Lee, CF; Kay, ER; Leigh, DA				Serreli, Viviana; Lee, Chin-Fa; Kay, Euan R.; Leigh, David A.			A molecular information ratchet	NATURE			English	Article							ROTAXANE SYNTHESIS; BROWNIAN MOTORS; DRIVEN; TRANSPORT; EQUILIBRIUM; SHUTTLE; ENERGY; MOTION; ROTOR	Motor proteins and other biological machines are highly efficient at converting energy into directed motion and driving chemical systems away from thermodynamic equilibrium(1). But even though these biological structures have inspired the design of many molecules that mimic aspects of their behaviour(2-15), artificial nanomachine systems operate almost exclusively by moving towards thermodynamic equilibrium, not away from it. Here we show that information about the location of a macrocycle in a rotaxane - a molecular ring threaded onto a molecular axle - can be used, on the input of light energy, to alter the kinetics of the shuttling of the macrocycle between two compartments on the axle. For an ensemble of such molecular machines, the macrocycle distribution is directionally driven away from its equilibrium value without ever changing the relative binding affinities of the ring for the different parts of the axle. The selective transport of particles between two compartments by brownian motion in this way bears similarities to the hypothetical task performed without an energy input by a 'demon' in Maxwell's famous thought experiment(16-19). Our observations demonstrate that synthetic molecular machines can operate by an information ratchet mechanism(20-22), in which knowledge of a particle's position is used to control its transport away from equilibrium.	Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Edinburgh	Leigh, DA (corresponding author), Univ Edinburgh, Sch Chem, Kings Bldg,W Mains Rd, Edinburgh EH9 3JJ, Midlothian, Scotland.	David.Leigh@ed.ac.uk	Leigh, David/K-5965-2015; Kay, Euan R/G-4473-2011	Leigh, David/0000-0002-1202-4507; Kay, Euan R/0000-0001-8177-6393	Engineering and Physical Sciences Research Council [EP/D029686/1, GR/T28645/01, EP/C526465/1, EP/C54501X/1, EP/C545001/1] Funding Source: researchfish; EPSRC [EP/D029686/1, EP/C54501X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ASHTON PR, 1995, ANGEW CHEM INT EDIT, V34, P1865, DOI 10.1002/anie.199518651; Astumian RD, 1998, EUR BIOPHYS J BIOPHY, V27, P474, DOI 10.1007/s002490050158; Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Berna J, 2005, NAT MATER, V4, P704, DOI 10.1038/nmat1455; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; Brouwer AM, 2001, SCIENCE, V291, P2124, DOI 10.1126/science.1057886; Chatterjee MN, 2006, J AM CHEM SOC, V128, P4058, DOI 10.1021/ja057664z; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Fletcher SP, 2005, SCIENCE, V310, P80, DOI 10.1126/science.1117090; HAMMOND GS, 1964, J AM CHEM SOC, V86, P3197, DOI 10.1021/ja01070a002; Harman P. M., 2002, SCI LETT PAPERS JC M, VIII, P185; HARMAN PM, 1995, LETT PAPERS JC MAXWE, V2, P331; Hernandez JV, 2004, SCIENCE, V306, P1532, DOI 10.1126/science.1103949; Kay ER, 2006, NATURE, V440, P286, DOI 10.1038/440286a; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; KOLCHINSKI AG, 1995, J CHEM SOC CHEM COMM, P1289, DOI 10.1039/c39950001289; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Leff HS., 2003, MAXWELLS DEMON, V2; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Liu Y, 2005, J AM CHEM SOC, V127, P9745, DOI 10.1021/ja051088p; Maxwell J. C., 1871, THEORY HEAT; MAXWELL JC, 1867, COMMUNICATION   1211; MAXWELL JC, 1875, COMMUNICATION; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Parmeggiani A, 1999, PHYS REV E, V60, P2127, DOI 10.1103/PhysRevE.60.2127; Parrondo JMR, 2002, APPL PHYS A-MATER, V75, P179, DOI 10.1007/s003390201332; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; SCHLIWA M, 2003, MOL MOTORS; Shirai Y, 2005, NANO LETT, V5, P2330, DOI 10.1021/nl051915k; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Tokunaga Y, 2003, CHEM COMMUN, P2250, DOI 10.1039/b306349f	32	467	470	6	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					523	527		10.1038/nature05452	http://dx.doi.org/10.1038/nature05452			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	131KI	17268466				2022-12-28	WOS:000243867300040
J	Bennetto, L; Patel, NK; Fuller, G				Bennetto, Luke; Patel, Nikunj K.; Fuller, Geraint			Trigeminal neuralgia and its management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MICROVASCULAR DECOMPRESSION; DIAGNOSIS; RECOMMENDATIONS; PAIN		Gloucester Royal Hosp, Gloucester GL1 3NN, England; Univ Bristol, Frenchay Hosp, Inst Clin Neurosci, Bristol BS16 1LE, Avon, England; Frenchay Hosp, Dept Neurosurg, Bristol, Avon, England	University of Bristol	Fuller, G (corresponding author), Gloucester Royal Hosp, Gloucester GL1 3NN, England.	geraint.fuller@glos.nhs.uk		Patel, Nikunj/0000-0001-5438-2356				Ashkan K, 2004, NEUROSURGERY, V55, P840, DOI 10.1227/01.NEU.0000137660.06337.C5; Canavero Sergio, 2006, Expert Rev Neurother, V6, P429, DOI 10.1586/14737175.6.3.429; CHENG TMW, 1993, NEUROLOGY, V43, P2298, DOI 10.1212/WNL.43.11.2298; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359.EE; KATUSIC S, 1990, ANN NEUROL, V27, P89, DOI 10.1002/ana.410270114; Li ST, 2004, SURG NEUROL, V62, P400, DOI 10.1016/j.surneu.2004.02.028; Lim JNW., 2004, CLIN EFFICACY SAFETY; Lopez BC, 2004, NEUROSURGERY, V54, P973, DOI 10.1227/01.NEU.0000114867.98896.F0; Lopez BC, 2004, J NEUROL NEUROSUR PS, V75, P1019, DOI 10.1136/jnnp.2003.018564; Love S, 2001, BRAIN, V124, P2347, DOI 10.1093/brain/124.12.2347; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; Nurmikko TJ, 2001, BRIT J ANAESTH, V87, P117, DOI 10.1093/bja/87.1.117; Patel NK, 2003, BRIT J NEUROSURG, V17, P60, DOI 10.1080/0268869031000093735; Sato J, 2004, ORAL SURG ORAL MED O, V97, P18, DOI 10.1016/j.tripleo.2003.08.003; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Wiffen P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001133.pub2; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]; Zakrzewska JM, 2005, NEUROSURGERY, V56, P1304, DOI 10.1227/01.NEU.0000159883.35957.E0; Zakrzewska JM, 1999, PAIN, V79, P51, DOI 10.1016/S0304-3959(98)00145-6; Zakrzewska JM, 2003, NEUROSURGERY, V53, P110, DOI 10.1227/01.NEU.0000068862.78930.EE; Zakrzewska JM, 2002, J NEUROL NEUROSUR PS, V72, P27; Zakrzewska JM, 2002, CLIN J PAIN, V18, P14, DOI 10.1097/00002508-200201000-00003; Zakrzewska Joanna M, 2005, Clin Evid, P1669	24	118	133	1	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					201	205		10.1136/bmj.39085.614792.BE	http://dx.doi.org/10.1136/bmj.39085.614792.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255614	Green Published			2022-12-28	WOS:000244027600037
J	Christensen, J; Agger, K; Cloos, PAC; Pasini, D; Rose, S; Sennels, L; Rappsilber, J; Hansen, KH; Salcini, AE; Helin, K				Christensen, Jesper; Agger, Karl; Cloos, Paul A. C.; Pasini, Diego; Rose, Simon; Sennels, Lau; Rappsilber, Juri; Hansen, Klaus H.; Salcini, Anna Elisabetta; Helin, Kristian			RBP2 belongs to a family of demethylases, specific for tri- and dimethylated lysine 4 on histone 3	CELL			English	Article							ESCAPES X-INACTIVATION; BINDING; METHYLATION; GENE; PROTEINS; TRANSCRIPTION; TRITHORAX; HOMOLOG; METHYLTRANSFERASE; INTERACTS	Methylation of histones; has been regarded as a stable modification defining the epigenetic program of the cell, which regulates chromatin structure and transcription. However, the recent discovery of histone demethylases has challenged the stable nature of histone methylation. Here we demonstrate that the JARID1 proteins RBP2, PLU1, and SMCX are histone demethylases specific for di- and trimethylated histone 3 lysine 4 (H3K4). Consistent with a role for the JARID1 Drosophila homolog Lid in regulating expression of homeotic genes during development, we show that RBP2 is displaced from Hox genes during embryonic stem (ES) cell differentiation correlating with an increase of their H3K4me3 levels and expression. Furthermore, we show that mutation or RNAi depletion of the C. elegans JARID1 homolog rbr-2 leads to increased levels of H3K4me3 during larval development and defects in vulva formation. Taken together, these results suggest that H3K4me3/me2 demethylation regulated by the JARID1 family plays an important role during development.	Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, Ctr Epigenet, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	lisa.salcini@bric.dk; kristian.helin@bric.dk	Salcini, Anna Elisabetta/G-4472-2017; Hu, Ruogu/B-2203-2008; Rappsilber, Juri/ABF-3328-2020; Pasini, Diego/J-9674-2012; Rappsilber, Juri/B-7265-2015; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Cloos, Paul/0000-0001-5863-0054; Salcini, Anna Elisabetta/0000-0001-5828-2512; Hansen, Klaus/0000-0001-9657-8816				AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRENNER S, 1974, GENETICS, V77, P71; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; CLARK SG, 1994, GENETICS, V137, P987; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Fay DS, 2000, GENESIS, V26, P279, DOI 10.1002/(SICI)1526-968X(200004)26:4<279::AID-GENE100>3.0.CO;2-C; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Heard E, 2004, COLD SPRING HARB SYM, V69, P89, DOI 10.1101/sqb.2004.69.89; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Vogt T, 1999, LAB INVEST, V79, P1615; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0	51	399	425	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1063	1076		10.1016/j.cell.2007.02.003	http://dx.doi.org/10.1016/j.cell.2007.02.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320161	Bronze			2022-12-28	WOS:000245396200014
J	Wilcox, AJ; Lie, RT; Solvoll, K; Taylor, J; McConnaughey, DR; Abyholm, F; Vindenes, H; Vollset, SE; Drevon, CA				Wilcox, Allen J.; Lie, Rov Terje; Solvoll, Kari; Taylor, Jack; McConnaughey, D. Robert; Abyholm, Frank; Vindenes, Hallvard; Vollset, Stein Emil; Drevon, Christian A.			Folic acid supplements and risk of facial clefts: national population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; OROFACIAL CLEFTS	Objective To explore the role of folic acid supplements, dietary folates, and multivitamins in the prevention of facial clefts. Design National population based case-control study. Setting Infants born 1996-2001 in Norway. Participants 377 infants with cleft lip with or without cleft palate; 196 infants with cleft palate alone; 763 controls. Main outcome measures Association of facial clefts with maternal intake of folic acid supplements, multivitamins, and folates in diet. Results Folic acid supplementation during early pregnancy (>= 400 mu g/day) was associated with a reduced risk of isolated cleft lip with or without cleft palate after adjustment for multivitamins, smoking, and other potential confounding factors (adjusted odds ratio 0.61, 95% confidence interval 0.39 to 0.96). Independent of supplements, diets rich in fruits, vegetables, and other high folate containing foods reduced the risk somewhat (adjusted odds ratio 0.75, 0.50 to 1.11). The lowest risk of cleft lip was among women with folate rich diets who also took folic acid supplements and multivitamins (0.36, 0.17 to 0.77). Folic acid provided no protection against cleft palate alone (1.07, 0.56 to 2.03). Conclusions Folic acid supplements during early pregnancy seem to reduce the risk of isolated cleft lip (with or without cleft palate) by about a third. Other vitamins and dietary factors may provide additional benefit.	NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; Univ Bergen, Dept Publ Hlth & Primary Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway; Univ Oslo, Fac Med, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; WESTAT Corp, Durham, NC USA; Univ Oslo, Rikshosp, Dept Plast Surg, N-0027 Oslo, Norway; Haukeland Hosp, Dept Plast Surg, N-5021 Bergen, Norway	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; University of Oslo; Westat; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	wilcox@niehs.nih.gov	Wilcox, Allen J/C-7723-2019; Drevon, Christian A/F-6012-2010; taylor, jack a/C-7154-2019	Wilcox, Allen J/0000-0002-3376-1311; taylor, jack a/0000-0001-5303-6398	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES049027, Z01ES049033] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Andersen LF, 2003, EUR J CLIN NUTR, V57, P279, DOI 10.1038/sj.ejcn.1601519; Bailey LB, 2005, AM J CLIN NUTR, V81, p1213S; Christensen K., 2002, CLEFT LIP PALATE ORI, P101; Hayes C, 1996, AM J EPIDEMIOL, V143, P1229, DOI 10.1093/oxfordjournals.aje.a008710; Itikala PR, 2001, TERATOLOGY, V63, P79, DOI 10.1002/1096-9926(200102)63:2&lt;79::AID-TERA1013&gt;3.0.CO;2-3; MOSSEY PA, 2002, CLEFT LIP PALATE ORI, P170; MUNGER RG, 2002, CLEFT LIP PALATE ORI, P170; NES M, 1992, EUR J CLIN NUTR, V46, P809; Rosenberg IH, 2005, AM J CLIN NUTR, V82, P279, DOI 10.1093/ajcn/82.2.279; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; SOLVOLL K, 1993, SCAND J NUTR, V37, P150; van Rooij IALM, 2004, PREV MED, V39, P689, DOI 10.1016/j.ypmed.2004.02.036; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070	14	226	245	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2007	334	7591					464	467		10.1136/bmj.39079.618287.0B	http://dx.doi.org/10.1136/bmj.39079.618287.0B			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144NB	17259187	Bronze, Green Published			2022-12-28	WOS:000244802000033
J	Bell, RE; Studinger, M; Shuman, CA; Fahnestock, MA; Joughin, I				Bell, Robin E.; Studinger, Michael; Shuman, Christopher A.; Fahnestock, Mark A.; Joughin, Ian			Large subglacial lakes in East Antarctica at the onset of fast-flowing ice streams	NATURE			English	Article							VOSTOK; WATER; DISCHARGE; ORIGIN	Water plays a crucial role in ice-sheet stability and the onset of ice streams. Subglacial lake water moves between lakes(1) and rapidly drains, causing catastrophic floods(2). The exact mechanisms by which subglacial lakes influence ice-sheet dynamics are unknown, however, and large subglacial lakes(3,4) have not been closely associated with rapidly flowing ice streams. Here we use satellite imagery and ice-surface elevations to identify a region of subglacial lakes, similar in total area to Lake Vostok, at the onset region of the Recovery Glacier ice stream in East Antarctica and predicted by ice-sheet models(5). We define four lakes through extensive, flat, featureless regions of ice surface bounded by upstream troughs and downstream ridges. Using ice velocities determined using interferometric synthetic aperture radar (InSAR), we find the onset of rapid flow ( moving at 20 to 30 m yr(-1)) of the tributaries to the Recovery Glacier ice stream in a 280-km-wide segment at the downslope margins of these four subglacial lakes. We conclude that the subglacial lakes initiate and maintain rapid ice flow through either active modification of the basal thermal regime of the ice sheet by lake accretion or through scouring bedrock channels in periodic drainage events. We suggest that the role of subglacial lakes needs to be considered in ice-sheet mass balance assessments.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA	Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System Of New Hampshire; University of New Hampshire; University of Washington; University of Washington Seattle	Bell, RE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	robinb@ldeo.columbia.edu	Joughin, Ian/AAR-7778-2021; Fahnestock, Mark/N-2678-2013; Joughin, Ian R/A-2998-2008	Joughin, Ian/0000-0001-6229-679X; Joughin, Ian R/0000-0001-6229-679X; Studinger, Michael/0000-0003-1265-4741				BEITZEL JE, 1971, ANTARCTIC SNOW ICE S, V2, P39; Bell RE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025207; Bell RE, 1998, NATURE, V394, P58, DOI 10.1038/27883; Bell RE, 2002, NATURE, V416, P307, DOI 10.1038/416307a; CUDLIP W, 1987, ANN GLACIOL, V9, P55; Fahnestock M, 2001, SCIENCE, V294, P2338, DOI 10.1126/science.1065370; Gray L, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021387; Gudmundsson GH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002107; Hulbe CL, 2004, J GLACIOL, V50, P471, DOI 10.3189/172756504781829738; Jezek KC, 2003, RADIO SCI, V38, DOI 10.1029/2002RS002643; Jezek KC, 2002, ANN GLACIOL-SER, V34, P263, DOI 10.3189/172756402781818030; JOHNSON JV, 2002, THESIS U MAINE; Joughin I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023844; Joughin I, 2006, PHILOS T R SOC A, V364, P1795, DOI 10.1098/rsta.2006.1799; Jouzel J, 1999, SCIENCE, V286, P2138, DOI 10.1126/science.286.5447.2138; KAMB B, 1985, SCIENCE, V227, P269; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Lewis AR, 2006, GEOLOGY, V34, P513, DOI 10.1130/G22145.1; Siegert MJ, 2000, J GLACIOL, V46, P702, DOI 10.3189/172756500781832783; Studinger M, 2003, EARTH PLANET SC LETT, V205, P195, DOI 10.1016/S0012-821X(02)01041-5; Tikku AA, 2004, EARTH PLANET SC LETT, V227, P249, DOI 10.1016/j.epsl.2004.09.021; Wingham DJ, 2006, NATURE, V440, P1033, DOI 10.1038/nature04660	22	184	195	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					904	907		10.1038/nature05554	http://dx.doi.org/10.1038/nature05554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314977				2022-12-28	WOS:000244341200046
J	Petrie, KJ; Muller, JT; Schirmbeck, F; Donkin, L; Broadbent, E; Ellis, CJ; Gamble, G; Rief, W				Petrie, Keith J.; Mueller, Jan Tobias; Schirmbeck, Frederike; Donkin, Liesje; Broadbent, Elizabeth; Ellis, Christopher J.; Gamble, Greg; Rief, Winfried			Effect of providing information about normal test results on patients' reassurance: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CHEST PAIN	Objective To investigate whether providing information about normal findings before a diagnostic test improves patients' reassurance and reduces anxiety about symptoms. Design Randomised controlled trial. Setting Outpatient cardiology clinic. Participants 92 patients with chest pain referred for a diagnostic exercise stress test. Intervention Before undergoing testing patients were randomised to receive standard information (n=28; control group), a pamphlet explaining the function of the test and the meaning of normal test results (n=30; pamphlet group), or the pamphlet and a brief discussion about the meaning of normal test results (n=34; discussion group). Main outcome measures The primary outcome was patients' reported reassurance on a 5 item scale immediately after the test and at one month. Secondary outcomes were the proportion of patients still with chest pain and still taking cardiac drugs at one month. Results The mean levels of reassurance after testing and feedback from the doctor were significantly higher in the discussion group (42.0, 95% confidence interval 39.7 to 44.2) than in the pamphlet (39.2, 36.1 to 42.3) and control groups (35.8, 31.6 to 39.9). This difference was maintained atone month. The proportion of patients still reporting chest pain at one month decreased significantly in the discussion group (to 17%) and pamphlet group (to 28%) but not in the control group (to 36%). A trend was for fewer patients in the discussion group to be taking cardiac drugs at one month. Conclusion Providing patients with information about normal test results before testing can improve rates of reassurance and reduce the likelihood of future reports of chest pain.	Univ Auckland, Fac Med & Hlth Sci, Dept Psychol Med, Auckland 1, New Zealand; Auckland City Hosp, Dept Cardiol, Auckland, New Zealand; Univ Marburg, Fac Psychol, Marburg, Germany	University of Auckland; Auckland City Hospital; Philipps University Marburg	Petrie, KJ (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Psychol Med, Private Bag 92019, Auckland 1, New Zealand.	kj.petrie@auckland.ac.nz	Rief, Winfried/ABD-4994-2021; Schirmbeck, Frederike/G-8187-2016	Rief, Winfried/0000-0002-7019-2250; Gamble, Greg/0000-0003-0412-3203; Donkin, Liesje/0000-0002-0457-8788; Broadbent, Elizabeth/0000-0003-3626-9100; Schirmbeck, Frederike/0000-0003-1700-0958				CHANNER KS, 1987, Q J MED, V63, P315; Donkin L, 2006, PSYCHOL HEALTH, V21, P421, DOI 10.1080/14768320500329292; Lucock MP, 1997, BRIT MED J, V315, P572; Meechan GT, 2005, PSYCHO-ONCOLOGY, V14, P239, DOI 10.1002/pon.841; Nijher GJ, 2001, BRIT MED J, V323, P1319, DOI 10.1136/bmj.323.7325.1319	5	79	80	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					352	354		10.1136/bmj.39093.464190.55	http://dx.doi.org/10.1136/bmj.39093.464190.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17259186	Green Published, Bronze			2022-12-28	WOS:000244560400032
J	Goldston, D				Goldston, David			A word in the right place	NATURE			English	Editorial Material									Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Princeton University	Goldston, D (corresponding author), Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA.								0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					698	698		10.1038/445698a	http://dx.doi.org/10.1038/445698a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301762	Bronze			2022-12-28	WOS:000244205200012
J	Zhou, TQ; Xu, L; Dey, B; Hessell, AJ; Van Ryk, D; Xiang, SH; Yang, XZ; Zhang, MY; Zwick, MB; Arthos, J; Burton, DR; Dimitrov, DS; Sodroski, J; Wyatt, R; Nabel, GJ; Kwong, PD				Zhou, Tongqing; Xu, Ling; Dey, Barna; Hessell, Ann J.; Van Ryk, Donald; Xiang, Shi-Hua; Yang, Xinzhen; Zhang, Mei-Yun; Zwick, Michael B.; Arthos, James; Burton, Dennis R.; Dimitrov, Dimiter S.; Sodroski, Joseph; Wyatt, Richard; Nabel, Gary J.; Kwong, Peter D.			Structural definition of a conserved neutralization epitope on HIV-1 gp120	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; RECEPTOR; RECOGNITION; ANTIGEN; PROTEIN; DOMAIN; IDENTIFICATION; REGIONS	The remarkable diversity, glycosylation and conformational flexibility of the human immunodeficiency virus type 1 (HIV-1) envelope (Env), including substantial rearrangement of the gp120 glycoprotein upon binding the CD4 receptor, allow it to evade antibody-mediated neutralization. Despite this complexity, the HIV-1 Env must retain conserved determinants that mediate CD4 binding. To evaluate how these determinants might provide opportunities for antibody recognition, we created variants of gp120 stabilized in the CD4-bound state, assessed binding of CD4 and of receptor-binding-site antibodies, and determined the structure at 2.3 angstrom resolution of the broadly neutralizing antibody b12 in complex with gp120. b12 binds to a conformationally invariant surface that overlaps a distinct subset of the CD4-binding site. This surface is involved in the metastable attachment of CD4, before the gp120 rearrangement required for stable engagement. A site of vulnerability, related to a functional requirement for efficient association with CD4, can therefore be targeted by antibody to neutralize HIV-1.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst, Boston, MA 02115 USA; NCI, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010	Zhou, Tongqing/0000-0002-3935-4637; Hessell, Ann/0000-0001-7471-9366	NATIONAL CANCER INSTITUTE [Z01BC010701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005022, U19AI067854, Z01AI000883, Z01AI005078, Z01AI005068] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAID NIH HHS [U19 AI067854-03, U19 AI067854] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arthos J, 2002, J BIOL CHEM, V277, P11456, DOI 10.1074/jbc.M111191200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; BURTON DR, 1997, AIDS SA, V11, P587; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fleury D, 2000, PROTEINS, V40, P572; *JOINT UN PROGR HI, 2006, REP GLOB AIDS EP; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; KOWALSKI M, 1987, SCIENCE, V237, P1351, DOI 10.1126/science.3629244; Kwong PD, 1999, J BIOL CHEM, V274, P4115, DOI 10.1074/jbc.274.7.4115; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LI Y, 2006, AIDS VACCINE 2006; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Parren PWHI, 1999, AIDS, V13, pS137; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200; PROFY AT, 1990, J IMMUNOL, V144, P4641; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2004, J VIROL, V78, P12975, DOI 10.1128/JVI.78.23.12975-12986.2004; Zhang MY, 2004, J MOL BIOL, V335, P209, DOI 10.1016/j.jmb.2003.09.055; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	50	627	659	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					732	737		10.1038/nature05580	http://dx.doi.org/10.1038/nature05580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301785	Green Published			2022-12-28	WOS:000244205200037
J	Tsiodras, S; Mooney, JD; Hatzakilis, A				Tsiodras, Sotirios; Mooney, John D.; Hatzakilis, Angelos			Role of combination antiviral therapy in pandemic influenza	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							A VIRUS; AMANTADINE; RIMANTADINE; RESISTANCE; ANTIINFLUENZA; PROPHYLAXIS; CHILDREN		Univ Athens, Sch Med, Acad Dept Internal Med 4, Athens 12462, Greece; Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens 12462, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Tsiodras, S (corresponding author), Univ Athens, Sch Med, Acad Dept Internal Med 4, Athens 12462, Greece.		Mooney, John D/O-3211-2019; Mooney, John/H-6459-2019; TSIODRAS, SOTIRIOS/AAD-8273-2019	Mooney, John/0000-0002-6639-8491; TSIODRAS, SOTIRIOS/0000-0002-0463-4321				Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; BELSHE RB, 1989, J INFECT DIS, V159, P430, DOI 10.1093/infdis/159.3.430; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Centers for Disease Control and Prevention, CDC REC US AM RIM TR; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Fedson DS, 2006, CLIN INFECT DIS, V43, P199, DOI 10.1086/505116; Fleming DM, 2001, INT J CLIN PRACT, V55, P189; GARTEN RJ, 2006, 5 INT C EM INF DIS; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Ilyushina NA, 2006, ANTIVIR RES, V70, P121, DOI 10.1016/j.antiviral.2006.01.012; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; MONTO AS, 1979, JAMA-J AM MED ASSOC, V241, P1003, DOI 10.1001/jama.241.10.1003; Monto AS, 2003, VACCINE, V21, P1796, DOI 10.1016/S0264-410X(03)00075-6; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Scholtissek C, 1998, ANTIVIR RES, V38, P213, DOI 10.1016/S0166-3542(98)00015-1; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; *WHO, 2006, WHO RAP ADV GUID PHA; *WHO, 2006, WHO PAND INF DRAFT P; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994	25	17	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2007	334	7588					293	294		10.1136/bmj.39105.428981.BE	http://dx.doi.org/10.1136/bmj.39105.428981.BE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MN	17289732	Green Published			2022-12-28	WOS:000244654100031
J	Leung, B; Waddell, S				Leung, Benjamin; Waddell, Scott			Smelling excitement in the antennal lobe	CELL			English	Editorial Material							MAP; REPRESENTATION; BRAIN; ODORS; FLY		Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Leung, B (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	benjamin.leung@umassmed.edu; scott.waddell@umassmed.edu		Waddell, Scott/0000-0003-4503-6229				Benton R, 2006, CELL MOL LIFE SCI, V63, P1579, DOI 10.1007/s00018-006-6130-7; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Jefferis GSXE, 2005, CURR BIOL, V15, pR668, DOI 10.1016/j.cub.2005.08.033; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; SHANG Y, 2007, CELL; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	11	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					431	432		10.1016/j.cell.2007.01.016	http://dx.doi.org/10.1016/j.cell.2007.01.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289561	Bronze			2022-12-28	WOS:000244842700008
J	Steinbrook, R				Steinbrook, Robert			Thailand and the compulsory licensing of efavirenz	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV					rsteinbrook@attglobal.net						Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; World Health Organization, 2006, PROGR GLOB ACC HIV A; World Health Organization, 2006, ANT THER HIV INF AD	4	29	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					544	546		10.1056/NEJMp068297	http://dx.doi.org/10.1056/NEJMp068297			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287474				2022-12-28	WOS:000244012700002
J	Uchida, K; Beck, DC; Yamamoto, T; Berclaz, P; Abe, S; Staudt, MK; Carey, BC; Filippi, M; Wert, SE; Denson, LA; Puchalski, JT; Hauck, DM; Trapnell, BC				Uchida, Kanji; Beck, David C.; Yamamoto, Takashi; Berclaz, Pierre-Yves; Abe, Shuichi; Staudt, Margaret K.; Carey, Brenna C.; Filippi, Marie-Dominique; Wert, Susan E.; Denson, Lee A.; Puchalski, Jonathan T.; Hauck, Diane M.; Trapnell, Bruce C.			GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; MACROPHAGE DIFFERENTIATION; AUTOIMMUNE-DISEASE; BONE-MARROW; PU.1; MICE; LUNG; PHAGOCYTOSIS; INNATE; ACTIVATION	BACKGROUND: Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in patients with pulmonary alveolar proteinosis and that GM-CSF autoantibodies cause the dysfunction. METHODS: We studied 12 subjects with pulmonary alveolar proteinosis, 61 healthy control subjects, and 12 control subjects with either cystic fibrosis or end-stage liver disease. We also studied GM-CSF(sup -/-) mice and wild-type mice. We evaluated basal neutrophil functions, neutrophil functions after priming by GM-CSF to augment antimicrobial functions, and the effects of highly purified GM-CSF autoantibodies on neutrophil functions in vitro and in vivo. RESULTS: Neutrophils from subjects with pulmonary alveolar proteinosis had normal ultrastructure and differentiation markers but impaired basal functions and antimicrobial functions after GM-CSF priming. GM-CSF(sup -/-) mice also had reduced basal neutrophil functions, but functions after GM-CSF priming were unimpaired. The neutrophil dysfunction characteristic of pulmonary alveolar proteinosis was reproduced in a dose-dependent fashion in blood specimens from healthy control subjects after incubation with affinity-purified GM-CSF autoantibodies isolated from patients with pulmonary alveolar proteinosis. The injection of mouse GM-CSF antibodies into wild-type mice also caused neutrophil dysfunction. CONCLUSIONS: The antimicrobial functions of neutrophils are impaired in patients with pulmonary alveolar proteinosis, owing to the presence of GM-CSF autoantibodies. The effects of these autoantibodies show that GM-CSF is an essential regulator of neutrophil functions.	Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Trapnell, BC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Rm 4029,TCHRF,3333 Burnet Ave, Cincinnati, OH 45229 USA.	bruce.trapnell@cchmc.org			NCRR NIH HHS [RR019498] Funding Source: Medline; NHLBI NIH HHS [HL69459, HL071823] Funding Source: Medline; NICHD NIH HHS [T32HD043005] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD043005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071823, R01HL069459] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAINTON DF, 1971, J EXP MED, V134, P907, DOI 10.1084/jem.134.4.907; Berclaz PY, 2002, J IMMUNOL, V169, P6332, DOI 10.4049/jimmunol.169.11.6332; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bonfield TL, 2003, AM J PHYSIOL-LUNG C, V285, pL1132, DOI 10.1152/ajplung.00216.2003; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Bozinovski S, 2004, AM J PHYSIOL-LUNG C, V286, pL877, DOI 10.1152/ajplung.00275.2003; CLARK RA, 2005, CURRENT PROTOCOLS IM, P2; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; DeForge LE, 2000, J IMMUNOL METHODS, V245, P79, DOI 10.1016/S0022-1759(00)00279-9; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; ENGLISH D, 1992, BLOOD, V80, P776; FLEISCHMANN J, 1986, BLOOD, V68, P708; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; GRAVES V, 1993, BLOOD, V81, P1668; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; HASSAN NF, 1988, J LEUKOCYTE BIOL, V43, P317, DOI 10.1002/jlb.43.4.317; Hellmich B, 2002, ARTHRITIS RHEUM, V46, P2384, DOI 10.1002/art.10497; Ikegami M, 1996, AM J PHYSIOL-LUNG C, V270, pL650, DOI 10.1152/ajplung.1996.270.4.L650; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kitamura T, 1999, J EXP MED, V190, P875, DOI 10.1084/jem.190.6.875; KOLLER DY, 1995, AM J RESP CRIT CARE, V152, P629, DOI 10.1164/ajrccm.152.2.7633718; Krinner EM, 2007, MOL IMMUNOL, V44, P916, DOI 10.1016/j.molimm.2006.03.020; Mann BS, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-59; Meager A, 1999, IMMUNOLOGY, V97, P526; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; ROSEN SH, 1958, NEW ENGL J MED, V258, P1123, DOI 10.1056/NEJM195806052582301; Rosenbloom AJ, 2005, CHEST, V127, P2139, DOI 10.1378/chest.127.6.2139; Rosenzweig SD, 2004, J ALLERGY CLIN IMMUN, V113, P620, DOI 10.1016/j.jaci.2004.02.001; Seymour JF, 1997, BLOOD, V90, P3037, DOI 10.1182/blood.V90.8.3037; Seymour JF, 2002, AM J RESP CRIT CARE, V166, P215, DOI 10.1164/rccm.2109105; Seymour John F, 2004, Treat Respir Med, V3, P229, DOI 10.2165/00151829-200403040-00003; Shibata Y, 2001, IMMUNITY, V15, P557, DOI 10.1016/S1074-7613(01)00218-7; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Trapnell BC, 2003, NEW ENGL J MED, V349, P2527, DOI 10.1056/NEJMra023226; TREWEEKE AT, 1994, J LEUKOCYTE BIOL, V55, P612, DOI 10.1002/jlb.55.5.612; Uchida K, 2004, BLOOD, V103, P1089, DOI 10.1182/blood-2003-05-1565; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869	38	187	197	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					567	579		10.1056/NEJMoa062505	http://dx.doi.org/10.1056/NEJMoa062505			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287477				2022-12-28	WOS:000244012700005
J	Segal, JB; Streiff, MB; Hoffman, LV; Thornton, K; Bass, EB				Segal, Jodi B.; Streiff, Michael B.; Hoffman, Lawrence V.; Thornton, Katherine; Bass, Eric B.			Management of venous thromboembolism: A systematic review for a practice guideline	ANNALS OF INTERNAL MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; CATHETER-DIRECTED THROMBOLYSIS; ORAL ANTICOAGULANT-THERAPY; LONG-TERM TREATMENT; INTRAVENOUS UNFRACTIONATED HEPARIN; COST-MINIMIZATION ANALYSIS; VENA-CAVAL FILTERS; PULMONARY-EMBOLISM; OUTPATIENT TREATMENT	Background: New treatments are available for treatment of venous thromboembolism. Purpose: To review the evidence on the efficacy of interventions for treatment of deep venous thrombosis (DVT) and pulmonary embolism. Data Sources: MEDLINE, MICROMEDEX, the Cochrane Controlled Trials Register, and Cochrane Database of Systematic Reviews from the 1950s through June 2006. Study Selection: Randomized, controlled trials; systematic reviews of trials; and observational studies; all restricted to English-language articles. Data Extraction: Paired reviewers assessed study quality and abstracted data. The authors pooled results about optimal duration of anticoagulation. Data Synthesis: This review includes 101 articles. Low-molecular-weight heparin (LMWH) is modestly superior to unfractionated heparin at preventing recurrent DVT and is at least as effective as unfractionated heparin for treatment of pulmonary embolism. Outpatient treatment of venous thromboembolism is likely to be effective and safe in carefully chosen patients, with appropriate services available. Inpatient or outpatient use of LMWH is cost-saving or cost-effective compared with unfractionated heparin. In observational studies, catheter-directed thrombolysis safely restored vein patency in select patients. Moderately strong evidence supports early use of compression stockings to reduce postthrombotic syndrome. Limited evidence suggests that vena cava filters are only modestly efficacious for prevention of pulmonary embolism. Conve ntional-intensity oral anticoagulation beyond 12 months may be optimal for patients with unprovoked venous thromboembolism, although patients with transient risk factors benefit little from more than 3 months of therapy. High-quality trials support use of LMWH in place of oral anticoagulation, particularly in patients with cancer. Little evidence is available to guide treatment of venous thromboembolism during pregnancy. Limitations: The authors could not address all management questions, and excluded non-English-language literature. Conclusions: The strength of evidence varies across the study questions but generally is strong.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	Johns Hopkins University; Stanford University	Segal, JB (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Room 8047, Baltimore, MD 21205 USA.	jsegal@jhmi.edu		Bass, Eric/0000-0001-9106-527X	PHS HHS [290-97-0006] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aburahma A F, 1993, W V Med J, V89, P445; AbuRahma AF, 2001, J VASC SURG, V33, P375, DOI 10.1067/mva.2001.111488; AbuRahma AF, 1999, AM SURGEON, V65, P164; Acharya G, 2005, ACTA OBSTET GYN SCAN, V84, P155, DOI 10.1111/j.0001-6349.2005.00565.x; Ageno W, 2002, HAEMATOLOGICA, V87, P286; Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Aujesky D, 2005, CHEST, V128, P1601, DOI 10.1378/chest.128.3.1601; Avritscher EBC, 2004, SUPPORT CARE CANCER, V12, P531, DOI 10.1007/s00520-004-0597-2; Backman K, 2004, SCAND J PRIM HEALTH, V22, P44, DOI 10.1080/02813430310003543; Barbour L A, 2001, Int J Gynaecol Obstet, V75, P203; Belcaro G, 1999, ANGIOLOGY, V50, P781; BERGQVIST A, 1983, ACTA OBSTET GYN SCAN, V62, P443, DOI 10.3109/00016348309154217; Bjarnason H, 1997, J VASC INTERV RADIOL, V8, P405, DOI 10.1016/S1051-0443(97)70581-5; Boccalon H, 2000, ARCH INTERN MED, V160, P1769, DOI 10.1001/archinte.160.12.1769; Boucher M, 2003, PHARMACOTHERAPY, V23, P301, DOI 10.1592/phco.23.3.301.32102; Brandjes DPM, 1997, LANCET, V349, P759, DOI 10.1016/S0140-6736(96)12215-7; Brewer D, 1998, J FAM PRACTICE, V47, P185; Caro JJ, 2002, PHARMACOECONOMICS, V20, P593, DOI 10.2165/00019053-200220090-00003; Castaneda F, 2002, J VASC INTERV RADIOL, V13, P577, DOI 10.1016/S1051-0443(07)61650-9; Chong BH, 2005, J THROMB THROMBOLYS, V19, P173, DOI 10.1007/s11239-005-1848-x; *CLOT INV, 2003, NEW ENGL J MED, V349, P146; Comerota AJ, 2000, J VASC SURG, V32, P130, DOI 10.1067/mva.2000.105664; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; Daskalakis G, 1997, EUR J OBSTET GYN R B, V74, P165, DOI 10.1016/S0301-2115(97)00110-3; Daskalopoulos ME, 2005, EUR J VASC ENDOVASC, V29, P638, DOI 10.1016/j.ejvs.2004.02.029; de Lissovoy G, 2000, ARCH INTERN MED, V160, P3160, DOI 10.1001/archinte.160.20.3160; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Dolovich M, 1997, PEDIATR PULM, P184; Ebell MH, 2004, AM FAM PHYSICIAN, V69, P548; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; Estrada CA, 2000, J GEN INTERN MED, V15, P108, DOI 10.1046/j.1525-1497.2000.03349.x; *EXT LOW INT ANT T, 2003, NEW ENGL J MED, V349, P631; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Ginsberg JS, 2001, ARCH INTERN MED, V161, P2105, DOI 10.1001/archinte.161.17.2105; Gomez-Outes A, 2006, PHARMACOECONOMICS, V24, P81, DOI 10.2165/00019053-200624010-00007; Gonzalez-Fajardo JA, 1999, J VASC SURG, V30, P283, DOI 10.1016/S0741-5214(99)70139-4; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; Gould MK, 1999, ANN INTERN MED, V130, P789, DOI 10.7326/0003-4819-130-10-199905180-00002; Grau E, 2001, AM J HEMATOL, V67, P10, DOI 10.1002/ajh.1069; GREEN D, 1994, PHARMACOL REV, V46, P89; Grunwald MR, 2004, J VASC INTERV RADIOL, V15, P347, DOI 10.1097/01.RVI.0000121407.46920.15; Hann CL, 2005, BLOOD REV, V19, P179, DOI 10.1016/j.blre.2004.08.002; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Hettiarachchi R J, 1998, Curr Opin Pulm Med, V4, P220, DOI 10.1097/00063198-199807000-00007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIRSH J, 1995, THROMB HAEMOSTASIS, V74, P360; Horne MK, 2000, AM J MED, V108, P251, DOI 10.1016/S0002-9343(99)00407-6; Howard PA, 1997, ANN PHARMACOTHER, V31, P192, DOI 10.1177/106002809703100212; Hull RD, 1997, ARCH INTERN MED, V157, P289; Hunt D, 1998, SOUTH MED J, V91, P2; Huse DM, 2002, AM J MANAG CARE, V8, pS10; Jacobsen AF, 2003, BJOG-INT J OBSTET GY, V110, P139; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kakkar VV, 2003, THROMB HAEMOSTASIS, V89, P674; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Laiho MK, 2004, EUR J VASC ENDOVASC, V28, P391, DOI 10.1016/j.ejvs.2004.06.007; Lapidus L, 2002, PATHOPHYSIOL HAEMO T, V32, P59, DOI 10.1159/000065077; Leizorovicz A, 1996, DRUGS, V52, P30, DOI 10.2165/00003495-199600527-00006; LENSING AWA, 1995, ARCH INTERN MED, V155, P601, DOI 10.1001/archinte.155.6.601; Lepercq J, 2001, BRIT J OBSTET GYNAEC, V108, P1134, DOI 10.1111/j.1471-0528.2003.00272.x; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Lloyd AC, 1997, ANN PHARMACOTHER, V31, P842, DOI 10.1177/106002809703100705; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Lopez-Beret P, 2001, J VASC SURG, V33, P77, DOI 10.1067/mva.2001.109336; Martineau P, 1998, ANN PHARMACOTHER, V32, P588, DOI 10.1345/aph.16450; Mewissen MW, 1999, RADIOLOGY, V211, P39, DOI 10.1148/radiology.211.1.r99ap4739; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Mismetti P, 2005, CHEST, V128, P2203, DOI 10.1378/chest.128.4.2203; Monreal M, 1998, HAEMOSTASIS, V28, P236; O'Brien B, 1999, ARCH INTERN MED, V159, P2298, DOI 10.1001/archinte.159.19.2298; O'Brien JA, 2002, PHARMACOECONOMICS, V20, P603, DOI 10.2165/00019053-200220090-00004; Ogawa T, 2005, J VASC SURG, V42, P940, DOI 10.1016/j.jvs.2005.07.041; Ouriel K, 2000, J VASC INTERV RADIOL, V11, P849, DOI 10.1016/S1051-0443(07)61799-0; Pearson S D, 1999, Eff Clin Pract, V2, P210; Pinede L, 2001, CIRCULATION, V103, P2453; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Raju S, 1998, J Miss State Med Assoc, V39, P81; Raschke R, 2003, ANN INTERN MED, V138, P720, DOI 10.7326/0003-4819-138-9-200305060-00008; Razavi MK, 2002, J ENDOVASC THER, V9, P593, DOI 10.1583/1545-1550(2002)009<0593:ICROTT>2.0.CO;2; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rocha E, 2000, HAEMATOLOGICA, V85, P935; Rodger M, 1998, CAN MED ASSOC J, V159, P931; Rodie VA, 2002, BJOG-INT J OBSTET GY, V109, P1020, DOI 10.1016/S1470-0328(02)01525-2; ROGER MA, 2003, THROMB RES, V112, P13; Rosfors S, 2001, EUR J VASC ENDOVASC, V22, P448, DOI 10.1053/ejvs.2001.1499; Rowan JA, 2003, AUST NZ J OBSTET GYN, V43, P123, DOI 10.1046/j.0004-8666.2003.00034.x; Rymes NL, 2002, CLIN LAB HAEMATOL, V24, P165, DOI 10.1046/j.1365-2257.2002.00440.x; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Segal J B, 2003, Evid Rep Technol Assess (Summ), P1; SEMBA CP, 1994, RADIOLOGY, V191, P487, DOI 10.1148/radiology.191.2.8153327; Sillesen H, 2005, EUR J VASC ENDOVASC, V30, P556, DOI 10.1016/j.ejvs.2005.06.012; Smith BJ, 2002, INTERN MED J, V32, P29, DOI 10.1046/j.1445-5994.2002.00146.x; Smith MP, 2004, AM J OBSTET GYNECOL, V190, P495, DOI 10.1016/S0002-9378(03)00953-0; Spyropoulos AC, 2002, CHEST, V122, P108, DOI 10.1378/chest.122.1.108; Stein PD, 2004, AM J CARDIOL, V94, P1090, DOI 10.1016/j.amjcard.2004.06.077; Sugimoto K, 2003, J VASC SURG, V37, P512, DOI 10.1067/mva.2003.41; TAWES RL, 1985, J CARDIOVASC SURG, V26, P303; Tillman DJ, 2000, ARCH INTERN MED, V160, P2926, DOI 10.1001/archinte.160.19.2926; Ulander VM, 2002, THROMB RES, V106, P13, DOI 10.1016/S0049-3848(02)00074-9; van Den Belt AG, 2000, COCHRANE DB SYST REV; van den Belt AGM, 1998, THROMB HAEMOSTASIS, V79, P259, DOI 10.1055/s-0037-1614975; van der Heijden JF, 2000, THROMB RES, V100, pV121; Veiga F, 2000, THROMB HAEMOSTASIS, V84, P559; Vinson DR, 2001, ANN EMERG MED, V37, P251, DOI 10.1067/mem.2001.113703; White RH, 2000, ARCH INTERN MED, V160, P2033, DOI 10.1001/archinte.160.13.2033	119	125	166	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					211	222		10.7326/0003-4819-146-3-200702060-00150	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00150			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17261856				2022-12-28	WOS:000243957400008
J	Braun, U; Beyth, RJ; Ford, ME; McCullough, LB				Braun, Ursula; Beyth, Rebecca J.; Ford, Marvella E.; McCullough, Laurence B.			Defining limits in care of terminally ill patients	BRITISH MEDICAL JOURNAL			English	Editorial Material							OF-LIFE DECISIONS; PREVENTIVE ETHICS; END		Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Sect Geriat, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Sect Hlth Serv Res, Houston, TX 77030 USA; N Florida S Georgia Vet Hlth Syst, Gainesville, FL 32608 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Hlth Dispar Res Programme, Charleston, SC 29425 USA; Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Medical University of South Carolina; Baylor College of Medicine	Braun, U (corresponding author), Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Sect Geriat, 2002 Holcombe Blvd, Houston, TX 77030 USA.	ubraun@bcm.tmc.edu						[Anonymous], 1986, HIST THEORY INFORM C; Back Anthony L, 2003, Ann Intern Med, V138, P439; Baker R, 2000, J AM GERIATR SOC, V48, pS61, DOI 10.1111/j.1532-5415.2000.tb03143.x; Borum ML, 2000, J AM GERIATR SOC, V48, pS194, DOI 10.1111/j.1532-5415.2000.tb03132.x; BRETT AS, 1986, NEW ENGL J MED, V315, P1347, DOI 10.1056/NEJM198611203152109; Buchanan Allen E., 1989, DECIDING OTHERS ETHI; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Chervenak FA, 1996, WOMEN HEALTH ISS, V6, P304, DOI 10.1016/1049-3867(96)00020-5; Field MJ, 1997, APPROACHING DEATH IM; FORROW L, 1993, J CLIN ETHIC, V4, P287; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; Gregory J., 1998, J GREGORYS WRITINGS, P161; LO B, 1995, JAMA-J AM MED ASSOC, V274, P1634, DOI 10.1001/jama.274.20.1634; Ravitsky V, 2005, BRIT MED J, V330, P415, DOI 10.1136/bmj.330.7488.415; Sullivan AM, 2003, J GEN INTERN MED, V18, P685, DOI 10.1046/j.1525-1497.2003.21215.x	15	18	18	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					239	241		10.1136/bmj.39048.475046.68	http://dx.doi.org/10.1136/bmj.39048.475046.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135SD	17272566	Green Published			2022-12-28	WOS:000244172400028
J	Fritz, DM; Reis, DA; Adams, B; Akre, RA; Arthur, J; Blome, C; Bucksbaum, PH; Cavalieri, AL; Engemann, S; Fahy, S; Falcone, RW; Fuoss, PH; Gaffney, KJ; George, MJ; Hajdu, J; Hertlein, MP; Hillyard, PB; Hoegen, MHV; Kammler, M; Kaspar, J; Kienberger, R; Krejcik, P; Lee, SH; Lindenberg, AM; McFarland, B; Meyer, D; Montagne, T; Murray, ED; Nelson, AJ; Nicoul, M; Pahl, R; Rudati, J; Schlarb, H; Siddons, DP; Sokolowski-Tinten, K; Tschentscher, T; von der Linde, D; Hastings, JB				Fritz, D. M.; Reis, D. A.; Adams, B.; Akre, R. A.; Arthur, J.; Blome, C.; Bucksbaum, P. H.; Cavalieri, A. L.; Engemann, S.; Fahy, S.; Falcone, R. W.; Fuoss, P. H.; Gaffney, K. J.; George, M. J.; Hajdu, J.; Hertlein, M. P.; Hillyard, P. B.; Hoegen, M. Horn-von; Kammler, M.; Kaspar, J.; Kienberger, R.; Krejcik, P.; Lee, S. H.; Lindenberg, A. M.; McFarland, B.; Meyer, D.; Montagne, T.; Murray, E. D.; Nelson, A. J.; Nicoul, M.; Pahl, R.; Rudati, J.; Schlarb, H.; Siddons, D. P.; Sokolowski-Tinten, K.; Tschentscher, Th.; von der Linde, D.; Hastings, J. B.			Ultrafast bond softening in bismuth: Mapping a solid's interatomic potential with X-rays	SCIENCE			English	Article							COHERENT PHONONS; DISPLACIVE EXCITATION; ANTIMONY; DYNAMICS; SILICON; PULSES; SB; BI	Intense femtosecond laser excitation can produce transient states of matter that would otherwise be inaccessible to laboratory investigation. At high excitation densities, the interatomic forces that bind solids and determine many of their properties can be substantially altered. Here, we present the detailed mapping of the carrier density-dependent interatomic potential of bismuth approaching a solid-solid phase transition. Our experiments combine stroboscopic techniques that use a high-brightness linear electron accelerator-based x-ray source with pulse-by-pulse timing reconstruction for femtosecond resolution, allowing quantitative characterization of the interatomic potential energy surface of the highly excited solid.	Univ Michigan, Dept Phys, FOCUS Ctr, Ann Arbor, MI 48109 USA; Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; Stanford Linear Accelerator Ctr, PULSE Ctr, Menlo Pk, CA 94025 USA; Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; DESY, D-22607 Hamburg, Germany; Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Natl Univ Ireland Univ Coll Cork, Dept Phys, Cork, Ireland; Natl Univ Ireland Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA; Univ Duisburg Essen, Inst Expt Phys, D-47057 Duisburg, Germany; Leibniz Univ Hannover, Inst Halbleitertechnol, Hannover, Germany; Korea Res Inst Stand & Sci, Taejon 305600, South Korea; Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; Univ Chicago, Conortium Adv Radiat Sources, Chicago, IL 60637 USA; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Stanford University; Stanford University; Max Planck Society; University College Cork; University College Cork; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory; Uppsala University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; University of Duisburg Essen; Leibniz University Hannover; Korea Research Institute of Standards & Science (KRISS); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Chicago; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Fritz, DM (corresponding author), Univ Michigan, Dept Phys, FOCUS Ctr, Ann Arbor, MI 48109 USA.	dmfritz@slac.stanford.edu	Gaffney, Kelly J/N-1597-2017; Sokolowski-Tinten, Klaus/A-5415-2015; Gaffney, Kelly/AAG-7136-2020; von Hoegen, Michael Horn/E-4969-2012; Adams, Bernhard/F-7195-2017; Murray, Eamonn/J-8476-2014	Gaffney, Kelly J/0000-0002-0525-6465; von Hoegen, Michael Horn/0000-0003-0324-3457; Murray, Eamonn/0000-0003-1526-663X; Adams, Bernhard/0000-0003-4725-6583; Kienberger, Reinhard/0000-0001-8781-3685; Nelson, Art/0000-0003-4050-0141; Bucksbaum, Philip/0000-0003-1258-5571				BISWAS R, 1982, PHYS REV B, V26, P1980, DOI 10.1103/PhysRevB.26.1980; BRIDGMAN PW, 1942, P AM ACAD ARTS SCI, V74, P438; Cavalieri AL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.114801; CHENG TK, 1990, APPL PHYS LETT, V57, P1004, DOI 10.1063/1.104090; CHENG TK, 1991, APPL PHYS LETT, V59, P1923, DOI 10.1063/1.106187; DeCamp MF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.092301; Fahy S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.109701; FISCHER P, 1978, J PHYS C SOLID STATE, V11, P1043, DOI 10.1088/0022-3719/11/6/011; GONZE X, 1990, PHYS REV B, V41, P11827, DOI 10.1103/PhysRevB.41.11827; Hase M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067401; Hase M, 1998, PHYS REV B, V58, P5448, DOI 10.1103/PhysRevB.58.5448; HUNSCHE S, 1995, PHYS REV LETT, V75, P1815, DOI 10.1103/PhysRevLett.75.1815; Kammler M, 2005, SURF SCI, V576, P56, DOI 10.1016/j.susc.2004.11.033; Lee SH, 2004, OPT LETT, V29, P2602, DOI 10.1364/OL.29.002602; Lindenberg AM, 2005, SCIENCE, V308, P392, DOI 10.1126/science.1107996; Murray ED, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.060301; Recoules V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.055503; Service RF, 2002, SCIENCE, V298, P1356, DOI 10.1126/science.298.5597.1356; SHANK CV, 1983, PHYS REV LETT, V50, P454, DOI 10.1103/PhysRevLett.50.454; Sokolowski-Tinten K, 2003, NATURE, V422, P287, DOI 10.1038/nature01490; STAMPFLI P, 1994, PHYS REV B, V49, P7299, DOI 10.1103/PhysRevB.49.7299; Stevens TE, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144304; ZEIGER HJ, 1992, PHYS REV B, V45, P768, DOI 10.1103/PhysRevB.45.768	23	298	299	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					633	636		10.1126/science.1135009	http://dx.doi.org/10.1126/science.1135009			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272718	Green Submitted			2022-12-28	WOS:000243909400039
J	Gray, HM; Gray, K; Wegner, DM				Gray, Heather M.; Gray, Kurt; Wegner, Daniel M.			Dimensions of mind perception	SCIENCE			English	Article									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Gray, HM (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	hgray@wjh.harvard.edu		Gray, Heather/0000-0001-8886-5989; Gray, Kurt/0000-0001-5816-2676	NIMH NIH HHS [MH-71053, MH-49127] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH071053] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baron-Cohen S., 1995, MINDBLINDNESS; Dennett D. C., 1996, KINDS MINDS UNDERSTA; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433	4	839	848	30	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					619	619		10.1126/science.1134475	http://dx.doi.org/10.1126/science.1134475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272713	Green Submitted			2022-12-28	WOS:000243909400034
J	Shafqat, S; Zaidi, AKM				Shafqat, Saad; Zaidi, Anita K. M.			Pakistani physicians and the repatriation equation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aga Khan Univ, Coll Med, Karachi, Pakistan	Aga Khan University	Shafqat, S (corresponding author), Aga Khan Univ, Coll Med, Karachi, Pakistan.							Bundred PE, 2000, LANCET, V356, P245, DOI 10.1016/S0140-6736(00)02492-2; GUPTA R, 2006, RETHINKING GLOBAL HL; *IN MED, 2003, WHO WILL KEEP PUBL H; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; WHO, 2006, WORK TOG HLTH WORLD	5	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					442	443		10.1056/NEJMp068261	http://dx.doi.org/10.1056/NEJMp068261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267903	Green Published			2022-12-28	WOS:000243860700003
J	Butcher, J				Butcher, James			Kari Stefansson: a general of genetics - Profile	LANCET			English	Biographical-Item												james@two-cultures.com							0	0	0	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					267	267		10.1016/S0140-6736(07)60133-0	http://dx.doi.org/10.1016/S0140-6736(07)60133-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17262915	Bronze			2022-12-28	WOS:000243912000015
J	Zanetti, R; Rosso, S				Zanetti, Roberto; Rosso, Stefano			Levodopa and the risk of melanoma	LANCET			English	Editorial Material							PARKINSONS-DISEASE; MALIGNANT-MELANOMA; L-DOPA; SMOKING		Piedmont Canc Registry CPO, I-10123 Turin, Italy		Zanetti, R (corresponding author), Piedmont Canc Registry CPO, I-10123 Turin, Italy.	roberto.zanetti@cpo.it						DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; GURNEY H, 1991, J INVEST DERMATOL, V96, P85, DOI 10.1111/1523-1747.ep12515896; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; *MEDL PLUS, LEV SYST; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Olsen JH, 2006, EPIDEMIOLOGY, V17, P582, DOI 10.1097/01.ede.0000229445.90471.5e; Quik M, 2004, TRENDS NEUROSCI, V27, P561, DOI 10.1016/j.tins.2004.06.008; SHOHAT B, 1975, EXPERIENTIA, V31, P110, DOI 10.1007/BF01924707; SKIBBA JL, 1972, ARCH PATHOL, V93, P556; Zanetti R, 2006, MELANOMA RES, V16, P201, DOI 10.1097/01.cmr.0000215043.61306.d7	10	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					257	258		10.1016/S0140-6736(07)60125-1	http://dx.doi.org/10.1016/S0140-6736(07)60125-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258651				2022-12-28	WOS:000243912000009
J	Kastrati, A; Mehilli, J; Pache, J; Kaiser, C; Valgimigli, M; Kelbaek, H; Menichelli, M; Sabate, M; Suttorp, MJ; Baumgart, D; Seyfarth, M; Pfisterer, ME; Schomig, A				Kastrati, Adnan; Mehilli, Julinda; Pache, Juergen; Kaiser, Christoph; Valgimigli, Marco; Kelbaek, Henning; Menichelli, Maurizio; Sabate, Manel; Suttorp, Maarten J.; Baumgart, Dietrich; Seyfarth, Melchior; Pfisterer, Matthias E.; Schoemig, Albert			Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDIVIDUAL PATIENT DATA; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CLINICAL-TRIALS; SMALL CORONARY-ARTERIES; SYSTEMATIC REVIEWS; UNCOATED STENTS; STANDARD STENT; DOUBLE-BLIND; FOLLOW-UP; METAANALYSIS	BACKGROUND: The long-term effects of treatment with sirolimus-eluting stents, as compared with bare-metal stents, have not been established. METHODS: We performed an analysis of individual data on 4958 patients enrolled in 14 randomized trials comparing sirolimus-eluting stents with bare-metal stents (mean follow-up interval, 12.1 to 58.9 months). The primary end point was death from any cause. Other outcomes were stent thrombosis, the composite end point of death or myocardial infarction, and the composite of death, myocardial infarction, or reintervention. RESULTS: The overall risk of death (hazard ratio, 1.03; 95% confidence interval [CI], 0.80 to 1.30) and the combined risk of death or myocardial infarction (hazard ratio, 0.97; 95% CI, 0.81 to 1.16) were not significantly different for patients receiving sirolimus-eluting stents versus bare-metal stents. There was a significant reduction in the combined risk of death, myocardial infarction, or reintervention (hazard ratio, 0.43; 95% CI, 0.34 to 0.54) associated with the use of sirolimus-eluting stents. There was no significant difference in the overall risk of stent thrombosis with sirolimus-eluting stents versus bare-metal stents (hazard ratio, 1.09; 95% CI, 0.64 to 1.86). However, there was evidence of a slight increase in the risk of stent thrombosis associated with sirolimus-eluting stents after the first year. CONCLUSIONS: The use of sirolimus-eluting stents does not have a significant effect on overall long-term survival and survival free of myocardial infarction, as compared with bare-metal stents. There is a sustained reduction in the need for reintervention after the use of sirolimus-eluting stents. The risk of stent thrombosis is at least as great as that seen with bare-metal stents.	Tech Univ, Deutsch Herzzentrum, D-80636 Munich, Germany; Univ Basel, Basel, Switzerland; Univ Ferrara, I-44100 Ferrara, Italy; Rigshosp, DK-2100 Copenhagen, Denmark; San Camillo Hosp, Rome, Italy; Hosp Santa Creu & Sant Pau, Cardiovasc Inst, Barcelona, Spain; St Antonius Hosp, Nieuwegein, Netherlands; Preventicum Klin Diagnost, Essen, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; University of Basel; University of Ferrara; Rigshospitalet; University of Copenhagen; Hospital of Santa Creu i Sant Pau; St. Antonius Hospital Utrecht	Kastrati, A (corresponding author), Tech Univ, Deutsch Herzzentrum, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; Valgimigli, Marco/AAE-9103-2019; Kaiser, Christoph/AAA-9284-2022; Menichelli, Maurizio/AAF-8525-2021; , Kastrati/Y-2389-2019; Sabate, Manel/AAX-7245-2021	Valgimigli, Marco/0000-0002-4353-7110; Sabate Tenas, Manel/0000-0002-2316-3705				Altman DG, 2001, BRIT MED J, V323, P446, DOI 10.1136/bmj.323.7310.446; Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727; Assali AR, 2006, AM J CARDIOL, V98, P729, DOI 10.1016/j.amjcard.2006.04.007; BAUMGART D, GERMAN MULTICENTER R; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Biondi-Zoccai GL, 2005, INT J CARDIOL, V100, P119, DOI 10.1016/j.ijcard.2004.11.001; CAMENZIND E, SAFETY DRUG ELUTING; CARROZZA JP, 1992, J AM COLL CARDIOL, V20, P328, DOI 10.1016/0735-1097(92)90098-8; CHAN C, OUTCOMES DIABETIC PA; Clarke M J, 1997, J Eval Clin Pract, V3, P207, DOI 10.1046/j.1365-2753.1997.00005.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 2001, SYSTEMATIC REV HLTH, P357; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holmes DR, 2006, EUR HEART J, V27, P2815, DOI 10.1093/eurheartj/ehl385; Iijima R, 2006, Minerva Cardioangiol, V54, P539; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kaiser C, 2005, LANCET, V366, P2086; Kaiser C, 2005, LANCET, V366, P921, DOI 10.1016/S0140-6736(05)67221-2; Katritsis DG, 2005, AM J CARDIOL, V95, P640, DOI 10.1016/j.amjcard.2004.10.041; Kelbaek H, 2006, J AM COLL CARDIOL, V47, P449, DOI 10.1016/j.jacc.2005.10.045; MENICHELLI M, RANDOMISED TRIAL SIR; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Pache J, 2005, EUR HEART J, V26, P1262, DOI 10.1093/eurheartj/ehi098; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Schuhlen H, 2004, AM HEART J, V147, P317, DOI 10.1016/j.ahj.2003.10.002; Shuchman M, 2006, NEW ENGL J MED, V355, P1949, DOI 10.1056/NEJMp068234; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STONE GW, 2006, FDA CIRC SYST DEV PA; Suttorp MJ, 2006, CIRCULATION, V114, P921, DOI 10.1161/CIRCULATIONAHA.106.613588; Vale CL, 2002, INT J EPIDEMIOL, V31, P107, DOI 10.1093/ije/31.1.107; Valgimigli M, 2005, JAMA-J AM MED ASSOC, V293, P2109, DOI 10.1001/jama.293.17.2109; Vermeersch P, 2006, J AM COLL CARDIOL, V48, P2423, DOI 10.1016/j.jacc.2006.09.021	46	785	837	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1030	1039		10.1056/NEJMoa067484	http://dx.doi.org/10.1056/NEJMoa067484			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296823				2022-12-28	WOS:000244699200007
J	Bernstein, BE; Meissner, A; Lander, ES				Bernstein, Bradley E.; Meissner, Alexander; Lander, Eric S.			The mammalian epigenome	CELL			English	Review							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; NON-CPG METHYLATION; DNA METHYLATION; DEVELOPMENTAL REGULATORS; COMPREHENSIVE ANALYSIS; HISTONE MODIFICATION; POLYCOMB COMPLEXES; EPIGENETIC CONTROL; GENE-EXPRESSION		Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bbernstein@partners.org	jia, xu/A-8386-2016					Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Das R, 2006, P NATL ACAD SCI USA, V103, P10713, DOI 10.1073/pnas.0602949103; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fan JB, 2006, NAT REV GENET, V7, P632, DOI 10.1038/nrg1901; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Mager J, 2005, NAT GENET, V37, P1194, DOI 10.1038/ng1664; Mallin DR, 1998, GENETICS, V148, P331; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Ng P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl444; Nishino K, 2004, J BIOL CHEM, V279, P22306, DOI 10.1074/jbc.M309513200; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qiu J, 2006, NATURE, V441, P143, DOI 10.1038/441143a; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Sigrist CJA, 1997, GENETICS, V147, P209; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	97	1517	1598	7	254	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					669	681		10.1016/j.cell.2007.01.033	http://dx.doi.org/10.1016/j.cell.2007.01.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320505	Bronze			2022-12-28	WOS:000245098600010
J	Bhutta, A; Gilliam, C; Honeycutt, M; Schexnayder, S; Green, J; Moss, M; Anand, KJS				Bhutta, Adnan; Gilliam, Craig; Honeycutt, Michele; Schexnayder, Stephen; Green, Jerril; Moss, Michele; Anand, K. J. S.			Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach	BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; NOSOCOMIAL INFECTIONS; RISK-FACTORS; PREVENTION; GUIDELINE	Problem Bloodstream infections associated with catheters were the most common nosocomial infections in one paediatric intensive care unit in 1994-7, with rates well above the national average. Design Clinical data were collected prospectively to assess the rates of infection from 1994 onwards. The high rates in 1994-7 led to the stepwise introduction of interventions over a five year period. At quarterly intervals, prospective data continued to be collected during this period and an additional three year follow-up period. Setting A 292 bed tertiary care children's hospital. Key measures for improvement We aimed to reduce our infection rates to below the national mean rates for similar units by 2000 (a 25% reduction). Strategies for change A stepwise introduction of interventions designed to reduce infection rates, including maximal barrier precautions, transition to antibiotic impregnated central venous catheters, annual handwashing campaigns, and changing the skin disinfectant from povidone-iodine to chlorhexidine. Effects of change Significant decreases in rates of infection occurred over the intervention period. These were sustained over the three year follow-up. Annual rates decreased from 9.7/1000 days with a central venous catheter in 1997 to 3.0/1000 days in 2005, which translates to a relative risk reduction of 75% (95% confidence interval 35% to 126%), an absolute risk reduction of 6% (2% to 10%), and a number needed to treat of 16 (10 to 35). Lessons learnt A stepwise introduction of interventions leading to a greater than threefold reduction in nosocomial infections can be implemented successfully. This requires a multidisciplinary team, support from hospital leadership, ongoing data collection, shared data interpretation, and introduction of evidence based interventions.	Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72202 USA; Arkansas Childrens Hosp, Little Rock, AR 72202 USA	Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Arkansas Children's Hospital	Bhutta, A (corresponding author), Univ Arkansas Med Sci Hosp, Arkansas Childrens Hosp, Dept Pediat, 800 Marshall St,Slot 512-3, Little Rock, AR 72202 USA.	bhuttaadnant@uams.edu	Bhutta, Adnan T/ADN-9072-2022; Bhutta, Adnan/AAN-8551-2021; Anand, Kanwaljeet/B-3287-2014	Bhutta, Adnan/0000-0003-3362-5835; Anand, Kanwaljeet/0000-0001-6498-1483				[Anonymous], 2005, MMWR MORB MORTAL WKL; Bourn J., 2000, MANAGEMENT CONTROL H; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Garland JS, 2002, PEDIATRICS, V110, P1009, DOI 10.1542/peds.110.5.1009; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; MILLIKEN J, 1988, CRIT CARE MED, V16, P233, DOI 10.1097/00003246-198803000-00005; *NNIS, 1998, DAT SUMM OCT 1986 AP; O'Grady NP, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e51; Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; PRATT RJ, 2004, COMPARISON INT PRACT; Raad Issam, 1999, P165; Richards MJ, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.4.e39; SinghNaz N, 1996, CRIT CARE MED, V24, P875, DOI 10.1097/00003246-199605000-00024; Slonim Anthony D., 2001, Pediatr Crit Care Med, V2, P170, DOI 10.1097/00130478-200104000-00012; *US DEP HHS, 2006, CDCS ROL MON PREV HE; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Weinstein RA, 1998, EMERG INFECT DIS, V4, P416, DOI 10.3201/eid0403.980320; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	19	64	66	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					362	365		10.1136/bmj.39064.457025.DE	http://dx.doi.org/10.1136/bmj.39064.457025.DE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303886	Green Published			2022-12-28	WOS:000244560400035
J	Dalton, R				Dalton, Rex			France strives for sharper image	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					699	699		10.1038/445699a	http://dx.doi.org/10.1038/445699a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301763				2022-12-28	WOS:000244205200013
J	Raviglione, MC; Smith, IM				Raviglione, Mario C.; Smith, Ian M.			XDR tuberculosis - Implications for global public health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Stop TB Dept, Geneva, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, Geneva, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P430; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; 2006, MMWR MORB MORTAL WKL, V55, P301	5	262	275	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					656	659		10.1056/NEJMp068273	http://dx.doi.org/10.1056/NEJMp068273			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301295				2022-12-28	WOS:000244193300002
J	Aschwanden, C				Aschwanden, Christie			Freedom to fund	CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					421	423		10.1016/j.cell.2007.01.022	http://dx.doi.org/10.1016/j.cell.2007.01.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289559	Bronze			2022-12-28	WOS:000244842700006
J	Leinwand, LA				Leinwand, Leslie A.			Molecular events underlying pregnancy-induced cardiornyopathy	CELL			English	Editorial Material							PERIPARTUM CARDIOMYOPATHY; SIGNAL TRANSDUCER; ACTIVATION; INHIBITION; PROLACTIN		Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leinwand@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810				Cataldo L, 2000, INT J ONCOL, V17, P1179; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Hilfiker-Kleiner D, 2005, TRENDS CARDIOVAS MED, V15, P152, DOI 10.1016/j.tcm.2005.05.002; Hilfiker-Kleiner D, 2007, CELL; MATHARU GS, 1984, POSTGRAD MED J, V60, P49, DOI 10.1136/pgmj.60.699.49; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Ng DCH, 2003, CARDIOVASC RES, V57, P333, DOI 10.1016/S0008-6363(02)00664-8; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; SALMINEN A, 1983, PHYSL B, V76, P93	10	9	9	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					437	438		10.1016/j.cell.2007.01.020	http://dx.doi.org/10.1016/j.cell.2007.01.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289564	Bronze			2022-12-28	WOS:000244842700011
J	Driscoll, R; Hudson, A; Jackson, SP				Driscoll, Robert; Hudson, Amanda; Jackson, Stephen P.			Yeast Rtt109 promotes genome stability by acetylating histone H3 on lysine 56	SCIENCE			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; S-PHASE; CHECKPOINT; REPAIR; INSTABILITY; INTEGRITY; NETWORK; HST3	Posttranslational modifications of the histone octamer play important roles in regulating responses to DNA damage. Here, we reveal that Saccharomyces cerevisiae Rtt109p promotes genome stability and resistance to DNA-damaging agents, and that it does this by functionally cooperating with the histone chaperone Asf1p to maintain normal chromatin structure. Furthermore, we show that, as for Asf1p, Rtt109p is required for histone H3 acetylation on lysine 56 (K56) in vivo. Moreover, we show that Rtt109p directly catalyzes this modification in vitro in a manner that is stimulated by Asf1p. These data establish Rtt109p as a member of a new class of histone acetyltransferases and show that its actions are critical for cell survival in the presence of DNA damage during S phase.	Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Cambridge CB2 1QN, England; Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	Cancer Research UK; University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Wellcome Trust & Canc Res UK, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; 	Biotechnology and Biological Sciences Research Council [BBS/S/D/2004/12546] Funding Source: Medline; Cancer Research UK [A5290] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		AGUILERA A, 1989, GENETICS, V122, P503; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Prado F, 2004, EMBO REP, V5, P497, DOI 10.1038/sj.embor.7400128; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Scholes DT, 2001, GENETICS, V159, P1449; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	19	342	347	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					649	652		10.1126/science.1135862	http://dx.doi.org/10.1126/science.1135862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272722	Green Accepted			2022-12-28	WOS:000243909400044
J	Tumpey, TM; Maines, TR; Van Hoeven, N; Glaser, L; Solorzano, A; Pappas, C; Cox, NJ; Swayne, DE; Palese, P; Katz, JM; Garcia-Sastre, A				Tumpey, Terrence M.; Maines, Taronna R.; Van Hoeven, Neal; Glaser, Laurel; Solorzano, Alicia; Pappas, Claudia; Cox, Nancy J.; Swayne, David E.; Palese, Peter; Katz, Jacqueline M.; Garcia-Sastre, Adolfo			A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission	SCIENCE			English	Article							RECEPTOR SPECIFICITY; PANDEMIC VIRUS; HUMAN AIRWAY; A VIRUSES; EVOLUTION; GENE; H2	The 1918 influenza pandemic was a catastrophic series of virus outbreaks that spread across the globe. Here, we show that only a modest change in the 1918 influenza hemagglutinin receptor binding site alters the transmissibility of this pandemic virus. Two amino acid mutations that cause a switch in receptor binding preference from the human alpha-2,6 to the avian alpha-2,3 sialic acid resulted in a virus incapable of respiratory droplet transmission between ferrets but that maintained its lethality and replication efficiency in the upper respiratory tract. Furthermore, poor transmission of a 1918 virus with dual alpha-2,6 and alpha-2,3 specificity suggests that a predominant human alpha-2,6 sialic acid binding preference is essential for optimal transmission of this pandemic virus. These findings confirm an essential role of hemagglutinin receptor specificity for the transmission of influenza viruses among mammals.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; USDA, SE Poultry Res Lab, Agr Res Lab, Athens, GA USA	Centers for Disease Control & Prevention - USA; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA)	Tumpey, TM (corresponding author), Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Mailstop G-16,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	tft9@cdc.gov	Swayne, David/AAP-7166-2020	Palese, Peter/0000-0002-0337-5823; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Swayne, David/0000-0001-7472-1992; Solorzano, Alicia/0000-0003-0072-3463	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062623, P01AI058113] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI058113, U19 AI62623] Funding Source: Medline; PHS HHS [U54 AIO57158] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Burnet F. M., 1942, INFLUENZA SURVEY LAS; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Frost W.H., 1920, PUB HLTH REP, V35, P584, DOI DOI 10.2307/4575511; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; PATTERSON KD, 1991, B HIST MED, V65, P4; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Viboud C, 2006, VACCINE, V24, P6701, DOI 10.1016/j.vaccine.2006.05.067; WHO, EP PAND AL RESP EPR	25	450	506	6	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					655	659		10.1126/science.1136212	http://dx.doi.org/10.1126/science.1136212			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272724				2022-12-28	WOS:000243909400046
J	Stern, E; Klemic, JF; Routenberg, DA; Wyrembak, PN; Turner-Evans, DB; Hamilton, AD; LaVan, DA; Fahmy, TM; Reed, MA				Stern, Eric; Klemic, James F.; Routenberg, David A.; Wyrembak, Pauline N.; Turner-Evans, Daniel B.; Hamilton, Andrew D.; LaVan, David A.; Fahmy, Tarek M.; Reed, Mark A.			Label-free immunodetection with CMOS-compatible semiconducting nanowires	NATURE			English	Article							ELECTRICAL DETECTION; SILICON NANOWIRES; NANOSENSORS; SENSORS; SURFACES; DEVICES; ARRAYS; DNA	Semiconducting nanowires have the potential to function as highly sensitive and selective sensors for the label-free detection of low concentrations of pathogenic microorganisms(1-10). Successful solution-phase nanowire sensing has been demonstrated for ions(3), small molecules(4), proteins(5,6), DNA(7) and viruses(8); however, 'bottom-up' nanowires ( or similarly configured carbon nanotubes(11)) used for these demonstrations require hybrid fabrication schemes(12,13), which result in severe integration issues that have hindered widespread application. Alternative 'top-down' fabrication methods of nanowire-like devices(9,10,14-17) produce disappointing performance because of process-induced material and device degradation. Here we report an approach that uses complementary metal oxide semiconductor (CMOS) field effect transistor compatible technology and hence demonstrate the specific label-free detection of below 100 femtomolar concentrations of antibodies as well as real-time monitoring of the cellular immune response. This approach eliminates the need for hybrid methods and enables system-scale integration of these sensors with signal processing and information systems. Additionally, the ability to monitor antibody binding and sense the cellular immune response in real time with readily available technology should facilitate widespread diagnostic applications.	Yale Univ, Dept Elect Engn, New Haven, CT 06511 USA; Yale Univ, Dept Biomed Engn, New Haven, CT 06511 USA; Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA; Yale Univ, Dept Appl Phys, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Reed, MA (corresponding author), Yale Univ, Dept Elect Engn, POB 208284, New Haven, CT 06511 USA.	tarek.fahmy@yale.edu; mark.reed@yale.edu	Reed, Mark/A-9970-2011; Turner-Evans, Daniel/J-4488-2016; LaVan, David/C-3943-2012	Reed, Mark/0000-0001-6479-7256; Turner-Evans, Daniel/0000-0002-8020-0170; LaVan, David/0000-0002-1952-0028				Beeson C, 1996, J EXP MED, V184, P777, DOI 10.1084/jem.184.2.777; Bunimovich YL, 2004, LANGMUIR, V20, P10630, DOI 10.1021/la047913h; Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Clement N, 2002, PHYSICA E, V13, P999, DOI 10.1016/S1386-9477(02)00288-6; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Elibol OH, 2003, APPL PHYS LETT, V83, P4613, DOI 10.1063/1.1630853; Englander O, 2005, NANO LETT, V5, P705, DOI 10.1021/nl050109a; Evoy S, 2004, MICROELECTRON ENG, V75, P31, DOI 10.1016/j.mee.2003.09.010; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ, pCH1; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; ISRAELACHVILI JN, 1985, INTERMOLECULAR SURFA, pCH12; Laws GM, 2002, PHYS STATUS SOLIDI B, V233, P83, DOI 10.1002/1521-3951(200209)233:1<83::AID-PSSB83>3.0.CO;2-#; Li Z, 2004, NANO LETT, V4, P245, DOI 10.1021/nl034958e; Lim DV, 2005, CLIN MICROBIOL REV, V18, P583, DOI 10.1128/CMR.18.4.583-607.2005; Liu YX, 2003, IEEE ELECTR DEVICE L, V24, P484, DOI 10.1109/LED.2003.815004; Madou MJ, 2003, P IEEE, V91, P830, DOI 10.1109/JPROC.2003.813577; Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101; Saitoh M, 2003, IEEE T NANOTECHNOL, V2, P241, DOI 10.1109/TNANO.2003.820796; Sheehan PE, 2005, NANO LETT, V5, P803, DOI 10.1021/nl050298x; Strother T, 2000, NUCLEIC ACIDS RES, V28, P3535, DOI 10.1093/nar/28.18.3535; SUN SC, 1980, IEEE J SOLID-ST CIRC, V15, P562, DOI 10.1109/JSSC.1980.1051439; SZE SM, 1981, PHYSICS SEMICONDUCTO, P849; TABATA O, 1992, SENSOR ACTUAT A-PHYS, V34, P51, DOI 10.1016/0924-4247(92)80139-T; Tang T, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1881783; Trautmann A, 2005, NAT IMMUNOL, V6, P1213, DOI 10.1038/ni1205-1213; Wang DW, 2006, NANO LETT, V6, P1096, DOI 10.1021/nl052558g; Wang WU, 2005, P NATL ACAD SCI USA, V102, P3208, DOI 10.1073/pnas.0406368102; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	30	1113	1178	6	406	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					519	522		10.1038/nature05498	http://dx.doi.org/10.1038/nature05498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268465				2022-12-28	WOS:000243867300039
J	Rahman, NM; Davies, RJO; Gleeson, FV				Rahman, N. M.; Davies, R. J. O.; Gleeson, F. V.			Investigating suspected malignant pleural effusion	BRITISH MEDICAL JOURNAL			English	Article									Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England; Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Gleeson, FV (corresponding author), Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England.	fergus.gleeson@clinical-medicine.oxford.ac.uk		Rahman, Najib M/0000-0003-1195-1680	MRC [G0600475] Funding Source: UKRI; Medical Research Council [G0600475] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2003, THORAX, V58, pii8, DOI DOI 10.1136/THX.58.SUPPL_2.II8; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Ferrer J, 2005, CHEST, V127, P1017, DOI 10.1378/chest.127.3.1017; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; Traill ZC, 2001, CLIN RADIOL, V56, P193, DOI 10.1053/crad.2000.0573	5	9	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					206	207		10.1136/bmj.39061.503866.0B	http://dx.doi.org/10.1136/bmj.39061.503866.0B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255615	Green Published			2022-12-28	WOS:000244027600038
J	Sharp, D				Sharp, David			Fusion energy far away	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							*EUR FUS DEV AGR, NUCL FUS BAS; GIRAUD JP, 2006, ITER REL IAEA FUS EN; *GREENP INT, 2005, NUCL FUS REACT PROJ; *ITER, 2001, ITER TECHN BAS 2001; *ITER, 2005, BEYOND ITER; Naranjo B, 2005, NATURE, V434, P1115, DOI 10.1038/nature03575; Sharp D, 2002, LANCET, V359, P908, DOI 10.1016/S0140-6736(02)08016-9	7	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					259	260		10.1016/S0140-6736(07)60126-3	http://dx.doi.org/10.1016/S0140-6736(07)60126-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258652				2022-12-28	WOS:000243912000010
J	Wahlgren, N; Ahmed, N; Davalos, A; Ford, GA; Grond, M; Hacke, W; Hennerici, MG; Kaste, M; Kuelkens, S; Larrue, V; Lees, KR; Roine, RO; Soinne, L; Toni, D; Vanhooren, G				Wahlgren, Nils; Ahmed, Niaz; Davalos, Antoni; Ford, Gary A.; Grond, Martin; Hacke, Werner; Hennerici, Michael G.; Kaste, Markku; Kuelkens, Sonja; Larrue, Vincent; Lees, Kennedy R.; Roine, Risto O.; Soinne, Lauri; Toni, Danilo; Vanhooren, Geert		SITS-MOST Investigators	Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study	LANCET			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; HEMORRHAGIC TRANSFORMATION; CONTROLLED-TRIAL; DOUBLE-BLIND; ECASS II; MANAGEMENT; ASSOCIATION; MULTICENTER; EXPERIENCE; ATLANTIS	Background The aim of the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST) was to assess the safety and efficacy of intravenous alteplase as thrombolytic therapy within the first 3 h of onset of acute ischaemic stroke. Under European Union regulations, SITS-MOST was required to assess the safety profile of alteplase in clinical practice by comparison with results in randomised controlled trials. Methods 6483 patients were recruited from 285 centres (50% with little previous experience in stroke thrombolysis) in 14 countries between 2002 and 2006 for this prospective, open, monitored, observational study. Primary outcomes were symptomatic (a deterioration in National Institutes of Health stroke scale score of 4) intracerebral. haemorrhage type 2 within 24 h and mortality at 3 months. We compared mortality, the proportion of patients with symptomatic intracerebral haemorrhage as per the Cochrane definition, and functional outcome at 3 months with relevant pooled results from randomised controlled trials. Findings Baseline characteristics of patients in SITS-MOST were much the same as those in the pooled randomised controlled trials. At 24 h, the proportion of patients with symptomatic intracerebral haemorrhage (per the SITS-MOST protocol) was 1.7% (107/6444; 95% CI 1.4.0); at 7 days, the proportion with the same condition as per the Cochrane definition was 7.3% (468/6438; 6.7-7.9) compared with 8.6% (40/465; 6.3-11.6) in the pooled randomised controlled trials. The mortality rate at 3 months in SITS-MOST was 11.3% (701/6218; 10.5-12.1) compared with 17.3% (83/479; 14.1-21.1) in the pooled randomised controlled trials. Interpretation These data confirm that intravenous alteplase is safe and effective in routine clinical use when used within 3 h of stroke onset, even by centres with little previous experience of thrombolytic therapy for acute stroke. The findings should encourage wider use of thrombolytic therapy for suitable patients treated in stroke centres.	Karolinska Univ Hosp, Karolinska Inst, Dept Neurol, Karolinska Stroke Res,SITS Int Coordinat Off, SE-17176 Stockholm, Sweden; Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Dept Neurosci, E-08193 Barcelona, Spain; Newcastle Gen Hosp, Freeman Hosp Stroke Serv, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Heidelberg, Dept Neurol, D-6800 Mannheim, Germany; Kreisklinikum Siegen, Siegen, Germany; Univ Heidelberg, Dept Neurol, Heidelberg, Germany; Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; Hop Rangueil, Dept Neurol, Toulouse, France; Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Acute Stroke Unit, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Western Infirm, Div Cardiovasc & Med Sci, Cerebrovasc Clin, Glasgow G11 6NT, Lanark, Scotland; Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; Univ Roma La Sapienza, Dept Neurol, Rome, Italy; Sint Jan, Dept Neurol, Brugge, Belgium	Karolinska Institutet; Karolinska University Hospital; Autonomous University of Barcelona; Hospital Germans Trias i Pujol; Newcastle Freeman Hospital; Newcastle General Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Helsinki; Helsinki University Central Hospital; CHU de Toulouse; University of Glasgow; University of Glasgow; University of Turku; Sapienza University Rome	Wahlgren, N (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Neurol, Karolinska Stroke Res,SITS Int Coordinat Off, SE-17176 Stockholm, Sweden.	nils.wahlgren@karolinska.se	Soinne, Lauri/E-3703-2019; Ford, Gary A/A-6353-2012; Ford, Gary/AAY-6405-2020; Ahmed, Niaz/AAV-4361-2020; Buchan, Alastair M/B-9095-2009; Ahmed, Niaz/G-6717-2013; Toni, Danilo/K-3151-2016; Hacke, Werner/ABE-8661-2020; Vanhooren, Geert/H-4433-2011	Ford, Gary/0000-0001-8719-4968; Buchan, Alastair M/0000-0002-2918-5200; Ahmed, Niaz/0000-0001-7970-0146; Toni, Danilo/0000-0003-2735-8427; Vanhooren, Geert/0000-0001-6818-9346; Kaste, Markku/0000-0001-6557-6412				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Berger C, 2001, STROKE, V32, P1330, DOI 10.1161/01.STR.32.6.1330; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hill MD, 2005, CAN MED ASSOC J, V172, P1307, DOI 10.1503/cmaj.1041561; *KAR STROK UPD, CONS STAT THROMB; Kaste M, 2003, LANCET NEUROL, V2, P207, DOI 10.1016/S1474-4422(03)00343-0; Katzan IL, 2000, JAMA-J AM MED ASSOC, V283, P1151, DOI 10.1001/jama.283.9.1151; Langhorne P, 1995, Rev Neurol, V23, P394; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; Lyden PD, 2006, LANCET NEUROL, V5, P722, DOI 10.1016/S1474-4422(06)70530-0; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Saver JL, 2004, ARCH NEUROL-CHICAGO, V61, P1066, DOI 10.1001/archneur.61.7.1066; Tanne D, 1999, NEUROLOGY, V53, P424, DOI 10.1212/WNL.53.2.424; Truelsen T, 2005, EUR J NEUROL, V12, P78, DOI 10.1111/j.1468-1331.2005.01199.x; Wardlaw J M, 2003, Cochrane Database Syst Rev, pCD000213; WARDLAW JM, 2000, COCHRANE DB SYST REV, V2	23	1649	1712	0	59	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					275	282		10.1016/S0140-6736(07)60149-4	http://dx.doi.org/10.1016/S0140-6736(07)60149-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258667				2022-12-28	WOS:000243912000031
J	Rosenthal, MB; Dudley, RA				Rosenthal, Meredith B.; Dudley, R. Adams			Pay-for-performance - Will the latest payment trend improve care?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FINANCIAL INCENTIVES; QUALITY; RISK; MORTALITY		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mrosenth@hsph.harvard.edu		Rosenthal, Meredith/0000-0003-3410-0184				Baker G., 2005, PROVIDER PAY FOR PER; BAKER G, 2004, EVOLUTION PAY PERFOR; Beaulieu ND, 2005, HEALTH SERV RES, V40, P1318, DOI 10.1111/j.1475-6773.2005.00414.x; BERNHEIM BD, 1986, ECONOMETRICA, V54, P923, DOI 10.2307/1912844; DUDLEY RA, 2006, PAY PERFORMANCE DECI; DUDLEY RA, 2004, STRATEGIES SUPPORT Q, V10; Frolich A, 2007, HEALTH POLICY, V80, P179, DOI 10.1016/j.healthpol.2006.03.001; Gaynor M, 1995, RAND J ECON, V26, P591, DOI 10.2307/2556008; GROSSMAN SJ, 1983, ECONOMETRICA, V51, P7, DOI 10.2307/1912246; HICKSON GB, 1987, PEDIATRICS, V80, P344; *I MED, 2002, UN TREATM CONFR RAC; Institute of Medicine, 2001, CROSSING QUALITY CHA; Jones RH, 1996, J AM COLL CARDIOL, V28, P1478, DOI 10.1016/S0735-1097(96)00359-2; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Mehrotra A, 2003, HEALTH AFFAIR, V22, P60, DOI 10.1377/hlthaff.22.2.60; *NAT BUS GROUP HLT, 2005, MAN HLTH CAR COSTS N; PEAR R, 2006, NY TIMES        1017, pA12; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2002, HEALTH AFFAIR, V21, P197, DOI 10.1377/hlthaff.21.4.197; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Schauffler HH, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.2.134; LEAPFROGS INCENTIVE	25	220	222	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					740	744		10.1001/jama.297.7.740	http://dx.doi.org/10.1001/jama.297.7.740			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312294				2022-12-28	WOS:000244291100027
J	Romano, A; Viola, M; Gueant-Rodriguez, RM; Gaeta, F; Valluzzi, R; Gueant, JL				Romano, Antonino; Viola, Marinella; Gueant-Rodriguez, Rosa-Maria; Gaeta, Francesco; Valluzzi, Rocco; Gueant, Jean-Louis			Brief communication: Tolerability of meropenem in patients with IgE-mediated hypersensitivity to penicillins	ANNALS OF INTERNAL MEDICINE			English	Article							CROSS-REACTIVITY; IMMEDIATE HYPERSENSITIVITY; ALLERGY; CARBAPENEMS; IMIPENEM	Background: Although clinicians avoid giving meropenem to patients with penicillin allergy because of potential cross-reactivity, the rate of cross-reactivity between penicillins and meropenem has not been prospectively determined. Objective: To assess the tolerability of meropenem in patients with documented penicillin allergy. Design: Prospective skin testing and antibiotic challenge. Setting: Allergy units of 2 Italian medical centers. Patients: 104 consecutive participants with immediate hypersensitivity reactions to penicillins and positive skin test results to at least 1 penicillin reagent. Measurements: Skin tests to meropenem and, if results were negative, challenges with escalating doses of meropenem. Results: One participant (0.9% [95% Cl, 0.02% to 5.2%]) had a positive intradermal test result to meropenem. The remaining 103 participants with negative skin test results to meropenem tolerated escalating dose challenges. Limitation: Challenges were not followed by therapeutic courses. Conclusions: These data indicate a low rate of cross-reactivity between penicillins and meropenem. Therefore, the practice of avoiding meropenem therapy in penicillin-allergic patients should be reconsidered. In patients who especially require meropenem treatment, the authors recommend pretreatment skin tests because negative results indicate tolerability.	Univ Cattolica Sacro Cuore, Rome, Italy; IRCCS, Troina, Italy; INSERM, F-54511 Vandoeuvre Les Nancy, France; CHU Nancy Brabois, Vandoeuvre Les Nancy, France	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy	Romano, A (corresponding author), Unita Allegol, Complesso Integrato Columbus,Via G Moscati,31, I-00168 Rome, Italy.	antoninoromano@h-columbus.it	Valluzzi, Rocco Luigi/Q-3879-2019; Romano, Antonino/D-3102-2017; Gaeta, Francesco/AAC-7107-2020	Valluzzi, Rocco Luigi/0000-0003-0029-6254; Romano, Antonino/0000-0001-9742-9898; Gaeta, Francesco/0000-0003-2942-7633				[Anonymous], 1999, ANN ALLERGY ASTHMA I; Bradley JS, 1999, INT J ANTIMICROB AG, V11, P93, DOI 10.1016/S0924-8579(98)00094-6; Brockow K, 2002, ALLERGY, V57, P45; Ciofu Oana, 1996, Clin Microbiol Infect, V2, P91, DOI 10.1111/j.1469-0691.1996.tb00212.x; Kelkar PS, 2001, NEW ENGL J MED, V345, P804, DOI 10.1056/NEJMra993637; Meier EA, 2005, J ALLERGY CLIN IMMUN, V116, P1169, DOI 10.1016/j.jaci.2005.06.036; Prescott WA, 2004, CLIN INFECT DIS, V38, P1102, DOI 10.1086/382880; Romano A, 2006, NEW ENGL J MED, V354, P2835, DOI 10.1056/NEJMc053529; Romano A, 2004, ANN INTERN MED, V141, P16, DOI 10.7326/0003-4819-141-1-200407060-00010; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; SAXON A, 1988, J ALLERGY CLIN IMMUN, V82, P213, DOI 10.1016/0091-6749(88)91001-9; Sodhi M, 2004, J ANTIMICROB CHEMOTH, V54, P1155, DOI 10.1093/jac/dkh454; Solensky R, 2003, CLIN REV ALLERG IMMU, V24, P201, DOI 10.1385/CRIAI:24:3:201; Zar J.H., 1999, BIOSTAT ANAL, V4th	14	91	96	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					266	269		10.7326/0003-4819-146-4-200702200-00005	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310050				2022-12-28	WOS:000244271000004
J	Bhasin, S; Enzlin, P; Coviello, A; Basson, R				Bhasin, Shalender; Enzlin, Paul; Coviello, Andrea; Basson, Rosemary			Sexual dysfunction 3 - Sexual dysfunction in men and women with endocrine disorders	LANCET			English	Review							QUALITY-OF-LIFE; SURGICALLY MENOPAUSAL WOMEN; TESTOSTERONE REPLACEMENT THERAPY; CONGENITAL ADRENAL-HYPERPLASIA; BENIGN PROSTATIC HYPERPLASIA; POLYCYSTIC-OVARY-SYNDROME; ERECTILE DYSFUNCTION; METABOLIC SYNDROME; ANDROGEN LEVELS; DESIRE DISORDER	Endocrine disease frequently interrupts sexual function, and sexual dysfunction may signal serious endocrine disease. Diabetic autonomic neuropathy and endothelial dysfunction impair erectile function, and phosphodiesterase inhibition produces only moderate benefit. The effect of diabetes on women's sexual function is complex: the most consistent finding is a correlation between sexual dysfunction and depression. Reductions in testosterone level in men are associated with low sexual desire and reduced nocturnal erections and ejaculate volume, all of which improve with testosterone supplementation. The age-dependent decline in testosterone production in men is not associated with precise sexual symptoms, and supplementation has not been shown to produce sexual benefit. In women, sexual dysfunction has not been associated with serum testosterone, but this may be confounded by limitations of assays at low concentrations and by the greater importance of intracellular production of testosterone in women than in men. Testosterone supplementation after menopause does improve some aspects of sexual function in women, but long-term outcome data are needed. More research on the sexual effects of abnormal adrenal and thyroid function, hyperprolactinaemia, and metabolic syndrome should also be prioritised. We have good data on local management of the genital consequences of oestrogen lack, but need to better understand the potential role of systemic oestrogen supplementation from menopause onwards in sexually symptomatic women.	Boston Univ, Sch Med, Boston Med Ctr, Sect Endocrinol Diabet & Nutr, Boston, MA 02199 USA; Catholic Univ Louvain, Inst Family & Sexuality Studies, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Psychiat, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Gynaecol, B-3000 Louvain, Belgium; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, BC Ctr Sexual Med, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Vancouver Gen Hosp, Vancouver, BC V5Z 1M9, Canada	Boston Medical Center; Boston University; Universite Catholique Louvain; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Bhasin, S (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Sect Endocrinol Diabet & Nutr, Boston, MA 02199 USA.	bhasin@bu.edu	Enzlin, Paul/AAW-3160-2020	Enzlin, Paul/0000-0002-6641-5159; Coviello, Andrea/0000-0003-0244-9787				Alexander GM, 1997, HORM BEHAV, V31, P110, DOI 10.1006/hbeh.1997.1372; Althof SE, 2005, J SEX MED, V2, P146, DOI 10.1111/j.1743-6109.2005.00130.x; Anderson RA, 1999, J CLIN ENDOCR METAB, V84, P3556, DOI 10.1210/jc.84.10.3556; Angulo J, 2003, BIOCHEM BIOPH RES CO, V312, P1202, DOI 10.1016/j.bbrc.2003.11.034; [Anonymous], 2005, MENOPAUSE, V12, P497, DOI 10.1097/01.gme.0000177709.65944.b0; Apperloo M, 2006, J SEX MED, V3, P541, DOI 10.1111/j.1743-6109.2006.00212.x; Archer JS, 2006, MENOPAUSE, V13, P528, DOI 10.1097/01.gme.0000188737.46746.cd; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Arver S, 1996, J UROLOGY, V155, P1604, DOI 10.1016/S0022-5347(01)66141-X; Aziz A, 2005, FERTIL STERIL, V83, P1021, DOI 10.1016/j.fertnstert.2004.12.008; Bachmann G, 2002, FERTIL STERIL, V77, P660, DOI 10.1016/S0015-0282(02)02969-2; BAGATELL CJ, 1994, J CLIN ENDOCR METAB, V78, P711, DOI 10.1210/jc.78.3.711; Bancroft J, 2005, J ENDOCRINOL, V186, P411, DOI 10.1677/joe.1.06233; Bansal TC, 2005, J SEX MED, V2, P96, DOI 10.1111/j.1743-6109.2005.20120.x; Barnabei VM, 2002, OBSTET GYNECOL, V100, P1209, DOI 10.1016/S0029-7844(02)02369-4; Basson R, 2003, J PSYCHOSOM OBST GYN, V24, P221, DOI 10.3109/01674820309074686; Basson RJ, 2001, SEX REPROD MED, V1, P11, DOI DOI 10.4172/1488-5069.1000004; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; BELISLE S, 2006, J OBSTET GYNAECOL CA, V172, P43; Bell RJ, 2006, MENOPAUSE, V13, P65, DOI 10.1097/01.gme.0000191212.58856.96; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P4970, DOI 10.1210/jc.2005-1328; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; Billups KL, 2005, AM J CARDIOL, V96, p57M, DOI 10.1016/j.amjcard.2005.10.007; Bivalacqua TJ, 2004, P NATL ACAD SCI USA, V101, P9121, DOI 10.1073/pnas.0400520101; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2001, DIABETOLOGIA, V44, P1296, DOI 10.1007/s001250100656; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; Buvat J, 1997, J UROLOGY, V158, P1764, DOI 10.1016/S0022-5347(01)64123-5; Carani C, 2005, J CLIN ENDOCR METAB, V90, P6472, DOI 10.1210/jc.2005-1135; Carani C, 2005, PSYCHONEUROENDOCRINO, V30, P413, DOI 10.1016/j.psyneuen.2004.10.004; CARANI C, 1990, ARCH SEX BEHAV, V19, P223, DOI 10.1007/BF01541548; Cardozo L, 1998, OBSTET GYNECOL, V92, P722, DOI 10.1016/S0029-7844(98)00175-6; Caruso S, 2006, FERTIL STERIL, V85, P1496, DOI 10.1016/j.fertnstert.2005.10.043; Cavallini G, 2004, UROLOGY, V63, P641, DOI 10.1016/j.urology.2003.11.009; CHOPRA IJ, 1974, J CLIN ENDOCR METAB, V38, P269, DOI 10.1210/jcem-38-2-269; Colao A, 2003, EUR J ENDOCRINOL, V148, P325, DOI 10.1530/eje.0.1480325; COLOA A, 2004, J CLIN ENDOCR METAB, V89, P1704; Conaglen HA, 2003, J SEX MARITAL THER, V29, P255, DOI 10.1080/00926230390195498; Corona G, 2004, EUR UROL, V46, P615, DOI 10.1016/j.eururo.2004.07.001; Corona G, 2004, EUR UROL, V46, P222, DOI 10.1016/j.eururo.2004.03.010; Corona G, 2006, EUR UROL, V50, P595, DOI 10.1016/j.eururo.2006.02.053; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; DAVIS SR, 2006, MATURITAS S, V554, pS1; Davis SR, 2006, MENOPAUSE, V13, P387, DOI 10.1097/01.gme.0000179049.08371.c7; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Dayal M, 2005, J WOMENS HEALTH, V14, P391, DOI 10.1089/jwh.2005.14.391; De Berardis G, 2005, DIABETES CARE, V28, P2637, DOI 10.2337/diacare.28.11.2637; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; De Rosa M, 2004, J CLIN ENDOCR METAB, V89, P621, DOI 10.1210/jc.2003-030852; de Tejada IS, 2002, DIABETES CARE, V25, P2159; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; Delavierre D, 1999, PROG UROL, V9, P1097; Dennerstein L, 2006, J SEX MED, V3, P212, DOI 10.1111/j.1743-6109.2006.00215.x; Dennerstein L, 2005, FERTIL STERIL, V84, P174, DOI 10.1016/j.fertnstert.2005.01.119; DEVRIESE AS, 2000, BRIT J PHARMACOL, V730, P963; Dew JE, 2003, CLIMACTERIC, V6, P45, DOI 10.1080/713605341; Dobs A S, 1998, Endocr Pract, V4, P355; Donnelly P, 2000, CLIN ENDOCRINOL, V52, P197, DOI 10.1046/j.1365-2265.2000.00918.x; Doruk H, 2005, ARCH ANDROLOGY, V51, P1, DOI 10.1080/014850190512798; El-Sakka AI, 2005, J UROLOGY, V174, P1026, DOI 10.1097/01.ju.0000170231.51306.32; Elsenbruch S, 2003, J CLIN ENDOCR METAB, V88, P5801, DOI 10.1210/jc.2003-030562; Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672; Erol B, 2003, INT J IMPOT RES, V15, P198, DOI 10.1038/sj.ijir.3900998; Erol B, 2002, J SEX MARITAL THER, V28, P55, DOI 10.1080/00926230252851195; Esposito K, 2005, INT J IMPOT RES, V17, P391, DOI 10.1038/sj.ijir.3901333; Esposito K, 2005, INT J IMPOT RES, V17, P224, DOI 10.1038/sj.ijir.3901310; Esposito K, 2005, DIABETES CARE, V28, P756, DOI 10.2337/diacare.28.3.756; Fedele D, 2000, INT J EPIDEMIOL, V29, P524, DOI 10.1093/ije/29.3.524; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750; Finley SK, 1999, J NEUROBIOL, V40, P446; Fonseca V, 2004, DIABETOLOGIA, V47, P1914, DOI 10.1007/s00125-004-1549-6; Gazzaruso C, 2004, CIRCULATION, V110, P22, DOI 10.1161/01.CIR.0000133278.81226.C9; Gerig NE, 1997, UROLOGY, V49, P239, DOI 10.1016/S0090-4295(96)00444-X; Glueck CJ, 2003, METABOLISM, V52, P908, DOI 10.1016/S0026-0495(03)00104-5; Golden SH, 2004, AM J EPIDEMIOL, V160, P540, DOI 10.1093/aje/kwh250; Goldstein I, 2003, DIABETES CARE, V26, P777, DOI 10.2337/diacare.26.3.777; Gontero P, 2005, INT J IMPOT RES, V17, P80, DOI 10.1038/sj.ijir.3901273; GORZYNSKI G, 1977, ARCH SEX BEHAV, V6, P215, DOI 10.1007/BF01541129; Hak AE, 2002, J CLIN ENDOCR METAB, V87, P3632, DOI 10.1210/jc.87.8.3632; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hines M, 2004, J SEX RES, V41, P75, DOI 10.1080/00224490409552215; Hirshkowitz M, 1997, J PSYCHOSOM RES, V42, P541, DOI 10.1016/S0022-3999(97)00006-8; Hunt PJ, 2000, J CLIN ENDOCR METAB, V85, P4650, DOI 10.1210/jc.85.12.4650; Israilov S, 2005, INT J IMPOT RES, V17, P431, DOI 10.1038/sj.ijir.3901337; Johannsson G, 2002, J CLIN ENDOCR METAB, V87, P2046, DOI 10.1210/jc.87.5.2046; Kadioglu P, 2005, J UROLOGY, V174, P1921, DOI 10.1097/01.ju.0000176456.50491.51; Kalter-Leibovici O, 2005, DIABETES CARE, V28, P1739, DOI 10.2337/diacare.28.7.1739; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM321, DOI 10.1093/gerona/57.5.M321; King BE, 1999, NEUROSCI LETT, V269, P149, DOI 10.1016/S0304-3940(99)00440-1; Klein R, 2005, J DIABETES COMPLICAT, V19, P35, DOI 10.1016/j.jdiacomp.2003.12.005; KOLODNY RC, 1971, DIABETES, V20, P557, DOI 10.2337/diab.20.8.557; KORENMAN SG, 1990, J CLIN ENDOCR METAB, V71, P963, DOI 10.1210/jcem-71-4-963; Korhonen S, 2003, FERTIL STERIL, V79, P1327, DOI 10.1016/S0015-0282(03)00347-9; Krassas GE, 2003, J ENDOCRINOL INVEST, V26, P372, DOI 10.1007/BF03345187; Krassas GE, 2002, J CLIN ENDOCR METAB, V87, P3667, DOI 10.1210/jc.87.8.3667; Krassas GE, 2000, FERTIL STERIL, V74, P1063, DOI 10.1016/S0015-0282(00)01589-2; Kulp JL, 2004, MENOPAUSE, V11, P116, DOI 10.1097/01.GME.0000079221.19081.11; Kupelian V, 2006, J CLIN ENDOCR METAB, V91, P843, DOI 10.1210/jc.2005-1326; Kushnir MM, 2006, CLIN CHEM, V52, P120, DOI 10.1373/clinchem.2005.052167; KWAN M, 1983, J CLIN ENDOCR METAB, V57, P557, DOI 10.1210/jcem-57-3-557; Laaksonen DE, 2005, J CLIN ENDOCR METAB, V90, P712, DOI 10.1210/jc.2004-0970; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Leiblum SR, 2006, MENOPAUSE, V13, P46, DOI 10.1097/01.gme.0000172596.76272.06; Liverman CT, 2004, TESTOSTERONE AGING C; Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769; MACFARLANE I, 1997, TXB DIABETES, P1; Meikle AW, 1997, J CLIN ENDOCR METAB, V82, P571, DOI 10.1210/jc.82.2.571; Mills TM, 1999, STEROIDS, V64, P605, DOI 10.1016/S0039-128X(99)00040-9; MORALI G, 1993, BIOL REPROD, V49, P577, DOI 10.1095/biolreprod49.3.577; Motofei IG, 2005, INT J ANDROL, V28, P78, DOI 10.1111/j.1365-2605.2004.00514.x; *N AM MEN SOC, 2003, MENOPAUSE, V10, P6; Nwokolo NC, 2000, DRUG AGING, V16, P335, DOI 10.2165/00002512-200016050-00003; Peng YS, 2005, KIDNEY INT, V68, P760, DOI 10.1111/j.1523-1755.2005.00454.x; Platz EA, 1999, PROSTATE CANCER P D, V2, P285, DOI 10.1038/sj.pcan.4500380; Pope HG, 2003, AM J PSYCHIAT, V160, P105, DOI 10.1176/appi.ajp.160.1.105; RABKIN JG, 1995, GEN HOSP PSYCHIAT, V17, P37, DOI 10.1016/0163-8343(94)00062-I; Reddy P, 2000, J CLIN PHARM THER, V25, P421, DOI 10.1046/j.1365-2710.2000.00309.x; Redoute J, 2005, PSYCHONEUROENDOCRINO, V30, P461, DOI 10.1016/j.psyneuen.2004.12.003; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Rhoden EL, 2005, BJU INT, V95, P615, DOI 10.1111/j.1464-410X.2005.05349.x; RYMER J, 1994, MATURITAS, V18, P127, DOI 10.1016/0378-5122(94)90050-7; Sam S, 2005, J CLIN ENDOCR METAB, V90, P4797, DOI 10.1210/jc.2004-2217; SANDS R, 1995, AM J MED, V98, pS76, DOI 10.1016/S0002-9343(99)80062-X; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; SCHIAVI RC, 1995, PSYCHIAT CLIN N AM, V18, P7, DOI 10.1016/S0193-953X(18)30067-4; Schroeder JP, 2000, NEUROSCI LETT, V282, P17, DOI 10.1016/S0304-3940(00)00839-9; Seftel AD, 1997, UROLOGY, V50, P1016, DOI 10.1016/S0090-4295(97)00512-8; Seidman SN, 2005, J CLIN PSYCHOPHARM, V25, P584, DOI 10.1097/01.jcp.0000185424.23515.e5; Seidman SN, 2001, J CLIN PSYCHIAT, V62, P406, DOI 10.4088/JCP.v62n0602; Seidman SN, 2001, BIOL PSYCHIAT, V50, P371, DOI 10.1016/S0006-3223(01)01148-9; Shifren JL, 2006, MENOPAUSE, V13, P770, DOI 10.1097/01.gme.0000227400.60816.52; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Singh AB, 2006, J CLIN ENDOCR METAB, V91, P136, DOI 10.1210/jc.2005-1640; SLAG MF, 1983, JAMA-J AM MED ASSOC, V249, P1736, DOI 10.1001/jama.249.13.1736; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Sobel JD, 2003, AM J OBSTET GYNECOL, V189, P1297, DOI 10.1067/S0002-9378(03)00726-9; Somboonporn W, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004509.pub2; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Stenberg A, 1996, MATURITAS, V24, P31, DOI 10.1016/0378-5122(95)00996-5; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tuiten A, 2000, ARCH GEN PSYCHIAT, V57, P149, DOI 10.1001/archpsyc.57.2.149; UTIAN WH, 1994, MENOPAUSE, V1, P39; van Lunsen RHW, 2004, MENOPAUSE, V11, P741, DOI 10.1097/01.GME.0000143704.48324.46; van Thiel SW, 2005, J CLIN ENDOCR METAB, V90, P3295, DOI 10.1210/jc.2004-1802; Van Uytfanghe K, 2004, CLIN CHEM, V50, P2101, DOI 10.1373/clinchem.2004.037358; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Veronelli A, 2006, INT J IMPOT RES, V18, P111, DOI 10.1038/sj.ijir.3901364; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Weiner CL, 2004, PSYCHOSOM MED, V66, P356, DOI 10.1097/01.psy.0000127871.46309.fe; Weisberg E, 2005, CLIMACTERIC, V8, P83, DOI 10.1080/13697130500087016; Wierman ME, 2006, J CLIN ENDOCR METAB, V91, P3697, DOI 10.1210/jc.2006-1121; Willhite LA, 2001, PHARMACOTHERAPY, V21, P464, DOI 10.1592/phco.21.5.464.34486; WINCZE JP, 1993, ARCH SEX BEHAV, V22, P587, DOI 10.1007/BF01543302; Wisniewski AB, 2004, J UROLOGY, V171, P2497, DOI 10.1097/01.ju.0000125269.91938.f7; WORTSMAN J, 1987, AM J MED, V82, P207, DOI 10.1016/0002-9343(87)90057-X; XIN Z, 2004, ZHONGGUO LINCHYUANG, V8, P4136; Zheng H, 2006, DIABETES RES CLIN PR, V71, P313, DOI 10.1016/j.diabres.2005.07.011; 2002, FERTIL STERIL S4, V77, P1	169	194	197	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					597	611		10.1016/S0140-6736(07)60280-3	http://dx.doi.org/10.1016/S0140-6736(07)60280-3			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307107				2022-12-28	WOS:000244368000034
J	Hellstrom, M; Phng, LK; Hofmann, JJ; Wallgard, E; Coultas, L; Lindblom, P; Alva, J; Nilsson, AK; Karlsson, L; Gaiano, N; Yoon, K; Rossant, J; Iruela-Arispe, ML; Kalen, M; Gerhardt, H; Betsholtz, C				Hellstroem, Mats; Phng, Li-Kun; Hofmann, Jennifer J.; Wallgard, Elisabet; Coultas, Leigh; Lindblom, Per; Alva, Jackelyn; Nilsson, Ann-Katrin; Karlsson, Linda; Gaiano, Nicholas; Yoon, Keejung; Rossant, Janet; Iruela-Arispe, M. Luisa; Kalen, Mattias; Gerhardt, Holger; Betsholtz, Christer			Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis	NATURE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GAMMA-SECRETASE; BRANCHING MORPHOGENESIS; VASCULAR DEVELOPMENT; ARTERIAL; MOUSE; MATURATION; LETHALITY	In sprouting angiogenesis, specialized endothelial tip cells lead the outgrowth of blood-vessel sprouts towards gradients of vascular endothelial growth factor (VEGF)-A(1,2). VEGF-A is also essential for the induction of endothelial tip cells(2), but it is not known how single tip cells are selected to lead each vessel sprout, and how tip-cell numbers are determined. Here we present evidence that delta-like 4 (Dll4) -Notch1 signalling regulates the formation of appropriate numbers of tip cells to control vessel sprouting and branching in the mouse retina. We show that inhibition of Notch signalling using gamma-secretase inhibitors, genetic inactivation of one allele of the endothelial Notch ligand Dll4, or endothelial-specific genetic deletion of Notch1, all promote increased numbers of tip cells. Conversely, activation of Notch by a soluble jagged1 peptide leads to fewer tip cells and vessel branches. Dll4 and reporters of Notch signalling are distributed in a mosaic pattern among endothelial cells of actively sprouting retinal vessels. At this location, Notch1-deleted endothelial cells preferentially assume tip-cell characteristics. Together, our results suggest that Dll4 - Notch1 signalling between the endothelial cells within the angiogenic sprout serves to restrict tip-cell formation in response to VEGF, thereby establishing the adequate ratio between tip and stalk cells required for correct sprouting and branching patterns. This model offers an explanation for the dose-dependency and haploinsufficiency of the Dll4 gene(3-5), and indicates that modulators of Dll4 or Notch signalling, such as gamma-secretase inhibitors developed for Alzheimer's disease, might find usage as pharmacological regulators of angiogenesis.	Angiogenet Sweden AB, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Med, SE-17177 Stockholm, Sweden; Canc Res UK, Vasc Biol Lab, London Res Inst, London WC2A 3PX, England; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Johns Hopkins Univ, Inst Cell Engn, Baltimore, MD 21205 USA	Karolinska Institutet; Karolinska Institutet; Cancer Research UK; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University	Hellstrom, M (corresponding author), Angiogenet Sweden AB, Scheeles Vag 2, SE-17177 Stockholm, Sweden.	mats.hellstrom@ki.se; holger.gerhardt@cancer.org.uk	Gerhardt, Holger/G-4610-2011; Iruela-Arispe, M. Luisa/AAJ-1297-2020; Phng, Li-Kun/L-7346-2013; Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Yoon, Keejung/0000-0002-2361-9039; Gerhardt, Holger/0000-0001-9228-7472; Hellstrom, Mats/0000-0002-7088-9533				Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Claxton S, 2004, GENE EXPR PATTERNS, V5, P123, DOI 10.1016/j.modgep.2004.05.004; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Shutter JR, 2000, GENE DEV, V14, P1313; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294	30	1205	1280	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					776	780		10.1038/nature05571	http://dx.doi.org/10.1038/nature05571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17259973				2022-12-28	WOS:000244205200047
J	Zhou, Z; Bai, YW				Zhou, Zheng; Bai, Yawen			Structural biology - Analysis of protein-folding cooperativity	NATURE			English	Letter							DOWNHILL		NCI, Biochem & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhou, Z (corresponding author), NCI, Biochem & Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37,Room 6114E, Bethesda, MD 20892 USA.	yawen@helix.nih.gov						Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Ferguson N, 2004, J MOL BIOL, V344, P295, DOI 10.1016/j.jmb.2004.09.069; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859	4	31	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					E16	E17		10.1038/nature05644	http://dx.doi.org/10.1038/nature05644			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301743				2022-12-28	WOS:000244205200034
J	Potter, JE; Burns, RB				Potter, Jennifer E.; Burns, Risa B.			A 60-year-old woman with sexual difficulties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BUPROPION SUSTAINED-RELEASE; SURGICALLY MENOPAUSAL WOMEN; ESTROGEN-ANDROGEN REPLACEMENT; HORMONE-BINDING GLOBULIN; QUALITY-OF-LIFE; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; AROUSAL DISORDER; TESTOSTERONE PATCH; DESIRE DISORDER	A growing body of evidence is available to guide care for women with sexual concerns. This article considers the case of a 60-year-old woman who with menopause developed decreased libido, rapidity of sexual arousal, and intensity of orgasm. She requests information about strategies to optimize sexual function. Effects of aging and menopause on female sexual response are reviewed and an evaluation approach presented to help clinicians respond productively to women who request intervention. The effectiveness and safety of different treatment options are discussed, including education, lifestyle changes, counseling, medications, mechanical devices, and pelvic floor exercises; recommendations are made to help postmenopausal women maximize sexual pleasure and satisfaction.	Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard Medical School	Potter, JE (corresponding author), Beth Israel Deaconess Med Ctr, Healthcare Assoc, 330 Brookline Ave,Atrium Suite, Boston, MA 02215 USA.	jpotter@bidmc.harvard.edu						Alboni Paolo, 2004, Ital Heart J, V5, P343; *AM PSYCH ASS, 2000, DSM4 TR DIAGN STAT M; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; [Anonymous], SCAND J SEXOL, DOI DOI 10.1176/APPI.AJP.2008.08050714; Arlt W, 2000, ENDOCR RES, V26, P505, DOI 10.3109/07435800009048561; Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9; Aziz A, 2005, MATURITAS, V51, P349, DOI 10.1016/j.maturitas.2004.08.018; Bachmann GA, 2004, MENOPAUSE, V11, P120, DOI 10.1097/01.GME.0000075502.60230.28; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Barber MD, 2005, CLEV CLIN J MED, V72, P225, DOI 10.3949/ccjm.72.3.225; Basson R, 2003, J PSYCHOSOM OBST GYN, V24, P221, DOI 10.3109/01674820309074686; Basson R, 2006, NEW ENGL J MED, V354, P1497, DOI 10.1056/NEJMcp050154; Basson R, 2004, EXPERT OPIN PHARMACO, V5, P1045, DOI 10.1517/14656566.5.5.1045; Basson R, 2003, BJOG-INT J OBSTET GY, V110, P1014, DOI 10.1016/S1470-0328(03)02938-0; Basson R, 2002, J WOMEN HEALTH GEN-B, V11, P367, DOI 10.1089/152460902317586001; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Bechara A, 2003, J SEX MARITAL THER, V29, P1, DOI 10.1080/00926230390154862; Berman JR, 2003, J UROLOGY, V170, P2333, DOI 10.1097/01.ju.0000090966.74607.34; Berman JR, 2001, J SEX MARITAL THER, V27, P411, DOI 10.1080/713846815; Berman LA, 2001, J SEX MARITAL THER, V27, P427, DOI 10.1080/713846821; Billups KL, 2002, WORLD J UROL, V20, P137, DOI 10.1007/s00345-002-0269-0; BINKS M, 2005, NAASO 2005 ANN SCI M; Bo K, 2000, ACTA OBSTET GYN SCAN, V79, P598, DOI 10.1034/j.1600-0412.2000.079007598.x; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; Cain VS, 2003, J SEX RES, V40, P266, DOI 10.1080/00224490309552191; Caruso S, 2006, FERTIL STERIL, V85, P1496, DOI 10.1016/j.fertnstert.2005.10.043; Clayton AH, 2004, J CLIN PSYCHIAT, V65, P62; Clayton AH, 2003, PSYCHIAT CLIN N AM, V26, P673, DOI 10.1016/S0193-953X(03)00043-1; Couzinet B, 2001, J CLIN ENDOCR METAB, V86, P5060, DOI 10.1210/jc.86.10.5060; Crandall C, 2002, J WOMEN HEALTH GEN-B, V11, P857, DOI 10.1089/154099902762203704; DAVIS SR, 1995, MATURITAS, V21, P227, DOI 10.1016/0378-5122(94)00898-H; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; Davis SR, 2006, MENOPAUSE, V13, P37, DOI 10.1097/01.gme.0000168061.32917.83; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; DeBattista C, 2005, J CLIN PSYCHIAT, V66, P844, DOI 10.4088/JCP.v66n0706; Dennerstein L, 2006, J SEX MED, V3, P212, DOI 10.1111/j.1743-6109.2006.00215.x; DENNERSTEIN L, 1980, OBSTET GYNECOL, V56, P316; Dennerstein L, 2005, FERTIL STERIL, V84, P174, DOI 10.1016/j.fertnstert.2005.01.119; Dennerstein L, 2001, FERTIL STERIL, V76, P456, DOI 10.1016/S0015-0282(01)01978-1; Derogatis L, 2004, J SEX MARITAL THER, V30, P25, DOI 10.1080/00926230490247183; Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448; Dobs AS, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI 10.1210/jc.87.4.1509; Dusing R, 2005, DRUGS, V65, P773; Finger WW, 1997, J FAM PRACTICE, V44, P33; Floter A, 2002, CLIMACTERIC, V5, P357, DOI 10.1080/713605315; Fourcroy JL, 2003, DRUGS, V63, P1445, DOI 10.2165/00003495-200363140-00002; Gambera A, 2004, MENOPAUSE, V11, P159, DOI 10.1097/01.GME.0000086700.47410.2A; Gerber JR, 2005, FERTIL STERIL, V83, P643, DOI 10.1016/j.fertnstert.2004.08.028; GITTELMAN MC, 2006, J SEX MED S3, V3, P224; GOLDSTEIN I, 2006, WOMENS SEXUAL FUNCTI; Guay AT, 2002, FERTIL STERIL, V77, pS83; HALLSTROM T, 1977, CLIN OBSTET GYNAECOL, V4, P227; Hatzichristou D, 2004, J SEX MED, V1, P49, DOI 10.1111/j.1743-6109.2004.10108.x; Hayes R, 2005, J SEX MED, V2, P317, DOI 10.1111/j.1743-6109.2005.20356.x; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Hines TM, 2001, AM J OBSTET GYNECOL, V185, P359, DOI 10.1067/mob.2001.115995; Islam A, 2001, J SEX MARITAL THER, V27, P531, DOI 10.1080/713846804; Ito TY, 2001, J SEX MARITAL THER, V27, P541, DOI 10.1080/713846828; JUDD HL, 1974, J CLIN ENDOCR METAB, V39, P1020, DOI 10.1210/jcem-39-6-1020; JUDD HL, 1974, AM J OBSTET GYNECOL, V118, P793, DOI 10.1016/0002-9378(74)90490-6; Kim DH, 2003, J AM ASSOC GYN LAP, V10, P60, DOI 10.1016/S1074-3804(05)60236-8; Kingsberg SA, 2002, ARCH SEX BEHAV, V31, P431, DOI 10.1023/A:1019844209233; Laughlin GA, 2000, J CLIN ENDOCR METAB, V85, P645, DOI 10.1210/jc.85.2.645; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Leiblum SR, 2002, WORLD J UROL, V20, P127, DOI 10.1007/s00345-002-0266-3; Lewis C, 1998, AM J HYPERTENS, V11, P733; Lobo RA, 2003, FERTIL STERIL, V79, P1341, DOI 10.1016/S0015-0282(03)00358-3; Long CY, 2006, MENOPAUSE, V13, P737, DOI 10.1097/01.gme.0000227401.98933.0b; Lowenstein L, 2005, EUR J OBSTET GYN R B, V119, P242, DOI 10.1016/j.ejogrb.2004.09.004; Maas CP, 2004, ANN REV SEX RES, V14, P83; MARTIN PL, 1979, JAMA-J AM MED ASSOC, V242, P2699, DOI 10.1001/jama.242.24.2699; MARUYAMA Y, 1984, ACTA ENDOCRINOL-COP, V106, P428, DOI 10.1530/acta.0.1060428; Masand PS, 2001, AM J PSYCHIAT, V158, P805, DOI 10.1176/appi.ajp.158.5.805; Master WH, 1970, HUMAN SEXUAL INADEQU; Menon Dileep V, 2006, Treat Endocrinol, V5, P37, DOI 10.2165/00024677-200605010-00005; Meston CM, 1998, ARCH GEN PSYCHIAT, V55, P652, DOI 10.1001/archpsyc.55.7.652; Meston CM, 2002, ARCH SEX BEHAV, V31, P323, DOI 10.1023/A:1016220225392; Modelska K, 2004, MATURITAS, V49, P124, DOI 10.1016/j.maturitas.2003.12.007; NATHORSTBOOS J, 1992, GYNECOL OBSTET INVES, V34, P97, DOI 10.1159/000292735; NATHORSTBOOS J, 1993, ACTA OBSTET GYN SCAN, V72, P656, DOI 10.3109/00016349309021160; NEWMAN DK, 2005, J WOUND OSTOMY CONT, V32, pS5; Nijland E, 2006, J SEX MED, V3, P763, DOI 10.1111/j.1743-6109.2006.00285.x; Nusbaum MRH, 2002, AM FAM PHYSICIAN, V66, P1705; Padma-Nathan H, 2003, J SEX MARITAL THER, V29, P329, DOI 10.1080/00926230390224710; Park K, 2002, J UROLOGY, V168, P1269, DOI 10.1016/S0022-5347(05)64638-1; PARK K, 2006, WOMENS SEXUAL FUNCTI, P193; Perkins J, 1998, J Wound Ostomy Continence Nurs, V25, P206; Pfaus J.G., 2005, CURR SEX HEALTH REP, V2, DOI [https://doi.org/10.1007/s11930-005-0010-2, DOI 10.1007/S11930-005-0010-2, DOI 10.1007/s11930-005-0010-2]; Quirk FH, 2002, J WOMEN HEALTH GEN-B, V11, P277, DOI 10.1089/152460902753668475; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P164, DOI 10.1111/j.1467-842X.2003.tb00804.x; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 1999, J SEX MARITAL THER, V25, P137, DOI 10.1080/00926239908403987; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubio-Aurioles E, 2002, J SEX MARITAL THER, V28, P205, DOI 10.1080/00926230252851339; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; Sarrel P, 1998, J REPROD MED, V43, P847; Sarrel PM, 2000, J WOMEN HEALTH GEN-B, V9, pS25, DOI 10.1089/152460900318830; Schober JM, 2004, BJU INT, V94, P589, DOI 10.1111/j.1464-410X.2004.05006.x; Segraves Robert Taylor, 2003, Expert Opin Emerg Drugs, V8, P515, DOI 10.1517/eoed.8.2.515.21142; Segraves RT, 2004, J CLIN PSYCHOPHARM, V24, P339, DOI 10.1097/01.jcp.0000125686.20338.c1; Serin IS, 2001, EUR J OBSTET GYN R B, V99, P222, DOI 10.1016/S0301-2115(01)00398-0; Settle EC, 1998, J CLIN PSYCHIAT, V59, P32; *SEX INF ED COUNC, SEX MIDDL LAT LIF FA; SHERWIN BB, 1991, J CLIN ENDOCR METAB, V72, P336, DOI 10.1210/jcem-72-2-336; SHERWIN BB, 1988, J AFFECT DISORDERS, V14, P177, DOI 10.1016/0165-0327(88)90061-4; Shifren JL, 2006, MENOPAUSE, V13, P770, DOI 10.1097/01.gme.0000227400.60816.52; Shifren JL, 2000, NEW ENGL J MED, V343, P682, DOI 10.1056/NEJM200009073431002; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Stimmel GL, 2006, CNS SPECTRUMS, V11, P24, DOI 10.1017/S1092852900026730; Suckling J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001500.pub2; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; TAYLOR JF, 1994, ARCH SEX BEHAV, V23, P627, DOI 10.1007/BF01541816; TRAISH AM, 2006, WOMENS SEXUAL FUNCTI, P181; Treadwell DF, 2003, PUBLIC RELAT REV, V29, P185, DOI 10.1016/S0363-8111(03)00014-6; Tuiten A, 2002, ARCH GEN PSYCHIAT, V59, P465, DOI 10.1001/archpsyc.59.5.465; *US CDCP, 1997, CDC UPD QUEST ANSW M; Warnock JK, 2005, MENOPAUSE, V12, P374, DOI 10.1097/01.GME.0000153933.50860.FD; WIKLUND I, 1993, AM J OBSTET GYNECOL, V168, P824, DOI 10.1016/S0002-9378(12)90828-5; Wilson S K, 2001, J Gend Specif Med, V4, P54; World Health Organization (WHO), 1992, ICD10 INT STAT CLASS	122	8	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					620	633		10.1001/jama.297.6.620	http://dx.doi.org/10.1001/jama.297.6.620			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135TU	17299197				2022-12-28	WOS:000244177400025
J	Studdert, DM; Mello, MM; Jedrey, CM; Brennan, TA				Studdert, David M.; Mello, Michelle M.; Jedrey, Christopher M.; Brennan, Troyen A.			Regulatory and judicial oversight of nonprofit hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLUE-CROSS CONVERSIONS; COMMUNITY BENEFITS; HEALTH-CARE; FOR-PROFIT; IMPACT		Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; McDermott Will & Emory, Boston, MA USA; Aetna, Hartford, CT USA	Harvard University; Harvard T.H. Chan School of Public Health	Studdert, DM (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270				BECKER C, 2005, MOD HEALTHCARE, V35, P10; BECKER C, 2006, MOD HEALTHCARE, V36, P14; BENKO LB, 2003, MOD HEALTHCARE, V33, P14; Bloche MG, 1995, MINN LAW REV, V80, P299; Burns LR, 2000, HEALTH AFFAIR, V19, P7, DOI 10.1377/hlthaff.19.1.7; CHOUDHRY S, 2005, SPECIALTY VERSUS COM; CLARK RC, 1980, HARVARD LAW REV, V93, P1416, DOI 10.2307/1340606; COFFEY P, 2003, HLTH LAW, V16, P1; COLLIVER V, 2006, SAN FRANCISCO C 0804, pC1; Conover CJ, 2005, HEALTH AFFAIR, V24, P473, DOI 10.1377/hlthaff.24.2.473; DAY K, 2006, WASH POST       1206, pD2; ESTLUND C, 2004, WORKING TOGETHER WOR; Fremont-Smith M.R., 2004, GOVERNING NONPROFIT; Greaney Thomas L, 2005, Yale J Health Policy Law Ethics, V5, P1; Hall MA, 2003, MILBANK Q, V81, P509, DOI 10.1046/j.0887-378X.2003.00293.x; Hanson J, 2005, LOYOLA CONSUM LAW RE, V17, P395; Hensler D. R., 2000, CLASS ACTION DILEMMA; Horwitz JR, 2003, UCLA LAW REV, V50, P1345; *KAIS FAM FDN, 2004, HOSP OWN TYP; KARNS JE, 2004, WIDENER LAW J, V12, P383; Katz Robert A., 2005, CHI KENT L REV, V80, P689; KURTZ D, 1988, BOARD LIABILITY GUID; MANCINO DM, 2004, TAXATION HOSP HLTH C; Needleman J, 2001, J HEALTH POLIT POLIC, V26, P1113, DOI 10.1215/03616878-26-5-1113; Needleman J, 1997, HEALTH AFFAIR, V16, P187, DOI 10.1377/hlthaff.16.2.187; Nicholson S, 2000, HEALTH AFFAIR, V19, P168, DOI 10.1377/hlthaff.19.6.168; PEAR R, 2006, NY TIMES        0619, pA15; Robinson JC, 2003, HEALTH AFFAIR, V22, P100, DOI 10.1377/hlthaff.22.4.100; ROWLAND C, 2006, BOSTON GLOBE    0324, pC1; *SEIU HOSP ACC PRO, 2004, NEGL TAXP HLTH ADV H; Starr P, 1982, SOCIAL TRANSFORMATIO; Stevens Rosemary, 1989, SICKNESS WEALTH AM H; STUHAN RG, 2005, HLTH LAWYERS NEW SEP, P18; Thorpe KE, 2000, HEALTH AFFAIR, V19, P187, DOI 10.1377/hlthaff.19.6.187; Young GJ, 1999, HEALTH AFFAIR, V18, P146, DOI 10.1377/hlthaff.18.5.146; ZIGMOND J, 2006, MOD HEALTHCARE, V36, P16; 2006, LOS ANGELES TIM 0616, pC2	37	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					625	631		10.1056/NEJMhpr063800	http://dx.doi.org/10.1056/NEJMhpr063800			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	133KV	17287484				2022-12-28	WOS:000244012700013
J	Legro, RS				Legro, Richard S.			A 27-year-old woman with a diagnosis of polycystic ovary syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INAPPROPRIATE GONADOTROPIN-SECRETION; IMPAIRED GLUCOSE-TOLERANCE; EXTENDED-RELEASE METFORMIN; LIFE-STYLE INTERVENTION; QUALITY-OF-LIFE; INSULIN-RESISTANCE; CLOMIPHENE CITRATE; DOUBLE-BLIND; OBESE WOMEN; WEIGHT-LOSS	Ms R, a 27-year-old woman with polycystic ovary syndrome (PCOS) diagnosed after irregular menses, hirsutism, and polycystic ovaries, is concerned about weight gain despite regular exercise and watching her diet. Prescribed oral contraceptives to regulate her menses and help reduce her androgen levels, she wants to know the alternatives for treatment of PCOS. The varying definitions of PCOS and its heterogeneity confound the interpretation of studies on PCOS. Specific diagnostic criteria have been established based on expert opinion but have not been validated. Several commonly performed laboratory tests are generally unhelpful and the pathophysiology is poorly understood. Treatment options for Ms R, including those that may affect her weight gain, are reviewed and implications for future fertility are discussed.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Legro, RS (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, 500 Univ Dr, Hershey, PA 17033 USA.	RSL1@psu.edu		Legro, Richard/0000-0001-9927-7584	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD038992, U54HD034449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001476, U54HD044315] Funding Source: NIH RePORTER; NICHD NIH HHS [U10 HD38992, HD044315, HD34449, K24 HD01476] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADASHI EY, 1981, ENDOCRINOLOGY, V108, P1441, DOI 10.1210/endo-108-4-1441; ADASHI EY, 1984, FERTIL STERIL, V42, P331; Archer JS, 2004, BEST PRACT RES CL OB, V18, P737, DOI 10.1016/j.bpobgyn.2004.05.007; Arroyo A, 1997, J CLIN ENDOCR METAB, V82, P3728, DOI 10.1210/jc.82.11.3728; ASCH RH, 1976, J REPROD MED, V17, P175; Atay V, 2006, J INT MED RES, V34, P73, DOI 10.1177/147323000603400109; Atiomo WU, 1998, FERTIL STERIL, V69, P236, DOI 10.1016/S0015-0282(97)00486-X; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P781, DOI 10.1210/jc.2005-2153; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2003, FERTIL STERIL, V79, P932, DOI 10.1016/S0015-0282(02)04914-2; Azziz R, 2001, J CLIN ENDOCR METAB, V86, P1626, DOI 10.1210/jc.86.4.1626; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Baillargeon JP, 2004, FERTIL STERIL, V82, P893, DOI 10.1016/j.fertnstert.2004.02.127; Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Beck JI, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002249.pub3; Blank SK, 2006, HUM REPROD UPDATE, V12, P351, DOI 10.1093/humupd/dml017; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Borch-Johnsen K, 1999, LANCET, V354, P617; Bridger T, 2006, ARCH PEDIAT ADOL MED, V160, P241, DOI 10.1001/archpedi.160.3.241; Broekmans FJ, 2006, BJOG-INT J OBSTET GY, V113, P1210, DOI 10.1111/j.1471-0528.2006.01008.x; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carmina E, 2003, HUM REPROD, V18, P2289, DOI 10.1093/humrep/deg440; Casper RF, 2006, J CLIN ENDOCR METAB, V91, P760, DOI 10.1210/jc.2005-1923; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Christian RC, 2003, J CLIN ENDOCR METAB, V88, P2562, DOI 10.1210/jc.2003-030334; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Cronin L, 1998, J CLIN ENDOCR METAB, V83, P1976, DOI 10.1210/jc.83.6.1976; Cryer DR, 2005, DIABETES CARE, V28, P539, DOI 10.2337/diacare.28.3.539; Daskalopoulou SS, 2004, ANGIOLOGY, V55, P589, DOI 10.1177/00033197040550i601; de Vries MJ, 1998, EUR J OBSTET GYN R B, V76, P91, DOI 10.1016/S0301-2115(97)00164-4; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Diamanti-Kandarakis E, 2003, J CLIN ENDOCR METAB, V88, P1927, DOI 10.1210/jc.2002-021528; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, J CLIN ENDOCR METAB, V90, P66, DOI 10.1210/jc.2004-0229; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; EHRMANN DA, 1995, J CLIN INVEST, V96, P520, DOI 10.1172/JCI118064; Elsenbruch S, 2003, J CLIN ENDOCR METAB, V88, P5801, DOI 10.1210/jc.2003-030562; FARQUHAR C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FRASER IS, 1994, CONTRACEPTION, V49, P399, DOI 10.1016/0010-7824(94)90035-3; Fujioka K, 2005, DIABETES OBES METAB, V7, P28, DOI 10.1111/j.1463-1326.2004.00369.x; Gallo MF, 2004, OBSTET GYNECOL, V103, P359, DOI 10.1097/01.AOG.0000107298.29343.6a; Gilbert C, 2006, FERTIL STERIL, V86, P658, DOI 10.1016/j.fertnstert.2006.02.098; GIVENS JR, 1974, J CLIN ENDOCR METAB, V38, P727, DOI 10.1210/jcem-38-5-727; Gomes MPV, 2004, ARCH INTERN MED, V164, P1965, DOI 10.1001/archinte.164.18.1965; Guido M, 2004, J CLIN ENDOCR METAB, V89, P2817, DOI 10.1210/jc.2003-031158; Guzick DS, 2004, J CLIN ENDOCR METAB, V89, P3694, DOI 10.1210/jc.2004-1136; Hall JE, 1998, J ENDOCRINOL INVEST, V21, P602, DOI 10.1007/BF03350785; Hardiman P, 2003, LANCET, V361, P1810, DOI 10.1016/S0140-6736(03)13409-5; Heinemann LAJ, 2004, DRUG SAFETY, V27, P1001, DOI 10.2165/00002018-200427130-00003; Hoeger KM, 2004, FERTIL STERIL, V82, P421, DOI 10.1016/j.fertnstert.2004.02.104; Holte J, 1998, J CLIN ENDOCR METAB, V83, P1143, DOI 10.1210/jc.83.4.1143; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; Hughes E, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000056.pub2, 10.1002/14651858.CD000097.pub2, 10.1002/14651858.CD000044.pub2]; Imani B, 1999, J CLIN ENDOCR METAB, V84, P1617, DOI 10.1210/jc.84.5.1617; Jonard S, 2005, HUM REPROD, V20, P2893, DOI 10.1093/humrep/dei159; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; KIDDY DS, 1992, CLIN ENDOCRINOL, V36, P105, DOI 10.1111/j.1365-2265.1992.tb02909.x; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kovacs G, 1996, HUM REPROD, V11, P20, DOI 10.1093/humrep/11.suppl_2.20; Krattenmacher R, 2000, CONTRACEPTION, V62, P29, DOI 10.1016/S0010-7824(00)00133-5; Legro RS, 2006, FERTIL STERIL, V86, P914, DOI 10.1016/j.fertnstert.2006.03.037; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Legro RS, 2004, HUM REPROD, V19, P1697, DOI 10.1093/humrep/deh322; Legro RS, 2003, ENDOCR REV, V24, P302, DOI 10.1210/er.2003-0004; Legro RS, 2002, J CLIN ENDOCR METAB, V87, P2128, DOI 10.1210/jc.87.5.2128; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Levri KM, 2005, ANN FAM MED, V3, P457, DOI 10.1370/afm.343; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Lloyd T, 2002, OBSTET GYNECOL, V100, P235, DOI 10.1016/S0029-7844(02)02056-2; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; LUCIANO AA, 1984, FERTIL STERIL, V41, P719; Maitra N, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004861; McLaughlin T, 1999, J CLIN ENDOCR METAB, V84, P578, DOI 10.1210/jc.84.2.578; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Moran LJ, 2006, AM J CLIN NUTR, V84, P77; Moran LJ, 2003, J CLIN ENDOCR METAB, V88, P812, DOI 10.1210/jc.2002-020815; Nestler JE, 1996, NEW ENGL J MED, V335, P617, DOI 10.1056/NEJM199608293350902; NESTLER JE, 1991, J CLIN ENDOCR METAB, V72, P83, DOI 10.1210/jcem-72-1-83; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; Nestler JE, 2000, INT J OBESITY, V24, pS71, DOI 10.1038/sj.ijo.0801282; Onalan G, 2005, EUR J OBSTET GYN R B, V123, P204, DOI 10.1016/j.ejogrb.2005.05.010; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Paradisi G, 2001, CIRCULATION, V103, P1410, DOI 10.1161/01.CIR.103.10.1410; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; Proctor ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001896.pub2; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REBAR R, 1976, J CLIN INVEST, V57, P1320, DOI 10.1172/JCI108400; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Scheffer GJ, 2002, ULTRASOUND OBST GYN, V20, P270, DOI 10.1046/j.1469-0705.2002.00787.x; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; Schwartz S, 2006, DIABETES CARE, V29, P759, DOI 10.2337/diacare.29.04.06.dc05-1967; Stamets K, 2004, FERTIL STERIL, V81, P630, DOI 10.1016/j.fertnstert.2003.08.023; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; STEIN IF, 1956, INT J FERTIL, V1, P333; Talbott E, 1998, J CLIN EPIDEMIOL, V51, P415, DOI 10.1016/S0895-4356(98)00010-9; Talbott EO, 2004, J CLIN ENDOCR METAB, V89, P6061, DOI 10.1210/jc.2003-032110; Talbott EO, 2000, ARTERIOSCL THROM VAS, V20, P2414, DOI 10.1161/01.ATV.20.11.2414; Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311; Taponen S, 2004, J CLIN ENDOCR METAB, V89, P2114, DOI 10.1210/jc.2003-031720; Tarkun I, 2004, J CLIN ENDOCR METAB, V89, P5592, DOI 10.1210/jc.2004-0751; van Grootheest K, 2003, BRIT MED J, V326, P257, DOI 10.1136/bmj.326.7383.257; Venkatesan AM, 2001, RECENT PROG HORM RES, V56, P295, DOI 10.1210/rp.56.1.295; Waggoner W, 1999, GYNECOL ENDOCRINOL, V13, P394, DOI 10.3109/09513599909167586; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Welt CK, 2002, J CLIN ENDOCR METAB, V87, P5559, DOI 10.1210/jc.2002-020546; Wild RA, 2005, J CLIN ENDOCR METAB, V90, P4112, DOI 10.1210/jc.2004-2243; Winters SJ, 2000, FERTIL STERIL, V73, P724, DOI 10.1016/S0015-0282(99)00641-X; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377; 2003, HUM REPROD UPDATE, V9, P263	115	15	16	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					509	519		10.1001/jama.297.5.509	http://dx.doi.org/10.1001/jama.297.5.509			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284701				2022-12-28	WOS:000243999100028
J	Basson, R				Basson, Rosemary			Sexuality in chronic illness: no longer ignored	LANCET			English	Editorial Material							TESTOSTERONE; DYSFUNCTION; MEN		Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Basson, R (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada.	sexmed@interchange.ubc.ca						Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Basson R, 2007, LANCET, V369, P409, DOI 10.1016/S0140-6736(07)60197-4; BHASIN S, IN PRESS LANCET; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; de Vries CS, 2006, MATURITAS, V53, P343, DOI 10.1016/j.maturitas.2005.06.004; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Labrie F, 2006, J STEROID BIOCHEM, V99, P182, DOI 10.1016/j.jsbmb.2006.02.004; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; REES P, IN PRESS LANCET; SANTORO A, 2005, J CLIN ENDOCR METAB, V90, P2004; *WHO, GEND REPR RIGHTS	11	25	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					350	352		10.1016/S0140-6736(07)60166-4	http://dx.doi.org/10.1016/S0140-6736(07)60166-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276757				2022-12-28	WOS:000243944400006
J	Baldwin, MP; Rhines, PB; Huang, HP; McIntyre, ME				Baldwin, Mark P.; Rhines, Peter B.; Huang, Huei-Ping; McIntyre, Michael E.			The jet-stream conundrum	SCIENCE			English	Editorial Material							KRILL EUPHAUSIA-SUPERBA; SCOTIA SEA; CIRCULATION; TRANSPORT; MODEL		NW Res Associates Inc, Bellevue, WA 98009 USA; Univ Washington, Dept Oceanog, Seattle, WA 98195 USA; Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	NorthWest Research Associates; University of Washington; University of Washington Seattle; Columbia University; University of Cambridge	Baldwin, MP (corresponding author), NW Res Associates Inc, POB 3027, Bellevue, WA 98009 USA.	mark@nwra.com; rhines@ocean.washington.edu; huei@ldeo.columbia.edu; m.e.mcintyre@damtp.cam.ac.uk	Baldwin, Mark/J-6720-2012					DRITSCHEL DG, IN PRESS J ATMOS SCI; DUNKERTON TJ, IN PRESS J ATMOS SCI; Fach BA, 2006, DEEP-SEA RES PT I, V53, P1011, DOI 10.1016/j.dsr.2006.03.007; Fach BA, 2006, DEEP-SEA RES PT I, V53, P987, DOI 10.1016/j.dsr.2006.03.006; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Heimpel M, 2005, NATURE, V438, P193, DOI 10.1038/nature04208; HUGHES CP, COMMUNICATION; JUCKES MN, 1987, NATURE, V328, P590, DOI 10.1038/328590a0; Nakano H, 2005, J PHYS OCEANOGR, V35, P474, DOI 10.1175/JPO2698.1; RHINES PB, 1975, J FLUID MECH, V69, P345; Richards KJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024645; SHETTY S, 2006, ANN M DIV FLUID DYN	12	70	70	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					467	468		10.1126/science.1131375	http://dx.doi.org/10.1126/science.1131375			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255499				2022-12-28	WOS:000243726600031
J	Sun, PQ; Yoshizuka, N; New, L; Moser, BA; Li, YL; Liao, R; Xie, CC; Chen, JM; Deng, QD; Yamout, M; Dong, MQ; Frangou, CG; Yates, JR; Wright, PE; Han, JH				Sun, Peiqing; Yoshizuka, Naoto; New, Liguo; Moser, Bettina A.; Li, Yilei; Liao, Rong; Xie, Changchuan; Chen, Jianming; Deng, Qingdong; Yamout, Mana; Dong, Meng-Qiu; Frangou, Costas G.; Yates, John R., III; Wright, Peter E.; Han, Jiahuai			PRAK is essential for ras-induced senescence and tumor suppression	CELL			English	Article							INDUCED PREMATURE SENESCENCE; CELL-CYCLE ARREST; ONCOGENIC RAS; HUMAN FIBROBLASTS; MOUSE SKIN; HUMAN P53; KINASE; ACTIVATION; PATHWAY; DEFICIENT	Like apoptosis, oncogene-induced senescence is a barrier to tumor development. However, relatively little is known about the signaling pathways mediating the senescence response. p38regulated/activated protein kinase (PRAK) is a p38 MAIPIK substrate whose physiological functions are poorly understood. Here we describe a role for PRAK in tumor suppression by demonstrating that PRAK mediates senescence upon activation by p38 in response to oncogenic ras. PRAK deficiency in mice enhances DMBA-induced skin carcinogenesis, coinciding with compromised senescence induction. In primary cells, inactivation of PRAK prevents senescence and promotes oncogenic transformation. Furthermore, we show that PRAK activates p53 by direct phosphorylation. We propose that phosphorylation of p53 by PRAK following activation of p38 MAPK by ras plays an important role in ras-induced senescence and tumor suppression.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Xiamen Univ, Sch Life Sci, Key Lab, Minist Educ Cell Biol, Xiamen 361005, Peoples R China	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Fred Hutchinson Cancer Center; Xiamen University	Sun, PQ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pqsun@scripps.edu; jhan@scripps.edu	Han, J/G-4671-2010; xie, chang/GYJ-2493-2022	Wright, Peter/0000-0002-1368-0223	NATIONAL CANCER INSTITUTE [R01CA106768, R01CA091922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067101] Funding Source: NIH RePORTER; NCI NIH HHS [CA106768, CA91922] Funding Source: Medline; NIAID NIH HHS [AI054696, AI041637] Funding Source: Medline; NIGMS NIH HHS [GM67101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Haq R, 2002, CANCER RES, V62, P5076; Inoue K, 2001, GENE DEV, V15, P2934, DOI 10.1101/gad.929901; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1999, CANCER RES, V59, P2217; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEESMILLER SP, 1992, MOL CELL BIOL, V12, P5041, DOI 10.1128/MCB.12.11.5041; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; New L, 2003, MOL BIOL CELL, V14, P2603, DOI 10.1091/mbc.E02-08-0538; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Seger YR, 2002, CANCER CELL, V2, P401, DOI 10.1016/S1535-6108(02)00183-6; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shi Y, 2003, MOL CELL BIOL, V23, P7732, DOI 10.1128/MCB.23.21.7732-7741.2003; Shi Y, 2002, BIOL CHEM, V383, P1519, DOI 10.1515/BC.2002.173; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	42	245	264	3	94	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					295	308		10.1016/j.cell.2006.11.050	http://dx.doi.org/10.1016/j.cell.2006.11.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254968	Bronze			2022-12-28	WOS:000244420500015
J	Martin, TJ; Mundy, GR				Martin, T. John; Mundy, Gregory R.			Bone metastasis - Can osteoclasts be excluded?	NATURE			English	Letter									St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; Vanderbilt Ctr Bone Biol, Nashville, TN 37232 USA	St. Vincent's Institute of Medical Research; Vanderbilt University	Martin, TJ (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	jmartin@svi.edu.au						ARGUELLO F, 1988, CANCER RES, V48, P6876; BOYDE A, 1986, Scanning Electron Microscopy, P1537; Gallwitz WE, 2002, J CLIN INVEST, V110, P1559, DOI 10.1172/JCI200211936; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451	8	12	14	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					E19	E19		10.1038/nature05657	http://dx.doi.org/10.1038/nature05657			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314931	Bronze			2022-12-28	WOS:000244341200039
J	Schofield, AJ				Schofield, Andrew J.			Physics - Two for the price of one	SCIENCE			English	Editorial Material									Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Schofield, AJ (corresponding author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.	ajs@th.ph.bham.ac.uk	Schofield, Andy J/C-5004-2009; Schofield, Andy/AAL-7382-2020	Schofield, Andy J/0000-0002-1218-8560; Schofield, Andy/0000-0002-1218-8560				[Anonymous], 2007, PRINCIPLES CONDENSED; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; DONIACH S, 1977, PHYSICA B & C, V91, P231, DOI 10.1016/0378-4363(77)90190-5; Gegenwart P, 2007, SCIENCE, V315, P969, DOI 10.1126/science.1136020; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405; Senthil T, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035111; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; Si QM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115103; Stewart GR, 2006, REV MOD PHYS, V78, P743, DOI 10.1103/RevModPhys.78.743; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626	15	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					945	946		10.1126/science.1139335	http://dx.doi.org/10.1126/science.1139335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303739				2022-12-28	WOS:000244229800026
J	Hitchins, MP; Wong, JJL; Suthers, G; Suter, CM; Martin, DIK; Hawkins, NJ; Ward, RL				Hitchins, Megan P.; Wong, Justin J. L.; Suthers, Graerne; Suter, Catherine M.; Martin, David I. K.; Hawkins, Nicholas J.; Ward, Robyn L.			Brief report: Inheritance of a cancer-associated MLH1 germ-line epimutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA METHYLATION; PROMOTER HYPERMETHYLATION; EPIGENETIC INHERITANCE; PATERNAL GENOME; MOUSE; GENE; ALLELE; HUMAN-CHROMOSOME-15; DEMETHYLATION	Persons who have hypermethylation of one allele of MLH1 in somatic cells throughout the body (a germ-line epimutation) have a predisposition for the development of cancer in a pattern typical of hereditary nonpolyposis colorectal cancer. By studying the families of two such persons, we found evidence that the epimutation was transmitted from a mother to her son but was erased in his spermatozoa. The affected maternal allele was inherited by three other siblings from these two families, but in those offspring the allele had reverted to the normal active state. These findings demonstrate a novel pattern of inheritance of cancer susceptibility and are consistent with transgenerational epigenetic inheritance.	St Vincents Hosp, Dept Med Oncol, Darlinghurst, NSW 2010, Australia; Univ New S Wales, Sch Med, Sydney, NSW, Australia; Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia; Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; Womens & Childrens Hospital Australia; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ward, RL (corresponding author), St Vincents Hosp, Dept Med Oncol, Victoria St, Darlinghurst, NSW 2010, Australia.	robyn@unsw.edu.au	Ward, Robyn L/I-2313-2013; Wong, Justin/AAE-7986-2020; Hawkins, Nicholas J/A-8461-2008; Hitchins, Megan/GXH-4566-2022	Ward, Robyn L/0000-0002-6877-8906; Wong, Justin/0000-0002-7038-5079; Hawkins, Nicholas J/0000-0002-2204-3189; 				Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Dittrich B, 1996, NAT GENET, V14, P163, DOI 10.1038/ng1096-163; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Gazzoli I, 2002, CANCER RES, V62, P3925; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hegde M, 2005, J MOL DIAGN, V7, P525, DOI 10.1016/S1525-1578(10)60584-3; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lynch HT, 2005, ONCOLOGY-NY, V19, P455; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; MORALES P, 1991, HUM REPROD, V6, P401; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; *NAT CTR BIOT INF, UNISTS DAT; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Roemer I, 1997, CURR BIOL, V7, P277, DOI 10.1016/S0960-9822(06)00124-2; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268	25	300	321	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					697	705		10.1056/NEJMoa064522	http://dx.doi.org/10.1056/NEJMoa064522			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301300				2022-12-28	WOS:000244193300007
J	Newburger, JW; Sleeper, LA; McCrindle, BW; Minich, LL; Gersony, W; Vetter, VL; Atz, AM; Li, JS; Takahashi, M; Baker, AL; Colan, SD; Mitchell, PD; Klein, GL; Sundel, RP				Newburger, Jane W.; Sleeper, Lynn A.; McCrindle, Brian W.; Minich, L. LuAnn; Gersony, Welton; Vetter, Victoria L.; Atz, Andrew M.; Li, Jennifer S.; Takahashi, Masato; Baker, Annette L.; Colan, Steven D.; Mitchell, Paul D.; Klein, Gloria L.; Sundel, Robert P.		Pediat Heart Network Investig	Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GAMMA-GLOBULIN THERAPY; AMERICAN-HEART-ASSOCIATION; CORONARY-ARTERY ANEURYSM; LONG-TERM MANAGEMENT; IMMUNOGLOBULIN TREATMENT; CARDIOVASCULAR-DISEASE; INITIAL TREATMENT; RHEUMATIC-FEVER; IMMUNE GLOBULIN; ACUTE-PHASE	BACKGROUND Treatment of acute Kawasaki disease with intravenous immune globulin and aspirin reduces the risk of coronary-artery abnormalities and systemic inflammation, but despite intravenous immune globulin therapy, coronary-artery abnormalities develop in some children. Studies have suggested that primary corticosteroid therapy might be beneficial and that adverse events are infrequent with short-term use. METHODS We conducted a multicenter, randomized, double-blind, placebo-controlled trial to determine whether the addition of intravenous methylprednisolone to conventional primary therapy for Kawasaki disease reduces the risk of coronary-artery abnormalities. Patients with 10 or fewer days of fever were randomly assigned to receive intravenous methylprednisolone, 30 mg per kilogram of body weight (101 patients), or placebo (98 patients). All patients then received conventional therapy with intravenous immune globulin, 2 g per kilogram, as well as aspirin, 80 to 100 mg per kilogram per day until they were afebrile for 48 hours and 3 to 5 mg per kilogram per day thereafter. RESULTS At week 1 and week 5 after randomization, patients in the two study groups had similar coronary dimensions, expressed as z scores adjusted for body-surface area, absolute dimensions, and changes in dimensions. As compared with patients receiving placebo, patients receiving intravenous methylprednisolone had a somewhat shorter initial period of hospitalization (P=0.05) and, at week 1, a lower erythrocyte sedimentation rate (P=0.02) and a tendency toward a lower C-reactive protein level (P=0.07). However, the two groups had similar numbers of days spent in the hospital, numbers of days of fever, rates of retreatment with intravenous immune globulin, and numbers of adverse events. CONCLUSIONS Our data do not provide support for the addition of a single pulsed dose of intravenous methylprednisolone to conventional intravenous immune globulin therapy for the routine primary treatment of children with Kawasaki disease.	Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; New England Res Inst, Watertown, MA 02172 USA; Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; Columbia Univ, Med Ctr, New York, NY USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Med Univ S Carolina, Charleston, SC 29425 USA; Duke Univ, Med Ctr, Durham, NC USA; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Univ So Calif, Los Angeles, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; HealthCore, Inc; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Medical University of South Carolina; Duke University; Children's Hospital Los Angeles; University of Southern California	Newburger, JW (corresponding author), Childrens Hosp, Dept Cardiol, 300 Longwood Ave, Boston, MA 02115 USA.	jane.newburger@cardio.chboston.org	Colan, Steven/ABB-4580-2020; Atz, Andrew/J-9196-2015	Atz, Andrew/0000-0002-4744-3832; Sundel, Robert/0000-0002-0083-5695	NCRR NIH HHS [RR 02172] Funding Source: Medline; NHLBI NIH HHS [U01 HL068288, U01 HL068270, U01 HL068269, U01 HL068290, U01 HL068292, U10 HL109778, U01 HL068281, U01 HL068279, U01 HL068285] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL068285, U01HL068281, U01HL068270, U01HL068290, U01HL068288, U01HL068269, U01HL068279, U01HL068292] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORZAK S, 1995, ANN INTERN MED, V123, P873, DOI 10.7326/0003-4819-123-11-199512010-00010; DAJANI AS, 1994, CIRCULATION, V89, P916, DOI 10.1161/01.CIR.89.2.916; Dale RC, 2000, J PEDIATR-US, V137, P723, DOI 10.1067/mpd.2000.108444; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; IMAI Y, 1997, PATHOLOGICAL STUDY R; Inoue Y, 2006, J PEDIATR-US, V149, P336, DOI 10.1016/j.jpeds.2006.05.025; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Ishii M, 2001, PEDIATR INT, V43, P211, DOI 10.1046/j.1442-200x.2001.01373.x; ITO S, 1992, DEV PHARMACOL THERAP, V19, P99, DOI 10.1159/000457470; KAN Z, 1990, J PEDIAT PRACT, V53, P328; KATO H, 1979, PEDIATRICS, V63, P175; KIJIMA Y, 1982, JPN CIRC J, V46, P1239, DOI 10.1253/jcj.46.1239; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KUSAKAWA S, 1983, ACTA PAEDIATR JAPON, V25, P205; Mahony L, 2006, PEDIATR CARDIOL, V27, P191, DOI 10.1007/s00246-005-1151-9; Muta H, 2006, ACTA PAEDIATR, V95, P189, DOI 10.1080/08035250500327328; NEUDORF U, 1993, INFUSIONSTHERAPIE, V20, P137; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Newburger JW, 1999, J PEDIATR-US, V135, P411, DOI 10.1016/S0022-3476(99)70160-5; Okada Y, 2003, J PEDIATR-US, V143, P363, DOI 10.1067/S0022-3476(03)00387-1; Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Shinohara M, 1999, J PEDIATR-US, V135, P465, DOI 10.1016/S0022-3476(99)70169-1; Shulman ST, 2003, J PEDIATR-US, V142, P601, DOI 10.1067/mpd.2003.258; SONE K, 1987, J PEDIAT PRACT, V50, P1175; Sundel RP, 2003, J PEDIATR-US, V142, P611, DOI 10.1067/mpd.2003.191; Suzuki N, 1999, PEDIATR INT, V41, P318, DOI 10.1046/j.1442-200x.1999.01058.x; Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6; Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78; Wooditch AC, 2005, PEDIATRICS, V116, P989, DOI 10.1542/peds.2005-0504; Wright DA, 1996, J PEDIATR-US, V128, P146, DOI 10.1016/S0022-3476(96)70447-X	33	257	275	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					663	675		10.1056/NEJMoa061235	http://dx.doi.org/10.1056/NEJMoa061235			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301297				2022-12-28	WOS:000244193300004
J	Peddinghaus, ME; Sustento-Reodica, N				Peddinghaus, Marie E.; Sustento-Reodica, Nedjema			A hearty finding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA	Drexel University	Peddinghaus, ME (corresponding author), Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19102 USA.	marie.peddinghaus@drexelmed.edu							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					714	714		10.1056/NEJMicm054465	http://dx.doi.org/10.1056/NEJMicm054465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301302				2022-12-28	WOS:000244193300009
J	Webb, SC				Webb, Spahr C.			The Earth's 'hum' is driven by ocean waves over the continental shelves	NATURE			English	Article							BACKGROUND FREE OSCILLATIONS; SOLID EARTH; ATMOSPHERE; EXCITATION; NOISE; GENERATION	Observations show that the seismic normal modes of the Earth at frequencies near 10 mHz are excited at a nearly constant level in the absence of large earthquakes(1). This background level of excitation has been called the 'hum' of the Earth(2), and is equivalent to the maximum excitation froma magnitude 5.75 earthquake(3). Its origin is debated, with most studies attributing the forcing to atmospheric turbulence, analogous to the forcing of solar oscillations by solar turbulence(2,4-7). Some reports also predicted that turbulence might excite the planetary modes of Mars to detectable levels(4). Recent observations on Earth, however, suggest that the predominant excitation source lies under the oceans(8-10). Here I show that turbulence is a very weak source, and instead it is interacting ocean waves over the shallow continental shelves that drive the hum of the Earth. Ocean waves couple into seismic waves through the quadratic nonlinearity of the surface boundary condition, which couples pairs of slowly propagating ocean waves of similar frequency to a high phase velocity component at approximately double the frequency. This is the process by which ocean waves generate the well known 'microseism peak' that dominates the seismic spectrum near 140 mHz (refs 11, 12), but at hum frequencies, the mechanism differs significantly in frequency and depth dependence. A calculation of the coupling between ocean waves and seismic modes reproduces the seismic spectrum observed. Measurements of the temporal correlation between ocean wave data and seismic data(9,10) have confirmed that ocean waves, rather than atmospheric turbulence, are driving the modes of the Earth.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	Webb, SC (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	scw@ldeo.columbia.edu		Webb, Spahr/0000-0002-7277-174X				AKHALKATSI M, 2004, INFRASOUND GENERATIO; Berger J, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003408; Dahlen F. A, 1998, THEORETICAL GLOBAL S; Ekstrom G, 2001, J GEOPHYS RES-SOL EA, V106, P26483, DOI 10.1029/2000JB000086; EKSTROM G, 2005, EOS S, V86; Fukao Y, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000153; Gaherty JB, 1996, J GEOPHYS RES-SOL EA, V101, P22291, DOI 10.1029/96JB01882; HASSELMANN K, 1963, REV GEOPHYS, V1, P177, DOI 10.1029/RG001i002p00177; Herbers THC, 1995, J GEOPHYS RES-OCEANS, V100, P24863, DOI 10.1029/95JC02680; HERBERS THC, 1995, J PHYS OCEANOGR, V25, P1063, DOI 10.1175/1520-0485(1995)025<1063:IFHMOT>2.0.CO;2; HERBERS THC, 2006, SAX04 EXPT DATA SET; HOWE MS, 1991, J ACOUST SOC AM, V90, P1041, DOI 10.1121/1.402292; Kobayashi N, 1998, NATURE, V395, P357, DOI 10.1038/26427; LIGHTHILL MJ, 1952, PROC R SOC LON SER-A, V211, P564, DOI 10.1098/rspa.1952.0060; Lognonne P, 1998, GEOPHYS J INT, V135, P388, DOI 10.1046/j.1365-246X.1998.00665.x; MEECHAM WC, 1971, J ATMOS TERR PHYS, V33, P149, DOI 10.1016/0021-9169(71)90193-0; Nishida K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013862; Nishida K, 2000, SCIENCE, V287, P2244, DOI 10.1126/science.287.5461.2244; Rhie J, 2004, NATURE, V431, P552, DOI 10.1038/nature02942; ROMANOWICZ B, 2005, EOS S, V86; Suda N, 1998, SCIENCE, V279, P2089, DOI 10.1126/science.279.5359.2089; Tanimoto T, 2005, GEOPHYS J INT, V160, P276, DOI 10.1111/J.1365-246X.2004.02484.X; Tanimoto T, 2001, ANNU REV EARTH PL SC, V29, P563, DOI 10.1146/annurev.earth.29.1.563; TATOM FB, 2001, SEISMOL RES LETT, V72, P12, DOI DOI 10.1785/GSSRL.72.1.12; Webb SC, 1998, REV GEOPHYS, V36, P105, DOI 10.1029/97RG02287; WOODHOUSE JH, 1988, SEISMOLOGICAL ALGORI, P321	26	132	135	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					754	756		10.1038/nature05536	http://dx.doi.org/10.1038/nature05536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301790				2022-12-28	WOS:000244205200042
J	Dhallan, R; Guo, X; Emche, S; Damewood, M; Bayliss, P; Cronin, M; Barry, J; Betz, J; Franz, K; Gold, K; Vallecillo, B; Varney, J				Dhallan, Ravinder; Guo, Xin; Emche, Sarah; Damewood, Marian; Bayliss, Philip; Cronin, Michael; Barry, Julie; Betz, Jordan; Franz, Kara; Gold, Katie; Vallecillo, Brett; Varney, John			A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study	LANCET			English	Article							CELLS; PLASMA; CIRCULATION	Background Use of free fetal DNA to diagnose fetal chromosomal abnormalities has been hindered by the inability to distinguish fetal DNA from maternal DNA. Our aim was to establish whether single nucleotide polymorphisms (SNPs) can be used to distinguish fetal DNA from maternal DNA-and to determine the number of fetal chromosomes-in maternal blood samples. Methods Formaldehyde-treated blood samples from 60 pregnant women and the stated biological fathers were analysed. Maternal plasma fractions were quantified at multiple SNPs, and the ratio of the unique fetal allele signal to the combined maternal and fetal allele signal calculated. The mean ratios of SNPs on chromosomes 13 and 21 were compared to test for potential fetal chromosomal abnormalities. Findings The mean proportion of free fetal DNA was 34.0% (median 32.5%, range 17.0-93-8). We identified three samples with significant differences in the fetal DNA ratios for chromosome 13 and chromosome 21,. indicative of trisomy 21; the remaining 57 samples were deemed to be normal. Amniocentesis or newborn reports from the clinical sites confirmed that the copy number of fetal chromosomes 13 and 21 was established correctly for 58 of the 60 samples, identifying 56 of the 57 normal samples, and two of the three trisomy 21 samples. Of the incorrectly identified samples, one was a false negative and one was a false positive. The sensitivity and positive predictive value were both 66.7% (95% CI 12.5-98.2) and the specificity and negative predictive values were both 98.2% (89.4-99.9). Interpretation The copy number of chromosomes of interest can be directly established from maternal plasma. Such a non-invasive prenatal test could provide a useful complement to currently used screening tests.	Ravgen Inc, Columbia, MD 21045 USA; York Hosp Wellspan Hlth, Dept Obstet & Gynecol, York, PA USA; Lancaster Gen Women & Babies Hosp, Dept Maternal Fetal Med, Lancaster, PA USA; Whyte Hirschboeck Dudek SC, Madison, WI USA		Dhallan, R (corresponding author), Ravgen Inc, 9241 Rumsey Rd, Columbia, MD 21045 USA.	rdhallan@ravgen.com	Betz, Jordan F/A-8833-2010	Betz, Jordan F/0000-0002-1257-2204				ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Alfirevic Z, 2004, BMJ-BRIT MED J, V329, P811, DOI 10.1136/bmj.329.7470.811; Alfirevic Z, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003252, 10.1002/14651858]; Amicucci P, 2000, CLIN CHEM, V46, P301; Avent ND, 2006, PRENATAL DIAG, V26, P598, DOI 10.1002/pd.1493; Benn PA, 2004, OBSTET GYNECOL, V103, P1255, DOI 10.1097/01.AOG.0000127008.14792.14; Berkowitz RL, 2006, OBSTET GYNECOL, V107, P715, DOI 10.1097/01.AOG.0000201976.00299.d2; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; BIANCHI DW, 1990, P NATL ACAD SCI USA, V87, P3279, DOI 10.1073/pnas.87.9.3279; d'Ercole C, 2003, CHILD NERV SYST, V19, P444, DOI 10.1007/s00381-003-0788-z; de Graaf IM, 1999, PRENATAL DIAG, V19, P648, DOI 10.1002/(SICI)1097-0223(199907)19:7<648::AID-PD600>3.0.CO;2-X; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; DHALLAN RS, 2005, Patent No. 6977162; DHALLAN RS, 2004, Patent No. 10661165; Fuchs KM, 2005, SEMIN PERINATOL, V29, P267, DOI 10.1053/j.semperi.2005.05.003; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Papp C, 2003, CURR OPIN OBSTET GYN, V15, P159, DOI 10.1097/00001703-200304000-00011; Pont-Kingdon G, 2003, CLIN CHEM, V49, P1087, DOI 10.1373/49.7.1087; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; Torricelli F, 2001, CLIN CHEM LAB MED, V39, P494, DOI 10.1515/CCLM.2001.082; Wilson RD, 2005, J OBSTET GYNAECOL CA, V27, P54, DOI 10.1016/S1701-2163(16)30173-6	25	89	174	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					474	481		10.1016/S0140-6736(07)60115-9	http://dx.doi.org/10.1016/S0140-6736(07)60115-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292767				2022-12-28	WOS:000244188300030
J	Whiteman, D				Whiteman, David			The modern researcher and the peacock's tail	LANCET			English	Editorial Material									PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Whiteman, D (corresponding author), PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	david.whiteman@qimr.edu.au	Whiteman, David C/P-2728-2014	Whiteman, David C/0000-0003-2563-9559				de Meis L, 2003, BRAZ J MED BIOL RES, V36, P1135, DOI 10.1590/S0100-879X2003000900001; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ludvigsson Jonas F, 2005, Nature, V434, P542, DOI 10.1038/nj7032-542b; Mason B, 2004, NATURE, V428, P690, DOI 10.1038/428690a; Waltz E, 2006, NAT MED, V12, P259, DOI 10.1038/nm0306-259a; Weinberg RA, 2006, CELL, V126, P9, DOI 10.1016/j.cell.2006.06.022	6	0	0	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					449	450		10.1016/S0140-6736(07)60212-8	http://dx.doi.org/10.1016/S0140-6736(07)60212-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292749				2022-12-28	WOS:000244188300010
J	Woolf, SH				Woolf, Steven H.			Potential health and economic consequences of misplaced priorities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		Virginia Commonwealth Univ, Dept Family Med, Richmond, VA USA; Virginia Commonwealth Univ, Dept Epidemiol, Richmond, VA USA; Virginia Commonwealth Univ, Dept Community Hlth, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, West Hosp, Dept Family Med, 1200 E Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						*BUDG US GOV, FISC YEAR 2006; Calltorp J, 1999, HEALTH POLICY, V50, P1, DOI 10.1016/S0168-8510(99)00061-5; Catlin A, 2007, HEALTH AFFAIR, V26, P142, DOI 10.1377/hlthaff.26.1.142; Centers for Disease Control and Prevention (CDC), 1992, MMWR-MORBID MORTAL W, V41, P529; GEEWAX M, 2007, SAN FRANCISCO C 0119; HOGAN C, 2000, MEDICARE BENEFICIARI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LAKDAWALLA DN, 2005, HLTH AFF MILLWOOD S2, V24; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT CTR HLTH STAT, HIST293 AG ADJ DEATH; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Organisation for Economic Co-Operation and Development, 2005, HLTH GLANC OECD IND; Satcher D, 2006, HEALTH AFFAIR, V25, P1009, DOI 10.1377/hlthaff.25.4.1009; Schoen C, 2004, HLTH AFF MILLWOOD S; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Woolf SH, 1999, JAMA-J AM MED ASSOC, V282, P2358, DOI 10.1001/jama.282.24.2358; Woolf SH, 2005, ANN FAM MED, V3, P545, DOI 10.1370/afm.406; Woolf SH, 2004, AM J PUBLIC HEALTH, V94, P2078, DOI 10.2105/AJPH.94.12.2078; Woolf SH, 2006, HARVARD HLTH POLICY, V7, P5; WOOLF SH, IN PRESS AM J PUBLIC; Woolf SH, 2006, AM J PREV MED, V31, P332, DOI 10.1016/j.amepre.2006.06.022; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352	25	51	52	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					523	526		10.1001/jama.297.5.523	http://dx.doi.org/10.1001/jama.297.5.523			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	133FP	17284703				2022-12-28	WOS:000243999100030
J	Kurella, M; Covinsky, KE; Collins, AJ; Chertow, GM				Kurella, Manjula; Covinsky, Kenneth E.; Collins, Alan J.; Chertow, Glenn M.			Octogenarians and nonagenarians starting dialysis in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; REPLACEMENT THERAPY; DECISION-MAKING; INITIATION; SURVIVAL; HEMODIALYSIS; PREVALENCE; VALIDATION; COHORT	Background: The elderly constitute the fastest-growing segment of the end-stage renal disease (ESRD) population, but the epidemiology and outcomes of dialysis among the very elderly, that is, those 80 years of age and older, have not been previously examined at a national level. Objective: To describe recent trends in the incidence and outcomes of octogenarians and nonagenarians starting dialysis. Design: Observational study. Setting: U.S. Renal Data System, a comprehensive, national registry of patients with ESRD. Participants: Octogenarians and nonagenarians initiating dialysis between 1996 and 2003. Measurements: Rates of dialysis initiation and survival. Results: The number of octogenarians and nonagenarians starting dialysis increased from 7054 persons in 1996 to 13 577 persons in 2003, corresponding to an average annual increase in dialysis initiation of 9.8%. After we accounted for population growth, the rate of dialysis initiation increased by 57% (rate ratio, 1.57 [95% CI, 1.53 to 1.62]) between 1996 and 2003. One-year mortality for octogenarians and nonagenarians after dialysis initiation was 46%. Compared with octogenarians and nonagenarians initiating dialysis in 1996, those starting dialysis in 2003 had a higher glomerular filtration rate and less morbidity related to chronic kidney disease but no difference in 1-year survival. Clinical characteristics strongly associated with death were older age, nonambulatory status, and more comorbid conditions. Limitations: Survival of patients with incident ESRD who did not begin dialysis could not be assessed. Conclusions: The number of octogenarians and nonagenarians initiating dialysis has increased considerably over the past decade, while overall survival for patients on dialysis remains modest. Estimates of prognosis based on patient characteristics, when considered in conjunction with individual values and preferences, may aid in dialysis decision making for the very elderly.	Univ Calif San Francisco, Div Nephrol, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA 94143 USA; US Renal Data Syst, Minneapolis, MN USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Kurella, M (corresponding author), Univ Calif San Francisco, Div Nephrol, UCSF Laurel Heights,Suite 430,3333 Calif St, San Francisco, CA 94143 USA.	manjula.kurella@ucsf.edu	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479; Chertow, Glenn/0000-0002-7599-0534	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG029812] Funding Source: NIH RePORTER; NIA NIH HHS [K24 AG029812] Funding Source: Medline; NIDDK NIH HHS [R01 DK01005, R01 DK58411] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arias Elizabeth, 2004, Natl Vital Stat Rep, V53, P1; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; BURNS A, 2005, AM SOC NEPHR REN WEE; Centers for Disease Control and Prevention, NAT CTR HLTH STAT NC; CHESTER AC, 1979, ARCH INTERN MED, V139, P1001, DOI 10.1001/archinte.139.9.1001; Collins AJ, 2005, AM J KIDNEY DIS, V45, pV, DOI 10.1053/j.ajkd.2004.10.009; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Korevaar JC, 2001, LANCET, V358, P1046, DOI 10.1016/S0140-6736(01)06180-3; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Longenecker JC, 2000, J AM SOC NEPHROL, V11, P520, DOI 10.1681/ASN.V113520; McDonald S, 2005, ADV CHRONIC KIDNEY D, V12, P32, DOI 10.1053/j.ackd.2004.10.011; Moss AH, 2001, AM J KIDNEY DIS, V37, P1081; Munshi SK, 2001, NEPHROL DIAL TRANSPL, V16, P128, DOI 10.1093/ndt/16.1.128; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Peri UN, 2001, NEPHROL DIAL TRANSPL, V16, P2201, DOI 10.1093/ndt/16.11.2201; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PORT FK, 1992, AM J KIDNEY DIS, V20, P3; Rohrich B, 1996, NEPHROL DIAL TRANSPL, V11, P2412, DOI 10.1093/oxfordjournals.ndt.a027205; Smith C, 2003, NEPHRON CLIN PRACT, V95, pC40, DOI 10.1159/000073708; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; Vandelli L, 1996, NEPHROL DIAL TRANSPL, V11, P89	25	399	419	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					177	183		10.7326/0003-4819-146-3-200702060-00006	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283348				2022-12-28	WOS:000243957400003
J	Farquhar, C				Farquhar, Cynthia			Endometriosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							TERM-FOLLOW-UP; PELVIC PAIN; RECTOVAGINAL ENDOMETRIOSIS; CONSERVATIVE SURGERY; CONTROLLED TRIAL; WOMEN		Univ Auckland, Dept Obstet & Gynaecol, Natl Womens Hosp, Auckland 1, New Zealand	University of Auckland	Farquhar, C (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Natl Womens Hosp, Auckland 1, New Zealand.	c.farquhar@auckland.ac.nz		Farquhar, Cynthia/0000-0002-3685-3553				Abbott J, 2004, FERTIL STERIL, V82, P878, DOI 10.1016/j.fertnstert.2004.03.046; Alcazar JL, 1997, FERTIL STERIL, V67, P487, DOI 10.1016/S0015-0282(97)80074-X; European Society for Human Reproduction and Embryology, ESHRE GUID DIAGN TRE; Fauconnier A, 2005, HUM REPROD UPDATE, V11, P595, DOI 10.1093/humupd/dmi029; Fedele L, 2004, AM J OBSTET GYNECOL, V190, P1020, DOI 10.1016/j.ajog.2003.10.698; Hart RJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004992.pub2; HUGHES E, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000155.PUB2; Kinkel K., 2006, MODERN MANAGEMENT EN, P71; Matorras R, 2002, FERTIL STERIL, V77, P303, DOI 10.1016/S0015-0282(01)02981-8; Mol BWJ, 1998, FERTIL STERIL, V70, P1101, DOI 10.1016/S0015-0282(98)00355-0; Petta CA, 2005, HUM REPROD, V20, P1993, DOI 10.1093/humrep/deh869; PRENTICE A, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002122; Proctor ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001896.pub2; RCOG Guideline, 2006, GREEN TOP GUID, V24; Redwine DB, 2001, FERTIL STERIL, V76, P358, DOI 10.1016/S0015-0282(01)01913-6; SAGSVEEN M, 2003, COCHRANE DB SYST REV; SELAK V, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000068.PUB2; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Vercellini P, 1996, FERTIL STERIL, V65, P299, DOI 10.1016/S0015-0282(16)58089-3; Vercellini P, 2005, FERTIL STERIL, V84, P1375, DOI 10.1016/j.fertnstert.2005.03.083; Vercellini P, 2003, FERTIL STERIL, V80, P305, DOI 10.1016/S0015-0282(03)00608-3; Wong BC, 2004, AM J OBSTET GYNECOL, V191, P598, DOI 10.1016/j.ajog.2004.05.079; Yap C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003678.PUB2	23	112	114	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2007	334	7587					249	253		10.1136/bmj.39073.736829.BE	http://dx.doi.org/10.1136/bmj.39073.736829.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272567	Green Published			2022-12-28	WOS:000244172400031
J	Brock, JD				Brock, Joel D.			Watching atoms move	SCIENCE			English	Editorial Material							SYNCHROTRON-RADIATION; PULSES		Cornell Univ, Sch Appl Engn & Phys, Ithaca, NY 14853 USA	Cornell University	Brock, JD (corresponding author), Cornell Univ, Sch Appl Engn & Phys, Ithaca, NY 14853 USA.	jdb20@cornell.edu	Brock, Joel/AAZ-3439-2020					Cavalieri AL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.114801; Cavalleri A, 2006, NATURE, V442, P664, DOI 10.1038/nature05041; Fritz DM, 2007, SCIENCE, V315, P633, DOI 10.1126/science.1135009; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Zholents AA, 1996, PHYS REV LETT, V76, P912, DOI 10.1103/PhysRevLett.76.912	5	6	7	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					609	610		10.1126/science.1136895	http://dx.doi.org/10.1126/science.1136895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272710				2022-12-28	WOS:000243909400031
J	Lim, MLM; Land, MF; Li, DQ				Lim, Matthew L. M.; Land, Michael F.; Li, Daiqin			Sex-specific UV and fluorescence signals in jumping spiders	SCIENCE			English	Article							SALTICIDAE; ARANEAE; SENSITIVITY		Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England; Hubei Univ, Coll Life Sci, Wuhan 430062, Hubei, Peoples R China	National University of Singapore; University of Sussex; Hubei University	Li, DQ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslidq@nus.edu.sg	Li, Daiqin/CAH-3746-2022; Li, Daiqin/D-6922-2013; Lim, Matthew LM/D-4154-2011; Lim, Matthew/Q-7406-2019	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Lim, Matthew LM/0000-0002-0888-3595; Lim, Matthew/0000-0002-0888-3595				Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; BLEST AD, 1981, J COMP PHYSIOL, V145, P227, DOI 10.1007/BF00605035; Land M.F., 1985, P53; Lim MLM, 2006, BIOL J LINN SOC, V89, P397, DOI 10.1111/j.1095-8312.2006.00704.x; Lim MLM, 2006, J COMP PHYSIOL A, V192, P871, DOI 10.1007/s00359-006-0126-5; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; TOVEE MJ, 1995, TRENDS ECOL EVOL, V10, P455, DOI 10.1016/S0169-5347(00)89179-X	8	108	113	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					481	481		10.1126/science.1134254	http://dx.doi.org/10.1126/science.1134254			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255504				2022-12-28	WOS:000243726600036
J	Mutrie, N; Campbell, AM; Whyte, F; McConnachie, A; Emslie, C; Lee, L; Kearney, N; Walker, A; Ritchie, D				Mutrie, Nanette; Campbell, Anna M.; Whyte, Fiona; McConnachie, Alex; Emslie, Carol; Lee, Laura; Kearney, Nora; Walker, Andrew; Ritchie, Diana			Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY LEVELS; FUNCTIONAL ASSESSMENT; DIAGNOSIS; SURVIVORS; VALIDATION; HEALTH	Objectives To determine functional and psychological benefits of a 12 week supervised group exercise programme during treatment for early stage breast cancer, with six month follow-up. Design Pragmatic randomised controlled prospective open trial. Setting Three National Health Service oncology clinics in Scotland and community exercise facilities. Participants 203 women entered the study; 177 completed the six month follow-up. Interventions Supervised 12 week group exercise programme in addition to usual care, compared with usual care. Main outcome measures Functional assessment of cancer therapy (FACT) questionnaire, Beck depression inventory, positive and negative affect scale, body mass index, seven day recall of physical activity, 12 minute walk test, and assessment of shoulder mobility. Results Mixed effects models with adjustment for baseline values, study site, treatment at baseline, and age gave intervention effect estimates (intervention minus control) at 12 weeks of 129 (95% confidence interval 83 to 176) for metres walked in 12 minutes, 182 (75 to 289) for minutes of moderate intensity activity reported in a week, 2.6 (1.6 to 3.7) for shoulder mobility, 2.5 (1.0 to 3.9) for breast cancer specific subscale of quality of life, and 4.0 (1.8 to 6.3) for positive mood. No significant effect was seen for general quality of life (FACT-G), which was the primary outcome. At the six month follow-up, most of these effects were maintained and an intervention effect for breast cancer specific quality of life emerged. No adverse effects were noted. Conclusion Supervised group exercise provided functional and psychological benefit after a 12 week intervention and six months later. Clinicians should encourage activity for their patients. Policy makers should consider the inclusion of exercise opportunities in cancer rehabilitation services.	Univ Strathclyde, Dept Sport Culture & Arts, Glasgow G13 1PP, Lanark, Scotland; Univ Glasgow, Nursing & Midwifery Sch, Glasgow G12 8LW, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland; MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Stirling, Canc Care Res Ctr, Dept Nursing & Midwifery, Stirling FK9 4LA, Scotland; Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland	University of Strathclyde; University of Glasgow; University of Glasgow; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Stirling; Beatson Oncology Centre	Mutrie, N (corresponding author), Univ Strathclyde, Dept Sport Culture & Arts, Glasgow G13 1PP, Lanark, Scotland.	nanette.mutrie@strath.ac.uk		Emslie, Carol/0000-0003-2170-2039	Medical Research Council [MC_U130059811] Funding Source: Medline; MRC [MC_U130059811] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; CAMPBELL A, 2007, CLIN EFFECTIVENESS N, V9, P211; Campbell Anna, 2005, Eur J Oncol Nurs, V9, P56, DOI 10.1016/j.ejon.2004.03.007; Cancer Research UK, BREAST CANC SURV STA; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Courneya KS, 2003, PSYCHO-ONCOLOGY, V12, P357, DOI 10.1002/pon.658; Courneya KS, 1999, ANN BEHAV MED, V21, P171, DOI 10.1007/BF02908298; Courneya KS, 2002, PHYSICIAN SPORTSMED, V30, P33, DOI 10.3810/psm.2002.08.402; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; EMSLIE C, IN PRESS HLTH ED RES; Fallowfield LJ, 1999, BREAST CANCER RES TR, V55, P189; Halverstadt A, 2000, ESSENTIAL EXERCISES; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Irwin ML, 2003, CANCER-AM CANCER SOC, V97, P1746, DOI 10.1002/cncr.11227; LOTHER M, 1999, BRIT J SPORT MED, V33, P1; LOWTHER M, 1999, BRIT J SPORT MED, V33, P1; MARCUS BH, 1994, J APPL SOC PSYCHOL, V24, P489, DOI 10.1111/j.1559-1816.1994.tb00595.x; Markes M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005001; MCGAVIN CR, 1976, BMJ-BRIT MED J, V1, P822, DOI 10.1136/bmj.1.6013.822; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Oldervoll LM, 2004, EUR J CANCER, V40, P951, DOI 10.1016/j.ejca.2003.12.005; Segal R, 2001, J CLIN ONCOL, V19, P657, DOI 10.1200/JCO.2001.19.3.657; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wilmoth MC, 2004, ONCOL NURS FORUM, V31, P1069, DOI 10.1188/04.ONF.1069-1075	28	264	274	2	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					517	520B		10.1136/bmj.39094.648553.AE	http://dx.doi.org/10.1136/bmj.39094.648553.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148VV	17307761	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000245106400041
J	Walter, MA; Briel, M; Christ-Crain, M; Bonnema, SJ; Connell, J; Cooper, DS; Bucher, HC; Muller-Brand, J; Muller, B				Walter, Martin A.; Briel, Matthias; Christ-Crain, Mirjam; Bonnema, Steen J.; Connell, John; Cooper, David S.; Bucher, Heiner C.; Mueller-Brand, Jan; Mueller, Beat			Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Review							GRAVES-DISEASE; I-131 THERAPY; HYPERTHYROIDISM; PROPYLTHIOURACIL; MANAGEMENT; MEDICATION; MORTALITY; RISK	Objective To determine the effect of adjunctive antithyroid drugs on the risk of treatment failure, hypothyroidism, and adverse events after radioiodine treatment. Design Meta-analysis. Data sources Electronic databases (Cochrane central register of controlled trials, Medline, Embase) searched to August 2006 and contact with experts. Review methods Three reviewers independently assessed trial eligibility and quality. Pooled relative risks for treatment failure and hypothyroidism after radioiodine treatment with and without adjunctive antithyroid drugs were calculated with a random effects model. Results We identified 14 relevant randomised controlled trials with a total of 1306 participants. Adjunctive antithyroid medication was associated with an increased risk of treatment failure (relative risk 1.28, 95% confidence interval 1.07 to 1.52; P=0.006) and a reduced risk for hypothyroidism (0.68, 0.53 to 0.87; P=0.006) after radioiodine treatment. We found no difference in summary estimates for the different antithyroid drugs or for whether antithyroid drugs were given before or after radioiodine treatment. Conclusions Antithyroid drugs potentially increase rates of failure and reduce rates of hypothyroidism if they are given in the week before or after radioiodine treatment, respectively.	Univ Basel Hosp, Inst Nucl Med, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Endocrinol Diabetol & Clin Nutr, CH-4031 Basel, Switzerland; Univ Basel Hosp, Basel Inst Clin Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Endocrinol Diabetol & Clin Nutr, CH-4031 Basel, Switzerland; Univ Hosp, Dept Endocrinol & Metab, Odense, Denmark; Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; Johns Hopkins Univ, Sch Med, Div Endocrinol, Baltimore, MD USA; Univ Basel Hosp, Inst Nucl Med, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel; University of Southern Denmark; Odense University Hospital; University of Glasgow; Johns Hopkins University; University of Basel	Walter, MA (corresponding author), Univ Basel Hosp, Inst Nucl Med, CH-4031 Basel, Switzerland.	m.a.walter@gmx.net	Walter, Martin A/B-5203-2017; Bonnema, Steen/AAE-6558-2021; Bonnema, Steen/AAF-1198-2020; Mueller, Beat/G-2662-2012; Briel, Matthias/AAT-9284-2021	Walter, Martin A/0000-0001-6487-5349; Christ-Crain, Mirjam/0000-0002-6336-0965; s, hema/0000-0002-3440-9475; Briel, Matthias/0000-0002-2070-5230				Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P1073, DOI 10.1210/jc.87.3.1073; BECKER DV, 1984, NEW ENGL J MED, V311, P464, DOI 10.1056/NEJM198408163110710; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRANKLYN JA, 1994, NEW ENGL J MED, V330, P1731; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HOLM LE, 1982, J NUCL MED, V23, P103; Imseis RE, 1998, J CLIN ENDOCR METAB, V83, P685, DOI 10.1210/jc.83.2.685; Lazarus JH, 1997, LANCET, V349, P339, DOI 10.1016/S0140-6736(96)08015-4; MCDERMOTT MT, 1983, AM J MED, V75, P353, DOI 10.1016/0002-9343(83)91217-2; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Sabri O, 1999, J CLIN ENDOCR METAB, V84, P1229, DOI 10.1210/jc.84.4.1229; Santos RB, 2004, THYROID, V14, P525, DOI 10.1089/1050725041517093; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sawin CT, 1997, THYROID, V7, P163, DOI 10.1089/thy.1997.7.163; SOLOMON B, 1990, J CLIN ENDOCR METAB, V70, P1518, DOI 10.1210/jcem-70-6-1518; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Walter MA, 2005, NUKLEARMED-NUCL MED, V44, P33; WILSON R, 1990, AUTOIMMUNITY, V8, P3, DOI 10.3109/08916939008998426	22	106	113	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 10	2007	334	7592					514	517		10.1136/bmj.39114.670150.BE	http://dx.doi.org/10.1136/bmj.39114.670150.BE			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17309884	Green Published, Bronze			2022-12-28	WOS:000245106400040
J	Gazdar, AF				Gazdar, Adi F.			DNA repair and survival in lung cancer - The two faces of Janus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERCC1; CISPLATIN		Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Gazdar, AF (corresponding author), Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA.				NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA070907] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Reed E, 2006, NEW ENGL J MED, V355, P1054, DOI 10.1056/NEJMe068162	5	55	61	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					771	773		10.1056/NEJMp068308	http://dx.doi.org/10.1056/NEJMp068308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314336				2022-12-28	WOS:000244326700003
J	Gostin, LO				Gostin, Lawrence O.			Biomedical research involving prisoners - Ethical values and legal regulation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Center on Juvenile and Criminal Justice, PUN DEC PRIS JAIL ES; Coleman Carl H., 2005, ETHICS REGULATION RE; Dostoevsky Fyodor, 1861, HOUSE DEAD; Gostin LO, 2006, ETHICAL CONSIDERATIO; Harrison P. M., 2006, PRISON JAIL INMATES; Hornblum Allen, 1998, ACRES SKIN HUMAN EXP; Hornblum AM, 1997, BRIT MED J, V315, P1437, DOI 10.1136/bmj.315.7120.1437; HORNBLUM AM, 2006, CHRON HIGH ED   1006; Hughes T., 2004, REENTRY TRENDS US; Mastroianni A, 2001, HASTINGS CENT REP, V31, P21, DOI 10.2307/3527551; Murphy DS., 2005, CALIFORNIAN J HLTH P, V3, P23, DOI 10.32398/cjhp.v3i2.1761; National Bioethics Advisory Commission, ETH POL ISS RES INV; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (NCPHS), 1976, RES INV PRIS; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research US Department of Health Education and Welfare, 1979, ETH PRINC GUID PROT; Raimer BG, 2004, JAMA-J AM MED ASSOC, V292, P485, DOI 10.1001/jama.292.4.485; URBINA I, 2006, NY TIMES        0813; US Department of Health and Human Services, 2003, FED REG, V68, P36929; 2006, USA TODAY       0821; 1953, TRIALS WAR CRIMINALS	19	36	36	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					737	740		10.1001/jama.297.7.737	http://dx.doi.org/10.1001/jama.297.7.737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312293				2022-12-28	WOS:000244291100026
J	Eiler, JM				Eiler, John M.			Geology - On the origins of granites	SCIENCE			English	Editorial Material							SOUTHEASTERN AUSTRALIA; ROCKS; MODEL		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Eiler, JM (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	eiler@gps.caltech.edu						CASTRO A, 1991, EARTH-SCI REV, V31, P237, DOI 10.1016/0012-8252(91)90020-G; Chappell BW, 2004, T ROY SOC EDIN-EARTH, V95, P125; GRAY CM, 1984, EARTH PLANET SC LETT, V70, P47, DOI 10.1016/0012-821X(84)90208-5; Hutton James, 1970, SYSTEM EARTH 1785 TH; Kemp AIS, 2007, SCIENCE, V315, P980, DOI 10.1126/science.1136154; PERFIT MR, 1980, CONTRIB MINERAL PETR, V73, P69, DOI 10.1007/BF00376261; VALLEY JW, 1994, EARTH PLANET SC LETT, V126, P187, DOI 10.1016/0012-821X(94)90106-6; WERNER AG, 1971, SHORT CLASSIFICATION, P38; WHITE AJR, 1983, GEOL SOC AM MEM, V159, P21; WHITE AJR, 1977, TECTONOPHYSICS, V43, P7, DOI 10.1016/0040-1951(77)90003-8	10	7	9	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					951	952		10.1126/science.1138065	http://dx.doi.org/10.1126/science.1138065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303743				2022-12-28	WOS:000244229800030
J	Couzin, I				Couzin, Iain			Collective minds	NATURE			English	Editorial Material							DECISION-MAKING; BEHAVIOR		Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Couzin, I (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Couzin, Iain D./Q-6862-2018	Couzin, Iain D./0000-0001-8556-4558				Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733	4	220	228	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 15	2007	445	7129					715	715		10.1038/445715a	http://dx.doi.org/10.1038/445715a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301775	Bronze			2022-12-28	WOS:000244205200025
J	Stone, GW; Bertrand, ME; Moses, JW; Ohman, EM; Lincoff, AM; Ware, JH; Pocock, SJ; McLaurin, BT; Cox, DA; Jafar, MZ; Chandna, H; Hartmann, F; Leisch, F; Strasser, RH; Desaga, M; Stuckey, TD; Zelman, RB; Lieber, IH; Cohen, DJ; Mehran, R; White, HD				Stone, Gregg W.; Bertrand, Michel E.; Moses, Jeffrey W.; Ohman, E. Magnus; Lincoff, A. Michael; Ware, James H.; Pocock, Stuart J.; McLaurin, Brent T.; Cox, David A.; Jafar, M. Zubair; Chandna, Harish; Hartmann, Franz; Leisch, Franz; Strasser, Ruth H.; Desaga, Martin; Stuckey, Thomas D.; Zelman, Richard B.; Lieber, Ira H.; Cohen, David J.; Mehran, Roxana; White, Harvey D.		ACUITY Investigators	Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes - The ACUITY Timing trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; UNSTABLE ANGINA; MYOCARDIAL-INFARCTION; RECEPTOR INHIBITION; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; INTERVENTION; PREDICTORS; MANAGEMENT; BENEFIT	Context In patients with moderate- and high-risk acute coronary syndromes (ACS) who undergo an early, invasive treatment strategy, current guidelines recommend administration of platelet glycoprotein IIb/IIIa (GpIIb/IIIa) inhibitors, either upstream to all patients prior to angiography or deferred for selective use in the catheterization laboratory just prior to angioplasty. The preferred approach is undetermined. Objective To determine the optimal strategy for the use of Gp IIb/IIIa inhibitors in patients with moderate- and high-risk ACS undergoing an early, invasive treatment strategy. Design Prospective, randomized, open-label trial with 30-day clinical follow-up. Setting Four hundred fifty academic and community-based institutions in 17 countries. Patients A total of 9207 patients with moderate- and high-risk ACS undergoing an invasive treatment strategy. Interventions Patients were randomly assigned to receive either routine upstream (n = 4605) or deferred selective (n = 4602) Gp IIb/IIIa inhibitor administration, respectively. Main Outcome Measures The primary outcome was assessment of noninferiority of deferred Gp IIb/IIIa inhibitor use compared with upstream administration for the prevention of composite ischemic events (death, myocardial infarction, or unplanned revascularization for ischemia) at 30 days, using a 1-sided alpha level of .025. Major secondary end points included noninferiority or superiority of major bleeding and net clinical outcomes (composite ischemia or major bleeding). Results Glycoprotein IIb/IIIa inhibitors were used more frequently (98.3% vs 55.7%, respectively) and for a significantly longer duration (median, 18.3 vs 13.1 hours; P < .001) in patients in the upstream group compared with the deferred group. Composite ischemia at 30 days occurred in 7.9% of patients assigned to deferred use compared with 7.1% of patients assigned to upstream administration (relative risk, 1.12; 95% confidence interval, 0.97-1.29; P = .044 for noninferiority; P = .13 for superiority); as such, the criterion for noninferiority was not met. Deferred use compared with upstream use resulted in reduced 30-day rates of major bleeding (4.9% vs 6.1%, respectively; P < .001 for noninferiority; P = .009 for superiority) and similar rates of net clinical outcomes (11.7% vs 11.7%; P < .001 for noninferiority; P = .93 for superiority). Conclusions Among patients with moderate- and high-risk ACS undergoing an invasive treatment strategy, deferring the routine upstream use of Gp IIb/IIIa inhibitors for selective administration in the cardiac catheterization laboratory only to patients undergoing percutaneous coronary intervention resulted in a numerical increase in composite ischemia that, while not statistically significant, did not meet the criterion for noninferiority. This finding was offset by a significant reduction in major bleeding.	Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; Hop Cardiol, F-59037 Lille, France; Duke Univ, Med Ctr, Durham, NC USA; Cleveland Clin, Cleveland, OH 44106 USA; Harvard Univ, Boston, MA 02115 USA; London Sch Hyg & Trop Med, London WC1, England; AnMed Hlth, Anderson, SC USA; Mid Carolina Cardiol, Charlotte, NC USA; Hudson Valley Heart Ctr, Poughkeepsie, NY USA; Victoria Heart & Vasc Ctr, Victoria, TX USA; Univ Klin Schleswig Holstein Campus Lubeck, Lubeck, Germany; Landeshauptstadt Linz, Allgemeines Offentl Krankenhaus, Linz, Austria; Tech Univ Dresden, D-8027 Dresden, Germany; Amper Kliniken AG, Klinikum Dachau, Dachau, Germany; Moses Cone Hosp, Greensboro, NC USA; LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; Cape Cod Res Inst, Hyannis, MA USA; N Houston Heart Ctr, Kingwood, TX USA; St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand	Cardiovascular Research Foundation (CRF); Columbia University; Universite de Lille - ISITE; CHU Lille; Duke University; Cleveland Clinic Foundation; Harvard University; University of London; London School of Hygiene & Tropical Medicine; Kepler University Hospital; Technische Universitat Dresden; Moses Cone Memorial Hospital; LeBauer-Brodie Center for Cardiovascular Research & Education; Saint Luke's Hospital - Missouri; Saint Luke's Mid America Heart Institute; Auckland City Hospital	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Floor, New York, NY 10022 USA.	gs2184@columbia.edu	Mehran, Roxana/ABF-4160-2021					Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Bertrand ME, 2003, EUR HEART J, V24, P1174, DOI 10.1016/S0195-668X(03)00231-8; Bertrand ME, 2003, EUR HEART J, V24, P485, DOI 10.1016/S0195-668X(03)00080-0; Boersma E, 1999, CIRCULATION, V100, P2045, DOI 10.1161/01.CIR.100.20.2045; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Bolognese L, 2006, J AM COLL CARDIOL, V47, P522, DOI 10.1016/j.jacc.2005.11.012; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; BRAUNWALD E, MANAGEMENT PATIENTS; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Giugliano RP, 2005, AM HEART J, V149, P994, DOI 10.1016/j.ahj.2005.03.029; Hamm CW, 1999, NEW ENGL J MED, V341, P548; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HEMANDEZ AV, 2006, AM HEART J, V151, P257; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Roe MT, 2003, AM HEART J, V146, P993, DOI 10.1016/S0002-8703(03)00517-9; Rothman MT, 2005, NAT CLIN PRACT CARD, V2, P465, DOI 10.1038/ncpcardio0311; Ryan JW, 2005, CIRCULATION, V112, P3049, DOI 10.1161/CIRCULATIONAHA.105.582346; Segev A, 2005, AM HEART J, V150, P690, DOI 10.1016/j.ahj.2004.11.012; Stone Gregg W, 2004, J Invasive Cardiol, V16 Suppl G, P12; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Tcheng JE, 2000, LANCET, V356, P2037; The ESPRIT Investigators, 2001, LANCET, V357, P1370; Topol E, 1998, NEW ENGL J MED, V339, P436; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Zhao XQ, 1999, CIRCULATION, V100, P1609, DOI 10.1161/01.CIR.100.15.1609	38	224	243	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					591	602		10.1001/jama.297.6.591	http://dx.doi.org/10.1001/jama.297.6.591			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135TU	17299194	Green Accepted			2022-12-28	WOS:000244177400022
J	Epstein, IR				Epstein, Irving R.			Can droplets and bubbles think?	SCIENCE			English	Editorial Material							NETWORKS; MEMORY	Bubbles flowing through narrow channels can be encoded with information and made to perform logic operations like those in a computer.	Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Epstein, IR (corresponding author), Brandeis Univ, Dept Chem, Waltham, MA 02254 USA.	epstein@brandeis.edu						Chiu DT, 2001, P NATL ACAD SCI USA, V98, P2961, DOI 10.1073/pnas.061014198; Epstein I.R., 1998, INTRO NONLINEAR CHEM; FROST R, 1921, MOUNTAIN INTERVAL, P9; Fuerstman MJ, 2007, SCIENCE, V315, P828, DOI 10.1126/science.1134514; Fuerstman MJ, 2003, LANGMUIR, V19, P4714, DOI 10.1021/la030054x; Garstecki P, 2006, LAB CHIP, V6, P207, DOI 10.1039/b510843h; Gorecki J, 2003, J PHYS CHEM A, V107, P1664, DOI 10.1021/jp021041f; Groisman A, 2003, SCIENCE, V300, P955, DOI 10.1126/science.1083694; Kaminaga A, 2006, ANGEW CHEM INT EDIT, V45, P3087, DOI 10.1002/anie.200600400; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Moorthy J, 2004, ELECTROPHORESIS, V25, P1705, DOI 10.1002/elps.200405888; Prakash M, 2007, SCIENCE, V315, P832, DOI 10.1126/science.1136907; Runyon MK, 2004, ANGEW CHEM INT EDIT, V43, P1531, DOI 10.1002/anie.200353428; Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203; Steinbock O, 1996, J PHYS CHEM-US, V100, P18970, DOI 10.1021/jp961209v; STEINBOCK O, 1995, SCIENCE, V267, P868, DOI 10.1126/science.267.5199.868; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230	18	26	28	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					775	776		10.1126/science.1138325	http://dx.doi.org/10.1126/science.1138325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289966				2022-12-28	WOS:000244069000034
J	Sane, SP; Dieudonne, A; Willis, MA; Daniel, TL				Sane, Sanjay P.; Dieudonne, Alexandre; Willis, Mark A.; Daniel, Thomas L.			Antennal mechanosensors mediate flight control in moths	SCIENCE			English	Article							AGLAIS-URTICAE L; CURRENT SENSE-ORGANS; MECHANICAL-PROPERTIES; BLOWFLY CALLIPHORA; LOCUSTA-MIGRATORIA; VISUAL CONTROL; L-LEPIDOPTERA; ORGANIZATION; EQUILIBRIUM; MOVEMENT	Flying insects have evolved sophisticated sensory capabilities to achieve rapid course control during aerial maneuvers. Among two-winged insects such as houseflies and their relatives, the hind wings are modified into club-shaped, mechanosensory halteres, which detect Coriolis forces and thereby mediate flight stability during maneuvers. Here, we show that mechanosensory input from the antennae serves a similar role during flight in hawk moths, which are four-winged insects. The antennae of flying moths vibrate and experience Coriolis forces during aerial maneuvers. The antennal vibrations are transduced by individual units of Johnston's organs at the base of their antennae in a frequency range characteristic of the Coriolis input. Reduction of the mechanical input to Johnston's organs by removing the antennal flagellum of these moths severely disrupted their flight stability, but reattachment of the flagellum restored their flight control. The antennae thus play a crucial role in maintaining flight stability of moths.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA	University of Washington; University of Washington Seattle; Case Western Reserve University	Sane, SP (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	sane@u.washington.edu						Chan WP, 1998, SCIENCE, V280, P289, DOI 10.1126/science.280.5361.289; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Dayan P., 2005, THEORETICAL NEUROSCI; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; GEWECKE M, 1980, J COMP PHYSIOL, V139, P357, DOI 10.1007/BF00610466; Gewecke M., 1974, P100; GEWECKE M, 1970, NATURE, V225, P1263, DOI 10.1038/2251263a0; GEWECKE M, 1981, J COMP PHYSIOL, V145, P249, DOI 10.1007/BF00605037; HEINZEL HG, 1987, J COMP PHYSIOL A, V161, P671, DOI 10.1007/BF00605008; Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767; NALBACH G, 1994, J COMP PHYSIOL A, V175, P695; NALBACH G, 1993, J COMP PHYSIOL A, V173, P293, DOI 10.1007/BF00212693; NIEHAUS M, 1978, ZOOMORPHOLOGIE, V91, P19, DOI 10.1007/BF00994151; NIEHAUS M, 1981, J COMP PHYSIOL, V145, P257, DOI 10.1007/BF00605038; OLBERG RM, 1981, J COMP PHYSIOL, V141, P327, DOI 10.1007/BF00609935; PIX W, 1993, NATURWISSENSCHAFTEN, V80, P371, DOI 10.1007/BF01138795; PRINGLE JWS, 1948, PHILOS T ROY SOC B, V233, P347, DOI 10.1098/rstb.1948.0007; Robert D, 2002, J INSECT PHYSIOL, V48, P189, DOI 10.1016/S0022-1910(01)00163-9; Sane SP, 2006, J EXP BIOL, V209, P43, DOI 10.1242/jeb.01958; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; Schneider D., 1956, Zoologische Jahrbuecher Jena Anatomie, V75, P287; VANDEBERG JS, 1971, J MORPHOL, V133, P439, DOI 10.1002/jmor.1051330407; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P553, DOI 10.1098/rstb.1986.0018; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; WIGGLESWORTH VB, 1946, NATURE, V157, P655, DOI 10.1038/157655a0	26	200	210	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					863	866		10.1126/science.1133598	http://dx.doi.org/10.1126/science.1133598			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17290001				2022-12-28	WOS:000244069000074
J	Dalmau, J; Gonzalez, RG; Lerwill, MF; Batchelor; Harris; Schmahmann; Ryan, DP; Brown, RH				Dalmau, Josep; Gilberto Gonzalez, R.; Lerwill, Melinda F.; Batchelor; Harris; Schmahmann; Ryan, David P.; Brown, Robert H., Jr.			A woman with rapidly progressive vertigo and ataxia - Paraneoplastic cerebellar degeneration due to anti-Yo antibodies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EATON MYASTHENIC SYNDROME; FDG-PET; NEUROLOGICAL SYNDROMES; DIAGNOSTIC-CRITERIA; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; BREAST-CANCER; LUNG-CANCER; DISORDERS; CELLS		Univ Penn, Hosp Univ Penn, Dept Neurol, Div Neurooncol, Philadelphia, PA 19104 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dalmau, J (corresponding author), Univ Penn, Hosp Univ Penn, Dept Neurol, Div Neurooncol, Philadelphia, PA 19104 USA.			Dalmau, Josep/0000-0001-5856-2813				Albert ML, 2000, ANN NEUROL, V47, P9; Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Baehring JM, 2003, J NEURO-ONCOL, V61, P237, DOI 10.1023/A:1022588812415; Bataller L, 2004, SEMIN NEUROL, V24, P461, DOI 10.1055/s-2004-861540; Bernal F, 2003, NEUROLOGY, V60, P230, DOI 10.1212/01.WNL.0000041495.87539.98; Chiang SB, 2003, CLIN NUCL MED, V28, P786, DOI 10.1097/01.rlu.0000082677.96653.22; CLOUSTON PD, 1992, NEUROLOGY, V42, P1944, DOI 10.1212/WNL.42.10.1944; DALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001; Darnell RB, 2004, ARCH NEUROL-CHICAGO, V61, P30, DOI 10.1001/archneur.61.1.30; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; El-Wakeel H, 2003, BREAST, V12, P302, DOI 10.1016/S0960-9776(03)00123-1; Galimberti V, 2004, BREAST CANCER RES TR, V88, P43, DOI 10.1007/s10549-004-9453-9; GLASPY JA, 1992, HEMATOL ONCOL CLIN N, V6, P1301, DOI 10.1016/S0889-8588(18)30276-4; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; HAUPT HM, 1985, AM J SURG PATHOL, V9, P165, DOI 10.1097/00000478-198503000-00001; Lerwill MF, 2004, AM J SURG PATHOL, V28, P1076, DOI 10.1097/01.pas.0000126780.10029.f0; Mason WP, 1997, BRAIN, V120, P1279, DOI 10.1093/brain/120.8.1279; Mathew RM, 2006, J NEUROL SCI, V250, P153, DOI 10.1016/j.jns.2006.06.029; McGuigan C, 2005, NEUROLOGY, V65, P165, DOI 10.1212/01.wnl.0000167540.89219.ac; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; PETERSON K, 1992, NEUROLOGY, V42, P1931, DOI 10.1212/wnl.42.10.1931; Rojas-Marcos I, 2003, MEDICINE, V82, P216, DOI 10.1097/00005792-200305000-00007; Rosen P. P., 2001, ROSENS BREAST PATHOL; Rousseau A, 2005, J NEURO-ONCOL, V71, P231, DOI 10.1007/s11060-004-1723-1; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shams'ili S, 2003, BRAIN, V126, P1409, DOI 10.1093/brain/awg133; Sharma OP, 1997, CHEST, V112, P220, DOI 10.1378/chest.112.1.220; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3; Verschuuren J, 1996, ACTA NEUROPATHOL, V91, P519, DOI 10.1007/s004010050460; WHITAKER JN, 1980, ANN NEUROL, V7, P58, DOI 10.1002/ana.410070111; Younes-Mhenni S, 2004, BRAIN, V127, P2331, DOI 10.1093/brain/awh247	33	24	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					612	620		10.1056/NEJMcpc069035	http://dx.doi.org/10.1056/NEJMcpc069035			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287482				2022-12-28	WOS:000244012700011
J	Hergott, LJ				Hergott, Lawrence J.			The importance of the right heart	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lhergott@comcast.net						Kenny DE, 2003, J ZOO WILDLIFE MED, V34, P394, DOI 10.1638/02-023; TZU C, 1965, WAY C TZU	2	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					447	448		10.1001/jama.297.5.447	http://dx.doi.org/10.1001/jama.297.5.447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284683				2022-12-28	WOS:000243999100001
J	Nicholls, SJ; Tuzcu, EM; Sipahi, I; Grasso, AW; Schoenhagen, P; Hu, T; Wolski, K; Crowe, T; Desai, MY; Hazen, SL; Kapadia, SR; Nissen, SE				Nicholls, Stephen J.; Tuzcu, E. Murat; Sipahi, Ilke; Grasso, Adam W.; Schoenhagen, Paul; Hu, Tingfei; Wolski, Kathy; Crowe, Tim; Desai, Milind Y.; Hazen, Stanley L.; Kapadia, Samir R.; Nissen, Steven E.			Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							APOLIPOPROTEIN-A-I; C-REACTIVE PROTEIN; HEART-DISEASE; SECONDARY PREVENTION; INTRAVASCULAR ULTRASOUND; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; ESTER TRANSFER; THERAPY; HDL	Context Statins reduce low-density lipoprotein cholesterol (LDL-C) levels and slow progression of coronary atherosclerosis. However, no data exist describing the relationship between statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and disease progression. Objective To investigate the relationship between changes in LDL-C and HDL-C levels and atheroma burden. Design, Setting, and Patients Post-hoc analysis combining raw data from 4 prospective randomized trials ( performed in the United States, North America, Europe, and Australia between 1999 and 2005), in which 1455 patients with angiographic coronary disease underwent serial intravascular ultrasonography while receiving statin treatment for 18 months or for 24 months. Ultrasound analysis was performed in the same core laboratory for all of the studies. Main Outcome Measure Relationship between changes in lipoprotein levels and coronary artery atheroma volume. Results During statin therapy, mean (SD) LDL-C levels were reduced from 124.0 (38.3) mg/dL (3.2 [0.99] mmol/L) to 87.5 (28.8) mg/dL (2.3 [0.75] mmol/L) (a 23.5% decrease; P <. 001), and HDL-C levels increased from 42.5 (11.0) mg/dL(1.1 [0.28] mmol/L) to 45.1 (11.4) mg/dL(1.2 [0.29] mmol/L)(a 7.5% increase; P <. 001). The ratio of LDL-C to HDL-C was reduced from a mean ( SD) of 3.0 ( 1.1) to 2.1 (0.9) (a 26.7% decrease; P <. 001). These changes were accompanied by a mean ( SD) increase in percent atheroma volume from 39.7% (9.8%) to 40.1% (9.7%) ( a 0.5% [3.9%] increase; P=. 001) and a mean ( SD) decrease in total atheroma volume of 2.4 (23.6) mm(3) ( P <. 001). In univariate analysis, mean levels and treatment-mediated changes in LDL-C, total cholesterol, non-HDL cholesterol, apolipoprotein B, and ratio of apolipoprotein B to apolipoprotein A-I were significantly correlated with the rate of atherosclerotic progression, whereas treatment-mediated changes in HDL-C were inversely correlated with atheroma progression. In multivariate analysis, mean levels of LDL-C ( beta coefficient, 0.11 [95% confidence interval, 0.07-0.15]) and increases in HDL-C( beta coefficient,- 0.26[ 95% confidence interval,- 0.41 to - 0.10]) remained independent predictors of atheroma regression. Substantial atheroma regression ( >= 5% reduction in atheroma volume) was observed in patients with levels of LDL-C less than the mean( 87.5 mg/dL) during treatment and percentage increases of HDL-C greater than the mean( 7.5%; P <. 001). No significant differences were found with regard to clinical events. Conclusions Statin therapy is associated with regression of coronary atherosclerosis when LDL-C is substantially reduced and HDL-C is increased by more than 7.5%. These findings suggest that statin benefits are derived from both reductions in atherogenic lipoprotein levels and increases in HDL-C, although it remains to be determined whether the atherosclerotic regression associated with these changes in lipid levels will translate to meaningful reductions in clinical events and improved clinical outcomes.	Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; Cleveland Clin, Dept Diagnost Radiol, Cleveland, OH 44195 USA; Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Nicholls, SJ (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Mail Code JJ65,9500 Euclid Ave, Cleveland, OH 44195 USA.	nichols1@ccf.org	Hazen, Stanley L/ABD-5845-2021; SIPAHI, ILKE/K-9745-2013; Schoenhagen, Paul/A-2808-2012	SIPAHI, ILKE/0000-0001-8581-9557; Schoenhagen, Paul/0000-0002-7751-5243; Nicholls, Stephen/0000-0002-9668-4368				Aikawa M, 2001, CIRCULATION, V103, P276; AMAUD C, 2005, ARTERIOSCLER THROMB, V25, P1231, DOI DOI 10.1161/01.ATV.0000163840.63685.0; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bays H, 2003, EXPERT OPIN PHARMACO, V4, P1901, DOI 10.1517/14656566.4.11.1901; Brousseau ME, 2004, NEW ENGL J MED, V350, P1505, DOI 10.1056/NEJMoa031766; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guerin M, 2000, ARTERIOSCL THROM VAS, V20, P189, DOI 10.1161/01.ATV.20.1.189; Jensen LO, 2004, CIRCULATION, V110, P265, DOI 10.1161/01.CIR.0000135215.75876.41; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Luc G, 2002, ARTERIOSCL THROM VAS, V22, P1155, DOI 10.1161/01.ATV.0000022850.59845.E0; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Ray KK, 2005, J AM COLL CARDIOL, V46, P1425, DOI 10.1016/j.jacc.2005.05.086; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Steiner G, 2001, LANCET, V357, P905; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Tonkin A, 1998, NEW ENGL J MED, V339, P1349	43	541	573	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					499	508		10.1001/jama.297.5.499	http://dx.doi.org/10.1001/jama.297.5.499			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284700				2022-12-28	WOS:000243999100027
J	Fuller, G; Kaye, C				Fuller, Geraint; Kaye, Claire			Masterclass for GPs - Headaches	BRITISH MEDICAL JOURNAL			English	Editorial Material							MIGRAINE		Gloucestershire Royal Hosp, Dept Neurol, Gloucester GL1 3NN, England	Gloucestershire Royal Hospital		clairekaye2003@yahoo.co.uk						*BRIT ASS STUD HEA, 2004, GUID ALL DOCT DIAGN; Bussone G, 2005, INT J CLIN PRACT, V59, P961, DOI 10.1111/j.1368-5031.2005.00612.x; Evers S, 2006, EUR J NEUROL, V13, P560, DOI 10.1111/j.1468-1331.2006.01411.x; Howard L, 2005, J NEUROL NEUROSUR PS, V76, P1558, DOI 10.1136/jnnp.2004.057851; Limmroth V, 2002, NEUROLOGY, V59, P1011, DOI 10.1212/WNL.59.7.1011	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					254	256		10.1136/bmj.39090.652847.DE	http://dx.doi.org/10.1136/bmj.39090.652847.DE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272568	Green Published			2022-12-28	WOS:000244172400032
J	Hochberg, LR; Taylor, DM				Hochberg, Leigh R.; Taylor, Down M.			Intuitive prosthetic limb control	LANCET			English	Editorial Material							RESTORATION; PLASTICITY; DEVICES		Dept Vet Affairs, Rehabil Res & Dev Serv, Ctr Restorat & Regenerat Med, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Brain Sci Program, Providence, RI 02912 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Stroke & Neurocrit Care Serv, Boston, MA USA; Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; Cleveland VA Med Ctr, Cleveland Funct Elect Stimulat Ctr, Cleveland, OH USA	Brown University; Brown University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Hochberg, LR (corresponding author), Dept Vet Affairs, Rehabil Res & Dev Serv, Ctr Restorat & Regenerat Med, Providence, RI 02912 USA.	leigh_hochberg@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273				Aaron Roy K, 2006, J Am Acad Orthop Surg, V14, pS198; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Karim AA, 2006, NEUROREHAB NEURAL RE, V20, P508, DOI 10.1177/1545968306290661; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Leuthardt EC, 2006, IEEE T NEUR SYS REH, V14, P194, DOI 10.1109/TNSRE.2006.875536; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Neuper C, 2006, PROG BRAIN RES, V159, P393, DOI 10.1016/S0079-6123(06)59025-9; Nudo RJ, 1996, J NEUROSCI, V16, P785; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Vaughan TM, 2006, IEEE T NEUR SYS REH, V14, P229, DOI 10.1109/TNSRE.2006.875577	20	4	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					345	346		10.1016/S0140-6736(07)60164-0	http://dx.doi.org/10.1016/S0140-6736(07)60164-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276755				2022-12-28	WOS:000243944400004
J	Sanov, A				Sanov, Andrei			Coherence and symmetry breaking at the molecular level	SCIENCE			English	Editorial Material							PHOTODISSOCIATION; I-2(-)		Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Arizona	Sanov, A (corresponding author), Univ Arizona, Dept Chem, Tucson, AZ 85721 USA.	sanov@u.arizona.edu						COHEN HD, 1966, PHYS REV, V150, P30, DOI 10.1103/PhysRev.150.30; Davis AV, 2003, J CHEM PHYS, V118, P999, DOI 10.1063/1.1536617; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Jonsson C, 1961, Z PHYS, V161, P454; Mabbs R, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1997131; Martin F, 2007, SCIENCE, V315, P629, DOI 10.1126/science.1136598; Rolles D, 2005, NATURE, V437, P711, DOI 10.1038/nature04040	7	3	3	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					610	611		10.1126/science.1138234	http://dx.doi.org/10.1126/science.1138234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272711				2022-12-28	WOS:000243909400032
J	Watts, DJ				Watts, Duncan J.			A twenty-first century science	NATURE			English	Editorial Material									Columbia Univ, Dept Sociol, New York, NY 10027 USA; Columbia Univ, Inst Social & Econ Res & Policy, New York, NY 10027 USA	Columbia University; Columbia University	Watts, DJ (corresponding author), Columbia Univ, Dept Sociol, 420 W 118th St,8th Floor, New York, NY 10027 USA.							Duke C. B., 2006, NETWORK SCI; Heyman K, 2006, SCIENCE, V313, P604, DOI 10.1126/science.313.5787.604; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066	4	197	211	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					489	489		10.1038/445489a	http://dx.doi.org/10.1038/445489a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131KI	17268455	Bronze			2022-12-28	WOS:000243867300024
J	Liu, KJ; Arron, JR; Stankunas, K; Crabtree, GR; Longaker, MT				Liu, Karen J.; Arron, Joseph R.; Stankunas, Kryn; Crabtree, Gerald R.; Longaker, Michael T.			Chemical rescue of cleft palate and midline defects in conditional GSK-3 beta mice	NATURE			English	Article							MODEL	Glycogen synthase kinase-3 beta (GSK-3 beta) has integral roles in a variety of biological processes, including development, diabetes, and the progression of Alzheimer's disease(1-4). As such, a thorough understanding of GSK-3 beta function will have a broad impact on human biology and therapeutics. Because GSK-3 beta interacts with many different pathways, its specific developmental roles remain unclear(5). We have discovered a genetic requirement for GSK-3 beta in midline development. Homozygous null mice display cleft palate, incomplete fusion of the ribs at the midline and bifid sternum as well as delayed sternal ossification. Using a chemically regulated allele of GSK-3 beta ( ref. 6), we have defined requirements for GSK-3 beta activity during discrete temporal windows in palatogenesis and skeletogenesis. The rapamycin-dependent allele of GSK-3 beta produces GSK-3 beta fused to a tag, FRB* (FKBP/rapamycin binding), resulting in a rapidly destabilized chimaeric protein. In the absence of drug, GSK-3 beta(FRB*/FRB*) mutants appear phenotypically identical to GSK-3 beta(-/-) mutants. In the presence of drug, GSK-3 beta FRB* is rapidly stabilized, restoring protein levels and activity(6). Using this system, mutant phenotypes were rescued by restoring endogenous GSK-3 beta activity during two distinct periods in gestation. This technology provides a powerful tool for defining windows of protein function during development.	Stanford Univ, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Liu, KJ (corresponding author), Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England.	karen.liu@kcl.ac.uk; longaker@stanford.edu	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Arron, Joseph/0000-0001-7677-9979				Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; CHEN JM, 1952, J ANAT, V86, P373; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FLAKE AW, 1987, J PEDIATR SURG, V22, P816, DOI 10.1016/S0022-3468(87)80643-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; SHARPE PM, 1988, J CELL SCI, P195; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X	20	111	113	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					79	82		10.1038/nature05557	http://dx.doi.org/10.1038/nature05557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17293880				2022-12-28	WOS:000244525600041
J	England, R; de Lay, P; Greener, R; Izazola, JA				England, Roger; de lay, Paul; Greener, Robert; Izazola, Jose Antonio			Are we spending too much on HIV?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UNAIDS, Evaluat Dept, CH-1211 Geneva, Switzerland	UNAIDS		roger.england@healthsystemsworkshop.org; communications@unaids.org							0	63	63	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2007	334	7589					344	345		10.1136/bmj.39113.402361.94	http://dx.doi.org/10.1136/bmj.39113.402361.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141EJ	17303881	Green Published			2022-12-28	WOS:000244560400029
J	Revicki, DA				Revicki, Dennis A.			FDA draft guidance and health-outcomes research	LANCET			English	Editorial Material							PAPER DIARIES		United Biosource Corp, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA	United Biosource Corporation	Revicki, DA (corresponding author), United Biosource Corp, Ctr Hlth Outcomes Res, Bethesda, MD 20814 USA.	Dennis.Revicki@Unitedbiosource.com						Committee for Medicinal Products for Human Use, 2005, REFL PAP REG GUID US; Kahneman D, 2004, SCIENCE, V306, P1776, DOI 10.1126/science.1103572; Lauritsen K, 2004, CONTROL CLIN TRIALS, V25, P585, DOI 10.1016/j.cct.2004.09.001; REEVE BB, IN PRESS MED CARE; Revicki DA, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-70; Stone AA, 2002, BMJ-BRIT MED J, V324, P1193, DOI 10.1136/bmj.324.7347.1193; US Food and Drug Administration, 2006, FED REGISTER, V71, P5862	7	65	67	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					540	542		10.1016/S0140-6736(07)60250-5	http://dx.doi.org/10.1016/S0140-6736(07)60250-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307086				2022-12-28	WOS:000244368000008
J	Smellie, WSA; Coleman, JJ				Smellie, W. Stuart A.; Coleman, Jamie J.			Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin	BMJ-BRITISH MEDICAL JOURNAL			English	Article							APPROPRIATENESS		Gen Hosp, Clin Lab, Auckland DL14 6AD, New Zealand; Univ Birmingham, Dept Clin Pharmacol, Div Med Sci, Birmingham B15 2TH, W Midlands, England	University of Birmingham	Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Auckland DL14 6AD, New Zealand.	info@smellie.com		Coleman, Jamie/0000-0002-7512-5153				American Heart Association, 2005, CIRCULATION, V112, P121; ARONSON JK, 1992, BRIT MED J, V305, P1215, DOI 10.1136/bmj.305.6863.1215; BUTLER J, 1995, CLIN BIOCH METABOLIC, P331; Canas F, 1999, ARCH INTERN MED, V159, P363, DOI 10.1001/archinte.159.4.363; Eagles JM, 2000, ACTA PSYCHIAT SCAND, V101, P349, DOI 10.1034/j.1600-0447.2000.101005349.x; HALLWORTH M, 1993, THER DRUG MONIT, P35; Hanna FWF, 1999, BRIT MED J, V319, P894, DOI 10.1136/bmj.319.7214.894; Litonjua MR, 2005, J PHARM PRACT, V18, P157, DOI 10.1177/0897190005276751; MARTIN BJ, 1988, SCOT MED J, V33, P273, DOI 10.1177/003693308803300309; REID LD, 1990, THER DRUG MONIT, V12, P72; Sanoski CA, 2002, CHEST, V121, P19, DOI 10.1378/chest.121.1.19; SCHOENENBERGER RA, 1995, JAMA-J AM MED ASSOC, V274, P1622, DOI 10.1001/jama.274.20.1622; Smellie WSA, 2006, J CLIN PATHOL, V59, P893, DOI 10.1136/jcp.2005.035212; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Stelfox HT, 2004, CLIN PHARMACOL THER, V75, P110, DOI 10.1016/j.clpt.2003.09.010; YOUNG IS, 1991, BRIT J CLIN PHARMACO, V32, P717; 2006, BRIT NATL FORMULARY, V52, P685	18	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2007	334	7588					312	315		10.1136/bmj.39090.709537.47	http://dx.doi.org/10.1136/bmj.39090.709537.47			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MN	17289735	Green Published			2022-12-28	WOS:000244654100041
J	Specht, S; Hoerauf, A				Specht, Sabine; Hoerauf, Achim			Does helminth elimination promote or prevent malaria?	LANCET			English	Editorial Material							FILARIAL NEMATODES; IMMUNE-RESPONSES; PARASITE GROWTH; CELLS; IMMUNOMODULATION; MODULATION; INFECTION; PROTECT		Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany.	hoerauf@parasit.meb.uni-bonn.de						BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437; Brutus L, 2006, AM J TROP MED HYG, V75, P194, DOI 10.4269/ajtmh.2006.75.194; Chatterjee S, 2001, TROP MED INT HEALTH, V6, P578, DOI 10.1046/j.1365-3156.2001.00758.x; Druilhe P, 2005, TRENDS PARASITOL, V21, P359, DOI 10.1016/j.pt.2005.06.011; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hoerauf A, 2005, PARASITE IMMUNOL, V27, P417, DOI 10.1111/j.1365-3024.2005.00792.x; Marshall FA, 2005, J IMMUNOL, V175, P5817, DOI 10.4049/jimmunol.175.9.5817; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; VELUPILLAI P, 1994, P NATL ACAD SCI USA, V91, P18, DOI 10.1073/pnas.91.1.18; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; WHO, 2005, MILL DEV GOALS EV IS	16	19	19	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					446	447		10.1016/S0140-6736(07)60210-4	http://dx.doi.org/10.1016/S0140-6736(07)60210-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292747				2022-12-28	WOS:000244188300008
J	Mazzali, PA; Ropke, FK; Benetti, S; Hillebrandt, W				Mazzali, Paolo A.; Roepke, Friedrich K.; Benetti, Stefano; Hillebrandt, Wolfgang			A common explosion mechanism for type Ia supernovae	SCIENCE			English	Article							WHITE-DWARF MODELS; LIGHT; SPECTRA	Type Ia supernovae, the thermonuclear explosions of white dwarf stars composed of carbon and oxygen, were instrumental as distance indicators in establishing the acceleration of the universe's expansion. However, the physics of the explosion are debated. Here we report a systematic spectral analysis of a large sample of well-observed type Ia supernovae. Mapping the velocity distribution of the main products of nuclear burning, we constrain theoretical scenarios. We find that all supernovae have low-velocity cores of stable iron-group elements. Outside this core, nickel-56 dominates the supernova ejecta. The outer extent of the iron-group material depends on the amount of nickel-56 and coincides with the inner extent of silicon, the principal product of incomplete burning. The outer extent of the bulk of silicon is similar in all supernovae, having an expansion velocity of similar to 11,000 kilometers per second and corresponding to a mass of slightly over one solar mass. This indicates that all the supernovae considered here burned similar masses and suggests that their progenitors had the same mass. Synthetic light-curve parameters and three-dimensional explosion simulations support this interpretation. A single explosion scenario, possibly a delayed detonation, may thus explain most type Ia supernovae.	Max Planck Inst Astrophys, D-85741 Garching, Germany; Univ Tokyo, Dept Astron, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Res Ctr Early Universe, Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osserv Astron Trieste, Ist Nazl Astrofis, I-34131 Trieste, Italy; Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; Osserv Astron Padova, Ist Nazl Astrofis, I-35122 Padua, Italy	Max Planck Society; University of Tokyo; University of Tokyo; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Santa Cruz; Istituto Nazionale Astrofisica (INAF); University of Padua	Mazzali, PA (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany.	mazzali@mpa-garching.mpg.de		Mazzali, Paolo/0000-0001-6876-8284; Benetti, Stefano/0000-0002-3256-0016; Ropke, Friedrich/0000-0002-4460-0097				ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; BRANCH D, 1985, ASTROPHYS J, V294, P619, DOI 10.1086/163329; Contardo G, 2000, ASTRON ASTROPHYS, V359, P876; Gamezo VN, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.211102; Goldhaber G, 2001, ASTROPHYS J, V558, P359, DOI 10.1086/322460; Golombek I, 2005, ASTRON ASTROPHYS, V438, P611, DOI 10.1051/0004-6361:20042402; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Howell DA, 2006, NATURE, V443, P308, DOI 10.1038/nature05103; KHOKHLOV AM, 1991, ASTRON ASTROPHYS, V245, P114; KUCHNER MJ, 1994, ASTROPHYS J, V426, pL89, DOI 10.1086/187347; Mazzali PA, 1998, ASTROPHYS J, V499, pL49, DOI 10.1086/311345; Mazzali PA, 2006, MON NOT R ASTRON SOC, V369, pL19, DOI 10.1111/j.1745-3933.2006.00165.x; Mazzali PA, 2001, ASTROPHYS J, V547, P988, DOI 10.1086/318428; Mazzali PA, 2001, ASTROPHYS J, V559, P1047, DOI 10.1086/322420; Niemeyer JC, 1997, ASTROPHYS J, V475, P740, DOI 10.1086/303544; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Pauldrach AWA, 1996, ASTRON ASTROPHYS, V312, P525; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Plewa T, 2004, ASTROPHYS J, V612, pL37, DOI 10.1086/424036; Reinecke M, 2002, ASTRON ASTROPHYS, V391, P1167, DOI 10.1051/0004-6361:20020885; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Ropke FK, 2006, ASTRON ASTROPHYS, V448, P1, DOI 10.1051/0004-6361:20053926; Stritzinger M, 2005, ASTRON ASTROPHYS, V431, P423, DOI 10.1051/0004-6361:20041630; Tanaka M, 2006, ASTROPHYS J, V645, P470, DOI 10.1086/504102; Woosley SE, 2004, ASTROPHYS J, V607, P921, DOI 10.1086/383530	26	265	268	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					825	828		10.1126/science.1136259	http://dx.doi.org/10.1126/science.1136259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289993	Green Submitted			2022-12-28	WOS:000244069000063
J	Martin, F; Fernandez, J; Havermeier, T; Foucar, L; Weber, T; Kreidi, K; Schoffler, M; Schmidt, L; Jahnke, T; Jagutzki, O; Czasch, A; Benis, EP; Osipov, T; Landers, AL; Belkacem, A; Prior, MH; Schmidt-Bocking, H; Cocke, CL; Dorner, R				Martin, F.; Fernandez, J.; Havermeier, T.; Foucar, L.; Weber, Th.; Kreidi, K.; Schoeffler, M.; Schmidt, L.; Jahnke, T.; Jagutzki, O.; Czasch, A.; Benis, E. P.; Osipov, T.; Landers, A. L.; Belkacem, A.; Prior, M. H.; Schmidt-Boecking, H.; Cocke, C. L.; Doerner, R.			Single photon-induced symmetry breaking of H-2 dissociation	SCIENCE			English	Article							PHOTOELECTRON ANGULAR-DISTRIBUTIONS; HYDROGEN MOLECULE; B-SPLINES; PHOTOIONIZATION; STATES; LOCALIZATION; IONIZATION; ELECTRONS; REGION; D-2	H-2, the smallest and most abundant molecule in the universe, has a perfectly symmetric ground state. What does it take to break this symmetry? We found that the inversion symmetry can be broken by absorption of a linearly polarized photon, which itself has inversion symmetry. In particular, the emission of a photoelectron with subsequent dissociation of the remaining H-2(+) fragment shows no symmetry with respect to the ionic H+ and neutral H atomic fragments. This lack of symmetry results from the entanglement between symmetric and antisymmetric H-2(+) states that is caused by autoionization. The mechanisms behind this symmetry breaking are general for all molecules.	Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany; Univ Autonoma Madrid, Dept Quim, E-28049 Madrid, Spain; Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; Auburn Univ, Dept Phys, Auburn, AL 36849 USA	Goethe University Frankfurt; Autonomous University of Madrid; Kansas State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Auburn University System; Auburn University	Dorner, R (corresponding author), Univ Frankfurt, Inst Kernphys, Max von Laue Str 1, D-60438 Frankfurt, Germany.	doerner@atom.uni-frankfurt.de	Benis, E P/G-9543-2011; Jahnke, Till/AGE-4901-2022; Schoeffler, Markus S/B-6261-2008; Landers, Allen/C-1213-2013; Weber, Thorsten/K-2586-2013; Martin, Fernando/C-3972-2014; Doerner, Reinhard/A-5340-2008	Benis, E P/0000-0002-5564-153X; Schoeffler, Markus S/0000-0001-9214-6848; Weber, Thorsten/0000-0003-3756-2704; Martin, Fernando/0000-0002-7529-925X; Doerner, Reinhard/0000-0002-3728-4268				Bachau H, 2001, REP PROG PHYS, V64, P1815, DOI 10.1088/0034-4885/64/12/205; BOTTCHER C, 1974, J PHYS B-AT MOL OPT, V7, pL5, DOI 10.1088/0022-3700/7/1/002; DILL D, 1976, J CHEM PHYS, V65, P1130, DOI 10.1063/1.433187; Dorner R, 2000, PHYS REP, V330, P95, DOI 10.1016/S0370-1573(99)00109-X; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Golovin AV, 1997, PHYS REV LETT, V79, P4554, DOI 10.1103/PhysRevLett.79.4554; HERZBERG G, 1979, MOL SPECTRA MOL STRU, V3; Ito K, 1996, J CHEM PHYS, V104, P8449, DOI 10.1063/1.471594; Jagutzki O, 2002, NUCL INSTRUM METH A, V477, P244, DOI 10.1016/S0168-9002(01)01839-3; Jahnke T, 2004, J ELECTRON SPECTROSC, V141, P229, DOI 10.1016/j.elspec.2004.06.010; Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259; Lafosse A, 2003, J PHYS B-AT MOL OPT, V36, P4683, DOI 10.1088/0953-4075/36/23/007; Latimer CJ, 1996, J PHYS B-AT MOL OPT, V29, P6113, DOI 10.1088/0953-4075/29/24/017; Laurent G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.173201; Lebech M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.073001; Levine I. N., 1975, MOL SPECTROSCOPY; Martin F, 1999, J PHYS B-AT MOL OPT, V32, pR197, DOI 10.1088/0953-4075/32/16/201; Rolles D, 2005, NATURE, V437, P711, DOI 10.1038/nature04040; Sanchez I, 1999, PHYS REV A, V60, P2200, DOI 10.1103/PhysRevA.60.2200; Sanchez I, 1999, PHYS REV LETT, V82, P3775, DOI 10.1103/PhysRevLett.82.3775; STRATHDEE S, 1979, J PHYS B-AT MOL OPT, V12, P1789, DOI 10.1088/0022-3700/12/11/007; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Vanroose W, 2005, SCIENCE, V310, P1787, DOI 10.1126/science.1120263	23	168	168	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					629	633		10.1126/science.1136598	http://dx.doi.org/10.1126/science.1136598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272717	Green Submitted			2022-12-28	WOS:000243909400038
J	Ballester, GE; Sing, DK; Herbert, F				Ballester, Gilda E.; Sing, David K.; Herbert, Floyd			The signature of hot hydrogen in the atmosphere of the extrasolar planet HD 209458b	NATURE			English	Article								About ten per cent of the known extrasolar planets are gas giants that orbit very close to their parent stars. The atmospheres of these 'hot Jupiters' are heated by the immense stellar irradiation(1-5). In the case of the planet HD 209458b, this energy deposition results in a hydrodynamic state in the upper atmosphere, allowing for sizeable expansion and escape of neutral hydrogen gas(2-6). HD 209458b was the first extrasolar planet discovered that transits in front of its parent star(7). The size of the planet can be measured using the total optical obscuration of the stellar disk during an observed transit, and the structure and composition of the planetary atmosphere can be studied using additional planetary absorption signatures in the stellar spectrum. Here we report the detection of absorption by hot hydrogen in the atmosphere of HD 209458b. Previously, the lower atmosphere and the full extended upper atmosphere of HD 209458b have been observed(2,6,8), whereas here we probe a layer where the escaping gas forms in the upper atmosphere of HD 209458b.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; UPMC, Inst Astrophys Paris, CNRS, F-75014 Paris, France	University of Arizona; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Ballester, GE (corresponding author), Univ Arizona, Lunar & Planetary Lab, Sonett Space Sci Bldg, Tucson, AZ 85721 USA.	gilda@vega.LPL.arizona.edu		Sing, David/0000-0001-6050-7645				Brown TM, 2001, ASTROPHYS J, V552, P699, DOI 10.1086/320580; BURROWS A, 1995, NATURE, V378, P333, DOI 10.1038/378333a0; CARROLL BW, 1996, INTRO MODERN ASTROPH, pCH8; Charbonneau D, 2002, ASTROPHYS J, V568, P377, DOI 10.1086/338770; Claret A, 2000, ASTRON ASTROPHYS, V363, P1081; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; des Etangs AL, 2004, ASTRON ASTROPHYS, V418, pL1, DOI 10.1051/0004-6361:20040106; HENRY GW, 2000, APJ, V529, P41; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; KURUCZ R, HD209458 STELLAR MOD; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mihalas D., 1978, STELLAR ATMOSPHERES, P99; Vidal-Madjar A, 2004, ASTROPHYS J, V604, pL69, DOI 10.1086/383347; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Yelle RV, 2006, ICARUS, V183, P508, DOI 10.1016/j.icarus.2006.05.001; Yelle RV, 2004, ICARUS, V170, P167, DOI 10.1016/j.icarus.2004.02.008	16	97	97	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					511	514		10.1038/nature05525	http://dx.doi.org/10.1038/nature05525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268463	Green Submitted			2022-12-28	WOS:000243867300037
J	Hansen, SK; Rainey, PB; Haagensen, JAJ; Molin, S				Hansen, Susse Kirkelund; Rainey, Paul B.; Haagensen, Janus A. J.; Molin, Soren			Evolution of species interactions in a biofilm community	NATURE			English	Article							MICROBIAL BIOFILMS; PSEUDOMONAS-PUTIDA; DIVERSITY; BIODIVERSITY; COEXISTENCE; ENVIRONMENT; COMPETITION; ADAPTATION; DYNAMICS; ECOLOGY	Biofilms are spatially structured communities of microbes whose function is dependent on a complex web of symbiotic interactions(1,2). Localized interactions within these assemblages are predicted to affect the coexistence of the component species(3-5), community structure(6) and function(7-10), but there have been few explicit empirical analyses of the evolution of interactions(11). Here we show, with the use of a two-species community, that selection in a spatially structured environment leads to the evolution of an exploitative interaction. Simple mutations in the genome of one species caused it to adapt to the presence of the other, forming an intimate and specialized association. The derived community was more stable and more productive than the ancestral community. Our results show that evolution in a spatially structured environment can stabilize interactions between species, provoke marked changes in their symbiotic nature and affect community function.	Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Tech Univ Denmark, Infect Microbiol Grp, Biocentrum DTU, DK-2800 Lyngby, Denmark	University of Auckland; Technical University of Denmark	Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1, New Zealand.	p.rainey@auckland.ac.nz	Rainey, Paul/A-3207-2008; Albers, Pieter/I-2563-2017	Rainey, Paul/0000-0003-0879-5795; Molin, Soren/0000-0002-7973-2639				An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; FRANKLIN FCH, 1981, P NATL ACAD SCI-BIOL, V78, P7458, DOI 10.1073/pnas.78.12.7458; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Kareiva, 1997, SPATIAL ECOLOGY; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; LAM JS, 2004, PSEUDOMONAS, V3, P3; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Moller S, 1996, APPL ENVIRON MICROB, V62, P4632; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman DK, 2002, SCIENCE, V296, P1071, DOI 10.1126/science.1010716; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urban MC, 2006, ECOLOGY, V87, P1616, DOI 10.1890/0012-9658(2006)87[1616:EMTAEP]2.0.CO;2	30	370	382	7	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					533	536		10.1038/nature05514	http://dx.doi.org/10.1038/nature05514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268468				2022-12-28	WOS:000243867300042
J	Tefferi, A				Tefferi, Ayalew			Focus on research: JAK2 mutations in ploycythemia vera - Molecular mechanisms and clinical applications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYELOPROLIFERATIVE DISORDERS		Mayo Clin Coll Med, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Tefferi, A (corresponding author), Mayo Clin Coll Med, Dept Internal Med, Div Hematol, Rochester, MN 55905 USA.							James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Tefferi A, 2005, CELL CYCLE, V4, P1053	5	32	43	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					444	445		10.1056/NEJMp068293	http://dx.doi.org/10.1056/NEJMp068293			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267904				2022-12-28	WOS:000243860700004
J	Legido-Quigley, H; McKee, M; Glinos, I; Baeten, R				Legido-Quigley, Helena; McKee, Martin; Glinos, Irene; Baeten, Rita			Patient mobility in the European Union - Getting healthcare in another European country should be straightforward, but it often creates problems for both patients and healthcare systems	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Observ Sociale Europeen, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine	Legido-Quigley, H (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Helena.legido-quigley@lshtm.ac.uk	McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; McKee, Martin/0000-0002-0121-9683				AGASI S, 2002, EUROHEALTH, V8, P37; Albreht T, 2006, PATIENT MOBILITY EUR, P9; BERTINATO L, 2004, CROSS BORDER HLTH CA; BOFFIN N, 2005, DUTCH PATIENTS EVALU; *EU BUS, SPAIN INV ALL LAT TE; *EUR COMM, 2006, COMM COMM CONS REG C; France G, 1997, EUR J PUBLIC HEALTH, V7, P18, DOI 10.1093/eurpub/7.3.18; Glinos I, 2005, CROSS BORDER CARE BE; Grech K, 2006, PATIENT MOBILITY EUR; HARANT P, 2006, PATIENT MOBILITY EUR, P157; Jesse M, 2006, PATIENT MOBILITY EUR, P23; Lowson K, 2002, EVALUATION TREATING; McKee M, 2002, IMPACT EU LAW HLTH C; Post B., 2000, CROSS BORDER URGENT; Rosenmoller M., 2006, PATIENT MOBILITY EUR, P59	15	37	37	2	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					188	190		10.1136/bmj.39086.497639.68	http://dx.doi.org/10.1136/bmj.39086.497639.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255612	Green Accepted, Green Published			2022-12-28	WOS:000244027600033
J	Yamashita, YM; Mahowald, AP; Perlin, JR; Fuller, MT				Yamashita, Yukiko M.; Mahowald, Anthony P.; Perlin, Julie R.; Fuller, Margaret T.			Asymmetric inheritance of mother versus daughter centrosome in stem cell division	SCIENCE			English	Article							DROSOPHILA; PROTEIN	Adult stem cells often divide asymmetrically to produce one self-renewed stem cell and one differentiating cell, thus maintaining both populations. The asymmetric outcome of stem cell divisions can be specified by an oriented spindle and local self-renewal signals from the stem cell niche. Here we show that developmentally programmed asymmetric behavior and inheritance of mother and daughter centrosomes underlies the stereotyped spindle orientation and asymmetric outcome of stem cell divisions in the Drosophila male germ line. The mother centrosome remains anchored near the niche while the daughter centrosome migrates to the opposite side of the cell before spindle formation.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Chicago; Stanford University	Yamashita, YM (corresponding author), Univ Michigan, Inst Life Sci, Room 5403,210 Washtenaw Ave, Ann Arbor, MI 48183 USA.	yukikomy@umich.edu; fuller@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987; Yamashita, Yukiko/0000-0001-5541-0216	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER; NIDDK NIH HHS [P01 DK53074, P01 DK053074] Funding Source: Medline; NIGMS NIH HHS [R01 GM080501] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tracey WD, 2000, GENETICS, V154, P273; TUTINA N, 2001, SCIENCE, V294, P2546; Vaizel-Ohayon D, 1999, CURR BIOL, V9, P889, DOI 10.1016/S0960-9822(99)80393-5; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795	13	398	414	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					518	521		10.1126/science.1134910	http://dx.doi.org/10.1126/science.1134910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255513	Green Accepted			2022-12-28	WOS:000243726600048
J	Rahmstorf, S; Cazenave, A; Church, JA; Hansen, JE; Keeling, RF; Parker, DE; Somerville, RCJ				Rahmstorf, Stefan; Cazenave, Anny; Church, John A.; Hansen, James E.; Keeling, Ralph F.; Parker, David E.; Somerville, Richard C. J.			Recent climate observations compared to projections	SCIENCE			English	Article						ocean; sea level			Potsdam Inst Climate Impact Res, D-14482 Potsdam, Germany; Lab Etud Geophys & Oceanog, F-31400 Toulouse, France; CSIRO, Marine & Atmospher Res & Antarctic Climate & Ecos, Hobart, Tas 7001, Australia; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	Potsdam Institut fur Klimafolgenforschung; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California San Diego; Scripps Institution of Oceanography; Met Office - UK; Hadley Centre	Rahmstorf, S (corresponding author), Potsdam Inst Climate Impact Res, D-14482 Potsdam, Germany.		Rahmstorf, Stefan/A-8465-2010; Thompson, Renee L/A-9675-2012; Church, John A/A-1541-2012	Rahmstorf, Stefan/0000-0001-6786-7723; Church, John A/0000-0002-7037-8194				Bell R., 2005, EOS T AM GEOPHYS UNI, V86, P226, DOI [10.1029/2005eo240003, 10.1029/2005EO240003, DOI 10.1029/2005EO240003]; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; Cazenave A, 2006, SCIENCE, V314, P1250, DOI 10.1126/science.1133325; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; IPCC, 2001, ADV CLIM CHANG RES; Willis JK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002260	6	434	447	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2007	316	5825					709	709		10.1126/science.1136843	http://dx.doi.org/10.1126/science.1136843			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163RR	17272686				2022-12-28	WOS:000246181400035
J	Leduc, G; Vidal, L; Tachikawa, K; Rostek, F; Sonzogni, C; Beaufort, L; Bard, E				Leduc, Guillaume; Vidal, Laurence; Tachikawa, Kazuyo; Rostek, Frauke; Sonzogni, Corinne; Beaufort, Luc; Bard, Edouard			Moisture transport across Central America as a positive feedback on abrupt climatic changes	NATURE			English	Article							SCALE CHANGES; RAPID CHANGES; ATLANTIC; OCEAN; SALINITY; TEMPERATURE; SIMULATIONS; CIRCULATION; SEDIMENTS	Moisture transport from the Atlantic to the Pacific ocean across Central America leads to relatively high salinities in the North Atlantic Ocean(1) and contributes to the formation of North Atlantic Deep Water(2). This deep water formation varied strongly between Dansgaard/ Oeschger interstadials and Heinrich events millennial- scale abrupt warm and cold events, respectively, during the last glacial period(3). Increases in the moisture transport across Central America have been proposed to coincide with northerly shifts of the Intertropical Convergence Zone and with Dansgaard/ Oeschger interstadials, with opposite changes for Heinrich events(4). Here we reconstruct sea surface salinities in the eastern equatorial Pacific Ocean over the past 90,000 years by comparing palaeotemperature estimates from alkenones and Mg/Ca ratios with foraminiferal oxygen isotope ratios that vary with both temperature and salinity. We detect millennial- scale fluctuations of sea surface salinities in the eastern equatorial Pacific Ocean of up to two to four practical salinity units. High salinities are associated with the southward migration of the tropical Atlantic Intertropical Convergence Zone, coinciding with Heinrich events and with Greenland stadials(5). The amplitudes of these salinity variations are significantly larger on the Pacific side of the Panama isthmus, as inferred from a comparison of our data with a palaeoclimate record from the Caribbean basin(6). We conclude that millennial-scale fluctuations of moisture transport constitute an important feedback mechanism for abrupt climate changes, modulating the North Atlantic freshwater budget and hence North Atlantic Deep Water formation.	Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, F-13545 Aix En Provence 04, France	UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Leduc, G (corresponding author), Univ Aix Marseille 3, Coll France, CNRS,UMR 6635, CEREGE, Europole Arbois,BP 80, F-13545 Aix En Provence 04, France.	leduc@cerege.fr; bard@cerege.fr	Vidal, Laurence/C-1860-2019; Beaufort, Luc/AAH-5305-2021; Beaufort, Luc/ABG-2289-2021; Sonzogni, Corinne/AAG-5816-2019; Leduc, Guillaume/A-8930-2008; Bard, Edouard/G-7717-2014	Beaufort, Luc/0000-0001-6055-9373; 				Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Bard E, 2002, PHYS TODAY, V55, P32, DOI 10.1063/1.1537910; Benway HM, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001208; Benway HM, 2004, EARTH PLANET SC LETT, V224, P493, DOI 10.1016/j.epsl.2004.05.014; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Broecker WS, 2003, SCIENCE, V300, P1519, DOI 10.1126/science.1083797; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Hostetler SW, 1999, NATURE, V399, P673, DOI 10.1038/21401; Ivanochko TS, 2005, EARTH PLANET SC LETT, V235, P302, DOI 10.1016/j.epsl.2005.04.002; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Liu WT, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005300; Manabe S, 1988, J CLIMATE, V1, P841, DOI 10.1175/1520-0442(1988)001<0841:TSEOAC>2.0.CO;2; Masson S, 2001, PHYS CHEM EARTH PT B, V26, P137, DOI 10.1016/S1464-1909(00)00230-6; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; Mignot J, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002005; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Schmidt GA, 1999, PALEOCEANOGRAPHY, V14, P422, DOI 10.1029/1999PA900008; Schmidt MW, 2006, NATURE, V443, P561, DOI 10.1038/nature05121; Schmidt MW, 2004, NATURE, V428, P160, DOI 10.1038/nature02346; Schmittner A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000633; Sonzogni C, 1997, QUATERNARY RES, V47, P344, DOI 10.1006/qres.1997.1885; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Vidal L, 2004, DEV PALEOENVIRON RES, V6, P31; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; ZAUCKER F, 1992, J GEOPHYS RES-ATMOS, V97, P2765, DOI 10.1029/91JD01699	28	170	175	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					908	911		10.1038/nature05578	http://dx.doi.org/10.1038/nature05578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314978				2022-12-28	WOS:000244341200047
J	Dentali, F; Douketis, JD; Gianni, M; Lim, W; Crowther, MA				Dentali, Francesco; Douketis, James D.; Gianni, Monica; Lim, Wendy; Crowther, Mark A.			Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients	ANNALS OF INTERNAL MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; LOW-DOSE HEPARIN; FATAL PULMONARY-EMBOLISM; PLACEBO-CONTROLLED TRIAL; UNFRACTIONATED HEPARIN; NONSURGICAL PATIENTS; CLINICAL-TRIALS; RISK-FACTORS; INPATIENTS	Background: Underutilization of anticoagulant prophylaxis may be due to lack of evidence that prophylaxis prevents clinically important outcomes in hospitalized medical patients at risk for venous thromboembolism. Purpose: To assess the effects of anticoagulant prophylaxis in reducing clinically important outcomes in hospitalized medical patients. Data Sources: MEDLINE, EMBASE, and Cochrane databases were searched to September 2006 without language restrictions. Study selection: Randomized trials comparing anticoagulant prophylaxis with no treatment in hospitalized medical patients. Data Extraction: Any symptomatic pulmonary embolism (PE), fatal PE, symptomatic deep venous thrombosis, all-cause mortality, and major bleeding. Pooled relative risks and associated 95% Cls were calculated. For treatment effects that were statistically significant, the authors determined the absolute risk reduction and the number needed to treat for benefit (NNTB) to prevent an outcome. Data Synthesis: 9 studies (n = 19 958) were included. During anticoagulant prophylaxis, patients had significant reductions in any PE (relative risk, 0.43 [Cl, 0.26 to 0.71]; absolute risk reduction, 0.29%; NNTB, 345) and fatal PE (relative risk, 0.38 [Cl, 0.21 to 0.69]; absolute risk reduction, 0.25%; NNTB, 400), a nonsignificant reduction in symptomatic deep venous thrombosis (relative risk, 0.47 [Cl, 0.22 to 1.00]), and a nonsignificant increase in major bleeding (relative risk, 1.32 [Cl, 0.73 to 2.37]). Anticoagulant prophylaxis had no effect on all-cause mortality (relative risk, 0.97 [Cl, 0.79 to 1.19]). Limitations: 2 of 9 included studies were not double-blind. Conclusions: Anticoagulant prophylaxis is effective in preventing symptomatic venous thromboembolism during anticoagulant prophylaxis in at-risk hospitalized medical patients. Additional research is needed to determine the risk for venous thromboembolism in these patients after prophylaxis has been stopped.	McMaster Univ, Hamilton, ON, Canada; St Josephs Healthcare Hamilton, Hamilton, ON, Canada	McMaster University; McMaster University	Douketis, JD (corresponding author), St Josephs Hosp, Room F-544,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.	jdouket@mcmaster.ca	Douketis, James/AAO-5659-2021					Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; ALLEN TW, 1996, J AM OSTEOPATH ASSOC, V96, P335; BELCH JJ, 1981, SCOT MED J, V26, P115, DOI 10.1177/003693308102600205; Bergmann JF, 1996, LANCET, V348, P205, DOI 10.1016/S0140-6736(05)66160-0; Bergmann JF, 1996, THROMB HAEMOSTASIS, V76, P529; CADE JF, 1982, CRIT CARE MED, V10, P448, DOI 10.1097/00003246-198207000-00006; Caprini JA, 2002, INT ANGIOL, V21, P78; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; DAHAN R, 1986, HAEMOSTASIS, V16, P159; de Lissovoy G, 2002, AM J MANAG CARE, V8, P1082; Desjardins L, 2004, ARCH PATHOL LAB MED, V128, P519; Fraisse F, 2000, AM J RESP CRIT CARE, V161, P1109, DOI 10.1164/ajrccm.161.4.9807025; Gallus AS, 1998, HAEMOSTASIS, V28, P71; Gardlund B, 1996, LANCET, V347, P1357; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Girolami B, 2003, BLOOD, V101, P2955, DOI 10.1182/blood-2002-07-2201; Goldhaber SZ, 2000, CHEST, V118, P1680, DOI 10.1378/chest.118.6.1680; GRAVES EJ, 1997, VITAL HLTH STAT, V1, P145; HALKIN H, 1982, ANN INTERN MED, V96, P561, DOI 10.7326/0003-4819-96-5-561; Harenberg J, 1996, HAEMOSTASIS, V26, P127; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; IBARRAPEREZ C, 1988, ANGIOLOGY, V39, P505, DOI 10.1177/000331978803900603; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Kahn SR, 2007, THROMB RES, V119, P145, DOI 10.1016/j.thromres.2006.01.011; Kleber FX, 2003, AM HEART J, V145, P614, DOI 10.1067/mhj.2003.189; Labarere J, 2004, J INTERN MED, V256, P338, DOI 10.1111/j.1365-2796.2004.01365.x; Lamy Andre, 2002, Can Respir J, V9, P169; Lechler E, 1996, HAEMOSTASIS, V26, P49; Lederle FA, 2006, AM J MED, V119, P54, DOI 10.1016/j.amjmed.2005.03.049; Lederle FA, 1998, ANN INTERN MED, V128, P768, DOI 10.7326/0003-4819-128-9-199805010-00011; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Lowe GDO, 2003, LANCET, V362, P504, DOI 10.1016/S0140-6736(03)14149-9; MACLURE M, 1987, AM J EPIDEMIOL, V126, P161, DOI 10.1093/aje/126.2.161; Mahe I, 2005, EUR J CLIN PHARMACOL, V61, P347, DOI 10.1007/s00228-005-0944-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Martel N, 2005, BLOOD, V106, P2710, DOI 10.1182/blood-2005-04-1546; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Mesko JW, 2001, J ARTHROPLASTY, V16, P679, DOI 10.1054/arth.2001.25506; Mismetti P, 2000, THROMB HAEMOSTASIS, V83, P14; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nuijten Mark J. C., 2002, Recenti Progressi in Medicina, V93, P80; PIRONE F, 1988, Clinica Terapeutica, V126, P267; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; SHOJANIA KG, 2006, MAKING HLTH CARE SAF; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stratton MA, 2000, ARCH INTERN MED, V160, P334, DOI 10.1001/archinte.160.3.334; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Vaitkus PT, 2002, VASC MED, V7, P269, DOI 10.1191/1358863x02vm449oa	51	391	406	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					278	288		10.7326/0003-4819-146-4-200702200-00007	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310052				2022-12-28	WOS:000244271000006
J	Wiese, MF; Ward, P; Jenkins, MP				Wiese, Martin F.; Ward, Patricia; Jenkins, Michael P.			Strutting stuff	LANCET			English	Editorial Material									Leicester Royal Infirm, Emergency Dept, Leicester LE1 5WW, Leics, England; St Marys Hosp, Dept Emergency Med, London, England; St Marys Hosp, Dept Vasc Surg, London, England	University of Leicester; Imperial College London; Imperial College London	Wiese, MF (corresponding author), Leicester Royal Infirm, Emergency Dept, Infirm Sq, Leicester LE1 5WW, Leics, England.	martin.wiese@uhl-tr.nhs.uk							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					586	586		10.1016/S0140-6736(07)60278-5	http://dx.doi.org/10.1016/S0140-6736(07)60278-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138MZ	17307105	Bronze			2022-12-28	WOS:000244368000032
J	Robinson, DJ; O'Neill, D				Robinson, David J.; O'Neill, Desmond			Access to health care records after death - Balancing confidentiality with appropriate disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL CONFIDENTIALITY		Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Adelaide & Meath Hosp, Dept Med Gerontol, Dublin 24, Ireland.	arhc@amnch.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				Annas GJ, 2005, NEW ENGL J MED, V352, P501, DOI 10.1056/NEJMlim042648; Behnke SH, 1998, J AM ACAD PSYCHIATRY, V26, P639; Billings J A, 1999, J Palliat Med, V2, P33, DOI 10.1089/jpm.1999.2.33; BISHOP L, 2005, NATL CONSUMER HEALTH; Caulfield H, 1998, Nurs Stand, V13, P47; Comijs HC, 1998, J AM GERIATR SOC, V46, P885, DOI 10.1111/j.1532-5415.1998.tb02724.x; deCinque N, 2004, J PAEDIATR CHILD H, V40, P131, DOI 10.1111/j.1440-1754.2004.00313.x; Dimond Bridgit, 2005, Br J Nurs, V14, P391; Glen S, 1997, NURS ETHICS, V4, P403; Kipnis K, 2006, AM J BIOETHICS, V6, P7, DOI 10.1080/15265160500506308; Lucassen AM, 2004, BMJ-BRIT MED J, V328, P952, DOI 10.1136/bmj.328.7445.952; McGuire W., 1978, CG JUNG SPEAKING INT; medical council, 2004, GUID ETH COND BEH; Phukan JFM, 2004, IR J MED SCI S1, V173, P47; RHODES H, 2003, PROTECTING PATIENT I; Sankar P, 2003, J GEN INTERN MED, V18, P659, DOI 10.1046/j.1525-1497.2003.20823.x; WORTHINGTON R, 2004, BMJ             0420	17	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 14	2007	297	6					634	636		10.1001/jama.297.6.634	http://dx.doi.org/10.1001/jama.297.6.634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135TU	17299198				2022-12-28	WOS:000244177400026
J	Pinton, P; Rimessi, A; Marchi, S; Orsini, F; Migliaccio, E; Giorgio, M; Contursi, C; Minucci, S; Mantovani, F; Wieckowski, MR; Del Sal, G; Pelicci, PG; Rizzuto, R				Pinton, Paolo; Rimessi, Alessandro; Marchi, Saverio; Orsini, Francesca; Migliaccio, Enrica; Giorgio, Marco; Contursi, Cristina; Minucci, Saverio; Mantovani, Fiamma; Wieckowski, Mariusz R.; Del Sal, Giannino; Pelicci, Pier Giuseppe; Rizzuto, Rosario			Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66(Shc)	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; OXIDATIVE STRESS; CA2+ SIGNALS; APOPTOSIS; MECHANISM	The 66-kilodalton isoform of the growth factor adapter Shc (p66(Shc)) translates oxidative damage into cell death by acting as reactive oxygen species (ROS) producer within mitochondria. However, the signaling link between cellular stress and mitochondrial proapoptotic activity of p66(Shc) was not known. We demonstrate that protein kinase C beta, activated by oxidative conditions in the cell, induces phosphorylation of p66Shc and triggers mitochondrial accumulation of the protein after it is recognized by the prolyl isomerase Pin1. Once imported, p66(Shc) causes alterations of mitochondrial Ca2+ responses and three-dimensional structure, thus inducing apoptosis. These data identify a signaling route that activates an apoptotic inducer shortening the life span and could be a potential target of pharmacological approaches to inhibit aging.	Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy; Univ Ferrara, ICSI, I-44100 Ferrara, Italy; Univ Ferrara, Emilia Romagna Lab Genom & Biotechnol, I-44100 Ferrara, Italy; European Inst Oncol, Dept Expt Oncol, Milan, Italy; FIRC, Inst Mol Oncol, Milan, Italy; Congenia SrL, Milan, Italy; Consorzio Interuniv Biotechnol, Lab Nazl, Trieste, Italy; Univ Trieste, Dept Biochim Biofis Chim Macromol, I-34127 Trieste, Italy; Polish Acad Sci, M Nencki Inst Expt Biol, Dept Cellular Biochem, PL-00901 Warsaw, Poland; Univ Milan, Dept Med & Surg, I-20122 Milan, Italy	University of Ferrara; University of Ferrara; University of Ferrara; IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; University of Trieste; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Milan	Rizzuto, R (corresponding author), Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, I-44100 Ferrara, Italy.	r.rizzuto@unife.it	Minucci, Saverio/J-9669-2012; Pelicci, Pier Giuseppe/AAL-6572-2020; rimessi, alessandro/O-3335-2019; Rizzuto, Rosario/B-6312-2008; Pinton, Paolo/J-8025-2012; Migliaccio, Enrica/AAQ-8880-2020; Marchi, Saverio/K-5997-2016; Giorgio, Marco/I-9425-2012; Marchi, Saverio/AAK-3308-2021; Rimessi, Alessandro/K-5420-2016	rimessi, alessandro/0000-0001-7091-5765; Pinton, Paolo/0000-0001-7108-6508; Marchi, Saverio/0000-0003-2708-1843; Giorgio, Marco/0000-0002-5842-6042; Marchi, Saverio/0000-0003-2708-1843; Rimessi, Alessandro/0000-0001-7091-5765; Wieckowski, Mariusz/0000-0003-0789-4521; DEL SAL, GIANNINO/0000-0003-2185-6003; Rizzuto, Rosario/0000-0001-7044-5097	Telethon [GGP05284] Funding Source: Medline	Telethon(Fondazione Telethon)		Bernardi P, 2001, TRENDS BIOCHEM SCI, V26, P112, DOI 10.1016/S0968-0004(00)01745-X; Bootman MD, 2001, J CELL SCI, V114, P2213; Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gonindard C, 1997, CELL BIOL TOXICOL, V13, P141, DOI 10.1023/A:1007321227010; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2004, J CELL BIOL, V165, P223, DOI 10.1083/jcb.200311061; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120	20	389	413	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					659	663		10.1126/science.1135380	http://dx.doi.org/10.1126/science.1135380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272725				2022-12-28	WOS:000243909400047
J	Scott, LM; Tong, W; Levine, RL; Scott, MA; Beer, PA; Stratton, MR; Futreal, PA; Erber, WN; McMullin, MF; Harrison, CN; Warren, AJ; Gilliland, DG; Lodish, HF; Green, AR				Scott, Linda M.; Tong, Wei; Levine, Ross L.; Scott, Mike A.; Beer, Philip A.; Stratton, Michael R.; Futreal, P. Andrew; Erber, Wendy N.; McMullin, Mary Frances; Harrison, Claire N.; Warren, Alan J.; Gilliland, D. Gary; Lodish, Harvey F.; Green, Anthony R.			JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE JAK2; V617F MUTATION; MYELOPROLIFERATIVE-DISORDERS; ESSENTIAL THROMBOCYTHEMIA; DIAGNOSTIC-CRITERIA; ACTIVATING MUTATION; MYELOID METAPLASIA; MYELOFIBROSIS; DISEASE; JAK2V617F	BACKGROUND: The V617F mutation, which causes the substitution of phenylalanine for valine at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis. However, the molecular basis of these myeloproliferative disorders in patients without the V617F mutation is unclear. METHODS: We searched for new mutations in members of the JAK and signal transducer and activator of transcription (STAT) gene families in patients with V617F-negative polycythemia vera or idiopathic erythrocytosis. The mutations were characterized biochemically and in a murine model of bone marrow transplantation. RESULTS: We identified four somatic gain-of-function mutations affecting JAK2 exon 12 in 10 V617F-negative patients. Those with a JAK2 exon 12 mutation presented with an isolated erythrocytosis and distinctive bone marrow morphology, and several also had reduced serum erythropoietin levels. Erythroid colonies could be grown from their blood samples in the absence of exogenous erythropoietin. All such erythroid colonies were heterozygous for the mutation, whereas colonies homozygous for the mutation occur in most patients with V617F-positive polycythemia vera. BaF3 cells expressing the murine erythropoietin receptor and also carrying exon 12 mutations could proliferate without added interleukin-3. They also exhibited increased phosphorylation of JAK2 and extracellular regulated kinase 1 and 2, as compared with cells transduced by wild-type JAK2 or V617F JAK2. Three of the exon 12 mutations included a substitution of leucine for lysine at position 539 of JAK2. This mutation resulted in a myeloproliferative phenotype, including erythrocytosis, in a murine model of retroviral bone marrow transplantation. CONCLUSIONS: JAK2 exon 12 mutations define a distinctive myeloproliferative syndrome that affects patients who currently receive a diagnosis of polycythemia vera or idiopathic erythrocytosis.	Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 2XY, England; Addenbrookes Natl Hlth Serv Trust, Cambridge, England; Whitehead Inst Biomed Res, Cambridge, England; MIT, Cambridge, England; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA; Wellcome Trust Sanger Inst, Hinxton, England; Queens Univ Belfast, Belfast, Antrim, North Ireland; St Thomas Hosp, London, England	University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Wellcome Trust Sanger Institute; Queens University Belfast; Guy's & St Thomas' NHS Foundation Trust	Green, AR (corresponding author), Cambridge Inst Med Res, Dept Haematol, Hills Rd, Cambridge CB2 2XY, England.	arg1000@cam.ac.uk	McMullin, Mary Frances/AAG-6078-2021; Erber, Wendy/A-1955-2012; levine, ross/AAE-7658-2019; McMullin, Mary F/AAF-6472-2020; Scott, Linda/D-9777-2012	McMullin, Mary Frances/0000-0002-0773-0204; Scott, Linda/0000-0003-0334-1479; Erber, Wendy/0000-0002-1028-9376; Green, Anthony/0000-0002-9795-0218; Tong, Wei/0000-0001-9951-2273; Beer, Philip/0000-0003-3056-5419	Medical Research Council [MC_U105161083, G0300497] Funding Source: Medline; NCI NIH HHS [P01 CA066996, K01 CA115679] Funding Source: Medline; NHLBI NIH HHS [P01 HL032262] Funding Source: Medline; NIDDK NIH HHS [P01 DK050654] Funding Source: Medline; Wellcome Trust [077012] Funding Source: Medline; MRC [G0300497, MC_U105161083] Funding Source: UKRI; Medical Research Council [G0300723B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K01CA115679, P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMSON JW, 1976, NEW ENGL J MED, V295, P913, DOI 10.1056/NEJM197610212951702; Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Campbell PJ, 2006, BLOOD, V107, P2098, DOI 10.1182/blood-2005-08-3395; Campbell PJ, 2005, LANCET, V366, P1945, DOI 10.1016/S0140-6736(05)67785-9; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Horn T, 2006, J MOL DIAGN, V8, P299, DOI 10.2353/jmoldx.2006.050128; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jamieson CHM, 2006, P NATL ACAD SCI USA, V103, P6224, DOI 10.1073/pnas.0601462103; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2006, BLOOD, V107, P4139, DOI 10.1182/blood-2005-09-3900; Lucet IS, 2006, BLOOD, V107, P176, DOI 10.1182/blood-2005-06-2413; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pearson TC, 2001, SEMIN HEMATOL, V38, P21, DOI 10.1053/shem.2001.23043; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; PRCHAL JF, 1974, NEW ENGL J MED, V290, P1382; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Scott LM, 2006, BLOOD, V108, P2435, DOI 10.1182/blood-2006-04-018259; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200	34	888	988	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					459	468		10.1056/NEJMoa065202	http://dx.doi.org/10.1056/NEJMoa065202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267906	Green Accepted, Bronze			2022-12-28	WOS:000243860700006
J	Grimmler, M; Wang, YF; Mund, T; Cilensek, Z; Keidel, EM; Waddell, MB; Jakel, H; Kullmann, M; Kriwacki, RW; Hengst, L				Grimmler, Matthias; Wang, Yuefeng; Mund, Thomas; Cilensek, Zoran; Keidel, Eva-Maria; Waddell, M. Brett; Jaekel, Heidelinde; Kullmann, Michael; Kriwacki, Richard W.; Hengst, Ludger			Cdk-inhibitory activity and stability of p27(Kip1) are directly regulated by oncogenic tyrosine kinases	CELL			English	Article							MYELOGENOUS LEUKEMIA-CELLS; DEPENDENT KINASES; UBIQUITIN LIGASE; CYCLIN-A; P27; PHOSPHORYLATION; PROGRESSION; DEGRADATION; ACTIVATION; PATHWAY	P27(Kip1) controls cell proliferation by binding to and regulating the activity of cyclin-dependent kinases (Cdks). Here we show that Cdk inhibition and p27 stability are regulated through direct phosphorylation by tyrosine kinases. A conserved tyrosine residue (Y88) in the Cdk-binding domain of p27 can be phosphorylated by the Src-family kinase Lyn and the oncogene product BCR-ABL. Y88 phosphorylation does not prevent p27 binding to cyclin A/Cdk2. Instead, it causes phosphorylated Y88 and the entire inhibitory 3(10)-helix of p27 to be ejected from the Cdk2 active site, thus restoring partial Cdk activity. Importantly, this allows Y88-phosphorylated p27 to be efficiently phosphorylated on threonine 187 by Cdk2 which in turn promotes its SCF-Skp2-dependent degradation. This direct link between transforming tyrosine kinases and p27 may provide an explanation for Cdk kinase activities observed in p27 complexes and for premature p27 elimination in cells that have been transformed by activated tyrosine kinases.	St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Innsbruck; Max Planck Society; University of Tennessee System; University of Tennessee Health Science Center	Kriwacki, RW (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.kriwacki@stjude.org; ludger.hengst@i-med.ac.at	WANG, YUE/GWQ-9256-2022; Kriwacki, Richard/N-8154-2018; Kullmann, Michael Keith/AGY-4711-2022	Kriwacki, Richard/0000-0002-9798-6018; Grimmler, Matthias/0000-0003-2860-3391; Hengst, Ludger/0000-0002-0605-0223; Kullmann, Michael Keith/0000-0003-3567-3806; Mund, Thomas/0000-0002-3957-1105	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA082491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014675] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765, R01 CA82491] Funding Source: Medline; NCRR NIH HHS [RR014675] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Andreu EJ, 2005, CANCER RES, V65, P3264, DOI 10.1158/0008-5472.CAN-04-1357; Blain SW, 2003, CANCER CELL, V3, P111, DOI 10.1016/S1535-6108(03)00026-6; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Coutts M, 2000, ONCOGENE, V19, P801, DOI 10.1038/sj.onc.1203398; DanhauserRiedl S, 1996, CANCER RES, V56, P3589; Donato NJ, 2003, BLOOD, V101, P690, DOI 10.1182/blood.V101.2.690; Dong F, 1998, MOL BIOL CELL, V9, P2081, DOI 10.1091/mbc.9.8.2081; Gesbert F, 2000, J BIOL CHEM, V275, P39223, DOI 10.1074/jbc.M007291200; HALL M, 1995, ONCOGENE, V11, P1581; Hallek M, 1997, EXP HEMATOL, V25, P1367; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hengst L, 1998, CURR TOP MICROBIOL, V227, P25; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Jonuleit T, 2000, BLOOD, V96, P1933, DOI 10.1182/blood.V96.5.1933.h8001933_1933_1939; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Moeller SJ, 2003, MOL CELL BIOL, V23, P3735, DOI 10.1128/MCB.23.11.3735-3752.2003; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Sugiyama Y, 2001, J BIOL CHEM, V276, P12084, DOI 10.1074/jbc.M010811200; Wang YF, 2005, CHEMBIOCHEM, V6, P2242, DOI 10.1002/cbic.200500260; Waugh DS, 1996, J BIOMOL NMR, V8, P184; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753	42	266	276	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					269	280		10.1016/j.cell.2006.11.047	http://dx.doi.org/10.1016/j.cell.2006.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254966	Bronze			2022-12-28	WOS:000244420500013
J	Lee, HK; Lund, JM; Ramanathan, B; Mizushima, N; Iwasaki, A				Lee, Heung Kyu; Lund, Jennifer M.; Ramanathan, Balaji; Mizushima, Noboru; Iwasaki, Akiko			Autophagy-dependent viral recognition by plasmacytoid dendritic cells	SCIENCE			English	Article							SINGLE-STRANDED RNA; RIG-I; ANTIVIRAL RESPONSES; DEGRADATION; 3-KINASE	Plasmacytoid dendritic cells (pDCs) detect viruses in the acidified endosomes by means of Toll-like receptors (TLRs). Yet, pDC responses to certain single-stranded RNA (ssRNA) viruses occur only after live viral infection. We present evidence here that the recognition of such viruses by TLR7 requires transport of cytosolic viral replication intermediates into the lysosome by the process of autophagy. In addition, autophagy was found to be required for the production of interferon-alpha by pDCs. These results support a key role for autophagy in mediating ssRNA virus detection and interferon-alpha secretion by pDCs and suggest that cytosolic replication intermediates of viruses serve as pathogen signatures recognized by TLR7.	Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; Tokyo Med & Dent Univ, Dept Cell Physiol, Grad Sch, Tokyo, Japan; Tokyo Med & Dent Univ, Dept Cell Physiol, Fac Med, Tokyo, Japan; Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaguchi, Japan	Yale University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.	iwasaki@yale.edu	Mizushima, Noboru/C-3635-2009; Lee, Heung Kyu/C-2073-2011; Iwasaki, Akiko/Z-1591-2019	Mizushima, Noboru/0000-0002-6258-6444; Lee, Heung Kyu/0000-0002-3977-1510; Iwasaki, Akiko/0000-0002-7824-9856; Lund, Jennifer/0000-0003-3284-979X	NIAID NIH HHS [AI054359, AI064705, AI07019] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI064705] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Crozat K, 2004, P NATL ACAD SCI USA, V101, P6835, DOI 10.1073/pnas.0401347101; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eloranta ML, 1999, SCAND J IMMUNOL, V49, P391; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2004, J IMMUNOL, V173, P5935, DOI 10.4049/jimmunol.173.10.5935; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	29	699	735	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1398	1401		10.1126/science.1136880	http://dx.doi.org/10.1126/science.1136880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17272685				2022-12-28	WOS:000244752200030
J	Reyburn, H; Mbakilwa, H; Mwangi, R; Mwerinde, M; Olomi, R; Drakeley, C; Whitty, CJM				Reyburn, Hugh; Mbakilwa, Hilda; Mwangi, Rose; Mwerinde, Mbeni; Olomi, Raimos; Drakeley, Chris; Whitty, Christopher J. M.			Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL ALGORITHMS; ENDEMIC AREA; CHILDREN; KENYA; MANAGEMENT; PREVALENCE; BACTEREMIA; ADULTS; FEVER	Objective To compare rapid diagnostic tests (RDTs) for malaria with routine microscopy in guiding treatment decisions for febrile patients. Design Randomised trial. Setting Outpatient departments in northeast Tanzania at varying levels of malaria transmission. Participants 2416 patients for whom a malaria test was requested. Intervention Staff received training on rapid diagnostic tests; patients sent for malaria tests were randomised to rapid diagnostic test or routine microscopy. Main outcome measure Proportion of patients with a negative test prescribed an antimalarial drug. Results Of 7589 outpatient consultations, 2425 (32%) had a malaria test requested. Of 1204 patients randomised to microscopy, 1030 (86%) tested negative for malaria; 523 (51%) of these were treated with an antimalarial drug. Of 1193 patients randomised to rapid diagnostic test, 1005 (84%) tested negative; 540 (54%) of these were treated for malaria (odds ratio 1.13, 95% confidence interval 0.95 to 1.34; P=0.18). Children aged under 5 with negative rapid diagnostic tests were more likely to be prescribed an antimalarial drug than were those with. negative slides (P=0.003). Patients with a negative test by any method were more likely to be prescribed an antibiotic (odds ratio 6.42, 4.72 to 8.75; P<0.001). More than 90% of prescriptions for antimalarial drugs in low-moderate transmission settings were for patients for whom a test requested by a clinician was negative for malaria. Conclusions Although many cases of malaria are missed outside the formal sector, within it malaria is massively over-diagnosed. This threatens the sustainability of deployment of artemisinin combination treatment, and treatable bacterial diseases are likely to be missed. Use of rapid diagnostic tests, with basic training for clinical staff, did not in itself lead to any reduction in over-treatment for malaria. Interventions to improve clinicians' management of febrile illness are essential but will not be easy.	Joint Malaria Programme, Moshi, Tanzania; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Kilimanjaro Christian Medical Centre	Reyburn, H (corresponding author), Joint Malaria Programme, POB 2228, Moshi, Tanzania.	hugh.reyburn@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027				Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; COLEMAN PG, 2004, BMJ; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; English M, 2004, LANCET, V364, P1622, DOI 10.1016/S0140-6736(04)17318-2; *GLOB FUND, 2006, GLOB FUND MAL TREATM; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013; LUBELL Y, IN PRESS AM J TROP M; LUBELL Y, 2007, IN PRESS AM J TROP M; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; *MIN HLTH TANZ, 2000, NAT GUID MAL DIAGN T, P41; Mundy C, 2000, T ROY SOC TROP MED H, V94, P583, DOI 10.1016/S0035-9203(00)90098-1; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Mutabingwa TK, 2005, LANCET, V365, P1474, DOI 10.1016/S0140-6736(05)66417-3; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Proux S, 2001, TROP MED INT HEALTH, V6, P99, DOI 10.1046/j.1365-3156.2001.00694.x; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; *WHO, 2001, WHOCDSCSRDSR20019; *WHO UNICEF, 2003, WHOCDSMAL20031093 UN, P70; Wiseman V, 2005, B WORLD HEALTH ORGAN, V83, P845; Wiseman V, 2006, PLOS MED, V3, P1844, DOI 10.1371/journal.pmed.0030373; World Health Organization, 2006, US MAL RAP DIAGN TES; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	34	294	294	0	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 24	2007	334	7590					403	406A		10.1136/bmj.39073.496829.AE	http://dx.doi.org/10.1136/bmj.39073.496829.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	142MQ	17259188	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000244654400029
J	Jones, PA; Baylin, SB				Jones, Peter A.; Baylin, Stephen B.			The epigenomics of cancer	CELL			English	Review							TUMOR-SUPPRESSOR GENES; EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE INHIBITORS; ISLAND METHYLATOR PHENOTYPE; MAMMARY EPITHELIAL-CELLS; GROUP PROTEIN EZH2; DNA METHYLATION; COLORECTAL-CANCER; DEVELOPMENTAL REGULATORS; CELLULAR-DIFFERENTIATION		Univ So Calif, Dept Urol Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA; Johns Hopkins Med Inst, Canc Biol Program, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	University of Southern California; Johns Hopkins University; Johns Hopkins Medicine	Jones, PA (corresponding author), Univ So Calif, Dept Urol Biochem & Mol Biol, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA.	jones_p@ccnt.usc.edu; sbaylin@jhmi.edu	Williams, Marimba/AAS-1007-2021; Jackson, Benjamin L/C-4297-2012		NCI NIH HHS [R01 CA116160, R01 CA083867, R01 CA082422, R01 CA04318, R01 CA043318] Funding Source: Medline; NIEHS NIH HHS [R01 ES011858] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082422, R01CA043318, R01CA116160, R01CA083867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bakker J, 2002, J BIOL CHEM, V277, P22573, DOI 10.1074/jbc.M203009200; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Cadieux B, 2006, CANCER RES, V66, P8469, DOI 10.1158/0008-5472.CAN-06-1547; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng JC, 2004, CANCER CELL, V6, P151, DOI 10.1016/j.ccr.2004.06.023; Chuang JC, 2005, MOL CANCER THER, V4, P1515, DOI 10.1158/1535-7163.MCT-05-0172; CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Esteller M, 2000, CANCER RES, V60, P4366; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Fang MZ, 2003, CANCER RES, V63, P7563; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Foster SA, 1998, MOL CELL BIOL, V18, P1793, DOI 10.1128/MCB.18.4.1793; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; GRAFF JR, 1995, CANCER RES, V55, P5195; Guarente L, 2000, GENE DEV, V14, P1021; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jenuwein T, 2006, FEBS J, V273, P3121, DOI 10.1111/j.1742-4658.2006.05343.x; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Karpf AR, 1999, P NATL ACAD SCI USA, V96, P14007, DOI 10.1073/pnas.96.24.14007; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang G, 2002, CANCER RES, V62, P961; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Valenta T, 2006, EMBO J, V25, P2326, DOI 10.1038/sj.emboj.7601147; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	90	3341	3514	16	576	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					683	692		10.1016/j.cell.2007.01.029	http://dx.doi.org/10.1016/j.cell.2007.01.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320506	Green Accepted, Bronze			2022-12-28	WOS:000245098600011
J	Hirsh, DA; Ogur, B; Thibault, GE; Cox, M				Hirsh, David A.; Ogur, Barbara; Thibault, George E.; Cox, Malcolm			"Continuity'' as an organizing principle for clinical education reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL-SCHOOL CURRICULUM; PRIMARY-CARE; STUDENTS; CLERKSHIPS; PROGRAM; HEALTH		Cambridge Hosp, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Boston, MA USA; Vet Hlth Adm, Washington, DC USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hirsh, DA (corresponding author), Cambridge Hosp, Cambridge, MA 02139 USA.							ANDERSON AS, 1994, ACAD MED, V69, P418, DOI 10.1097/00001888-199405000-00036; Armstrong E, 2005, ACAD MED, V80, P680, DOI 10.1097/00001888-200507000-00013; Armstrong EG, 2004, ACAD MED, V79, P721, DOI 10.1097/00001888-200408000-00002; *ASS AM MED COLL, 2000, ED MED STUD 10 STOR, P92; Association of American Medical Colleges, 2004, ED DOCT PROV HIGH QU; Beckman TJ, 2004, ACAD MED, V79, P343, DOI 10.1097/00001888-200404000-00011; Bransford JD., 2000, PEOPLE LEARN; Carney PA, 2002, ACAD MED, V77, P681, DOI 10.1097/00001888-200207000-00007; Christakis DA, 1997, JAMA-J AM MED ASSOC, V278, P739, DOI 10.1001/jama.278.9.739; CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; Cohen PA, 2005, J GEN INTERN MED, V20, P26; Davis MH, 2003, MED TEACH, V25, P596, DOI 10.1080/0142159032000144383; Elam CL, 2003, TEACH LEARN MED, V15, P194, DOI 10.1207/S15328015TLM1503_08; Elvin DM, 2005, J GEN INTERN MED, V20, P38; Fenton Cynthia, 2002, Acad Med, V77, P1159, DOI 10.1097/00001888-200211000-00024; Fishbein RH, 2000, J EVAL CLIN PRACT, V6, P241; Foley RP, 1997, TEACH LEARN MED, V9, P4, DOI 10.1080/10401339709539805; *GEN MED COUNC, 2003, TOM DOCT; Glick TH, 2001, MED EDUC, V35, P505, DOI 10.1046/j.1365-2923.2001.00935.x; Hafferty FW, 1998, ACAD MED, V73, P403, DOI 10.1097/00001888-199804000-00013; Halaas Gwen W, 2005, Rural Remote Health, V5, P453; HANSEN LA, 1992, ACAD MED, V67, P817, DOI 10.1097/00001888-199212000-00003; Harden RM, 2000, MED EDUC, V34, P391; Hirsh D, 2006, J GEN INTERN MED, V21, P186; Hunt CE, 1999, ARCH PEDIAT ADOL MED, V153, P297; Hurt MM, 2005, ACAD MED, V80, P973, DOI 10.1097/00001888-200511000-00002; Institute of Medicine, 2003, HLTH PROFESSIONS ED; IRBY DM, 1995, ACAD MED, V70, P898, DOI 10.1097/00001888-199510000-00014; Kenny NP, 2003, ACAD MED, V78, P1203, DOI 10.1097/00001888-200312000-00002; Ko M, 2005, ACAD MED, V80, P803, DOI 10.1097/00001888-200509000-00004; Lempp H, 2004, BMJ-BRIT MED J, V329, P770, DOI 10.1136/bmj.329.7469.770; Lewin L O, 1999, Acad Med, V74, pS82, DOI 10.1097/00001888-199901000-00037; Ludmerer K., 1999, TIME HEAL AM MED ED; Magrane D, 2000, ACAD MED, V75, P1066, DOI 10.1097/00001888-200011000-00009; Norman G, 2005, MED EDUC, V39, P418, DOI 10.1111/j.1365-2929.2005.02127.x; O'Neill PA, 2003, MED EDUC, V37, P1100, DOI 10.1046/j.1365-2923.2003.01714.x; O'Neill PA, 2000, MED EDUC, V34, P222; Ogrinc G, 2002, ACAD MED, V77, P688, DOI 10.1097/00001888-200207000-00008; OGUR B, IN PRESS ACAD MED; Oswald N, 2001, MED EDUC, V35, P782, DOI 10.1046/j.1365-2923.2001.00981.x; Peters AS, 2001, ACAD MED, V76, P484, DOI 10.1097/00001888-200105000-00023; Pipas CF, 2004, FAM MED, V36, pS126; Ramsey PG, 2001, ACAD MED, V76, P765, DOI 10.1097/00001888-200108000-00006; Roberts L W, 1997, Acad Med, V72, P423, DOI 10.1097/00001888-199705000-00049; Solyom AE, 2005, ACAD MED, V80, P1089, DOI 10.1097/00001888-200512000-00004; SPEER AJ, 1995, AM J MED, V99, P451, DOI 10.1016/S0002-9343(99)80217-4; The Commonwealth Fund Commission on a High Performance Health System, 2006, WHY NOT BEST RES NAT; van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x; VERBY JE, 1991, JAMA-J AM MED ASSOC, V266, P110, DOI 10.1001/jama.266.1.110; Watson RT, 2003, ACAD MED, V78, P659, DOI 10.1097/00001888-200307000-00002; Weinberger SE, 2006, ANN INTERN MED, V144, P927, DOI 10.7326/0003-4819-144-12-200606200-00124; Whitcomb ME, 2005, ACAD MED, V80, P1077, DOI 10.1097/00001888-200512000-00001; Whitcomb ME, 2005, ACAD MED, V80, P615, DOI 10.1097/00001888-200507000-00001; Wood DF, 2003, BMJ-BRIT MED J, V326, P328, DOI 10.1136/bmj.326.7384.328; Worley P, 2000, MED EDUC, V34, P558, DOI 10.1046/j.1365-2923.2000.00668.x	55	320	325	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					858	866		10.1056/NEJMsb061660	http://dx.doi.org/10.1056/NEJMsb061660			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314348				2022-12-28	WOS:000244326700016
J	Linz, B; Balloux, F; Moodley, Y; Manica, A; Liu, H; Roumagnac, P; Falush, D; Stamer, C; Prugnolle, F; van der Merwe, SW; Yamaoka, Y; Graham, DY; Perez-Trallero, E; Wadstrom, T; Suerbaum, S; Achtman, M				Linz, Bodo; Balloux, Francois; Moodley, Yoshan; Manica, Andrea; Liu, Hua; Roumagnac, Philippe; Falush, Daniel; Stamer, Christiana; Prugnolle, Franck; van der Merwe, Schalk W.; Yamaoka, Yoshio; Graham, David Y.; Perez-Trallero, Emilio; Wadstrom, Torkel; Suerbaum, Sebastian; Achtman, Mark			An African origin for the intimate association between humans and Helicobacter pylori	NATURE			English	Article							HUMAN-POPULATIONS; GENETIC DIVERSITY; INFECTION; EXPANSION; GEOGRAPHY; EVOLUTION; DISTANCE; HISTORY; MODEL	Infection of the stomach by helicobacter pylori is ubiquitous among humans. However, although H. pylori strains from different geographic areas are associated with clear phylogeographic differentiation(1-4), the age of an association between these bacteria with humans remains highly controversial(5,6). Here we show, using sequences from a large data set of bacterial strains that, as in humans, genetic diversity in H. pylori decreases with geographic distance from east Africa, the cradle of modern humans. We also observe similar clines of genetic isolation by distance (IBD) for both H. pylori and its human host at a worldwide scale. Like humans, simulations indicate that H. pylori seems to have spread from east Africa around 58,000 yr ago. Even at more restricted geographic scales, where IBD tends to become blurred, principal component clines in H. pylori from Europe strongly resemble the classical clines for Europeans described by Cavalli-Sforza and colleagues(7). Taken together, our results establish that anatomically modern humans were already infected by H. pylori before their migrations from Africa and demonstrate that H. pylori has remained intimately associated with their human host populations ever since.	Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany; Univ Cambridge, Dept Genet, Theoret & Mol Populat Genet Grp, Cambridge CB2 3EH, England; Univ Cambridge, Dept Zool, Evolut Ecol Grp, Cambridge CB2 3EJ, England; Univ Oxford, Dept Stat, Oxford OX1 3SY, England; Ctr IRD Montpellier, CNRS, UMR 2724, IRD, F-34394 Montpellier 05, France; Univ Pretoria, Dept Internal Med & Gastroenterol, ZA-0002 Pretoria, South Africa; Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; Donostia Hosp, Dept Microbiol, San Sebastian, Spain; Lund Univ, Dept Lab Med, SE-22632 Lund, Sweden; Hannover Med Sch, Inst Med Mikrobiol & Krankenhaushyg, D-30625 Hannover, Germany	Max Planck Society; University of Cambridge; University of Cambridge; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Pretoria; Baylor College of Medicine; Baylor College of Medicine; University Hospital Donostia; Lund University; Hannover Medical School	Achtman, M (corresponding author), Max Planck Inst Infekt Biol, Dept Mol Biol, D-10117 Berlin, Germany.	fb255@mole.bio.cam.ac.uk; Suerbaum.Sebastian@mh-hannover.de; achtman@mpiib-berlin.mpg.de	Manica, Andrea/N-9013-2019; Balloux, Francois/D-4783-2009; Balloux, Francois/X-7856-2019; Manica, Andrea/B-5497-2008; Graham, David/AAL-2165-2021	Manica, Andrea/0000-0003-1895-450X; Balloux, Francois/0000-0003-1978-7715; Balloux, Francois/0000-0003-1978-7715; Manica, Andrea/0000-0003-1895-450X; Yamaoka, Yoshio/0000-0002-1222-5819; Prugnolle, Franck/0000-0001-8519-1253; Moodley, Yoshan/0000-0003-4216-2924; Van der Merwe, Schalk/0000-0002-9891-2686; Achtman, Mark/0000-0001-6815-0070	Biotechnology and Biological Sciences Research Council [BB/C007123/1] Funding Source: Medline; Wellcome Trust [069662] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Dailidiene D, 2004, J BACTERIOL, V186, P356, DOI 10.1128/JB.186.2.356-365.2004; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Momynaliev KT, 2005, RUSS J GENET+, V41, P1182, DOI 10.1007/s11177-005-0217-3; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Relethford JH, 2004, HUM BIOL, V76, P499, DOI 10.1353/hub.2004.0060; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120	24	620	651	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					915	918		10.1038/nature05562	http://dx.doi.org/10.1038/nature05562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287725	Green Accepted, Green Published			2022-12-28	WOS:000244341200049
J	Learmonth, ID; Case, CP				Learmonth, Ian D.; Case, C. Patrick			Metallic debris from orthopaedic implants	LANCET			English	Editorial Material							TOTAL HIP-REPLACEMENT; ARTHROPLASTY; COBALT		Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England	University of Bristol	Learmonth, ID (corresponding author), Univ Bristol, Dept Orthopaed Surg, Bristol BS2 8HW, Avon, England.	Ian.Learmonth@bristol.ac.uk						Archibeck M J, 2001, Instr Course Lect, V50, P185; *CAN JOINT REPL RE, 2004, 2004 REP TOT HIP TOT, P30; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; GILLESPIE WJ, 1988, J BONE JOINT SURG BR, V70, P539, DOI 10.1302/0301-620X.70B4.3403594; Gillispie WJ, 1996, CLIN ORTHOP S, V329s, P290; Goldacre MJ, 2005, BRIT J CANCER, V92, P1298, DOI 10.1038/sj.bjc.6602511; Grubl A, 2006, J BONE JOINT SURG BR, V88B, P1003, DOI 10.1302/0301-620X.88B8; HARRIS WH, 1994, ACTA ORTHOP SCAND, V65, P113, DOI 10.3109/17453679408993734; Huk OL, 2004, J ARTHROPLASTY, V19, P84, DOI 10.1016/j.arth.2004.09.011; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Ladon D, 2004, J ARTHROPLASTY, V19, P78, DOI 10.1016/j.arth.2004.09.010; Mahomed NN, 2003, J BONE JOINT SURG AM, V85A, P27, DOI 10.2106/00004623-200301000-00005; McGregor DB, 2000, EUR J CANCER, V36, P307, DOI 10.1016/S0959-8049(99)00312-3; *NAT I CLIN EXC, 2002, GUID US MET MET HIP; *UK DEP HLTH, 2006, STAT BIOL EFF WEAR D; VISURI T, 1991, ORTHOPEDICS, V14, P137; Visuri TI, 2006, P I MECH ENG H, V220, P399, DOI 10.1243/095441105X63282; Witzleb WC, 2006, ACTA ORTHOP, V77, P697, DOI 10.1080/17453670610012863	18	11	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					542	544		10.1016/S0140-6736(07)60251-7	http://dx.doi.org/10.1016/S0140-6736(07)60251-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307087				2022-12-28	WOS:000244368000009
J	Lindford, AJ; Hettiaratchy, S; Schonauer, F				Lindford, Andrew J.; Hettiaratchy, Shehan; Schonauer, Fabrizio			Postpartum splinting of ear deformities	BRITISH MEDICAL JOURNAL			English	Article							CONGENITAL AURICULAR DEFORMITIES; NONSURGICAL CORRECTION; LOP EAR		Queen Victoria Hosp, Dept Plast & Reconstruct Surg, E Grinstead RH19 3DZ, E Sussex, England		Hettiaratchy, S (corresponding author), Charing Cross Hosp, Dept Plast & Reconstruct Surg, London W6 8RF, England.	shehan_h@hotmail.com	Schonauer, Fabrizio/AAN-6473-2020	Schonauer, Fabrizio/0000-0002-9155-2884				BROWN FE, 1986, PEDIATRICS, V78, P406; KUROZUMI N, 1982, BRIT J PLAST SURG, V35, P181, DOI 10.1016/0007-1226(82)90160-6; MATSUO K, 1984, PLAST RECONSTR SURG, V73, P38, DOI 10.1097/00006534-198401000-00009; MATSUO K, 1990, CLIN PLAST SURG, V17, P383; Merlob P, 1995, J Perinatol, V15, P293; Porter CJW, 2005, PLAST RECONSTR SURG, V115, P1701, DOI 10.1097/01.PRS.0000161454.08384.0A; SCHONAUER F, 2004, EUR J PLAST SURG, V47, P575; TAN ST, 1994, BRIT J PLAST SURG, V47, P575, DOI 10.1016/0007-1226(94)90144-9; TAN ST, 1994, BRIT J PLAST SURG, V47, P573, DOI 10.1016/0007-1226(94)90143-0; TANZER RC, 1975, PLAST RECONSTR SURG, V55, P406; Ullmann Y, 2002, PLAST RECONSTR SURG, V109, P907, DOI 10.1097/00006534-200203000-00013; Yotsuyanagi T, 1998, PLAST RECONSTR SURG, V101, P907, DOI 10.1097/00006534-199804040-00004	12	17	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					366	368		10.1136/bmj.39063.501377.BE	http://dx.doi.org/10.1136/bmj.39063.501377.BE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303887	Green Published			2022-12-28	WOS:000244560400036
J	Bradshaw, D; Warren, JE; Rosseinsky, MJ				Bradshaw, Darren; Warren, John E.; Rosseinsky, Matthew J.			Reversible concerted ligand substitution at alternating metal sites in an extended solid	SCIENCE			English	Article							COORDINATION-POLYMER; FRAMEWORK MATERIAL; HYDROGEN; ADSORPTION; DESORPTION; CRYSTALS	We report a synthetic material, [Co-2(bipy)(3)(SO4)(2)(H2O)(2)](bipy)(CH3OH), ( 1, where bipy = 4,4'-bipyridyl) that contains discrete reactive and inert structural motifs that undergo a reversible substitution reaction involving the concerted and spatially controlled introduction of bipyridine and methanol molecules at the reactive sites. This reaction defines the pore geometry of the resulting open-framework structure and controls the manner in which this structure sorbs small molecules. The molecules involved in the reaction are positioned by an array of well-defined interactions during their path to binding to the metal centers.	Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; SERC, Daresbury Lab, Synchrotron Radiat Source, Council Cent Lab,Res Council, Warrington WA4 4AD, Cheshire, England	University of Liverpool; STFC Daresbury Laboratory	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	m.j.rosseinsky@liv.ac.uk	Bradshaw, Darren/D-6174-2013; Warren, John/B-5219-2008; Warren, John E/H-6071-2019	Warren, John/0000-0002-8755-7981; Warren, John E/0000-0002-8755-7981	Engineering and Physical Sciences Research Council [EP/C511794/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Atwood JL, 2002, SCIENCE, V298, P1000, DOI 10.1126/science.1077591; Beauvais LG, 2000, J AM CHEM SOC, V122, P2763, DOI 10.1021/ja994186h; Carlucci L, 1997, J CHEM SOC DALTON, P1801, DOI 10.1039/a702146a; Chen CL, 2005, ANGEW CHEM INT EDIT, V44, P6673, DOI 10.1002/anie.200502309; Chesnut DJ, 1999, COORDIN CHEM REV, V190, P737, DOI 10.1016/S0010-8545(99)00119-8; Dietzel PDC, 2006, CHEM COMMUN, P959, DOI 10.1039/b515434k; Hagrman D, 1998, CHEM MATER, V10, P2091, DOI 10.1021/cm9707566; Halder GJ, 2005, J AM CHEM SOC, V127, P7891, DOI 10.1021/ja042420k; Hanson K, 2004, J AM CHEM SOC, V126, P10502, DOI 10.1021/ja0474190; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Lee EY, 2005, J AM CHEM SOC, V127, P6374, DOI 10.1021/ja043756x; Li HL, 1998, J AM CHEM SOC, V120, P2186, DOI 10.1021/ja974172g; Loiseau T, 2004, CHEM-EUR J, V10, P1373, DOI 10.1002/chem.200305413; Maspoch D, 2003, NAT MATER, V2, P190, DOI 10.1038/nmat834; Shimizu GKH, 2005, J SOLID STATE CHEM, V178, P2519, DOI 10.1016/j.jssc.2005.07.003; Spek A. L., 1999, PLATON; Takaoka K, 2005, ANGEW CHEM INT EDIT, V44, P2151, DOI 10.1002/anie.200462214; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	18	241	243	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					977	980		10.1126/science.1135445	http://dx.doi.org/10.1126/science.1135445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303750				2022-12-28	WOS:000244229800038
J	Lee, DM; Kiener, HP; Agarwal, SK; Noss, EH; Watts, GFM; Chisaka, O; Takeichi, M; Brenner, MB				Lee, David M.; Kiener, Hans P.; Agarwal, Sandeep K.; Noss, Erika H.; Watts, Gerald F. M.; Chisaka, Osamu; Takeichi, Masatoshi; Brenner, Michael B.			Cadherin-11 in synovial lining formation and pathology in arthritis	SCIENCE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; RHEUMATOID-ARTHRITIS; JOINT DESTRUCTION; CELLS; DISEASE; ADHESION; ROLES; EPITHELIUM; ENZYME	The normal synovium forms a membrane at the edges of joints and provides lubrication and nutrients for the cartilage. In rheumatoid arthritis, the synovium is the site of inflammation, and it participates in an organized tissue response that damages cartilage and bone. We identified cadherin-11 as essential for the development of the synovium. Cadherin-11-deficient mice have a hypoplastic synovial lining, display a disorganized synovial reaction to inflammation, and are resistant to inflammatory arthritis. Cadherin-11 therapeutics prevent and reduce arthritis in mouse models. Thus, synovial cadherin-11 determines the behavior of synovial cells in their proinflammatory and destructive tissue response in inflammatory arthritis.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Kyoto Univ, Dept Cell & Dev Biol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyoto University; RIKEN	Brenner, MB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, 1 Jimmy Fund Way, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; Watts, Gerald/0000-0003-2276-1524	NIAMS NIH HHS [K08 AR2214, R01 AR48114] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002214, R01AR048114] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATHANASOU NA, 1991, ANN RHEUM DIS, V50, P311, DOI 10.1136/ard.50.5.311; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; HENDERSON B, 1985, SEMIN ARTHRITIS RHEU, V15, P1, DOI 10.1016/0049-0172(85)90007-1; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Higgins JMG, 1998, J CELL BIOL, V140, P197, DOI 10.1083/jcb.140.1.197; HOLLYWELL C, 1983, VIRCHOWS ARCH A, V400, P345, DOI 10.1007/BF00612195; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Kiener HP, 2006, AM J PATHOL, V168, P1486, DOI 10.2353/ajpath.2006.050999; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KULKA JP, 1955, ARCH PATHOL, V59, P129; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; LEE DM, 2004, KELLEYS TXB RHEUMATO; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; MEDOF ME, 1987, J EXP MED, V165, P848, DOI 10.1084/jem.165.3.848; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; SCHUMACHER HR, 1972, ARTHRITIS RHEUM-US, V15, P465, DOI 10.1002/art.1780150502; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	26	296	317	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1006	1010		10.1126/science.1137306	http://dx.doi.org/10.1126/science.1137306			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17255475				2022-12-28	WOS:000244229800048
J	Perry, L; Dickau, R; Zarrillo, S; Holst, I; Pearsall, DM; Piperno, DR; Berman, MJ; Cooke, RG; Rademaker, K; Ranere, AJ; Raymond, JS; Sandweiss, DH; Scaramelli, F; Tarble, K; Zeidler, JA				Perry, Linda; Dickau, Ruth; Zarrillo, Sonia; Holst, Irene; Pearsall, Deborah M.; Piperno, Dolores R.; Berman, Mary Jane; Cooke, Richard G.; Rademaker, Kurt; Ranere, Anthony J.; Raymond, J. Scott; Sandweiss, Daniel H.; Scaramelli, Franz; Tarble, Kay; Zeidler, James A.			Starch fossils and the domestication and dispersal of chili peppers (Capsicum spp. L.) in the Americas	SCIENCE			English	Article							3 DOG SITE; ORINOCO VALLEY; SAN-SALVADOR; REAL-ALTO; ARTIFACTS; REVEAL; MAIZE	Chili peppers ( Capsicum spp.) are widely cultivated food plants that arose in the Americas and are now incorporated into cuisines worldwide. Here, we report a genus-specific starch morphotype that provides a means to identify chili peppers from archaeological contexts and trace both their domestication and dispersal. These starch microfossils have been found at seven sites dating from 6000 years before present to European contact and ranging from the Bahamas to southern Peru. The starch grain assemblages demonstrate that maize and chilies occurred together as an ancient and widespread Neotropical plant food complex that predates pottery in some regions.	Smithsonian Natl Museum Nat Hist, Archaeobiol Program, Dept Anthropol, Washington, DC 20013 USA; Univ Calgary, Dept Archaeol, Calgary, AB T2N 1N4, Canada; Smithsonian Trop Res Inst, Balboa 03092, Panama; Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; Miami Univ, Ctr Amer & World Cult, Oxford, OH 45056 USA; Univ Maine, Climate Change Inst, Orono, ME 04469 USA; Temple Univ, Dept Anthropol, Philadelphia, PA 19122 USA; Univ Maine, Dept Anthropol, Orono, ME 04469 USA; Carretera Panamer, Ctr Antropol, Inst Venezolano Invest Cient, Altos De Pipe, Venezuela; Cent Univ Venezuela, Dept Arqueol Etnohist & Ecol Cult, Escuela Antropol, Fac Ciencias Econ & Sociales, Caracas 1041, Venezuela; Colorado State Univ, Ctr Environm Management Mil Lands, Ft Collins, CO 80523 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Calgary; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Missouri System; University of Missouri Columbia; University System of Ohio; Miami University; University of Maine System; University of Maine Orono; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Maine System; University of Maine Orono; Venezuelan Institute Science Research; University of Central Venezuela; Colorado State University	Perry, L (corresponding author), Smithsonian Natl Museum Nat Hist, Archaeobiol Program, Dept Anthropol, POB 37012, Washington, DC 20013 USA.		Sandweiss, Daniel/K-5808-2019; Rademaker, Kurt/AAH-1075-2021	Rademaker, Kurt/0000-0001-5676-4884				Berman MJ, 1999, LAT AM ANTIQ, V10, P415, DOI 10.2307/971965; BERMAN MJ, 1995, WORLD ARCHAEOL, V26, P421, DOI 10.1080/00438243.1995.9980285; Berman MJ, 2000, LAT AM ANTIQ, V11, P219, DOI 10.2307/972175; Bohs L, 1997, SYST BOT, V22, P5, DOI 10.2307/2419674; Chandler-Ezell K, 2006, ECON BOT, V60, P103, DOI 10.1663/0013-0001(2006)60[103:RATPAS]2.0.CO;2; COOKE R, 1992, WORLD ARCHAEOL, V24, P114, DOI 10.1080/00438243.1992.9980197; DEBOER WR, 1975, AM ANTIQUITY, V40, P419, DOI 10.2307/279328; Dickau R., 2005, THESIS TEMPLE U PHIL; Eshbaugh W. H., 1993, New crops., P132; Heiser C., 1976, EVOLUTION CROP PLANT, P265; LATHRAP DW, 1977, ARCHAEOLOGY, V30, P2; LENTZ DL, 1996, LAT AM ANTIQ, V7, P247; Newsom L. A., 2004, LAND SEA NATIVE AM U; Pearsall DM, 2003, ARCHAEOLOGY OF FORMATIVE ECUADOR, P213; Pearsall DM, 2004, J ARCHAEOL SCI, V31, P423, DOI 10.1016/j.jas.2003.09.010; Perry L, 2005, LAT AM ANTIQ, V16, P409, DOI 10.2307/30042507; Perry L, 2006, NATURE, V440, P76, DOI 10.1038/nature04294; Perry L, 2004, J ARCHAEOL SCI, V31, P1069, DOI 10.1016/j.jas.2004.01.002; PICKERSGILL B, 1988, BIOL ZBL, V107, P381; PICKERSGILL B, 1969, AM ANTIQUITY, V34, P54, DOI 10.2307/278313; PICKERSGILL B, 1984, PRECOLUMBIAN PLANT M, P105; Piperno D.R., 1998, ORIGINS AGR LOWLAND; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Ranere A.J., 1996, PATHS CENTRAL AM PRE, P49; Raymond J. S., 1999, PACIFIC LATIN AM PRE, P149; Smith CE., 1967, PREHISTORY TEHUACAN, P220; Spencer C., 1994, LAT AM ANTIQ, V5, P119, DOI DOI 10.2307/971559; TARBLE K, 2006, THESIS U CHICAGO CHI; ZEIDLER JA, ARCHAEOLOGY FORMATIV, P48703	29	259	286	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					986	988		10.1126/science.1136914	http://dx.doi.org/10.1126/science.1136914			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	136MW	17303753				2022-12-28	WOS:000244229800041
J	Shneiderman, B; Preece, J				Shneiderman, Ben; Preece, Jennifer			Public health - 911.gov	SCIENCE			English	Editorial Material									Univ Maryland, Human Comp Interact Lab, College Pk, MD 20742 USA; Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA; Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shneiderman, B (corresponding author), Univ Maryland, Human Comp Interact Lab, College Pk, MD 20742 USA.	ben@cs.umd.edu; preece@umd.edu						COX J, 2006, COMMUNICATING EVEN N; HAGAR C, 2005, THESIS U ILLINOIS UR; Kajitani Y., 2005, NAT HAZARDS REV, V6, P41, DOI DOI 10.1061/(ASCE)1527-6988(2005)6:1(41); Maloney-Krichmar D., 2005, ACM Transactions on Computer-Human Interaction, V12, P201, DOI 10.1145/1067860.1067864; Preece J., 2000, ONLINE COMMUNITIES D; Shaw R, 2004, DISASTERS, V28, P16, DOI 10.1111/j.0361-3666.2004.00241.x; Stephenson M, 2005, DISASTERS, V29, P337, DOI 10.1111/j.0361-3666.2005.00296.x; Turoff M., 2004, J INFORM TECHNOLOGY, V5, P1	8	24	25	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					944	944		10.1126/science.1139088	http://dx.doi.org/10.1126/science.1139088			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303738				2022-12-28	WOS:000244229800025
J	Morrow, RH				Morrow, Richard H.			Antimalarial drug combinations in vastly different settings	LANCET			English	Editorial Material							INTERMITTENT PREVENTIVE TREATMENT; PLASMODIUM-VIVAX; MALARIA		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Hlth Syst Program, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Morrow, RH (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Hlth Syst Program, Baltimore, MD 21205 USA.	rhmorrow@comcast.net						BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Molineaux L, 2020, GARKI PROJECT RES EP, V8; RATCLIFF A, 2007, LANCET          0209, DOI DOI 10.1016/S0140-6736(07)60160-3; Rosen JB, 2004, LANCET, V363, P1386, DOI 10.1016/S0140-6736(04)16052-2; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	10	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					444	445		10.1016/S0140-6736(07)60209-8	http://dx.doi.org/10.1016/S0140-6736(07)60209-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	135XX	17292746				2022-12-28	WOS:000244188300007
J	Smith, KL; Soriano, TA; Boal, J				Smith, Kristofer L.; Soriano, Theresa A.; Boal, Jeremy			Brief communication: National quality-of-care standards in home-based primary care	ANNALS OF INTERNAL MEDICINE			English	Article							VULNERABLE OLDER-PEOPLE; ELDERS; PROGRAM	Background: Home-based primary care for homebound seniors is complex, and practice constraints are unique. No quality-of-care standards exist. Objective: To identify process quality indicators that are essential to high-quality, home-based primary care. Design: An expert development panel reviewed established and new quality indicators for applicability to home-based primary care. A separate national evaluation panel used a modified Delphi process to rate the validity and importance of the potential quality indicators. Participants: Two national panels whose members varied in practice type, location, and setting. Results: The panels considered 260 quality indicators and endorsed 200 quality indicators that cover 23 geriatric conditions. Twenty-one (10.5%) quality indicators were newly created, 52 (26%) were modified, and 127 (63.5%) were unchanged. The quality indicators have decreased emphasis on interventions and have placed greater emphasis on quality of life. Limitations: The quality indicator set may not apply to all home-bound seniors and might be difficult to implement for a typical home-based primary care program. Conclusions: The quality indicator set provides a comprehensive home-based primary care quality framework and will allow for future comparative research. Provision of these evidence-based measures could improve patient quality of life and longevity.	Mt Sinai Sch Med, Mt Sinai Visiting Doctors Program, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Soriano, TA (corresponding author), Mt Sinai Sch Med, Mt Sinai Visiting Doctors Program, Box 1216,1 Gustave L Levy Pl, New York, NY 10029 USA.	theresa.soriano@mssm.edu			PHS HHS [5 K01 HP 00053-02] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM AC HOM CAR PHY, 2005, EX SUMM PUBL POL STA; *CTR MED MED SERV, NON DAT FIL PHYS SUP; Fried TR, 1998, J AM GERIATR SOC, V46, P226; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; Kellogg FR, 2000, J AM GERIATR SOC, V48, P1002, DOI 10.1111/j.1532-5415.2000.tb06902.x; Leff B, 2001, J GERONTOL A-BIOL, V56, pM603, DOI 10.1093/gerona/56.10.M603; Levine SA, 2003, JAMA-J AM MED ASSOC, V290, P1203, DOI 10.1001/jama.290.9.1203; MERRICK NJ, 1987, AM J PUBLIC HEALTH, V77, P187, DOI 10.2105/AJPH.77.2.187; Min LC, 2005, J AM GERIATR SOC, V53, P1705, DOI 10.1111/j.1532-5415.2005.53520.x; *NAT CTR HLTH STAT, 2005, US 2005 CHARTB TREND; Saliba D, 2001, J AM GERIATR SOC, V49, P1691, DOI 10.1046/j.1532-5415.2001.49281.x; Saliba Debra, 2004, J Am Med Dir Assoc, V5, P297, DOI 10.1016/S1525-8610(04)70019-5; Shekelle PG, 1998, NEW ENGL J MED, V338, P1888, DOI 10.1056/NEJM199806253382607; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Smith KL, 2006, J AM GERIATR SOC, V54, P1283, DOI 10.1111/j.1532-5415.2006.00835.x; Solomon DH, 2003, J AM GERIATR SOC, V51, P902, DOI 10.1046/j.1365-2389.2003.513331.x; United States Department of Health and Human Services, 2003, PUBL US DEP HLTH HUM; Washington DL, 2003, MED CARE, V41, P1374, DOI 10.1097/01.MLR.0000100583.76137.3E; Wenger NS, 2001, ANN INTERN MED, V135, P642, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00002	19	26	27	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					188	192		10.7326/0003-4819-146-3-200702060-00008	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132QN	17283350				2022-12-28	WOS:000243957400005
J	Ioannidis, JPA; Ahmed, T; Awasthi, S; Clarfied, AM; Clark, J; Dandona, L; Howe, A; Lozano, JM; Li, YP; Madani, H; Marusic, A; Mohammed, I; Purcell, GP; Rhoads, M; Sliwa-Hahnle, K; Straus, SE; Edejer, TT; Tugwell, P; Ward, R; Wilkes, MS; Smith, R				Ioannidis, John P. A.; Ahmed, Tahmeed; Awasthi, Shally; Clarfied, A. Mark; Clark, Jocalyn; Dandona, Lalit; Howe, Amanda; Lozano, Juari M.; Li, Youping; Madani, Hardi; Marusic, Ana; Mohammed, Idris; Purcell, Gretchen P.; Rhoads, Maragaret; Sliwa-Haehnle, Karen; Straus, Sharon E.; Edejer, Tessa Tan-Torres; Tugwell, Peter; Ward, Robyn; Wilkes, Michael S.; Smith, Richard			Open letter to the leaders of academic medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece	University of Ioannina	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.		Tugwell, Peter/AFD-8076-2022; Ioannidis, John P. A./G-9836-2011; Ward, Robyn L/I-2313-2013; Marusic, Ana/E-7683-2013	Tugwell, Peter/0000-0001-5062-0556; Ward, Robyn L/0000-0002-6877-8906; Marusic, Ana/0000-0001-6272-0917; Clark, Jocalyn/0000-0002-8014-3989				Clark J, 2005, BRIT MED J, V331, P101, DOI 10.1136/bmj.331.7508.101	1	9	9	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					191	193		10.1136/bmj.39043.676898.94	http://dx.doi.org/10.1136/bmj.39043.676898.94			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255613	Green Published			2022-12-28	WOS:000244027600034
J	Chu, I; Sun, J; Arnaout, A; Kahn, H; Hanna, W; Narod, S; Sun, P; Tan, CK; Hengst, L; Slingerland, J				Chu, Isabel; Sun, Jun; Arnaout, Angel; Kahn, Harriette; Hanna, Wedad; Narod, Steven; Sun, Ping; Tan, Cheng-Keat; Hengst, Ludger; Slingerland, Joyce			p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2	CELL			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN-BREAST-CANCER; MEDIATED G(1) ARREST; CELL-CYCLE; DEPENDENT-KINASE; TYROSINE KINASE; C-SRC; ESTROGEN-RECEPTOR; CDK INHIBITOR; FACTOR-BETA	The kinase inhibitor p27(Kip1) regulates the G, cell cycle phase. Here, we present data indicating that the oncogenic kinase Src regulates p27 stability through phosphorylation of p27 at tyrosine 74 and tyrosine 88. Src inhibitors increase cellular p27 stability, and Src overexpression accelerates p27 proteolysis. Src-phosphorylated p27 is shown to inhibit cyclin E-Cdk2 poorly in vitro, and Src transfection reduces p27-cyclin E-Cdk2 complexes. Our data indicate that phosphorylation by Src impairs the Cdk2 inhibitory action of p27 and reduces its steady-state binding to cyclin E-Cdk2 to facilitate cyclin E-Cdk2-dependent p27 proteolysis. Furthermore, we find that Src-activated breast cancer lines show reduced p27 and observe a correlation between Src activation and reduced nuclear p27 in 482 primary human breast cancers. Importantly, we report that in tamoxifen-resistant breast cancer cell lines, Src inhibition can increase p27 levels and restore tamoxifen sensitivity. These data provide a new rationale for Src inhibitors in cancer therapy.	Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; Univ Toronto, Dept Pathol & Lab Med, Toronto, ON M4N 3M5, Canada; Univ Innsbruck, Bioctr, Div Med Biochem, A-6020 Innsbruck, Austria	University of Miami; University of Miami; University of Toronto; University of Innsbruck	Slingerland, J (corresponding author), Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Narod, Steven A/AAA-6112-2022	Hengst, Ludger/0000-0002-0605-0223	NATIONAL CANCER INSTITUTE [R01CA105118, R01CA123415] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA105118, R01-CA105118, R01 CA123415] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Biscardi JS, 2000, BREAST CANCER RES, V2, P203, DOI 10.1186/bcr55; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen T, 2006, ANTI-CANCER DRUG, V17, P123, DOI 10.1097/00001813-200602000-00002; Chu I, 2005, CANCER RES, V65, P18; Ciarallo S, 2002, MOL CELL BIOL, V22, P2993, DOI 10.1128/MCB.22.9.2993-3002.2002; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Egan C, 1999, ONCOGENE, V18, P1227, DOI 10.1038/sj.onc.1202233; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Florenes VA, 1996, ONCOGENE, V13, P2447; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Gopfert U, 2003, HUM MOL GENET, V12, P1767, DOI 10.1093/hmg/ddg177; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; HENGST L, 1994, P NATL ACAD SCI USA, V91, P5291, DOI 10.1073/pnas.91.12.5291; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kardinal C, 2006, BLOOD, V107, P1133, DOI 10.1182/blood-2005-05-1771; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; KOFF A, 1993, SCIENCE, V260, P536, DOI 10.1126/science.8475385; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lenferink AEG, 2000, P NATL ACAD SCI USA, V97, P9609, DOI 10.1073/pnas.160564197; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NICHOLSON S, 1990, J STEROID BIOCHEM, V37, P811, DOI 10.1016/0960-0760(90)90424-J; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Ple PA, 2004, J MED CHEM, V47, P871, DOI 10.1021/jm030317k; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Radeva G, 1997, J BIOL CHEM, V272, P13937, DOI 10.1074/jbc.272.21.13937; Riley D, 2001, ONCOGENE, V20, P5941, DOI 10.1038/sj.onc.1204826; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Song RX, 2004, P NATL ACAD SCI USA, V101, P2076, DOI 10.1073/pnas.0308334100; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsutsui S, 2002, BREAST CANCER RES TR, V71, P67, DOI 10.1023/A:1013397232011; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Yang HY, 2000, J BIOL CHEM, V275, P24735, DOI 10.1074/jbc.C000147200	64	286	301	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					281	294		10.1016/j.cell.2006.11.049	http://dx.doi.org/10.1016/j.cell.2006.11.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254967	Green Accepted, Bronze			2022-12-28	WOS:000244420500014
J	Tothova, Z; Kollipara, R; Huntly, BJ; Lee, BH; Castrillon, DH; Cullen, DE; McDowell, EP; Lazo-Kallanian, S; Williams, IR; Sears, C; Armstrong, SA; Passegue, E; DePinho, RA; Gilliland, DG				Tothova, Zuzana; Kollipara, Ramya; Huntly, Brian J.; Lee, Benjamin H.; Castrillon, Diego H.; Cullen, Dana E.; McDowell, Elizabeth P.; Lazo-Kallanian, Suzan; Williams, Ifor R.; Sears, Christopher; Armstrong, Scott A.; Passegue, Emmanuelle; DePinho, Ronald A.; Gilliland, D. Gary			FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress	CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; LIFE-SPAN; PHOSPHOINOSITIDE 3-KINASE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; PROLIFERATION; ACTIVATION; PROGENITOR; PROTEIN; KINASE	To understand the role of FoxO family members in hematopoiesis, we conditionally deleted FoxO1, FoxO3, and FoxO4 in the adult hematopoietic system. FoxO-deficient mice exhibited myeloid lineage expansion, lymphoid developmental abnormalities, and a marked decrease of the lineage-negative Sca-1(+), c-Kit(+) (LSK) compartment that contains the short- and long-term hematopoietic stem cell (HSC) populations. FoxO-deficient bone marrow had defective long-term repopulating activity that correlated with increased cell cycling and apoptosis of HSC. Notably, there was a marked context-dependent increase in reactive oxygen species (ROS) in FoxO-deficient HSC compared with wild-type HSC that correlated with changes in expression of genes that regulate ROS. Furthermore, in vivo treatment with the antioxidative agent N-acetyl-L-cysteine resulted in reversion of the FoxO-deficient HSC phenotype. Thus, FoxO proteins play essential roles in the response to physiologic oxidative stress and thereby mediate quiescence and enhanced survival in the HSC compartment, a function that is required for its long-term regenerative potential.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Robert A & Renee E Belfer Fdn Inst Innovat Canc S, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Cambridge, Med Res Inst, Dept Haematol, Cambridge CB2 2XY, England; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Cambridge; Emory University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California San Francisco	Gilliland, DG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 02115 USA.	ggilliland@rics.bwh.harvard.edu	huntly, brian JP/E-6725-2014; Williams, Ifor R/D-3648-2011	huntly, brian JP/0000-0003-0312-161X; Williams, Ifor R/0000-0002-8810-2911; Passegue, Emmanuelle/0000-0002-3516-297X; DePinho, Ronald/0000-0002-5625-577X	MRC [G116/187] Funding Source: UKRI; Medical Research Council [G116/187] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Borkhardt A, 1997, ONCOGENE, V14, P195, DOI 10.1038/sj.onc.1200814; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gu TL, 2004, BLOOD, V103, P4622, DOI 10.1182/blood-2003-03-0820; Hillion J, 1997, BLOOD, V90, P3714, DOI 10.1182/blood.V90.9.3714; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Martinez-Gac L, 2004, MOL CELL BIOL, V24, P2181, DOI 10.1128/MCB.24.5.2181-2189.2004; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; PARRY P, 1994, GENE CHROMOSOME CANC, V11, P79, DOI 10.1002/gcc.2870110203; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scheijen B, 2004, ONCOGENE, V23, P3338, DOI 10.1038/sj.onc.1207456; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747	43	1182	1231	2	97	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					325	339		10.1016/j.cell.2007.01.003	http://dx.doi.org/10.1016/j.cell.2007.01.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254970	Bronze			2022-12-28	WOS:000244420500017
J	Li, B; Carey, M; Workman, JL				Li, Bing; Carey, Michael; Workman, Jerry L.			The role of chromatin during transcription	CELL			English	Review							RNA-POLYMERASE-II; HISTONE H2B UBIQUITYLATION; NUCLEOSOME ASSEMBLY PROTEIN-1; REGULATES H3 METHYLATION; HEAT-SHOCK FACTOR; PAF1 COMPLEX; ELONGATION-FACTORS; ACTIVATOR INTERACTIONS; FACILITATED BINDING; OCTAMER TRANSFER		Stowers Med Res Inst, Kansas City, MO 64110 USA; Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA	Stowers Institute for Medical Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Workman, JL (corresponding author), Stowers Med Res Inst, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers-institute.org	Li, Chia Cheng/D-9906-2015; li, ran/K-1896-2012	Carey, Michael/0000-0003-3899-6280	NIGMS NIH HHS [R37 GM047867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Boeger H, 2004, MOL CELL, V14, P667, DOI 10.1016/j.molcel.2004.05.013; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; CHEN H, 1994, EMBO J, V13, P380, DOI 10.1002/j.1460-2075.1994.tb06272.x; CLARK DJ, 1992, CELL, V71, P11, DOI 10.1016/0092-8674(92)90262-B; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Deckert J, 2001, MOL CELL BIOL, V21, P2726, DOI 10.1128/MCB.21.8.2726-2735.2001; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Doyen CM, 2006, EMBO J, V25, P4234, DOI 10.1038/sj.emboj.7601310; Doyen CM, 2006, MOL CELL BIOL, V26, P1156, DOI 10.1128/MCB.26.3.1156-1164.2006; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Green MR, 2005, MOL CELL, V18, P399, DOI 10.1016/j.molcel.2005.04.017; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hassan AH, 2006, J BIOL CHEM, V281, P18126, DOI 10.1074/jbc.M602851200; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ito T, 2000, GENE DEV, V14, P1899; Jason LJM, 2002, BIOESSAYS, V24, P166, DOI 10.1002/bies.10038; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Landry J, 2003, MOL CELL BIOL, V23, P5972, DOI 10.1128/MCB.23.17.5972-5978.2003; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Lorch Y, 2006, P NATL ACAD SCI USA, V103, P3090, DOI 10.1073/pnas.0511050103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Park YJ, 2005, J BIOL CHEM, V280, P1817, DOI 10.1074/jbc.M411347200; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond TJ, 2006, NATURE, V442, P750, DOI 10.1038/442750a; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rosonina E, 2005, MOL CELL, V20, P167, DOI 10.1016/j.molcel.2005.10.004; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simic R, 2003, EMBO J, V22, P1846, DOI 10.1093/emboj/cdg179; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; STUDITSKY VM, 1995, CELL, V83, P19, DOI 10.1016/0092-8674(95)90230-9; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; STUDITSKY VM, 1994, CELL, V76, P371, DOI 10.1016/0092-8674(94)90343-3; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; WALTER PP, 1995, MOL CELL BIOL, V15, P6178; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2006, NAT STRUCT MOL BIOL, V13, P572, DOI 10.1038/nsmb0706-572; Zhao J, 2005, MOL CELL BIOL, V25, P8985, DOI 10.1128/MCB.25.20.8985-8999.2005	133	2511	2599	11	457	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					707	719		10.1016/j.cell.2007.01.015	http://dx.doi.org/10.1016/j.cell.2007.01.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320508	Bronze			2022-12-28	WOS:000245098600013
J	Rando, OJ; Verstrepen, KJ				Rando, Oliver J.; Verstrepen, Kevin J.			Timescales of genetic and epigenetic inheritance	CELL			English	Review							ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; PHASE-VARIATION; MORPHOLOGICAL EVOLUTION; PHENOTYPIC VARIATION; ANTIGENIC VARIATION; BACILLUS-SUBTILIS; MUTATION-RATES; LAC REPRESSOR; CELL-SURFACE		Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Katholieke Univ Leuven, Fac Appl Biosci & Engn, Dept Mol & Microbial Syst, B-3001 Heverlee, Belgium	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; KU Leuven	Rando, OJ (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	oliver.rando@umassmed.edu; kverstrepen@cgr.harvard.edu	Verstrepen, Kevin/AAA-4343-2021	Rando, Oliver/0000-0003-1516-9397; Verstrepen, Kevin/0000-0002-3077-6219	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER; NIGMS NIH HHS [5P50 GM068763-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Aertsen A, 2006, TRENDS MICROBIOL, V14, P421, DOI 10.1016/j.tim.2006.08.006; Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Andersson DI, 1998, SCIENCE, V282, P1133, DOI 10.1126/science.282.5391.1133; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berka RM, 2002, MOL MICROBIOL, V43, P1331, DOI 10.1046/j.1365-2958.2002.02833.x; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; BLYN LB, 1989, EMBO J, V8, P613, DOI 10.1002/j.1460-2075.1989.tb03416.x; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; CAIRNS J, 1988, NATURE, V335, P142, DOI 10.1038/335142a0; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; CULLIS CA, 1973, NATURE, V243, P515, DOI 10.1038/243515a0; Drake JW, 1999, ANN NY ACAD SCI, V870, P100, DOI 10.1111/j.1749-6632.1999.tb08870.x; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FARABAUGH PJ, 1978, J MOL BIOL, V126, P847, DOI 10.1016/0022-2836(78)90023-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Greig D, 1998, P ROY SOC B-BIOL SCI, V265, P1017, DOI 10.1098/rspb.1998.0393; Hahn J, 2005, CELL, V122, P59, DOI 10.1016/j.cell.2005.04.035; Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; HASINGS PJ, 2004, PLOS BIOL, V2, pE399, DOI DOI 10.1371/JOURNAL.PBIO.0020399; Henikoff S, 2005, PLANT CELL, V17, P2852, DOI 10.1105/tpc.105.038000; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Hernday A, 2002, P NATL ACAD SCI USA, V99, P16470, DOI 10.1073/pnas.182427199; Honjo T, 2005, NAT IMMUNOL, V6, P655, DOI 10.1038/ni1218; Jablonka E, 1995, PHILOS T R SOC B, V350, P133, DOI 10.1098/rstb.1995.0147; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; KLEMM P, 1986, EMBO J, V5, P1389, DOI 10.1002/j.1460-2075.1986.tb04372.x; Koturbash I, 2006, ONCOGENE, V25, P4267, DOI 10.1038/sj.onc.1209467; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Luria SE, 1943, GENETICS, V28, P491; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; McLaren A, 1999, TRENDS GENET, V15, P169, DOI 10.1016/S0168-9525(99)01732-1; Metzgar D, 2000, CELL, V101, P581, DOI 10.1016/S0092-8674(00)80869-7; MILLER JH, 1977, J MOL BIOL, V109, P275, DOI 10.1016/S0022-2836(77)80034-X; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nolin SL, 2003, AM J HUM GENET, V72, P454, DOI 10.1086/367713; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Olsen PB, 1998, FEMS MICROBIOL LETT, V162, P17; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Plotkin JB, 2004, NATURE, V428, P942, DOI 10.1038/nature02458; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Ruthenberg MS, 1998, ROM LANG AN, V9, P336; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; SIMON M, 1980, SCIENCE, V209, P1370, DOI 10.1126/science.6251543; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Weismann A., 1893, UBER DIE VERERBUNG; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Wright BE, 2004, MOL MICROBIOL, V52, P643, DOI 10.1111/j.1365-2958.2004.04012.x	76	307	318	3	65	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					655	668		10.1016/j.cell.2007.01.023	http://dx.doi.org/10.1016/j.cell.2007.01.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320504	Bronze, Green Accepted			2022-12-28	WOS:000245098600009
J	Camilleri, M				Camilleri, Michael			Diabetic gastroparesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTRIC ELECTRICAL-STIMULATION; QUALITY-OF-LIFE; GASTROINTESTINAL SYMPTOMS; DOUBLE-BLIND; HEALTHY-SUBJECTS; MELLITUS; DOMPERIDONE; OUTCOMES; THERAPY; TYPE-1		Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic	Camilleri, M (corresponding author), Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Charlton 8-110,200 1st St SW, Rochester, MN 55905 USA.	camilleri.michael@mayo.edu			NIDDK NIH HHS [P01 DK068055, P01-DK068055, K24-DK02638, R01-DK067071] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067071, K24DK002638, P01DK068055] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abell T, 2003, GASTROENTEROLOGY, V125, P421, DOI 10.1016/S0016-5085(03)00878-3; Abell TL, 2006, NEUROGASTROENT MOTIL, V18, P263, DOI 10.1111/j.1365-2982.2006.00760.x; Abidi N, 2006, NEUROGASTROENT MOTIL, V18, P334, DOI 10.1111/j.1365-2982.2006.00765.x; Arts J, 2005, GASTROENTEROLOGY, V128, pA81; Braden B, 2002, ALIMENT PHARM THERAP, V16, P1341, DOI 10.1046/j.1365-2036.2002.01257.x; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; CAMILLERI M, 1991, DIGEST DIS SCI, V36, P609, DOI 10.1007/BF01297027; CAMILLERI M, 1984, EUR J CLIN INVEST, V14, P420, DOI 10.1111/j.1365-2362.1984.tb01206.x; Camilleri M, 2006, GASTROENTEROLOGY, V131, P640, DOI 10.1053/j.gastro.2006.03.023; Couturier O, 2004, NUCL MED COMMUN, V25, P1143, DOI 10.1097/00006231-200411000-00013; DIVE A, 1995, CRIT CARE MED, V23, P1356, DOI 10.1097/00003246-199508000-00008; Dutta U, 1999, Trop Gastroenterol, V20, P116; ENCK P, 1994, Z GASTROENTEROL, V32, P637; FELDMAN M, 1984, GASTROENTEROLOGY, V87, P895; Fontana RJ, 1996, AM J GASTROENTEROL, V91, P2174; Franzese A, 2002, ALIMENT PHARM THER, V16, P951, DOI 10.1046/j.1365-2036.2002.01240.x; FRASER RJ, 1990, DIABETOLOGIA, V33, P675, DOI 10.1007/BF00400569; GABER AO, 1991, DIGEST DIS, V9, P437; He CL, 2001, GASTROENTEROLOGY, V121, P427, DOI 10.1053/gast.2001.26264; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Horowitz M, 2002, DIABETIC MED, V19, P177, DOI 10.1046/j.1464-5491.2002.00658.x; HUNT JN, 1960, J PHYSIOL-LONDON, V154, P254, DOI 10.1113/jphysiol.1960.sp006577; JANATUINEN E, 1993, SCAND J GASTROENTERO, V28, P427, DOI 10.3109/00365529309098244; JANSSENS J, 1990, NEW ENGL J MED, V322, P1028, DOI 10.1056/NEJM199004123221502; Jones KL, 2002, AM J MED, V113, P449, DOI 10.1016/S0002-9343(02)01228-7; Jones MP, 2003, AM J GASTROENTEROL, V98, P2122, DOI 10.1016/S0002-9270(03)00754-8; KASSANDER P, 1958, ANN INTERN MED, V48, P797, DOI 10.7326/0003-4819-48-4-797; Kong MF, 1999, DIABETES CARE, V22, P503, DOI 10.2337/diacare.22.3.503; Lee JS, 2000, AM J GASTROENTEROL, V95, P2751, DOI 10.1016/S0002-9270(00)01976-6; Lin Z, 2006, NEUROGASTROENT MOTIL, V18, P18, DOI 10.1111/j.1365-2982.2005.00732.x; Little TJ, 2006, J CLIN ENDOCR METAB, V91, P1916, DOI 10.1210/jc.2005-2220; Maleki D, 2000, ARCH INTERN MED, V160, P2808, DOI 10.1001/archinte.160.18.2808; Maple JT, 2005, AM J GASTROENTEROL, V100, P2681, DOI 10.1111/j.1572-0241.2005.00334.x; MCCALLUM RW, 1983, DIABETES CARE, V6, P463, DOI 10.2337/diacare.6.5.463; MEYER JH, 1981, GASTROENTEROLOGY, V80, P1489; OBRIEN MD, 1995, GASTROENTEROLOGY, V108, P1024, DOI 10.1016/0016-5085(95)90199-X; Park MI, 2006, AM J GASTROENTEROL, V101, P1129, DOI 10.1111/j.1572-0241.2006.00640.x; Parkman HP, 2004, GASTROENTEROLOGY, V127, P1592, DOI 10.1053/j.gastro.2004.09.055; Patterson D, 1999, AM J GASTROENTEROL, V94, P1230, DOI 10.1111/j.1572-0241.1999.00456.x; Ratner RE, 2004, DIABETIC MED, V21, P1204, DOI 10.1111/j.1464-5491.2004.01319.x; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; RICHARDS RD, 1993, AM J GASTROENTEROL, V88, P203; Silvers D, 1998, CLIN THER, V20, P438, DOI 10.1016/S0149-2918(98)80054-4; Soykan I, 1998, DIGEST DIS SCI, V43, P2398, DOI 10.1023/A:1026665728213; Soykan I, 1997, AM J GASTROENTEROL, V92, P976; Talley NJ, 2001, AM J GASTROENTEROL, V96, P71; Talley NJ, 2001, AM J GASTROENTEROL, V96, P1033; Tougas G, 2000, AM J GASTROENTEROL, V95, P78; Vella A, 2002, NEUROGASTROENT MOTIL, V14, P123, DOI 10.1046/j.1365-2982.2002.00311.x; Viramontes BE, 2001, NEUROGASTROENT MOTIL, V13, P567, DOI 10.1046/j.1365-2982.2001.00288.x; Wang CK, 2004, TECHNOVATION, V24, P163, DOI 10.1016/S0166-4972(02)00016-0; Watkins CC, 2000, J CLIN INVEST, V106, P803, DOI 10.1172/JCI8273C1; Watkins CC, 2000, J CLIN INVEST, V106, P373, DOI 10.1172/JCI8273	54	199	242	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					820	829		10.1056/NEJMcp062614	http://dx.doi.org/10.1056/NEJMcp062614			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314341				2022-12-28	WOS:000244326700008
J	Kaufman, DS; Saksena, MA; Young, RH; Tabatabaei, S				Kaufman, Donald S.; Saksena, Mansi A.; Young, Robert H.; Tabatabaei, Shahin			A 28-year-old man with a mass in the testis - Mixed germ-cell tumor (embryonal carcinoma, teratoma, and scant yolk-sac tumor).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPH-NODE DISSECTION; LONG-TERM SURVIVORS; TESTICULAR CANCER; CLINICAL STAGE; CHEMOTHERAPY; RISK; DIAGNOSIS; TOXICITY; SURVEILLANCE; IMPACT		Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Urol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Kaufman, DS (corresponding author), Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA.							Albers P, 2003, J CLIN ONCOL, V21, P1505, DOI 10.1200/JCO.2003.07.169; Bokemeyer C, 1996, J CLIN ONCOL, V14, P2923, DOI 10.1200/JCO.1996.14.11.2923; BOSL GJ, 1986, J CLIN ONCOL, V4, P1684, DOI 10.1200/JCO.1986.4.11.1684; BOSL GJ, 1981, LANCET, V2, P970; Divrik RT, 2006, J UROLOGY, V176, P1424, DOI 10.1016/j.juro.2006.06.012; Emerson RE, 2005, SEMIN DIAGN PATHOL, V22, P33, DOI 10.1053/j.semdp.2005.11.003; Ernst D Scott, 2005, Can J Urol, V12, P2575; GREENE FL, 2002, AJCC CANC STAGING MA, P317; Harisinghani MG, 2005, UROLOGY, V66, P1066, DOI 10.1016/j.urology.2005.05.049; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Mead GM, 1997, J CLIN ONCOL, V15, P594; Meinardi MT, 2000, J CLIN ONCOL, V18, P1725, DOI 10.1200/JCO.2000.18.8.1725; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; PROUT GR, 1984, AM FAM PHYSICIAN, V29, P205; Spermon JR, 2002, UROLOGY, V59, P923, DOI 10.1016/S0090-4295(02)01528-5; Steingart R, 2005, J CLIN ONCOL, V23, P9051, DOI 10.1200/JCO.2005.04.1731; Stephenson AJ, 2005, J CLIN ONCOL, V23, P2781, DOI 10.1200/JCO.2005.07.132; Studer UE, 2000, J UROLOGY, V163, P1785, DOI 10.1016/S0022-5347(05)67543-X; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Ulbright TM, 2005, AM J SURG PATHOL, V29, P500, DOI 10.1097/01.pas.0000155146.60670.3f; Ulbright TM, 1999, ATLAS TUMOR PATHOLOG; VOGELZANG NJ, 1981, ANN INTERN MED, V95, P288, DOI 10.7326/0003-4819-95-3-288; Weijl NI, 2000, J CLIN ONCOL, V18, P2169, DOI 10.1200/JCO.2000.18.10.2169	23	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					842	849		10.1056/NEJMcpc069037	http://dx.doi.org/10.1056/NEJMcpc069037			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314344				2022-12-28	WOS:000244326700012
J	Lowes, MA; Bowcock, AM; Krueger, JG				Lowes, Michelle A.; Bowcock, Anne M.; Krueger, James G.			Pathogenesis and therapy of psoriasis	NATURE			English	Review							T-CELL; DENDRITIC CELLS; HAPLOTYPE ANALYSIS; PLAQUE PSORIASIS; HLA-C; SUSCEPTIBILITY; SKIN; GENE; ACTIVATION; EXPRESSION	Psoriasis is one of the most common human skin diseases and is considered to have key genetic underpinnings. It is characterized by excessive growth and aberrant differentiation of keratinocytes, but is fully reversible with appropriate therapy. The trigger of the keratinocyte response is thought to be activation of the cellular immune system, with T cells, dendritic cells and various immune-related cytokines and chemokines implicated in pathogenesis. The newest therapies for psoriasis target its immune components and may predict potential treatments for other inflammatory human diseases.	Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Rockefeller University; Washington University (WUSTL)	Krueger, JG (corresponding author), Rockefeller Univ, Invest Dermatol Lab, 1230 York Ave,Box 178, New York, NY 10021 USA.	jgk@rockefeller.edu	; Lowes, Michelle A/G-9585-2016	Bowcock, Anne/0000-0001-8691-9090; Lowes, Michelle A/0000-0003-4256-478X				Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Birnbaum RY, 2006, NAT GENET, V38, P749, DOI 10.1038/ng1813; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Boyman O, 2005, BRIT J DERMATOL, V152, P1211, DOI 10.1111/j.1365-2133.2005.06701.x; Boyman O, 2004, J EXP MED, V199, P731, DOI 10.1084/jem.20031482; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chen DM, 2004, J AM ACAD DERMATOL, V50, pP1, DOI 10.1016/j.jaad.2003.10.008; Christensen TE, 2006, J INVEST DERMATOL, V126, P2397, DOI 10.1038/sj.jid.5700489; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; ELDER JT, 1994, ARCH DERMATOL, V130, P216, DOI 10.1001/archderm.130.2.216; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Finch PW, 1997, AM J PATHOL, V151, P1619; Foerster J, 2004, J INVEST DERMATOL, V122, P61, DOI 10.1046/j.0022-202X.2003.22104.x; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Gottlieb AB, 2005, BRIT J DERMATOL, V152, P1219, DOI 10.1111/j.1365-2133.2005.06661.x; Gottlieb AB, 2005, NAT REV DRUG DISCOV, V4, P19, DOI 10.1038/nrd1607; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Haider AS, 2006, J INVEST DERMATOL, V126, P912, DOI 10.1038/sj.jid.5700183; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Huffmeier U, 2006, J MED GENET, V43, P517, DOI 10.1136/jmg.2005.037515; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Koks S, 2004, GENES IMMUN, V5, P662, DOI 10.1038/sj.gene.6364141; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Kruger-Krasagakis S, 2006, BRIT J DERMATOL, V154, P460, DOI 10.1111/j.1365-2133.2005.07078.x; Larregina AT, 2005, J INVEST DERMATOL, V124, P1, DOI 10.1111/j.1523-1747.2004.23554.x; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; Lew W, 2004, BRIT J DERMATOL, V150, P668, DOI 10.1111/j.0007-0963.2004.05891.x; Liu Y, 2007, GENES IMMUN, V8, P1, DOI 10.1038/sj.gene.6364351; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nickoloff BJ, 2000, J DERMATOL SCI, V24, P212, DOI 10.1016/S0923-1811(00)00120-1; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Papp KA, 2006, ARCH DERMATOL RES, V298, P7, DOI 10.1007/s00403-006-0660-6; PRINZ JC, 1994, EUR J IMMUNOL, V24, P593, DOI 10.1002/eji.1830240315; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Tsunemi Y, 2002, J DERMATOL SCI, V30, P161, DOI 10.1016/S0923-1811(02)00072-5; Veal CD, 2002, AM J HUM GENET, V71, P554, DOI 10.1086/342289; Villadsen LS, 2003, J CLIN INVEST, V112, P1571, DOI 10.1172/JCI200318986; Vugmeyster Y, 2004, CLIN IMMUNOL, V113, P38, DOI 10.1016/j.clim.2004.06.001; Wang F, 2006, J INVEST DERMATOL, V126, P1590, DOI 10.1038/sj.jid.5700310; Weinberg Jeffrey M, 2005, J Drugs Dermatol, V4, P544; Weninger W, 2003, SEMIN IMMUNOL, V15, P257, DOI 10.1016/j.smim.2003.08.007; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; ZHENG Y, 2006, NATURE          1224, DOI DOI 10.1038/NATURE05505; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	65	1283	1350	7	292	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					866	873		10.1038/nature05663	http://dx.doi.org/10.1038/nature05663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314973				2022-12-28	WOS:000244341200037
J	Baker, DW; Persell, SD; Thompson, JA; Soman, NS; Burgner, KM; Liss, D; Kmetik, KS				Baker, David W.; Persell, Stephen D.; Thompson, Jason A.; Soman, Neilesh S.; Burgner, Karen M.; Liss, David; Kmetik, Karen S.			Automated review of electronic health records to assess quality of care for outpatients with heart failure	ANNALS OF INTERNAL MEDICINE			English	Article							PAY-FOR-PERFORMANCE; PRACTICE GUIDELINES; PITFALLS	Background: Electronic health records (EHRs) may be used to assess quality of care. Objective: To evaluate the accuracy of automated review of EHR data to measure quality of care for outpatients with heart failure. Design: Observational study of quality of care for heart failure comparing automated review of EHR data with automated review followed by manual review of electronic notes for patients with apparent quality deficits (hybrid review). Setting: An academic general internal medicine clinic with several years' experience using a commercial EHR. Patients: 517 adults with a qualifying International Classification of Diseases, Ninth Revision, diagnosis of heart failure in their EHR data and 2 or more clinic visits over the past 18 months. Measurements: Left ventricular ejection fraction (LVEF), prescription of a G-blocker and an angiotensin-converting enzyme (ACE) inhibitor or angiotensin-receptor blocker (ARB) for patients with left ventricular systolic dysfunction (LVEF < 0.40) and prescription of warfarin for patients with comorbid atrial fibrillation. Results: Performance based on automated review of EHR data was similar to that based on hybrid review for assessing LVEF measurement (94.6% vs. 97.3%), prescription of beta-blockers (90.9% vs. 92.8%), and prescription of ACE inhibitors or ARBs (93.9% vs. 98.7%). However, performance based on automated review was lower than that based on hybrid review for prescription of warfarin for atrial fibrillation (70.4% vs. 93.6%), primarily because automated review did not detect documentation of accepted reasons for not prescribing warfarin. Limitations: The findings may not be applicable to other practices and other EHRs. The authors used EHR data to identify eligible patients, so the study may have excluded some patients with heart failure. Patient charts were manually reviewed only if a provider appeared to fail a quality measure on automated review and did not determine the sensitivity and specificity of automated review according to standard definitions. Conclusions: Automated review of EHR data to measure the quality of care of outpatients with heart failure missed many exclusion criteria for medications documented only in providers' notes. As a result, it sometimes underestimated performance on medication-based quality measures.	Northwestern Univ, Chicago, IL 60611 USA	Northwestern University	Baker, DW (corresponding author), 676 N St,Clair St,Suite 200, Chicago, IL 60611 USA.	dwbaker@northwestern.edu		Liss, David/0000-0001-5505-2922	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS013690] Funding Source: NIH RePORTER; AHRQ HHS [5 U18 HS013690] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM MED ASS, 2006, CPT 2 COD; [Anonymous], 2005, J AM COLL CARDIOL, V46, P1144, DOI 10.1016/j.jacc.2005.07.012; Borzecki AM, 2004, AM J MANAG CARE, V10, P473; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; *CTR MED MED SERV, 2006, QUAL IN GEN INF; *CTR MED MED SERV, 2006, PHSY FOC QUAL IN; *DOQIT, 2006, DOCT OFF QUAL INF TE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Franks P, 2002, MED CARE, V40, P717, DOI 10.1097/00005650-200208000-00011; Institute of Medicine, 2002, LEAD EX COORD GOV RO; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555; *MED PAYM ADV COMM, 2003, REP C VAR INN MED; Milgate K, 2006, HEALTH AFFAIR, V25, P413, DOI 10.1377/hlthaff.25.2.413; Parameswaran AC, 2005, AM HEART J, V149, P921, DOI 10.1016/j.ahj.2004.07.026; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; *PHYS CONS PERF IM, 2006, PERF MEAS HEART FAIL; Santell JP, 2006, JT COMM J QUAL PATIE, V32, P225, DOI 10.1016/S1553-7250(06)32029-6; *SNOMED, 2006, SYST NOM MED CLIN TE; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466	23	66	66	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					270	277		10.7326/0003-4819-146-4-200702200-00006	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310051				2022-12-28	WOS:000244271000005
J	Gandhi, GY; Nuttall, GA; Abel, MD; Mullany, CJ; Schaff, HV; O'Brien, PC; Johnson, MG; Williams, AR; Cutshall, SM; Mundy, LM; Rizza, RA; McMahon, MM				Gandhi, Gunjan Y.; Nuttall, Gregory A.; Abel, Martin D.; Mullany, Charles J.; Schaff, Hartzell V.; O'Brien, Peter C.; Johnson, Matthew G.; Williams, Arthur R.; Cutshall, Susanne M.; Mundy, Lisa M.; Rizza, Robert A.; McMahon, M. Molly			Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOPULMONARY BYPASS; PERIOPERATIVE OUTCOMES; DIABETIC-PATIENTS; CLINICAL-TRIALS; ILL PATIENTS; HYPERGLYCEMIA; MORTALITY; NORMOGLYCEMIA	Background: It is not known whether rigorous intraoperative glycemic control reduces death and morbidity in cardiac surgery patients. Objective: To compare outcomes of intensive insulin therapy during cardiac surgery with those of conventional intraoperative glucose management. Design: A randomized, open-label, controlled trial with blinded end point assessment. Setting: Tertiary care center. Patients: Adults with and without diabetes who were undergoing on-pump cardiac surgery. Measurements: The primary outcome was a composite of death, sternal infections, prolonged ventilation, cardiac arrhythmias, stroke, and renal failure within 30 days after surgery. Secondary outcome measures were length of stay in the intensive care unit and hospital. Intervention: Patients were randomly assigned to receive continuous insulin infusion to maintain intraoperative glucose levels between 4.4 (80 mg/dL) and 5.6 mmol/L (100 mg1dQ (n = 199) or conventional treatment (n = 201). Patients in the conventional treatment group were not given insulin during surgery unless glucose levels were greater than 11.1 mmol/L (> 200 mg/dL). Both groups were treated with insulin infusion to maintain normoglycemia after surgery. Results: Mean glucose concentrations were statistically significantly lower in the intensive treatment group at the end of surgery (6.3 mmol/L [SD, 1.6] [114 mg/dL {SID, 29}] in the intensive treatment group vs. 8.7 mmol/L [SID, 2.3] [157 mg/dL [SID, 421] in the conventional treatment group; difference, -2.4 mmol/L [95% Cl, -2.8 to - 1.9 mmol/L] [-43 mg/dL {Cl, -50 to - 35 mg/dL}]). Eighty two of 185 patients (44%) in the intensive treatment group and 86 of 186 patients (46%) in the conventional treatment group had an event (risk ratio, 1.0 [Cl, 0.8 to 1.2]). More deaths (4 deaths vs. 0 deaths; P = 0.061) and strokes (8 strokes vs. 1 strokes; P = 0.020) occurred in the intensive treatment group. Length of stay in the intensive care unit (mean, 2 days [SID, 2] vs. 2 days [SID, 31; difference, 0 days [Cl, -1 to 1 days]) and in the hospital (mean, 8 days [SD, 4] vs. 8 days [SID, 5]; difference, 0 days [Cl, -1 to 0 days]) was similar for both groups. Limitations: This single-center study used a composite end point and could not examine whether outcomes differed by diabetes status. Conclusions: Intensive insulin therapy during cardiac surgery does not reduce perioperative death or morbidity. The increased incidence of death and stroke in the intensive treatment group raises concern about routine implementation of this intervention.	Mayo Clin, Coll Med, Rochester, MN 55905 USA	Mayo Clinic	Gandhi, GY (corresponding author), Mayo Clin, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	gandhi.gunjan@mayo.edu		Schaff, Hartzell/0000-0003-0994-027X				BLACK CT, 1990, J TRAUMA, V30, P830, DOI 10.1097/00005373-199007000-00012; Carvalho G, 2004, ANESTH ANALG, V99, P319, DOI 10.1213/01.ANE.0000121769.62638.EB; Chaney MA, 1999, ANESTH ANALG, V89, P1091, DOI 10.1213/00000539-199911000-00004; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Doenst T, 2005, J THORAC CARDIOV SUR, V130, P1144, DOI 10.1016/j.jtcvs.2005.05.049; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Garber Alan J, 2004, Endocr Pract, V10 Suppl 2, P4; Groban L, 2002, J CARDIOTHOR VASC AN, V16, P405, DOI 10.1053/jcan.2002.125152; HOSTETTER MK, 1990, DIABETES, V39, P271, DOI 10.2337/diabetes.39.3.271; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; MCMAHON MM, 1995, INFECT DIS CLIN N AM, V9, P1; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Montori VM, 2002, JAMA-J AM MED ASSOC, V288, P2167, DOI 10.1001/jama.288.17.2167; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ouattara A, 2005, ANESTHESIOLOGY, V103, P687, DOI 10.1097/00000542-200510000-00006; Rassias AJ, 2002, ANESTH ANALG, V94, P1113, DOI 10.1097/00000539-200205000-00010; SCHRICKER T, 1998, CLIN INTENSIVE CARE, V9, P118, DOI DOI 10.3109/tcic.9.3.118.128; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	24	388	409	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					233	243		10.7326/0003-4819-146-4-200702200-00002	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310047				2022-12-28	WOS:000244271000001
J	D'Cruz, DP; Khamashta, MA; Hughes, GRV				D'Cruz, David P.; Khamashta, Munther A.; Hughes, Graham R. V.			Systemic lupus erythematosus	LANCET			English	Review							PRIMARY ANTIPHOSPHOLIPID SYNDROME; INTERNATIONAL CONSENSUS STATEMENT; DISEASE-ACTIVITY INDEX; TERM-FOLLOW-UP; MYCOPHENOLATE-MOFETIL; RISK-FACTORS; LONG-TERM; NEUROPSYCHIATRIC MANIFESTATIONS; IMMUNOSUPPRESSIVE THERAPY; CLASSIFICATION CRITERIA	Systemic lupus erythematosus is an autoimmune connective-tissue disorder with a wide range of clinical features, which predominantly affects women, especially from certain ethnic groups. Diagnosis is based on clinical assessment supported by investigations, including the finding of autoantibodies. Treatments range from antimalarial agents to corticosteroids and immunosuppressive agents. This Seminar draws attention to advances in the epidemiology, genetics, cardiovascular risks, lupus nephritis, CNS disease, the antiphospholipid syndrome, assessment of disease activity and damage, and pregnancy related and quality of life issues. New therapeutic approaches, such as biological agents and mycophenolate mofetil, will also be discussed.	St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	D'Cruz, DP (corresponding author), St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England.	david.d'cruz@kcli.ac.uk						Anolik JH, 2003, ARTHRITIS RHEUM, V48, P455, DOI 10.1002/art.10764; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Asherson RA, 2003, LUPUS, V12, P530, DOI 10.1191/0961203303lu394oa; ASHERSON RA, 1990, J RHEUMATOL, V17, P1292; Baron MA, 2005, ANN RHEUM DIS, V64, P144, DOI 10.1136/ard.2003.016204; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Burt RK, 2006, JAMA-J AM MED ASSOC, V295, P527, DOI 10.1001/jama.295.5.527; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Carmona F, 2005, AM J REPROD IMMUNOL, V53, P182, DOI 10.1111/j.1600-0897.2005.00263.x; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Chan TM, 2005, J AM SOC NEPHROL, V16, P1076, DOI 10.1681/ASN.2004080686; Contreras G, 2004, NEW ENGL J MED, V350, P971, DOI 10.1056/NEJMoa031855; Cooper GS, 2004, J RHEUMATOL, V31, P1928; Cooper GS, 2002, ARTHRITIS RHEUM, V46, P1830, DOI 10.1002/art.10365; Costedoat-Chalumeau N, 2003, ARTHRITIS RHEUM, V48, P3207, DOI 10.1002/art.11304; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Cuadrado MJ, 2000, MEDICINE, V79, P57, DOI 10.1097/00005792-200001000-00006; D'Cruz DP, 2004, J RHEUMATOL, V31, P280; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; de Carvalho MRP, 2005, ARTHRIT RHEUM-ARTHR, V53, P838, DOI 10.1002/art.21605; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Dorner T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1942; El-Magadmi M, 2004, CIRCULATION, V110, P399, DOI 10.1161/01.CIR.0000136807.78534.50; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Fujii Y, 2006, AUTOIMMUN REV, V5, P143, DOI 10.1016/j.autrev.2005.09.004; Galie N, 2005, LUPUS, V14, P713, DOI 10.1191/0961203305lu2206oa; George J, 1997, LUPUS, V6, P559, DOI 10.1177/096120339700600701; Ginzler EM, 2005, NEW ENGL J MED, V353, P2219, DOI 10.1056/NEJMoa043731; Girardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gladman DD, 2002, J RHEUMATOL, V29, P288; Gomez-Puerta JA, 2005, MEDICINE, V84, P225, DOI 10.1097/01.md.0000172074.53583.ea; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gross AJ, 2005, J IMMUNOL, V174, P6599, DOI 10.4049/jimmunol.174.11.6599; HAU J, 2006, ARTHRITIS RHEUM, V54, P1906; Houssiau FA, 2004, ARTHRITIS RHEUM-US, V50, P3934, DOI 10.1002/art.20666; Houssiau FA, 2002, ARTHRITIS RHEUM-US, V46, P2121, DOI 10.1002/art.10461; Hughes GRV, 2003, ANN RHEUM DIS, V62, P1127, DOI 10.1136/ard.2003.006163; Hughes GRV, 2003, POSTGRAD MED J, V79, P81, DOI 10.1136/pmj.79.928.81; Hughes GRV, 2001, LUPUS, V10, P778, DOI 10.1177/096120330101001103; Ibanez D, 2003, J RHEUMATOL, V30, P1977; Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624; Johnson SR, 2004, LUPUS, V13, P506, DOI 10.1191/0961203303lu1051oa; Jump RL, 2005, J RHEUMATOL, V32, P1699; Lampropoulos CE, 2005, ARTHRITIS RHEUM-US, V52, P841, DOI 10.1002/art.20957; Leandro MJ, 2002, ARTHRITIS RHEUM-US, V46, P2673, DOI 10.1002/art.10541; Leong KP, 2005, RHEUMATOLOGY, V44, P1267, DOI 10.1093/rheumatology/keh605; Levine SR, 2004, JAMA-J AM MED ASSOC, V291, P576, DOI 10.1001/jama.291.5.576; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; McClain MT, 2004, ARTHRITIS RHEUM-US, V50, P1226, DOI 10.1002/art.20120; Medina G, 2003, ANN RHEUM DIS, V62, P607, DOI 10.1136/ard.62.7.607; Meier CR, 1998, J RHEUMATOL, V25, P1515; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mok CC, 2001, SEMIN ARTHRITIS RHEU, V30, P426, DOI 10.1053/sarh.2001.22498; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; Morelli S, 2003, LUPUS, V12, P805, DOI 10.1191/0961203303lu468oa; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; Ohlenschlaeger T, 2004, NEW ENGL J MED, V351, P260, DOI 10.1056/NEJMoa033122; Parks CG, 2002, ARTHRITIS RHEUM-US, V46, P1840, DOI 10.1002/art.10368; Peterson PL, 2003, LUPUS, V12, P897, DOI 10.1191/0961203303lu499oa; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ruiz-Irastorza G, 2001, LANCET, V357, P1027, DOI 10.1016/S0140-6736(00)04239-2; Ruiz-Irastorza G, 2004, LUPUS, V13, P679, DOI 10.1191/0961203304lu1099oa; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Sanchez-Guerrero J, 2005, NEW ENGL J MED, V353, P2539, DOI 10.1056/NEJMoa050817; SanchezGuerrero J, 1997, ARTHRITIS RHEUM, V40, P804, DOI 10.1002/art.1780400505; SANCHEZGUERRERO J, 1995, ANN INTERN MED, V122, P430, DOI 10.7326/0003-4819-122-6-199503150-00005; Sangle S, 2005, ANN RHEUM DIS, V64, P147, DOI 10.1136/ard.2004.020743; Sangle S, 2004, ANN RHEUM DIS, V63, P1241, DOI 10.1136/ard.2003.016105; Sangle SR, 2003, ANN RHEUM DIS, V62, P999, DOI 10.1136/ard.62.10.999; Sanna G, 2003, J RHEUMATOL, V30, P985; Shoenfeld Y, 2004, J RHEUMATOL, V31, P1344; Statkute L, 2005, BLOOD, V106, P2700, DOI 10.1182/blood-2005-01-0330; Stoll T, 2004, RHEUMATOLOGY, V43, P1039, DOI 10.1093/rheumatology/keh238; Sundar K, 2004, J AUTOIMMUN, V23, P127, DOI 10.1016/j.jaut.2004.06.001; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; Tandon A, 2004, ARTHRITIS RHEUM-US, V50, P3941, DOI 10.1002/art.20638; Tektonidou MG, 2003, ARTHRITIS RHEUM-US, V48, P732, DOI 10.1002/art.10835; Tektonidou MG, 2001, ANN RHEUM DIS, V60, P43, DOI 10.1136/ard.60.1.43; Tench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289; Trager J, 2001, CURR OPIN RHEUMATOL, V13, P345, DOI 10.1097/00002281-200109000-00002; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; Urowitz MB, 2005, J RHEUMATOL, V32, P1467; Vigna-Perez M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1954; Wajed J, 2004, RHEUMATOLOGY, V43, P7, DOI 10.1093/rheumatology/keg436; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Zandman-Goddard G, 2005, CLIN REV ALLERG IMMU, V29, P219, DOI 10.1385/CRIAI:29:3:219	93	547	612	1	75	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					587	596		10.1016/S0140-6736(07)60279-7	http://dx.doi.org/10.1016/S0140-6736(07)60279-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138MZ	17307106				2022-12-28	WOS:000244368000033
J	Leung, WK; Bjarnason, I; Wong, VWS; Sung, JJY; Chan, FKL				Leung, Wai K.; Bjarnason, Ingvar; Wong, Vincent W. S.; Sung, Joseph J. Y.; Chan, Francis K. L.			Small bowel enteropathy associated with chronic low-dose aspirin therapy	LANCET			English	Editorial Material							NSAID		Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Shatin, Hong Kong, Peoples R China; Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Kings Coll Hosp NHS Trust, Dept Gastroenterol, London SE5 9PJ, England	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Leung, WK (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	wkleung@cuhk.edu.hk	Wong, Vincent WS/K-3864-2014; Sung, Joseph J. Y./R-3203-2018; Chan, Francis K. L./F-4851-2010; Leung, Wai Keung/B-8140-2011	Wong, Vincent WS/0000-0003-2215-9410; Sung, Joseph J. Y./0000-0003-3125-5199; Chan, Francis K. L./0000-0001-7388-2436; Leung, Wai Keung/0000-0002-5993-1059				BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Laine L, 2003, GASTROENTEROLOGY, V124, P288, DOI 10.1053/gast.2003.50054; MORRIS AJ, 1994, ALIMENT PHARM THERAP, V8, P343	5	48	51	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 17	2007	369	9561					614	614		10.1016/S0140-6736(07)60282-7	http://dx.doi.org/10.1016/S0140-6736(07)60282-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138MZ	17307109				2022-12-28	WOS:000244368000036
J	Heinze, S; Homberg, U				Heinze, Stanley; Homberg, Uwe			Maplike representation of celestial E-vector orientations in the brain of an insect	SCIENCE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; LIGHT-SENSITIVE NEURONS; ANTERIOR OPTIC TUBERCLE; TETHERED FLYING LOCUSTS; CENTRAL COMPLEX; HEAD-DIRECTION; DROSOPHILA-MELANOGASTER; POLARIZATION VISION; CONNECTIONS; CORTEX	For many insects, the polarization pattern of the blue sky serves as a compass cue for spatial navigation. E-vector orientations are detected by photoreceptors in a dorsal rim area of the eye. Polarized-light signals from both eyes are finally integrated in the central complex, a brain area consisting of two subunits, the protocerebral bridge and the central body. Here we show that a topographic representation of zenithal E-vector orientations underlies the columnar organization of the protocerebral bridge in a locust. The maplike arrangement is highly suited to signal head orientation under the open sky.	Univ Marburg, Dept Biol, D-35032 Marburg, Germany	Philipps University Marburg	Homberg, U (corresponding author), Univ Marburg, Dept Biol, D-35032 Marburg, Germany.	homberg@staff.uni-marburg.de	Homberg, Uwe/AFH-8214-2022; Heinze, Stanley/I-4440-2019	Homberg, Uwe/0000-0002-8229-7236; Heinze, Stanley/0000-0002-8145-3348				Batschelet E., 1981, CIRCULAR STAT BIOL; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Chisum HJ, 2004, NEURAL NETWORKS, V17, P681, DOI 10.1016/j.neunet.2004.05.002; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Homberg U, 2003, J COMP NEUROL, V462, P415, DOI 10.1002/cne.10771; Homberg U, 1997, J COMP NEUROL, V386, P329; Horvath G., 2004, POLARIZED LIGHT ANIM; KNUDSEN EI, 1987, ANNU REV NEUROSCI, V10, P41, DOI 10.1146/annurev.ne.10.030187.000353; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; Mappes M, 2007, J COMP PHYSIOL A, V193, P43, DOI 10.1007/s00359-006-0166-x; Mittelstaedt H, 2000, BIOL CYBERN, V83, P261, DOI 10.1007/s004220000169; Mooser F, 2004, NAT NEUROSCI, V7, P872, DOI 10.1038/nn1287; Muller M, 1997, CELL TISSUE RES, V288, P159, DOI 10.1007/s004410050803; Pfeiffer K, 2005, J NEUROPHYSIOL, V94, P3903, DOI 10.1152/jn.00276.2005; PFEIFFER K, P 6 M GERM NEUR SOC, P218; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; Vitzthum H, 2002, J NEUROSCI, V22, P1114, DOI 10.1523/JNEUROSCI.22-03-01114.2002; Wehner R, 2001, J EXP BIOL, V204, P2589; WILLIAMS JLD, 1975, J ZOOL, V176, P67; Zar JH., 1999, BIOSTAT ANAL, V663rd	25	240	249	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					995	997		10.1126/science.1135531	http://dx.doi.org/10.1126/science.1135531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303756				2022-12-28	WOS:000244229800044
J	Jacques, V; Wu, E; Grosshans, F; Treussart, F; Grangier, P; Aspect, A; Roch, JF				Jacques, Vincent; Wu, E.; Grosshans, Frederic; Treussart, Francois; Grangier, Philippe; Aspect, Alain; Roch, Jean-Francois			Experimental realization of Wheeler's delayed-choice gedanken experiment	SCIENCE			English	Article							WHICH-WAY INFORMATION; SINGLE-PHOTON SOURCE; FRINGE VISIBILITY; QUANTUM; WAVE; CENTERS; STATE; LIGHT	Wave-particle duality is strikingly illustrated by Wheeler's delayed-choice gedanken experiment, where the configuration of a two-path interferometer is chosen after a single-photon pulse has entered it: Either the interferometer is closed ( that is, the two paths are recombined) and the interference is observed, or the interferometer remains open and the path followed by the photon is measured. We report an almost ideal realization of that gedanken experiment with single photons allowing unambiguous which-way measurements. The choice between open and closed configurations, made by a quantum random number generator, is relativistically separated from the entry of the photon into the interferometer.	Ecole Normale Super, Lab Photon Quantique & Mol, UMR 8537, F-94235 Cachan, France; E China Normal Univ, Key Lab Opt & Magnet Resonance Spect, Shanghai 200062, Peoples R China; CNRS, Lab Charles Fabry, Inst Opt, UMR 8501, F-91127 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; East China Normal University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Roch, JF (corresponding author), Ecole Normale Super, Lab Photon Quantique & Mol, UMR 8537, F-94235 Cachan, France.	roch@physique.ens-cachan.fr	Jacques, Vincent/D-3881-2014; TREUSSART, François/M-3274-2013; Wu, E/A-3207-2012	TREUSSART, François/0000-0002-1755-0688; Grosshans, Frederic/0000-0001-8170-9668				Aichele T, 2005, AIP CONF PROC, V750, P35, DOI 10.1063/1.1874555; Alleaume R, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/092; Alley C. O., 1987, P 2 INT S FDN QUANT, P36; [Anonymous], [No title captured]; Bachor H.A., 2004, GUIDE EXPT QUANTUM O; BALDZUHN J, 1989, Z PHYS B CON MAT, V77, P347, DOI 10.1007/BF01313681; Bell J. S., 1987, SPEAKABLE UNSPEAKABL; Beveratos A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187901; Beveratos A, 2002, EUR PHYS J D, V18, P191, DOI 10.1140/epjd/e20020023; Brouri R, 2000, OPT LETT, V25, P1294, DOI 10.1364/OL.25.001294; Durr S, 1998, PHYS REV LETT, V81, P5705, DOI 10.1103/PhysRevLett.81.5705; Englert BG, 1996, PHYS REV LETT, V77, P2154, DOI 10.1103/PhysRevLett.77.2154; Feynman R. P., 1965, LECT PHYS; GRANGIER P, 1986, EUROPHYS LETT, V1, P173, DOI 10.1209/0295-5075/1/4/004; GRANGIER P, 1986, THESIS I OPTIQUE U P; Greenstein G., 1997, QUANTUM CHALLENGE; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; HELLMUT I, 1987, PHYS REV A, V72, P2533; Jacques V, 2005, EUR PHYS J D, V35, P561, DOI 10.1140/epjd/e2005-00201-y; Jelezko F, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.041802; Kawai T, 1998, NUCL INSTRUM METH A, V410, P259, DOI 10.1016/S0168-9002(98)00263-0; Kim YH, 2000, PHYS REV LETT, V84, P1, DOI 10.1103/PhysRevLett.84.1; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; Lamb W. E., 1969, POLARIZATION MATTER, P363; LawsonDaku BJ, 1996, PHYS REV A, V54, P5042, DOI 10.1103/PhysRevA.54.5042; Schwindt PDD, 1999, PHYS REV A, V60, P4285, DOI 10.1103/PhysRevA.60.4285; Wheeler J. A., 1984, QUANTUM THEORY MEASU, P182; Zeilinger A, 2005, NATURE, V433, P230, DOI 10.1038/nature03280	28	313	321	11	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					966	968		10.1126/science.1136303	http://dx.doi.org/10.1126/science.1136303			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303748	Green Submitted			2022-12-28	WOS:000244229800035
J	Selim, M				Selim, Magdy			Current concepts - Perioperative stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-ARTERY-BYPASS; POSTOPERATIVE ATRIAL-FIBRILLATION; CARDIAC-SURGERY; RANDOMIZED-TRIAL; INTRAARTERIAL THROMBOLYSIS; CARDIOPULMONARY BYPASS; ASYMPTOMATIC PATIENTS; ORAL ANTICOAGULANTS; CAROTID STENOSIS; RISK-FACTOR		Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cerebrovasc Dis, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Selim, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cerebrovasc Dis, 330 Brookline Ave,Palmer 127, Boston, MA 02215 USA.	mselim@bidmc.harvard.edu						Albert AA, 2003, ANN THORAC SURG, V75, P1550, DOI 10.1016/S0003-4975(02)04376-X; Arrowsmith JE, 1998, STROKE, V29, P2357, DOI 10.1161/01.STR.29.11.2357; Birincioglu CL, 1999, J CARDIAC SURG, V14, P417; Bond R, 2004, CEREBROVASC DIS, V18, P37, DOI 10.1159/000078606; Breen Patrick, 2002, Int Anesthesiol Clin, V40, P61; Brooker RF, 1998, ANN THORAC SURG, V65, P1651, DOI 10.1016/S0003-4975(98)00289-6; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Chalela JA, 2001, STROKE, V32, P1365, DOI 10.1161/01.STR.32.6.1365; Charlesworth DC, 2003, ANN THORAC SURG, V76, P436, DOI 10.1016/S0003-4975(03)00528-9; CHARLSON ME, 1990, ANN SURG, V212, P567, DOI 10.1097/00000658-199011000-00003; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; CRYSTAL E, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD00361.PUB2; Das SK, 2000, INT J CARDIOL, V74, P47, DOI 10.1016/S0167-5273(00)00251-5; Dixon B, 2005, CHEST, V128, P229, DOI 10.1378/chest.128.1.229; Dunn AS, 2005, MED DECIS MAKING, V25, P387, DOI 10.1177/0272989X05278432; Dunn AS, 2003, ARCH INTERN MED, V163, P901, DOI 10.1001/archinte.163.8.901; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Epstein AE, 2005, CHEST, V128, p24S, DOI 10.1378/chest.128.2_suppl.24S; Gandhi GY, 2005, MAYO CLIN PROC, V80, P862, DOI 10.4065/80.7.862; Genewein U, 1996, BRIT J HAEMATOL, V92, P479, DOI 10.1046/j.1365-2141.1996.d01-1499.x; GERRATY RP, 1993, STROKE, V24, P1115, DOI 10.1161/01.STR.24.8.1115; Gold JP, 2004, ANN THORAC SURG, V78, P1579, DOI 10.1016/j.athoracsur.2004.05.051; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; GUTIERREZ IZ, 1987, AM SURGEON, V53, P487; Hinterhuber G, 2006, DERMATOL SURG, V32, P632, DOI 10.1111/j.1524-4725.2006.32134.x; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Kam PCA, 1997, ANAESTHESIA, V52, P879, DOI 10.1111/j.1365-2044.1997.136-az0129.x; Krinsley, 2005, MAYO CLIN PROC, V80, P1101; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Lahtinen J, 2004, ANN THORAC SURG, V77, P1241, DOI 10.1016/j.athoracsur.2003.09.077; Lamm G, 2006, J CARDIOTHOR VASC AN, V20, P51, DOI 10.1053/j.jvca.2005.03.026; Larson BJG, 2005, CHEST, V127, P922, DOI 10.1378/chest.127.3.922; Lev-Ran O, 2005, J THORAC CARDIOV SUR, V129, P307, DOI 10.1016/j.jtcvs.2004.06.013; Likosky DS, 2004, HEART SURG FORUM, V7, pE271, DOI 10.1532/HSF98.20041035; Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3; Limburg M, 1998, NEUROLOGY, V50, P895, DOI 10.1212/WNL.50.4.895; Mackey AE, 1997, NEUROLOGY, V48, P896, DOI 10.1212/WNL.48.4.896; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; Maulaz AB, 2005, ARCH NEUROL-CHICAGO, V62, P1217, DOI 10.1001/archneur.62.8.1217; McKhann GM, 2006, STROKE, V37, P562, DOI 10.1161/01.STR.0000199032.78782.6c; Moazami N, 2001, ANN THORAC SURG, V72, P1933, DOI 10.1016/S0003-4975(01)03030-2; Molloy J, 1999, STROKE, V30, P1440, DOI 10.1161/01.STR.30.7.1440; Naylor AR, 2002, EUR J VASC ENDOVASC, V23, P283, DOI 10.1053/ejvs.2002.1609; NOSAN DK, 1993, ANN OTO RHINOL LARYN, V102, P717, DOI 10.1177/000348949310200913; OKEEFE JH, 1993, AM J CARDIOL, V71, P897, DOI 10.1016/0002-9149(93)90903-P; PARAMO JA, 1991, HAEMOSTASIS, V21, P58; Rees K, 2001, COCHRANE DATABASE SY, V1, pCD002138; Restrepo L, 2002, STROKE, V33, P2909, DOI 10.1161/01.STR.0000040408.75704.15; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Sharony R, 2004, J THORAC CARDIOV SUR, V127, P406, DOI 10.1016/j.jtcvs.2003.08.011; Soinne L, 2003, STROKE, V34, P1655, DOI 10.1161/01.STR.0000075605.36068.D9; Taggart DP, 2003, HEART, V89, P897, DOI 10.1136/heart.89.8.897; Turner Brian Keith, 2005, AANA J, V73, P297; van Wermeskerken GK, 2000, ANN THORAC SURG, V69, P1077, DOI 10.1016/S0003-4975(99)01443-5; Wimmer-Greinecker G, 2003, EUR J CARDIO-THORAC, V23, P159, DOI 10.1016/S1010-7940(02)00742-X; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; [No title captured], DOI DOI 10.1002/14651858.CD001458	57	315	348	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					706	713		10.1056/NEJMra062668	http://dx.doi.org/10.1056/NEJMra062668			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301301				2022-12-28	WOS:000244193300008
J	Lord, KM; Turekian, VC				Lord, Kristin M.; Turekian, Vaughan C.			Time for a new era of science diplomacy	SCIENCE			English	Editorial Material								Scientists are among America's most effective diplomats.	George Washington Univ, Elliott Sch Int Affairs, Washington, DC 20052 USA; AAAS, Washington, DC 20005 USA	George Washington University	Turekian, VC (corresponding author), George Washington Univ, Elliott Sch Int Affairs, Washington, DC 20052 USA.	vturekia@aaas.org						DARCY MB, 2005, WASHINGTON TIME 0817; HUGHES, 2007, COMMUNICATION   0105; Lord K. M., 2005, AM POL SCI ASS POL C; *NAT AC SCI NAT AC, 2005, RIS GATH STORM EN EM; National Research Council, 2006, FUND ROL SCI TECHN I; Wang ZY, 1999, HIST STUD PHYS BIOL, V30, P249, DOI 10.2307/27757826; Zogby John, 2004, IMPRESSIONS AM ARABS	7	28	30	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					769	770		10.1126/science.1139880	http://dx.doi.org/10.1126/science.1139880			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134FN	17289962				2022-12-28	WOS:000244069000030
J	Park, HH; Logette, E; Raunser, S; Cuenin, S; Walz, T; Tschopp, J; Wu, H				Park, Hyun Ho; Logette, Emmanuelle; Raunser, Stefan; Cuenin, Solange; Walz, Thomas; Tschopp, Jurg; Wu, Hao			Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex	CELL			English	Article							MUTATIONAL ANALYSIS; PROVIDES INSIGHTS; CELL-DEATH; CASPASE-2; PROTEIN; APOPTOSIS; ACTIVATION; PIDD; SUPERFAMILY; MODEL	Proteins of the death domain (DD) superfamily mediate assembly of oligomeric signaling complexes for the activation of caspases and kinases via unknown mechanisms. Here we report the crystal structure of the PIDD DD and RAIDD DD complex, which forms the core of the caspase-2-activating complex PIDDo-some. Although RAIDD DD and PIDD DD are monomers, they assemble into a complex that comprises seven RAIDD DDs and five PIDD DDs. Despite the use of an asymmetric assembly mechanism, all DDs in the complex are in quasi-equivalent environments. The structure provided eight unique asymmetric interfaces, which can be classified into three types. These three types of interactions together cover a majority of the DD surface. Mutagenesis on almost all interfaces leads to disruption of the assembly, resulting in defective caspase-2 activation. The three types of interactions may represent most, if not all, modes of interactions in the DD superfamily for assembling complexes of different stoichiometry.	Univ Cordoba, Weill Med Coll, New York, NY 10021 USA; Univ Cordoba, Grad Sch Med Sci, New York, NY 10021 USA; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Cornell University; University of Lausanne; Harvard University; Harvard Medical School	Wu, H (corresponding author), Univ Cordoba, Weill Med Coll, New York, NY 10021 USA.	haowu@med.cornell.edu	Raunser, Stefan/AHE-1573-2022; park, hyun ho/D-2627-2011	park, hyun ho/0000-0001-9928-0847; Raunser, Stefan/0000-0001-9373-3016; Walz, Thomas/0000-0003-2606-2835	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050872-06A1, R01 AI050872] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Hill JM, 2004, J BIOL CHEM, V279, P1474, DOI 10.1074/jbc.M304996200; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohl A, 2004, CR BIOL, V327, P1077, DOI 10.1016/j.crvi.2004.08.006; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Park HH, 2006, J MOL BIOL, V357, P358, DOI 10.1016/j.jmb.2005.12.082; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pick R, 2006, BIOCHEM BIOPH RES CO, V349, P1329, DOI 10.1016/j.bbrc.2006.08.176; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Read SH, 2002, J CELL BIOL, V159, P739, DOI 10.1083/jcb.200209004; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Salvesen GS, 2002, ESSAYS BIOCHEM, V38, P9, DOI 10.1042/bse0380009; Sandu C, 2005, J BIOL CHEM, V280, P31974, DOI 10.1074/jbc.M506938200; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Telliez JB, 2000, BBA-PROTEIN STRUCT M, V1478, P280, DOI 10.1016/S0167-4838(00)00029-7; Telliez JB, 2000, J MOL BIOL, V300, P1323, DOI 10.1006/jmbi.2000.3899; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thakar J, 2006, PROTEINS, V63, P413, DOI 10.1002/prot.20895; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tinel A, 2007, EMBO J, V26, P197, DOI 10.1038/sj.emboj.7601473; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Weber CH, 2001, FEBS LETT, V492, P171, DOI 10.1016/S0014-5793(01)02162-7; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	44	208	210	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					533	546		10.1016/j.cell.2007.01.019	http://dx.doi.org/10.1016/j.cell.2007.01.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289572	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000244842700019
J	Prakash, M; Gershenfeld, N				Prakash, Manu; Gershenfeld, Neil			Microfluidic bubble logic	SCIENCE			English	Article							LONG BUBBLES; MOTION; DROPLETS; PRESSURE; SIZE	We demonstrate universal computation in an all-fluidic two-phase microfluidic system. Nonlinearity is introduced into an otherwise linear, reversible, low-Reynolds number flow via bubble-to-bubble hydrodynamic interactions. A bubble traveling in a channel represents a bit, providing us with the capability to simultaneously transport materials and perform logical control operations. We demonstrate bubble logic AND/OR/NOT gates, a toggle flip-flop, a ripple counter, timing restoration, a ring oscillator, and an electro-bubble modulator. These show the nonlinearity, gain, bistability, synchronization, cascadability, feedback, and programmability required for scalable universal computation. With increasing complexity in large-scale microfluidic processors, bubble logic provides an on-chip process control mechanism integrating chemistry and computation.	MIT, Ctr Bits & Atoms, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Prakash, M (corresponding author), MIT, Ctr Bits & Atoms, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	manup@mit.edu	Prakash, Madappa/D-9820-2016	Prakash, Manu/0000-0002-8046-8388				Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Belsterling C.A., 1971, FLUIDIC SYSTEMS DESI; BRETHERTON FP, 1961, J FLUID MECH, V10, P166, DOI 10.1017/S0022112061000160; Chang H., 1975, MAGNETIC BUBBLE TECH; CONWAY A, 1972, GUIDE FLUIDICS; Cristobal G, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2221929; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; Fuerstman MJ, 2007, SCIENCE, V315, P828, DOI 10.1126/science.1134514; FUERSTMAN MJ, 2007, SCIENCE         0104, DOI DOI 10.1126/SCIENCE.1134514; Garstecki P, 2004, APPL PHYS LETT, V85, P2649, DOI 10.1063/1.1796526; Gascoyne PRC, 2004, LAB CHIP, V4, P299, DOI 10.1039/b404130e; Groisman A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.094501; Groisman A, 2003, SCIENCE, V300, P955, DOI 10.1126/science.1083694; He MY, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1997280; Jensen K, 2004, LAB CHIP, V4, p31N, DOI 10.1039/b409797c; Joanicot M, 2005, SCIENCE, V309, P887, DOI 10.1126/science.1112615; Jousse F, 2005, LAB CHIP, V5, P646, DOI 10.1039/b416666c; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; PARK CW, 1992, PHYS FLUIDS A-FLUID, V4, P2335, DOI 10.1063/1.858475; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Steinbock O, 1996, J PHYS CHEM-US, V100, P18970, DOI 10.1021/jp961209v; Tan YC, 2004, LAB CHIP, V4, P292, DOI 10.1039/b403280m; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; THORSEN T, 2002, SCIENCE         0926, DOI DOI 10.1126/SCIENCE.1076996; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vestad T, 2004, APPL PHYS LETT, V84, P5074, DOI 10.1063/1.1764592; Ward T, 2005, ELECTROPHORESIS, V26, P3716, DOI 10.1002/elps.200500173; WONG H, 1995, J FLUID MECH, V292, P95, DOI 10.1017/S0022112095001455; Zheng B, 2003, J AM CHEM SOC, V125, P11170, DOI 10.1021/ja037166v	32	401	419	5	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					832	835		10.1126/science.1136907	http://dx.doi.org/10.1126/science.1136907			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289994	Green Submitted			2022-12-28	WOS:000244069000065
J	Kurakawa, T; Ueda, N; Maekawa, M; Kobayashi, K; Kojima, M; Nagato, Y; Sakakibara, H; Kyozuka, J				Kurakawa, Takashi; Ueda, Nanae; Maekawa, Masahiko; Kobayashi, Kaoru; Kojima, Mikiko; Nagato, Yasuo; Sakakibara, Hitoshi; Kyozuka, Junko			Direct control of shoot meristem activity by a cytokinin-activating enzyme	NATURE			English	Article							RESPONSE REGULATORS; ARABIDOPSIS; BIOSYNTHESIS; EXPRESSION; GENES; RICE; METABOLISM; PLANTS; ISOPENTENYLTRANSFERASE; ENCODES	The growth of plants depends on continuous function of the meristems. Shoot meristems are responsible for all the post-embryonic aerial organs, such as leaves, stems and flowers(1). It has been assumed that the phytohormone cytokinin has a positive role in shoot meristem function(2-4). A severe reduction in the size of meristems in a mutant that is defective in all of its cytokinin receptors has provided compelling evidence that cytokinin is required for meristem activity(5,6). Here, we report a novel regulation of meristem activity, which is executed by the meristem-specific activation of cytokinins. The LONELY GUY ( LOG) gene of rice is required to maintain meristem activity and its loss of function causes premature termination of the shoot meristem. LOG encodes a novel cytokinin-activating enzyme that works in the final step of bioactive cytokinin synthesis. Revising the long-held idea of multistep reactions, LOG directly converts inactive cytokinin nucleotides to the free-base forms, which are biologically active, by its cytokinin-specific phosphoribohydrolase activity. LOG messenger RNA is specifically localized in shoot meristem tips, indicating the activation of cytokinins in a specific developmental domain. We propose the fine-tuning of concentrations and the spatial distribution of bioactive cytokinins by a cytokinin-activating enzyme as a mechanism that regulates meristem activity.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan; RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Okayama Univ, Res inst Bioresources, Okayama 7100046, Japan	University of Tokyo; RIKEN; Okayama University	Kyozuka, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138652, Japan.	sakaki@riken.jp; akyozuka@mail.ecc.u-tokyo.ac.jp	Kojima, Mikiko/D-1459-2017; Kyozuka, Junko/E-7844-2012; Ding, Cheng-Qiang/B-6287-2011; Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492; Kyozuka, Junko/0000-0003-2242-7171				Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; CHEN CM, 1981, PLANT PHYSIOL, V68, P1020, DOI 10.1104/pp.68.5.1020; CHEN CM, 1981, PLANT PHYSIOL, V67, P494, DOI 10.1104/pp.67.3.494; CRESPI M, 1994, J BACTERIOL, V176, P2492, DOI 10.1128/JB.176.9.2492-2501.1994; Faiss M, 1997, PLANT J, V12, P401, DOI 10.1046/j.1365-313X.1997.12020401.x; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Howell SH, 2003, TRENDS PLANT SCI, V8, P453, DOI 10.1016/S1360-1385(03)00191-2; Jain M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-1; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KOUCHI H, 1995, PLANT CELL, V7, P1143, DOI 10.1105/tpc.7.8.1143; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Moriguchi K, 2001, J MOL BIOL, V307, P771, DOI 10.1006/jmbi.2001.4488; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Sakamoto T, 2006, PLANT PHYSIOL, V142, P54, DOI 10.1104/pp.106.085811; Sentoku N, 1999, PLANT CELL, V11, P1651, DOI 10.1105/tpc.11.9.1651; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2006, PLANT BIOLOGY, V8, P371, DOI 10.1055/s-2006-923928; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	30	607	675	14	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					652	655		10.1038/nature05504	http://dx.doi.org/10.1038/nature05504			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287810				2022-12-28	WOS:000244039400045
J	Li, JS; Eisenstein, EL; Grabowski, HG; Reid, ED; Mangum, B; Schulman, KA; Goldsmith, JV; Murphy, MD; Califf, RM; Benjamin, DK				Li, Jennifer S.; Eisenstein, Eric L.; Grabowski, Henry G.; Reid, Elizabeth D.; Mangum, Barry; Schulman, Kevin A.; Goldsmith, John V.; Murphy, M. Dianne; Califf, Robert M.; Benjamin, Daniel K., Jr.			Economic return of clinical trials performed under the pediatric exclusivity program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TREATING DEPRESSION; CHILDREN; ANTIDEPRESSANTS; PATENTS; RISK	Context In 1997, Congress authorized the US Food and Drug Administration (FDA) to grant 6-month extensions of marketing rights through the Pediatric Exclusivity Program if industry sponsors complete FDA-requested pediatric trials. The program has been praised for creating incentives for studies in children and has been criticized as a "windfall" to the innovator drug industry. This critique has been a substantial part of congressional debate on the program, which is due to expire in 2007. Objective To quantify the economic return to industry for completing pediatric exclusivity trials. Design and Setting A cohort study of programs conducted for pediatric exclusivity. Nine drugs that were granted pediatric exclusivity were selected. From the final study reports submitted to the FDA (2002-2004), key elements of the clinical trial design and study operations were obtained, and the cost of performing each study was estimated and converted into estimates of after-tax cash outflows. Three-year market sales were obtained and converted into estimates of after-tax cash inflows based on 6 months of additional market protection. Net economic return ( cash inflows minus outflows) and net return-to-costs ratio ( net economic return divided by cash outflows) for each product were then calculated. Main Outcome Measures Net economic return and net return-to-cost ratio. Results The indications studied reflect a broad representation of the program: asthma, tumors, attention-deficit/hyperactivity disorder, hypertension, depression/ generalized anxiety disorder, diabetes mellitus, gastroesophageal reflux, bacterial infection, and bone mineralization. The distribution of net economic return for 6 months of exclusivity varied substantially among products ( net economic return ranged from -$ 8.9 million to $507.9 million and net return-to-cost ratio ranged from - 0.68 to 73.63). Conclusions The economic return for pediatric exclusivity is variable. As an incentive to complete much-needed clinical trials in children, pediatric exclusivity can generate lucrative returns or produce more modest returns on investment.	Duke Univ, Duke Clin Res Inst, Dept Pediat, Durham, NC 27705 USA; Duke Univ, Dept Econ, Durham, NC 27705 USA; US FDA, Off Policy & Planning, Rockville, MD 20857 USA; US FDA, Off Pediat Therapeut, Rockville, MD 20857 USA; US FDA, Off Commissioner, Rockville, MD 20857 USA	Duke University; Duke University; US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Li, JS (corresponding author), Duke Univ, Duke Clin Res Inst, Dept Pediat, POB 17969, Durham, NC 27705 USA.	jennifer.li@duke.edu			NCRR NIH HHS [UL1 RR024128-01, UL1 RR024128, 1UL 1RR024128-01] Funding Source: Medline; NICHD NIH HHS [K23 HD044799-02, K23 HD044799, 1U10-HD45962-02, HD-044799-02, U10 HD045962-02, U10 HD045962] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD045962, K23HD044799] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barton JH, 2005, JAMA-J AM MED ASSOC, V294, P2075, DOI 10.1001/jama.294.16.2075; Benjamin DK, 2006, J PERINATOL, V26, P290, DOI 10.1038/sj.jp.7211496; Benjamin DK, 2006, JAMA-J AM MED ASSOC, V296, P1266, DOI 10.1001/jama.296.10.1266; Benjamin DK, 2006, ANTIMICROB AGENTS CH, V50, P632, DOI 10.1128/AAC.50.2.632-638.2006; Brent DA, 2004, NEW ENGL J MED, V351, P1598; FINKLER SA, 1994, ISSUES COST ACCOUNTI, P124; Flynn JT, 2004, J PEDIATR-US, V145, P353, DOI 10.1016/j.jpeds.2004.04.009; Grabowski H, 2002, PHARMACOECONOMICS, V20, P11, DOI 10.2165/00019053-200220003-00002; Hampton T, 2004, JAMA-J AM MED ASSOC, V291, P2060, DOI 10.1001/jama.291.17.2060; KAITIN KI, 2005, US PEDIAT STUDIES IN; Kesselheim AS, 2006, JAMA-J AM MED ASSOC, V295, P434, DOI 10.1001/jama.295.4.434; Li JS, 2004, HYPERTENSION, V44, P289, DOI 10.1161/01.HYP.0000138069.68413.f0; Milne C-P., 2001, PEDIAT STUDIES INCEN; Newman TB, 2004, NEW ENGL J MED, V351, P1595; *US FDA, 2007, SUMM MED CLIN PHARM; *US FDA, 2006, PED EXCL LAB CHANG N; Wilson JT, 1999, PEDIATRICS, V104, P585; 1994, FED REG, V59, P64242	18	109	112	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					480	488		10.1001/jama.297.5.480	http://dx.doi.org/10.1001/jama.297.5.480			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284698	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000243999100025
J	Watts, G				Watts, Geoff			One for the album	BRITISH MEDICAL JOURNAL			English	Editorial Material							ULTRASOUND					geoff@scileg.freeserve.co.uk						Campbell S, 2006, ULTRASOUND OBST GYN, V27, P243, DOI 10.1002/uog.2738; Campbell S., 1982, J PSYCHOSOM OBST GYN, V1, P57, DOI [DOI 10.3109/01674828209081226, 10.3109/01674828209081226]; Chervenak FA, 2005, AM J OBSTET GYNECOL, V192, P31, DOI 10.1016/j.ajog.2004.09.024; Dykes K, 2001, J REPROD INFANT PSYC, V19, P95, DOI 10.1080/02646830123343; *FDA CTR DEV RAD H, FET KEEPS VID; Olasky M, WORLD MAGAZINE; Sedgmen B, 2006, ULTRASOUND OBST GYN, V27, P245, DOI 10.1002/uog.2703	7	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					232	233		10.1136/bmj.39106.494931.94	http://dx.doi.org/10.1136/bmj.39106.494931.94			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272561	Green Published			2022-12-28	WOS:000244172400024
J	Grady, EF				Grady, Eileen F.			beta-arrestin, a two-fisted terminator	SCIENCE			English	Editorial Material							RECEPTORS; TRAFFICKING; DEGRADATION		Univ Calif San Francisco, UCSF Ctr Neurobiol Digest Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Grady, EF (corresponding author), Univ Calif San Francisco, UCSF Ctr Neurobiol Digest Dis, San Francisco, CA 94143 USA.	gradye@surgery.ucsf.edu						Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Hardie RC, 2007, J PHYSIOL-LONDON, V578, P9, DOI 10.1113/jphysiol.2006.118372; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Puckerin A, 2006, J BIOL CHEM, V281, P31131, DOI 10.1074/jbc.M605000200; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008	12	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					605	606		10.1126/science.1138505	http://dx.doi.org/10.1126/science.1138505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272707				2022-12-28	WOS:000243909400028
J	Lindenauer, PK; Remus, D; Roman, S; Rothberg, MB; Benjamin, EM; Ma, A; Bratzler, DW				Lindenauer, Peter K.; Remus, Denise; Roman, Sheila; Rothberg, Michael B.; Benjamin, Evan M.; Ma, Allen; Bratzler, Dale W.			Public reporting and pay for performance in hospital quality improvement	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; US HOSPITALS; IMPACT; INCENTIVES; MEDICARE; LESSONS	BACKGROUND: Public reporting and pay for performance are intended to accelerate improvements in hospital care, yet little is known about the benefits of these methods of providing incentives for improving care. METHODS: We measured changes in adherence to 10 individual and 4 composite measures of quality over a period of 2 years at 613 hospitals that voluntarily reported information about the quality of care through a national public-reporting initiative, including 207 facilities that simultaneously participated in a pay-for-performance demonstration project funded by the Centers for Medicare and Medicaid Services; we then compared the pay-for-performance hospitals with the 406 hospitals with public reporting only (control hospitals). We used multivariable modeling to estimate the improvement attributable to financial incentives after adjusting for baseline performance and other hospital characteristics. RESULTS: As compared with the control group, pay-for-performance hospitals showed greater improvement in all composite measures of quality, including measures of care for heart failure, acute myocardial infarction, and pneumonia and a composite of 10 measures. Baseline performance was inversely associated with improvement; in pay-for-performance hospitals, the improvement in the composite of all 10 measures was 16.1% for hospitals in the lowest quintile of baseline performance and 1.9% for those in the highest quintile (P<0.001). After adjustments were made for differences in baseline performance and other hospital characteristics, pay for performance was associated with improvements ranging from 2.6 to 4.1% over the 2-year period. CONCLUSIONS: Hospitals engaged in both public reporting and pay for performance achieved modestly greater improvements in quality than did hospitals engaged only in public reporting. Additional research is required to determine whether different incentives would stimulate more improvement and whether the benefits of these programs outweigh their costs.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Premier Healthcare Informat, Charlotte, NC USA; Ctr Medicare & Medicaid Serv, Baltimore, MD USA; Oklahoma Fdn Med Qual, Oklahoma City, OK USA	Baystate Medical Center; Tufts University; Centers for Medicare & Medicaid Services	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St,P-5931, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Greiver, Michelle/N-8764-2015; Young, Alexander/A-1523-2009	Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213				Agency for Healthcare Research and Quality, 2005, NAT HEALTHC QUAL REP; Berwick DM, 2003, HEALTH AFFAIR, V22, P8, DOI 10.1377/hlthaff.22.6.8; Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; *CMS PREM, 2006, CMS PREM HOSP QUAL I; *DEP HLTH HUM SERV, 2006, HOSP COMP QUAL TOOL; Dudley RA, 1998, MILBANK Q, V76, P649, DOI 10.1111/1468-0009.00109; DUDLEY RA, 2004, AHRQ PUBLICATION; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hibbard JH, 2005, HEALTH AFFAIR, V24, P1150, DOI 10.1377/hlthaff.24.4.1150; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2002, LEAD EX COORD GOV RO; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P2647; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Krumholz HM, 2002, JAMA-J AM MED ASSOC, V287, P1277, DOI 10.1001/jama.287.10.1277; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; Marshall MN, 2000, JAMA-J AM MED ASSOC, V283, P1866, DOI 10.1001/jama.283.14.1866; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Millenson ML, 2004, QUAL SAF HEALTH CARE, V13, P323, DOI 10.1136/qshc.2004.011668; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Robinowitz DL, 2006, ANNU REV PUBL HEALTH, V27, P517, DOI 10.1146/annurev.publhealth.27.021405.102210; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Schauffler HH, 2001, ANNU REV PUBL HEALTH, V22, P69, DOI 10.1146/annurev.publhealth.22.1.69; Vladeck BC, 2004, HEALTH AFFAIR, V23, P285, DOI 10.1377/hlthaff.23.2.285; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Werner RM, 2005, JAMA-J AM MED ASSOC, V293, P1239, DOI 10.1001/jama.293.10.1239; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	31	589	596	1	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					486	496		10.1056/NEJMsa064964	http://dx.doi.org/10.1056/NEJMsa064964			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	131HW	17259444				2022-12-28	WOS:000243860700009
J	Arden, KC				Arden, Karen C.			FoxOs in tumor suppression and stem cell maintenance	CELL			English	Editorial Material							FORKHEAD TRANSCRIPTION FACTOR; NUCLEAR EXPORT; INHIBITORS; MICE	The FoxO transcription factors have been implicated in many processes including tumor suppression and cell death. In this issue, two groups now report on mice that conditionally lack the three predominant FoxO transcription factors. Tothova et al. (2007) demonstrate that FoxOs are critical for the long-term maintenance of hematopoietic stem cells, and Paik et al. (2007) show that FoxOs suppress the formation of hemangiomas and lymphomas in mice.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Arden, KC (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	karden@ucsd.edu						Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; PAIK JH, 2007, CELL; Schroeder FC, 2005, J NAT PROD, V68, P574, DOI 10.1021/np049624z; TOTHOVA Z, 2007, CELL	9	68	73	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					235	237		10.1016/j.cell.2007.01.009	http://dx.doi.org/10.1016/j.cell.2007.01.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254960	Bronze			2022-12-28	WOS:000244420500007
J	Komiyama, T; Sweeney, LB; Schuldiner, O; Garcia, KC; Luo, LQ				Komiyama, Takaki; Sweeney, Lora B.; Schuldiner, Oren; Garcia, K. Christopher; Luo, Liqun			Graded expression of Semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons	CELL			English	Article							REPULSIVE GUIDANCE MOLECULE; DROSOPHILA ANTENNAL LOBE; TRANSMEMBRANE SEMAPHORIN; WIRING SPECIFICITY; AXON GUIDANCE; BRANCH EXTENSION; RETINAL AXONS; RECEPTOR; SYSTEM; MAP	Gradients of axon guidance molecules instruct the formation of continuous neural maps, such as the retinotopic map in the vertebrate visual system. Here we show that molecular gradients can also instruct the formation of a discrete neural map. In the fly olfactory system, axons of 50 classes of olfactory receptor neurons (ORNs) and dendrites of 50 classes of projection neurons (PNs) form one-to-one connections at discrete units called glomeruli. We provide expression, loss- and gain-of-function data to demonstrate that the levels of transmembrane Semaphorin-la (Sema-la), acting cell-autonomously as a receptor or part of a receptor complex, direct the dendritic targeting of PNs along the dorsolateral to ventromedial axis of the antennal lobe. Sema-1a also regulates PN axon targeting in higher olfactory centers. Thus, graded expression of Sema-1a contributes to connection specificity from ORNs to PNs and then to higher brain centers, ensuring proper representation of olfactory information in the brain.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Komiyama, Takaki/0000-0001-9609-4600; Sweeney, Lora/0000-0001-9242-5601; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cramer KS, 2005, HEARING RES, V206, P42, DOI 10.1016/j.heares.2004.11.024; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KOMIYAMA T, 2007, IN PRESS CURR BIOL; Kumanogoh A, 2004, CELL MOL LIFE SCI, V61, P292, DOI 10.1007/s00018-003-3257-7; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; MCGUIRE SE, 2004, SCI STKE, V220, P16; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	57	132	134	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					399	410		10.1016/j.cell.2006.12.028	http://dx.doi.org/10.1016/j.cell.2006.12.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254975	Bronze			2022-12-28	WOS:000244420500022
J	Smith, I				Smith, Ian			Single-molecule catalysis	SCIENCE			English	Editorial Material									Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge	Smith, I (corresponding author), Univ Cambridge, Chem Lab, Lensfield Rd, Cambridge CB2 1EW, England.	i.w.m.smith@bham.ac.uk						Greenwald EE, 2005, J PHYS CHEM A, V109, P6031, DOI 10.1021/jp058041a; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; RAVISHANKARA AR, 1994, J CHEM SOC FARADAY T, V90, P2159, DOI 10.1039/ft9949002159; Smith IWM, 2000, ACCOUNTS CHEM RES, V33, P261, DOI 10.1021/ar990099i; Vohringer-Martinez E, 2007, SCIENCE, V315, P497, DOI 10.1126/science.1134494; WAYNE RP, 2000, CHEM ATMOSPHERES, P164	6	26	26	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					470	471		10.1126/science.1138496	http://dx.doi.org/10.1126/science.1138496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255501				2022-12-28	WOS:000243726600033
J	Vallina, SM; Simo, R				Vallina, Sergio M.; Simo, Rafel			Strong relationship between DMS and the solar radiation dose over the global surface ocean	SCIENCE			English	Article							ATMOSPHERIC SULFUR; DIMETHYLSULFIDE; CLIMATE; SEA	Marine biogenic dimethylsulfide (DMS) is the main natural source of tropospheric sulfur, which may play a key role in cloud formation and albedo over the remote ocean. Through a global data analysis, we found that DMS concentrations are highly positively correlated with the solar radiation dose in the upper mixed layer of the open ocean, irrespective of latitude, plankton biomass, or temperature. This is a necessary condition for the feasibility of a negative feedback in which light-attenuating DMS emissions are in turn driven by the light dose received by the pelagic ecosystem.	CSIC, Inst Ciencias Mar, E-08003 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Vallina, SM (corresponding author), CSIC, Inst Ciencias Mar, Passeig Maritim Barceloneta 37-49, E-08003 Barcelona, Catalonia, Spain.	sergio.vallina@icm.csic.es; rsimo@icm.csic.es		VALLINA, Sergio/0000-0002-1335-9237; Simo, Rafel/0000-0003-3276-7663				Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; BATES TS, 1987, NATURE, V329, P319, DOI 10.1038/329319a0; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Chuck AL, 2002, SCIENCE, V297, P1151, DOI 10.1126/science.1073896; Dacey JWH, 1998, DEEP-SEA RES PT I, V45, P2085, DOI 10.1016/S0967-0637(98)00048-X; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hirsch AI, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002443; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P225, DOI 10.1029/1999GB900065; Meir P, 2006, TRENDS ECOL EVOL, V21, P254, DOI 10.1016/j.tree.2006.03.005; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Simo R, 1999, NATURE, V402, P396, DOI 10.1038/46516; Simo R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001829; Simo R, 2004, CAN J FISH AQUAT SCI, V61, P673, DOI 10.1139/F04-030; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Singh H, 2001, NATURE, V410, P1078, DOI 10.1038/35074067; Sunda W, 2002, NATURE, V418, P317, DOI 10.1038/nature00851; Toole DA, 2006, DEEP-SEA RES PT I, V53, P136, DOI 10.1016/j.dsr.2005.09.003; Toole DA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019581; Vallina SM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002597	24	209	220	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					506	508		10.1126/science.1133680	http://dx.doi.org/10.1126/science.1133680			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255509				2022-12-28	WOS:000243726600044
J	Campbell, A; Bentley, DP; Prescott, RJ; Routledge, PA; Shetty, HGM; Williamson, IJ				Campbell, A.; Bentley, D. P.; Prescott, R. J.; Routledge, P. A.; Shetty, H. G. M.; Williamson, I. J.			Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							1ST EPISODE; VENOUS THROMBOEMBOLISM; THERAPY; DURATION; HEPARIN; RISK	Objective To determine the optimum duration of oral anticoagulant therapy after an episode of deep vein thrombosis or pulmonary embolism, or both. Design Multicentre, prospective, randomised study with follow-up for one year. Setting 46 hospitals in United Kingdom. Participants Patients aged >= 18 with deep vein thrombosis or pulmonary embolism, or both. Interventions Three (n=369) or six months (n=380) of anticoagulation with heparin for five days accompanied and followed by warfarin, with a target international normalised ratio of 2.0-3.5. Main outcome measures Death from deep vein thrombosis or pulmonary embolism; failure to resolve, extension, recurrence of during treatment; recurrence after treatment; and major haemorrhage during treatment. Results In the patients allocated to three months' treatment two died from deep vein thrombosis or pulmonary embolism during or after treatment, compared with three in the six month group. During treatment deep vein thrombosis or pulmonary embolism failed to resolve, extended, or recurred in six patients in the three month group without fatal consequences, compared with 10 in the six month group. After treatment there were 23 nonfatal recurrences in the three month group and 16 in the six month group. Fatal and non-fatal deep vein thrombosis or pulmonary embolism during treatment, and aftertreatment thus occurred in 31(8%) of those who had received three months' anticoagulation compared with 29 (8%) of those who had received six months' (P=0.80, 95% confidence interval for difference -3.1% to 4.7%). There were no fatal haemorrhages during treatment but there were eight major haemorrhages in those treated for six months and none in those treated for three months (P=0.008, -3.5% to -0.7%). Thus 31 (8%) of the patients receiving three months' anticoagulation experienced adverse outcomes as a result of deep vein thrombosis or pulmonary embolism or its treatment compared with 35 (9%) of those receiving six months' (P=0.79, -4.9% to 3.2%). Conclusion For patients in the UK with deep vein thrombosis or pulmonary embolism and no known risk factors for recurrence, there seems to be little, if any, advantage in increasing the duration of anticoagulation from three to six months. Any possible advantage would be small and would need to be judged against the increased risk of haemorrhage associated with the longer duration of treatment with warfarin.	Llandough Hosp, Cardiff CF64 2XX, Wales; Univ Edinburgh, Dept Publ Hlth Sci, Edinburgh, Midlothian, Scotland; Univ Wales Hosp, Cardiff, Wales; Royal Gwent Hosp, Newport NPT 2VB, Gwent, Wales	University of Edinburgh; Cardiff University; Royal Gwent Hospital	Campbell, A (corresponding author), Llandough Hosp, Cardiff CF64 2XX, Wales.	iancampbell@cardiffandvale.wales.nhs.uk						Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; [Anonymous], 1999, STAT MED, V18, P1905; Baglin TP, 2006, BRIT J HAEMATOL, V132, P277, DOI 10.1111/j.1365-2141.2005.05856.x; BARRITT DW, 1960, LANCET, V1, P1309; Bigaroni A, 2000, BLOOD COAGUL FIBRIN, V11, P199, DOI 10.1097/00001721-200011020-00012; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Campbell IA, 2003, THORAX, V58, P470; COON WW, 1969, ANN SURG, V170, P559, DOI 10.1097/00000658-196910000-00007; FENNERTY A, 1988, BMJ-BRIT MED J, V297, P1285, DOI 10.1136/bmj.297.6659.1285; FENNERTY AG, 1987, CLIN LAB HAEMATOL, V9, P17; GALLUS A, 1986, LANCET, V2, P1293; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; HIRSH J, 1995, NEW ENGL J MED, V332, P1710, DOI 10.1056/NEJM199506223322510; HOLMGREN KAJ, 1985, ACTA MED SCAND, V218, P279; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; MORRELL MT, 1963, BRIT MED J, P830, DOI 10.1136/bmj.2.5361.830; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; OSULLIVAN EF, 1972, MED J AUSTRALIA, V2, P1104, DOI 10.5694/j.1326-5377.1972.tb103752.x; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Pearson MG, 1997, THORAX, V52, pS1; Pinede L, 2001, CIRCULATION, V103, P2453; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schulman S, 1999, Wien Med Wochenschr, V149, P66; Schulman S, 2006, J THROMB HAEMOST, V4, P734, DOI 10.1111/j.1538-7836.2006.01795.x; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; SCHULMAN S, 1984, THROMB HAEMOSTASIS, V52, P276; SUDLOW MF, 1992, LANCET, V340, P873; 1988, LANCET, V1, P275	30	102	109	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2007	334	7595					674	677		10.1136/bmj.39098.583356.55	http://dx.doi.org/10.1136/bmj.39098.583356.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	154ON	17289685	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000245517100033
J	Reddy, P; Jang, SY; Segalman, RA; Majumdar, A				Reddy, Pramod; Jang, Sung-Yeon; Segalman, Rachel A.; Majumdar, Arun			Thermoelectricity in molecular junctions	SCIENCE			English	Article							CONDUCTANCE; TRANSISTOR; MICROSCOPY; MONOLAYERS; CELLS	By trapping molecules between two gold electrodes with a temperature difference across them, the junction Seebeck coefficients of 1,4-benzenedithiol (BDT), 4,4'-dibenzenedithiol, and 4,4''-tribenzenedithiol in contact with gold were measured at room temperature to be + 8.7 +/- 2.1 microvolts per kelvin (mu V/K), + 12.9 +/- 2.2 mu V/K, and + 14.2 +/- 3.2 mu V/ K, respectively ( where the error is the full width half maximum of the statistical distributions). The positive sign unambiguously indicates p-type ( hole) conduction in these heterojunctions, whereas the Au Fermi level position for Au-BDT-Au junctions was identified to be 1.2 eV above the highest occupied molecular orbital level of BDT. The ability to study thermoelectricity in molecular junctions provides the opportunity to address these fundamental unanswered questions about their electronic structure and to begin exploring molecular thermoelectric energy conversion.	Univ Calif Berkeley, Appl Sci & Technol Program, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Reddy, P (corresponding author), Univ Calif Berkeley, Appl Sci & Technol Program, Berkeley, CA 94720 USA.	majumdar@me.berkeley.edu; segalman@berkeley.edu		Majumdar, Arunava/0000-0003-4226-9705; Segalman, Rachel/0000-0002-4292-5103				AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; BLATT FJ, 1976, THERMOELECTRIC POWER, P264, DOI DOI 10.1007/978-1-4613-4268-7; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; Damle P, 2002, CHEM PHYS, V281, P171, DOI 10.1016/S0301-0104(02)00496-2; de Boer B, 2003, LANGMUIR, V19, P4272, DOI 10.1021/la0341052; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; Emberly EG, 1998, PHYS REV B, V58, P10911, DOI 10.1103/PhysRevB.58.10911; Humphrey TE, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.096601; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Jang SY, 2006, NANO LETT, V6, P2362, DOI 10.1021/nl0609495; Kushmerick JG, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.086802; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Lyeo HK, 2004, SCIENCE, V303, P816, DOI 10.1126/science.1091600; Mahan GD, 1996, P NATL ACAD SCI USA, V93, P7436, DOI 10.1073/pnas.93.15.7436; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Paulsson M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.241403; POLER JC, 1995, LANGMUIR, V11, P2689, DOI 10.1021/la00007a058; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Shi L, 2002, J HEAT TRANS-T ASME, V124, P329, DOI 10.1115/1.1447939; Taylor J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.138301; Wang RY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358856; WILLIAMS CC, 1990, NATURE, V344, P317, DOI 10.1038/344317a0; Xiao XY, 2004, NANO LETT, V4, P267, DOI 10.1021/nl035000m; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zahid F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245317	26	747	755	9	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 16	2007	315	5818					1568	1571		10.1126/science.1137149	http://dx.doi.org/10.1126/science.1137149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17303718				2022-12-28	WOS:000244934800050
J	Mauri, L; Hsieh, WH; Massaro, JM; Ho, KKL; D'Agostino, R; Cutlip, DE				Mauri, Laura; Hsieh, Wen-hua; Massaro, Joseph M.; Ho, Kalon K. L.; D'Agostino, Ralph; Cutlip, Donald E.			Stent thrombosis in randomized clinical trials of drug-eluting stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; SLOW-RELEASE; VASCULAR BRACHYTHERAPY; BALLOON ANGIOPLASTY; POOLED ANALYSIS; STANDARD STENT; DOUBLE-BLIND; RESTENOSIS; LESIONS	BACKGROUND: Definitions of stent thrombosis that have been used in clinical trials of drug-eluting stents have been restrictive and have not been used in a uniform manner. METHODS: We applied a hierarchical classification of stent thrombosis set by the Academic Research Consortium (ARC) across randomized trials involving 878 patients treated with sirolimus-eluting stents, 1400 treated with paclitaxel-eluting stents, and 2267 treated with bare-metal stents. We then pooled 4 years of follow-up data. All events were adjudicated by an independent clinical-events committee. RESULTS: The cumulative incidence of stent thrombosis according to the original protocol definitions was 1.2% in the sirolimus-stent group versus 0.6% in the bare-metal-stent group (P=0.20; 95% confidence interval [CI], -0.4 to 1.5) and 1.3% in the paclitaxel-stent group versus 0.8% in the bare-metal-stent group (P=0.24; 95% CI, -0.3 to 1.4). The incidence of definite or probable stent thrombosis as defined by the ARC was 1.5% in the sirolimus-stent group versus 1.7% in the bare-metal-stent group (P=0.70; 95% CI, -1.5 to 1.0) and 1.8% in the paclitaxel-stent group versus 1.4% in the bare-metal-stent group (P=0.52; 95% CI, -0.7 to 1.4). The incidence of definite or probable events occurring 1 to 4 years after implantation was 0.9% in the sirolimus-stent group versus 0.4% in the bare-metal-stent group and 0.9% in the paclitaxel-stent group versus 0.6% in the bare-metal-stent group. CONCLUSIONS: The incidence of stent thrombosis did not differ significantly between patients with drug-eluting stents and those with bare-metal stents in randomized clinical trials, although the power to detect small differences in rates was limited.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Clin Res Inst, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Boston Univ, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	Cutlip, DE (corresponding author), Beth Israel Deaconess Med Ctr, Baker 4,185 Pilgrim Rd, Boston, MA 02215 USA.	don.cutlip@hcri.harvard.edu	mauri, laura/GPS-4868-2022	Ho, Kalon/0000-0001-5946-6428; Massaro, Joseph/0000-0002-2682-4812				CAMENZIND E, 2006, SAFETY DRUG ELUTING; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Cutlip DE, 2001, CIRCULATION, V103, P1967; DAEMEN J, IN PRESS LANCET; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Food and Drug Administration, CIRC SYST DEV PAN M; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Mak KH, 1996, J AM COLL CARDIOL, V27, P494, DOI 10.1016/0735-1097(95)00466-1; Moreno R, 2005, J AM COLL CARDIOL, V45, P954, DOI 10.1016/j.jacc.2004.11.065; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nordmann AJ, 2006, EUR HEART J, V27, P2784, DOI 10.1093/eurheartj/ehl282; Ong ATL, 2005, J AM COLL CARDIOL, V45, P2088, DOI 10.1016/j.jacc.2005.02.086; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Popma JJ, 2002, CIRCULATION, V106, P1090, DOI 10.1161/01.CIR.0000027814.96651.72; Schampaert E, 2004, J AM COLL CARDIOL, V43, P1110, DOI 10.1016/j.jacc.2004.01.024; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Waksman R, 2000, J AM COLL CARDIOL, V36, P65, DOI 10.1016/S0735-1097(00)00681-1; Williams DO, 2000, CIRCULATION, V102, P2945	30	1178	1260	0	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 8	2007	356	10					1020	1029		10.1056/NEJMoa067731	http://dx.doi.org/10.1056/NEJMoa067731			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143DC	17296821				2022-12-28	WOS:000244699200006
J	von Mering, C; Hugenholtz, P; Raes, J; Tringe, SG; Doerks, T; Jensen, LJ; Ward, N; Bork, P				von Mering, C.; Hugenholtz, P.; Raes, J.; Tringe, S. G.; Doerks, T.; Jensen, L. J.; Ward, N.; Bork, P.			Quantitative phylogenetic assessment of microbial communities in diverse environments	SCIENCE			English	Article							DNA EXTRACTION; MICROORGANISMS; EVOLUTION; RECONSTRUCTION; METAGENOMICS; PROKARYOTE; CLONING; SAMPLES; VIEW; TREE	The taxonomic composition of environmental communities is an important indicator of their ecology and function. We used a set of protein-coding marker genes, extracted from large-scale environmental shotgun sequencing data, to provide a more direct, quantitative, and accurate picture of community composition than that provided by traditional ribosomal RNA-based approaches depending on the polymerase chain reaction. Mapping marker genes from four diverse environmental data sets onto a reference species phylogeny shows that certain communities evolve faster than others. The method also enables determination of preferred habitats for entire microbial clades and provides evidence that such habitat preferences are often remarkably stable over time.	European Mol Biol Lab, D-69117 Heidelberg, Germany; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Inst Genom Res, Rockville, MD 20850 USA	European Molecular Biology Laboratory (EMBL); United States Department of Energy (DOE); J. Craig Venter Institute	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	peer.bork@embl.de	Bork, Peer/F-1813-2013; Jensen, Lars Juhl/C-6492-2008; raes, jeroen/D-7835-2018; Hugenholtz, Philip/AAD-9138-2019; von Mering, Christian/B-3300-2008	Bork, Peer/0000-0002-2627-833X; Jensen, Lars Juhl/0000-0001-7885-715X; raes, jeroen/0000-0002-1337-041X; Hugenholtz, Philip/0000-0001-5386-7925; von Mering, Christian/0000-0001-7734-9102				Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Doolittle RF, 2005, CURR OPIN STRUC BIOL, V15, P248, DOI 10.1016/j.sbi.2005.04.001; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kauffmann IM, 2004, APPL MICROBIOL BIOT, V64, P665, DOI 10.1007/s00253-003-1528-8; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Luna GM, 2006, ENVIRON MICROBIOL, V8, P308, DOI 10.1111/j.1462-2920.2005.00896.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Strimmer K, 2002, P ROY SOC B-BIOL SCI, V269, P137, DOI 10.1098/rspb.2001.1862; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103	33	243	246	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1126	1130		10.1126/science.1133420	http://dx.doi.org/10.1126/science.1133420			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17272687	Green Submitted			2022-12-28	WOS:000244387600037
J	Arashvand, K				Arashvand, Kayvan			Images in clinical medicine - Central retinal artery occlusion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Southend Hosp, Westcliff On Sea SS0 0RY, Essex, England		Arashvand, K (corresponding author), Southend Hosp, Westcliff On Sea SS0 0RY, Essex, England.	k_arashvand@yahoo.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					841	841		10.1056/NEJMicm054424	http://dx.doi.org/10.1056/NEJMicm054424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314343				2022-12-28	WOS:000244326700010
J	Charrel, RN; de Lamballerie, X; Raoult, D				Charrel, Remi N.; de Lamballerie, Xavier; Raoult, Didier			Chikungunya outbreaks - The globalization of vectorborne diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS		Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France; Univ Aix Marseille 2, Fac Med, Unite Rickettsies, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Charrel, RN (corresponding author), Univ Aix Marseille 2, Fac Med, Unite Virus Emergents, Marseille, France.		RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251				Mudur Ganapati, 2006, BMJ, V333, P773, DOI 10.1136/bmj.333.7572.773-c; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Shirley SM, 2006, PLOS BIOL, V4, P1311, DOI 10.1371/journal.pbio.0040279; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	5	303	324	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					769	771		10.1056/NEJMp078013	http://dx.doi.org/10.1056/NEJMp078013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314335				2022-12-28	WOS:000244326700002
J	Syntichaki, P; Troulinaki, K; Tavernarakis, N				Syntichaki, Popi; Troulinaki, Kostoula; Tavernarakis, Nektarios			eIF4E function in somatic cells modulates ageing in Caenorhabditis elegans	NATURE			English	Article							INITIATION-FACTOR 4E; CALORIC RESTRICTION; OXIDATIVE STRESS; C-ELEGANS; LIFE-SPAN; PROTEIN-SYNTHESIS; TRANSLATION; PHOSPHORYLATION; TURNOVER; KINASE	Regulation of protein synthesis is critical for cell growth and maintenance. Ageing in many organisms, including humans, is accompanied by marked alterations in both general and specific protein synthesis(1). Whether these alterations are simply a corollary of the ageing process or have a causative role in senescent decline remains unclear. An array of protein factors facilitates the tight control of messenger RNA translation initiation(2). The eukaryotic initiation factor 4E (eIF4E), which binds the 7-monomethyl guanosine cap at the 5' end of all nuclear mRNAs, is a principal regulator of protein synthesis(3). Here we show that loss of a specific eIF4E isoform (IFE-2) that functions in somatic tissues(4) reduces global protein synthesis, protects from oxidative stress and extends lifespan in Caenorhabditis elegans. Lifespan extension is independent of the forkhead transcription factor DAF-16, which mediates the effects of the insulin-like signalling pathway on ageing. Furthermore, IFE-2 deficiency further extends the lifespan of long-lived age and daf nematode mutants. Similarly, lack of IFE-2 enhances the long-lived phenotype of clk and dietary-restricted eat mutant animals. Knockdown of target of rapamycin ( TOR), a phosphatidylinositol kinase-related kinase that controls protein synthesis in response to nutrient cues, further increases the longevity of ife-2 mutants. Thus, signalling via eIF4E in the soma is a newly discovered pathway influencing ageing in C. elegans.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Tavernarakis, N (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	tavernarakis@imbb.forth.gr	Tavernarakis, Nektarios/B-9684-2013; Syntichaki, Popi/ABA-7218-2020	Tavernarakis, Nektarios/0000-0002-5253-1466; Syntichaki, Popi/0000-0001-9536-8905				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Amiri A, 2001, DEVELOPMENT, V128, P3899; Arquier N, 2005, CURR BIOL, V15, P19, DOI 10.1016/j.cub.2004.12.037; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; HANSEN M, 2006, AGEING CELL; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; PAN KZ, 2006, AGEING CELL; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5; Reiling JH, 2005, CURR BIOL, V15, P24, DOI 10.1016/j.cub.2004.12.034; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Tavernarakis N, 2002, MECH AGEING DEV, V123, P215, DOI 10.1016/S0047-6374(01)00341-4; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Ward WF, 2000, BIOGERONTOLOGY, V1, P195, DOI 10.1023/A:1010076818119; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	32	253	277	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					922	926		10.1038/nature05603	http://dx.doi.org/10.1038/nature05603			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17277769				2022-12-28	WOS:000244341200051
J	Hibbeln, JR; Davis, JM; Steer, C; Emmett, P; Rogers, I; Williams, C; Golding, J				Hibbeln, Joseph R.; Davis, John M.; Steer, Colin; Emmett, Pauline; Rogers, Imogen; Williams, Cathy; Golding, Jean			Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study	LANCET			English	Article							POLYUNSATURATED FATTY-ACIDS; DIFFICULTIES QUESTIONNAIRE; UNITED-KINGDOM; BIRTH-WEIGHT; FISH INTAKE; SOUTH-WEST; POPULATION; STRENGTHS; CHILDREN; FOOD	Background Seafood is the predominant source of omega-3 fatty acids, which are essential for optimum neural development. However, in the USA, women are advised to limit their seafood intake during pregnancy to 340 g per week. We used the Avon Longitudinal Study of Parents and Children (ALSPAC) to assess the possible benefits and hazards to a child's development of different levels of maternal seafood intake during pregnancy. Methods 11875 pregnant women completed a food frequency questionnaire assessing seafood consumption at 32 weeks' gestation. Multivariable logistic regression models including 28 potential confounders assessing social disadvantage, perinatal, and dietary items were used to compare developmental, behavioural, and cognitive outcomes of the children from age 6 months to 8 years in women consuming none, some (1-340 g per week), and >340 g per week. Findings After adjustment, maternal seafood intake during pregnancy of less than 340 g per week was associated with increased risk of their children being in the lowest quartile for verbal intelligence quotient (IQ) (no seafood consumption, odds ratio [OR] 1.48, 95% Cl 1.16-1.90; some, 1.09, 0.92-1.29; overall trend, p=0.004), compared with mothers who consumed more than 340 g per week. Low maternal seafood intake was also associated with increased risk of suboptimum outcomes for prosocial behaviour, fine motor, communication, and social development scores. For each outcome measure, the lower the intake of seafood during pregnancy, the higher the risk of suboptimum developmental outcome. Interpretation Maternal seafood consumption of less than 340 g per week in pregnancy did not protect children from adverse outcomes; rather, we recorded beneficial effects on child development with maternal seafood intakes of more than 340 g per week, suggesting that advice to limit seafood consumption could actually be detrimental. These results show that risks from the loss of nutrients were greater than the risks of harm from exposure to trace contaminants in 340 g seafood eaten weekly.	US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, Bethesda, MD 20952 USA; Univ Illinois, Chicago, IL USA; Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Bristol	Hibbeln, JR (corresponding author), US Natl Inst Alcohol Abuse & Alcoholism, Lab Membrane Biophys & Biochem, US Natl Inst Hlth, 31 Ctr Dr Rm 31,1B58,MSC 2088, Bethesda, MD 20952 USA.	jhibbeln@mail.nih.gov	Emmett, Pauline/AAL-6815-2021; Robles-Sardin, Alma E/M-7714-2015; Williams, Cathy/K-4919-2015	Robles-Sardin, Alma E/0000-0003-2044-7793; Golding, Jean/0000-0003-2826-3307; Williams, Cathy/0000-0002-9133-2021; Rogers, Imogen/0000-0001-7275-2437; Emmett, Pauline/0000-0003-1076-4779	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9815508] Funding Source: Medline; NIMH NIH HHS [1 P01MH68580-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH068580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000115] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], [No title captured]; Calderon F, 2004, J NEUROCHEM, V90, P1540, DOI 10.1111/j.1471-4159.2004.02808.x; Caldwell B.M., 1979, HOME OBSERVATION MEA; Daniels JL, 2004, EPIDEMIOLOGY, V15, P394, DOI 10.1097/01.ede.0000129514.46451.ce; DWARKA S, 1995, HUM EXP TOXICOL, V14, P451, DOI 10.1177/096032719501400511; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Emond Alan, 2005, Dev Med Child Neurol, V47, P646, DOI 10.1017/S0012162205001271; Erkkola M, 2001, AM J EPIDEMIOL, V154, P466, DOI 10.1093/aje/154.5.466; FAO/WHO, 1994, FAO FOOD NUTR PAP, V57, P1; FRANKENBURG WK, 1967, J PEDIATR-US, V71, P181, DOI 10.1016/S0022-3476(67)80070-2; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Griffiths R, 1984, ABILITIES YOUNG CHIL; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Heron J, 2004, PEDIATRICS, V114, P577, DOI 10.1542/peds.2003-1176-L; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Kodas E, 2004, J NEUROCHEM, V89, P695, DOI 10.1111/j.1471-4159.2004.02401.x; Mahaffey KR, 2004, ENVIRON HEALTH PERSP, V112, P562, DOI 10.1289/ehp.6587; Martinez M, 2001, J MOL NEUROSCI, V16, P309, DOI 10.1385/JMN:16:2-3:309; Ministry of Agriculture Fisheries and Food London (United Kingdom), 1998, FATT AC 7 SUPPL 5 ED, V7; National Research Council, 2000, TOX EFF METH; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Rice DC, 2003, RISK ANAL, V23, P107, DOI 10.1111/1539-6924.00294; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Rogers I, 2003, EUR J CLIN NUTR, V57, P854, DOI 10.1038/sj.ejcn.1601619; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Rojas CV, 2003, INVEST OPHTH VIS SCI, V44, P3170, DOI 10.1167/iovs.02-1138; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; *SCI ADV COMM NUTR, 2004, ADV SEAF CONS BEN RI, P80; Shatenstein B, 1999, ENVIRON RES, V80, pS71, DOI 10.1006/enrs.1998.3925; Simopoulos Artemis P., 1999, Journal of the American College of Nutrition, V18, P487, DOI 10.1046/j.1440-6047.1999.00123.x; *U BRIST SURV DEP, MERC IMP FISH SHELLF; *US DEP HHS, EPA823R04005 US DEP; Wechsler D., 1992, WISC IIIUK WECHSLER; Whalley LJ, 2004, AM J CLIN NUTR, V80, P1650, DOI 10.1093/ajcn/80.6.1650; Willatts P, 1998, LANCET, V352, P688, DOI 10.1016/S0140-6736(97)11374-5; Williams C, 2001, AM J CLIN NUTR, V73, P316	41	673	708	1	153	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					578	585		10.1016/S0140-6736(07)60277-3	http://dx.doi.org/10.1016/S0140-6736(07)60277-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307104				2022-12-28	WOS:000244368000031
J	Creel, S; Christianson, D; Liley, S; Winnie, JA				Creel, Scott; Christianson, David; Liley, Stewart; Winnie, John A., Jr.			Predation risk affects reproductive physiology and demography of elk	SCIENCE			English	Article							NATIONAL-PARK; YELLOWSTONE; WOLVES		Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Creel, S (corresponding author), Montana State Univ, Dept Ecol, 310 Lewis Hall, Bozeman, MT 59717 USA.	screel@montana.edu						Barber Shannon M., 2005, Yellowstone Science, V13, P37; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P306; Varley N, 2006, ECOL MODEL, V193, P315, DOI 10.1016/j.ecolmodel.2005.09.001; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Winnie J, 2006, BEHAV ECOL SOCIOBIOL, V61, P277, DOI 10.1007/s00265-006-0258-1	10	382	389	3	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					960	960		10.1126/science.1135918	http://dx.doi.org/10.1126/science.1135918			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303746				2022-12-28	WOS:000244229800033
J	Kemp, AIS; Hawkesworth, CJ; Foster, GL; Paterson, BA; Woodhead, JD; Hergt, JM; Gray, CM; Whitehouse, MJ				Kemp, A. I. S.; Hawkesworth, C. J.; Foster, G. L.; Paterson, B. A.; Woodhead, J. D.; Hergt, J. M.; Gray, C. M.; Whitehouse, M. J.			Magmatic and crustal differentiation history of granitic rocks from Hf-O isotopes in zircon	SCIENCE			English	Article							LACHLAN FOLD BELT; CONTINENTAL-CRUST; SIERRA-NEVADA; MIXING MODEL; S-TYPE; ASSIMILATION; LAVAS	Granitic plutonism is the principal agent of crustal differentiation, but linking granite emplacement to crust formation requires knowledge of the magmatic evolution, which is notoriously difficult to reconstruct from bulk rock compositions. We unlocked the plutonic archive through hafnium (Hf) and oxygen (O) isotope analysis of zoned zircon crystals from the classic hornblende-bearing (I-type) granites of eastern Australia. This granite type forms by the reworking of sedimentary materials by mantle-like magmas instead of by remelting ancient metamorphosed igneous rocks as widely believed. I-type magmatism thus drives the coupled growth and differentiation of continental crust.	Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England; James Cook Univ N Queensland, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; Ctr Theoret Isotope Studies, Greensborough, Vic 3088, Australia; Swedish Museum Nat Hist, SE-10405 Stockholm, Sweden	University of Bristol; James Cook University; University of Melbourne; Swedish Museum of Natural History	Kemp, AIS (corresponding author), Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England.	tony.kemp@jcu.edu.au	Foster, Gavin/CAF-4654-2022; Woodhead, Jon/C-2227-2012; Foster, Gavin/W-5968-2019; Kemp, Anthony/H-5179-2014; Whitehouse, Martin J/E-1425-2013; Facility, Edinburgh Ion Microprobe/AAD-8512-2020	Foster, Gavin/0000-0003-3688-9668; Whitehouse, Martin J/0000-0003-2227-577X; Facility, Edinburgh Ion Microprobe/0000-0001-6248-6657; Hergt, Janet/0000-0003-3410-1670; Kemp, Anthony/0000-0003-1642-0360; Woodhead, Jon/0000-0002-7614-0136	Natural Environment Research Council [NER/I/S/2002/00720] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Annen C, 2006, J PETROL, V47, P505, DOI 10.1093/petrology/egi084; CAMPBELL IH, 1983, GEOPHYS RES LETT, V10, P1061, DOI 10.1029/GL010i011p01061; Chappell BW, 1996, J PETROL, V37, P449, DOI 10.1093/petrology/37.3.449; Couch S, 2001, NATURE, V411, P1037, DOI 10.1038/35082540; Davidson JP, 1997, SCIENCE, V275, P826, DOI 10.1126/science.275.5301.826; DEPAOLO DJ, 1981, EARTH PLANET SC LETT, V53, P189, DOI 10.1016/0012-821X(81)90153-9; DEPAOLO DJ, 1980, SCIENCE, V209, P684, DOI 10.1126/science.209.4457.684; Eiler JM, 2001, REV MINERAL GEOCHEM, V43, P319, DOI 10.2138/gsrmg.43.1.319; Glazner A.F., 2004, GSA TODAY, V14, P4, DOI [10.1130/1052-5173(2004)0142.0.CO;2, DOI 10.1130/1052-5173(2004)014<0004:APA0M0>2.0.C0;2, DOI 10.1130/1052-5173(2004)0142.0.CO;2]; GRAY CM, 1984, EARTH PLANET SC LETT, V70, P47, DOI 10.1016/0012-821X(84)90208-5; Griffin WL, 2002, LITHOS, V61, P237, DOI 10.1016/S0024-4937(02)00082-8; HAMILTON PJ, 1980, NATURE, V287, P279, DOI 10.1038/287279a0; Hawkesworth C, 2004, EARTH PLANET SC LETT, V218, P1, DOI 10.1016/S0012-821X(03)00634-4; Hawkesworth CJ, 2006, NATURE, V443, P811, DOI 10.1038/nature05191; Hine R., 1978, J GEOL SOC AUST, V25, P219, DOI [DOI 10.1080/00167617808729029, 10.1080/00167617808729029]; Jackson MD, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001050; Jahn BM, 2000, T ROY SOC EDIN-EARTH, V91, P181, DOI 10.1017/S0263593300007367; Keay S, 1997, GEOLOGY, V25, P307, DOI 10.1130/0091-7613(1997)025<0307:ATCSNI>2.3.CO;2; Kemp AIS, 2005, CONTRIB MINERAL PETR, V150, P230, DOI 10.1007/s00410-005-0019-6; Lackey JS, 2005, EARTH PLANET SC LETT, V235, P315, DOI 10.1016/j.epsl.2005.04.003; MCCULLOCH MT, 1982, EARTH PLANET SC LETT, V58, P51, DOI 10.1016/0012-821X(82)90102-9; Neil J.R., 1977, J GEOL SOC LONDON, V133, P559; Peck WH, 2003, AM MINERAL, V88, P1003, DOI 10.2138/am-2003-0708; Thompson AB, 2002, J PETROL, V43, P403, DOI 10.1093/petrology/43.3.403; VAILEY JW, 2006, SCIENCE, V312, pA1139; Valley JW, 2005, CONTRIB MINERAL PETR, V150, P561, DOI 10.1007/s00410-005-0025-8; Vazquez JA, 2004, SCIENCE, V305, P991, DOI 10.1126/science.1096994; Waight TE, 2000, CONTRIB MINERAL PETR, V139, P227, DOI 10.1007/s004100000128; WHITE AJR, 1977, TECTONOPHYSICS, V43, P7, DOI 10.1016/0040-1951(77)90003-8; Wiebe RA, 1998, J STRUCT GEOL, V20, P1273, DOI 10.1016/S0191-8141(98)00059-5	30	1052	1182	22	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					980	983		10.1126/science.1136154	http://dx.doi.org/10.1126/science.1136154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303751				2022-12-28	WOS:000244229800039
J	Hsu, YC; Chern, JJ; Cai, Y; Liu, MY; Choi, KW				Hsu, Ya-Chieh; Chern, Joshua J.; Cai, Yi; Liu, Mingyao; Choi, Kwang-Wook			Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase	NATURE			English	Article							CONTROLLED TUMOR PROTEIN; CELL-GROWTH; DIRECT TARGET; RHEB GTPASE; ACTIVATION; EXCHANGE; HOMOLOG; TSC1; SIZE	Cellular growth and proliferation are coordinated during organogenesis. Misregulation of these processes leads to pathological conditions such as cancer. Tuberous sclerosis (TSC) is a benign tumour syndrome caused by mutations in either TSC1 or TSC2 tumour suppressor genes. Studies in Drosophila and other organisms have identified TSC signalling as a conserved pathway for growth control. Activation of the TSC pathway is mediated by Rheb (Ras homologue enriched in brain), a Ras superfamily GTPase(1,2). Rheb is a direct target of TSC2 and is negatively regulated by its GTPase-activating protein activity(3-5). However, molecules required for positive regulation of Rheb have not been identified. Here we show that a conserved protein, translationally controlled tumour protein ( TCTP), is an essential new component of the TSC - Rheb pathway. Reducing Drosophila TCTP (dTCTP) levels reduces cell size, cell number and organ size, which mimics Drosophila Rheb (dRheb) mutant phenotypes. dTCTP is genetically epistatic to Tsc1 and dRheb, but acts upstream of dS6k, a downstream target of dRheb. dTCTP directly associates with dRheb and displays guanine nucleotide exchange activity with it in vivo and in vitro. Human TCTP (hTCTP) shows similar biochemical properties compared to dTCTP and can rescue dTCTP mutant phenotypes, suggesting that the function of TCTP in the TSC pathway is evolutionarily conserved. Our studies identify TCTP as a direct regulator of Rheb and a potential therapeutic target for TSC disease.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Texas A&M Univ Syst Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Choi, KW (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	kchoi@bcm.tmc.edu	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Liu, Mingyao/0000-0001-7339-5048				BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Guo XG, 2003, J BIOL CHEM, V278, P13207, DOI 10.1074/jbc.M208896200; Huang H, 1999, DEVELOPMENT, V126, P5365; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sharma PM, 1998, J BIOL CHEM, V273, P18528, DOI 10.1074/jbc.273.29.18528; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stowers RS, 1999, GENETICS, V152, P1631; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; von Lintig FC, 2000, ONCOGENE, V19, P4029, DOI 10.1038/sj.onc.1203741; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	30	235	251	2	40	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					785	788		10.1038/nature05528	http://dx.doi.org/10.1038/nature05528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301792				2022-12-28	WOS:000244205200049
J	Blanpain, C; Horsley, V; Fuchs, E				Blanpain, Cedric; Horsley, Valerie; Fuchs, Elaine			Epithelial stem cells: Turning over new leaves	CELL			English	Review							HAIR FOLLICLE MORPHOGENESIS; MAMMARY-GLAND DEVELOPMENT; LABEL-RETAINING CELLS; BETA-CATENIN; SELF-RENEWAL; TRANSIENT ACTIVATION; FATE DETERMINATION; SIGNALING PATHWAY; INTESTINAL CRYPTS; TRANSGENIC MICE		Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Blanpain, Cedric/ABD-8392-2021; Fuchs, Elaine/G-1565-2016		NIAMS NIH HHS [R01 AR050452-04, R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barker N, 1999, AM J PATHOL, V154, P29, DOI 10.1016/S0002-9440(10)65247-9; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; CUNHA GR, 1995, ACTA ANAT, V152, P195; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Ferraris C, 2000, DEVELOPMENT, V127, P5487; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He X, 2006, CELL, V127, P40, DOI 10.1016/j.cell.2006.09.016; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; OCONNOR NE, 1981, LANCET, V1, P75; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Richardson GD, 2005, J INVEST DERM SYMP P, V10, P180, DOI 10.1111/j.1087-0024.2005.10101.x; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sun TT, 2004, J INVEST DERM SYMP P, V9, P202, DOI 10.1111/j.1087-0024.2004.09311.x; Suzuki K, 2005, BIOCHEM BIOPH RES CO, V328, P348, DOI 10.1016/j.bbrc.2004.12.174; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vauclair S, 2005, DEV BIOL, V284, P184, DOI 10.1016/j.ydbio.2005.05.018; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zeps N, 1998, DIFFERENTIATION, V62, P221, DOI 10.1046/j.1432-0436.1998.6250221.x	104	417	436	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					445	458		10.1016/j.cell.2007.01.014	http://dx.doi.org/10.1016/j.cell.2007.01.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289566	Green Accepted, Bronze			2022-12-28	WOS:000244842700013
J	Goldemberg, J				Goldemberg, Jose			Ethanol for a sustainable energy future	SCIENCE			English	Editorial Material								Renewable energy is one of the most efficient ways to achieve sustainable development. Increasing its share in the world matrix will help prolong the existence of fossil fuel reserves, address the threats posed by climate change, and enable better security of the energy supply on a global scale. Most of the "new renewable energy sources" are still undergoing large-scale commercial development, but some technologies are already well established. These include Brazilian sugarcane ethanol, which, after 30 years of production, is a global energy commodity that is fully competitive with motor gasoline and appropriate for replication in many countries.	Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Goldemberg, J (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	goldemb@iee.usp.br						British Petroleum, BP STAT REV WORLD EN; COELHO ST, 2006, DEVELOPMENT, V10, P26; DASILVA JG, 1978, SCIENCE, V201, P903, DOI 10.1126/science.201.4359.903; ELOBEID A, 2006, 36WP427; Goldemberg J, 2004, ENERG POLICY, V32, P1141, DOI 10.1016/S0301-4215(03)00077-6; Goldemberg J, 2004, BIOMASS BIOENERG, V26, P301, DOI 10.1016/S0961-9534(03)00125-9; GOLDENBERG J, 2004, INT C REN EN BONN; HEALEY JR, 2006, USA TODAY       0330; IEA, 2005, KEY WORLD EN STAT; MACEDO IC, GREENHOUSE GAS EMISS; SHAPOURI H, 721 USDA EC RES SERV; *UN, 1987, UN GEN ASS 96 PLEN M; *UNDP UNDESA WEC, 2005, WORLD EN ASS OV 2004; USDA, 2006, EC FEASIBILITY ETHAN; WOODS J, BU200785REPURN03982; *WORLD BANK, 2006, WORLD BANKS EN FRAM; 2006, REN21 GLOB STAT REP	17	853	907	8	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					808	810		10.1126/science.1137013	http://dx.doi.org/10.1126/science.1137013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289989				2022-12-28	WOS:000244069000057
J	Knight, ZA; Shokat, KM				Knight, Zachary A.; Shokat, Kevan M.			Chemical genetics: Where genetics and pharmacology meet	CELL			English	Article							INSULIN-RESISTANCE; PRESSURE-OVERLOAD; CATALYTIC SUBUNIT; PROTEIN-KINASE; RECEPTOR; 3-KINASE; GAMMA; ACTIVATION; P110-ALPHA; PI3K-GAMMA		Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu		Knight, Zachary/0000-0001-7621-1478				Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bishop A, 2000, ANNU REV BIOPH BIOM, V29, P577, DOI 10.1146/annurev.biophys.29.1.577; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; KOBAYASHI M, 1983, FEBS LETT, V163, P50, DOI 10.1016/0014-5793(83)81160-0; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Stern Bodo, 1996, Trends in Genetics, V12, P345, DOI 10.1016/0168-9525(96)10036-6; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200	23	191	196	0	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					425	430		10.1016/j.cell.2007.01.021	http://dx.doi.org/10.1016/j.cell.2007.01.021			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289560	Bronze			2022-12-28	WOS:000244842700007
J	Potocnik, J				Potocnik, Janez			Renewable energy sources and the realities of setting an energy agenda	SCIENCE			English	Editorial Material								The European Commission has been devoting considerable attention to energy issues. This Perspective describes recent progress in Europe toward achieving goals for renewable energy use, and the role that technology can play, as well as the new Strategic Energy Package.	Commiss European Communities, B-1049 Brussels, Belgium		Potocnik, J (corresponding author), Commiss European Communities, B-1049 Brussels, Belgium.							[Anonymous], 2006, STERN REV EC CLIM CH; *COMM EUR COMM, 2006, GREEN PAP EUR STRAT, P317; Commission of European Communities, 2007, COMM COMM EUR COUNC; *EUR COM, 2007, STRAT EN TECHN PLAN, P847; *EUR COMM, 2006, L412 EUR COMM; European Commission, 2006, EN TECHN KNOWL PERC; European Commission, 2006, WORLD EN TECHN OUTL	7	111	118	5	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					810	811		10.1126/science.1139086	http://dx.doi.org/10.1126/science.1139086			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134FN	17289990				2022-12-28	WOS:000244069000058
J	Basson, R; Schultz, WW				Basson, Rosemary; Schultz, Willibrord Weijmar			Sexual Dysfunction 1 - Sexual sequelae of general medical disorders	LANCET			English	Review							SURGICALLY MENOPAUSAL WOMEN; COGNITIVE-BEHAVIORAL THERAPY; BENIGN PROSTATIC HYPERPLASIA; VULVAR VESTIBULITIS SYNDROME; URINARY-TRACT SYMPTOMS; SLEEP-APNEA-SYNDROME; ERECTILE-DYSFUNCTION; TESTOSTERONE PATCH; BRAIN ACTIVATION; VAGINAL ATROPHY	That sexual symptoms can signal serious underlying disease confirms the importance of sexual enquiry as an integral component of medical assessment. Data on sexual function are sparse in some medical specialties. However, increased scientific understanding of the central and peripheral physiology of sexual response could help to identify the pathophysiology of sexual dysfunction from disease and medical interventions, and also to ameliorate or prevent some dysfunctions. Many common general medical disorders have negative effects on desire, arousal, orgasm, ejaculation, and freedom from pain during sex. Chronic disease also interferes indirectly with sexual function, by altering relationships and self-image and causing fatigue, pain, disfigurement, and dependency. Current approaches to assessment of sexual dysfunction are based on models that combine psychological and biological aspects.	Vancouver Gen Hosp, British Columbia Ctr Sexual Med, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, British Columbia Ctr Sexual Med, Dept Obstet & Gynaecol, Vancouver, BC, Canada; Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9700 AB Groningen, Netherlands	University of British Columbia; University of British Columbia; University of Groningen	Basson, R (corresponding author), Vancouver Gen Hosp, British Columbia Ctr Sexual Med, Dept Psychiat, 855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.	sexmed@interchange.ubc.ca						Akkus E, 2002, EUR UROL, V41, P298, DOI 10.1016/S0302-2838(02)00027-1; Althof SE, 2005, J SEX MED, V2, P146, DOI 10.1111/j.1743-6109.2005.00130.x; ALZATE H, 1985, J SEX MARITAL THER, V11, P271, DOI 10.1080/00926238508405453; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], SCAND J SEXOL, DOI DOI 10.1176/APPI.AJP.2008.08050714; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Atmaca M, 2005, INT J IMPOT RES, V17, P201, DOI 10.1038/sj.ijir.3901260; Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9; Babula O, 2004, AM J OBSTET GYNECOL, V191, P762, DOI 10.1016/j.ajog.2004.03.073; Bacon CG, 2003, ANN INTERN MED, V139, P161, DOI 10.7326/0003-4819-139-3-200308050-00005; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Bancroft J, 2005, J ENDOCRINOL, V186, P411, DOI 10.1677/joe.1.06233; Basson R, 2003, J PSYCHOSOM OBST GYN, V24, P221, DOI 10.3109/01674820309074686; Basson R, 2001, J SEX MARITAL THER, V27, P33, DOI 10.1080/00926230152035831; Basson R, 2001, OBSTET GYNECOL, V98, P350, DOI 10.1016/S0029-7844(01)01452-1; Basson R, 2004, SEXUAL MED SEXUAL FU, P922; BEGERON S, 2001, PAIN, V91, P297; Bellinghieri G, 2004, SEMIN NEPHROL, V24, P488, DOI 10.1016/j.semnephrol.2004.06.002; Bergeron S, 2001, PAIN, V91, P297, DOI 10.1016/S0304-3959(00)00449-8; Bergmark K, 2005, J SEX MARITAL THER, V31, P361, DOI 10.1080/00926230591006476; BHASIN S, 2006, IN PRESS LANCET; BITA G, 1999, KIDNEY INT, V56, P232; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Blumentals WA, 2004, INT J IMPOT RES, V16, P350, DOI 10.1038/sj.ijir.3901174; Bocchi EA, 2002, CIRCULATION, V106, P1097, DOI 10.1161/01.CIR.0000027149.83473.B6; Bohm-Starke N, 2004, J REPROD MED, V49, P888; Bohm-Starke N, 1998, GYNECOL OBSTET INVES, V46, P256, DOI 10.1159/000010045; Bonierbale M, 2003, CURR MED RES OPIN, V19, P114, DOI 10.1185/030079902125001461; Bornstein J, 2004, GYNECOL OBSTET INVES, V58, P171, DOI 10.1159/000079663; Brandenburg U, 2002, GEBURTSH FRAUENHEILK, V62, P1, DOI 10.1055/s-2002-29100; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; Cain VS, 2003, J SEX RES, V40, P266, DOI 10.1080/00224490309552191; Chivers ML, 2005, BIOL PSYCHOL, V70, P115, DOI 10.1016/j.biopsycho.2004.12.002; Clayton AH, 2003, INT CLIN PSYCHOPHARM, V18, P151, DOI 10.1097/01.yic.0000066456.73432.09; Cranston-Cuebas MA., 1990, ANN REV SEX RES, V1, P119, DOI 10.1080/10532528.1990.10559858; Croft H, 1999, CLIN THER, V21, P643, DOI 10.1016/S0149-2918(00)88317-4; Danielsson I, 2003, SCAND J PUBLIC HEALT, V31, P113, DOI 10.1080/14034940210134040; Davis SR, 2006, MENOPAUSE, V13, P387, DOI 10.1097/01.gme.0000179049.08371.c7; De Knott HMR, 2005, CONTACT DERMATITIS, V53, P214, DOI 10.1111/j.0105-1873.2005.00685.x; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; DeLamater JD, 2005, J SEX RES, V42, P138, DOI 10.1080/00224490509552267; Dennerstein L, 2000, OBSTET GYNECOL, V96, P351, DOI 10.1016/S0029-7844(00)00930-3; Derby CA, 2000, UROLOGY, V56, P302, DOI 10.1016/S0090-4295(00)00614-2; Doruk H, 2005, ARCH ANDROLOGY, V51, P1, DOI 10.1080/014850190512798; Dossenbach M, 2005, INT J NEUROPSYCHOPH, V8, P195, DOI 10.1017/S1461145704005012; Drory Y, 2000, AM J CARDIOL, V85, P1283, DOI 10.1016/S0002-9149(00)00756-6; Duncan LE, 2000, AM J HYPERTENS, V13, P640, DOI 10.1016/S0895-7061(99)00288-5; Dusing R, 2005, DRUGS, V65, P773; ELLIOTT S, 2000, J SOC OBSTET GYNECOL, V22, P26; Enzlin P, 2002, DIABETES CARE, V25, P672, DOI 10.2337/diacare.25.4.672; Eriksen BC, 1999, AM J OBSTET GYNECOL, V180, P1072, DOI 10.1016/S0002-9378(99)70597-1; Erol B, 2002, J SEX MARITAL THER, V28, P55, DOI 10.1080/00926230252851195; Fall M, 2004, EUR UROL, V46, P681, DOI 10.1016/j.eururo.2004.07.030; Fogari R, 1998, AM J HYPERTENS, V11, P1244, DOI 10.1016/S0895-7061(98)00139-3; Fogari R, 2005, AM J HYPERTENS, V18, P577, DOI 10.1016/j.amjhyper.2004.11.020; Fogari R, 2002, EUR J CLIN PHARMACOL, V58, P177, DOI 10.1007/s00228-002-0456-3; Foster DC, 2004, J REPROD MED, V49, P503; Foster DC, 2002, OBSTET GYNECOL, V100, P145, DOI 10.1016/S0029-7844(02)02080-X; Franzen D, 2001, INT J IMPOT RES, V13, P348, DOI 10.1038/sj.ijir.3900787; Friedman S, 2000, AM J CARDIOL, V86, p46F; Fung MM, 2004, J AM COLL CARDIOL, V43, P1405, DOI 10.1016/j.jacc.2003.11.041; Gerber S, 2003, EUR J OBSTET GYN R B, V107, P74, DOI 10.1016/S0301-2115(02)00276-2; Gerber S, 2002, AM J OBSTET GYNECOL, V186, P361, DOI 10.1067/mob.2002.121091; Giesecke J, 2004, OBSTET GYNECOL, V104, P126, DOI 10.1097/01.AOG.0000129238.49397.4e; Giuliano F, 2006, BJU INT, V97, P34, DOI 10.1111/j.1464-410X.2006.06104.x; GLATT AE, 1990, OBSTET GYNECOL, V75, P433; Goldstein I, 2000, INT J IMPOT RES, V12, pS152, DOI 10.1038/sj.ijir.3900596; Gorodeski GI, 2005, ENDOCRINOLOGY, V146, P816, DOI 10.1210/en.2004-1153; Goswami D, 2006, J INFECTION, V52, P111, DOI 10.1016/j.jinf.2005.03.005; Grady D, 2001, OBSTET GYNECOL, V97, P116, DOI 10.1016/S0029-7844(00)01115-7; Granot M, 2005, J PAIN, V6, P168, DOI 10.1016/j.jpain.2004.11.010; GRAY H, 1977, GRAYS ANATOMY CLASSI, P650; Guirao Sanchez L, 2002, Aten Primaria, V30, P290; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Handa VL, 2004, AM J OBSTET GYNECOL, V191, P751, DOI 10.1016/j.ajog.2003.11.017; Harlow Bernard L, 2003, J Am Med Womens Assoc (1972), V58, P82; Hartmann U, 2002, WORLD J UROL, V20, P79, DOI 10.1007/s00345-002-0280-5; HAWTON K, 1986, BEHAV RES THER, V24, P377, DOI 10.1016/0005-7967(86)90002-1; Holstege G, 1998, BEHAV BRAIN RES, V92, P103, DOI 10.1016/S0166-4328(97)00182-4; Hultgren R, 1999, EUR J VASC ENDOVASC, V17, P306, DOI 10.1053/ejvs.1998.0770; Jonker-Pool G, 2001, ARCH SEX BEHAV, V30, P55, DOI 10.1023/A:1026468707362; Kadioglu P, 2005, J UROLOGY, V174, P1921, DOI 10.1097/01.ju.0000176456.50491.51; Kaiser DR, 2004, J AM COLL CARDIOL, V43, P179, DOI 10.1016/j.jacc.2003.07.042; Kalogeraki A, 1996, IN VIVO, V10, P597; Kalsi JS, 2005, J SEX MED, V2, P53, DOI 10.1111/j.1743-6109.2005.20105.x; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kennedy SH, 1999, J AFFECT DISORDERS, V56, P201, DOI 10.1016/S0165-0327(99)00050-6; Kloner RA, 2004, CIRCULATION, V110, P3149, DOI 10.1161/01.CIR.0000146906.42375.D3; Kloner RA, 2001, AM J HYPERTENS, V14, P70, DOI 10.1016/S0895-7061(00)01177-8; Knegtering H, 2006, J SEX MARITAL THER, V32, P315, DOI 10.1080/00926230600666378; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Kodesh A, 2003, CLIN NEUROPHARMACOL, V26, P193, DOI 10.1097/00002826-200307000-00008; Komisaruk BR, 2004, BRAIN RES, V1024, P77, DOI 10.1016/j.brainres.2004.07.029; Kostis JB, 2005, AM J CARDIOL, V96, P313, DOI 10.1016/j.amjcard.2005.03.065; Kukkonen TM, 2006, J SEX MARITAL THER, V32, P281, DOI 10.1080/00926230600666220; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; LEIBLUM S, 1983, JAMA-J AM MED ASSOC, V249, P2195, DOI 10.1001/jama.249.16.2195; Leiblum SR, 2001, J SEX MARITAL THER, V27, P365, DOI 10.1080/009262301317081115; LOWE FC, 1993, UROLOGY, V42, P51, DOI 10.1016/0090-4295(93)90338-B; MacDonald S, 2003, BRIT J PSYCHIAT, V182, P50, DOI 10.1192/bjp.182.1.50; MAHALLESI E, 2005, INT J GYNECOL OBSTET, V88, P276; Maravilla KR, 2003, J MAGN RESON IMAGING, V18, P216, DOI 10.1002/jmri.10344; Margel D, 2004, UROLOGY, V63, P545, DOI 10.1016/j.urology.2003.10.016; MESTON C, 2006, IN PRESS ARCH SEX BE; Metz ME, 2000, J SEX MARITAL THER, V26, P293, DOI 10.1080/009262300438715; Meuleman EJH, 2005, BJU INT, V95, P291, DOI 10.1111/j.1464-410X.2005.05285.x; Montejo AL, 2001, J CLIN PSYCHIAT, V62, P10; Montorsi F, 2003, BJU INT, V91, P446, DOI 10.1046/j.1464-410X.2003.04093.x; Montorsi F, 2003, EUR UROL, V44, P360, DOI 10.1016/S0302-2838(03)00305-1; Montorsi F, 2003, EUR UROL, V43, P405, DOI 10.1016/S0302-2838(03)00053-8; MUSONE D, 2003, MINERVA UROL NEFROL, V655, P193; Mynderse LA, 2002, INT J IMPOT RES, V14, P340, DOI 10.1038/sj.ijir.3900869; *N AM MEN SOC, 2003, MENOPAUSE, V10, P6; Nadarajah S, 2005, J Pediatr Adolesc Gynecol, V18, P39, DOI 10.1016/j.jpag.2004.11.008; Nickel JC, 2005, BJU INT, V95, P571, DOI 10.1111/j.1464-410X.2005.05341.x; Nickel JC, 2004, J UROLOGY, V171, P1594, DOI 10.1097/01.ju.0000117811.40279.19; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; On YK, 2002, HYPERTENS RES, V25, P365, DOI 10.1291/hypres.25.365; Palmer BF, 2003, ADV RENAL REPLACE TH, V10, P48, DOI 10.1053/jarr.2003.50003; Pandit L, 1997, AM J MED SCI, V314, P228, DOI 10.1097/00000441-199710000-00004; Payne KA, 2005, EUR J PAIN, V9, P427, DOI 10.1016/j.ejpain.2004.10.003; Peng YS, 2005, KIDNEY INT, V68, P760, DOI 10.1111/j.1523-1755.2005.00454.x; Perimenis P, 2004, INT J IMPOT RES, V16, P256, DOI 10.1038/sj.ijir.3901219; Perkins DO, 2002, J CLIN PSYCHIAT, V63, P1121, DOI 10.4088/JCP.v63n1206; Pukall CF, 2006, CLIN J PAIN, V22, P601, DOI 10.1097/01.ajp.0000210903.67849.af; Pukall CF, 2005, PAIN, V115, P118, DOI 10.1016/j.pain.2005.02.020; Pukall CF, 2002, PAIN, V96, P163, DOI 10.1016/S0304-3959(01)00442-0; Redoute J, 2005, PSYCHONEUROENDOCRINO, V30, P461, DOI 10.1016/j.psyneuen.2004.12.003; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Rendell MS, 1999, JAMA-J AM MED ASSOC, V281, P421, DOI 10.1001/jama.281.5.421; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Rogers GR, 2001, INT UROGYNECOL J, V12, P361, DOI 10.1007/s001920170012; Romans S, 2002, PSYCHOTHER PSYCHOSOM, V71, P141, DOI 10.1159/000056281; Rosano GMC, 2005, AM J CARDIOL, V95, P327, DOI 10.1016/j.amjcard.2004.09.028; Rosas SE, 2001, KIDNEY INT, V59, P2259, DOI 10.1046/j.1523-1755.2001.00742.x; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Rosen RC, 2006, BJU INT, V97, P29, DOI 10.1111/j.1464-410X.2006.06103.x; RYMER J, 1994, MATURITAS, V18, P127, DOI 10.1016/0378-5122(94)90050-7; de Tejada IS, 2004, J SEX MED, V1, P254, DOI 10.1111/j.1743-6109.04038.x; Safarinejad MR, 2006, INT J IMPOT RES, V18, P527, DOI 10.1038/sj.ijir.3901466; Salonia A, 2004, EUR UROL, V45, P642, DOI 10.1016/j.eururo.2003.11.023; SANCHIANG W, 2001, SCAND J UROL NEPHROL, V35, P136; Sarma AV, 1999, SEX TRANSM INFECT, V75, P320, DOI 10.1136/sti.75.5.320; SCHIAVI RC, 1995, PSYCHIAT CLIN N AM, V18, P7, DOI 10.1016/S0193-953X(18)30067-4; Schultz W. C.Weijmar, 1992, ANN REV SEX RES, V3, P151; Schultz WCMW, 2002, J PSYCHOSOM OBST GYN, V23, P5, DOI 10.3109/01674820209093408; Schultz WW, 1999, BRIT MED J, V319, P1596, DOI 10.1136/bmj.319.7225.1596; SEIDMAN SN, 2001, AM J PSYCHIAT, V15; Servoss SJ, 2002, PROG CARDIOVASC DIS, V44, P369, DOI 10.1053/pcad.2002.123470; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Smith MA, 2002, IEEE ACM T NETWORK, V10, P193, DOI 10.1109/90.993301; Solomon H, 2003, AM J CARDIOL, V91, P230, DOI 10.1016/S0002-9149(02)03113-2; Soykan A, 2005, INT J IMPOT RES, V17, P359, DOI 10.1038/sj.ijir.3901324; Steele TE, 1996, J AM SOC NEPHROL, V7, P1165; Stoleru S, 2003, PSYCHIAT RES-NEUROIM, V124, P67, DOI 10.1016/S0925-4927(03)00068-4; Taylor HA, 1999, AM J CARDIOL, V84, p6N; Taylor MJ, 2005, J AFFECT DISORDERS, V88, P241, DOI 10.1016/j.jad.2005.07.006; ter Kuile MM, 2007, BEHAV RES THER, V45, P359, DOI 10.1016/j.brat.2006.03.013; Toorians AWFT, 1997, NEPHROL DIAL TRANSPL, V12, P2654, DOI 10.1093/ndt/12.12.2654; Traish AM, 2006, J SEX MED, V3, P382, DOI 10.1111/j.1743-6109.2006.00245.x; Tympanidis P, 2003, BRIT J DERMATOL, V148, P1021, DOI 10.1046/j.1365-2133.2003.05308.x; van Lankveld JJDM, 2006, J CONSULT CLIN PSYCH, V74, P168, DOI 10.1037/0022-006X.74.1.168; van Lankveld JJDM, 2000, ARCH SEX BEHAV, V29, P479, DOI 10.1023/A:1001995704034; van Lunsen RHW, 2004, MENOPAUSE, V11, P741, DOI 10.1097/01.GME.0000143704.48324.46; Vaziri ND, 2002, HYPERTENSION, V39, P135, DOI 10.1161/hy0102.100540; Verit Fatma Ferda, 2006, Archives of Gynecology and Obstetrics, V274, P297, DOI 10.1007/s00404-006-0178-3; Waldinger MD, 2004, INT J IMPOT RES, V16, P369, DOI 10.1038/sj.ijir.3901172; Weisberg E, 2005, CLIMACTERIC, V8, P83, DOI 10.1080/13697130500087016; Westrom LV, 1998, OBSTET GYNECOL, V91, P572, DOI 10.1016/S0029-7844(97)00719-9; *WHO, 2001, INT J STD AIDS, V12, P1; WSCHIANSKY F, 2004, MED HYG, V62, P591; Yang SSD, 2005, J UROLOGY, V173, P1361, DOI 10.1097/01.ju.0000156556.11235.3f; Yildiz Hicran, 2004, Anadolu Kardiyol Derg, V4, P309; Zamd M, 2004, ANN ENDOCRINOL-PARIS, V65, P194; Zivadinov R, 2003, J NEUROL SCI, V210, P73, DOI 10.1016/S0022-510X(03)00025-X	178	181	186	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					409	424		10.1016/S0140-6736(07)60197-4	http://dx.doi.org/10.1016/S0140-6736(07)60197-4			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276781				2022-12-28	WOS:000243944400035
J	Koniaris, LG; Sheldon, JP; Zirnmers, TA				Koniaris, Leonidas G.; Sheldon, Jon P.; Zirnmers, Teresa A.			Can lethal injection for execution really be "fixed"?	LANCET			English	Editorial Material									Univ Miami, Miami, FL 33156 USA	University of Miami	Koniaris, LG (corresponding author), Univ Miami, Miami, FL 33156 USA.	LKoniaris@med.miami.edu		Zimmers, Teresa/0000-0001-7872-0540				ALPER T, 2006, CHAMPION MAG, V30, P41; FELLNER J, 2006, HUMAN RIGHTS WATCH; Gawande A, 2006, NEW ENGL J MED, V354, P1221, DOI 10.1056/NEJMp068042; Groner JI, 2002, BRIT MED J, V325, P1026, DOI 10.1136/bmj.325.7371.1026; KENNEDY J, 2006, ORLANDO SENTINE 1216, pA1; Koniaris LG, 2005, LANCET, V365, P1412, DOI 10.1016/S0140-6736(05)66377-5; LIPTAK A, 2006, NY TIMES        1216, P11; TISCH C, 2006, ST PETERSBURG T 1214, pA1	8	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					352	353		10.1016/S0140-6736(07)60167-6	http://dx.doi.org/10.1016/S0140-6736(07)60167-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276758				2022-12-28	WOS:000243944400007
J	Enquist, BJ; Allen, AP; Brown, JH; Gillooly, JF; Kerkhoff, AJ; Niklas, KJ; Price, CA; West, GB				Enquist, Brian J.; Allen, Andrew P.; Brown, James H.; Gillooly, James F.; Kerkhoff, Andrew J.; Niklas, Karl J.; Price, Charles A.; West, Geoffrey B.			Does the exception prove the rule?	NATURE			English	Letter							GLOBAL ALLOCATION RULES; PLANT ALLOMETRY; SEED PLANTS; SIZE; PRODUCTIVITY; TEMPERATURE; NITROGEN; PATTERNS; GROWTH; TREE		Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; Kenyon Coll, Dept Math, Gambier, OH 43022 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	University of Arizona; The Santa Fe Institute; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of New Mexico; State University System of Florida; University of Florida; Kenyon College; Kenyon College; Cornell University	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@email.arizona.edu	Price, Charles A/B-1171-2011; Enquist, Brian J/B-6436-2008; Niklas, Karl/AAV-4760-2021; Price, Chuck A/HIK-1431-2022; Allen, Andrew/B-8045-2011	Enquist, Brian J/0000-0002-6124-7096; Allen, Andrew/0000-0003-0304-7544; Kerkhoff, Andrew/0000-0001-9617-8687				Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Hedin LO, 2006, NATURE, V439, P399, DOI 10.1038/439399a; HEMMINGSEN A. M., 1950, Rep. Steno Mem. Hosp., V4, P7; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Kerkhoff AJ, 2006, AM NAT, V168, pE103, DOI 10.1086/507879; Niklas KJ, 2004, P NATL ACAD SCI USA, V101, P15661, DOI 10.1073/pnas.0405857101; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; PRICE CA, IN PRESS ECOLOGY; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Sack L, 2002, SCIENCE, V296, pA1923, DOI 10.1126/science.296.5575.1923a; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	15	108	124	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 1	2007	445	7127					E9	E10		10.1038/nature05548	http://dx.doi.org/10.1038/nature05548			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268426				2022-12-28	WOS:000243867300032
J	Handwerker, J; Raptopoulos, VD				Handwerker, Jason; Raptopoulos, Vassilios D.			A medical mystery: Dilated bowel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Handwerker, J (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	jhandwer@bidmc.harvard.edu							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					503	503		10.1056/NEJMicm053388	http://dx.doi.org/10.1056/NEJMicm053388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267910				2022-12-28	WOS:000243860700011
J	Comer, FI; Parent, CA				Comer, Frank I.; Parent, Carole A.			Phosphoinositides specify polarity during epithelial organ development	CELL			English	Editorial Material							APICAL-POLARITY; CELLS; MORPHOGENESIS; MEMBRANE; TUBES	The molecular mechanisms that integrate cellular polarity with tissue architecture during epithelial morphogenesis are poorly understood. Using a three-dimensional model of epithelial morphogenesis, Martin-Belmonte et al. (2007) report that the phosphatase PTEN and phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P-2] regulate the GTPase Cdc42 and the kinase aPKC to generate the apical plasma membrane domain and maintain apical-basolateral polarity.	NCI, Cellular & Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Canc Res Ctr, NIH, 37 Convent Dr,Bldg 37,Room 2066, Bethesda, MD 20892 USA.	parentc@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010418, Z01BC010418] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bagorda A, 2006, THROMB HAEMOSTASIS, V95, P12, DOI 10.1160/TH05-07-0483; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; MARTINBELMONTE F, 2007, CELL; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Rosario M, 2003, TRENDS CELL BIOL, V13, P328, DOI 10.1016/S0962-8924(03)00104-1; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045	10	62	65	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					239	240		10.1016/j.cell.2007.01.010	http://dx.doi.org/10.1016/j.cell.2007.01.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254962	Bronze			2022-12-28	WOS:000244420500009
J	Connor, CM; Morrison, FJ; Fishman, BJ; Schatschneider, C; Underwood, P				Connor, Carol McDonald; Morrison, Frederick J.; Fishman, Barry J.; Schatschneider, Christopher; Underwood, Phyllis			The early years - Algorithm-guided individualized reading instruction	SCIENCE			English	Editorial Material							CHILDREN; GROWTH		Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32301 USA; Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Educ, Ann Arbor, MI 48109 USA	State University System of Florida; Florida State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Connor, CM (corresponding author), Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32301 USA.	cconnor@fsu.edu	Morrison, Fred/AAH-6680-2020; Underwood, Phyllis/Q-6594-2019	Schatschneider, Christopher/0000-0002-1700-7685	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048539] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD48539] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Connor CM, 2006, J EDUC PSYCHOL, V98, P665, DOI 10.1037/0022-0663.98.4.665; Connor CM, 2004, J EDUC PSYCHOL, V96, P682, DOI 10.1037/0022-0663.96.4.682; Connor CM, 2004, SCI STUD READ, V8, P305, DOI 10.1207/s1532799xssr0804_1; CONOR CM, 2007, SCI STUD READ, V11, P243; Cunningham P. M., 1998, TEACHING EVERY CHILD, P32; DAHL KL, 1995, READ RES QUART, V30, P50, DOI 10.2307/747744; Foorman BR, 1998, J EDUC PSYCHOL, V90, P37, DOI 10.1037//0022-0663.90.2.235; Guthrie JT, 2001, J EDUC RES, V94, P145, DOI 10.1080/00220670109599912; Juel C, 2000, READ RES QUART, V35, P458, DOI 10.1598/RRQ.35.4.2; Morrison F. J., 2005, IMPROVING LITERACY A; *NAT ASS ED PROGR, 2005, NAT REP CARD; National Reading Panel, 2000, NIH PUB; PRESSLEY M, 1998, READING INSTRUCTION; RAVITCH D, 2001, GREAT CURRICULUM DEB, P210; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; Reynolds AJ, 2004, CHILD YOUTH SERV REV, V26, P1, DOI 10.1016/j.childyouth.2003.11.005; Ross SM, 1997, PSYCHOL SCHOOLS, V34, P171, DOI 10.1002/(SICI)1520-6807(199704)34:2<171::AID-PITS9>3.0.CO;2-T; Snow C., 2001, READING UNDERSTANDIN; Sternberg RJ, 1996, HUMAN ABILITIES, P167; Taylor BM, 2000, ELEM SCHOOL J, V101, P121, DOI 10.1086/499662; Torgesen JK., 2000, LEARNING DISABILITIE, V15, P55, DOI [10.1207/sldrp1501_6, 10.1207/SLDRP1501_6, DOI 10.1207/SLDRP1501_6]; Vellutino FR, 1996, J EDUC PSYCHOL, V88, P601, DOI 10.1037/0022-0663.88.4.601; Woodcock R. W., 2001, WOODCOCK JOHNSON 3 T	23	147	148	4	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					464	465		10.1126/science.1134513	http://dx.doi.org/10.1126/science.1134513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	129JU	17255498				2022-12-28	WOS:000243726600029
J	Sacco, RL; Chong, JY; Prabhakaran, S; Elkind, MSV				Sacco, Ralph L.; Chong, Ji Y.; Prabhakaran, Shyam; Elkind, Mitchell S. V.			Experimental treatments for acute ischaemic stroke	LANCET			English	Review							TISSUE-PLASMINOGEN ACTIVATOR; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLACEBO-CONTROLLED TRIAL; ALIAS PILOT TRIAL; DOSE-ESCALATION; DOUBLE-BLIND; INTRAARTERIAL THROMBOLYSIS; INTRAVENOUS THROMBOLYSIS; MECHANICAL THROMBECTOMY; SCIENTIFIC STATEMENT	Treatments for acute ischaemic stroke continue to evolve. Experimental approaches to restore cerebral perfusion include techniques to augment recanalising therapies, including combination of antiplatelet agents with intravenous thrombolysis, bridging therapy of combining intravenous with intra-arterial thrombolysis, and trials of new thrombolytic agents. Trials with MRI selection criteria are underway to expand the window of opportunity for thrombolysis. Sonothrombolysis and novel endovascular mechanical devices to retrieve or dissolve acute cerebral occlusions are being tested. Approaches to improve cerebral perfusion with other devices and induced hypertension are also being considered. Although numerous neuroprotective agents have not shown benefit, trials of hypothermia, magnesium, caffeinol, high doses of statins, and albumin are continuing. The findings of these randomised trials are anticipated to allow improved treatment of patients with acute stroke.	Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Columbia University; Columbia University; Rush University	Sacco, RL (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.	rls1@columbia.edu	Sacco, Ralph/Y-9278-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048134, R01NS050724] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS 50724, R01 NS 48134] Funding Source: Medline; PHS HHS [K23 42912] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Agarwal P, 2004, CATHETER CARDIO INTE, V62, P396, DOI 10.1002/ccd.20092; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Albers GV, 2001, JAMA-J AM MED ASSOC, V286, P2673, DOI 10.1001/jama.286.21.2673; ALBERS GW, 1995, STROKE, V26, P254, DOI 10.1161/01.STR.26.2.254; Albers GW, 2001, STROKE, V32, P1598, DOI 10.1161/01.STR.32.7.1598; Alexandrov AV, 2004, NEW ENGL J MED, V351, P2170, DOI 10.1056/NEJMoa041175; Alexandrov AV, 2002, NEUROLOGY, V59, P862, DOI 10.1212/WNL.59.6.862; Alexandrov AV, 2001, CIRCULATION, V103, P2897, DOI 10.1161/01.CIR.103.24.2897; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2006, NEW ENGL J MED, V355, P549; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Ballantyne CM, 2003, AM J CARDIOL, V92, p3K, DOI 10.1016/S0002-9149(03)00768-9; Bath PMW, 2000, STROKE, V31, P2257; Belayev L, 2004, BRAIN RES, V1008, P278, DOI 10.1016/j.brainres.2004.02.039; Berlis A, 2004, STROKE, V35, P1112, DOI 10.1161/01.STR.0000124126.17508.d3; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Butcher KS, 2005, STROKE, V36, P1153, DOI 10.1161/01.STR.0000166181.86928.8b; Campbell MS, 2004, STROKE, V35, P291; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chopko BW, 2000, NEUROSURGERY, V46, P1529, DOI 10.1097/00006123-200006000-00046; Clark WM, 2001, NEUROLOGY, V57, P1595, DOI 10.1212/WNL.57.9.1595; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; *CLINICALTRIALS GO, 2006, MR REC STROK CLOTS U; *CLINICALTRIALS GO, 2006, ICTUS STUD INT CIT T; *CLINICALTRIALS GO, 2006, COMB APPR LYS UT EPT; *CLINICALTRIALS GO, 2005, MICR ULTR STROK TRIA; *CLINICALTRIALS GO, 2006, SAF EFF NEUROFLO TEC; *CLINICALTRIALS GO, 2006, SAF STUD INT BET 1A; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Davis SM, 1997, LANCET, V349, P32, DOI 10.1016/S0140-6736(05)62166-6; Demchuk AM, 2001, STROKE, V32, P89, DOI 10.1161/01.STR.32.1.89; Diener HC, 1999, STROKE, V30, P234; Dijkmans P A, 2004, Eur J Echocardiogr, V5, P245, DOI 10.1016/j.euje.2004.02.001; Dippel DWJ, 2003, BMC CARDIOVASC DISOR, V3, DOI 10.1186/1471-2261-3-2; *ENL AC STROK TRIA, 2001, NEUROLOGY, V547, P1428; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2005, STROKE, V36, P1808, DOI 10.1161/01.STR.0000173403.60553.27; Fisher M, 2003, STROKE, V34, P1539, DOI 10.1161/01.STR.0000072983.64326.53; Fourie P, 2003, AM J NEURORADIOL, V24, P630; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Furlan AJ, 2006, STROKE, V37, P1227, DOI 10.1161/01.STR.0000217403.66996.6d; GEORGIA MA, 2004, NEUROLOGY, V63, P312; Ginsberg MD, 2006, STROKE, V37, P2100, DOI 10.1161/01.STR.0000231388.72646.05; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gropen TI, 2006, NEUROLOGY, V67, P88, DOI 10.1212/01.wnl.0000223622.13641.6d; Grotta J, 2001, CEREBROVASC DIS, V12, P258, DOI 10.1159/000047713; Hacke W, 2005, STROKE, V36, P66, DOI 10.1161/01.STR.0000149938.08731.2c; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Haley EC, 2005, STROKE, V36, P607, DOI 10.1161/01.STR.0000154872.73240.e9; Hennerici MG, 2006, LANCET, V368, P1871, DOI 10.1016/S0140-6736(06)69776-6; Hickenbottom SL, 1998, SEMIN NEUROL, V18, P485, DOI 10.1055/s-2008-1040901; Hillis AE, 2003, CEREBROVASC DIS, V16, P236, DOI 10.1159/000071122; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horn J, 2001, STROKE, V32, P461, DOI 10.1161/01.STR.32.2.461; Kerber CW, 2002, J VASC INTERV RADIOL, V13, P1269, DOI 10.1016/S1051-0443(07)61978-2; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Lee DH, 2002, J VASC INTERV RADIOL, V13, P769; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Liu M, 2003, COCHRANE DB SYST REV, V3; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Mahon BR, 2003, AM J NEURORADIOL, V24, P534; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MOHR JP, 1994, CEREBROVASC DIS, V4, P197, DOI 10.1159/000108482; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Montaner J, 2004, STROKE, V35, P293; Nakano S, 2002, STROKE, V33, P2872, DOI 10.1161/01.STR.0000038985.26269.F2; Nesbit Gary M, 2004, J Vasc Interv Radiol, V15, pS103; Ohman EM, 1997, CIRCULATION, V95, P846; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; Qizilbash N, 2000, COCHRANE DB SYST REV, V2; Reddrop C, 2005, STROKE, V36, P1241, DOI 10.1161/01.STR.0000166050.84056.48; Ribo M, 2006, STROKE, V37, P1000, DOI 10.1161/01.STR.0000206443.96112.d9; Ringer AJ, 2001, NEUROSURGERY, V48, P1282, DOI 10.1097/00006123-200106000-00019; Rordorf G, 2001, NEUROLOGY, V56, P1210, DOI 10.1212/WNL.56.9.1210; Sacco RL, 2001, JAMA-J AM MED ASSOC, V285, P1719, DOI 10.1001/jama.285.13.1719; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Schellinger PD, 2003, STROKE, V34, P575, DOI 10.1161/01.STR.0000051504.10095.9C; Schumacher HC, 2003, CARDIOVASC INTER RAD, V26, P305, DOI 10.1007/s00270-003-2719-5; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; Scott P, 1996, STROKE, V27, P1453; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Smith WS, 2006, AM J NEURORADIOL, V27, P1177; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; *STROK CTR STROK T, 2006, DESM AC ISCH STROK 2; *STROK CTR STROK T, REP STROK SAF STUD I; *STROK CTR STROK T, 2006, 3 INT STROK TRIAL; *STROK CTR STROK T, 2006, TREATM HYP ISCH STRO; *STROK CTR STROK T, 2005, GLUC REG AC STROK PA; *STROK CTR STROK T, PICL PAT AC ISCH STR; *STROK CTR STROK T, 2006, NAN ENH CLOTBUST TRE; *STROK CTR STROK T, 2005, CONTR HYP HYP IMM PO; *STROK CTR STROK T, 2005, INT MAN STROK STUD; Sugg RM, 2006, ARCH NEUROL-CHICAGO, V63, P1057, DOI 10.1001/archneur.63.8.1057; Thomalla G, 2006, STROKE, V37, P852, DOI 10.1161/01.STR.0000204120.79399.72; Thomas D, 2003, RES AFR LITERATURES, V34, P214, DOI 10.2979/RAL.2003.34.3.214; TSAI FY, 1994, AM J NEURORADIOL, V15, P1823; Ueda T, 1998, STROKE, V29, P2568, DOI 10.1161/01.STR.29.12.2568; Warach S, 2000, ANN NEUROL, V48, P713, DOI 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.3.CO;2-R; Zhang L, 2005, CIRCULATION, V112, P3486, DOI 10.1161/CIRCULATIONAHA.104.516757	112	89	95	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					331	341		10.1016/S0140-6736(07)60155-X	http://dx.doi.org/10.1016/S0140-6736(07)60155-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258673				2022-12-28	WOS:000243912000037
J	Rapp, M; Seppala, S; Granseth, E; von Heijne, G				Rapp, Mikaela; Seppala, Susanna; Granseth, Erik; von Heijne, Gunnar			Emulating membrane protein evolution by rational design	SCIENCE			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; X-RAY-STRUCTURE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; CRYSTAL-STRUCTURE; ABC TRANSPORTER; EMRE; MECHANISM; TOPOLOGY; SELECTIVITY	How do integral membrane proteins evolve in size and complexity? Using the small multidrug-resistance protein EmrE from Escherichia coli as a model, we experimentally demonstrated that the evolution of membrane proteins composed of two homologous but oppositely oriented domains can occur in a small number of steps: An original dual-topology protein evolves, through a gene-duplication event, to a heterodimer formed by two oppositely oriented monomers. This simple evolutionary pathway can explain the frequent occurrence of membrane proteins with an internal pseudo-two-fold symmetry axis in the plane of the membrane.	Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; AlbaNova, Stockholm Bioinformat Ctr, SE-10691 Stockholm, Sweden	Stockholm University	von Heijne, G (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	gunnar@dbb.su.se	von Heijne, Gunnar/AAH-9389-2019; Rapp, Mikaela/K-2298-2015; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569; Rapp, Mikaela/0000-0002-4401-9518; Seppala, Susanna/0000-0002-2983-3669				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	27	103	104	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2007	315	5816					1282	1284		10.1126/science.1135406	http://dx.doi.org/10.1126/science.1135406			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	141FR	17255477				2022-12-28	WOS:000244564700051
J	Stanger, BZ; Tanaka, AJ; Melton, DA				Stanger, Ben Z.; Tanaka, Akemi J.; Melton, Douglas A.			Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; GENE-EXPRESSION; TRANSGENIC MICE; BETA-CATENIN; GROWTH; DIFFERENTIATION; COMPLEMENTATION; EPITHELIUM; LINEAGE; FGF10	The determinants of vertebrate organ size are poorly understood, but the process is thought to depend heavily on growth factors and other environmental cues. In the blood and central nervous system, for example, organ mass is determined primarily by growth-factor-regulated cell proliferation and apoptosis to achieve a final target size. Here, we report that the size of the mouse pancreas is constrained by an intrinsic programme established early in development, one that is essentially not subject to growth compensation. Specifically, final pancreas size is limited by the size of the progenitor cell pool that is set aside in the developing pancreatic bud. By contrast, the size of the liver is not constrained by reductions in the progenitor cell pool. These findings show that progenitor cell number, independently of regulation by growth factors, can be a key determinant of organ size.	Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA; Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Melton, DA (corresponding author), Harvard Univ, Stem Cell Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bstanger@mail.med.upenn.edu; dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Stanger, Ben/0000-0003-0410-4037				Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gallant P, 2005, CANCER RES, V65, P6485, DOI 10.1158/0008-5472.CAN-05-1101; Gilbert S.F., 2000, DEV BIOL; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KALTHOFF K, 1996, ANAL BIOL DEV; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Liegeois NJ, 1996, P NATL ACAD SCI USA, V93, P1303, DOI 10.1073/pnas.93.3.1303; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Offield MF, 1996, DEVELOPMENT, V122, P983; Papadopoulou S, 2005, DIABETES, V54, P2844, DOI 10.2337/diabetes.54.10.2844; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Twitty VC, 1931, J EXP ZOOL, V59, P61, DOI 10.1002/jez.1400590105; Wang ZD, 2004, DEV BIOL, V275, P192, DOI 10.1016/j.ydbio.2004.06.026; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw; WOLPERT L, 1981, BRIT MED BULL, V37, P215, DOI 10.1093/oxfordjournals.bmb.a071705	42	266	272	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					886	891		10.1038/nature05537	http://dx.doi.org/10.1038/nature05537			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259975				2022-12-28	WOS:000244341200042
J	Zheng, Z; Chen, TG; Li, XL; Haura, E; Sharma, A; Bepler, G				Zheng, Zhong; Chen, Tingan; Li, Xueli; Haura, Eric; Sharma, Anupama; Bepler, Gerold			DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REDUCTASE SUBUNIT M1; PHASE-III TRIAL; RIBONUCLEOTIDE REDUCTASE; PROTEIN EXPRESSION; GEMCITABINE; CISPLATIN; SURVIVAL; MUTATIONS; PTEN; SUPPRESSION	Background: RRM1, the regulatory subunit of ribonucleotide reductase, is involved in carcinogenesis, tumor progression, and the response of non-small-cell lung cancer to treatment. Methods: We developed an automated quantitative determination of the RRM1 protein in routinely processed histologic specimens. In these specimens, we measured the expression of RRM1 and two other proteins that are relevant to non-small-cell lung cancer: the excision repair cross-complementation group 1 (ERCC1) protein and the phosphatase and tensin homologue (PTEN). We compared the results with the clinical outcomes in 187 patients with early-stage non-small-cell lung cancer who had received only surgical treatment. Results: RRM1 expression correlated with the expression of ERCC1 (P < 0.001) but not with the expression of PTEN (P=0.37). The median disease-free survival exceeded 120 months in the group of patients with tumors that had high expression of RRM1 and was 54.5 months in the group with low expression of RRM1 (hazard ratio for disease progression or death in the high-expression group, 0.46; P=0.004). The overall survival was more than 120 months for patients with tumors with high expression of RRM1 and 60.2 months for those with low expression of RRM1 (hazard ratio for death, 0.61; P=0.02). Among these 187 patients, the survival advantage was limited to the 30% of patients with tumors that had a high expression of both RRM1 and ERCC1. Conclusions: RRM1 and ERCC1 are determinants of survival after surgical treatment of early-stage, non-small-cell lung cancer.	H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Bepler, G (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Div Thorac Oncol, MRC-4W,Rm 4046,12902 Magnolia Dr, Tampa, FL 33612 USA.	beplerg@moffitt.usf.edu			NCI NIH HHS [R21-CA110487, R01-CA102726] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102726, R21CA110487] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2002, J CLIN ONCOL, V20, P1353, DOI 10.1200/JCO.20.5.1353; BEPLER G, 2006, ASCO 2006 ED BOOK, P431; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bertheau P, 1998, J CLIN PATHOL, V51, P370, DOI 10.1136/jcp.51.5.370; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; CARBONE DP, 1994, CHEST, V106, pS377, DOI 10.1378/chest.106.6.377S; Ceppi P, 2006, ANN ONCOL, V17, P1818, DOI 10.1093/annonc/mdl300; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Fan HZ, 1997, P NATL ACAD SCI USA, V94, P13181, DOI 10.1073/pnas.94.24.13181; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Gridelli C, 2003, J CLIN ONCOL, V21, P3025, DOI 10.1200/JCO.2003.06.099; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Pitterle DM, 1999, MAMM GENOME, V10, P916, DOI 10.1007/s003359901114; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; Rosell R, 2005, J CLIN ONCOL, V23, p621S; RUCKDESCHEL JC, 2004, CLIN ONCOLOGY, P1649; Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shi SR, 1997, J HISTOCHEM CYTOCHEM, V45, P327, DOI 10.1177/002215549704500301; Simon GR, 2005, CHEST, V127, P978, DOI 10.1378/chest.127.3.978; Treat J, 2005, J CLIN ONCOL, V23, p627S; Tsao MS, 2006, NEW ENGL J MED, V355, P1746; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736	32	397	436	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					800	808		10.1056/NEJMoa065411	http://dx.doi.org/10.1056/NEJMoa065411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314339	Bronze			2022-12-28	WOS:000244326700006
J	Ah-See, KW; Evans, AS				Ah-See, Kim W.; Evans, Andrew S.			Sinusitis and its management	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALLERGIC RHINITIS; RHINOSINUSITIS; DIAGNOSIS; ASTHMA		Aberdeen Royal Infirm, Dept Otolaryngol Head & Neck Surg, Aberdeen AB25 2ZN, Scotland	University of Aberdeen	Ah-See, KW (corresponding author), Aberdeen Royal Infirm, Dept Otolaryngol Head & Neck Surg, Aberdeen AB25 2ZN, Scotland.	kim.ah-see@nhs.net						*AG HLTH CAR POL R, 1999, EVID REP TECHNOL ASS, V9, P1; AHSEE KW, CLIN EVIDENCE; Baroody FM, 1997, J ALLERGY CLIN IMMUN, V100, P563, DOI 10.1016/S0091-6749(97)70151-9; Benninger MS, 2003, OTOLARYNG HEAD NECK, V129, pS1, DOI 10.1016/S0194-5998(03)01397-4; BENNINGER MS, 1992, AM J RHINOL, V6, P37, DOI 10.2500/105065892781874829; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; FERGUSON BJ, 2005, CUMMINGS OTOLARYNGOL; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; FRIEDMAN DP, 1993, AM J ROENTGENOL, V160, P1095, DOI 10.2214/ajr.160.5.8470584; KARLSSON G, 1994, ACTA OTO-LARYNGOL, P26; Kennedy D, 2001, DIS SINUSES DIAGNOSI; Krouse JH, 2000, OTOLARYNG HEAD NECK, V123, P389, DOI 10.1067/mhn.2000.109476; Lane AP, 2001, OTOLARYNG HEAD NECK, V124, P9, DOI 10.1067/mhn.2001.111602; Lindbaek M, 2002, BRIT J GEN PRACT, V52, P491; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Meltzer EO, 2005, ALLERGY ASTHMA PROC, V26, P445; MESSERKLINGER W, 1987, LARYNGO RHINO OTOL, V66, P293, DOI 10.1055/s-2007-998659; Osguthorpe JD, 1999, OTOLARYNG HEAD NECK, V120, P451, DOI 10.1053/hn.1999.v120.a95228; Ramadan HH, 1999, AM J RHINOL, V13, P345, DOI 10.2500/105065899781367500; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Scheid DC, 2004, AM FAM PHYSICIAN, V70, P1685; Williams Jr JW, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000243	22	31	34	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2007	334	7589					358	361		10.1136/bmj.39092.679722.BE	http://dx.doi.org/10.1136/bmj.39092.679722.BE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	141EJ	17303885	Green Published			2022-12-28	WOS:000244560400034
J	Li, HT; Xu, H; Zhou, Y; Zhang, J; Long, CZ; Li, SQ; Chen, S; Zhou, JM; Shao, F				Li, Hongtao; Xu, Hao; Zhou, Yan; Zhang, Jie; Long, Chengzu; Li, Shuqin; Chen, She; Zhou, Jian-Min; Shao, Feng			The phosphothreonine lyase activity of a bacterial type III effector family	SCIENCE			English	Article							VIRULENCE PLASMID; SECRETION SYSTEM; ACTIVATION; EXPRESSION; INFECTION	Pathogenic bacteria use the type III secretion system to deliver effector proteins into host cells to modulate the host signaling pathways. In this study, the Shigella type III effector OspF was shown to inactivate mitogen-activated protein kinases (MAPKs) [ extracellular signal-regulated kinases 1 and 2 ( Erk1/2), c-Jun N-terminal kinase, and p38]. OspF irreversibly removed phosphate groups from the phosphothreonine but not from the phosphotyrosine residue in the activation loop of MAPKs. Mass spectrometry revealed a mass loss of 98 daltons in p-Erk2, due to the abstraction of the a proton concomitant with cleavage of the C-OP bond in the phosphothreonine residue. This unexpected enzymatic activity, termed phosphothreonine lyase, appeared specific for MAPKs and was shared by other OspF family members.	Natl Inst Biol Sci, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhou, Jian-Min/A-3140-2013	Zhou, Jian-Min/0000-0002-9943-2975; Xu, Hao/0000-0003-3286-0710				Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; GULIG PA, 1993, INFECT IMMUN, V61, P504, DOI 10.1128/IAI.61.2.504-511.1993; Kane CD, 2002, J BACTERIOL, V184, P4409, DOI 10.1128/JB.184.16.4409-4419.2002; Kohler H, 2002, INFECT IMMUN, V70, P1150, DOI 10.1128/IAI.70.3.1150-1158.2002; Le Gall T, 2005, MICROBIOL-SGM, V151, P951, DOI 10.1099/mic.0.27639-0; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Libby SJ, 1997, INFECT IMMUN, V65, P1786, DOI 10.1128/IAI.65.5.1786-1792.1997; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Ogawa M, 2006, CELL MICROBIOL, V8, P177, DOI 10.1111/j.1462-5822.2005.00652.x; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Philpott DJ, 2001, CURR OPIN IMMUNOL, V13, P410; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06	17	316	334	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					1000	1003		10.1126/science.1138960	http://dx.doi.org/10.1126/science.1138960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303758				2022-12-28	WOS:000244229800046
J	Raoult, D; Abbara, S; Jassal, DS; Kradin, RL; Myers, JE; Harris, NL; Plank, RM; Felsenstein, D				Raoult, Didier; Abarra, Suhny; Jassal, Davinder S.; Kradin, Richard L.; Myers, Julie E.; Harris, Nancy Lee; Plank, Rebeca M.; Felsenstein, Donna			A 53-year-old man with a prosthetic aortic valve and recent onset of fatigue, dyspnea, weight loss, and sweats - C-burnetii (Q fever) endocarditis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTIVE ENDOCARDITIS; DIAGNOSIS; QUINTANA		Univ Aix Marseille 2, Fac Med, Dept Clin Microbiol, Unite Rickettsies, Marseille, France; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	UDICE-French Research Universities; Aix-Marseille Universite; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Raoult, D (corresponding author), Univ Aix Marseille 2, Fac Med, Dept Clin Microbiol, Unite Rickettsies, Marseille, France.		RAOULT, Didier/A-8434-2008; Abbara, Suhny/C-3692-2014	RAOULT, Didier/0000-0002-0633-5974; Jassal, Davinder/0000-0002-3639-9047; Abbara, Suhny/0000-0003-2552-7362				Baron EJ, 2005, CLIN INFECT DIS, V41, P1677, DOI 10.1086/497595; Brouqui P, 2001, CLIN MICROBIOL REV, V14, P177, DOI 10.1128/CMR.14.1.177-207.2001; Brouqui P, 2006, FEMS IMMUNOL MED MIC, V47, P1, DOI 10.1111/j.1574-695X.2006.00054.x; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; DRANCOURT M, 1995, NEW ENGL J MED, V332, P419, DOI 10.1056/NEJM199502163320702; Fournier PE, 2001, MEDICINE, V80, P245, DOI 10.1097/00005792-200107000-00003; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Lepidi H, 2005, CLIN INFECT DIS, V40, P655, DOI 10.1086/427504; Lepidi H, 2002, INFECT DIS CLIN N AM, V16, P339, DOI 10.1016/S0891-5520(02)00005-3; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; MARRIE TJ, 1988, J INFECT DIS, V158, P101, DOI 10.1093/infdis/158.1.101; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Millar BC, 2004, EUR J CLIN MICROBIOL, V23, P353, DOI 10.1007/s10096-004-1132-6; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; PINSKY RL, 1991, J INFECT DIS, V164, P202, DOI 10.1093/infdis/164.1.202; Raoult D, 2005, J CLIN MICROBIOL, V43, P5238, DOI 10.1128/JCM.43.10.5238-5242.2005	16	13	14	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					715	725		10.1056/NEJMcpc069036	http://dx.doi.org/10.1056/NEJMcpc069036			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301303				2022-12-28	WOS:000244193300011
J	Gornall, J				Gornall, Jonathan			Where do we draw the line?	BRITISH MEDICAL JOURNAL			English	Editorial Material							EXTREMELY PRETERM BIRTH; DEVELOPMENTAL-DISABILITY; ABORTION; RISK											*BMA MED ETH COMM, 2005, AB TIM LIM BRIEF PAP; Brind J, 1996, J EPIDEMIOL COMMUN H, V50, P481, DOI 10.1136/jech.50.5.481; CAMPBELL S, 2006, DAILY TELEGRAPH 1004; DORRIES N, NADINE REPRESENT ABO; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; *GOV STAT SERV, 2006, STAT B GOV STAT SERV, V1; LEE E, ABORTION ITS MENTAL; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mellor DJ, 2005, BRAIN RES REV, V49, P455, DOI 10.1016/j.brainresrev.2005.01.006; Moreau C, 2005, BJOG-INT J OBSTET GY, V112, P430, DOI 10.1111/j.1471-0528.2004.00478.x; Nuffield Council on Bioethics, 2006, CRIT CAR DEC FET NEO; OAKESHOTT I, 2003, EVENING STANDAR 0912; *ROYAL COLL OBST G, 2004, NAT EV BAS CLIN GUID; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	14	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 10	2007	334	7588					285	289		10.1136/bmj.39114.466875.BE	http://dx.doi.org/10.1136/bmj.39114.466875.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	142MN	17289728	Green Published			2022-12-28	WOS:000244654100027
J	Jaegle, L				Jaegle, Lyatt			Pumping up surface air	SCIENCE			English	Editorial Material							TRANSPORT	Towering cumulus clouds associated with thunderstorms enable the spread of pollution on intercontinental scales.	Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Jaegle, L (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	jaegle@atmos.washington.edu	Jaegle, Lyatt/M-6536-2015	Jaegle, Lyatt/0000-0003-1866-801X				BERTRAM TH, 2007, SCIENCE         0104, DOI DOI 10.1126/SCIENCE.1134548; Bertram TH, 2007, SCIENCE, V315, P816, DOI 10.1126/science.1134548; Clarke AD, 1998, J GEOPHYS RES-ATMOS, V103, P16397, DOI 10.1029/97JD02987; DICKERSON RR, 1987, SCIENCE, V235, P460, DOI 10.1126/science.235.4787.460; GIDEL LT, 1983, J GEOPHYS RES-OCEANS, V88, P6587, DOI 10.1029/JC088iC11p06587; PICKERING KE, 1992, J GEOPHYS RES-ATMOS, V97, P17985, DOI 10.1029/92JD01716; RIND D, 1991, NATURE, V349, P500, DOI 10.1038/349500a0; Singh HB, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007905	8	8	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					772	773		10.1126/science.1138988	http://dx.doi.org/10.1126/science.1138988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289964				2022-12-28	WOS:000244069000032
J	Serber, Z; Ferrell, JE				Serber, Zach; Ferrell, James E., Jr.			Tuning bulk electrostatics to regulate protein function	CELL			English	Review							PHOSPHORYLATION; BINDING; THRESHOLD; KINASES; PATHWAY		Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, MC 5174, Stanford, CA 94305 USA.	james.ferrell@stanford.edu						BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; CHANG F, 1992, MOL BIOL CELL, V3, P445, DOI 10.1091/mbc.3.4.445; CHOI KY, 1994, CELL, V78, P499; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; KIM JY, 1994, J BIOL CHEM, V269, P28214; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; OEHLEN LJWM, 1994, GENE DEV, V8, P1058, DOI 10.1101/gad.8.9.1058; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pufall MA, 2005, SCIENCE, V309, P142, DOI 10.1126/science.1111915; STRICKFADEN SC, 2007, CELL; Wassmann K, 1997, J BIOL CHEM, V272, P13180, DOI 10.1074/jbc.272.20.13180; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020	19	93	95	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					441	444		10.1016/j.cell.2007.01.018	http://dx.doi.org/10.1016/j.cell.2007.01.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289565	Bronze			2022-12-28	WOS:000244842700012
J	Young, WF				Young, William F., Jr.			The incidentally discovered adrenal mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBCLINICAL CUSHINGS-SYNDROME; DEXAMETHASONE-SUPPRESSION TEST; CONTRAST-ENHANCED CT; TERM-FOLLOW-UP; UNSUSPECTED PHEOCHROMOCYTOMA; PRIMARY ALDOSTERONISM; CARDIOVASCULAR RISK; DIAGNOSIS; MANAGEMENT; PREVALENCE		Mayo Clin & Mayo Fdn, Div Endocrinol Diabet Metab Nutr & Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Young, WF (corresponding author), Mayo Clin & Mayo Fdn, Div Endocrinol Diabet Metab Nutr & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	young.william@mayo.edu						Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Angeli A, 1997, HORM RES, V47, P279, DOI 10.1159/000185477; Arellano Ronald S, 2003, Curr Probl Diagn Radiol, V32, P3, DOI 10.1067/cdr.2003.120002; Barzon L, 2002, EUR J ENDOCRINOL, V146, P61, DOI 10.1530/eje.0.1460061; Barzon L, 1999, J CLIN ENDOCR METAB, V84, P520, DOI 10.1210/jc.84.2.520; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Brunaud L, 2006, MED SCI MONITOR, V12, pCR355; Bulow B, 2006, EUR J ENDOCRINOL, V154, P419, DOI 10.1530/eje.1.02110; CASOLA G, 1986, RADIOLOGY, V159, P733, DOI 10.1148/radiology.159.3.3517958; Chiodini I, 2002, J CLIN ENDOCR METAB, V87, P5491, DOI 10.1210/jc.2002-020399; Emral R, 2003, ENDOCR J, V50, P399, DOI 10.1507/endocrj.50.399; Erbil Y, 2006, WORLD J SURG, V30, P1665, DOI 10.1007/s00268-005-0681-x; Gorges R, 1999, J ENDOCRINOL INVEST, V22, P241; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Harisinghani MG, 2002, CLIN RADIOL, V57, P898, DOI 10.1053/crad.2002.1054; Hennings J, 2006, J CLIN ENDOCR METAB, V91, P1410, DOI 10.1210/jc.2005-2273; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hussain Hero K, 2004, Magn Reson Imaging Clin N Am, V12, P515, DOI 10.1016/j.mric.2004.03.008; IKEDA O, IN PRESS ABDOM IMAGI; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Korobkin M, 1998, AM J ROENTGENOL, V170, P747, DOI 10.2214/ajr.170.3.9490968; Kudva YC, 2003, J CLIN ENDOCR METAB, V88, P4533, DOI 10.1210/jc.2003-030720; Lee JE, 1998, SURGERY, V124, P1115, DOI 10.1067/msy.1998.92009; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Lenert JT, 2001, SURGERY, V130, P1060, DOI 10.1067/msy.2001.118369; Libe R, 2002, EUR J ENDOCRINOL, V147, P489, DOI 10.1530/eje.0.1470489; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; MCCORKELL SJ, 1985, AM J ROENTGENOL, V145, P113, DOI 10.2214/ajr.145.1.113; MCLEOD MK, 1990, AM SURGEON, V56, P398; Meyer A, 2005, INT J UROL, V12, P239, DOI 10.1111/j.1442-2042.2005.01034.x; Montori VM, 2002, ENDOCRIN METAB CLIN, V31, P619, DOI 10.1016/S0889-8529(02)00013-0; Motta-Ramirez GA, 2005, AM J ROENTGENOL, V185, P684, DOI 10.2214/ajr.185.3.01850684; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; NUGENT CA, 1965, ARCH INTERN MED, V116, P172, DOI 10.1001/archinte.1965.03870020012006; Pena CS, 2000, RADIOLOGY, V217, P798, DOI 10.1148/radiology.217.3.r00dc29798; PERRY CG, IN PRESS CLIN ENDOCR; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P553, DOI 10.1210/jc.2002-021251; Sawka Anna M, 2004, BMC Endocr Disord, V4, P2, DOI 10.1186/1472-6823-4-2; SUTTON MGS, 1981, MAYO CLIN PROC, V56, P354; Szolar DH, 2005, RADIOLOGY, V234, P479, DOI 10.1148/radiol.2342031876; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-011766; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.998; Tsagarakis S, 2006, J ENDOCRINOL INVEST, V29, P471, DOI 10.1007/BF03344133; Tsagarakis S, 1998, CLIN ENDOCRINOL, V49, P165, DOI 10.1046/j.1365-2265.1998.00509.x; WELCH TJ, 1994, RADIOLOGY, V193, P341, DOI 10.1148/radiology.193.2.7972740; Young WF, 2000, ENDOCRIN METAB CLIN, V29, P159, DOI 10.1016/S0889-8529(05)70122-5; YOUNG WF, IN PRESS CLIN ENDOCR; Yun MJ, 2001, J NUCL MED, V42, P1795	49	683	719	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					601	610		10.1056/NEJMcp065470	http://dx.doi.org/10.1056/NEJMcp065470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287480				2022-12-28	WOS:000244012700008
J	Zanazzi, A; Kohn, MJ; MacFadden, BJ; Terry, DO				Zanazzi, Alessandro; Kohn, Matthew J.; MacFadden, Bruce J.; Terry, Dennis O., Jr.			Large temperature drop across the Eocene-Oligocene transition in central North America	NATURE			English	Article							EXTINCTIONS; GLACIATION	The Eocene - Oligocene transition towards a cool climate (similar to 33.5 million years ago) was one of the most pronounced climate events during the Cenozoic era(1). The marine record of this transition has been extensively studied. However, significantly less research has focused on continental climate change at the time, yielding partly inconsistent results on the magnitude and timing of the changes(2-8). Here we use a combination of in vivo stable isotope compositions of fossil tooth enamel with diagenetic stable isotope compositions of fossil bone to derive a high-resolution ( about 40,000 years) continental temperature record for the Eocene - Oligocene transition. We find a large drop in mean annual temperature of 8.2 +/- 3.1 degrees C over about 400,000 years, the possibility of a small increase in temperature seasonality, and no resolvable change in aridity across the transition. The large change in mean annual temperature, exceeding changes in sea surface temperatures at comparable latitudes(9,10) and possibly delayed in time with respect to marine changes by up to 400,000 years, explains the faunal turnover for gastropods, amphibians and reptiles, whereas most mammals in the region were unaffected. Our results are in agreement with modelling studies that attribute the climate cooling at the Eocene - Oligocene transition to a significant drop in atmospheric carbon dioxide concentrations.	Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA; Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; Temple Univ, Dept Geol, Philadelphia, PA 19122 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Zanazzi, A (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29208 USA.	azanazzi@geol.sc.edu; mjk@geol.sc.edu	Kohn, Matthew/A-2562-2012	Kohn, Matthew/0000-0002-7202-4525				Aubry Marie-Pierre, 1992, P272; Baldauf JG., 1992, EOCENE OLIGOCENE CLI, P310; Bestland EA, 1997, J GEOL, V105, P153, DOI 10.1086/515906; Cerling T.E., 1993, CLIMATE CHANGE CONTI, V78, P217; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chase C.G., 1998, TECTONIC BOUNDARY CO, V39, P73, DOI 10.2475/02.2012.05; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Evanoff E, 1992, EOCENE OLIGOCENE BIO, P116, DOI DOI 10.1515/9781400862924.116; Hansen TA, 2004, PALAEOGEOGR PALAEOCL, V214, P233, DOI 10.1016/j.palaeo.2004.06.017; Hendricks MB, 2000, GLOBAL BIOGEOCHEM CY, V14, P851, DOI 10.1029/1999GB001198; Hutchison J. Howard, 1992, P451; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; JANIS C, 1976, EVOLUTION, V30, P757, DOI 10.1111/j.1558-5646.1976.tb00957.x; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Kohn MJ, 2006, GEOCHIM COSMOCHIM AC, V70, P931, DOI 10.1016/j.gca.2005.10.023; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; KOHN MJ, IN PRESS PALEOBIOS; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Prothero D.R., 1996, TERRESTRIAL EOCENE O, P262, DOI DOI 10.1017/CB09780511665431.014; Prothero Donald R., 1998, Geological Society of America Special Paper, V325, P39; Prothero DR, 1996, PALAEOGEOGR PALAEOCL, V127, P257, DOI 10.1016/S0031-0182(96)00099-5; Retallack GJ, 1992, EOCENE OLIGOCENE CLI, P382; SWISHER CC, 1990, SCIENCE, V249, P760, DOI 10.1126/science.249.4970.760; Terry DO, 2001, PALAEOGEOGR PALAEOCL, V168, P1, DOI 10.1016/S0031-0182(00)00248-0; Toggweiler JR, 2000, J QUATERNARY SCI, V15, P319, DOI 10.1002/1099-1417(200005)15:4<319::AID-JQS545>3.0.CO;2-C; WOLFE JA, 1994, PALAEOGEOGR PALAEOCL, V108, P195, DOI 10.1016/0031-0182(94)90233-X; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	29	200	214	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					639	642		10.1038/nature05551	http://dx.doi.org/10.1038/nature05551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287808				2022-12-28	WOS:000244039400042
J	O'Donnell, MJ; Kearon, C; Johnson, J; Robinson, M; Zondag, M; Turpie, I; Turpie, AG				O'Donnell, Martin J.; Kearon, Clive; Johnson, Judy; Robinson, Marlene; Zondag, Michelle; Turpie, Irene; Turpie, Alexander G.			Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							PERIOPERATIVE MANAGEMENT; ELECTIVE SURGERY; ENOXAPARIN; PATIENT; THERAPY	Background: Preoperative low-molecular-weight heparin (LMWH) is often used when warfarin therapy is interrupted for surgery. Objective: To determine the preoperative anticoagulant activity of LMWH following a standardized "bridging" regimen. Design: Prospective cohort study. Setting: Single university hospital. Patients: Consecutive patients who had warfarin therapy interrupted before an invasive procedure. Intervention: Enoxaparin, 1 mg/kg of body weight, twice daily. The last dose was administered the evening before surgery. Measurements: Blood anti-factor Xa heparin levels measured shortly before surgery. Results: Preoperative anti-Xa heparin levels were obtained in 80 patients at an average of 14 hours after the last dose of enoxaparin was administered. The average anti-Xa heparin level was 0.6 U/mL. The anti-Xa heparin level, measured shortly before surgery, was 0.5 U/mL or greater in 54 (68%) patients and 1.0 U/mL or greater in 13 (16%) patients. A shorter interval since the last dose (P < 0.001) and a higher body mass index (P = 0.001) were associated with higher preoperative anti-Xa heparin levels. Limitations: The small sample size limits accurate estimates of the frequency of the clinical outcomes. A single regimen of LMWH was evaluated. Conclusions: Anti-Xa heparin levels often remain high at the time of surgery if a last dose of a twice-daily regimen of LMWH is given the evening before surgery.	McMaster Univ, Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; Hamilton Hlth Sci Fdn, Hamilton, ON, Canada	McMaster University	O'Donnell, MJ (corresponding author), McMaster Univ, Henderson Res Ctr, 70 Wing,Room 220,711 Concess St, Hamilton, ON L8V 1C3, Canada.	odonnm@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020	O'Donnell, Martin/0000-0002-7347-7761				Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S; Becker RC, 2002, AM HEART J, V143, P753, DOI 10.1067/mhj.2002.120774; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Douketis JD, 2004, ARCH INTERN MED, V164, P1319, DOI 10.1001/archinte.164.12.1319; Douketis JD, 2002, THROMB HAEMOSTASIS, V88, P37; Douketis JD, 2000, CAN J CARDIOL, V16, P326; Fareed J, 1998, AM J CARDIOL, V82, p3L, DOI 10.1016/S0002-9149(98)00105-2; Garcia DA, 2005, J THROMB THROMBOLYS, V18, P199, DOI 10.1007/s11239-005-0346-5; Heit JA, 2001, J THROMB THROMBOLYS, V12, P81, DOI 10.1023/A:1012746729537; Kearon C, 1997, NEW ENGL J MED, V336, P1506, DOI 10.1056/NEJM199705223362107; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Montalescot G, 2004, CIRCULATION, V110, P392, DOI 10.1161/01.CIR.0000136830.65073.C7; O'Donnell M, 2006, CLIN GERIATR MED, V22, P199, DOI 10.1016/j.cger.2005.09.008; Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x; Turpie AG, 2004, BLOOD, V104, p202A, DOI 10.1182/blood.V104.11.703.703; Wilson SJ, 2001, HAEMOSTASIS, V31, P42	16	71	74	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					184	187		10.7326/0003-4819-146-3-200702060-00007	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283349				2022-12-28	WOS:000243957400004
J	Potts, M; Fotso, JC				Potts, Malcolm; Fotso, Jean-Christophe			Population growth and the millennium development goals	LANCET			English	Editorial Material									Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94707 USA; Shelter Afrique Ctr, African Populat & Hlth Resource Ctr, Nairobi, Kenya	University of California System; University of California Berkeley; African Population & Health Research Centre	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94707 USA.	pottsmalcolm@berkeley.edu						All Party Parliamentary Group On Population D. A. R. H., 2007, RET POP GROWTH FACT; Campbell M, 2006, STUD FAMILY PLANN, V37, P87, DOI 10.1111/j.1728-4465.2006.00088.x; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; LEE RD, 2001, POPULATION DOES MATT, P00137; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; United Nations Population Funds (UNFPA), 1994, INT C POP DEV CAIR S	6	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 3	2007	369	9559					354	355		10.1016/S0140-6736(07)60158-5	http://dx.doi.org/10.1016/S0140-6736(07)60158-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	132LN	17276759				2022-12-28	WOS:000243944400008
J	Coombes, R				Coombes, Rebecca			Is killing pain worth the risk? MPs argue that the regulator went too far when it banned co-proxamol	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JAN 27	2007	334	7586					186	187		10.1136/bmj.39104.415961.68	http://dx.doi.org/10.1136/bmj.39104.415961.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133QN	17255610	Green Published			2022-12-28	WOS:000244027600031
J	Basak, S; Kim, H; Kearns, JD; Tergaonkar, V; O'Dea, E; Werner, SL; Benedict, CA; Ware, CF; Ghosh, G; Verma, IM; Hoffmann, A				Basak, Soumen; Kim, Hana; Kearns, Jeffrey D.; Tergaonkar, Vinay; O'Dea, Ellen; Werner, Shannon L.; Benedict, Chris A.; Ware, Carl F.; Ghosh, Gourisankar; Verma, Inder M.; Hoffmann, Alexander			A fourth I kappa B protein within the NF-kappa B signaling module	CELL			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; GENE-EXPRESSION; ACTIVATION PATHWAYS; LYMPHOID-TISSUES; TEMPORAL CONTROL; TARGET GENES; DNA-BINDING; IKK-ALPHA; NF-KAPPA-B2; KINASE	Inflammatory NF-kappa B/RelA activation is mediated by the three canonical inhibitors, I kappa B alpha, -beta, and -epsilon. We report here the characterization of a fourth inhibitor, nf kappa b2/p100, that forms two distinct inhibitory complexes with RelA, one of which mediates developmental NF-kappa B activation. Our genetic evidence confirms that p100 is required and sufficient as a fourth I kappa B protein for noncanonical NF-kappa B signaling downstream of NIK and IKK1. We develop a mathematical model of the four-I kappa B-containing NF-kappa B signaling module to account for NF-kappa B/BelA:p50 activation in response to inflammatory and developmental stimuli and find signaling crosstalk between them that determines gene-expression programs. Further combined computational and experimental studies reveal that mutant cells with altered balances between canonical and noncanonical I kappa B proteins may exhibit inappropriate inflammatory gene expression in response to developmental signals. Our results have important implications for physiological and pathological scenarios in which inflammatory and developmental signals converge.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Signaling Syst Lab, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; La Jolla Institute for Immunology	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu		Basak, Soumen/0000-0002-3586-1279	NCI NIH HHS [P01 CA069381, CA69381] Funding Source: Medline; NIAID NIH HHS [R37AI33068, AI61549, R21 AI061549] Funding Source: Medline; NIGMS NIH HHS [GM071573, GM071862, P01 GM071862, R01 GM071573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA069381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033068, R21AI061549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071573, P01GM071862] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alcamo E, 2002, J EXP MED, V195, P233, DOI 10.1084/jem.20011885; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; MERCURIO F, 1993, GENE DEV, V7, P705, DOI 10.1101/gad.7.4.705; Moorthy AK, 2003, J BIOL CHEM, V278, P556, DOI 10.1074/jbc.M207515200; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Mordmuller B, 2003, EMBO REP, V4, P82, DOI 10.1038/embor710; Muller JR, 2003, J BIOL CHEM, V278, P12006, DOI 10.1074/jbc.M210768200; NAUMANN M, 1993, ONCOGENE, V8, P2275; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rennert PD, 1998, IMMUNITY, V9, P71, DOI 10.1016/S1074-7613(00)80589-0; Schneider K, 2004, IMMUNOL REV, V202, P49, DOI 10.1111/j.0105-2896.2004.00206.x; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; Weih DS, 2001, J IMMUNOL, V167, P1909, DOI 10.4049/jimmunol.167.4.1909; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zarnegar B, 2004, P NATL ACAD SCI USA, V101, P8108, DOI 10.1073/pnas.0402629101	40	292	302	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					369	381		10.1016/j.cell.2006.12.033	http://dx.doi.org/10.1016/j.cell.2006.12.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254973	Bronze, Green Accepted			2022-12-28	WOS:000244420500020
J	Rothwell, PM				Rothwell, Peter M.			Observational comparisons of different clinical services	LANCET			English	Editorial Material							STROKE; INDIVIDUALS; TRIALS; ATTACK; DRUGS; RISK; CARE		Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				Candelise L, 2007, LANCET, V369, P299, DOI 10.1016/S0140-6736(07)60152-4; Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rothwell PM, 2005, LANCET, V365, P256; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; *STROK UN TRIAL CO, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000197; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4	13	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN-FEB	2007	369	9558					254	255		10.1016/S0140-6736(07)60123-8	http://dx.doi.org/10.1016/S0140-6736(07)60123-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258649				2022-12-28	WOS:000243912000007
J	Klose, RJ; Yan, Q; Tothova, Z; Yamane, K; Erdjument-Bromage, H; Tempst, P; Gilliland, DG; Zhang, Y; Kaelin, WG				Klose, Robert J.; Yan, Qin; Tothova, Zuzana; Yamane, Kenichi; Erdjument-Bromage, Hediye; Tempst, Paul; Gilliland, D. Gary; Zhang, Yi; Kaelin, William G., Jr.			The retinoblastoma binding protein RBP2 is an H3K4 demethylase	CELL			English	Article							HISTONE H3; MYELOID PROGENITOR; OXIDATIVE DEMETHYLATION; LYSINE-4 METHYLATION; STRUCTURAL BASIS; MOLECULAR-BASIS; JARID1C GENE; PHD FINGER; FAMILY; DOMAIN	Changes in histone methylation status regulate chromatin structure and DNA-dependent processes such as transcription. Recent studies indicate that, analogous to other histone modifications, histone methylation is reversible. Retinoblastoma binding protein 2 (RBP2), a nuclear protein implicated in the regulation of transcription and differentiation by the retinoblastoma tumor suppressor protein, contains a JmjC domain recently defined as a histone demethylase signature motif. Here we report that RBP2 is a demethylase that specifically catalyzes demethylation on H3K4, whose methylation is normally associated with transcriptionally active genes. RBP2-/- mouse cells displayed enhanced transcription of certain cytokine genes, which, in the case of SDF1, was associated with increased H3K4 trimethylation. Furthermore, RBP2 specifically demethylated H3K4 in biochemical and cell-based assays. These studies provide mechanistic insights into transcriptional regulation by RBP2 and provide the first example of a mammalian enzyme capable of erasing trimethylated H3K4.	Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Linenberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol,Dept Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu; william_kaelin@dfci.harvard.edu	Yan, Qin/E-8893-2012; Hu, Ruogu/B-2203-2008	Yan, Qin/0000-0003-4077-453X; Zhang, Yi/0000-0002-2789-0811; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [CA 076120] Funding Source: Medline; NIGMS NIH HHS [GM 68804] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chan SW, 2001, J BIOL CHEM, V276, P28402, DOI 10.1074/jbc.M100313200; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; FATTAEY AR, 1993, ONCOGENE, V8, P3149; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gildea JJ, 2000, GENETICS, V156, P645; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; KIM YW, 1994, MOL CELL BIOL, V14, P7256, DOI 10.1128/MCB.14.11.7256; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Osoegawa K, 2000, GENOME RES, V10, P116; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; QUARTIN RS, 1994, J VIROL, V68, P1334, DOI 10.1128/JVI.68.3.1334-1341.1994; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	60	333	346	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 9	2007	128	5					889	900		10.1016/j.cell.2007.02.013	http://dx.doi.org/10.1016/j.cell.2007.02.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17320163	Bronze			2022-12-28	WOS:000245073400014
J	Kouzarides, T				Kouzarides, Tony			Chromatin modifications and their function	CELL			English	Review							HISTONE H3 LYSINE-9; SACCHAROMYCES-CEREVISIAE; H3K56 ACETYLATION; STRUCTURAL BASIS; JMJD2 FAMILY; METHYLATION; DNA; RECOGNITION; PHOSPHORYLATION; RECRUITMENT		Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	t.kouzarides@gurdon.cam.ac.uk	Jansen, Nils/G-1835-2011; li, ran/K-1896-2012	Kouzarides, Tony/0000-0002-8918-4162				Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Clements A, 2003, MOL CELL, V12, P461, DOI 10.1016/S1097-2765(03)00288-0; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Fillingham J, 2006, BIOCHEM CELL BIOL, V84, P568, DOI 10.1139/O06-072; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Fukagawa T, 2004, CHROMOSOME RES, V12, P557, DOI 10.1023/B:CHRO.0000036590.96208.83; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hidaka Y, 2005, FEBS LETT, V579, P4088, DOI 10.1016/j.febslet.2005.06.035; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Krishnamoorthy T, 2006, GENE DEV, V20, P2580, DOI 10.1101/gad.1457006; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Macek B, 2006, MOL CELL PROTEOMICS, V5, P949, DOI 10.1074/mcp.T500042-MCP200; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	90	7488	7808	39	1564	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					693	705		10.1016/j.cell.2007.02.005	http://dx.doi.org/10.1016/j.cell.2007.02.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320507	Bronze			2022-12-28	WOS:000245098600012
J	Maciejewski, PK; Zhang, BH; Block, SD; Prigerson, HG				Maciejewski, Paul K.; Zhang, Baohui; Block, Susan D.; Prigerson, Holly G.			An empirical examination of the stage theory of grief	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPOUSAL BEREAVEMENT; DEPRESSION; DEATH; SCALE	Context The stage theory of grief remains a widely accepted model of bereavement adjustment still taught in medical schools, espoused by physicians, and applied in diverse contexts. Nevertheless, the stage theory of grief has previously not been tested empirically. Objective To examine the relative magnitudes and patterns of change over time post-loss of 5 grief indicators for consistency with the stage theory of grief. Design, Setting, and Participants Longitudinal cohort study (Yale Bereavement Study) of 233 bereaved individuals living in Connecticut, with data collected between January 2000 and January 2003. Main Outcome Measures Five rater-administered items assessing disbelief, yearning, anger, depression, and acceptance of the death from 1 to 24 months postloss. Results Counter to stage theory, disbelief was not the initial, dominant grief indicator. Acceptance was the most frequently endorsed item and yearning was the dominant negative grief indicator from 1 to 24 months postloss. In models that take into account the rise and fall of psychological responses, once rescaled, disbelief decreased from an initial high at 1 month postloss, yearning peaked at 4 months postloss, anger peaked at 5 months postloss, and depression peaked at 6 months postloss. Acceptance increased throughout the study observation period. The 5 grief indicators achieved their respective maximum values in the sequence (disbelief, yearning, anger, depression, and acceptance) predicted by the stage theory of grief. Conclusions Identification of the normal stages of grief following a death from natural causes enhances understanding of how the average person cognitively and emotionally processes the loss of a family member. Given that the negative grief indicators all peak within approximately 6 months postloss, those who score high on these indicators beyond 6 months postloss might benefit from further evaluation.	Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Psychiat, Womens Hlth Res & Magnet Resonance Res Ctr, New Haven, CT USA; Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Prigerson, HG (corresponding author), Dana Farber Canc Inst, Ctr Psychooncol & Palliat Care Res, 44 Binney St SW,G440A, Boston, MA 02115 USA.	holly_prigerson@dfci.harvard.edu	Prigerson, Holly/L-3800-2019; Prigerson, Holly/GWV-3283-2022	Prigerson, Holly/0000-0002-7075-4268; 	NATIONAL CANCER INSTITUTE [R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892, R01MH056529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K25NS044316] Funding Source: NIH RePORTER; NCI NIH HHS [CA106370, R01 CA106370] Funding Source: Medline; NIMH NIH HHS [MH56529, MH63892] Funding Source: Medline; NINDS NIH HHS [NS044316] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P684; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; Bonanno GA, 2002, J PERS SOC PSYCHOL, V83, P1150, DOI 10.1037//0022-3514.83.5.1150; BOWLBY J, 1961, INT J PSYCHOANAL, V42, P317; Bowlby J., 1980, ATTACHMENT AND LOSS; Chochinov HM, 1997, AM J PSYCHIAT, V154, P674; CLAYTON PJ, 1972, BRIT J PSYCHIAT, V120, P71, DOI 10.1192/bjp.120.554.71; Currier JM, 2006, DEATH STUD, V30, P403, DOI 10.1080/07481180600614351; DowneWamboldt B, 1997, DEATH STUD, V21, P177; GRAY C, 1991, AM J ORTHOPSYCHIAT, V61, P138, DOI 10.1037/h0079223; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; HOYERT DL, 2005, VITAL HLTH STAT, V15, P16; Jacobs SC, 1993, PATHOLOGIC GRIEF MAL; Kubler-Ross E., 1969, DEATH DYING; Leibenluft E, 1988, Psychiatr Hosp, V19, P169; Middleton W, 1998, AUST NZ J PSYCHIAT, V32, P235, DOI 10.3109/00048679809062734; *NAT CANC I, CANC TOP LOSS GRIEF; Ott CH, 2002, DEATH STUD, V26, P387, DOI 10.1080/07481180290087375; Parkes CM, 1983, RECOVERY BEREAVEMENT; Parkes Collin Murray, 1972, BEREAVEMENT STUDIES; Prigerson H., 2001, HDB BEREAVEMENT RES, P588; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; PRIGERSON HG, 2007, HDB BEREAVEMENT RES; Prigerson HG, 2005, OMEGA-J DEATH DYING, V52, P9; *US BUR CENS, POP HOUS EC GEOGR DA; WORTMAN CB, 1989, J CONSULT CLIN PSYCH, V57, P349, DOI 10.1037/0022-006X.57.3.349; Zhang BH, 2006, J PALLIAT MED, V9, P1188, DOI 10.1089/jpm.2006.9.1188; ZISOOK S, 1991, AM J PSYCHIAT, V148, P1346; ZISOOK S, 1994, J CLIN PSYCHIAT, V55, P29	30	312	319	2	97	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					716	723		10.1001/jama.297.7.716	http://dx.doi.org/10.1001/jama.297.7.716			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	137KI	17312291	Bronze			2022-12-28	WOS:000244291100023
J	Levi, Z; Rozen, P; Hazazi, R; Vilkin, A; Waked, A; Maoz, E; Birkenfeld, S; Leshno, M; Niv, Y				Levi, Zohar; Rozen, Paul; Hazazi, Rachel; Vilkin, Alex; Waked, Amal; Maoz, Eran; Birkenfeld, Shlomo; Leshno, Moshe; Niv, Yaron			A quantitative immunochemical fecal occult blood test for colorectal neoplasia	ANNALS OF INTERNAL MEDICINE			English	Article							PERFORMANCE-CHARACTERISTICS; CHINESE POPULATION; CANCER; COLONOSCOPY; QUANTIFICATION; ADENOMAS; RISK	Background: Guaiac-based fecal occult blood tests (FOBTs) for colorectal cancer screening are not specific for human hemoglobin and have low sensitivity. Automated-development, immunochemical FOBT is quality-controlled, is specific for human hemoglobin, and does not require diet restriction. Objectives: To measure the sensitivity and specificity of quantitative immunochernical fecal hemoglobin measurements for detection of cancer and advanced adenoma in patients undergoing colonoscopy, to determine fecal hemoglobin thresholds that give the highest posttest probability for neoplasia, and to determine the number of immunochemical FOBTs needed. Design: Prospective, cross-sectional study. Setting: Ambulatory endoscopy services of the main health medical organization in Tel Aviv, Israel. Participants: 1000 consecutive ambulatory patients-some asymptornatic but at increased risk for colorectal neoplasia and some symptomatic-who were undergoing elective colonoscopy and volunteered to prepare immunochemical FOBTs. Intervention: The hemoglobin content of 3 bowel movements was measured, and the highest value was compared with colonoscopy findings. Measurements: Sensitivity, specificity, predictive values, likelihood ratios, and 95% Cls of fecal hemoglobin measurements for clinically significant neoplasia, their relationship to the amount of fecal hemoglobin measured, and the number of immunochemical FOBTs performed. Results: Colonoscopy identified clinically significant neoplasia in 91 patients (cancer in 17 patients and advanced adenomas in 74 patients). Using 3 immunochemical FOBTs and a hemoglobin threshold of 75 ng/mL of buffer, sensitivity and specificity were 94.1% (95% Cl, 82.9% to 100.0%) and 87.5% (Cl, 85.4% to 89.6%), respectively, for cancer and 67% (Cl, 57.4% to 76.7%) and 91.4% (Cl, 89.6% to 93.2%), respectively, for any clinically significant neoplasia. Limitations: The fecal sampling method is standardized, but the sample size depends on fecal consistency. Some patients were tested while discontinuing aspirin and anticoagulant therapies. Study patients were at increased risk, and results might not apply to average-risk populations. Conclusions: Quantitative immunochemical FOBT has good sensitivity and specificity for detection of clinically significant neoplasia. Test performance in screening average-risk populations is not known.	Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; Clalit Hlth Serv, Tel Aviv, Israel; Clalit Hlth Serv, Bat Yam, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Clalit Health Services; Clalit Health Services; Tel Aviv University	Rozen, P (corresponding author), Beilinson Med Ctr, Dept Gastroenterol, Rabin Med Ctr, 39 Jabotinsky St, IL-49100 Petah Tiqwa, Israel.	paulro@clalit.org.il		Levi, Zohar/0000-0003-2456-8891				Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Bampton PA, 2005, GUT, V54, P803, DOI 10.1136/gut.2004.043786; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Castiglione G, 2000, J MED SCREEN, V7, P35, DOI 10.1136/jms.7.1.35; Castiglione G, 2002, J MED SCREEN, V9, P99, DOI 10.1136/jms.9.3.99; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Crotta S, 2004, EUR J GASTROEN HEPAT, V16, P33, DOI 10.1097/00042737-200401000-00006; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Fattah ASMA, 1998, HEPATO-GASTROENTEROL, V45, P712; Fenocchi E, 2006, EUR J CANCER PREV, V15, P384, DOI 10.1097/00008469-200610000-00002; Haug U, 2005, CANCER EPIDEM BIOMAR, V14, P422, DOI 10.1158/1055-9965.EPI-04-0411; Kunii Y, 2004, DIGEST DIS SCI, V49, P1899, DOI 10.1007/s10620-004-9590-3; Launoy GD, 2005, INT J CANCER, V115, P493, DOI 10.1002/ijc.20921; Levi Z, 2006, ALIMENT PHARM THER, V24, P1475, DOI 10.1111/j.1365-2036.2006.03152.x; Levi Z, 2006, ALIMENT PHARM THER, V23, P1359, DOI 10.1111/j.1365-2036.2006.02898.x; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; McCarthy DM, 2005, CLIN GASTROENTEROL H, V3, P1071, DOI 10.1016/S1542-3565(05)00851-7; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Nakama H, 2000, EUR J CANCER, V36, P647, DOI 10.1016/S0959-8049(00)00020-4; Nakama H, 2001, EUR J CANCER, V37, P398, DOI 10.1016/S0959-8049(00)00387-7; Nakama H, 1998, HEPATO-GASTROENTEROL, V45, P1579; Nakama H, 1999, HEPATO-GASTROENTEROL, V46, P228; NIV Y, 1990, J CLIN GASTROENTEROL, V12, P393, DOI 10.1097/00004836-199008000-00007; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Rozen P, 2006, MED SCI MONITOR, V12, pMT27; Rozen P, 1997, DIGEST DIS SCI, V42, P2064, DOI 10.1023/A:1018866400973; Rozen P, 2000, CANCER-AM CANCER SOC, V89, P46; Saito H, 2000, ONCOL REP, V7, P815; Selinger RRE, 2003, AM J MED, V114, P64, DOI 10.1016/S0002-9343(02)01350-5; SOX HC, 1988, MED DECIS MAKING, P142; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; Wong BCY, 2003, ALIMENT PHARM THER, V18, P941, DOI 10.1046/j.1365-2036.2003.01783.x; Wong WM, 2003, CANCER-AM CANCER SOC, V97, P2420, DOI 10.1002/cncr.11369; Young GP, 2002, AM J GASTROENTEROL, V97, P2499, DOI 10.1111/j.1572-0241.2002.06046.x; YOUNG GP, 2004, PRACT GASTROENTEROL, V18, P46; Young GP, 2005, COLORECTAL CANC CLIN, P97	38	255	266	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2007	146	4					244	255		10.7326/0003-4819-146-4-200702200-00003	http://dx.doi.org/10.7326/0003-4819-146-4-200702200-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137CS	17310048				2022-12-28	WOS:000244271000002
J	Firestein, GS				Firestein, Gary S.			Biomedicine - Every joint has a silver lining	SCIENCE			English	Editorial Material							RHEUMATOID-ARTHRITIS SYNOVIUM; FIBROBLAST-LIKE SYNOVIOCYTES; MUTATIONS		Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Firestein, GS (corresponding author), Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, 9500 Gilman Dr,MC 0656, La Jolla, CA 92093 USA.	gfirestein@ucsd.edu						Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Firestein GS, 1997, P NATL ACAD SCI USA, V94, P10895, DOI 10.1073/pnas.94.20.10895; Franz JK, 2000, ARTHRITIS RHEUM, V43, P599, DOI 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Mandik-Nayak L, 2005, IMMUNOL RES, V32, P5, DOI 10.1385/IR:32:1-3:005; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Valencia X, 2004, J EXP MED, V200, P1673, DOI 10.1084/jem.20041545; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199	9	10	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					952	953		10.1126/science.1139574	http://dx.doi.org/10.1126/science.1139574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303744				2022-12-28	WOS:000244229800031
J	Galbraith, CG; Yamada, KM; Galbraith, JA				Galbraith, Catherine G.; Yamada, Kenneth M.; Galbraith, James A.			Polymerizing actin fibers position integrins primed to probe for adhesion sites	SCIENCE			English	Article							CELL-MIGRATION; GROWTH CONES; MOTILITY; CYTOSKELETON; LAMELLIPODIA; FIBROBLASTS; LINKAGES; PROTEINS; LOCOMOTION; MOVEMENTS	Migrating cells extend protrusions, probing the surrounding matrix in search of permissive sites to form adhesions. We found that actin fibers polymerizing along the leading edge directed local protrusions and drove synchronous sideways movement of beta(1) integrin adhesion receptors. These movements lead to the clustering and positioning of conformationally activated, but unligated, beta(1) integrins along the leading edge of fibroblast lamellae and growth cone filopodia. Thus, rapid actin-based movement of primed integrins along the leading edge suggests a "sticky fingers" mechanism to probe for new adhesion sites and to direct migration.	Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Yamada, KM (corresponding author), Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA.	kyamada@dir.nidcr.nih.gov		Yamada, Kenneth/0000-0003-1512-6805	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002551, Z01NS002551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1970, EXP CELL RES, V62, P389, DOI 10.1016/0014-4827(70)90570-7; ABERCROMBIE M, 1970, EXP CELL RES, V59, P393, DOI 10.1016/0014-4827(70)90646-4; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Danuser G, 2000, BIOPHYS J, V79, P191, DOI 10.1016/S0006-3495(00)76283-7; DEPASQUALE JA, 1991, J CELL BIOL, V113, P1351, DOI 10.1083/jcb.113.6.1351; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	26	211	217	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					992	995		10.1126/science.1137904	http://dx.doi.org/10.1126/science.1137904			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303755	Green Submitted			2022-12-28	WOS:000244229800043
J	Hrdy, DB				Hrdy, Daniel B.			Low-carbohydrate diet and coronary heart disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Citrona Farms, Winters, CA 95694 USA		Hrdy, DB (corresponding author), Citrona Farms, Winters, CA 95694 USA.							Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341	1	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					750	750						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17310524				2022-12-28	WOS:000244193300031
J	Malhotra-Kumar, S; Lammens, C; Coenen, S; Van Herck, K; Goossens, H				Malhotra-Kumar, Surbhi; Lammens, Christine; Coenen, Samuel; Van Herck, Koen; Goossens, Herman			Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study	LANCET			English	Article							EPITHELIAL LINING FLUID; ANTIBACTERIAL RESISTANCE; PNEUMONIAE; FLORA; OROPHARYNGEAL; ANTIBIOTICS; PERSISTENCE; SERUM; PHARMACOKINETICS; SUSCEPTIBILITY	Background Resistance to antibiotics is a major public-health problem, and studies that link antibiotic use and resistance have shown an association but not a causal effect. We used the macrolides azithromycin and clarithromycin to investigate the direct effect of antibiotic exposure on resistance in the oral streptococcal flora of healthy volunteers. Methods Volunteers were treated with azithromycin (n=74), clarithromycin (74), or placebo (76) in a randomised, double-blind trial. Pharyngeal swabs were obtained before and after administration of study treatment through 180 days. The proportion of streptococci that were macrolide resistant was assessed and the molecular basis of any change in resistance investigated. Analyses were done on an intent-to-treat basis. This study is registered with ClinicalTrials.gov, number NCT00354952. Findings The number of dropouts (n=20) was much the same in all groups until day 42; dropouts increased substantially at day 180 (105). Both macrolides significantly increased the proportion of macrolide-resistant streptococci compared with the placebo at all points studied, peaking at day 8 in the clarithromycin group (mean increase 50.0%, 95% CI 41.7-58.2; p<0.0001) and at day 4 in the azithromycin group (53.4%, 43.4-63.5; p<0.0001). The proportion of macrolide-resistant streptococci was higher after azithromycin treatment than after clarithromycin use, with the largest difference between the two groups at day 28 (17.4% difference, 9.2-25.6; p<0.0001). Use of clarithromycin, but not of azithromycin, selected for the erm(B) gene, which confers high-level macrolide resistance. Interpretation This study shows that, notwithstanding the different outcomes of resistance selection, macrolide use is the single most important driver of the emergence of macrolide resistance in vivo. Physicians prescribing antibiotics should take into account the striking ecological side-effects of such antibiotics.	Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Gen Practice, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; Res Fdn Flanders, Brussels, Belgium; Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands	University of Antwerp; University of Antwerp; University of Antwerp; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Goossens, H (corresponding author), Univ Antwerp Hosp, Dept Microbiol, Wilrijkstr 10, B-2650 Antwerp, Belgium.	herman.goossens@uza.be	Van Herck, Koen/L-2549-2019; Van Herck, Koen/G-5223-2013; Coenen, Samuel JA/A-6410-2011	Van Herck, Koen/0000-0003-0717-2406; Van Herck, Koen/0000-0003-0717-2406; Coenen, Samuel JA/0000-0002-1238-8052				Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Berg HF, 2004, ANTIMICROB AGENTS CH, V48, P4183, DOI 10.1128/AAC.48.11.4183-4188.2004; Bergman M, 2004, CLIN INFECT DIS, V38, P1251, DOI 10.1086/383309; Blondeau J.M., 2005, THERAPY, V2, P813; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; Coenen S, 2006, J ANTIMICROB CHEMOTH, V58, P418, DOI 10.1093/jac/dkl184; DAVIDSON RJ, 2001, CLIN MICROBIOL INFEC, V9, P240; Donnan PT, 2004, BRIT MED J, V328, P1297, DOI 10.1136/bmj.328.7451.1297; Feikin DR, 2000, J INFECT DIS, V181, P1501, DOI 10.1086/315382; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; GIBSON LF, 1986, LETT APPL MICROBIOL, V3, P127, DOI 10.1111/j.1472-765X.1986.tb01565.x; GILCHRIS.JE, 1973, APPL MICROBIOL, V25, P244, DOI 10.1108/03068299810193425; Girard D, 2005, J ANTIMICROB CHEMOTH, V56, P365, DOI 10.1093/jac/dki241; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; GOOSSENS H, IN PRESS CLIN INFECT; Hoban D, 2005, INT J INFECT DIS, V9, P262, DOI 10.1016/j.ijid.2004.07.008; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Jenkins SG, 2005, J INFECTION, V51, P355, DOI 10.1016/j.jinf.2005.04.015; Kastner U, 2001, INFECTION, V29, P251, DOI 10.1007/s15010-001-1072-3; KAUKAS A, 1988, J APPL BACTERIOL, V64, P57, DOI 10.1111/j.1365-2672.1988.tb02429.x; King A, 2002, CLIN MICROBIOL INFEC, V8, P85, DOI 10.1046/j.1469-0691.2002.00347.x; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; LEVY SB, 1976, NEW ENGL J MED, V295, P583, DOI 10.1056/NEJM197609092951103; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Malhotra-Kumar S, 2005, EMERG INFECT DIS, V11, P939, DOI 10.3201/eid1106.041247; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; Malhotra-Kumar S, 2004, J ANTIMICROB CHEMOTH, V53, P271, DOI 10.1093/jac/dkh026; Matute AJ, 2002, EUR J CLIN MICROBIOL, V21, P427, DOI 10.1007/s10096-002-0728-y; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459; Nightingale CH, 1997, PEDIATR INFECT DIS J, V16, P438, DOI 10.1097/00006454-199704000-00027; Noreddin AM, 2002, ANTIMICROB AGENTS CH, V46, P4029, DOI 10.1128/AAC.46.12.4029-4034.2002; Reinert RR, 2005, ANTIMICROB AGENTS CH, V49, P2903, DOI 10.1128/AAC.49.7.2903-2913.2005; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Stadler C, 2002, ANTIMICROB AGENTS CH, V46, P3690, DOI 10.1128/AAC.46.11.3690-3691.2002; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Wallis RS, 1999, ANTIMICROB AGENTS CH, V43, P2600, DOI 10.1128/AAC.43.11.2600; Zhanel GG, 2003, J ANTIMICROB CHEMOTH, V52, P83, DOI 10.1093/jac/dkg278	39	328	342	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					482	490		10.1016/S0140-6736(07)60235-9	http://dx.doi.org/10.1016/S0140-6736(07)60235-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292768				2022-12-28	WOS:000244188300031
J	Poligone, B; Christensen, SR; Lazova, R; Heald, PW				Poligone, Brian; Christensen, Sean R.; Lazova, Rossitza; Heald, Peter W.			Bazex syndrome (acrokeratosis paraneoplastica)	LANCET			English	Editorial Material									W Haven Vet Adm Hosp, Serv Dermatol, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA	Yale University	Heald, PW (corresponding author), W Haven Vet Adm Hosp, Serv Dermatol, West Haven, CT 06516 USA.	peter.heald@yale.edu						Bazex A., 1965, B SOC FR DERMATOL SY, V72, P182; BOLOGNIA JL, 1991, MEDICINE, V70, P269, DOI 10.1097/00005792-199107000-00004; RICHARD M, 1987, J AM ACAD DERMATOL, V16, P178, DOI 10.1016/S0190-9622(87)80057-9; Valdivielso M, 2005, J EUR ACAD DERMATOL, V19, P340, DOI 10.1111/j.1468-3083.2005.01083.x	4	16	17	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 10	2007	369	9560					530	530		10.1016/S0140-6736(07)60240-2	http://dx.doi.org/10.1016/S0140-6736(07)60240-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292773				2022-12-28	WOS:000244188300036
J	Giannone, G; Dubin-Thaler, BJ; Rossier, O; Cai, YF; Chaga, O; Jiang, GY; Beaver, W; Dobereiner, HG; Freund, Y; Borisy, G; Sheetz, MP				Giannone, Gregory; Dubin-Thaler, Benjamin J.; Rossier, Olivier; Cai, Yunfei; Chaga, Oleg; Jiang, Guoying; Beaver, William; Dobereiner, Hans-Gunther; Freund, Yoav; Borisy, Gary; Sheetz, Michael P.			Lamellipodial actin mechanically links myosin activity with adhesion-site formation	CELL			English	Article							LEADING-EDGE; CYTOSKELETON; TURNOVER; DYNAMICS; FORCE; PROTRUSION; CONTRACTIONS; FIBRONECTIN; RIGIDITY; COMPLEX	Cell motility proceeds by cycles of edge protrusion, adhesion, and retraction. Whether these functions are coordinated by biochemical or biomechanical processes is unknown. We find that myosin II pulls the rear of the lamellipodial actin network, causing upward bending, edge retraction, and initiation of new adhesion sites. The network then separates from the edge and condenses over the myosin. Protrusion resumes as lamellipodial actin regenerates from the front and extends rearward until it reaches newly assembled myosin, initiating the next cycle. Upward bending, observed by evanescence and electron microscopy, results in ruffle formation when adhesion strength is low. Correlative fluorescence and electron microscopy shows that the regenerating lamellipodium forms a cohesive, separable layer of actin above the lamellum. Thus, actin polymerization periodically builds a mechanical link, the lamellipodium, connecting myosin motors with the initiation of adhesion sites, suggesting that the major functions driving motility are coordinated by a biomechanical process.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Univ Bordeaux 2, CNRS, UMR 5091, F-33077 Bordeaux, France; Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; Columbia Univ, Dept Biol Sci, Sherman Fairchild Ctr, New York, NY 10027 USA	Columbia University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Northwestern University; University of California System; University of California San Diego; Columbia University	Sheetz, MP (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ms2001@columbia.edu	Döbereiner, Hans-Günther/F-7302-2012; Rossier, Olivier M/I-6569-2013; Beaver, William/A-1124-2009	Döbereiner, Hans-Günther/0000-0003-1691-634X; Rossier, Olivier M/0000-0002-6932-931X; Giannone, Gregory/0000-0002-0932-1690; Borisy, Gary/0000-0002-0266-8018; freund, yoav/0000-0002-3850-6184	NATIONAL EYE INSTITUTE [PN1EY016586] Funding Source: NIH RePORTER; NEI NIH HHS [PN1 EY016586] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Bohnet S, 2006, BIOPHYS J, V90, P1810, DOI 10.1529/biophysj.105.064600; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Dulyaninova NG, 2004, J CELL SCI, V117, P1481, DOI 10.1242/jcs.00993; FELDER S, 1990, J CELL BIOL, V111, P2513, DOI 10.1083/jcb.111.6.2513; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Gov NS, 2006, BIOPHYS J, V90, P454, DOI 10.1529/biophysj.105.062224; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Henson JH, 1999, MOL BIOL CELL, V10, P4075, DOI 10.1091/mbc.10.12.4075; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Marcy Y, 2004, P NATL ACAD SCI USA, V101, P5992, DOI 10.1073/pnas.0307704101; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mogilner A, 2006, CURR OPIN CELL BIOL, V18, P32, DOI 10.1016/j.ceb.2005.11.001; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2005, BIOPHYS J, V89, P3456, DOI 10.1529/biophysj.104.058701; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1998, METHOD ENZYMOL, V298, P570, DOI 10.1016/S0076-6879(98)98045-4; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Wolgemuth CW, 2005, BIOPHYS J, V89, P1643, DOI 10.1529/biophysj.105.066720; Yamazaki D, 2005, GENES CELLS, V10, P381, DOI 10.1111/j.1365-2443.2005.00845.x; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zhang XF, 2003, NEURON, V40, P931, DOI 10.1016/S0896-6273(03)00754-2	45	381	384	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					561	575		10.1016/j.cell.2006.12.039	http://dx.doi.org/10.1016/j.cell.2006.12.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289574	Green Accepted, Bronze			2022-12-28	WOS:000244842700021
J	Hilfiker-Kleiner, D; Kaminski, K; Podewski, E; Bonda, T; Schaefer, A; Sliwa, K; Forster, O; Quint, A; Landmesser, U; Doerries, C; Luchtefeld, M; Poli, V; Schneider, MD; Balligand, JL; Desjardins, F; Ansari, A; Struman, I; Nguyen, NQN; Zschemisch, NH; Klein, G; Heusch, G; Schulz, R; Hilfiker, A; Drexler, H				Hilfiker-Kleiner, Denise; Kaminski, Karol; Podewski, Edith; Bonda, Tomasz; Schaefer, Arnd; Sliwa, Karen; Forster, Olaf; Quint, Anja; Landmesser, Ulf; Doerries, Carola; Luchtefeld, Maren; Poli, Valeria; Schneider, Michael D.; Balligand, Jean-Luc; Desjardins, Fanny; Ansari, Aftab; Struman, Ingrid; Nguyen, Ngoc Q. N.; Zschemisch, Nils H.; Klein, Gunnar; Heusch, Gerd; Schulz, Rainer; Hilfiker, Andres; Drexler, Helmut			A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy	CELL			English	Article							PERIPARTUM CARDIOMYOPATHY; SIGNAL TRANSDUCER; OXIDATIVE STRESS; PRESSURE-OVERLOAD; HEART-FAILURE; MICE; ACTIVATION; PREGNANCY; APOPTOSIS; TRANSCRIPTION-3	Postpartum cardiomyopathy (PPCM) is a disease of unknown etiology and exposes women to high risk of mortality after delivery. Here, we show that female mice with a cardiomyocyte-specific deletion of stat3 develop PPCM. In these mice, cardiac cathepsin D (CD) expression and activity is enhanced and associated with the generation of a cleaved antiangiogenic and proapoptotic 16 kDa form of the nursing hormone prolactin. Treatment with bromocriptine, an inhibitior of prolactin secretion, prevents the development of PPCM, whereas forced myocardial generation of 16 kDa prolactin impairs the cardiac capillary network and function, thereby recapitulating the cardiac phenotype of PPCM. Myocardial STAT3 protein levels are reduced and serum levels of activated CD and 16 kDa prolactin are elevated in PPCM patients. Thus, a biologically active derivative of the pregnancy hormone prolactin mediates PPCM, implying that inhibition of prolactin release may represent a novel therapeutic strategy for PPCM.	MHH, Dept Cardiol & Angiol, D-30625 Hannover, Germany; MHH, Dept Thorac & Cardiovasc Surg, D-30625 Hannover, Germany; Univ Witwatersrand, Dept Cardiol, Chris Hani Baragwanath Hosp, ZA-2013 Johannesburg, South Africa; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Univ Louvain, Sch Med, Dept Pharmacol & Therapeut, B-1200 Brussels, Belgium; Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Univ Liege, Ctr Biomed Integrat Genoproteom, B-4000 Cointe Ougree, Belgium; Univ Klinikum Essen, Dept Pathophysiol, D-45122 Essen, Germany	Hannover Medical School; Hannover Medical School; University of Witwatersrand; University of Turin; Baylor College of Medicine; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Emory University; University of Liege; University of Duisburg Essen	Hilfiker-Kleiner, D (corresponding author), MHH, Dept Cardiol & Angiol, D-30625 Hannover, Germany.	hilfiker.denise@mh-hannover.de	Heusch, Gerd/ABE-6675-2020; Balligand, Jean-Luc J/D-7543-2012; Kaminski, Karol A./J-4515-2014; Poli, Valeria/A-9215-2012; Bonda, Tomasz A/U-7746-2018; Schulz, Rainer/ABD-5069-2021	Kaminski, Karol A./0000-0002-9465-2581; Poli, Valeria/0000-0002-3739-3966; Bonda, Tomasz A/0000-0001-8735-1572; Schulz, Rainer/0000-0003-3017-0476; BALLIGAND, Jean-Luc/0000-0002-0522-4156; struman, ingrid/0000-0003-2550-3707; Schneider, Michael/0000-0001-9645-1938				Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Cataldo L, 2000, INT J ONCOL, V17, P1179; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Engberding N, 2004, CIRCULATION, V110, P2175, DOI 10.1161/01.CIR.0000144303.24894.1C; Gonzalez C, 2004, ENDOCRINOLOGY, V145, P5714, DOI 10.1210/en.2004-0647; HARRISON RG, 1979, SEMIN PERINATOL, V3, P287; Hayakawa Y, 2003, CIRCULATION, V108, P3036, DOI 10.1161/01.CIR.0000101920.72665.58; Hilfiker-Kleiner D, 2004, CIRC RES, V95, P187, DOI 10.1161/01.RES.0000134921.50377.61; Hilfiker-Kleiner D, 2004, CIRCULATION, V109, P2227, DOI 10.1161/01.CIR.0000127952.90508.9D; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hudlicka O, 1996, J VASC RES, V33, P266, DOI 10.1159/000159155; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Klein G, 2005, CIRC RES, V96, P748, DOI 10.1161/01.RES.0000161999.86198.1e; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Kunisada K, 2000, P NATL ACAD SCI USA, V97, P315, DOI 10.1073/pnas.97.1.315; Liao JK, 2004, J INVEST MED, V52, P248, DOI 10.1136/jim-52-04-33; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Mukherjee R, 2005, J MOL CELL CARDIOL, V39, P259, DOI 10.1016/j.yjmcc.2005.03.012; Nagafuchi H, 1999, J RHEUMATOL, V26, P1890; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Pan H, 2004, INVEST OPHTH VIS SCI, V45, P2413, DOI 10.1167/iovs.03-1001; Pelat M, 2003, CIRCULATION, V107, P2480, DOI 10.1161/01.CIR.0000065601.83526.3E; Reimold SC, 2001, NEW ENGL J MED, V344, P1629, DOI 10.1056/NEJM200105243442110; Roberg K, 1998, AM J PATHOL, V152, P1151; Sliwa K, 2004, AM J CARDIOL, V93, P1441, DOI 10.1016/j.amjcard.2004.02.053; Sliwa K, 2002, EUR J HEART FAIL, V4, P305, DOI 10.1016/S1388-9842(02)00008-9; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; Spiekermann S, 2003, CIRCULATION, V107, P1383, DOI 10.1161/01.CIR.0000056762.69302.46; Tabruyn SP, 2003, MOL ENDOCRINOL, V17, P1815, DOI 10.1210/me.2003-0132; Toescu V, 2002, CLIN ENDOCRINOL, V57, P609, DOI 10.1046/j.1365-2265.2002.01638.x; Tziakas DN, 2005, AM J CARDIOL, V96, P1449, DOI 10.1016/j.amjcard.2005.06.096; Van Remmen H, 2001, AM J PHYSIOL-HEART C, V281, pH1422, DOI 10.1152/ajpheart.2001.281.3.H1422; Weinbrenner T, 2003, ATHEROSCLEROSIS, V168, P99, DOI 10.1016/S0021-9150(03)00053-4	37	583	609	0	57	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 9	2007	128	3					589	600		10.1016/j.cell.2006.12.036	http://dx.doi.org/10.1016/j.cell.2006.12.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289576	Bronze			2022-12-28	WOS:000244842700023
J	McStay, CM; Gordon, PE				McStay, Christopher M.; Gordon, Peter E.			Urine fluorescence in ethylene glycol poisoning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Bellevue Hosp Ctr, New York, NY 10016 USA	Bellevue Hospital Center; New York University	McStay, CM (corresponding author), NYU, Bellevue Hosp Ctr, New York, NY 10016 USA.	mcstac01@med.nyu.edu	Theelen, Thomas/A-3192-2012	Theelen, Thomas/0000-0001-9067-1171					0	4	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					611	611		10.1056/NEJMicm050226	http://dx.doi.org/10.1056/NEJMicm050226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287481				2022-12-28	WOS:000244012700009
J	Wong, T; Mitchell, P				Wong, Tien; Mitchell, Paul			The eye in hypertension	LANCET			English	Review							OPEN-ANGLE GLAUCOMA; RETINAL MICROVASCULAR ABNORMALITIES; AGE-RELATED MACULOPATHY; SYSTEMIC BLOOD-PRESSURE; ENDOTHELIAL GROWTH-FACTOR; TYPE-2 DIABETES-MELLITUS; CORONARY HEART-DISEASE; VASCULAR RISK-FACTORS; BLUE MOUNTAINS EYE; VESSEL WALL SIGNS	Hypertension has a range of effects on the eye. Hypertensive retinopathy refers to retinal microvascular signs that develop in response to raised blood pressure. Signs of hypertensive retinopathy are frequently seen in adults 40 years and older, and are predictive of incident stroke, congestive heart failure, and cardiovascular mortality-independently of traditional risk factors. Hypertension is also a major risk factor for the development of other retinal vascular diseases, such as retinal vein and artery occlusion, and ischaemic optic neuropathy. High blood pressure increases the risk of both development of diabetic retinopathy and its progression. Adequate control of blood pressure has been proven in randomised clinical trials to reduce vision loss associated with diabetic retinopathy. Finally, hypertension has been implicated in the pathogenesis of glaucoma and age-related macular degeneration. Recognition of the ocular effects of blood pressure could allow physicians to better manage patients with hypertension, and to monitor its end-organ effects.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117548, Singapore; Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia	Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center; University of Sydney	Wong, T (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014	Wong, Tien Yin/0000-0002-8448-1264; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL077166] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 1986, Arch Ophthalmol, V104, P34; [Anonymous], 1984, AM J OPHTHALMOL, V98, P271; Arnold M, 2005, J NEUROL NEUROSUR PS, V76, P196, DOI 10.1136/jnnp.2004.037135; Atebara NH, 1995, OPHTHALMOLOGY, V102, P2029, DOI 10.1016/S0161-6420(95)30758-0; BOCK KD, 1984, HYPERTENSION, V6, P158; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; BROWN DM, 1994, BRIT J OPHTHALMOL, V78, P534, DOI 10.1136/bjo.78.7.534; BRUNO A, 1995, ANN INTERN MED, V122, P249, DOI 10.7326/0003-4819-122-4-199502150-00002; BRUNO A, 1992, STROKE, V23, P900, DOI 10.1161/01.STR.23.6.900; Chaturvedi N, 1997, LANCET, V349, P1787, DOI 10.1016/S0140-6736(96)10244-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425; CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1434; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Cugati S, 2006, STROKE, V37, P908, DOI 10.1161/01.STR.0000204118.87477.46; Cuspidi C, 2004, J HYPERTENS, V22, P2095, DOI 10.1097/00004872-200411000-00010; DEBONO DP, 1981, LANCET, V1, P343; Delles C, 2004, STROKE, V35, P1289, DOI 10.1161/01.STR.0000126597.11534.3b; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; DIELEMANS I, 1995, OPHTHALMOLOGY, V102, P54; DIMMITT SB, 1989, LANCET, V1, P1103; Duncan BB, 2002, BRIT J OPHTHALMOL, V86, P1002, DOI 10.1136/bjo.86.9.1002; Estacio RO, 2000, DIABETES CARE, V23, pB54; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gottlieb JL, 1998, ARCH OPHTHALMOL-CHIC, V116, P577, DOI 10.1001/archopht.116.5.577; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; GRAHAM SL, 1995, OPHTHALMOLOGY, V102, P61; Greiner K, 1999, AM J OPHTHALMOL, V128, P69, DOI 10.1016/S0002-9394(99)00074-4; GRUNWALD JE, 1984, OPHTHALMOLOGY, V91, P1690; GUYER DR, 1985, ARCH OPHTHALMOL-CHIC, V103, P1136; HANKEY GJ, 1991, BMJ-BRIT MED J, V302, P499, DOI 10.1136/bmj.302.6775.499; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hattenhauer MG, 1997, AM J OPHTHALMOL, V123, P103, DOI 10.1016/S0002-9394(14)70999-7; Hayreh SS, 1999, SURV OPHTHALMOL, V43, pS27, DOI 10.1016/S0039-6257(99)00018-1; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; HAYREH SS, 1994, AM J OPHTHALMOL, V118, P766, DOI 10.1016/S0002-9394(14)72557-7; HAYREH SS, 1994, AM J OPHTHALMOL, V117, P603, DOI 10.1016/S0002-9394(14)70067-4; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hennis A, 2003, OPHTHALMOLOGY, V110, P908, DOI 10.1016/S0161-6420(03)00075-7; HOLLENHORST R, 1961, JAMA-J AM MED ASSOC, V178, P23, DOI 10.1001/jama.1961.03040400025005; HSUEH WA, 1992, HYPERTENSION, V20, P253, DOI 10.1161/01.HYP.20.2.253; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Ivanisevic M, 2001, OPHTHALMOLOGICA, V215, P245, DOI 10.1159/000050868; Jacobson DM, 1997, ARCH OPHTHALMOL-CHIC, V115, P1403, DOI 10.1001/archopht.1997.01100160573008; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; Jonas JB, 2005, PROG RETIN EYE RES, V24, P587, DOI 10.1016/j.preteyeres.2005.01.004; KEITH NM, 1974, AM J MED SCI, V268, P336, DOI 10.1097/00000441-197412000-00004; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Klein R, 1997, Trans Am Ophthalmol Soc, V95, P329; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1446, DOI 10.1001/archopht.121.10.1446; KLEIN R, 1989, ARCH INTERN MED, V149, P2427, DOI 10.1001/archinte.149.11.2427; Klein R, 1997, OPHTHALMOLOGY, V104, P1804, DOI 10.1016/S0161-6420(97)30023-2; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1063; Klein R, 2002, BRIT J OPHTHALMOL, V86, P84, DOI 10.1136/bjo.86.1.84; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; KLEIN R, 1993, OPHTHALMOLOGY, V100, P406; Klein R, 2000, T AM OPHTHAL SOC, V98, P133; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; KOSTRABA JN, 1991, AM J EPIDEMIOL, V133, P381, DOI 10.1093/oxfordjournals.aje.a115892; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; Langman MJS, 2005, BRIT J OPHTHALMOL, V89, P960, DOI 10.1136/bjo.2004.053397; Le A, 2003, INVEST OPHTH VIS SCI, V44, P3783, DOI 10.1167/iovs.03-0077; Leske MC, 2002, ARCH OPHTHALMOL-CHIC, V120, P954, DOI 10.1001/archopht.120.7.954; Leung H, 2004, J HYPERTENS, V22, P1543, DOI 10.1097/01.hjh.0000125455.28861.3f; Logan JFJ, 2004, BRIT J OPHTHALMOL, V88, P1049, DOI 10.1136/bjo.2003.034884; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; MICHELSON EL, 1979, ARCH INTERN MED, V139, P1139, DOI 10.1001/archinte.139.10.1139; Mitchell P, 1997, STROKE, V28, P63, DOI 10.1161/01.STR.28.1.63; Mitchell P, 2000, CLIN EXP OPHTHALMOL, V28, P13, DOI 10.1046/j.1442-9071.2000.00218.x; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Mitchell P, 2005, OPHTHALMOLOGY, V112, P245, DOI 10.1016/j.ophtha.2004.08.015; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; Mitchell P, 1996, ARCH OPHTHALMOL-CHIC, V114, P1243, DOI 10.1001/archopht.1996.01100140443012; Miyazaki M, 2003, BRIT J OPHTHALMOL, V87, P469, DOI 10.1136/bjo.87.4.469; Morishita R, 1992, Blood Press Suppl, V3, P41; Mueller AJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P1377, DOI 10.1001/archopht.121.10.1377; Nakamura M, 2005, OPHTHALMOLOGICA, V219, P1, DOI 10.1159/000081775; Newman NJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1366; PANTON RW, 1990, BRIT J OPHTHALMOL, V74, P595, DOI 10.1136/bjo.74.10.595; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; PATZ A, 1978, NEW ENGL J MED, V298, P1451, DOI 10.1056/NEJM197806292982605; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; RABB MF, 1988, SURV OPHTHALMOL, V33, P73, DOI 10.1016/0039-6257(88)90160-9; RASSAM SMB, 1995, EXP PHYSIOL, V80, P53, DOI 10.1113/expphysiol.1995.sp003834; Recchia F M, 2000, Curr Opin Ophthalmol, V11, P462, DOI 10.1097/00055735-200012000-00013; Rucker JC, 2004, CURR OPIN NEUROL, V17, P27, DOI 10.1097/00019052-200402000-00006; Rumelt S, 1999, AM J OPHTHALMOL, V128, P733, DOI 10.1016/S0002-9394(99)00359-1; Saitoh M, 1998, INTERNAL MED, V37, P576, DOI 10.2169/internalmedicine.37.576; SAVINO PJ, 1977, ARCH OPHTHALMOL-CHIC, V95, P1185, DOI 10.1001/archopht.1977.04450070083005; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Sharma S, 1998, ARCH OPHTHALMOL-CHIC, V116, P1602, DOI 10.1001/archopht.116.12.1602; Sharma S, 1996, ARCH OPHTHALMOL-CHIC, V114, P1189, DOI 10.1001/archopht.1996.01100140389004; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Suzuma I, 2001, DIABETES, V50, P444, DOI 10.2337/diabetes.50.2.444; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Tsai WC, 2005, CLIN SCI, V109, P39, DOI 10.1042/CS20040307; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Ueda Y, 2002, JPN J OPHTHALMOL, V46, P209, DOI 10.1016/S0021-5155(01)00500-7; van den Born BJH, 2005, BMJ-BRIT MED J, V331, P73, DOI 10.1136/bmj.331.7508.73; Van Leeuwen R, 2004, OPHTHALMOLOGY, V111, P1169, DOI 10.1016/j.ophtha.2003.10.024; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; Wang JJ, 2004, BRIT J OPHTHALMOL, V88, P104, DOI 10.1136/bjo.88.1.104; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Weber J, 1998, STROKE, V29, P2076, DOI 10.1161/01.STR.29.10.2076; Wijman CAC, 2004, STROKE, V35, pE100, DOI 10.1161/01.STR.0000125009.05353.7c; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WILSON LA, 1979, LANCET, V1, P292; Wong TY, 2006, ANN INTERN MED, V145, P98, DOI 10.7326/0003-4819-145-2-200607180-00007; Wong Tien Yin, 2002, Curr Opin Ophthalmol, V13, P142, DOI 10.1097/00055735-200206000-00002; Wong TY, 2002, JAMA-J AM MED ASSOC, V288, P67, DOI 10.1001/jama.288.1.67; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wong TY, 2005, OPHTHALMOLOGY, V112, P540, DOI 10.1016/j.ophtha.2004.10.039; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63; Wong TY, 2004, NEW ENGL J MED, V351, P2310, DOI 10.1056/NEJMra032865; Wong TY, 2004, J AM SOC NEPHROL, V15, P2469, DOI 10.1097/01.ASN.0000136133.28194.E4; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2003, NEUROLOGY, V61, P806, DOI 10.1212/01.WNL.0000086372.05488.8D; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Wong TY, 2002, STROKE, V33, P1487, DOI 10.1161/01.STR.0000016789.56668.43; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5; Wu SY, 1997, ARCH OPHTHALMOL-CHIC, V115, P1572, DOI 10.1001/archopht.1997.01100160742012; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83; 2000, OPHTHALMOL, V107, P2224	152	401	416	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					425	435		10.1016/S0140-6736(07)60198-6	http://dx.doi.org/10.1016/S0140-6736(07)60198-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276782				2022-12-28	WOS:000243944400036
J	Boyd, PW; Jickells, T; Law, CS; Blain, S; Boyle, EA; Buesseler, KO; Coale, KH; Cullen, JJ; de Baar, HJW; Follows, M; Harvey, M; Lancelot, C; Levasseur, M; Owens, NPJ; Pollard, R; Rivkin, RB; Sarmiento, J; Schoemann, V; Smetacek, V; Takeda, S; Tsuda, A; Turner, S; Watson, AJ				Boyd, P. W.; Jickells, T.; Law, C. S.; Blain, S.; Boyle, E. A.; Buesseler, K. O.; Coale, K. H.; Cullen, J. J.; de Baar, H. J. W.; Follows, M.; Harvey, M.; Lancelot, C.; Levasseur, M.; Owens, N. P. J.; Pollard, R.; Rivkin, R. B.; Sarmiento, J.; Schoemann, V.; Smetacek, V.; Takeda, S.; Tsuda, A.; Turner, S.; Watson, A. J.			Mesoscale iron enrichment experiments 1993-2005: Synthesis and future directions	SCIENCE			English	Review							ATLANTIC BLOOM EXPERIMENT; EQUATORIAL PACIFIC-OCEAN; SOUTHERN-OCEAN; PHYTOPLANKTON BLOOM; FERTILIZATION EXPERIMENT; ATMOSPHERIC CO2; DUST; LIMITATION; BIOMASS; GROWTH	Since the mid-1980s, our understanding of nutrient limitation of oceanic primary production has radically changed. Mesoscale iron addition experiments (FeAXs) have unequivocally shown that iron supply limits production in one-third of the world ocean, where surface macronutrient concentrations are perennially high. The findings of these 12 FeAXs also reveal that iron supply exerts controls on the dynamics of plankton blooms, which in turn affect the biogeochemical cycles of carbon, nitrogen, silicon, and sulfur and ultimately influence the Earth climate system. However, extrapolation of the key results of FeAXs to regional and seasonal scales in some cases is limited because of differing modes of iron supply in FeAXs and in the modern and paleo-oceans. New research directions include quantification of the coupling of oceanic iron and carbon biogeochemistry.	Univ Otago, Natl Inst Water & Atmospher Res NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; NIWA, Wellington, New Zealand; Lab Oceanog & Biogeochim, F-16288 Marseille 09, France; MIT, Dept Earth Atmosphere & Planetary Sci, Cambridge, MA 02139 USA; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Moss Landing Marine Labs, Moss Landing, CA 95039 USA; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Libre Bruxelles, B-1050 Brussels, Belgium; Univ Laval, Dept Biol Quebec Ocean, Ste Foy, PQ G1K 7P4, Canada; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Mem Univ Newfoundland, Ctr Ocean Sci, St John, NF A1C 5S7, Canada; Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1138657, Japan	University of Otago; University of East Anglia; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution; Moss Landing Marine Laboratories; Dalhousie University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Universite Libre de Bruxelles; Laval University; Plymouth Marine Laboratory; NERC National Oceanography Centre; University of Southampton; Memorial University Newfoundland; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Tokyo; University of Tokyo	Boyd, PW (corresponding author), Univ Otago, Natl Inst Water & Atmospher Res NIWA, Ctr Chem & Phys Oceanog, Dept Chem, Dunedin, New Zealand.	pboyd@alkali.otago.ac.nz	Owens, Nicholas/B-6639-2015; Owens, Nicholas John Paul/GRX-5013-2022; Harvey, Mike/A-5354-2010; Cuillen, John/AAE-1371-2019; blain, stéphane/F-6917-2010; Follows, Michael/G-9824-2011; Boyd, Philip W/J-7624-2014; Cullen, John J/B-6105-2008	Owens, Nicholas/0000-0003-4245-5858; Owens, Nicholas John Paul/0000-0001-7972-7285; Harvey, Mike/0000-0002-0979-0227; Cuillen, John/0000-0002-7740-0999; blain, stéphane/0000-0002-5234-2446; Boyd, Philip W/0000-0001-7850-1911; Cullen, John J/0000-0002-7740-0999; Law, Cliff/0000-0002-7669-2475; Watson, Andrew/0000-0002-9654-8147; Takeda, Shigenobu/0000-0002-4997-1583	Natural Environment Research Council [soc010008, pml010002, pml010001] Funding Source: researchfish; NERC [pml010001, pml010002, soc010008] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Abelmann A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001199; Baker AR, 2006, MAR CHEM, V98, P43, DOI 10.1016/j.marchem.2005.06.004; BANSE K, 1991, LIMNOL OCEANOGR, V36, P1886, DOI 10.4319/lo.1991.36.8.1886; Bell J, 2002, DEEP-SEA RES PT I, V49, P2103, DOI 10.1016/S0967-0637(02)00126-7; Bergquist BA, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002505; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; BOWIE AR, 2001, DEEP SEA RES 2, V47, P1708; BOYD P, UNPUB; Boyd PW, 2005, LIMNOL OCEANOGR, V50, P1872, DOI 10.4319/lo.2005.50.6.1872; Boyd PW, 2003, GLOB CHANGE IGBP SER, P157; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014210; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Boyd PW, 1999, DEEP-SEA RES PT II, V46, P2761, DOI 10.1016/S0967-0645(99)00083-1; Buesseler KO, 2003, DEEP-SEA RES PT II, V50, P579, DOI 10.1016/S0967-0645(02)00585-4; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; Frew RD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002558; Frost BW, 1996, NATURE, V383, P475, DOI 10.1038/383475a0; GARCIA HE, 2006, WORLD OCEAN ATLAS, V4; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Gnanadesikan A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001940; Hoffmann LJ, 2006, LIMNOL OCEANOGR, V51, P1217, DOI 10.4319/lo.2006.51.3.1217; HUTCHINS DA, 1995, LIMNOL OCEANOGR, V40, P989, DOI 10.4319/lo.1995.40.5.0989; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jickells TD, 1999, MAR CHEM, V68, P5, DOI 10.1016/S0304-4203(99)00061-4; JOHNSON K, 2006, EOS, V86; Johnson KS, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002004; Le Clainche Y, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002947; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; LOCHTE K, 1993, DEEP-SEA RES PT II, V40, P91, DOI 10.1016/0967-0645(93)90008-B; Maldonado MT, 2001, LIMNOL OCEANOGR, V46, P1802, DOI 10.4319/lo.2001.46.7.1802; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1993, DEEP-SEA RES PT II, V40, P115, DOI 10.1016/0967-0645(93)90009-C; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Morel F.M.M., 1991, OCEANOGRAPHY, V4, P56, DOI [10.5670/oceanog.1991.03, DOI 10.5670/0CEAN0G.1991.03]; Parekh P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002280; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith WO, 2000, DEEP-SEA RES PT II, V47, P3073, DOI 10.1016/S0967-0645(00)00059-X; Strzepek RF, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002490; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, MAR CHEM, V57, P169, DOI 10.1016/S0304-4203(97)00045-5; Takeda S, 2005, PROG OCEANOGR, V64, P95, DOI 10.1016/j.pocean.2005.02.004; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; WATSON A, 1991, LIMNOL OCEANOGR, V36, P1960, DOI 10.4319/lo.1991.36.8.1960; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Wells ML, 2003, MAR CHEM, V82, P101, DOI 10.1016/S0304-4203(03)00055-0; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251	55	985	1026	16	605	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					612	617		10.1126/science.1131669	http://dx.doi.org/10.1126/science.1131669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272712				2022-12-28	WOS:000243909400033
J	McMahon, GT; Arky, RA				McMahon, Graham T.; Arky, Ronald A.			Inhaled insulin for diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPARATIVE TRIAL; ADJUNCTIVE THERAPY; GLYCEMIC CONTROL; SAFETY PROFILE; PARALLEL-GROUP; TYPE-1; EFFICACY; EXUBERA; DELIVERY; SATISFACTION		Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	McMahon, GT (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave,RFB-2, Boston, MA 02115 USA.	gmcmahon@partners.org	Gross, Jorge L/G-9138-2012; McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535				Agu RU, 2001, RESP RES, V2, P198; Barnett AH, 2006, DIABETES CARE, V29, P1282, DOI 10.2337/dc05-1879; Barnett AH, 2006, DIABETES CARE, V29, P1818, DOI 10.2337/dc05-1880; Becker RHA, 2006, DIABETES CARE, V29, P277, DOI 10.2337/diacare.29.02.06.dc05-1913; Cappelleri JC, 2002, CLIN THER, V24, P552, DOI 10.1016/S0149-2918(02)85131-1; *CDCP, 2005, INS DIAB MED US DAT; Cefalu WT, 2001, ANN INTERN MED, V134, P203, DOI 10.7326/0003-4819-134-3-200102060-00011; Cefalu WT, 2001, ANN MED, V33, P579; Ceglia L, 2006, ANN INTERN MED, V145, P665, DOI 10.7326/0003-4819-145-9-200611070-00009; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; DeFronzo RA, 2005, DIABETES CARE, V28, P1922, DOI 10.2337/diacare.28.8.1922; DeWitt DE, 2003, JAMA-J AM MED ASSOC, V289, P2254, DOI 10.1001/jama.289.17.2254; *EUR MED AG, 2006, EUR PUBL ASS REP EX; *EUR MED AG, 2006, PROD OV EX; Fineberg SE, 2005, J CLIN ENDOCR METAB, V90, P3287, DOI 10.1210/jc.2004-2229; *FOOD DRUG ADM, 2006, FDA APPR 1 EV INH IN; *FOOD DRUG ADM, 2004, STAT REV EV EX; Freemantle N, 2005, DIABETES CARE, V28, P427, DOI 10.2337/diacare.28.2.427; Himmelmann A, 2003, DIABETES CARE, V26, P677, DOI 10.2337/diacare.26.3.677; Hollander PA, 2004, DIABETES CARE, V27, P2356, DOI 10.2337/diacare.27.10.2356; Hsia CCW, 2005, AM J MED, V118, P205, DOI 10.1016/j.amjmed.2004.09.019; Hunt LM, 1997, DIABETES CARE, V20, P292, DOI 10.2337/diacare.20.3.292; *I QUAL EFF HLTH C, 2006, 01 I QUAL EFF HLTH C; *NIH CLIN EXC, 2006, INH INS TREATM DIAB; NIVEN RW, 1995, CRIT REV THER DRUG, V12, P151, DOI 10.1615/CritRevTherDrugCarrierSyst.v12.i2-3.20; Patton JS, 1999, ADV DRUG DELIVER REV, V35, P235, DOI 10.1016/S0169-409X(98)00074-X; Patton JS, 2004, CLIN PHARMACOKINET, V43, P781, DOI 10.2165/00003088-200443120-00002; Petersen M, 2003, DIABETES CARE, V26, P917; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; *PFIZ, 2007, EX; *PFIZ PHARM, 2005, ADV COMM BRIEF DOC E; Quattrin T, 2004, DIABETES CARE, V27, P2622, DOI 10.2337/diacare.27.11.2622; RAMIREZ LC, 1991, AM J MED, V91, P371, DOI 10.1016/0002-9343(91)90154-P; Rave K, 2005, DIABETES CARE, V28, P1077, DOI 10.2337/diacare.28.5.1077; Richardson T, 2003, AM J CLIN DERMATOL, V4, P661, DOI 10.2165/00128071-200304100-00001; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2004, DIABETES CARE, V27, P1318, DOI 10.2337/diacare.27.6.1318; Rosenstock J, 2005, ANN INTERN MED, V143, P549, DOI 10.7326/0003-4819-143-8-200510180-00005; Sadri H, 2005, PHARMACOECONOMICS, V23, P1215, DOI 10.2165/00019053-200523120-00006; SANDERSON I, 2006, EXUBER PRICING MORE; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Summers KH, 2004, CLIN THER, V26, P1498, DOI 10.1016/j.clinthera.2004.09.009; *THOMS PDR, 2006, 2006 RED BOOK PHARM; WEARLEY LL, 1991, CRIT REV THER DRUG, V8, P331; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zambanini A, 1999, LANCET, V354, P74, DOI 10.1016/S0140-6736(05)75342-3; Zambanini A, 1999, DIABETES RES CLIN PR, V46, P239, DOI 10.1016/S0168-8227(99)00099-6; Zambanini A, 1997, DIABETIC MED, V14, P321, DOI 10.1002/(SICI)1096-9136(199704)14:4<321::AID-DIA356>3.0.CO;2-H	48	40	43	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					497	502		10.1056/NEJMct063533	http://dx.doi.org/10.1056/NEJMct063533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267909				2022-12-28	WOS:000243860700010
J	Nathan, DM				Nathan, David M.			Finding new treatments for diabetes - How many, how fast ... How good?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PEPTIDASE-4 INHIBITOR SITAGLIPTIN; EFFICACY; SAFETY; MONOTHERAPY; THERAPY		Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nathan, DM (corresponding author), Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA.							Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; *CDC PREV, 2004, NAT DIAB SURV SYST; Charbonnel B, 2006, DIABETES CARE, V29, P2638, DOI 10.2337/dc06-0706; Raz I, 2006, DIABETOLOGIA, V49, P2564, DOI 10.1007/s00125-006-0416-z; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007	5	170	177	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					437	440		10.1056/NEJMp068294	http://dx.doi.org/10.1056/NEJMp068294			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267901				2022-12-28	WOS:000243860700001
J	Tom, SM; Fox, CR; Trepel, C; Poldrack, RA				Tom, Sabrina M.; Fox, Craig R.; Trepel, Christopher; Poldrack, Russell A.			The neural basis of loss aversion in decision-making under risk	SCIENCE			English	Article							EVENT-RELATED FMRI; HUMAN BRAIN; PROSPECT-THEORY; EXPERIENCE; UTILITY; THEOREM; CORTEX; CHOICE; BIASES	People typically exhibit greater sensitivity to losses than to equivalent gains when making decisions. We investigated neural correlates of loss aversion while individuals decided whether to accept or reject gambles that offered a 50/50 chance of gaining or losing money. A broad set of areas ( including midbrain dopaminergic regions and their targets) showed increasing activity as potential gains increased. Potential losses were represented by decreasing activity in several of these same gain-sensitive areas. Finally, individual differences in behavioral loss aversion were predicted by a measure of neural loss aversion in several regions, including the ventral striatum and prefrontal cortex.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Anderson Sch Management, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Poldrack, RA (corresponding author), Univ Calif Los Angeles, Dept Psychol, Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	poldrack@ucla.edu	Fox, Craig/A-2293-2014		NCRR NIH HHS [P20 RR020750] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020750] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABDELLAOUI M, IN PRESS MANAGEMENT; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer C, 2005, J MARKETING RES, V42, P129, DOI 10.1509/jmkr.42.2.129.62286; Chen MK, 2006, J POLIT ECON, V114, P517, DOI 10.1086/503550; CONGDON E, 2005, COGNIT NEUROSCI REV, V4, P262; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Harbaugh WT, 2001, ECON LETT, V70, P175, DOI 10.1016/S0165-1765(00)00359-1; HARDIE BGS, 1993, MARKET SCI, V12, P378, DOI 10.1287/mksc.12.4.378; JOHNSON EJ, 2006, 2015 IZA I STUD LAB; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Novemsky N, 2005, J MARKETING RES, V42, P119, DOI 10.1509/jmkr.42.2.119.62292; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006; Zuckerman M, 2000, J PERS, V68, P999, DOI 10.1111/1467-6494.00124	28	1052	1084	8	313	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					515	518		10.1126/science.1134239	http://dx.doi.org/10.1126/science.1134239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	129JU	17255512				2022-12-28	WOS:000243726600047
J	Howat, IM; Joughin, I; Scambos, TA				Howat, Ian M.; Joughin, Ian; Scambos, Ted A.			Rapid changes in ice discharge from Greenland outlet glaciers	SCIENCE			English	Article							JAKOBSHAVN ISBRAE; MASS-LOSS; ACCELERATION; SHEET; THICKNESS	Using satellite-derived surface elevation and velocity data, we found major short-term variations in recent ice discharge and mass loss at two of Greenland's largest outlet glaciers. Their combined rate of mass loss doubled in less than a year in 2004 and then decreased in 2006 to near the previous rates, likely as a result of fast re-equilibration of calving-front geometry after retreat. Total mass loss is a fraction of concurrent gravity-derived estimates, pointing to an alternative source of loss and the need for high-resolution observations of outlet dynamics and glacier geometry for sea-level rise predictions.	Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder	Howat, IM (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.	ihowat@apl.washington.edu	Joughin, Ian/AAR-7778-2021; Joughin, Ian R/A-2998-2008; Scambos, Ted A/B-1856-2009; Howat, Ian M/A-3474-2008	Joughin, Ian/0000-0001-6229-679X; Joughin, Ian R/0000-0001-6229-679X; Howat, Ian M/0000-0002-8072-6260				Gogineni S, 2001, J GEOPHYS RES-ATMOS, V106, P33761, DOI 10.1029/2001JD900183; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Joughin I, 2006, SCIENCE, V311, P1719, DOI 10.1126/science.1124496; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2002, ANN GLACIOL-SER, V34, P195, DOI 10.3189/172756402781817978; KAMB B, 1986, J GLACIOL, V32, P267, DOI 10.3189/S0022143000015604; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; San BT, 2005, INT J REMOTE SENS, V26, P5013, DOI 10.1080/01431160500177620; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; SCAMBOS TA, 1992, REMOTE SENS ENVIRON, V42, P177, DOI 10.1016/0034-4257(92)90101-O; Thomas RH, 2004, J GLACIOL, V50, P57, DOI 10.3189/172756504781830321; Thomas RH, 2003, J GLACIOL, V49, P231, DOI 10.3189/172756503781830764; Thomas RH, 2000, GEOPHYS RES LETT, V27, P1291, DOI 10.1029/1999GL008473; VANDERVEEN CJ, 1999, FUNDAMENTALS GLACIER, P313; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; WEIDICK A, 1995, US GEOL SURV PROF C, V386, pC85	21	347	353	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 16	2007	315	5818					1559	1561		10.1126/science.1138478	http://dx.doi.org/10.1126/science.1138478			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146LB	17289940	Green Submitted			2022-12-28	WOS:000244934800047
J	Tsukazaki, A; Ohtomo, A; Kita, T; Ohno, Y; Ohno, H; Kawasaki, M				Tsukazaki, A.; Ohtomo, A.; Kita, T.; Ohno, Y.; Ohno, H.; Kawasaki, M.			Quantum Hall effect in polar oxide heterostructures	SCIENCE			English	Article							INVERSION LAYERS; ELECTRON-GAS; SEMICONDUCTOR; ZNO; RESISTANCE; CRYSTAL	We observed Shubnikov-de Haas oscillation and the quantum Hall effect in a high-mobility two-dimensional electron gas in polar ZnO/MgxZn1-xO heterostructures grown by laser molecular beam epitaxy. The electron density could be controlled in a range of 0.7 x 10(12) to 3.7 x 10(12) per square centimeter by tuning the magnesium content in the barriers and the growth polarity. From the temperature dependence of the oscillation amplitude, the effective mass of the two-dimensional electrons was derived as 0.32 +/- 0.03 times the free electron mass. Demonstration of the quantum Hall effect in an oxide heterostructure presents the possibility of combining quantum Hall physics with the versatile functionality of metal oxides in complex heterostructures.	Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, ERATO Semicond Spintron Project, Sendai, Miyagi 9800023, Japan; Tohoku Univ, Lab Nanoelect & Spintron, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan	Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST)	Ohtomo, A (corresponding author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	aohtomo@imr.tohoku.ac.jp; kawasaki@imr.tohoku.ac.jp	Fonseca, James E/G-1018-2011; Ohtomo, Akira/C-4944-2008; Kawasaki, Masashi/B-5826-2008; Ohno, Hideo/E-6453-2010; Tsukazaki, Atsushi/C-3972-2008; Kita, Tomohiro/G-2063-2014	Ohtomo, Akira/0000-0003-0300-4712; Ohno, Hideo/0000-0001-9688-8259; Kita, Tomohiro/0000-0001-5247-939X; Ohno, Yuzo/0000-0002-4364-3386; Ohno, Yuzo/0000-0002-7092-9793; Tsukazaki, Atsushi/0000-0003-0251-063X				Ambacher O, 2000, J APPL PHYS, V87, P334, DOI 10.1063/1.371866; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; BUTTON KJ, 1972, PHYS REV LETT, V28, P1637, DOI 10.1103/PhysRevLett.28.1637; Chichibu SF, 2006, J APPL PHYS, V99, DOI 10.1063/1.2193162; EISENSTEIN JP, 1984, PHYS REV LETT, V53, P2579, DOI 10.1103/PhysRevLett.53.2579; JERPHAGNON J, 1971, APPL PHYS LETT, V18, P245, DOI 10.1063/1.1653649; KHAN MA, 1992, APPL PHYS LETT, V60, P3027, DOI 10.1063/1.106798; KOBIAKOV IB, 1980, SOLID STATE COMMUN, V35, P305, DOI 10.1016/0038-1098(80)90502-5; Nomura K, 2003, SCIENCE, V300, P1269, DOI 10.1126/science.1083212; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Ohtomo A, 1999, APPL PHYS LETT, V75, P980, DOI 10.1063/1.124573; Ohtomo A, 1998, APPL PHYS LETT, V72, P2466, DOI 10.1063/1.121384; Sarma S. D., 1983, PHYS REV B, V27; Sasaki M, 1999, SOLID STATE COMMUN, V109, P357, DOI 10.1016/S0038-1098(98)00420-7; SLADEK RJ, 1958, PHYS REV, V110, P817, DOI 10.1103/PhysRev.110.817; STERN F, 1972, PHYS REV B, V5, P4891, DOI 10.1103/PhysRevB.5.4891; STORMER HL, 1983, PHYS REV LETT, V51, P126, DOI 10.1103/PhysRevLett.51.126; TSUI DC, 1981, APPL PHYS LETT, V38, P550, DOI 10.1063/1.92408; Tsukazaki A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193727; Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; WAKABAYASHI JI, 1978, J PHYS SOC JPN, V44, P1839, DOI 10.1143/JPSJ.44.1839; WILLETT R, 1987, PHYS REV LETT, V59, P1776, DOI 10.1103/PhysRevLett.59.1776	25	491	504	6	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2007	315	5817					1388	1391		10.1126/science.1137430	http://dx.doi.org/10.1126/science.1137430			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	143UP	17255474				2022-12-28	WOS:000244752200026
J	Libert, S; Zwiener, J; Chu, XW; VanVoorhies, W; Roman, G; Pletcher, SD				Libert, Sergiy; Zwiener, Jessica; Chu, Xiaowen; VanVoorhies, Wayne; Roman, Gregg; Pletcher, Scott D.			Regulation of Drosophila life span by olfaction and food-derived odors	SCIENCE			English	Article							DIETARY RESTRICTION; MOLECULAR-BASIS; MELANOGASTER; REPRODUCTION; ELEGANS	Smell is an ancient sensory system present in organisms from bacteria to humans. In the nematode Caeonorhabditis elegans, gustatory and olfactory neurons regulate aging and longevity. Using the fruit fly, Drosophila melanogaster, we showed that exposure to nutrient-derived odorants can modulate life span and partially reverse the longevity-extending effects of dietary restriction. Furthermore, mutation of odorant receptor Or83b resulted in severe olfactory defects, altered adult metabolism, enhanced stress resistance, and extended life span. Our findings indicate that olfaction affects adult physiology and aging in Drosophila, possibly through the perceived availability of nutritional resources, and that olfactory regulation of life span is evolutionarily conserved.	Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cellular & Mol Biol, Houston, TX 77030 USA; New Mexico State Univ, Program Mol Biol, Las Cruces, NM 88003 USA; Univ Houston, Dept Biol & Biochem, Houston, TX 77024 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; New Mexico State University; University of Houston System; University of Houston; Baylor College of Medicine	Pletcher, SD (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.	pletcher@bcm.tmc.edu	Roman, Gregg/W-1586-2019; Libert, Sergiy/D-8136-2016; Chu, Xiaowen/AAF-2857-2020	Roman, Gregg/0000-0003-1519-4699; Libert, Sergiy/0000-0003-2497-5390; Chu, Xiaowen/0000-0001-9745-4372	NCI NIH HHS [U54 CA132383, U56 CA096286] Funding Source: Medline; NIA NIH HHS [R01AG023166] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U56CA096286, U54CA132383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023166] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Elmore T, 2003, J NEUROSCI, V23, P9906; Good TP, 2001, J INSECT PHYSIOL, V47, P1467, DOI 10.1016/S0022-1910(01)00138-X; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; TAFAR M, 2003, SCIENCE, V299, P1346; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Zheng JY, 2005, AGING CELL, V4, P209, DOI 10.1111/j.1474-9726.2005.00159.x	22	257	276	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2007	315	5815					1133	1137		10.1126/science.1136610	http://dx.doi.org/10.1126/science.1136610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138UA	17272684	Green Submitted			2022-12-28	WOS:000244387600039
J	Bohmer, R				Bohmer, Richard			The rise if in-store clinics - Threat or opportunity?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WILL		Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University	Bohmer, R (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.							Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Christensen CM, 2000, HARVARD BUS REV, V78, P102; SCOTT MK, HLTH CARE EXPRESS LA	3	62	62	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					765	768		10.1056/NEJMp068289	http://dx.doi.org/10.1056/NEJMp068289			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314334				2022-12-28	WOS:000244326700001
J	MacNeil, S				MacNeil, Sheila			Progress and opportunities for tissue-engineered skin	NATURE			English	Review							RECONSTRUCTED HUMAN SKIN; FULL-THICKNESS BURNS; HUMAN EPIDERMAL KERATINOCYTES; DIABETIC FOOT ULCERS; IN-VITRO MODEL; BASEMENT-MEMBRANE; DONOR SKIN; CULTURED EPITHELIUM; MELANOMA INVASION; RANDOMIZED-TRIAL	Tissue-engineered skin is now a reality. For patients with extensive full-thickness burns, laboratory expansion of skin cells to achieve barrier function can make the difference between life and death, and it was this acute need that drove the initiation of tissue engineering in the 1980s. A much larger group of patients have ulcers resistant to conventional healing, and treatments using cultured skin cells have been devised to restart the wound-healing process. In the laboratory, the use of tissue-engineered skin provides insight into the behaviour of skin cells in healthy skin and in diseases such as vitiligo, melanoma, psoriasis and blistering disorders.	Univ Sheffield, Dept Mat Engn, Tissue Engn Grp, Sheffield S3 7HQ, S Yorkshire, England; Univ Sheffield, Kroto Res Inst, Div Biomed Sci & Med, Sheffield S3 7HQ, S Yorkshire, England	University of Sheffield; University of Sheffield	MacNeil, S (corresponding author), Univ Sheffield, Dept Mat Engn, Tissue Engn Grp, N Campus,Broad Lane, Sheffield S3 7HQ, S Yorkshire, England.	s.macneil@shef.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barker CL, 2004, J INVEST DERMATOL, V123, P892, DOI 10.1111/j.0022-202X.2004.23435.x; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bello Y M, 2002, J Wound Care, V11, P182; Bessou S, 1996, J INVEST DERMATOL, V107, P684, DOI 10.1111/1523-1747.ep12365574; Bittencourt FV, 2000, PEDIATRICS, V106, P736, DOI 10.1542/peds.106.4.736; Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc; Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016; BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008; Boyce ST, 1999, J BURN CARE REHABIL, V20, P453, DOI 10.1097/00004630-199920060-00006; BRAIN A, 1989, BRIT MED J, V298, P917, DOI 10.1136/bmj.298.6678.917; BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005; *BURN FDN, 1999, BURN INC TREATM US 1; Cario-Andre M, 2006, PIGM CELL RES, V19, P434, DOI 10.1111/j.1600-0749.2006.00326.x; CARVER N, 1991, TRANSPLANTATION, V52, P918; Chakrabarty KH, 2001, WOUND REPAIR REGEN, V9, P95, DOI 10.1046/j.1524-475x.2001.00095.x; COOPER ML, 1991, J INVEST DERMATOL, V97, P649, DOI 10.1111/1523-1747.ep12483707; CUONO C, 1986, LANCET, V1, P1123, DOI 10.1016/S0140-6736(86)91838-6; Currie LJ, 2003, BURNS, V29, P677, DOI 10.1016/S0305-4179(03)00155-4; DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7; DELVOYE P, 1988, J INVEST DERMATOL, V90, P276, DOI 10.1111/1523-1747.ep12456042; DEMARCHEZ M, 1992, TRANSPLANTATION, V54, P317, DOI 10.1097/00007890-199208000-00023; Eves P, 2003, CLIN EXP METASTAS, V20, P685, DOI 10.1023/B:CLIN.0000006824.41376.b0; Eves P, 2000, BRIT J DERMATOL, V142, P210, DOI 10.1046/j.1365-2133.2000.03287.x; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Facy V, 2005, TOXICOL IN VITRO, V19, P787, DOI 10.1016/j.tiv.2005.03.018; FALANGA V, 1993, J INVEST DERMATOL, V100, P721, DOI 10.1111/1523-1747.ep12472373; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Ferrari S, 2006, EXPERT OPIN BIOL TH, V6, P367, DOI 10.1517/14712598.6.4.367; France RM, 1998, J MATER CHEM, V8, P37, DOI 10.1039/a705098d; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356; HARRISON CA, 2006, TISSUE ENG      1001; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; HERMANS MHE, 1989, BURNS, V15, P57, DOI 10.1016/0305-4179(89)90074-0; HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006; HERNDON DN, 1986, J TRAUMA, V26, P149, DOI 10.1097/00005373-198602000-00009; Hernon CA, 2006, REGEN MED, V1, P809, DOI 10.2217/17460751.1.6.809; Horch RE, 2001, TRANSPLANT P, V33, P642, DOI 10.1016/S0041-1345(00)02181-3; Horch RE, 2000, TISSUE ENG, V6, P53, DOI 10.1089/107632700320892; Huang QH, 2004, WOUND REPAIR REGEN, V12, P276, DOI 10.1111/j.1067-1927.2004.012312.x; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc; Kandarova H, 2006, ATLA-ALTERN LAB ANIM, V34, P393, DOI 10.1177/026119290603400407; KONIG A, 1991, J INVEST DERMATOL, V96, P803, DOI 10.1111/1523-1747.ep12474424; Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x; Lipkin S, 2003, WOUNDS, V15, P230; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416; Medalie DA, 1997, TRANSPLANTATION, V64, P454, DOI 10.1097/00007890-199708150-00015; Meier F, 2000, AM J PATHOL, V156, P193, DOI 10.1016/S0002-9440(10)64719-0; Moustafa M, 2004, DIABETIC MED, V21, P786, DOI 10.1111/j.1464-5491.2004.01166.x; Navarro FA, 2000, J BURN CARE REHABIL, V21, P513, DOI 10.1097/00004630-200021060-00007; Netzaff F, 2005, EUR J PHARM BIOPHARM, V60, P167, DOI 10.1016/j.ejpb.2005.03.004; OCONNOR NE, 1981, LANCET, V1, P75; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; PHILLIPS T, 1994, J AM ACAD DERMATOL, V31, P49, DOI 10.1016/S0190-9622(94)70134-2; Ralston DR, 1997, BRIT J PLAST SURG, V50, P408, DOI 10.1016/S0007-1226(97)90327-1; Ralston DR, 1999, BRIT J DERMATOL, V140, P605; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; ROSE J, 1997, J LEARNING DISABILIT, V1, P19; Sahota PS, 2003, WOUND REPAIR REGEN, V11, P275, DOI 10.1046/j.1524-475X.2003.11407.x; SAUER UG, 2002, ALTEX-ALTERN TIEREXP, V22, P59; Shah M, 1999, AM J PATHOL, V154, P1115, DOI 10.1016/S0002-9440(10)65364-3; Shier D., 1999, HOLES HUMAN ANATOMY, P160; SOUREN JEM, 1989, IN VITRO CELL DEV B, V25, P1039, DOI 10.1007/BF02624138; STERN R, 1990, Journal of Burn Care and Rehabilitation, V11, P7, DOI 10.1097/00004630-199001000-00003; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023; Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023; Swope VB, 2006, PIGM CELL RES, V19, P424, DOI 10.1111/j.1600-0749.2006.00325.x; Tausche AK, 2003, WOUND REPAIR REGEN, V11, P248, DOI 10.1046/j.1524-475X.2003.11403.x; Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006; Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009; Wright KA, 1998, BURNS, V24, P7, DOI 10.1016/S0305-4179(97)00075-2; Zhu N, 2005, EUR J PLAST SURG, V28, P319, DOI 10.1007/s00238-005-0777-4	82	742	782	23	384	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					874	880		10.1038/nature05664	http://dx.doi.org/10.1038/nature05664			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314974				2022-12-28	WOS:000244341200038
J	Sato, T; Atomi, H; Imanaka, T				Sato, Takaaki; Atomi, Haruyuki; Imanaka, Tadayuki			Archaeal type IIIRuBisCOs function in a pathway for AMP metabolism	SCIENCE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; PYROCOCCUS-KODAKARAENSIS KOD1; METHIONINE SALVAGE PATHWAY; HYPERTHERMOPHILIC ARCHAEON; BISPHOSPHATE CARBOXYLASE/OXYGENASE; MAXIMUM-LIKELIHOOD; RUBISCO; PROTEIN; FIXATION	The type III ribulose-1,5-bisphosphate carboxylase-oxygenase (RuBisCO) present in the archaeon Thermococcus kodakaraensis was found to participate in adenosine 5'-monophosphate ( AMP) metabolism, a role that is distinct from that of classical RuBisCOs of the Calvin-Benson-Bassham cycle. Genes annotated as thymidine phosphorylase (deoA) and eucaryal translation initiation factor 2B (e2b2) were found to encode AMP phosphorylase and ribose-1,5-bisphosphate isomerase, respectively. These enzymes supplied the RuBisCO substrate, ribulose-1,5-bisphosphate, from AMP and phosphate. Archaea with type III RuBisCOs all harbor both DeoA and the corresponding E2b2 homologs. In this pathway, adenine was released from AMP and the phosphoribose moiety entered central-carbon metabolism.	Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Kyoto University	Imanaka, T (corresponding author), Kyoto Univ, Dept Synth Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	imanaka@sbchem.kyoto-u.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426				Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Schiffer A, 2006, BIOCHEMISTRY-US, V45, P2960, DOI 10.1021/bi0521689; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; WALTER MR, 1990, J BIOL CHEM, V265, P14016; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; WRAY JW, 1995, J BIOL CHEM, V270, P3147, DOI 10.1074/jbc.270.7.3147	26	151	158	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					1003	1006		10.1126/science.1135999	http://dx.doi.org/10.1126/science.1135999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303759				2022-12-28	WOS:000244229800047
J	Belshe, RB; Edwards, KM; Vesikari, T; Black, SV; Walker, RE; Hultquist, M; Kemble, G; Connor, EM				Belshe, Robert B.; Edwards, Kathryn M.; Vesikari, Timo; Black, Steven V.; Walker, Robert E.; Hultquist, Micki; Kemble, George; Connor, Edward M.		CAIV-T Comparative Efficacy	Live attenuated versus inactivated influenza vaccine in infants and young children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS VACCINE; EFFICACY; TRIVALENT; SAFETY	BACKGROUND Universal vaccination of children 6 to 59 months of age with trivalent inactivated influenza vaccine has recently been recommended by U.S. advisory bodies. To evaluate alternative vaccine approaches, we compared the safety and efficacy of intranasally administered live attenuated influenza vaccine with those of inactivated vaccine in infants and young children. METHODS Children 6 to 59 months of age, without a recent episode of wheezing illness or severe asthma, were randomly assigned in a 1:1 ratio to receive either cold-adapted trivalent live attenuated influenza vaccine (a refrigeration-stable formulation of live attenuated intranasally administered influenza vaccine) or trivalent inactivated vaccine in a double-blind manner. Influenza-like illness was monitored with cultures throughout the 2004-2005 influenza season. RESULTS Safety data were available for 8352 children, and 7852 children completed the study according to the protocol. There were 54.9% fewer cases of cultured-confirmed influenza in the group that received live attenuated vaccine than in the group that received inactivated vaccine (153 vs. 338 cases, P<0.001). The superior efficacy of live attenuated vaccine, as compared with inactivated vaccine, was observed for both antigenically well-matched and drifted viruses. Among previously unvaccinated children, wheezing within 42 days after the administration of dose 1 was more common with live attenuated vaccine than with inactivated vaccine, primarily among children 6 to 11 months of age; in this age group, 12 more episodes of wheezing were noted within 42 days after receipt of dose 1 among recipients of live attenuated vaccine (3.8%) than among recipients of inactivated vaccine (2.1%, P=0.076). Rates of hospitalization for any cause during the 180 days after vaccination were higher among the recipients of live attenuated vaccine who were 6 to 11 months of age (6.1%) than among the recipients of inactivated vaccine in this age group (2.6%, P=0.002). CONCLUSIONS Among young children, live attenuated vaccine had significantly better efficacy than inactivated vaccine. An evaluation of the risks and benefits indicates that live attenuated vaccine should be a highly effective, safe vaccine for children 12 to 59 months of age who do not have a history of asthma or wheezing.	St Louis Univ, Sch Med, Div Infect Dis & Immunol, Hlth Sci Ctr, St Louis, MO 63110 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; Medimmune Inc, Gaithersburg, MD 20878 USA	Saint Louis University; Vanderbilt University; Tampere University; Kaiser Permanente; AstraZeneca; Medimmune	Belshe, RB (corresponding author), St Louis Univ, Sch Med, Div Infect Dis & Immunol, Hlth Sci Ctr, 3635 Vista Ave FDT-8N, St Louis, MO 63110 USA.	belsherb@slu.edu		HUANG, LI-MIN/0000-0002-9291-260X				Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Belshe RB, 2003, IMMUNOL ALLERGY CLIN, V23, P745, DOI 10.1016/S0889-8561(03)00098-5; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; BELSHE RB, 2004, VACCINES, P371; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Bergen R, 2004, PEDIATR INFECT DIS J, V23, P138, DOI 10.1097/01.inf.0000109392.96411.4f; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P619; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Glezen W Paul, 2004, Expert Rev Vaccines, V3, P131, DOI 10.1586/14760584.3.2.131; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6; 2004, MMWR MORB MORTAL WKL, V53, P1183; 2001, MMWR MORB MORTAL WKL, V50, P582	18	628	655	1	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2007	356	7					685	696		10.1056/NEJMoa065368	http://dx.doi.org/10.1056/NEJMoa065368			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135ZV	17301299				2022-12-28	WOS:000244193300006
J	Richardson, TL; Jackson, GA				Richardson, Tammi L.; Jackson, George A.			Small phytoplankton and carbon export from the surface ocean	SCIENCE			English	Article							EQUATORIAL PACIFIC; FOOD WEBS; COMMUNITY STRUCTURE; BIOGENIC CARBON; PICOPLANKTON; MODEL; COAGULATION; PARTICLES; FLUXES; TEP	Autotrophic picoplankton dominate primary production over large oceanic regions but are believed to contribute relatively little to carbon export from surface layers. Using analyses of data from the equatorial Pacific Ocean and Arabian Sea, we show that the relative direct and indirect contribution of picoplankton to export is proportional to their total net primary production, despite their small size. We suggest that all primary producers, not just the large cells, can contribute to export from the surface layer of the ocean at rates proportional to their production rates.	Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Texas A&M University System; Texas A&M University College Station	Richardson, TL (corresponding author), Univ S Carolina, Mat Sci Program, Columbia, SC 29208 USA.	richardson@biol.sc.edu	Richardson, Tammi/ABB-4163-2021	Richardson, Tammi/0000-0002-0667-3455				Albertano P, 1997, J PLANKTON RES, V19, P1405, DOI 10.1093/plankt/19.10.1405; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Boyd PW, 1999, DEEP-SEA RES PT I, V46, P63, DOI 10.1016/S0967-0637(98)00066-1; BUESSELER KO, 2006, 116 SCOR WORK GROUP; CADEE GC, 1985, MAR ECOL PROG SER, V24, P193, DOI 10.3354/meps024193; Chai F, 2002, DEEP-SEA RES PT II, V49, P2713, DOI 10.1016/S0967-0645(02)00055-3; GOMES HDR, 1992, J PLANKTON RES, V14, P1307, DOI 10.1093/plankt/14.9.1307; Jackson GA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023180; JACKSON GA, 1990, DEEP-SEA RES, V37, P1197, DOI 10.1016/0198-0149(90)90038-W; Jackson GA, 2001, DEEP-SEA RES PT I, V48, P95, DOI 10.1016/S0967-0637(00)00040-6; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; KLUT ME, 1991, CAN J FISH AQUAT SCI, V48, P1092, DOI 10.1139/f91-129; LAMPITT RS, 1993, MAR BIOL, V116, P689, DOI 10.1007/BF00355486; Landry MR, 1997, LIMNOL OCEANOGR, V42, P405, DOI 10.4319/lo.1997.42.3.0405; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; LEGENDRE L, 1995, AQUAT MICROB ECOL, V9, P69, DOI 10.3354/ame009069; Mari X, 2004, MAR ECOL PROG SER, V279, P13, DOI 10.3354/meps279013; MICHAELS AF, 1988, DEEP-SEA RES, V35, P473, DOI 10.1016/0198-0149(88)90126-4; NIVAL P, 1976, LIMNOL OCEANOGR, V21, P24, DOI 10.4319/lo.1976.21.1.0024; Noji TT, 1997, J PLANKTON RES, V19, P863, DOI 10.1093/plankt/19.7.863; Olli K, 1999, J MARINE SYST, V23, P165, DOI 10.1016/S0924-7963(99)00056-1; Passow U, 1999, J PLANKTON RES, V21, P2203, DOI 10.1093/plankt/21.11.2203; REVELANTE N, 1991, J EXP MAR BIOL ECOL, V146, P217, DOI 10.1016/0022-0981(91)90027-T; Richardson TL, 2006, DEEP-SEA RES PT II, V53, P555, DOI 10.1016/j.dsr2.2006.01.015; Richardson TL, 2004, DEEP-SEA RES PT I, V51, P1245, DOI 10.1016/j.dsr.2004.05.005; Rivkin RB, 1996, SCIENCE, V272, P1163, DOI 10.1126/science.272.5265.1163; Roman MR, 2001, DEEP-SEA RES PT II, V49, P175; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; Waite AM, 2000, LIMNOL OCEANOGR, V45, P87, DOI 10.4319/lo.2000.45.1.0087; [No title captured]	30	381	407	13	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2007	315	5813					838	840		10.1126/science.1133471	http://dx.doi.org/10.1126/science.1133471			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289995				2022-12-28	WOS:000244069000067
J	Whitesides, GM; Crabtree, GW				Whitesides, George M.; Crabtree, George W.			Don't forget long-term fundamental research in energy	SCIENCE			English	Editorial Material								Achieving a fundamental understanding of the phenomena that will underpin both global stewardship and future technologies in energy calls for a thoughtful balance between large-scale immediate solutions using existing technology and the fundamental research needed to provide better solutions in the 50-year period.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	Harvard University; United States Department of Energy (DOE); Argonne National Laboratory	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu						[Anonymous], 2004, MAKING TECHNOLOGY WO; Dresselhaus MS, 2001, NATURE, V414, P332, DOI 10.1038/35104599; International Energy Agency, 2004, WORLD EN OUTL 2004; Kung H., 2005, BASIC RES NEEDS SOLA; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; *NAT REN EN LAB, SYST LIF CYCL EN TEC; *PCAST, 2006, EN IMP TECHN ROL EM; Stringer J., 2003, BASIC RES NEEDS ASSU	8	143	148	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					796	798		10.1126/science.1140362	http://dx.doi.org/10.1126/science.1140362			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289985				2022-12-28	WOS:000244069000053
J	Todd, T; Caroe, T				Todd, Tony; Caroe, Tim			10-Minute consultation - Newly diagnosed iron deficiency anaemia in a premenopausal woman	BRITISH MEDICAL JOURNAL			English	Editorial Material									Addenbrookes Hosp, Cambridge CB2 2QQ, England; Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 1TN, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Todd, T (corresponding author), Addenbrookes Hosp, Hills Rd, Cambridge CB2 2QQ, England.	tony.todd@addenbrookes.nhs.uk							0	7	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 3	2007	334	7587					259	259		10.1136/bmj.39003.602338.94	http://dx.doi.org/10.1136/bmj.39003.602338.94			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135SD	17272570	Green Published			2022-12-28	WOS:000244172400034
J	Walther, GR				Walther, Gian-Reto			Tackling ecological complexity in climate impact research	SCIENCE			English	Editorial Material							RESPONSES		Univ Bayreuth, Dept Plant Ecol, D-95440 Bayreuth, Germany	University of Bayreuth	Walther, GR (corresponding author), Univ Bayreuth, Dept Plant Ecol, POB 101251, D-95440 Bayreuth, Germany.	gian-reto.walther@uni-bayreuth.de						Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Andelman SJ, 2004, SCIENCE, V305, P1565; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; EDWARDS PJ, 1994, LARGE SCALE ECOLOGY; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Kareiva P, 1989, COMMUNITY ECOLOGY, P35; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Likens G.E., 1989, SPACE FOR TIME SUBST, DOI DOI 10.1007/978-1-4615-7358-6; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; TILMAN D, 1989, P136; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266	12	27	28	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					606	607		10.1126/science.1138574	http://dx.doi.org/10.1126/science.1138574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131YR	17272708				2022-12-28	WOS:000243909400029
J	Naqvi, NH; Rudrauf, D; Damasio, H; Bechara, A				Naqvi, Nasir H.; Rudrauf, David; Damasio, Hanna; Bechara, Antoine			Damage to the insula disrupts addiction to cigarette smoking	SCIENCE			English	Article							DECISION-MAKING; DRUG-ADDICTION; NEURAL SYSTEMS; CORTEX LESIONS; BRAIN ACTIVITY; NICOTINE; ACTIVATION; TOBACCO; STIMULI	A number of brain systems have been implicated in addictive behavior, but none have yet been shown to be necessary for maintaining the addiction to cigarette smoking. We found that smokers with brain damage involving the insula, a region implicated in conscious urges, were more likely than smokers with brain damage not involving the insula to undergo a disruption of smoking addiction, characterized by the ability to quit smoking easily, immediately, without relapse, and without persistence of the urge to smoke. This result suggests that the insula is a critical neural substrate in the addiction to smoking.	Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Neurol, Lab Computat Neuroimaging, Iowa City, IA 52242 USA; Univ So Calif, Dornsife Cognit Neurosci Imaging Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	University of Iowa; University of Iowa; University of Southern California; University of Southern California	Bechara, A (corresponding author), Univ Iowa, Carver Coll Med, Dept Neurol, Div Cognit Neurosci, 200 Hawkins Dr, Iowa City, IA 52242 USA.	bechara@usc.edu	Naqvi, Nasir/AAW-7933-2021	Rudrauf, David/0000-0002-9621-1800; Bechara, Antoine/0000-0001-5127-2549	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA016708, F30DA016847] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA16708, R21 DA016708, F30 DA016847] Funding Source: Medline; NIGMS NIH HHS [T32 GM007337] Funding Source: Medline; NINDS NIH HHS [P01 NS019632] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*APA, 2000, DIAGN STAT MAN MENT, P191; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Brody AL, 2002, ARCH GEN PSYCHIAT, V59, P1162, DOI 10.1001/archpsyc.59.12.1162; Buchhalter AR, 2005, ADDICTION, V100, P550, DOI 10.1111/j.1360-0443.2005.01030.x; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Damasio A, 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hatsukami D, 1985, NIDA Res Monogr, V53, P56; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Naqvi NH, 2005, PHARMACOL BIOCHEM BE, V81, P821, DOI 10.1016/j.pbb.2005.06.005; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P761, DOI 10.1001/archpsyc.62.7.761; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pickworth WB, 1998, PSYCHONEUROENDOCRINO, V23, P131, DOI 10.1016/S0306-4530(97)00075-9; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Rose JE, 2006, PSYCHOPHARMACOLOGY, V184, P274, DOI 10.1007/s00213-005-0250-x; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; *US DEP HHS, 1988, 1988 SURG GEN REP HL, P377; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; WESTMAN EC, 1995, CHEST, V107, P1358, DOI 10.1378/chest.107.5.1358	29	801	880	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 26	2007	315	5811					531	534		10.1126/science.1135926	http://dx.doi.org/10.1126/science.1135926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255515	Green Accepted			2022-12-28	WOS:000243726600052
J	Paik, JH; Kollipara, R; Chu, G; Ji, HK; Xiao, YH; Ding, ZH; Miao, LL; Tothova, Z; Horner, JW; Carrasco, DR; Jiang, S; Gilliland, DG; Chin, L; Wong, WH; Castrillon, DH; DePinho, RA				Paik, Ji-Hye; Kollipara, Ramya; Chu, Gerald; Ji, Hongkai; Xiao, Yonghong; Ding, Zhihu; Miao, Lili; Tothova, Zuzana; Horner, James W.; Carrasco, Daniel R.; Jiang, Shan; Gilliland, D. Gary; Chin, Lynda; Wong, Wing H.; Castrillon, Diego H.; DePinho, Ronald A.			FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis	CELL			English	Article							TRANSCRIPTION FACTORS; TARGETED DISRUPTION; PTEN LEADS; GENE; AKT; SPROUTY; MICE; P27(KIP1); IDENTIFICATION; INHIBITION	Activated phosphoinositide 3-kinase (PI3K)AKT signaling appears to be an obligate event in the development of cancer. The highly related members of the mammalian FoxO transcription factor family, FoxO1, FoxO3, and FoxO4, represent one of several effector arms of PI3K-AKT signaling, prompting genetic analysis of the role of FoxOs in the neoplastic phenotypes linked to PI3K-AKT activation. While germline or somatic deletion of up to five FoxO alleles produced remarkably modest neoplastic phenotypes, broad somatic deletion of all FoxOs engendered a progressive cancer-prone condition characterized by thymic lymphomas and hemangionnas, demonstrating that the mammalian FoxOs are indeed bona fide tumor suppressors. Transcriptome and promoter analyses of differentially affected endothelium identified direct FoxO targets and revealed that FoxO regulation of these targets in vivo is highly context-specific, even in the same cell type. Functional studies validated Sprouty2 and PBX1, among others, as FoxO-regulated mediators of endothelial cell morphogenesis and vascular homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Fdn,Inst Innovat Canc Sci,Ctr Appl Canc Sc, Boston, MA 02115 USA; Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Univ Texas, SW Med Sch, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Sch, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Castrillon, DH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	diego.castrillon@utsouthwestern.edu; ron_depinho@dfci.harvard.edu		DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA117969, R01CA084628, U01CA084313, P01CA095616] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084313, R01 CA084628, P01 CA117969, P01 CA095616] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Benezra R, 2001, TRENDS CARDIOVAS MED, V11, P237, DOI 10.1016/S1050-1738(01)00117-7; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carreira CM, 2001, CANCER RES, V61, P8079; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Geisen C, 2003, ONCOGENE, V22, P1724, DOI 10.1038/sj.onc.1206340; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Heryanto B, 2002, REPRODUCTION, V123, P107, DOI 10.1530/rep.0.1230107; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kato J, 2005, ARTERIOSCL THROM VAS, V25, P2480, DOI 10.1161/01.ATV.0000184759.91369.f8; Kramer S, 1999, DEVELOPMENT, V126, P2515; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Li G, 2002, DEVELOPMENT, V129, P4159; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nikitenko LL, 2006, BRIT J CANCER, V94, P1, DOI 10.1038/sj.bjc.6602832; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RAMIREZ F, 1993, BIOESSAYS, V15, P589, DOI 10.1002/bies.950150904; Reich A, 1999, DEVELOPMENT, V126, P4139; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Schneider A, 2003, AM J PHYSIOL-RENAL, V284, pF411, DOI 10.1152/ajprenal.00235.2002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wanner M, 2001, J AM ACAD DERMATOL, V44, P183, DOI 10.1067/mjd.2001.110390; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Wu XL, 2005, P NATL ACAD SCI USA, V102, P14058, DOI 10.1073/pnas.0506714102; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099	64	823	851	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					309	323		10.1016/j.cell.2006.12.029	http://dx.doi.org/10.1016/j.cell.2006.12.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254969	Green Accepted, Bronze			2022-12-28	WOS:000244420500016
J	Spradling, AC; Zheng, YX				Spradling, Allan C.; Zheng, Yixian			The mother of all stem cells?	SCIENCE			English	Editorial Material							ASYMMETRIC INHERITANCE; CENTROSOME		Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA; Carnegie Inst Sci, Howard Hughes Med Inst, Baltimore, MD 21218 USA	Carnegie Institution for Science; Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Preble AM, 2000, CURR TOP DEV BIOL, V49, P207; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	11	18	20	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					469	470		10.1126/science.1138237	http://dx.doi.org/10.1126/science.1138237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	129JU	17255500				2022-12-28	WOS:000243726600032
J	Khaja, AM; Grotta, JC				Khaja, Aslam M.; Grotta, James C.			Established treatments for acute ischaemic stroke	LANCET			English	Review							TISSUE-PLASMINOGEN ACTIVATOR; DEEP-VEIN THROMBOSIS; HEALTH-CARE PROFESSIONALS; CEREBRAL-ARTERY TERRITORY; MOLECULAR-WEIGHT HEPARIN; PLACEBO-CONTROLLED TRIAL; ACADEMY-OF-NEUROLOGY; GUIDELINE DEVELOPMENT COMMITTEE; LARYNGEAL COUGH REFLEX; GENERAL MEDICAL WARDS	This article reviews the recommended management of patients presenting to accident and emergency departments with acute ischaemic stroke, and focuses on thrombolysis. The review includes initial management, recommended clinical, laboratory, and radiographic examinations. Appropriate general medical care, consisting of monitoring of oxygenation, fever, blood pressure, and blood glucose concentrations are examined. Criteria for thrombolysis with intravenous recombinant tissue plasminogen activator (rt-PA) are discussed. Complications of rt-PA therapy, such as haemorrhagic transformation and angio-oedema, are reviewed. An approach to management of rt-PA complications is outlined. Only a small percentage of acute ischaemic stroke patients meet criteria for rt-PA; therefore, alternative acute treatment strategies are also discussed. Acute medical and neurological complications in stroke patients are analysed, along with recommendations for treatment.	Univ Texas, Dept Neurol, Houston, TX 77030 USA	University of Texas System	Khaja, AM (corresponding author), Univ Texas, Dept Neurol, Houston, TX 77030 USA.	aslam.m.khaja@uth.tmc.edu	Grotta, James/AAH-7423-2021					*ABESTT II INV, 2006, CEREBROVASC DIS S4, V21; Adams H, 2005, STROKE, V36, P916, DOI 10.1161/01.STR.0000163257.66207.2d; Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; Adams HP, 2005, STROKE, V36, P880, DOI 10.1161/01.STR.0000157668.39374.56; Adams HP, 2002, STROKE, V33, P856, DOI 10.1161/hs0302.104628; Adams HP, 1996, CIRCULATION, V94, P1167, DOI 10.1161/01.CIR.94.5.1167; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Adams HP, 2000, STROKE, V31, P601; ADAMS HP, 1994, CIRCULATION, V90, P1588, DOI 10.1161/01.CIR.90.3.1588; Addington WR, 1999, ARCH PHYS MED REHAB, V80, P150, DOI 10.1016/S0003-9993(99)90112-0; Addington WR, 1999, STROKE, V30, P1203, DOI 10.1161/01.STR.30.6.1203; Al-Sadat A, 2002, STROKE, V33, P1574, DOI 10.1161/01.STR.0000018081.33541.E3; Albers CW, 2001, CHEST, V119, p300S, DOI 10.1378/chest.119.1_suppl.300S; Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; [Anonymous], 1998, JAMA, V279, P1265; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; ASPLUND K, 1988, STROKE, V19, P464; Asplund K, 1997, STROKE, V28, P2139, DOI 10.1161/01.STR.28.11.2139; Awada A, 1999, ACTA NEUROL SCAND, V99, P265, DOI 10.1111/j.1600-0404.1999.tb00674.x; Ay H, 1999, NEUROLOGY, V52, P1784, DOI 10.1212/WNL.52.9.1784; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Barber PA, 1999, STROKE, V30, P2059, DOI 10.1161/01.STR.30.10.2059; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Barber PA, 1998, NEUROLOGY, V51, P418, DOI 10.1212/WNL.51.2.418; Bauer RB, 1973, STROKE, V4, P547, DOI 10.1161/01.STR.4.4.547; Baumann CR, 2006, STROKE, V37, P1332, DOI 10.1161/01.STR.0000217272.38455.a2; Berrouschot J, 1998, INTENS CARE MED, V24, P620, DOI 10.1007/s001340050625; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; BOGOUSSLAVSKY J, 1985, ACTA NEUROL SCAND, V71, P464; BRITTON M, 1979, ACTA MED SCAND, V205, P425; Broderick J, 2004, STROKE, V35, P904, DOI 10.1161/01.STR.0000121641.77121.98; Brott T, 1998, STROKE, V29, P1504, DOI 10.1161/01.STR.29.8.1504; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; Bushnell CD, 1999, NEUROLOGY, V52, P1374, DOI 10.1212/WNL.52.7.1374; Camerlingo M, 2005, STROKE, V36, P2415, DOI 10.1161/01.STR.0000185730.50480.e7; CANDELISE L, 1985, ARCH NEUROL-CHICAGO, V42, P661, DOI 10.1001/archneur.1985.04060070051014; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Castillo J, 1999, CEREBROVASC DIS, V9, P1, DOI 10.1159/000047548; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2005, CEREBROVASC DIS, V19, P402, DOI 10.1159/000086100; Chen ZM, 1997, LANCET, V349, P1641, DOI 10.1016/S0140-6736(97)04010-5; Chua HC, 1999, CLIN NEUROL NEUROSUR, V101, P44; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P235; Coull BM, 2002, STROKE, V33, P1934, DOI 10.1161/01.STR.0000028456.18614.93; Coull BM, 2002, NEUROLOGY, V59, P13, DOI 10.1212/WNL.59.1.13; COUNSELL C, 2001, COCHRANE DB SYST REV, V4; CROCKARD HA, 1973, BMJ-BRIT MED J, V4, P634, DOI 10.1136/bmj.4.5893.634; Daniels SK, 1999, DYSPHAGIA, V14, P85, DOI 10.1007/PL00009592; Davalos A, 1997, CEREBROVASC DIS, V7, P19, DOI 10.1159/000108271; de Bruijn SFTM, 1999, STROKE, V30, P484, DOI 10.1161/01.STR.30.3.484; DELASHAW JB, 1990, STROKE, V21, P874, DOI 10.1161/01.STR.21.6.874; Demaerschalk BM, 2005, STROKE, V36, P2500, DOI 10.1161/01.STR.0000185699.37843.14; Demchuk AM, 2005, STROKE, V36, P2110, DOI 10.1161/01.STR.0000181116.15426.58; DEPIPPO KL, 1992, ARCH NEUROL-CHICAGO, V49, P1259, DOI 10.1001/archneur.1992.00530360057018; DIMANT J, 1977, STROKE, V8, P449, DOI 10.1161/01.STR.8.4.448; DUMAS R, 1994, AGE AGEING, V23, P512, DOI 10.1093/ageing/23.6.512; Einhaupl K, 2006, EUR J NEUROL, V13, P553, DOI 10.1111/j.1468-1331.2006.01398.x; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Elmstahl S, 1999, DYSPHAGIA, V14, P61, DOI 10.1007/PL00009588; Engelter ST, 2005, NEUROLOGY, V65, P1795, DOI 10.1212/01.wnl.0000183702.04080.27; Engelter ST, 2005, J NEUROL, V252, P1167, DOI 10.1007/s00415-005-0789-9; Ernst R, 2000, STROKE, V31, P2552, DOI 10.1161/01.STR.31.11.2552; Fiebach JB, 2004, STROKE, V35, P502, DOI 10.1161/01.STR.0000114203.75678.88; Furlan Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS31; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Gobin YP, 2004, STROKE, V35, P2848, DOI 10.1161/01.STR.0000147718.12954.60; GOLDSTEIN LB, 1989, ARCH NEUROL-CHICAGO, V46, P660, DOI 10.1001/archneur.1989.00520420080026; Gonzales NR, 2006, STROKE, V37, P621; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Gould MK, 1999, ANN INTERN MED, V130, P800, DOI 10.7326/0003-4819-130-10-199905180-00003; GROTTA J, 1995, NEUROLOGY, V45, P640, DOI 10.1212/WNL.45.4.640; GROTTA JC, 1989, STROKE, V20, P317; GUBITZ G, 2000, COCHRANE DB SYST REV, V2; Gujjar AR, 1998, NEUROLOGY, V51, P447, DOI 10.1212/WNL.51.2.447; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; HACKE W, 1991, CEREBROVASC DIS, V1, P93, DOI 10.1159/000108903; Hacke W, 2004, LANCET, V363, P768; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Heinsius T, 1998, NEUROLOGY, V50, P341, DOI 10.1212/WNL.50.2.341; Hill MD, 2003, NEUROLOGY, V60, P1525, DOI 10.1212/01.WNL.0000058840.66596.1A; Hill MD, 2002, STROKE, V33, P279, DOI 10.1161/hs0102.101900; Hyers TM, 1998, CHEST, V114, p561S, DOI 10.1378/chest.114.5_Supplement.561S; Indredavik B, 1999, STROKE, V30, P1524, DOI 10.1161/01.STR.30.8.1524; Indredavik B, 1998, STROKE, V29, P895, DOI 10.1161/01.STR.29.5.895; *IT AC STROK STUD, 1988, LANCET, V331, P318; JACOBS L, 1976, NEUROLOGY, V26, P1111, DOI 10.1212/WNL.26.12.1111; Joint Commission on Accreditation of Healthcare Organizations, 2005, JT COMM PERSPECT, V25, P3; Jorgensen HS, 1999, STROKE, V30, P930, DOI 10.1161/01.STR.30.5.930; Jorgensen HS, 1999, STROKE, V30, P2008, DOI 10.1161/01.STR.30.10.2008; Jorgensen HS, 2000, STROKE, V31, P434, DOI 10.1161/01.STR.31.2.434; KALIA KK, 1993, ARCH NEUROL-CHICAGO, V50, P1293, DOI 10.1001/archneur.1993.00540120010005; Kappelle L J, 2004, Curr Neurol Neurosci Rep, V4, P36, DOI 10.1007/s11910-004-0009-5; Kidwell CS, 2000, ANN NEUROL, V47, P462, DOI 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.3.CO;2-P; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, V47, P157, DOI 10.1001/archneur.1990.00530020053014; KILPATRICK CJ, 1992, ARCH NEUROL-CHICAGO, V49, P509, DOI 10.1001/archneur.1992.00530290097017; Kocan M J, 1999, Prog Cardiovasc Nurs, V14, P61; Kohrmann M, 2006, LANCET NEUROL, V5, P661, DOI 10.1016/S1474-4422(06)70499-9; Koh MS, 2000, SURG NEUROL, V53, P225, DOI 10.1016/S0090-3019(00)00163-4; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; KOLLER M, 1990, STROKE, V21, P1429, DOI 10.1161/01.STR.21.10.1429; KONDZIOLKA D, 1988, NEUROSURGERY, V23, P143, DOI 10.1227/00006123-198808000-00002; Kucinski T, 2005, NEUROIMAG CLIN N AM, V15, P397, DOI 10.1016/j.nic.2005.06.006; Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781; Langhorne P, 1999, CEREBROVASC DIS, V9, P2, DOI 10.1159/000047570; Larrue V, 1997, STROKE, V28, P957, DOI 10.1161/01.STR.28.5.957; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; LAVY S, 1974, STROKE, V5, P775, DOI 10.1161/01.STR.5.6.775; Lee LJ, 2000, STROKE, V31, P1081, DOI 10.1161/01.STR.31.5.1081; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; Lewandowski CA, 1999, STROKE, V30, P2598, DOI 10.1161/01.STR.30.12.2598; Lisboa RC, 2002, STROKE, V33, P2866, DOI 10.1161/01.STR.0000038987.62325.14; Lovblad KO, 1997, ANN NEUROL, V42, P164; Lovblad KO, 1998, AM J NEURORADIOL, V19, P1061; Lutsep HL, 1997, ANN NEUROL, V41, P574, DOI 10.1002/ana.410410505; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MARSH ML, 1977, ANESTHESIOLOGY, V47, P149, DOI 10.1097/00000542-197708000-00006; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MATTHEWS WB, 1976, BRAIN, V99, P193, DOI 10.1093/brain/99.2.193; MCCARTHY ST, 1977, LANCET, V2, P800; MCCARTHY ST, 1986, AGE AGEING, V15, P84, DOI 10.1093/ageing/15.2.84; MCDERMOTT MM, 1994, STROKE, V25, P1820, DOI 10.1161/01.STR.25.9.1820; Mezzapesa DM, 2006, NEURORADIOLOGY, V48, P238, DOI 10.1007/s00234-005-0045-0; MIKOLICH JR, 1981, JAMA-J AM MED ASSOC, V246, P1314, DOI 10.1001/jama.246.12.1314; Mohsenipour I, 1999, ZBL NEUROCHIR, V60, P68; Moulin T, 1996, NEUROLOGY, V47, P366, DOI 10.1212/WNL.47.2.366; Muir KW, 2005, J NEUROL NEUROSUR PS, V76, P19, DOI 10.1136/jnnp.2005.075168; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; MYERS MG, 1982, STROKE, V13, P838, DOI 10.1161/01.STR.13.6.838; Nakagawa T, 1997, ARCH INTERN MED, V157, P321, DOI 10.1001/archinte.157.3.321; Norris JW, 2005, STROKE, V36, P2041, DOI 10.1161/01.STR.0000177504.72886.6b; NORRIS JW, 1982, LANCET, V1, P328; NORRIS JW, 1978, STROKE, V9, P392, DOI 10.1161/01.STR.9.4.392; NORRIS JW, 1986, BMJ-BRIT MED J, V292, P21, DOI 10.1136/bmj.292.6512.21; NORRIS JW, 1976, ARCH NEUROL-CHICAGO, V33, P69, DOI 10.1001/archneur.1976.00500010071014; O'Brien J, 2000, LANCET, V355, P1295; Ogasawara Kuniaki, 1995, Neurological Surgery, V23, P43; OPPENHEIMER SM, 1992, NEUROL CLIN, V10, P167, DOI 10.1016/S0733-8619(18)30239-1; OPPENHEIMER SM, 1994, CURR OPIN NEUROL, V7, P20, DOI 10.1097/00019052-199402000-00005; PANZER RJ, 1985, ARCH INTERN MED, V145, P1800, DOI 10.1001/archinte.145.10.1800; Patel SC, 2001, JAMA-J AM MED ASSOC, V286, P2830, DOI 10.1001/jama.286.22.2830; PHILLIPS SJ, 1994, HYPERTENSION, V23, P131, DOI 10.1161/01.HYP.23.1.131; Plum F, 1966, Res Publ Assoc Res Nerv Ment Dis, V41, P318; POWERS WJ, 1993, NEUROLOGY, V43, P461, DOI 10.1212/WNL.43.3_Part_1.461; Prat R, 2004, REV NEUROLOGIA, V38, P133, DOI 10.33588/rn.3802.2003200; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; RIEKE K, 1995, CRIT CARE MED, V23, P1576, DOI 10.1097/00003246-199509000-00019; Robbins J, 1999, ANN NEUROL, V46, P279, DOI 10.1002/1531-8249(199909)46:3<279::AID-ANA1>3.0.CO;2-1; RodenJullig A, 1997, CEREBROVASC DIS, V7, P2, DOI 10.1159/000108267; Ronning OM, 1998, STROKE, V29, P586, DOI 10.1161/01.STR.29.3.586; Ronning OM, 1998, STROKE, V29, P58, DOI 10.1161/01.STR.29.1.58; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P26, DOI 10.1001/archneur.1984.04050130032017; Rordorf G, 1997, STROKE, V28, P2133, DOI 10.1161/01.STR.28.11.2133; Rumbach L, 2000, NEUROLOGY, V54, P350, DOI 10.1212/WNL.54.2.350; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sagar G, 1996, CLIN RADIOL, V51, P499, DOI 10.1016/S0009-9260(96)80190-5; Sakai K, 1998, NEUROL MED-CHIR, V38, P131, DOI 10.2176/nmc.38.131; Sandercock P, 1997, LANCET, V349, P1569; SANDERCOCK PAG, 1993, J NEUROL NEUROSUR PS, V56, P17, DOI 10.1136/jnnp.56.1.17; SANDSET PM, 1990, SEMIN THROMB HEMOST, V16, P25; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Saver JL, 2004, ARCH NEUROL-CHICAGO, V61, P1066, DOI 10.1001/archneur.61.7.1066; Schwab S, 1996, NEUROLOGY, V47, P393, DOI 10.1212/WNL.47.2.393; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Selim Magdy, 2004, Curr Treat Options Cardiovasc Med, V6, P249, DOI 10.1007/s11936-996-0020-z; Sherman DG, 2000, JAMA-J AM MED ASSOC, V283, P2395, DOI 10.1001/jama.283.18.2395; Sherman DG, 2004, CEREBROVASC DIS, V17, P138, DOI 10.1159/000074806; SHERMAN DG, 1994, STROKE, V25, P1755; Singer OC, 2004, NEUROLOGY, V62, P1848, DOI 10.1212/01.WNL.0000125320.53244.FA; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Sobesky J, 2005, STROKE, V36, P980, DOI 10.1161/01.STR.0000160751.79241.a3; Stegmayr B, 1999, STROKE, V30, P709, DOI 10.1161/01.STR.30.4.709; STEIGER HJ, 1991, ACTA NEUROCHIR, V111, P73, DOI 10.1007/BF01400491; Steiner T, 1998, CEREBROVASC DIS, V8, P198, DOI 10.1159/000015851; Stoll M, 1998, NEUROL RES, V20, P231, DOI 10.1080/01616412.1998.11740511; STRAND T, 1992, STROKE, V23, P657, DOI 10.1161/01.STR.23.5.657; Suarez JI, 2002, NEUROSURGERY, V50, P251, DOI 10.1097/00006123-200202000-00005; Sylaja PN, 2006, J NEUROL NEUROSUR PS, V77, P826, DOI 10.1136/jnnp.2005.086595; Tanne D, 2002, CIRCULATION, V105, P1679, DOI 10.1161/01.CIR.0000012747.53592.6A; THOMPSON PL, 1978, BRIT MED J, V2, P457, DOI 10.1136/bmj.2.6135.457; TINKER JH, 1976, ANESTHESIOLOGY, V45, P340, DOI 10.1097/00000542-197609000-00016; Tomanek AI, 2006, CAN J NEUROL SCI, V33, P58, DOI 10.1017/S0317167100004704; Tong DC, 1998, NEUROLOGY, V50, P864, DOI 10.1212/WNL.50.4.864; Treib J, 2000, INTENS CARE MED, V26, P1598, DOI 10.1007/s001340000667; TURPIE AGG, 1992, ANN INTERN MED, V117, P353, DOI 10.7326/0003-4819-117-5-353; Uhl E, 2004, J NEUROL NEUROSUR PS, V75, P270; van der Worp HB, 1998, CEREBROVASC DIS, V8, P124, DOI 10.1159/000015830; van Everdingen KJ, 1998, STROKE, V29, P1783, DOI 10.1161/01.STR.29.9.1783; van Oostenbrugge RJ, 2006, J NEUROL NEUROSUR PS, V77, P375, DOI 10.1136/jnnp.2005.070292; VINGERHOETS F, 1993, STROKE, V24, P26, DOI 10.1161/01.STR.24.1.26; VONARBIN M, 1981, STROKE, V12, P288, DOI 10.1161/01.STR.12.3.288; VONARBIN M, 1980, J CHRON DIS, V33, P215, DOI 10.1016/0021-9681(80)90066-1; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Walzl M, 1998, ATHEROSCLEROSIS, V139, P385, DOI 10.1016/S0021-9150(98)00080-X; Wang Y, 2000, STROKE, V31, P404, DOI 10.1161/01.STR.31.2.404; WARACH S, 1992, NEUROLOGY, V42, P1717, DOI 10.1212/WNL.42.9.1717; WARACH S, 1995, ANN NEUROL, V37, P231, DOI 10.1002/ana.410370214; Ween JE, 1996, NEUROLOGY, V47, P659, DOI 10.1212/WNL.47.3.659; Wijdicks EFM, 1998, MAYO CLIN PROC, V73, P829, DOI 10.4065/73.9.829; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Yamamoto H, 1998, ARCH NEUROL-CHICAGO, V55, P481, DOI 10.1001/archneur.55.4.481; Yusuf S, 2001, NEW ENGL J MED, V345, P494	220	66	75	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					319	330		10.1016/S0140-6736(07)60154-8	http://dx.doi.org/10.1016/S0140-6736(07)60154-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258672				2022-12-28	WOS:000243912000036
J	Paliwal, S; Iglesias, PA; Campbell, K; Hilioti, Z; Groisman, A; Levchenko, A				Paliwal, Saurabh; Iglesias, Pablo A.; Campbell, Kyle; Hilioti, Zoe; Groisman, Alex; Levchenko, Andre			MAPK-mediated bimodal gene expression and adaptive gradient sensing in yeast	NATURE			English	Article							PHEROMONE RESPONSE PATHWAY; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; POSITIVE FEEDBACK; ESCHERICHIA-COLI; KINASE; KSS1; HYSTERESIS; GROWTH; DIFFERENTIATION	The mating pathway in Saccharomyces cerevisiae has been the focus of considerable research effort, yet many quantitative aspects of its regulation still remain unknown. Using an integrated approach involving experiments in microfluidic chips and computational modelling, we studied gene expression and phenotypic changes associated with the mating response under well-defined pheromone gradients. Here we report a combination of switch-like and graded pathway responses leading to stochastic phenotype determination in a specific range of pheromone concentrations. Furthermore, we show that these responses are critically dependent on mitogen-activated protein kinase (MAPK)-mediated regulation of the activity of the pheromone-response-specific transcription factor, Ste12, as well as on the autoregulatory feedback of Ste12. In particular, both the switch-like characteristics and sensitivity of gene expression in shmooing cells to pheromone concentration were significantly diminished in cells lacking Kss1, one of the MAP kinases activated in the mating pathway. In addition, the dynamic range of gradient sensing of Kss1-deficient cells was reduced compared with wild type. We thus provide unsuspected functional significance for this kinase in regulation of the mating response.	Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Whitehead Inst Biomed Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Elect Engn & Comp Engn, Baltimore, MD 21218 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Johns Hopkins University; University of California System; University of California San Diego	Levchenko, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	agroisman@ucsd.edu; alev@jhu.edu	Groisman, Alexander/AAU-7843-2021; Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X; HILIOTI, ZOE/0000-0003-4330-0129	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020839] Funding Source: Medline; NIGMS NIH HHS [R01 GM072024] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 1998, GENE DEV, V12, P2887, DOI 10.1101/gad.12.18.2887; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Colman-Lerner A, 2006, NATURE, V439, P502, DOI 10.1038/nature04476; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Farley FW, 1999, GENETICS, V151, P1425; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Guthrie C., 1991, METHODS ENZYMOLOGY G; Isbister CM, 2003, J NEUROSCI, V23, P193; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; MA D, 1995, MOL BIOL CELL, V6, P889, DOI 10.1091/mbc.6.7.889; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; MOORE SA, 1983, J BIOL CHEM, V258, P3849; NINFA AJ, 2004, SCI STKE, V232, pPE20; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; SEGALL JE, 1993, P NATL ACAD SCI USA, V90, P8332, DOI 10.1073/pnas.90.18.8332; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113	31	222	227	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	2007	446	7131					46	51		10.1038/nature05561	http://dx.doi.org/10.1038/nature05561			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	140RY	17310144				2022-12-28	WOS:000244525600033
J	Tremethick, DJ				Tremethick, David J.			Higher-order structures of chromatin: The elusive 30 nm fiber	CELL			English	Review							INTERPHASE CHROMATIN; CHROMOSOME STRUCTURE; NUCLEOSOME ARRAYS; CONDENSATION; ORGANIZATION; COMPACTION; SURFACE; MODEL; DNA		Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Tremethick, DJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	david.tremethick@anu.edu.au		Tremethick, David/0000-0001-5274-8078				Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Daban JR, 2003, BIOCHEM CELL BIOL, V81, P91, DOI 10.1139/o03-037; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Greaves IK, 2007, P NATL ACAD SCI USA, V104, P525, DOI 10.1073/pnas.0607870104; Grigoryev SA, 2004, FEBS LETT, V564, P4, DOI 10.1016/S0014-5793(04)00258-3; Horn PJ, 2002, NAT STRUCT BIOL, V9, P167, DOI 10.1038/nsb762; Horowitz-Scherer RA, 2006, CHROMOSOMA, V115, P1, DOI 10.1007/s00412-005-0035-3; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kireeva N, 2004, J CELL BIOL, V166, P775, DOI 10.1083/jcb.200406049; McBryant SJ, 2006, CHROMOSOME RES, V14, P39, DOI 10.1007/s10577-006-1025-x; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rydberg B, 1998, J MOL BIOL, V284, P71, DOI 10.1006/jmbi.1998.2150; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Strick R, 2001, J CELL BIOL, V155, P899, DOI 10.1083/jcb.200105026	20	242	253	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	FEB 23	2007	128	4					651	654		10.1016/j.cell.2007.02.008	http://dx.doi.org/10.1016/j.cell.2007.02.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320503	Bronze			2022-12-28	WOS:000245098600008
J	Cai, HQ; Yu, S; Menon, S; Cai, YY; Lazarova, D; Fu, CM; Reinisch, K; Hay, JC; Ferro-Novick, S				Cai, Huaqing; Yu, Sidney; Menon, Shekar; Cai, Yiying; Lazarova, Darina; Fu, Chunmei; Reinisch, Karin; Hay, Jesse C.; Ferro-Novick, Susan			TRAPPI tethers COPII vesicles by binding the coat subunit Sec23	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; FUSION; PROTEIN; DOCKING; INTERMEDIATE; HYDROLYSIS; COMPLEXES; SITES	The budding of endoplasmic reticulum (ER)-derived vesicles is dependent on the COPII coat complex(1). Coat assembly is initiated when Sar1-GTP recruits the cargo adaptor complex, Sec23/Sec24, by binding to its GTPase-activating protein ( GAP) Sec23 (ref. 2). This leads to the capture of transmembrane cargo by Sec24 (refs 3, 4) before the coat is polymerized by the Sec13/Sec31 complex(5). The initial interaction of a vesicle with its target membrane is mediated by tethers(6). We report here that in yeast and mammalian cells the tethering complex TRAPPI ( ref. 7) binds to the coat subunit Sec23. This event requires the Bet3 subunit. In vitro studies demonstrate that the interaction between Sec23 and Bet3 targets TRAPPI to COPII vesicles to mediate vesicle tethering. We propose that the binding of TRAPPI to Sec23 marks a coated vesicle for fusion with another COPII vesicle or the Golgi apparatus. An implication of these findings is that the intracellular destination of a transport vesicle may be determined in part by its coat and its associated cargo.	Howard Hughes Med Inst, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA; Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Howard Hughes Medical Institute; Yale University; University of Montana System; University of Montana	Ferro-Novick, S (corresponding author), Howard Hughes Med Inst, New Haven, CT 06519 USA.	susan.ferronovick@yale.edu	Bin Sidney Yu, Siu/R-4936-2018	Bin Sidney Yu, Siu/0000-0001-9643-2729; Cai, Huaqing/0000-0001-8434-6639	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM080616] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Menon S, 2006, BIOCHEM BIOPH RES CO, V350, P669, DOI 10.1016/j.bbrc.2006.09.096; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; OKA T, 1994, J CELL BIOL, V124, P425, DOI 10.1083/jcb.124.4.425; Peyroche A, 2001, METHOD ENZYMOL, V329, P290; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; Sato K, 2005, NAT STRUCT MOL BIOL, V12, P167, DOI 10.1038/nsmb893; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Whyte JRC, 2002, J CELL SCI, V115, P2627; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044	28	185	197	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					941	944		10.1038/nature05527	http://dx.doi.org/10.1038/nature05527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17287728				2022-12-28	WOS:000244341200055
J	Calverley, PMA; Anderson, JA; Celli, B; Ferguson, GT; Jenkins, C; Jones, PW; Yates, JC; Vestbo, J; Calverley, PMA; Anderson, JA; Celli, B; Ferguson, GT; Jenkins, C; Jones, PW; Knobil, K; Yates, JC; Vestbo, J; Cherniack, R; Similowski, T; Cleland, J; Whitehead, A; Wise, R; McGarvey, L; John, M				Calverley, Peter M. A.; Anderson, Julie A.; Celli, Bartolome; Ferguson, Gary T.; Jenkins, Christine; Jones, Paul W.; Yates, Julie C.; Vestbo, Jorgen; Calverley, P. M. A.; Anderson, J. A.; Celli, B.; Ferguson, G. T.; Jenkins, C.; Jones, P. W.; Knobil, K.; Yates, J. C.; Vestbo, J.; Cherniack, R.; Similowski, T.; Cleland, J.; Whitehead, A.; Wise, R.; McGarvey, L.; John, M.		TORCH Investigators	Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED CORTICOSTEROIDS; MORTALITY		Aintree Univ Hosp NHS Fdn Trust, Dept Med, Ctr Clin Sci, Liverpool L9 7AL, Merseyside, England; GlaxoSmithKline Res & Dev Ltd, Greenford, Middx, England; Caritas St Elizabeths Med Ctr, Boston, MA USA; Pulm Res Inst SE Michigan, Livonia, MI USA; Woolcock Inst Med Res, Sydney, NSW, Australia; St Georges Univ London, London, England; GlaxoSmithKline Res & Dev Ltd, Res Triangle Pk, NC USA; Wythenshawe Hosp, Manchester M23 9LT, Lancs, England; Univ Copenhagen, Hvidovre Hosp, DK-2650 Hvidovre, Denmark	Aintree University Hospitals NHS Foundation Trust; University of Liverpool; GlaxoSmithKline; St. Elizabeth's Medical Center; University of Sydney; Woolcock Institute of Medical Research; St Georges University London; GlaxoSmithKline; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Copenhagen	Calverley, PMA (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Dept Med, Ctr Clin Sci, Longmoor Lane, Liverpool L9 7AL, Merseyside, England.	pmacal@liverpool.ac.uk	Vestbo, Jorgen/Y-2912-2019; Lapa e Silva, Jose R./AAS-4793-2020	Lapa e Silva, Jose R./0000-0003-3116-0253; Vestbo, Jorgen/0000-0001-6355-6362				Alsaeedi A, 2002, AM J MED, V113, P59, DOI 10.1016/S0002-9343(02)01143-9; [Anonymous], 1980, Ann Intern Med, V93, P391; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P1660; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley P, 2004, EUR RESPIR J, V24, P206; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Fishman A, 2003, NEW ENGL J MED, V348, P2059; FLENLEY DC, 1981, LANCET, V1, P681; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mahler DA, 2002, AM J RESP CRIT CARE, V166, P1084, DOI 10.1164/rccm.2112055; Man SFP, 2003, JAMA-J AM MED ASSOC, V290, P2313, DOI 10.1001/jama.290.17.2313; PEDERSEN TR, 1994, LANCET, V344, P1383; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Sutherland ER, 2003, THORAX, V58, P937, DOI 10.1136/thorax.58.11.937; Whitehead J., 1999, DESIGN ANAL SEQUENTI	25	2408	2509	3	113	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					775	789		10.1056/NEJMoa063070	http://dx.doi.org/10.1056/NEJMoa063070			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314337				2022-12-28	WOS:000244326700004
J	Boccardo, F; Rubagotti, A				Boccardo, Francesco; Rubagotti, Alessandro			Switching to aromatase inhibitors in early breast cancer	LANCET			English	Editorial Material							POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; TAMOXIFEN; ANASTROZOLE; THERAPY		Univ Genoa, Sch Med, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; Natl Inst Canc Res, Dept Med Oncol, Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Boccardo, F (corresponding author), Natl Inst Canc Res, Dept Med Oncol, Genoa, Italy.	f.boccardo@unige.it	Boccardo, Francesco Mario/AAF-2654-2019	Boccardo, Francesco Mario/0000-0002-5392-4077; RUBAGOTTI, Alessandra/0000-0002-4009-8829				*ATAC TRIAL GROUP, 2005, LANCET, V69, P60; Boccardo F, 2001, J CLIN ONCOL, V19, P4209, DOI 10.1200/JCO.2001.19.22.4209; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Boccardo F, 2007, CANCER-AM CANCER SOC, V109, P1060, DOI 10.1002/cncr.22513; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Cuzick J, 2006, BRIT J CANCER, V94, P460, DOI 10.1038/sj.bjc.6602964; Hillner BE, 2004, CANCER-AM CANCER SOC, V101, P1311, DOI 10.1002/cncr.20492; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jonat W, 2006, LANCET ONCOL, V7, P991, DOI 10.1016/S1470-2045(06)70948-2; KAUFMANN M, 2006, ARNO 95 STUD AM SOC; Lonning PE, 2006, ANN ONCOL, V17, P217, DOI 10.1093/annonc/mdj048; Punglia RS, 2005, J CLIN ONCOL, V23, P5178, DOI 10.1200/JCO.2005.02.964; Tovey S, 2005, CLIN CANCER RES, V11, P4835, DOI 10.1158/1078-0432.CCR-05-0196; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121	15	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					533	535		10.1016/S0140-6736(07)60201-3	http://dx.doi.org/10.1016/S0140-6736(07)60201-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307082				2022-12-28	WOS:000244368000004
J	Davis, K				Davis, Karen			Uninsured in America: problems and possible solutions	BRITISH MEDICAL JOURNAL			English	Editorial Material									Commonwealth Fund, New York, NY 10021 USA	Commonwealth Fund	Davis, K (corresponding author), Commonwealth Fund, 1 E 7th St, New York, NY 10021 USA.		Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				Claxton G, 2006, HEALTH AFFAIR, V25, pW476, DOI 10.1377/hlthaff.25.w476; COLLINS SR, 2006, GAPS HLTH INSURANCE; Fronstin P, 2006, WORKERS HLTH INSURAN; GAUTHEIR A, 2006, HIGH PERFORMANCE HLT; Ham C, 2005, BRIT MED J, V330, P597, DOI 10.1136/bmj.330.7491.597; HUYNH PT, 2006, US HLTH CARE DIVIDE; Institute of Medicine (US) Committee on the Consequences of Uninsurance, 2003, HIDD COSTS VAL LOST; SCHOEN C, 2005, HLTH AFFAIRS 2005 WE, V5, P289; *US BUR CENS, 2006, HLTH INS COV 2001	9	17	17	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	FEB 17	2007	334	7589					346	348		10.1136/bmj.39091.493588.BE	http://dx.doi.org/10.1136/bmj.39091.493588.BE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	141EJ	17303883	Green Published			2022-12-28	WOS:000244560400030
J	Benachi, A; Costa, JM				Benachi, Alexandra; Costa, Jean-Marc			Non-invasive prenatal diagnosis of fetal aneuploidies	LANCET			English	Editorial Material							MATERNAL PLASMA; DNA		Univ Paris 05, Fac Med, Hop Necker Enfants Malad, APHP, F-75015 Paris, France; Hop Amer PAris, Mol Biol Lab, Neuilly Sur Seine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Benachi, A (corresponding author), Univ Paris 05, Fac Med, Hop Necker Enfants Malad, APHP, F-75015 Paris, France.	alexandra.benachi@nck.aphp.fr						ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Costa JM, 2002, NEW ENGL J MED, V346, P1502, DOI 10.1056/NEJM200205093461918; Dhallan R, 2004, JAMA-J AM MED ASSOC, V291, P1114, DOI 10.1001/jama.291.9.1114; DHALLAN R, 2007, LANCET          0202, DOI DOI 10.1016/S0140-6736(07)60115-9; Li Y, 2006, ELECTROPHORESIS, V27, P3889, DOI 10.1002/elps.200600084; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; Tsui NBY, 2005, CLIN CHEM, V51, P2358, DOI 10.1373/clinchem.2005.056978	12	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	2007	369	9560					440	442		10.1016/S0140-6736(07)60116-0	http://dx.doi.org/10.1016/S0140-6736(07)60116-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	135XX	17292744				2022-12-28	WOS:000244188300005
J	Garcia-Bassets, I; Kwon, YS; Telese, F; Prefontaine, GG; Hutt, KR; Cheng, CS; Ju, BG; Ohgi, KA; Wang, J; Escoubet-Lozach, L; Rose, DW; Glass, CK; Fu, XD; Rosenfeld, MG				Garcia-Bassets, Ivan; Kwon, Young-Soo; Telese, Francesca; Prefontaine, Gratien G.; Hutt, Kasey R.; Cheng, Christine S.; Ju, Bong-Gun; Ohgi, Kenneth A.; Wang, Jianxun; Escoubet-Lozach, Laure; Rose, David W.; Glass, Christopher K.; Fu, Xiang-Dong; Rosenfeld, Michael G.			Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors	CELL			English	Article							THYROID-HORMONE RECEPTOR; ANDROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; ESTROGEN-RECEPTOR; CO-REPRESSOR; INDEPENDENT ACTIVATION; CHROMATIN-STRUCTURE; LYSINE METHYLATION; SIGNALING PATHWAY; BREAST-CANCER	Nuclear receptors undergo ligand-dependent conformational changes that are required for corepressor-coactivator exchange, but whether there is an actual requirement for specific epigenetic landmarks to impose ligand dependency for gene activation remains unknown. Here we report an unexpected and general strategy that is based on the requirement for specific cohorts of inhibitory histone methyltransferases (HMTs) to impose gene-specific gatekeeper functions that prevent unliganded nuclear receptors and other classes of regulated transcription factors from binding to their target gene promoters and causing constitutive gene activation in the absence of stimulating signals. This strategy, based at least in part on an HMT-dependent inhibitory histone code, imposes a requirement for specific histone demethylases, including LSD1, to permit ligand- and signal-dependent activation of regulated gene expression. These events link an inhibitory methylation component of the histone code to a broadly used strategy that circumvents pathological constitutive gene induction by physiologically regulated transcription factors.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ckg@ucsd.edu; xdfu@ucsd.edu; mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592; Telese, Francesca/0000-0003-3877-0628; Garcia-Bassets, Ivan/0000-0002-6941-9585	NATIONAL CANCER INSTITUTE [R33CA114184, R01CA097134, R01CA052599] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R37DK039949, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA052599, CA52599, R01 CA097134, CA97134, R33 CA114184, CA114184] Funding Source: Medline; NHGRI NIH HHS [R01 HG003119, HG003119] Funding Source: Medline; NIDDK NIH HHS [R37 DK039949, DK39949, P30 DK063491, DK063491, R01 DK039949] Funding Source: Medline; NINDS NIH HHS [NS34934, R01 NS034934] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Carling T, 2004, MOL CELL BIOL, V24, P7032, DOI 10.1128/MCB.24.16.7032-7042.2004; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; CULIG Z, 1994, CANCER RES, V54, P5474; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Du Y, 2001, CANCER RES, V61, P8094; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Forneris F, 2006, J BIOL CHEM, V281, P35289, DOI 10.1074/jbc.M607411200; Gazzerro P, 2006, EXP CELL RES, V312, P340, DOI 10.1016/j.yexcr.2005.11.002; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Hakimi MA, 2003, J BIOL CHEM, V278, P7234, DOI 10.1074/jbc.M208992200; He LS, 1998, CANCER RES, V58, P4238; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kim J, 2005, J MOL ENDOCRINOL, V34, P107, DOI 10.1677/jme.1.01701; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Metivier R, 2004, EMBO J, V23, P3653, DOI 10.1038/sj.emboj.7600377; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Rogatsky I, 1999, J BIOL CHEM, V274, P22296, DOI 10.1074/jbc.274.32.22296; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Steele-Perkins G, 2001, GENE DEV, V15, P2250, DOI 10.1101/gad.870101; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	74	348	375	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					505	518		10.1016/j.cell.2006.12.038	http://dx.doi.org/10.1016/j.cell.2006.12.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289570	Green Accepted, Bronze			2022-12-28	WOS:000244842700017
J	Keller, EF				Fox Keller, Evelyn			A clash of two cultures	NATURE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keller, EF (corresponding author), MIT, 77 Mass Ave,E51-185, Cambridge, MA 02139 USA.							Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Beatty J, 1995, CONCEPTS, THEORIES, AND RATIONALITY IN THE BIOLOGICAL SCIENCES, P45; Keller E. F., 2002, MAKING SENSE LIFE EX; Keller EF, 2005, BIOESSAYS, V27, P1060, DOI 10.1002/bies.20294	4	22	22	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					603	603		10.1038/445603a	http://dx.doi.org/10.1038/445603a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287800	Bronze			2022-12-28	WOS:000244039400028
J	Mueller, JM				Mueller, Janice M.			Taking TRIPS to India - Novartis, patent law, and access to medicines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Pittsburgh, Sch Law, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mueller, JM (corresponding author), Univ Pittsburgh, Sch Law, Pittsburgh, PA 15260 USA.							[Anonymous], 2006, NOVARTIS CHALLENGES; BHARGAVA A, 2006, HINDU           1017; *SRI, 2006, NGOS ATT NOV DRUG AC; 2006, 24754 WP	4	25	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					541	543		10.1056/NEJMp068245	http://dx.doi.org/10.1056/NEJMp068245			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287473				2022-12-28	WOS:000244012700001
J	Patrick, JH; Keenan, MAE				Patrick, John H.; Keenan, Mary Ann E.			Gait analysis to assist walking after stroke	LANCET			English	Editorial Material							DEFORMITY; FOOT		Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England; Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania	Patrick, JH (corresponding author), Robert Jones & Agnes Hunt Orthopaed & Dist Hosp N, ORLAU Movement Anal Serv, Oswestry SY10 7AG, Shrops, England.	John.Patrick@rjah.nhs.uk	Keenan, Mary Ann/ABB-1551-2020					Carson MC, 2001, J BIOMECH, V34, P1299, DOI 10.1016/S0021-9290(01)00101-4; *DAN NAT I HLTH, 2002, DAN NAT HLTH POP FOR; Fuller DA, 2002, FOOT ANKLE INT, V23, P738, DOI 10.1177/107110070202300810; Gage Jr, 2004, CLIN DEV MED, P238; Jorgensen HS, 1999, STROKE, V30, P930, DOI 10.1161/01.STR.30.5.930; NENE AV, 2005, GAIT POST S, V22, pS18; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; Takahashi S, 2002, J BONE JOINT SURG BR, V84B, P978, DOI 10.1302/0301-620X.84B7.12905	8	22	25	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					256	257		10.1016/S0140-6736(07)60124-X	http://dx.doi.org/10.1016/S0140-6736(07)60124-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258650				2022-12-28	WOS:000243912000008
J	Lin, JY; Fisher, DE				Lin, Jennifer Y.; Fisher, David E.			Melanocyte biology and skin pigmentation	NATURE			English	Review							INDUCED DNA-DAMAGE; HUMAN MELANOCORTIN-1 RECEPTOR; RANDOMIZED CONTROLLED-TRIAL; SUNSCREEN USE; C-KIT; STIMULATING HORMONE; MALIGNANT-MELANOMA; STEM-CELL; CUTANEOUS MELANOMA; MASTER REGULATOR	Melanocytes are phenotypically prominent but histologically inconspicuous skin cells. They are responsible for the pigmentation of skin and hair, and thereby contribute to the appearance of skin and provide protection from damage by ultraviolet radiation. Pigmentation mutants in various species are highly informative about basic genetic and developmental pathways, and provide important clues to the processes of photoprotection, cancer predisposition and even human evolution. Skin is the most common site of cancer in humans. Continued understanding of melanocyte contributions to skin biology will hopefully provide new opportunities for the prevention and treatment of skin diseases.	Childrens Hosp Boston, Dana Farber Canc Inst, Melanoma Program, Boston, MA 02115 USA; Massachusetts Gen Hosp, Harvard Combined Program Dermatol, Boston, MA 02115 USA; Childrens Hosp Boston, Dana Farber Canc Inst, Dept Pediat Hematol & Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Fisher, DE (corresponding author), Childrens Hosp Boston, Dana Farber Canc Inst, Melanoma Program, 44 Binney St, Boston, MA 02115 USA.	david_fisher@dfci.harvard.edu						Ancans J, 2003, ANN NY ACAD SCI, V994, P373, DOI 10.1111/j.1749-6632.2003.tb03202.x; AUTIER P, 1995, INT J CANCER, V61, P749, DOI 10.1002/ijc.2910610602; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Barsh G, 2000, PIGM CELL RES, V13, P48, DOI 10.1034/j.1600-0749.13.s8.10.x; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Boissy RE, 2003, EXP DERMATOL, V12, P5, DOI 10.1034/j.1600-0625.12.s2.1.x; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Christiansen JH, 2000, CURR OPIN CELL BIOL, V12, P719, DOI 10.1016/S0955-0674(00)00158-7; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Dennis LK, 1996, AM J EPIDEMIOL, V143, P248; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; ELLER MS, 1994, NATURE, V372, P413, DOI 10.1038/372413a0; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Everts RE, 2000, ANIM GENET, V31, P194, DOI 10.1046/j.1365-2052.2000.00639.x; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Furumura M, 1996, PIGM CELL RES, V9, P191, DOI 10.1111/j.1600-0749.1996.tb00109.x; Gallagher RDP, 2000, JAMA-J AM MED ASSOC, V283, P2955, DOI 10.1001/jama.283.22.2955; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Heenen M, 2001, J PHOTOCH PHOTOBIO B, V63, P84, DOI 10.1016/S1011-1344(01)00205-6; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hill HZ, 2000, PIGM CELL RES, V13, P140, DOI 10.1034/j.1600-0749.13.s8.25.x; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; KAMB A, 1994, NATURE, V372, P730, DOI 10.1038/372730a0; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; KOLLIAS N, 1991, J PHOTOCH PHOTOBIO B, V9, P135, DOI 10.1016/1011-1344(91)80147-A; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LANDSBERG JJ, 1977, EXP AGR, V13, P273, DOI 10.1017/S0014479700008000; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Legros L, 2005, BRIT J DERMATOL, V153, P691, DOI 10.1111/j.1365-2133.2005.06813.x; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li G, 1998, J INVEST DERMATOL, V110, P72, DOI 10.1046/j.1523-1747.1998.00090.x; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Mak SS, 2006, DEV BIOL, V291, P144, DOI 10.1016/j.ydbio.2005.12.025; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Mones JM, 2003, AM J DERMATOPATH, V25, P223, DOI 10.1097/00000372-200306000-00007; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Oetting WS, 2003, PIGM CELL RES, V16, P307, DOI 10.1034/j.1600-0749.2003.00045.x; OLSON E, 2006, NY TIMES        0619; Otsuka T, 1998, CANCER RES, V58, P5157; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Paus R, 1999, ANN NY ACAD SCI, V885, P350; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Perez-Losada J, 2002, BLOOD, V100, P1274, DOI 10.1182/blood.V100.4.1274.h81602001274_1274_1286; Pfahlberg A, 2004, PREV MED, V38, P382, DOI 10.1016/j.ypmed.2003.11.015; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; Rana BK, 1999, GENETICS, V151, P1547; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Ruan HB, 2005, GENETICS, V169, P819, DOI 10.1534/genetics.104.027177; Sanchez-Martin MS, 2003, AM J MED GENET A, V122A, P125, DOI 10.1002/ajmg.a.20345; SCHAUER E, 1994, J CLIN INVEST, V93, P2258, DOI 10.1172/JCI117224; Scott MC, 2002, J CELL SCI, V115, P2349; SEARLE AG, 1968, J HERED, V59, P341, DOI 10.1093/oxfordjournals.jhered.a107739; Shears D, 2004, CLIN GENET, V65, P384, DOI 10.1111/j.0009-9163.2004.00235.x; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Sollitto RB, 1997, J AM ACAD DERMATOL, V37, P942, DOI 10.1016/S0190-9622(97)70069-0; Spritz RA, 1998, AM J MED GENET, V75, P101, DOI 10.1002/(SICI)1096-8628(19980106)75:1<101::AID-AJMG20>3.0.CO;2-P; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Suzuki K, 2003, ONCOGENE, V22, P6988, DOI 10.1038/sj.onc.1206881; Takeuchi S, 2004, P NATL ACAD SCI USA, V101, P15076, DOI 10.1073/pnas.0403994101; Tsao AS, 2003, CANCER, V98, P2483, DOI 10.1002/cncr.11812; Tsatmali M, 2000, PIGM CELL RES, V13, P125, DOI 10.1034/j.1600-0749.13.s8.22.x; Vainio H, 2000, INT J CANCER, V88, P838, DOI 10.1002/1097-0215(20001201)88:5<838::AID-IJC25>3.0.CO;2-X; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang SQ, 2001, J AM ACAD DERMATOL, V44, P837, DOI 10.1067/mjd.2001.114594; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; WEINSTOCK MA, 1992, J INVEST DERMATOL, V98, P809, DOI 10.1111/1523-1747.ep12499962; Wenczl E, 1998, J INVEST DERMATOL, V111, P678, DOI 10.1046/j.1523-1747.1998.00357.x; Wolf P, 1998, MELANOMA RES, V8, P370, DOI 10.1097/00008390-199808000-00012; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0; Ziegler I, 2003, PIGM CELL RES, V16, P172, DOI 10.1034/j.1600-0749.2003.00044.x	100	773	826	14	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					843	850		10.1038/nature05660	http://dx.doi.org/10.1038/nature05660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314970				2022-12-28	WOS:000244341200034
J	Scott, JD; Gretch, DR				Scott, John D.; Gretch, David R.			Molecular diagnostics of hepatitis C virus infection - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTERFERON-ALPHA THERAPY; POLYMERASE-CHAIN-REACTION; HCV RNA DETECTION; PERFORMANCE-CHARACTERISTICS; PLUS RIBAVIRIN; VIRAL LOAD; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; MULTICENTER EVALUATION; SUSTAINED RESPONSE	Context Hepatitis C virus (HCV) is a common blood-borne pathogen that relies heavily on nucleic acid testing for confirmation of infection. Nucleic acid tests are invaluable for the diagnosis of HCV infection and provide critical prognostic information for guiding treatment and measuring the response to antiviral therapy. Objective To review the currently available molecular diagnostic tests for HCV, their clinical applications, and how these tests shed light on the natural history of HCV. Evidence Acquisition Search of MEDLINE (1966 to July 2006), article reference lists, and national meeting abstracts for the diagnosis and applications of molecular diagnostic tests for HCV. Studies were selected on the basis of clinical relevance. Evidence Synthesis Qualitative nucleic acid tests have low limits of detection (<50 IU HCV RNA/mL) and are used for confirmation of HCV infection and for screening blood donations. Hepatitis C virus genotype test results provide important prognostic information related to therapeutic response and are routinely used for selecting treatment regimens. Quantitative HCV RNA testing provides prognostic information regarding likelihood of treatment response and plays an important role in monitoring the antiviral response to treatment. Sustained virological response is defined as testing negative for HCV RNA 6 months after cessation of therapy. Recent studies suggest that the rate of response to therapy is also important. For example, conversion to an HCV RNA negative test result after 4 weeks of therapy constitutes a rapid virological response and is a strong predictor of treatment success. Patients who have not had an early virological response, defined as at least a 2-log decline in HCV RNA after 12 weeks of therapy, are unlikely to respond with an additional 36 weeks of therapy, and should stop therapy. Conclusions A sensitive nucleic acid test should be used to confirm all cases of acute or chronic HCV infection. A genotype test and quantitative HCV RNA test should be performed on all patients prior to therapy to best assess probability of response and to aid in selection of appropriate therapeutic regimen. Monitoring HCV RNA during treatment provides important information on likelihood of sustained virological response. The same type of quantitative HCV RNA test should be used throughout a patient's treatment course.	Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gretch, DR (corresponding author), Harborview Med Ctr, Box 359690 Virol Div UW,325 9th Ave, Seattle, WA 98104 USA.	gretch@u.washington.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049168, R01AI066209] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albadalejo J, 1998, J CLIN MICROBIOL, V36, P862, DOI 10.1128/JCM.36.4.862-865.1998; Alberti A, 2002, HEPATOLOGY, V36, pS195, DOI 10.1053/jhep.2002.36808; ALBERTI A, 1992, LANCET, V340, P697, DOI 10.1016/0140-6736(92)92234-7; ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ., 2003, MMWR RECOMM REP, V52, P1; Anderson JC, 2003, J CLIN VIROL, V28, P27, DOI 10.1016/S1386-6532(02)00235-4; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Barbeau JM, 2004, J CLIN MICROBIOL, V42, P3739, DOI 10.1128/JCM.42.8.3739-3746.2004; Berg T, 2006, GASTROENTEROLOGY, V130, P1086, DOI 10.1053/j.gastro.2006.02.015; Bourlet T, 2002, J CLIN MICROBIOL, V40, P3252, DOI 10.1128/JCM.40.9.3252-3255.2002; Bruce MG, 2006, LIVER INT, V26, P643, DOI 10.1111/j.1478-3231.2006.01281.x; Carithers RL, 2000, SEMIN LIVER DIS, V20, P159; Carreno V, 2006, J INFECT DIS, V194, P53, DOI 10.1086/504692; Castillo I, 2004, J INFECT DIS, V189, P7, DOI 10.1086/380202; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Desombere I, 2005, J CLIN MICROBIOL, V43, P2590, DOI 10.1128/JCM.43.6.2590-2597.2005; Elbeik T, 2004, J CLIN MICROBIOL, V42, P563, DOI 10.1128/JCM.42.2.563-569.2004; Fanning L, 1999, HEPATOLOGY, V29, P904, DOI 10.1002/hep.510290310; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Ferreira-Gonzalez A, 2004, SEMIN LIVER DIS, V24, P9, DOI 10.1055/s-2004-832923; Flamm SL, 2003, JAMA-J AM MED ASSOC, V289, P2413, DOI 10.1001/jama.289.18.2413; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GORDON SC, 1994, AM J GASTROENTEROL, V89, P1458; Gretch DR, 1997, HEPATOLOGY, V26, pS43, DOI 10.1002/hep.510260708; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; HAGIWARA H, 1993, GASTROENTEROL JPN, V28, P48, DOI 10.1007/BF02989205; Hayashi J, 1998, DIGEST DIS SCI, V43, P384, DOI 10.1023/A:1018874910195; Hisada M, 2000, J INFECT DIS, V181, P1475, DOI 10.1086/315396; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Jauncey M, 2004, J INFECT DIS, V190, P1270, DOI 10.1086/423943; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kamal SM, 2006, HEPATOLOGY, V43, P923, DOI 10.1002/hep.21197; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; KATO N, 1993, HEPATOLOGY, V18, P16, DOI 10.1002/hep.1840180104; Konnick EQ, 2002, J CLIN MICROBIOL, V40, P768, DOI 10.1128/JCM.40.3.768-773.2002; Kwiatkowski CF, 2002, ADDICTION, V97, P1289, DOI 10.1046/j.1360-0443.2002.00208.x; LAU JYN, 1995, J INFECT DIS, V171, P281, DOI 10.1093/infdis/171.2.281; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee WM, 2005, J INFECT DIS, V192, P1088, DOI 10.1086/432917; Mangia A, 2005, NEW ENGL J MED, V352, P2609, DOI 10.1056/NEJMoa042608; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; MARTINOTPEIGNOUX M, 1995, HEPATOLOGY, V22, P1050, DOI 10.1016/0270-9139(95)90608-8; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Morishima C, 2004, J CLIN MICROBIOL, V42, P421, DOI 10.1128/JCM.42.1.421-425.2004; Morishima C, 1999, Clin Liver Dis, V3, P717, DOI 10.1016/S1089-3261(05)70235-X; Morishima C, 2006, HEPATOLOGY, V44, P360, DOI 10.1002/hep.21265; Nguyen TT, 1996, J VIRAL HEPATITIS, V3, P75, DOI 10.1111/j.1365-2893.1996.tb00084.x; Nolte FS, 2001, J CLIN MICROBIOL, V39, P4005, DOI 10.1128/JCM.39.11.4005-4012.2001; Nowicki MJ, 2005, J INFECT DIS, V192, P1557, DOI 10.1086/491742; Pawlotsky JM, 2000, HEPATOLOGY, V32, P654, DOI 10.1053/jhep.2000.16603; Polywka S, 2006, J MED VIROL, V78, P305, DOI 10.1002/jmv.20540; Radkowski M, 2005, HEPATOLOGY, V41, P106, DOI 10.1002/hep.20518; Richter SS, 2002, J CLIN MICROBIOL, V40, P4407, DOI 10.1128/JCM.40.12.4407-4412.2002; Ross RS, 2001, J CLIN LAB ANAL, V15, P308, DOI 10.1002/jcla.1042; Sarrazin C, 2001, J CLIN MICROBIOL, V39, P2850, DOI 10.1128/JCM.39.8.2850-2855.2001; Scott JD, 2006, CLIN INFECT DIS, V42, P945, DOI 10.1086/500938; Shiffman M, 2006, HEPATOLOGY, V44, p316A; Shuhart MC, 1997, HEPATOLOGY, V26, P1646; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085; Terrault NA, 2005, J VIRAL HEPATITIS, V12, P465, DOI 10.1111/j.1365-2893.2005.00615.x; Trabaud MA, 1997, J MED VIROL, V52, P105, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;105::AID-JMV17&gt;3.0.CO;2-L; von Wagner M, 2005, GASTROENTEROLOGY, V129, P522, DOI 10.1053/j.gastro.2005.05.008; Wang CC, 2006, J INFECT DIS, V193, P672, DOI 10.1086/499602; Watanabe H, 2003, J MED VIROL, V71, P56, DOI 10.1002/jmv.10448; Weiland O, 1999, SCAND J INFECT DIS, V31, P115, DOI 10.1080/003655499750006119; YAMADA G, 1995, HEPATOLOGY, V22, P1351, DOI 10.1002/hep.1840220502; YUN ZB, 1994, SCAND J INFECT DIS, V26, P263, DOI 10.3109/00365549409011794	75	130	152	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 21	2007	297	7					724	732		10.1001/jama.297.7.724	http://dx.doi.org/10.1001/jama.297.7.724			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137KI	17312292	Bronze			2022-12-28	WOS:000244291100024
J	Lifson, AR; Rybicki, SL				Lifson, Alan R.; Rybicki, Sarah L.			Routine opt-out HIV testing	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTION		Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lifson, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	lifso001@umn.edu						Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CA STD HIV PREV T, ASK SCREEN INT RISK; Cunningham WE, 2006, MED CARE, V44, P1038, DOI 10.1097/01.mlr.0000242942.17968.69; Duffus W., 2006, Morbidity and Mortality Weekly Report, V55, P1269; Gielen AC, 1997, WOMEN HEALTH, V25, P19, DOI 10.1300/J013v25n03_02; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Lo B, 2000, J ACQ IMMUN DEF SYND, V25, pS136, DOI 10.1097/00126334-200012152-00008; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; *MONT MED CTR AD A, ASS CONS TEST SUPP	10	20	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					539	540		10.1016/S0140-6736(07)60249-9	http://dx.doi.org/10.1016/S0140-6736(07)60249-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307085				2022-12-28	WOS:000244368000007
J	Newton, ILG; Woyke, T; Auchtung, TA; Dilly, GF; Dutton, RJ; Fisher, MC; Fontanez, KM; Lau, E; Stewart, FJ; Richardson, PM; Barry, KW; Saunders, E; Detter, JC; Wu, D; Eisen, JA; Cavanaugh, CM				Newton, I. L. G.; Woyke, T.; Auchtung, T. A.; Dilly, G. F.; Dutton, R. J.; Fisher, M. C.; Fontanez, K. M.; Lau, E.; Stewart, F. J.; Richardson, P. M.; Barry, K. W.; Saunders, E.; Detter, J. C.; Wu, D.; Eisen, J. A.; Cavanaugh, C. M.			The Calyptogena magnifica chemoautotrophic symbiont genome	SCIENCE			English	Article							GALAPAGOS SPREADING CENTER; HYDROTHERMAL VENT CLAM; GENE-CLUSTER; SULFIDE	Chemoautotrophic endosymbionts are the metabolic cornerstone of hydrothermal vent communities, providing invertebrate hosts with nearly all of their nutrition. The Calyptogena magnifica (Bivalvia: Vesicomyidae) symbiont, Candidatus Ruthia magnifica, is the first intracellular sulfur-oxidizing endosymbiont to have its genome sequenced, revealing a suite of metabolic capabilities. The genome encodes major chemoautotrophic pathways as well as pathways for biosynthesis of vitamins, cofactors, and all 20 amino acids required by the clam.	Harvard Univ, Biolabs 4080, Cambridge, MA 02138 USA; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Inst Genom Res, Rockville, MD 20850 USA; Univ Calif Davis, Genome Ctr, Genome & Biomed Sci Facil, Davis, CA 95616 USA	Harvard University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Harvard University; Harvard Medical School; J. Craig Venter Institute; University of California System; University of California Davis	Cavanaugh, CM (corresponding author), Harvard Univ, Biolabs 4080, 16 Divin Ave, Cambridge, MA 02138 USA.	cavanaug@fas.harvard.edu	Barry, Kerrie Whitelaw/AAA-5500-2020; Newton, Irene/H-5939-2019; Eisen, Jonathan A./H-2706-2019	Barry, Kerrie Whitelaw/0000-0002-8999-6785; Newton, Irene/0000-0002-7118-0374; Eisen, Jonathan A./0000-0002-0159-2197; Dilly, Geoffrey/0000-0003-2140-4955; Auchtung, Thomas/0000-0002-0135-6266; Lau, Evan/0000-0002-7434-4362				BOSS KJ, 1980, MALACOLOGIA, V20, P161; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Cavanaugh CM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P285; CAVANAUGH CM, 2004, PROKARYOTES; CHILDRESS JJ, 1991, PHYSIOL ZOOL, V64, P1444, DOI 10.1086/physzool.64.6.30158224; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; FISHER CR, 1988, DEEP-SEA RES, V35, P1811, DOI 10.1016/0198-0149(88)90051-9; JOHNSON KS, 1988, DEEP-SEA RES, V35, P1723, DOI 10.1016/0198-0149(88)90046-5; Kumagai H, 1997, BIOCHEMISTRY-US, V36, P5509, DOI 10.1021/bi970014q; ROBINSON JJ, 1997, THESIS HARVARD U CAM; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; Verte F, 2002, BIOCHEMISTRY-US, V41, P2932, DOI 10.1021/bi011404m; Wernegreen JJ, 2002, NAT REV GENET, V3, P850, DOI 10.1038/nrg931; Wood AP, 2004, FEMS MICROBIOL REV, V28, P335, DOI 10.1016/j.femsre.2003.12.001; Zal F, 2000, CAH BIOL MAR, V41, P413	16	138	378	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 16	2007	315	5814					998	1000		10.1126/science.1138438	http://dx.doi.org/10.1126/science.1138438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303757	Green Submitted			2022-12-28	WOS:000244229800045
J	Ferguson, N; Sharpe, TD; Johnson, CM; Schartau, PJ; Fersht, AR				Ferguson, Neil; Sharpe, Timothy D.; Johnson, Christopher M.; Schartau, Pamela J.; Fersht, Alan R.			Structural biology - Analysis of 'downhill' protein folding	NATURE			English	Letter							STATE		MRC Ctr, Med Res Council Ctr Prot Engn, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Ferguson, N (corresponding author), MRC Ctr, Med Res Council Ctr Prot Engn, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008; Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Sharpe, Timothy/0000-0002-4980-1330	Medical Research Council [MC_U105484373] Funding Source: Medline; MRC [MC_U105484373] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ferguson N, 2005, J MOL BIOL, V353, P427, DOI 10.1016/j.jmb.2005.08.031; Ferguson N, 2004, J MOL BIOL, V344, P295, DOI 10.1016/j.jmb.2004.09.069; Nicholson EM, 1996, BIOCHEMISTRY-US, V35, P11369, DOI 10.1021/bi960863y; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859	5	41	41	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2007	445	7129					E14	E15		10.1038/nature05643	http://dx.doi.org/10.1038/nature05643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136EK	17301742				2022-12-28	WOS:000244205200033
J	Watters, AL; Deka, P; Corrent, C; Callender, D; Varani, G; Sosnick, T; Baker, D				Watters, Alexander L.; Deka, Pritilekha; Corrent, Colin; Callender, David; Varani, Gabriele; Sosnick, Tobin; Baker, David			The highly cooperative folding of small naturally occurring proteins is likely the result of natural selection	CELL			English	Article							ENERGY LANDSCAPES; BINDING DOMAIN; EVOLUTION; 2-STATE; DESIGN; AGGREGATION; KINETICS; NMR; STABILITY; INTERMEDIATE	To illuminate the evolutionary pressure acting on the folding free energy landscapes of naturally occurring proteins, we have systematically characterized the folding free energy landscape of Top7, a computationally designed protein lacking an evolutionary history. Stopped-flow kinetics, circular dichroism, and NMR experiments reveal that there are at least three distinct phases in the folding of Top7, that a nonnative conformation is stable at equilibrium, and that multiple fragments of Top7 are stable in isolation. These results indicate that the folding of Top7 is significantly less cooperative than the folding of similarly sized naturally occurring proteins, suggesting that the cooperative folding and smooth free energy landscapes observed for small naturally occurring proteins are not general properties of polypeptide chains that fold to unique stable structures but are instead a product of natural selection.	Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Chicago, Dept Biochem & Mol Biol, Inst Biophys Dynam, Chicago, IL 60637 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Chicago; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Freed, Karl F/J-7764-2018; Baker, David/K-8941-2012	Freed, Karl F/0000-0001-6240-2599; Baker, David/0000-0001-7896-6217				ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Bai YW, 2003, BIOCHEM BIOPH RES CO, V305, P785, DOI 10.1016/S0006-291X(03)00800-3; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Bolon DN, 2001, BIOCHEMISTRY-US, V40, P10047, DOI 10.1021/bi010427y; Calloni G, 2003, J MOL BIOL, V330, P577, DOI 10.1016/S0022-2836(03)00627-2; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Chamberlain AK, 1998, BIOCHEMISTRY-US, V37, P1736, DOI 10.1021/bi972692i; Chan HS, 2000, PROTEINS, V40, P543, DOI 10.1002/1097-0134(20000901)40:4<543::AID-PROT20>3.0.CO;2-O; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dantas G, 2003, J MOL BIOL, V332, P449, DOI 10.1016/S0022-2836(03)00888-X; Dantas G, 2006, J MOL BIOL, V362, P1004, DOI 10.1016/j.jmb.2006.07.092; DeLano W.L, PYMOL MOL GRAPHICS S; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson N, 2006, STRUCTURE, V14, P847, DOI 10.1016/j.str.2006.02.011; Ferguson N, 2005, J MOL BIOL, V353, P427, DOI 10.1016/j.jmb.2005.08.031; Ferguson N, 2004, J MOL BIOL, V344, P295, DOI 10.1016/j.jmb.2004.09.069; Ferguson N, 1999, J MOL BIOL, V286, P1597, DOI 10.1006/jmbi.1998.2548; FLANAGAN JM, 1992, P NATL ACAD SCI USA, V89, P748, DOI 10.1073/pnas.89.2.748; Fukunishi Y, 1998, PROTEINS, V33, P408, DOI 10.1002/(SICI)1097-0134(19981115)33:3<408::AID-PROT9>3.0.CO;2-2; Gillespie B, 2003, J MOL BIOL, V330, P813, DOI 10.1016/S0022-2836(03)00616-8; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GO N, 1984, ADV BIOPHYS, V18, P149, DOI 10.1016/0065-227X(84)90010-8; GOVINDARAJAN S, 1995, PROTEINS, V22, P413, DOI 10.1002/prot.340220411; GRANT JS, 1997, J FAMILY NURSING, V3, P36; GU HD, 1995, PROTEIN SCI, V4, P1108, DOI 10.1002/pro.5560040609; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3; Jack CIA, 2001, AGE AGEING, V30, P428, DOI 10.1093/ageing/30.5.428; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065; JERNTH P, 2004, P NATL ACAD SCI USA, V101, P6450; Jewett AI, 2003, J MOL BIOL, V326, P247, DOI 10.1016/S0022-2836(02)01356-6; Kaya H, 2003, J MOL BIOL, V326, P911, DOI 10.1016/S0022-2836(02)01434-1; Krantz BA, 2000, BIOCHEMISTRY-US, V39, P11696, DOI 10.1021/bi000792+; Krantz BA, 2002, J MOL BIOL, V324, P359, DOI 10.1016/S0022-2836(02)01029-X; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Ladurner AG, 1997, J MOL BIOL, V273, P317, DOI 10.1006/jmbi.1997.1303; MATOUSCHEK A, 1991, METHOD ENZYMOL, V202, P82; Maxwell KL, 2005, PROTEIN SCI, V14, P602, DOI 10.1110/ps.041205405; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Plaxco KW, 1999, NAT STRUCT BIOL, V6, P554; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sadqi M, 2006, NATURE, V442, P317, DOI 10.1038/nature04859; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Scalley ML, 1997, BIOCHEMISTRY-US, V36, P3373, DOI 10.1021/bi9625758; Scalley-Kim M, 2004, J MOL BIOL, V338, P573, DOI 10.1016/j.jmb.2004.02.055; Silow M, 1999, BIOCHEMISTRY-US, V38, P13006, DOI 10.1021/bi9909997; Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084; Srimathi T, 2002, J BIOL CHEM, V277, P47507, DOI 10.1074/jbc.M203407200; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Van Mierlo CPM, 2000, PROTEIN SCI, V9, P145; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yahara I, 1999, GENES CELLS, V4, P375, DOI 10.1046/j.1365-2443.1999.00271.x; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	64	109	111	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					613	624		10.1016/j.cell.2006.12.042	http://dx.doi.org/10.1016/j.cell.2006.12.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289578	Bronze			2022-12-28	WOS:000244842700025
J	Greenamyre, JT				Greenamyre, J. Timothy			Huntington's disease - Making connections	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEURODEGENERATION; DEFECTS		Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greenamyre, JT (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.		Greenamyre, J. Timothy/B-4049-2011	Greenamyre, J. Timothy/0000-0003-3468-7878				Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	7	20	20	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					518	520		10.1056/NEJMcibr067022	http://dx.doi.org/10.1056/NEJMcibr067022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267914				2022-12-28	WOS:000243860700016
J	Henley, DV; Lipson, N; Korach, KS; Bloch, CA				Henley, Derek V.; Lipson, Natasha; Korach, Kenneth S.; Bloch, Clifford A.			Brief report - Prepubertal gynecomastia linked to lavender and tea tree oils	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER-CELLS; ESTROGENIC ACTIVITY; ANDROGEN; RECEPTOR; EXPRESSION; ESTRADIOL; MDA-KB2	Most cases of male prepubertal gynecomastia are classified as idiopathic. We investigated possible causes of gynecomastia in three prepubertal boys who were otherwise healthy and had normal serum concentrations of endogenous steroids. In all three boys, gynecomastia. coincided with the topical application of products that contained lavender and tea tree oils. Gynecomastia resolved in each patient shortly after the use of products containing these oils was discontinued. Furthermore, studies in human cell lines indicated that the two oils had estrogenic and antiandrogenic activities. We conclude that repeated topical exposure to lavender and tea tree oils probably caused prepubertal gynecomastia in these boys.	NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; Pediat Endocrine Associates, Greenwood Village, CO USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Korach, KS (corresponding author), NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, MD B3-02,POB 12233, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov		Korach, Kenneth/0000-0002-7765-418X	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES070065, Z01ES070065] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BRAUNSTEIN GD, 1993, NEW ENGL J MED, V328, P490; Brody Steven A, 2003, Endocr Pract, V9, P370; Chung BH, 2006, CANCER LETT, V236, P222, DOI 10.1016/j.canlet.2005.05.023; Deroo BJ, 2004, ENDOCRINOLOGY, V145, P5485, DOI 10.1210/en.2004-0471; DESCAMPS H, 1985, ARCH FR PEDIATR, V42, P87; Dhar S. K., 1995, Indian Journal of Physiology and Pharmacology, V39, P63; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; DUBIK D, 1987, CANCER RES, V47, P6517; Einav-Bachar R, 2004, CLIN ENDOCRINOL, V61, P55, DOI 10.1111/j.1365-2265.2004.02059.x; FINKELSTEIN JS, 1988, NEW ENGL J MED, V318, P961, DOI 10.1056/NEJM198804143181505; GELDOF AA, 1992, UROL RES, V20, P139, DOI 10.1007/BF00296526; Howes MJR, 2002, J PHARM PHARMACOL, V54, P1521, DOI 10.1211/002235702216; Huynh H, 1996, J BIOL CHEM, V271, P1016, DOI 10.1074/jbc.271.2.1016; Ma RS, 2003, TOXICOL SCI, V74, P43, DOI 10.1093/toxsci/kfg102; Perry NSL, 2001, J PHARM PHARMACOL, V53, P1347, DOI 10.1211/0022357011777846; Tabanca N, 2004, PLANTA MED, V70, P728, DOI 10.1055/s-2004-827203; WESTLEY BR, 1987, NUCLEIC ACIDS RES, V15, P3773, DOI 10.1093/nar/15.9.3773; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69	18	167	170	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					479	485		10.1056/NEJMoa064725	http://dx.doi.org/10.1056/NEJMoa064725			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267908				2022-12-28	WOS:000243860700008
J	Irion, U; St Johnston, D				Irion, Uwe; St Johnston, Daniel			bicoid RNA localization requires specific binding of an endosomal sorting complex	NATURE			English	Article							MESSENGER-RNA; ESCRT-II; DROSOPHILA EMBRYO; ANTERIOR LOCALIZATION; DEPENDENT MANNER; PROTEIN; STAUFEN; GENE; TRANSPORT; OOCYTES	bicoid messenger RNA localizes to the anterior of the Drosophila egg, where it is translated to form a morphogen gradient of Bicoid protein that patterns the head and thorax of the embryo. Although bicoid was the first localized cytoplasmic determinant to be identified(1-4), little is known about how the mRNA is coupled to the microtubule-dependent transport pathway that targets it to the anterior, and it has been proposed that the mRNA is recognized by a complex of many redundant proteins, each of which binds to the localization element in the 3' untranslated region (UTR) with little or no specificity(5). Indeed, the only known RNA-binding protein that co-localizes with bicoid mRNA is Staufen, which binds non-specifically to double-stranded RNA in vitro(6,7). Here we show that mutants in all subunits of the ESCRT-II complex (VPS22, VPS25 and VPS36) abolish the final Staufen-dependent step in bicoid mRNA localization. ESCRT-II is a highly conserved component of the pathway that sorts ubiquitinated endosomal proteins into internal vesicles(8,9), and functions as a tumour-suppressor by removing activated receptors from the cytoplasm(10,11). However, the role of ESCRT-II in bicoid localization seems to be independent of endosomal sorting, because mutations in ESCRT-I and III components do not affect the targeting of bicoid mRNA. Instead, VPS36 functions by binding directly and specifically to stem-loop V of the bicoid 39 UTR through its amino-terminal GLUE domain(12), making it the first example of a sequence-specific RNA-binding protein that recognizes the bicoid localization signal. Furthermore, VPS36 localizes to the anterior of the oocyte in a bicoid-mRNA-dependent manner, and is required for the subsequent recruitment of Staufen to the bicoid complex. This function of ESCRT-II as an RNA-binding complex is conserved in vertebrates and may clarify some of its roles that are independent of endosomal sorting.	Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	Irion, Uwe/ABC-8635-2020; St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Irion, Uwe/0000-0003-2823-5840	Cancer Research UK [A14492] Funding Source: Medline; Wellcome Trust [092096, 049818] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Arn EA, 2003, DEV CELL, V4, P41, DOI 10.1016/S1534-5807(02)00397-0; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; FROHNHOFER HG, 1987, GENE DEV, V1, P880, DOI 10.1101/gad.1.8.880; Jin Y, 2005, DEV CELL, V9, P63, DOI 10.1016/j.devcel.2005.04.016; Kamura T, 2001, J BIOL CHEM, V276, P16528, DOI 10.1074/jbc.M010142200; MACDONALD PM, 1991, GENE DEV, V5, P2455, DOI 10.1101/gad.5.12b.2455; MACDONALD PM, 1993, DEVELOPMENT, V118, P1233; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moon WJ, 2004, CURR BIOL, V14, P1957, DOI 10.1016/j.cub.2004.10.023; Putz U, 1996, NUCLEIC ACIDS RES, V24, P4838, DOI 10.1093/nar/24.23.4838; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Schmidt AE, 1999, J BIOL CHEM, V274, P21981, DOI 10.1074/jbc.274.31.21981; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STJOHNSTON D, 1989, DEVELOPMENT S, V107, P131; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vogt N, 2006, DEVELOPMENT, V133, P3963, DOI 10.1242/dev.02570; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427	30	141	146	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2007	445	7127					554	558		10.1038/nature05503	http://dx.doi.org/10.1038/nature05503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131KI	17268469	Green Accepted			2022-12-28	WOS:000243867300047
J	Lautrette, A; Darmon, M; Megarbane, B; Joly, LM; Chevret, S; Adrie, C; Barnoud, D; Bleichner, G; Bruel, C; Choukroun, G; Curtis, JR; Fieux, F; Galliot, R; Garrouste-Orgeas, M; Georges, H; Goldgran-Toledano, D; Jourdain, M; Loubert, G; Reignier, J; Saidi, F; Souweine, B; Vincent, F; Barnes, NK; Pochard, F; Schlemmer, B; Azoulay, E				Lautrette, Alexandre; Darmon, Michael; Megarbane, Bruno; Joly, Luc Marie; Chevret, Sylvie; Adrie, Christophe; Barnoud, Didier; Bleichner, Gerard; Bruel, Cedric; Choukroun, Gerald; Curtis, J. Randall; Fieux, Fabienne; Galliot, Richard; Garrouste-Orgeas, Maite; Georges, Hugues; Goldgran-Toledano, Dany; Jourdain, Merce; Loubert, Georges; Reignier, Jean; Saidi, Faycal; Souweine, Bertrand; Vincent, Francois; Barnes, Nancy Kentish; Pochard, Frederic; Schlemmer, Benoit; Azoulay, Elie			A communication strategy and brochure for relatives of patients dying in the ICU	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; END-OF-LIFE; CRITICALLY-ILL PATIENTS; FAMILY-MEMBERS; IMPACT; WITHDRAWAL; OPPORTUNITIES; CONFERENCES; DEPRESSION; SYMPTOMS	BACKGROUND: There is a need for close communication with relatives of patients dying in the intensive care unit (ICU). We evaluated a format that included a proactive end-of-life conference and a brochure to see whether it could lessen the effects of bereavement. METHODS: Family members of 126 patients dying in 22 ICUs in France were randomly assigned to the intervention format or to the customary end-of-life conference. Participants were interviewed by telephone 90 days after the death with the use of the Impact of Event Scale (IES; scores range from 0, indicating no symptoms, to 75, indicating severe symptoms related to post-traumatic stress disorder [PTSD]) and the Hospital Anxiety and Depression Scale (HADS; subscale scores range from 0, indicating no distress, to 21, indicating maximum distress). RESULTS: Participants in the intervention group had longer conferences than those in the control group (median, 30 minutes [interquartile range, 19 to 45] vs. 20 minutes [interquartile range, 15 to 30]; P<0.001) and spent more of the time talking (median, 14 minutes [interquartile range, 8 to 20] vs. 5 minutes [interquartile range, 5 to 10]). On day 90, the 56 participants in the intervention group who responded to the telephone interview had a significantly lower median IES score than the 52 participants in the control group (27 vs. 39, P=0.02) and a lower prevalence of PTSD-related symptoms (45% vs. 69%, P=0.01). The median HADS score was also lower in the intervention group (11, vs. 17 in the control group; P=0.004), and symptoms of both anxiety and depression were less prevalent (anxiety, 45% vs. 67%; P=0.02; depression, 29% vs. 56%; P=0.003). CONCLUSIONS: Providing relatives of patients who are dying in the ICU with a brochure on bereavement and using a proactive communication strategy that includes longer conferences and more time for family members to talk may lessen the burden of bereavement.	Hop St Louis, Serv Reanimat Med, F-75010 Paris, France; Univ Paris 07, Assistance Publ Hop Paris, Paris, France; Lariboisiere Hosp, Paris, France; Hop Bichat Claude Bernard, F-75877 Paris 18, France; Cochin Hosp, Paris, France; Univ Paris 05, Paris, France; Rouen Univ Hosp, Rouen, France; St Denis Hosp, St Denis, Reunion, France; Univ Hosp, Grenoble, France; Argenteuil Hosp, Argenteuil, France; Pontoise Hosp, Pontoise, France; St Joseph Hosp, St Joseph, France; Tourcoing Hosp, Tourcoing, France; Gonesse Hosp, Gonesse, France; Salengro Hosp, Lille, France; Univ Versailles, Raymond Poincare Hosp, F-78000 Versailles, France; La Roche Yon Hosp, La Roche Sur Yon, France; Nemours Hosp, Nemours, France; Clermont Ferrand Hosp, Clermont Ferrand, France; Avicenne Hosp, Avicenne, France; Univ Washington, Seattle, WA 98195 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; CHU Grenoble Alpes; Centre Hospitalier Rene Dubos, Pontoise; Hopital Paris Saint-Joseph; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHD Vendee; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; University of Washington; University of Washington Seattle	Azoulay, E (corresponding author), Hop St Louis, Serv Reanimat Med, 1 Ave Claude Vellefaux, F-75010 Paris, France.	elie.azoulay@sls-ap-hop-paris.fr	souweine, bertrand/HHR-8972-2022	chevret, sylvie/0000-0001-6449-4730; Megarbane, Bruno/0000-0002-2522-2764; kentish-barnes, nancy/0000-0003-0024-0429; Darmon, Michael/0000-0003-4198-8038	NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR005226] Funding Source: NIH RePORTER; NINR NIH HHS [R01NR005226] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2001, AM J RESP CRIT CARE, V163, P135, DOI 10.1164/ajrccm.163.1.2005117; Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2002, AM J RESP CRIT CARE, V165, P438, DOI 10.1164/ajrccm.165.4.200108-006oc; Azoulay E, 2003, INTENS CARE MED, V29, P1498, DOI 10.1007/s00134-003-1904-y; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Azoulay E, 2004, CRIT CARE MED, V32, P2323, DOI 10.1097/01.CCM.0000145950.57614.04; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P803, DOI 10.1164/rccm.2501004; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell ML, 2003, CHEST, V123, P266, DOI 10.1378/chest.123.1.266; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Curtis JR, 2005, AM J RESP CRIT CARE, V171, P844, DOI 10.1164/rccm.200409-1267OC; Curtis JR, 2001, CRIT CARE MED, V29, pN26, DOI 10.1097/00003246-200102001-00006; Cuthbertson SJ, 2000, CRIT CARE MED, V28, P1196, DOI 10.1097/00003246-200004000-00047; Fallowfield L, 2002, LANCET, V359, P650, DOI 10.1016/S0140-6736(02)07810-8; Fassier T, 2005, CURR OPIN CRIT CARE, V11, P616, DOI 10.1097/01.ccx.0000184299.91254.ff; Heyland DK, 2003, CHEST, V124, P392, DOI 10.1378/chest.124.1.392; Keenan SP, 2000, J PALLIAT CARE, V16, pS40, DOI 10.1177/082585970001601S08; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lemaire FJP, 2004, INTENS CARE MED, V30, P2120, DOI 10.1007/s00134-004-2457-4; Lilly CM, 2000, AM J MED, V109, P469, DOI 10.1016/S0002-9343(00)00524-6; Malacrida R, 1998, CRIT CARE MED, V26, P1187, DOI 10.1097/00003246-199807000-00018; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Pochard F, 2001, CRIT CARE MED, V29, P1893, DOI 10.1097/00003246-200110000-00007; Schneiderman LJ, 2003, JAMA-J AM MED ASSOC, V290, P1166, DOI 10.1001/jama.290.9.1166; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Sundin EC, 2003, PSYCHOSOM MED, V65, P870, DOI 10.1097/01.PSY.0000084835.46074.F0; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Way J, 2002, BMJ-BRIT MED J, V325, P1342, DOI 10.1136/bmj.325.7376.1342; White DB, 2005, CURR OPIN CRIT CARE, V11, P610, DOI 10.1097/01.ccx.0000184301.76007.70; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zisook S, 1998, Ann Clin Psychiatry, V10, P157, DOI 10.3109/10401239809147032	35	800	827	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					469	478		10.1056/NEJMoa063446	http://dx.doi.org/10.1056/NEJMoa063446			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267907	Bronze			2022-12-28	WOS:000243860700007
J	Day, SE; Ward, H				Day, Sophie E.; Ward, Helen			British policy makes sex workers vulnerable	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Goldsmiths Coll, London SE14 6NW, England; Imperial Coll Sch Med, Div Epidemiol Publ Hlth & Primary Care, London, England	University of London; Goldsmiths University London; Imperial College London	Day, SE (corresponding author), Univ London Goldsmiths Coll, London SE14 6NW, England.		Ward, Helen/A-1836-2009	Ward, Helen/0000-0001-8238-5036; Day, Sophie/0000-0002-9822-9094				Goodyear MDE, 2007, BMJ-BRIT MED J, V334, P52, DOI 10.1136/bmj.39087.642801.BE	1	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2007	334	7586					187	187		10.1136/bmj.39104.638785.59	http://dx.doi.org/10.1136/bmj.39104.638785.59			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	133QN	17255611	Green Published			2022-12-28	WOS:000244027600032
J	Barabash, S; Fedorov, A; Lundin, R; Sauvaud, JA				Barabash, Stas; Fedorov, Andrei; Lundin, Rickard; Sauvaud, Jean-Andre			Martian atmospheric erosion rates	SCIENCE			English	Article							MARS; PLASMA; ENVIRONMENT; EVOLUTION; ASPERA-3; OUTFLOW; EXPRESS	Mars was once wet but is now dry, and the fate of its ancient carbon dioxide atmosphere is one of the biggest puzzles in martian planetology. We have measured the current loss rate due to the solar wind interaction for different species: Q(O+) = 1.6 . 10(23) per second = 4 grams per second ( g s(-1)), Q(O-2(+)) = 1.5 . 10(23) s(-1) = 8 g s(-1), and Q(CO2+) = 8 . 10(22) s(-1) = 6 g s(-1) in the energy range of 30 to 30,000 electron volts per charge. These rates can be propagated backward over a period of 3.5 billion years, resulting in the total removal of 0.2 to 4 millibar of carbon dioxide and a few centimeters of water. The escape rate is low, and thus one has to continue searching for water reservoirs and carbon dioxide stores on or beneath the planetary surface and investigate other escape channels.	Swedish Inst Space Phys, S-98128 Kiruna, Sweden; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France		Barabash, S (corresponding author), Swedish Inst Space Phys, Box 812, S-98128 Kiruna, Sweden.	stas@irf.se						Acuna MH, 1998, SCIENCE, V279, P1676, DOI 10.1126/science.279.5357.1676; BARABASH S, 2004, ESA SPECIAL PUBLICAT, P121; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Carlsson E, 2006, ICARUS, V182, P320, DOI 10.1016/j.icarus.2005.09.020; DUBININ E, 1993, J GEOPHYS RES-SPACE, V98, P3991, DOI 10.1029/92JA02233; Dubinin E, 2006, ICARUS, V182, P343, DOI 10.1016/j.icarus.2005.08.023; Fedorov A, 2006, ICARUS, V182, P329, DOI 10.1016/j.icarus.2005.09.021; Fox JL, 1997, GEOPHYS RES LETT, V24, P2901, DOI 10.1029/97GL52842; Kallio E, 1996, J GEOPHYS RES-SPACE, V101, P11133, DOI 10.1029/96JA00164; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; Lammer H, 2003, ICARUS, V165, P9, DOI 10.1016/S0019-1035(03)00170-2; Lundin R, 2004, SCIENCE, V305, P1933, DOI 10.1126/science.1101860; LUNDIN R, 1990, GEOPHYS RES LETT, V17, P873, DOI 10.1029/GL017i006p00873; Ma YJ, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010367; MCKAY CP, 1989, REV GEOPHYS, V27, P189, DOI 10.1029/RG027i002p00189; Modolo R, 2005, ANN GEOPHYS-GERMANY, V23, P433, DOI 10.5194/angeo-23-433-2005; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559; VENGIN M, 1991, PLANET SPACE SCI, V39, P131	18	213	217	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2007	315	5811					501	503		10.1126/science.1134358	http://dx.doi.org/10.1126/science.1134358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	129JU	17255508				2022-12-28	WOS:000243726600042
J	Sinclair, AH; Schofield, PR				Sinclair, Andrew H.; Schofield, Peter R.			Human embryonic stem cell research: An Australian perspective	CELL			English	Editorial Material							DONATION	A conscience vote of individual parliamentarians in the Australian government last month regarding amendments to current legislation regulating human embryonic stem cell research yielded a surprising outcome. Despite opposition by the Australian Prime Minister, the Senate and House of Representatives voted to adopt the recommendations of the Lockhart Review and approve human somatic cell nuclear transfer, thus providing a consistent national policy for all researchers in Australia.	Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Prince Wales Med Res Inst, Sydney, NSW 2031, Australia; Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Prince Wales Medical Research Institute; University of New South Wales Sydney	Sinclair, AH (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	andrew.sinclair@mcri.edu.au; p.schofield@unsw.edu.au	Sinclair, Andrew H/A-3598-2010; Schofield, Peter/C-9669-2011	Sinclair, Andrew H/0000-0003-2741-7992; Schofield, Peter/0000-0003-2967-9662				Leeton J, 2004, AUST NZ J OBSTET GYN, V44, P495, DOI 10.1111/j.1479-828X.2004.00305.x; Magnus D, 2005, SCIENCE, V308, P1747, DOI 10.1126/science.1114454; Steinbrook R, 2006, NEW ENGL J MED, V354, P324, DOI 10.1056/NEJMp058313; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	4	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					221	223		10.1016/j.cell.2007.01.008	http://dx.doi.org/10.1016/j.cell.2007.01.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254957	Bronze			2022-12-28	WOS:000244420500004
J	Iwase, S; Lan, F; Bayliss, P; de la Torre-Ubieta, L; Huarte, M; Qi, HH; Whetstine, JR; Bonni, A; Roberts, TM; Shi, Y				Iwase, Shigeki; Lan, Fei; Bayliss, Peter; de la Torre-Ubieta, Luis; Huarte, Maite; Qi, Hank H.; Whetstine, Johnathan R.; Bonni, Azad; Roberts, Thomas M.; Shi, Yang			The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases	CELL			English	Article							DOMAIN-CONTAINING PROTEINS; METHYLATION PATTERNS; ANDROGEN-RECEPTOR; MAMMALIAN-CELLS; ARID PROTEINS; BREAST-CANCER; JARID1C GENE; JMJD2 FAMILY; TRANSCRIPTION; CHROMATIN	Histone methylation regulates chromatin structure and transcription. The recently identified histone demethylase lysine-specific demethylase 1 (LSD1) is chemically restricted to demethylation of only mono- and di- but not tri-methylated histone H3 lysine 4 (H3K4me3). We show that the X-linked mental retardation (XLMR) gene SMCX (JARID1C), which encodes a JmjC-domain protein, reversed H3K4me3 to di- and mono- but not unmethylated products. Other SMCX family members, including SMCY, RBP2, and PLU-1, also demethylated H3K4me3. SMCX bound H3K9me3 via its N-terminal PHD (plant homeodomain) finger, which may help coordinate H3K4 demethylation and H3K9 methylation in transcriptional repression. Significantly, several XLMR-patient point mutations reduced SMCX demethylase activity and binding to H3K9me3 peptides, respectively. Importantly, studies in zebrafish and primary mammalian neurons demonstrated a role for SMCX in neuronal survival and dendritic development and a link to the demethylase activity. Our findings thus identify a family of H3K4me3 demethylases and uncover a critical link between histone modifications and XLMR.	Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dana Farber Inst, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	yang_shi@hms.harvard.edu	Hu, Ruogu/B-2203-2008; Huarte, Maite/J-6903-2014; Iwase, Shigeki/J-8294-2019	Huarte, Maite/0000-0003-3753-6493; Iwase, Shigeki/0000-0003-2280-7422; Qi, Hank/0000-0002-3401-4940; de la Torre-Ubieta, Luis/0000-0001-8059-6243; Bayliss, Peter/0000-0003-4807-6365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070095, R01GM071004, R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021, R01NS051255] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 071004, GM 58012, GM 70095] Funding Source: Medline; NINDS NIH HHS [NS41021, NS051255] Funding Source: Medline; PHS HHS [NCI118487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGULNIK AI, 1994, HUM MOL GENET, V3, P873, DOI 10.1093/hmg/3.6.873; Ahmed S, 2004, MOL CELL BIOL, V24, P3660, DOI 10.1128/MCB.24.9.3660-3669.2004; Barrett A, 2002, INT J CANCER, V101, P581, DOI 10.1002/ijc.10644; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Santos C, 2006, EUR J HUM GENET, V14, P583, DOI 10.1038/sj.ejhg.5201608; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SCOTT DM, 1995, NATURE, V376, P695, DOI 10.1038/376695a0; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzschach A, 2006, HUM MUTAT, V27, P389, DOI 10.1002/humu.9420; WANG W, 1995, SCIENCE, V269, P1588, DOI 10.1126/science.7667640; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; YIN CY, 2006, IN PRESS DEB BI 1219; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	50	500	517	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2007	128	6					1077	1088		10.1016/j.cell.2007.02.017	http://dx.doi.org/10.1016/j.cell.2007.02.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	152XS	17320160	Bronze			2022-12-28	WOS:000245396200015
J	Joffe, M; Bennett, J; Best, N; Jensen, TK				Joffe, Mike; Bennett, James; Best, Nicky; Jensen, Tina Kold			Sex ratio and time to pregnancy: analysis of four large European population surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MALE REPRODUCTIVE HAZARDS; TESTICULAR CANCER; FERTILITY; TRENDS; MEN	Objective To test whether the secondary sex ratio (proportion of male births) is associated with time to pregnancy, a marker of fertility. Design Analysis of four large population surveys. Setting Denmark and the United Kingdom. Participants 49 506 pregnancies. Main outcome measure Secondary sex ratio. Results No association was found between the sex ratio and time to pregnancy and no discernible trend was found for sex ratio with time to pregnancy, either within individual datasets or in the pooled analysis. The odds ratios were 0.97 (95% confidence interval 0.90 to 1.04) for contraceptive failures, 1.01 (0.96 to 1.05) for time to pregnancy of 2-4 months, 1.02 (0.97 to 1.08) for 5-10 months, 0.98 (0.93 to 1.03) for 11 months or more, and 0.88 (0.74 to 1.06) for fertility treatment, with 0-1 months as the reference category. Conclusion No association was found between the secondary sex ratio and time to pregnancy.	Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ So Denmark, Inst Publ Hlth, Odense, Denmark	Imperial College London; University of Southern Denmark	Joffe, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England.	m.joffe@imperial.ac.uk		Jensen, Tina Kold/0000-0003-2311-5778; Bennett, James Elston/0000-0002-9616-6878	MRC [G9900635] Funding Source: UKRI; Medical Research Council [G9900635] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ARMSTRONG BK, 1995, PRINCIPLES EXPOSURE; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; *COMM TOX CHEM FOO, 2001, STAT TOL DAIL INT DI; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; DECOCK J, 1995, OCCUP ENVIRON MED, V52, P429; FRANCE JT, 1992, INT J FERTIL, V37, P244; Jacobsen R, 2000, HUM REPROD, V15, P1958, DOI 10.1093/humrep/15.9.1958; Jacobsen R, 2000, HUM REPROD, V15, P2369, DOI 10.1093/humrep/15.11.2369; James WH, 1996, LANCET, V347, P773, DOI 10.1016/S0140-6736(96)90133-6; Jensen TK, 2000, AM J EPIDEMIOL, V152, P565, DOI 10.1093/aje/152.6.565; Joffe M, 2000, LANCET, V355, P1961, DOI 10.1016/S0140-6736(00)02328-X; Joffe M, 2005, AM J EPIDEMIOL, V162, P115, DOI 10.1093/aje/kwi172; Joffe M, 2003, BRIT MED BULL, V68, P47, DOI 10.1093/bmb/ldg025; Joffe M, 2003, OCCUP ENVIRON MED, V60, P752, DOI 10.1136/oem.60.10.752; JOFFE M, 1995, J EPIDEMIOL COMMUN H, V49, P314, DOI 10.1136/jech.49.3.314; Karmaus W, 2002, J OCCUP ENVIRON MED, V44, P8, DOI 10.1097/00043764-200201000-00003; Martin JF, 1997, HUM REPROD, V12, P611; Moller H, 1998, APMIS, V106, P232, DOI 10.1111/j.1699-0463.1998.tb01341.x; OLSEN J, TIME PREGNANCY SEX O; POTASHNIK G, 1995, J OCCUP ENVIRON MED, V37, P1287, DOI 10.1097/00043764-199511000-00007; Richthoff J, 2003, ENVIRON HEALTH PERSP, V111, P409, DOI 10.1289/ehp.5767; SLAMA R, ARE SUBFERTILE COUPL; Smits LJM, 2005, BRIT MED J, V331, P1437, DOI 10.1136/bmj.331.7530.1437; Weijin Z, 1996, OCCUP ENVIRON MED, V53, P503, DOI 10.1136/oem.53.7.503-b	24	17	17	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2007	334	7592					524	526A		10.1136/bmj.39097.508426.BE	http://dx.doi.org/10.1136/bmj.39097.508426.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148VV	17277014	Green Published, Bronze			2022-12-28	WOS:000245106400043
J	Goldberg, AD; Allis, CD; Bernstein, E				Goldberg, Aaron D.; Allis, C. David; Bernstein, Emily			Epigenetics: A landscape takes shape	CELL			English	Article							HISTONE H3; DNA METHYLATION; HETEROCHROMATIN; LYSINE-4; POLYCOMB; BINDING		Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA	Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA.	alliscd@rockefeller.edu; bernste@rockefeller.edu	Goldberg, Aaron/C-6565-2009	Goldberg, Aaron/0000-0002-2892-2643	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allis CD, 2007, EPIGENETICS; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Waddington C. H., 1957, STRATEGY GENES, P11; Watson James D, 2003, Sci Am, V288, P66; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	22	1520	1612	13	381	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 23	2007	128	4					635	638		10.1016/j.cell.2007.02.006	http://dx.doi.org/10.1016/j.cell.2007.02.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148TX	17320500	Bronze			2022-12-28	WOS:000245098600005
J	Hennessy, K; Badolato, A; Winger, M; Gerace, D; Atature, M; Gulde, S; Falt, S; Hu, EL; Imamoglu, A				Hennessy, K.; Badolato, A.; Winger, M.; Gerace, D.; Atatuere, M.; Gulde, S.; Faelt, S.; Hu, E. L.; Imamoglu, A.			Quantum nature of a strongly coupled single quantum dot-cavity system	NATURE			English	Article							ELECTRODYNAMICS; PHOTONS; REGIME; ATOMS	Cavity quantum electrodynamics ( QED) studies the interaction between a quantum emitter and a single radiation-field mode. When an atom is strongly coupled to a cavity mode 1,2, it is possible to realize important quantum information processing tasks, such as controlled coherent coupling and entanglement of distinguishable quantum systems. Realizing these tasks in the solid state is clearly desirable, and coupling semiconductor self-assembled quantum dots to monolithic optical cavities is a promising route to this end. However, validating the efficacy of quantum dots in quantum information applications requires confirmation of the quantum nature of the quantum-dot-cavity system in the strong-coupling regime. Here we find such confirmation by observing quantum correlations in photoluminescence from a photonic crystal nanocavity(3-5) interacting with one, and only one, quantum dot located precisely at the cavity electric field maximum. When off-resonance, photon emission from the cavity mode and quantum-dot excitons is anticorrelated at the level of single quanta, proving that the mode is driven solely by the quantum dot despite an energy mismatch between cavity and excitons. When tuned to resonance, the exciton and cavity enter the strong-coupling regime of cavity QED and the quantum-dot exciton lifetime reduces by a factor of 145. The generated photon stream becomes antibunched, proving that the strongly coupled exciton/photon system is in the quantum regime. Our observations unequivocally show that quantum information tasks are achievable in solid-state cavity QED.	ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; Univ Calif Santa Barbara, Calif NanoSyst Inst, Santa Barbara, CA 93106 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Barbara	Imamoglu, A (corresponding author), ETH, Inst Quantum Elect, HPT G10, CH-8093 Zurich, Switzerland.	imamoglu@phys.ethz.ch	Atature, Mete/ABD-9297-2020; Fält, Stefan/F-8171-2010; Badolato, Antonio/E-9778-2015; Gerace, Dario/L-4405-2013; Hu, Evelyn/AAD-8459-2019	GERACE, Dario/0000-0002-7442-125X; Atature, Mete/0000-0003-3852-0944; Badolato, Antonio/0000-0001-8266-2902				Akahane Y, 2003, NATURE, V425, P944, DOI 10.1038/nature02063; Andreani LC, 1999, PHYS REV B, V60, P13276, DOI 10.1103/PhysRevB.60.13276; Badolato A, 2005, SCIENCE, V308, P1158, DOI 10.1126/science.1109815; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Childs JJ, 1996, PHYS REV LETT, V77, P2901, DOI 10.1103/PhysRevLett.77.2901; Englund D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.013904; Haroche S., 1992, FUNDAMENTAL SYSTEMS; Hennessy K., 2004, PHOTONIC NANOSTRUCT, V2, P65; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kiraz A, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161303; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; PAU S, 1995, PHYS REV B, V51, P14437, DOI 10.1103/PhysRevB.51.14437; Peter E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067401; PURCELL EM, 1946, PHYS REV, V69, P681; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Strauf S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164922; Strauf S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127404; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119	24	1438	1451	8	443	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					896	899		10.1038/nature05586	http://dx.doi.org/10.1038/nature05586			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17259971	Green Submitted			2022-12-28	WOS:000244341200044
J	Stafford, N				Stafford, Ned			Spy in the sky	NATURE			English	News Item																			0	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					808	809		10.1038/445808a	http://dx.doi.org/10.1038/445808a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	138CR	17314946				2022-12-28	WOS:000244341200011
J	Myers, GJ; Davidson, PW				Myers, Gary J.; Davidson, Philip W.			Maternal fish consumption benefits children's development	LANCET			English	Editorial Material							PRENATAL METHYLMERCURY EXPOSURE; MERCURY		Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Myers, GJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	gary_myers@urmc.rochester.edu	Myers, Gary J/I-4901-2013	Myers, Gary J/0000-0003-4317-015X				COX C, 1989, ENVIRON RES, V49, P318, DOI 10.1016/S0013-9351(89)80075-1; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; *CTR CONS FREED, 2006, 61 PERC AM MIST BEL; Debes F, 2006, NEUROTOXICOL TERATOL, V28, P363, DOI [10.1016/j.ntt.2006.02.005, 10.1016/j.ntt.2006.02.004]; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; HOLLIDAY MA, 1971, PEDIATRICS, V47, P169; LAWRENCE RA, 1999, BREASTFEEDING GUIDE; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Oken E, 2003, OBSTET GYNECOL, V102, P346, DOI 10.1016/S0029-7844(03)00484-8; Tsubaki T., 1977, MINAMATA DIS METHYLM; US Department of Health and Human Services US Environmental Protection Agency, 2004, WHAT YOU NEED KNOW M; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130	13	13	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	2007	369	9561					537	538		10.1016/S0140-6736(07)60248-7	http://dx.doi.org/10.1016/S0140-6736(07)60248-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138MZ	17307084				2022-12-28	WOS:000244368000006
J	Barber, RT				Barber, Richard T.			Picoplankton do some heavy lifting	SCIENCE			English	Editorial Material							FISH PRODUCTION; ARABIAN SEA; MARINE	Tiny unicellular plants called picoplankton play an unexpectedly large role in the transport of organic matter to the deep ocean.	Duke Univ, Nicholas Sch Environm & Earth Sci, Beaufort, NC 28516 USA	Duke University	Barber, RT (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Beaufort, NC 28516 USA.	rbarber@duke.edu						AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Barber RT, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002726; Barber RT, 2001, DEEP-SEA RES PT II, V48, P1127, DOI 10.1016/S0967-0645(00)00134-X; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Landry MR, 1997, LIMNOL OCEANOGR, V42, P405, DOI 10.4319/lo.1997.42.3.0405; LANDRY MR, 1982, MAR BIOL, V67, P283, DOI 10.1007/BF00397668; Landry MR, 1998, DEEP-SEA RES PT II, V45, P2353, DOI 10.1016/S0967-0645(98)00074-5; LI WKW, 1983, SCIENCE, V219, P292, DOI 10.1126/science.219.4582.292; PLATT T, 1983, NATURE, V300, P701; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0	15	32	36	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					777	778		10.1126/science.1137438	http://dx.doi.org/10.1126/science.1137438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289968				2022-12-28	WOS:000244069000036
J	Youle, RJ				Youle, Richard J.			Cellular demolition and the rules of engagement	SCIENCE			English	Editorial Material							BH3-ONLY PROTEINS; BCL-2; BAX; OLIGOMERIZATION; APOPTOSIS; DEATH; MCL-1	Does cell death occur by pulling the plug on Bcl-2 life support or pulling the trigger on Bax activation?	NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youler@ninds.nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002674, Z01NS002859] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105	11	48	51	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813					776	777		10.1126/science.1138870	http://dx.doi.org/10.1126/science.1138870			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289967				2022-12-28	WOS:000244069000035
J	Barreto, G; Schafer, A; Marhold, J; Stach, D; Swaminathan, SK; Handa, V; Doderlein, G; Maltry, N; Wu, W; Lyko, F; Niehrs, C				Barreto, Guillermo; Schaefer, Andrea; Marhold, Joachim; Stach, Dirk; Swaminathan, Suresh K.; Handa, Vikas; Doederlein, Gabi; Maltry, Nicole; Wu, Wei; Lyko, Frank; Niehrs, Christof			Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation	NATURE			English	Article							METHYLATION; EXPRESSION; PROTEIN; CELLS; CYCLE	DNA methylation is an epigenetic modification that is essential for gene silencing and genome stability in many organisms. Although methyltransferases that promote DNA methylation are well characterized, the molecular mechanism underlying active DNA demethylation is poorly understood and controversial(1,2). Here we show that Gadd45a ( growth arrest and DNA-damage-inducible protein 45 alpha), a nuclear protein involved in maintenance of genomic stability, DNA repair and suppression of cell growth 3,4, has a key role in active DNA demethylation. Gadd45a overexpression activates methylation-silenced reporter plasmids and promotes global DNA demethylation. Gadd45a knockdown silences gene expression and leads to DNA hypermethylation. During active demethylation of oct4 in Xenopus laevis oocytes(5), Gadd45a is specifically recruited to the site of demethylation. Active demethylation occurs by DNA repair and Gadd45a interacts with and requires the DNA repair endonuclease XPG. We conclude that Gadd45a relieves epigenetic gene silencing by promoting DNA repair, which erases methylation marks.	German Canc Res Ctr, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), German Canc Res Ctr, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz.de	Barreto, Guillermo/U-5718-2017	Barreto, Guillermo/0000-0002-7777-4712				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Carrier F, 1999, MOL CELL BIOL, V19, P1673; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Escher G, 2005, J LIPID RES, V46, P356, DOI 10.1194/jlr.D400014-JLR200; Fang JY, 2003, WORLD J GASTROENTERO, V9, P1976, DOI 10.3748/wjg.v9.i9.1976; Furukawa T, 2002, GENE CHROMOSOME CANC, V35, P1, DOI 10.1002/gcc.10100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hollander MC, 2002, ONCOGENE, V21, P6228, DOI 10.1038/sj.onc.1205774; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; Jaenisch R, 2004, COLD SPRING HARB SYM, V69, P19, DOI 10.1101/sqb.2004.69.19; Jost JP, 2001, NUCLEIC ACIDS RES, V29, P4452, DOI 10.1093/nar/29.21.4452; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; PRIVES C, 1991, METHOD CELL BIOL, V36, P185; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Shou WY, 1996, MOL BIOL CELL, V7, P457, DOI 10.1091/mbc.7.3.457; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Smith ML, 1996, ONCOGENE, V13, P2255; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yi YW, 2000, BIOCHEM BIOPH RES CO, V272, P193	29	570	612	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					671	675		10.1038/nature05515	http://dx.doi.org/10.1038/nature05515			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17268471				2022-12-28	WOS:000244039400049
J	Legro, RS; Barnhart, HX; Schlaff, WD; Carr, BR; Diamond, MP; Carson, SA; Steinkampf, MP; Coutifaris, C; McGovern, PG; Cataldo, NA; Gosman, GG; Nestler, JE; Giudice, LC; Leppert, PC; Myers, ER				Legro, Richard S.; Barnhart, Huiman X.; Schlaff, William D.; Carr, Bruce R.; Diamond, Michael P.; Carson, Sandra A.; Steinkampf, Michael P.; Coutifaris, Christos; McGovern, Peter G.; Cataldo, Nicholas A.; Gosman, Gabriella G.; Nestler, John E.; Giudice, Linda C.; Leppert, Phyllis C.; Myers, Evan R.		Cooperative Multicenter Reprod Med	Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTENDED-RELEASE METFORMIN; CITRATE-RESISTANT WOMEN; SURROGATE END-POINTS; EARLY-PREGNANCY LOSS; DOUBLE-BLIND; OVULATION INDUCTION; INSULIN-RESISTANCE; PLACEBO; OBESITY; RATES	BACKGROUND: The polycystic ovary syndrome is a common cause of infertility. Clomiphene and insulin sensitizers are used alone and in combination to induce ovulation, but it is unknown whether one approach is superior. METHODS: We randomly assigned 626 infertile women with the polycystic ovary syndrome to receive clomiphene citrate plus placebo, extended-release metformin plus placebo, or a combination of metformin and clomiphene for up to 6 months. Medication was discontinued when pregnancy was confirmed, and subjects were followed until delivery. RESULTS: The live-birth rate was 22.5% (47 of 209 subjects) in the clomiphene group, 7.2% (15 of 208) in the metformin group, and 26.8% (56 of 209) in the combination-therapy group (P<0.001 for metformin vs. both clomiphene and combination therapy; P=0.31 for clomiphene vs. combination therapy). Among pregnancies, the rate of multiple pregnancy was 6.0% in the clomiphene group, 0% in the metformin group, and 3.1% in the combination-therapy group. The rates of first-trimester pregnancy loss did not differ significantly among the groups. However, the conception rate among subjects who ovulated was significantly lower in the metformin group (21.7%) than in either the clomiphene group (39.5%, P=0.002) or the combination-therapy group (46.0%, P<0.001). With the exception of pregnancy complications, adverse-event rates were similar in all groups, though gastrointestinal side effects were more frequent, and vasomotor and ovulatory symptoms less frequent, in the metformin group than in the clomiphene group. CONCLUSIONS: Clomiphene is superior to metformin in achieving live birth in infertile women with the polycystic ovary syndrome, although multiple birth is a complication.	Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA; Duke Univ, Med Ctr, Durham, NC USA; Univ Colorado, Denver, CO 80202 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Wayne State Univ, Detroit, MI USA; Baylor Coll Med, Houston, TX 77030 USA; Univ Alabama Birmingham, Birmingham, AL USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Stanford Univ, Stanford, CA 94305 USA; Univ Pittsburgh, Pittsburgh, PA USA; Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; NICHHD, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Duke University; University of Colorado System; University of Colorado Denver; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Wayne State University; Baylor College of Medicine; University of Alabama System; University of Alabama Birmingham; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Virginia Commonwealth University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Legro, RS (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, 500 Univ Dr,H103, Hershey, PA 17033 USA.	rsl1@psu.edu		Legro, Richard/0000-0001-9927-7584; Diamond, Michael/0000-0001-6353-4489	NCRR NIH HHS [M01RR00056, C06 RR016499, M01RR10732] Funding Source: Medline; NICHD NIH HHS [U10 HD39005, U10 HD38999, U10 HD38998, U10 HD38992, U10 HD38988, U10 HD33172, U10 HD27049, U10 HD27011, U01 HD38997, U54-HD29834] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD038998, U10HD027049, U10HD039005, U10HD038992] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD038997, U10HD027011, U10HD033172, U10HD038999, R01HD029834, U10HD038988] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010732, C06RR016499, M01RR000056] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ACOG, 2002, OBSTET GYNECOL, V99, P869; *AM COLL OBST GYN, 2001, ACOG PRACT B CLIN MA, V30; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2001, J CLIN ENDOCR METAB, V86, P1626, DOI 10.1210/jc.86.4.1626; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; *CDCP, 2003, 2003 ASS REPR TECHN; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Fujioka K, 2005, DIABETES OBES METAB, V7, P28, DOI 10.1111/j.1463-1326.2004.00369.x; Gusler G, 2001, J CLIN PHARMACOL, V41, P655, DOI 10.1177/00912700122010546; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; Hull M G, 1987, Gynecol Endocrinol, V1, P235, DOI 10.3109/09513598709023610; Jakubowicz DJ, 2002, J CLIN ENDOCR METAB, V87, P524, DOI 10.1210/jc.87.2.524; Johnson NP, 2006, AUST NZ J OBSTET GYN, V46, P141, DOI 10.1111/j.1479-828X.2006.00544.x; Kocak M, 2002, FERTIL STERIL, V77, P101, DOI 10.1016/S0015-0282(01)02941-7; Legro RS, 2006, FERTIL STERIL, V86, P914, DOI 10.1016/j.fertnstert.2006.03.037; Legro RS, 2004, HUM REPROD, V19, P1697, DOI 10.1093/humrep/deh322; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; MCGOVERN PG, IN PRESS FERTIL STER; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Myers ER, 2005, CONTEMP CLIN TRIALS, V26, P271, DOI 10.1016/j.cct.2005.01.006; Nestler JE, 1998, NEW ENGL J MED, V338, P1876, DOI 10.1056/NEJM199806253382603; Nestler JE, 1999, NEW ENGL J MED, V340, P1314, DOI 10.1056/NEJM199904293401703; Norman RJ, 2004, CURR OPIN OBSTET GYN, V16, P245, DOI 10.1097/00001703-200406000-00007; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P3945; Palomba S, 2005, J CLIN ENDOCR METAB, V90, P4068, DOI 10.1210/jc.2005-0110; Palomba S, 2004, J CLIN ENDOCR METAB, V89, P4801, DOI 10.1210/jc.2004-0689; REBAR R, 1976, J CLIN INVEST, V57, P1320, DOI 10.1172/JCI108400; Sahin Y, 2004, EUR J OBSTET GYN R B, V113, P214, DOI 10.1016/j.ejogrb.2003.09.036; Schwartz S, 2006, DIABETES CARE, V29, P759, DOI 10.2337/diacare.29.04.06.dc05-1967; Stein IF, 1935, AM J OBSTET GYNECOL, V29, P181, DOI 10.1016/S0002-9378(15)30642-6; TAKAHASHI K, 1994, FERTIL STERIL, V62, P48; Vandermolen DT, 2001, FERTIL STERIL, V75, P310, DOI 10.1016/S0015-0282(00)01675-7; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	39	614	649	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2007	356	6					551	566		10.1056/NEJMoa063971	http://dx.doi.org/10.1056/NEJMoa063971			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133KV	17287476	Green Published			2022-12-28	WOS:000244012700004
J	Mangano, DT; Miao, YH; Vuylsteke, A; Tudor, IC; Juneja, R; Filipescu, D; Hoeft, A; Fontes, ML; Hillel, Z; Ott, E; Titov, T; Dietzel, C; Levin, J				Mangano, Dennis T.; Miao, Yinghui; Vuylsteke, Alain; Tudor, Iulia C.; Juneja, Rajiv; Filipescu, Daniela; Hoeft, Andreas; Fontes, Manuel L.; Hillel, Zak; Ott, Elisabeth; Titov, Tatiana; Dietzel, Cynthia; Levin, Jack		Multicenter Study Perioperative Is; Ischemia Res Education Foundation	Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; LONG-TERM MORTALITY; PROPENSITY SCORE; RANDOMIZED-TRIAL; SURVIVAL CURVES; RISK-FACTORS; ANGIOPLASTY; REVASCULARIZATION; STRATIFICATION; THERAPY	Context Acute safety concerns have been raised recently regarding certain hemorrhage-sparing medications commonly used in cardiac surgery. However, no comprehensive data exist regarding their associations with long-term mortality. Objective To contrast long-term all-cause mortality in patients undergoing coronary artery bypass graft (CABG) surgery according to use of 2 lysine analog antifibrinolytics ( aminocaproic acid and tranexamic acid), the serine protease inhibitor aprotinin, or no antibleeding agent. Design, Setting, and Participants Observational study of mortality conducted between November 11, 1996, and December 7, 2006. Following index hospitalization ( 4374 patients; 69 medical centers), survival was prospectively assessed at 6 weeks, 6 months, and annually for 5 years after CABG surgery among 3876 patients enrolled in a 62-center international cohort study. The associations of survival with hemorrhage-sparing medications were compared using multivariable analyses including propensity adjustments. Main Outcome Measure Death ( all-cause) over 5 years. Results Aprotinin treatment ( 223 deaths among 1072 patients [20.8% 5-year mortality]) was associated with significantly increased mortality compared with control ( 128 deaths among 1009 patients [12.7%]; covariate adjusted hazard ratio for death, 1.48; 95% confidence interval, 1.19-1.85), whereas neither aminocaproic acid ( 132 deaths among 834 patients [15.8%]; adjusted hazard ratio for death, 1.03; 95% confidence interval, 0.80-1.33) nor tranexamic acid ( 65 deaths among 442 patients [14.7%]; adjusted hazard ratio for death, 1.07; 95% confidence interval, 0.80-1.45) was associated with increased mortality. In multivariable logistic regression, either with propensity adjustment or without, aprotinin was independently predictive of 5-year mortality ( adjusted odds ratio with propensity adjustment, 1.48; 95% confidence interval, 1.13-1.93; P=. 005) among patients with diverse risk profiles, as well as among those surviving their index hospitalization. Neither aminocaproic nor tranexamic acid was associated with increased risk of death. Conclusions These findings indicate that in addition to the previously reported acute renal and vascular safety concerns, aprotinin use is associated with an increased risk of long-term mortality following CABG surgery. Use of aprotinin among patients undergoing CABG surgery does not appear prudent because safer and less expensive alternatives (ie, aminocaproic acid and tranexamic acid) are available.	Ischemia Res & Educ Fdn, Editorial Off, San Bruno, CA 94066 USA; Papworth Hosp, Dept Anesthesia, Cambridge CB3 8RE, England; Escorts Heart Inst, Dept Anesthesia, New Delhi, India; Inst Cardiol, Dept Cardiac Anesthesia & Intens Care, Bucharest, Romania; Univ Bonn, Klin & Poliklin Anaesthesiol & Spezielle Intens M, D-5300 Bonn, Germany; Yale Univ, Dept Anesthesiol, New Haven, CT 06510 USA; St Lukes Roosevelt Hosp, Dept Cardiac Anesthesia, New York, NY 10025 USA; Univ Munich, Inst Anasthesiol, Munich, Germany; Univ Calif San Francisco, Sch Med, Dept Lab Med, San Francisco, CA 94143 USA	Papworth Hospital; University of Bonn; Yale University; Mount Sinai St. Luke's; Mount Sinai West; University of Munich; University of California System; University of California San Francisco	Mangano, DT (corresponding author), Ischemia Res & Educ Fdn, Editorial Off, 1111 Bayhill Dr,Suite 480, San Bruno, CA 94066 USA.	dtb@iref.org	Filipescu, Daniela/AAP-6967-2020; Vuylsteke, Alain/AAF-2108-2020	Filipescu, Daniela/0000-0003-2144-464X				Ad N, 2006, CIRCULATION, V114, P476; Alderman EL, 1997, JAMA-J AM MED ASSOC, V277, P715; Alderman EL, 1998, J THORAC CARDIOV SUR, V116, P716, DOI 10.1016/S0022-5223(98)00431-0; Alvarez JM, 1999, J CARDIOTHOR VASC AN, V13, P623, DOI 10.1016/S1053-0770(99)90019-8; [Anonymous], 1995, Lancet, V346, P1179; Baigent C, 1998, BMJ-BRIT MED J, V316, P1337, DOI 10.1136/bmj.316.7141.1337; BIDSTRUP BP, 1993, J THORAC CARDIOV SUR, V105, P147, DOI 10.1016/S0022-5223(19)33859-0; Brener SJ, 2004, CIRCULATION, V109, P2290, DOI 10.1161/01.CIR.0000126826.58526.14; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cooper JR, 2006, J THORAC CARDIOV SUR, V131, P963, DOI 10.1016/j.jtcvs.2006.01.005; COSGROVE DM, 1992, ANN THORAC SURG, V54, P1031, DOI 10.1016/0003-4975(92)90066-D; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Feit F, 2000, CIRCULATION, V101, P2795, DOI 10.1161/01.CIR.101.24.2795; Ferraris VA, 2006, NEW ENGL J MED, V354, P1953; FitzGibbon GM, 1996, J AM COLL CARDIOL, V28, P616, DOI 10.1016/0735-1097(96)00206-9; Franzosi MG, 1998, CIRCULATION, V98, P2659, DOI 10.1161/01.CIR.98.24.2659; Gao DX, 2006, ANN THORAC SURG, V81, P793, DOI 10.1016/j.athoracsur.2005.08.005; Grover FL, 1996, ANN THORAC SURG, V62, pS6, DOI 10.1016/0003-4975(96)00821-1; HATTLER BG, 1994, ANN THORAC SURG, V58, P1348, DOI 10.1016/0003-4975(94)91911-9; HAVEL M, 1994, J THORAC CARDIOV SUR, V107, P807; HAVEL MP, 1992, J THORAC CARDIOV SUR, V104, P654; Henderson RA, 1998, LANCET, V352, P1419, DOI 10.1016/S0140-6736(98)03358-3; HIGGINS TL, 1992, JAMA-J AM MED ASSOC, V267, P2344, DOI 10.1001/jama.267.17.2344; Hill GE, 1997, ANN THORAC SURG, V63, P74; Hunter D, 2006, NEW ENGL J MED, V354, P329, DOI 10.1056/NEJMp058235; Kaehler J, 2005, EUR HEART J, V26, P2148, DOI 10.1093/eurheartj/ehi385; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; Keeley EC, 2001, J AM COLL CARDIOL, V38, P659, DOI 10.1016/S0735-1097(01)01420-6; KING SB, 1994, NEW ENGL J MED, V331, P1044, DOI 10.1056/NEJM199410203311602; LEE J, 1992, COMPUT APPL BIOSCI, V8, P23; LEMMER JH, 1994, J THORAC CARDIOV SUR, V107, P543, DOI 10.1016/S0022-5223(94)70101-6; MANGANO DT, 1992, JAMA-J AM MED ASSOC, V268, P233, DOI 10.1001/jama.268.2.233; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Michel P, 2003, EUR J CARDIO-THORAC, V23, P684, DOI 10.1016/S1010-7940(03)00074-5; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Nilsson J, 2006, EUR HEART J, V27, P867, DOI 10.1093/eurheartj/ehi720; Papadimos Thomas J, 2005, BMC Surg, V5, P10, DOI 10.1186/1471-2482-5-10; RODRIGUEZ A, 1993, J AM COLL CARDIOL, V22, P1060, DOI 10.1016/0735-1097(93)90416-X; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; SAFFITZ JE, 1993, AM J CARDIOL, V72, P1080, DOI 10.1016/0002-9149(93)90867-C; SAMAMA CM, 1994, THROMB HAEMOSTASIS, V71, P663; U. S. Food and Drug Administration, 2006, FED REGISTER, V71, P10978; Ulker S, 2002, CARDIOVASC RES, V55, P830, DOI 10.1016/S0008-6363(02)00489-3; *US FDA, 2006, FDA PUBL HLTH ADV AP; *US FDA, 2006, M CARD REN ADV COMM; *US FDA, QUEST ANSW APR MARK; Westaby S, 1998, J THORAC CARDIOV SUR, V116, P731, DOI 10.1016/S0022-5223(98)00457-7	52	281	299	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 7	2007	297	5					471	479		10.1001/jama.297.5.471	http://dx.doi.org/10.1001/jama.297.5.471			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	133FP	17284697	Bronze			2022-12-28	WOS:000243999100024
J	Kuiken, TA; Miller, LA; Lipschutz, RD; Lock, BA; Stubblefield, K; Marasco, PD; Zhou, P; Dumanian, GA				Kuiken, Todd A.; Miller, Laura A.; Lipschutz, Robert D.; Lock, Blair A.; Stubblefield, Kathy; Marasco, Paul D.; Zhou, Ping; Dumanian, Gregory A.			Targeted reinnervation for enhanced prosthetic arm function in a woman with a proximal amputation: a case study	LANCET			English	Article							NERVE; EMG; INTERFACES; DESIGN; SYSTEM	Background The function of current artificial arms is limited by inadequate control methods. We developed a technique that used nerve transfers to muscle to develop new electromyogram control signals and nerve transfers to skin, to provide a pathway for cutaneous sensory feedback to the missing hand. Methods We did targeted reinnervation surgery on a woman with a left arm amputation at the humeral neck. The ulnar, median, musculocutaneous, and distal. radial nerves were transferred to separate segments of her pectoral and serratus muscles. Two sensory nerves were cut and the distal ends were anastomosed to the ulnar and median nerves. After full recovery the patient was fit with a new prosthesis using the additional targeted muscle reinnervation sites. Functional testing was done and sensation in the reinnervated skin was quantified. Findings The patient described the control as intuitive; she thought about using her hand or elbow and the prosthesis responded appropriately. Functional testing showed substantial improvement: mean scores in the blocks and box test increased from 4.0 (SD 1.0) with the conventional prosthesis to 15.6 (1.5) with the new prosthesis. Assessment of Motor and Process Skills test scores increased from 0.30 to 1.98 for motor skills and from 0.90 to 1.98 for process skills. The denervated anterior chest skin was reinnervated by both the ulnar and median nerves; the patient felt that her hand was being touched when this chest skin was touched, with near-normal thresholds in all sensory modalities. Interpretation Targeted reinnervation improved prosthetic function and ease of use in this patient. Targeted sensory reinnervation provides a potential pathway for meaningful sensory feedback.	Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Plast Surg, Chicago, IL 60611 USA; Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University	Kuiken, TA (corresponding author), Rehabil Inst Chicago, Neural Engn Ctr Artificial Limbs, Chicago, IL 60611 USA.	tkuiken@northwestern.edu	Miller, Laura A/E-1110-2011	Miller, Laura A/0000-0002-7271-6214; Marasco, Paul/0000-0002-1689-7161	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053402] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-5-3402] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barniv Y, 2005, IEEE T BIO-MED ENG, V52, P1078, DOI 10.1109/TBME.2005.848378; BELL JA, 1995, SENSIBILITY TESTING; Branner A, 2004, IEEE T BIO-MED ENG, V51, P146, DOI 10.1109/TBME.2003.820321; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Chu JU, 2006, IEEE T BIO-MED ENG, V53, P2232, DOI 10.1109/TBME.2006.883695; Crampon MA, 2002, BIO-MED MATER ENG, V12, P397; Deng J, 2005, J NEURAL ENG, V2, P131, DOI 10.1088/1741-2560/2/4/009; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; DYCK PJ, 2005, QUANTITATIVE SENSATI; FISHER AG, 1993, AM J OCCUP THER, V47, P319, DOI 10.5014/ajot.47.4.319; FISHER AG, 2003, DEV STANDARDIZATION; Hijjawi JB, 2006, PLAST RECONSTR SURG, V118, P1573, DOI 10.1097/01.prs.0000242487.62487.fb; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOFFER JA, 1980, ANN BIOMED ENG, V8, P351, DOI 10.1007/BF02363438; Huang YH, 2005, IEEE T BIO-MED ENG, V52, P1801, DOI 10.1109/TBME.2005.856295; Kuiken TA, 2004, PROSTHET ORTHOT INT, V28, P245; KUIKEN TA, 1995, BRAIN RES, V676, P113, DOI 10.1016/0006-8993(95)00102-V; Lowery MM, 2006, IEEE T BIO-MED ENG, V53, P1926, DOI 10.1109/TBME.2006.881774; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Merzenich M M, 1993, J Hand Ther, V6, P89; Middlebrooks JC, 2005, CURR OPIN NEUROBIOL, V15, P488, DOI 10.1016/j.conb.2005.06.004; Millan JD, 2004, IEEE T BIO-MED ENG, V51, P1026, DOI 10.1109/TBME.2004.827086; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; Sears H., 1992, ATLAS LIMB PROSTHETI; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Stieglitz T, 2002, BIOSENS BIOELECTRON, V17, P685, DOI 10.1016/S0956-5663(02)00019-2; Sunderland S., 1978, NERVES NERVE INJURIE; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	30	274	293	2	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					371	380		10.1016/S0140-6736(07)60193-7	http://dx.doi.org/10.1016/S0140-6736(07)60193-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276777				2022-12-28	WOS:000243944400031
J	Nanayakkara, PWB; van Bunderen, CC; van Bunderen, CC; Santerse, B				Nanayakkara, Prabath W. B.; van Bunderen, Crista C.; van Bunderen, Christa C.; Santerse, Boudewijn			A bumpy ride to a discarded diagnosis	LANCET			English	Editorial Material							NEPHROPTOSIS		VU Univ, Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands; Med Spectrum Twente, Dept Urol, Enschede, Netherlands	Vrije Universiteit Amsterdam; Medical Spectrum Twente	Nanayakkara, PWB (corresponding author), VU Univ, Med Ctr, Dept Internal Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	p.nanayakkara@vumc.nl	van Bunderen, Christa/ABB-5278-2021	van Bunderen, Christa/0000-0003-0006-7726				Barber NJ, 2004, EUR UROL, V46, P428, DOI 10.1016/j.eururo.2004.03.023; Bynum B, 2001, Lancet, V357, P76, DOI 10.1016/S0140-6736(05)71581-6; HIGHTOWER JM, 1995, WESTERN J MED, V162, P471; Hoenig DM, 1999, UROLOGY, V54, P590, DOI 10.1016/S0090-4295(99)00279-4; MCWINNIE DL, 1984, BRIT MED J, V288, P845	5	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 3	2007	369	9559					436	436		10.1016/S0140-6736(07)60199-8	http://dx.doi.org/10.1016/S0140-6736(07)60199-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276783				2022-12-28	WOS:000243944400037
J	Phrommintikul, A; Haas, SJ; Elsik, M; Krum, H				Phrommintikul, Arintaya; Haas, Steven Joseph; Elsik, Maros; Krum, Henry			Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis	LANCET			English	Article							LEFT-VENTRICULAR MASS; EPOETIN-ALPHA; HEMODIALYSIS-PATIENTS; DIALYSIS; TRIAL; HEMATOCRIT; THERAPY; QUALITY; EVENTS; NORMALIZATION	Background Recombinant human erythropoietin is commonly used for treatment of anaemia. Our aim was to determine whether targeting different haemoglobin concentrations with such treatment is associated with altered all-cause mortality and cardiovascular events in patients with anaemia caused by chronic kidney disease. Methods We did a meta-analysis of randomised controlled clinical trials that were identified in medical databases and trial registration websites. Trials were eligible for inclusion if they assessed the effects of targeting different haemoglobin concentrations in patients with anaemia caused by chronic disease who were randomly assigned to treatment with recombinant human erythropoietin, recruited at least 100 patients, and had a minimum follow-up of 12 weeks. Findings We analysed nine randomised controlled trials that enrolled 5143 patients. There was a significantly higher risk of all-cause mortality (risk ratio 1.17, 95% CI 1.01-1.35; p=0.031) and arteriovenous access thrombosis (1.34, 1.16-1.54; p=0.0001) in the higher haemoglobin target group than in the lower haemoglobin target group in the fixed effects model without heterogeneity between studies. There was a significantly higher risk of poorly controlled blood pressure (1.27,1.08-1.50; p=0.004) in the higher haemoglobin target group than in the lower target haemoglobin group with the fixed effects model; however, this was not significant in the random effects model (1.31, 0.97-1.78; p=0.075). The incidence of myocardial infarction was much the same in the two groups. Interpretation To target higher haemoglobin concentrations when treating patients with anaemia caused by chronic kidney disease with recombinant human erythropoietin puts such patients at increased risk of death. Current guidelines do not include an upper limit for the target haemoglobin concentration; such an upper limit should be considered in future recommendations.	Monash Univ, Alfred Hosp,Cent & Eastern Clin Sch, NHMRC Ctr Clin Res Excellence Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; Chiang Mai Univ, Fac Med, Dept Internal Med, Chiang Mai 50000, Thailand	Florey Institute of Neuroscience & Mental Health; Monash University; Chiang Mai University	Krum, H (corresponding author), Monash Univ, Alfred Hosp,Cent & Eastern Clin Sch, NHMRC Ctr Clin Res Excellence Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au	Phrommintikul, Arintaya/X-1881-2019	Phrommintikul, Arintaya/0000-0003-3986-1951				Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; BAHLMANN J, 1991, CONTRIB NEPHROL, V88, P90; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; GUTHRIE M, 1993, CLIN NEPHROL, V39, P97; Haas SJ, 2006, SCHIZOPHR RES, V86, P331, DOI 10.1016/j.schres.2006.06.032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis J P, 1999, Jt Comm J Qual Improv, V25, P462; Jones M, 2004, KIDNEY INT, V65, P757, DOI 10.1111/j.1523-1755.2004.00450.x; KLINKMANN H, 1993, ARTIF ORGANS, V17, P219; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; LAUPACIS A, 1991, CONTROL CLIN TRIALS, V12, pS168, DOI 10.1016/S0197-2456(05)80021-2; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Locatelli F, 2004, AM J KIDNEY DIS, V44, pS27, DOI 10.1053/j.ajkd.2004.08.008; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P2, DOI 10.1093/ndt/gfh1005; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; MACDOUGALL IC, 1991, NEPHROL DIAL TRANSPL, V6, P862, DOI 10.1093/ndt/6.11.862; Mix TCH, 2005, AM HEART J, V149, P408, DOI 10.1016/j.ahj.2004.09.047; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; NISSENSON AR, 1995, J AM SOC NEPHROL, V5, P1517; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; PAGANINI EP, 1989, SEMIN NEPHROL, V9, P3; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; SOBH MA, 1992, SCAND J UROL NEPHROL, V26, P65, DOI 10.3109/00365599209180398; SOBOTA JT, 1989, CONTRIB NEPHROL, V76, P166; Sterne JAC, 2001, SYSTEMATIC REV HLTH, P347, DOI [DOI 10.1002/9780470693926.CH18, 10.1002/9780470693926.ch18]; STRIPPOLI GF, 2006, COCHRANE DATABASE SY, V4; TAYLOR JE, 1992, NEPHROL DIAL TRANSPL, V7, P235, DOI 10.1093/oxfordjournals.ndt.a092112; Tobu M, 2004, CLIN APPL THROMB-HEM, V10, P225, DOI 10.1177/107602960401000304; Topuzovic N, 1999, INT J CARDIAC IMAG, V15, P233, DOI 10.1023/A:1006171626861; Vaziri N D, 1989, ASAIO Trans, V35, P505, DOI 10.1097/00002480-198907000-00107; Vaziri ND, 1999, AM J KIDNEY DIS, V33, P821, DOI 10.1016/S0272-6386(99)70413-0; Volkova N, 2006, AM J KIDNEY DIS, V47, P24, DOI 10.1053/j.ajkd.2005.09.007; Young JB, 2006, J CARD FAIL, V12, pS77, DOI 10.1016/j.cardfail.2006.06.264	47	451	474	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					381	388		10.1016/S0140-6736(07)60194-9	http://dx.doi.org/10.1016/S0140-6736(07)60194-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276778				2022-12-28	WOS:000243944400032
J	Strippoli, GFM; Tognoni, G				Strippoli, Giovanni F. M.; Tognoni, Giovanni			Haemoglobin targets: we were wrong, time to move on	LANCET			English	Editorial Material							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; ANEMIA; MORTALITY; HEMODIALYSIS; ASSOCIATION		Univ Sydney, Sch Publ Hlth, Cochrane Renal Grp, Sydney, NSW 2006, Australia; Univ Sydney, Sch Publ Hlth, Ctr Kidney Res, Sydney, NSW 2006, Australia; Univ Sydney, Sch Publ Hlth, NHMRC Ctr Clin Res Excellence Renal Med, Sydney, NSW 2006, Australia; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; Univ Rochester, Div Nephrol, Rochester, NY USA	University of Sydney; University of Sydney; University of Sydney; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Rochester	Strippoli, GFM (corresponding author), Univ Sydney, Sch Publ Hlth, Cochrane Renal Grp, Sydney, NSW 2006, Australia.	strippoli@negrisud.it	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Strippoli, Giovanni/0000-0002-6936-0616				[Anonymous], 2004, LANCET ONCOL, V5, P1; ARMSTRONG D, WALL STREET J; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Locatelli F, 2006, J AM SOC NEPHROL, V17, pS262, DOI 10.1681/ASN.2006080924; Mix TCH, 2005, AM HEART J, V149, P408, DOI 10.1016/j.ahj.2004.09.047; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; Remuzzi G, 2006, NEW ENGL J MED, V355, P2144, DOI 10.1056/NEJMe068233; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steinbrook R, 2006, LANCET, V368, P2191, DOI 10.1016/S0140-6736(06)69707-9; Stevens L, 2002, SEMIN DIALYSIS, V15, P8, DOI 10.1046/j.1525-139x.2002.00004.x; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; Strippoli GFM, 2005, AM J KIDNEY DIS, V46, P970, DOI 10.1053/j.ajkd.2005.09.009; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P3154, DOI 10.1097/01.ASN.0000145436.09176.A7; *US REN DAT SYST, ANN DAT REP 2006 ATL; Volkova N, 2006, AM J KIDNEY DIS, V47, P24, DOI 10.1053/j.ajkd.2005.09.007	18	76	78	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	2007	369	9559					346	350		10.1016/S0140-6736(07)60165-2	http://dx.doi.org/10.1016/S0140-6736(07)60165-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132LN	17276756				2022-12-28	WOS:000243944400005
J	Gross, T; Siepmann, A; Sturm, D; Windgassen, M; Scarcelli, JJ; Seedorf, M; Cole, CN; Krebber, H				Gross, Thomas; Siepmann, Anja; Sturm, Dorothee; Windgassen, Merle; Scarcelli, John J.; Seedorf, Matthias; Cole, Charles N.; Krebber, Heike			The DEAD-box RNA helicase Dbp5 functions in translation termination	SCIENCE			English	Article							MESSENGER-RNA; POLY(A)-BINDING PROTEIN; EXPORT; TRANSPORT; NONSENSE	In eukaryotes, termination of messenger RNA (mRNA) translation is mediated by the release factors eRF1 and eRF3. Using Saccharomyces cerevisiae as a model organism, we have identified a member of the DEAD-box protein (DBP) family, the DEAD-box RNA helicase and mRNA export factor Dbp5, as a player in translation termination. Dbp5 interacts genetically with both release factors and the polyadenlyate-binding protein Pab1. A physical interaction was specifically detected with eRF1. Moreover, we show that the helicase activity of Dbp5 is required for efficient stop-codon recognition, and intact Dbp5 is essential for recruitment of eRF3 into termination complexes. Therefore, Dbp5 controls the eRF3-eRF1 interaction and thus eRF3-mediated downstream events.	Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany; Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; Heidelberg Univ, Zentrum Mol Biol, D-69129 Heidelberg, Germany	Philipps University Marburg; Dartmouth College; Ruprecht Karls University Heidelberg	Krebber, H (corresponding author), Univ Marburg, Inst Mol Biol & Tumorforsch, Emil Mannkopff Str 2, D-35037 Marburg, Germany.	krebber@imt.uni-marburg.de	Cole, Charles/GRR-1551-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033998] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Bidou L, 2000, RNA, V6, P952, DOI 10.1017/S1355838200000443; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Jacobson A, 2005, NAT STRUCT MOL BIOL, V12, P474, DOI 10.1038/nsmb0605-474; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Zhao J, 2002, EMBO J, V21, P1177, DOI 10.1093/emboj/21.5.1177	13	107	108	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					646	649		10.1126/science.1134641	http://dx.doi.org/10.1126/science.1134641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272721				2022-12-28	WOS:000243909400043
J	Nelson, CD; Perry, SJ; Regier, DS; Prescott, SM; Topham, MK; Lefkowitz, RJ				Nelson, Christopher D.; Perry, Stephen J.; Regier, Debra S.; Prescott, Stephen M.; Topham, Matthew K.; Lefkowitz, Robert J.			Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins	SCIENCE			English	Article							PHOSPHATIDIC-ACID; KINASE-ZETA; TRANSFORMED CELLS; CLATHRIN ADAPTER; TRANSLOCATION; PROTEIN; ENDOCYTOSIS; MECHANISM; COMPLEX; CLONING	Seven-transmembrane receptor (7TMR) signaling is transduced by second messengers such as diacylglycerol (DAG) generated in response to the heterotrimeric guanine nucleotide-binding protein G(q) and is terminated by receptor desensitization and degradation of the second messengers. We show that beta-arrestins coordinate both processes for the G(q)-coupled M1 muscarinic receptor. beta-Arrestins physically interact with diacylglycerol kinases (DGKs), enzymes that degrade DAG. Moreover, beta-arrestins are essential for conversion of DAG to phosphatidic acid after agonist stimulation, and this activity requires recruitment of the beta-arrestin-DGK complex to activated 7TMRs. The dual function of beta-arrestins, limiting production of diacylglycerol (by receptor desensitization) while enhancing its rate of degradation, is analogous to their ability to recruit adenosine 3',5'-monophosphate phosphodiesterases to G(s)-coupled beta(2)-adrenergic receptors. Thus, beta-arrestins can serve similar regulatory functions for disparate classes of 7TMRs through structurally dissimilar enzymes that degrade chemically distinct second messengers.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL CANCER INSTITUTE [R01CA095463] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NCI NIH HHS [CA95463] Funding Source: Medline; NHLBI NIH HHS [HL70631, HL16037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; KATO H, 1988, BIOCHEM BIOPH RES CO, V154, P959, DOI 10.1016/0006-291X(88)90233-1; KATO M, 1987, J BIOL CHEM, V262, P5696; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luo B, 2004, CELL SIGNAL, V16, P983, DOI 10.1016/j.cellsig.2004.03.016; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Santos T, 2002, J BIOL CHEM, V277, P30300, DOI 10.1074/jbc.M200999200; Siddhanta A, 1998, J BIOL CHEM, V273, P17995, DOI 10.1074/jbc.273.29.17995; STERNWEIS PC, 1992, PHILOS T ROY SOC B, V336, P35, DOI 10.1098/rstb.1992.0041; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; VANDERBEND RL, 1994, J BIOL CHEM, V269, P4098	20	110	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					663	666		10.1126/science.1134562	http://dx.doi.org/10.1126/science.1134562			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272726				2022-12-28	WOS:000243909400048
J	Schreier, WJ; Schrader, TE; Koller, FO; Gilch, P; Crespo-Hernandez, CE; Swaminathan, VN; Carell, T; Zinth, W; Kohler, B				Schreier, Wolfgang J.; Schrader, Tobias E.; Koller, Florian O.; Gilch, Peter; Crespo-Hernandez, Carlos E.; Swaminathan, Vijay N.; Carell, Thomas; Zinth, Wolfgang; Kohler, Bern			Thymine dimerization in DNA is an ultrafast photoreaction	SCIENCE			English	Article							EXCITED-STATE DYNAMICS; SINGLE-STRANDED-DNA; DIMER FORMATION; PYRIMIDINE DIMERS; INTERNAL-CONVERSION; CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; BASES; POLYNUCLEOTIDES; PHOTODIMERIZATION	Femtosecond time-resolved infrared spectroscopy was used to study the formation of cyclobutane dimers in the all-thymine oligodeoxynucleotide (dT)(18) by ultraviolet light at 272 nanometers. The appearance of marker bands in the time-resolved spectra indicates that the dimers are fully formed similar to 1 picosecond after ultraviolet excitation. The ultrafast appearance of this mutagenic photolesion points to an excited-state reaction that is approximately barrierless for bases that are properly oriented at the instant of light absorption. The low quantum yield of this photoreaction is proposed to result from infrequent conformational states in the unexcited polymer, revealing a strong link between conformation before light absorption and photodamage.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Univ Munich, Dept Phys, D-80538 Munich, Germany; Univ Munich, Fak Chem & Pharm, D-81377 Munich, Germany	University System of Ohio; Ohio State University; University of Munich; University of Munich	Zinth, W (corresponding author), Ohio State Univ, Dept Chem, 100 W 8th Ave, Columbus, OH 43210 USA.	wolfgang.zinth@physik.uni-muenchen.de; kohler@chemistry.ohio-state.edu	Schreier, Wolfgang/B-1336-2012; Kohler, Bern/A-1728-2011; Crespo-Hernández, Carlos E./A-9915-2008; Carell, Thomas/G-4799-2012	Kohler, Bern/0000-0001-5353-1655; Crespo-Hernández, Carlos E./0000-0002-3594-0890; Carell, Thomas/0000-0001-7898-2831; Zinth, Wolfgang/0000-0003-3695-9486	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064563] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM064563-04, GM064563] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4; BECKER MM, 1984, NATURE, V309, P682, DOI 10.1038/309682a0; BECKER MM, 1989, J BIOL CHEM, V264, P4163; BERNARDI F, 1990, J AM CHEM SOC, V112, P1737, DOI 10.1021/ja00161a013; Butenandt J, 1998, CHEM-EUR J, V4, P642, DOI 10.1002/(SICI)1521-3765(19980416)4:4<642::AID-CHEM642>3.0.CO;2-K; Cadet J., 1990, BIOORGANIC PHOTOCHEM, V1, P1; Crespo-Hernandez CE, 2004, CHEM REV, V104, P1977, DOI 10.1021/cr0206770; Crespo-Hernandez CE, 2005, NATURE, V436, P1141, DOI 10.1038/nature03933; DEERING RA, 1963, BIOCHIM BIOPHYS ACTA, V68, P526; Douki T, 2006, J PHOTOCH PHOTOBIO B, V82, P45, DOI 10.1016/j.jphotobiol.2005.08.009; Fuss W, 2002, PHOTOCH PHOTOBIO SCI, V1, P60, DOI 10.1039/b107442c; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Hare PM, 2007, P NATL ACAD SCI USA, V104, P435, DOI 10.1073/pnas.0608055104; HOSSZU JL, 1967, BIOCHEM BIOPH RES CO, V29, P327, DOI 10.1016/0006-291X(67)90457-3; Kuimova MK, 2006, P NATL ACAD SCI USA, V103, P2150, DOI 10.1073/pnas.0506860103; Kundu LM, 2004, CHEM-EUR J, V10, P5697, DOI 10.1002/chem.200305731; LAMOLA AA, 1968, P NATL ACAD SCI USA, V59, P46, DOI 10.1073/pnas.59.1.46; LIAN TQ, 1994, J PHYS CHEM-US, V98, P11648, DOI 10.1021/j100096a005; LISEWSKI R, 1970, PHOTOCHEM PHOTOBIOL, V11, P327, DOI 10.1111/j.1751-1097.1970.tb06006.x; LYAMICHEV V, 1991, NUCLEIC ACIDS RES, V19, P4491, DOI 10.1093/nar/19.16.4491; Marguet S, 2005, J AM CHEM SOC, V127, P5780, DOI 10.1021/ja050648h; Martinez JM, 2001, J AM CHEM SOC, V123, P12279, DOI 10.1021/ja0108786; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; Mills JB, 1999, J MOL BIOL, V285, P245, DOI 10.1006/jmbi.1998.2287; MITCHELL DL, 1984, PHOTOCHEM PHOTOBIOL, V40, P735; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; RAHN RO, 1968, PHOTOCHEM PHOTOBIOL, V7, P637, DOI 10.1111/j.1751-1097.1968.tb08046.x; RAHN RO, 1966, SCIENCE, V154, P503, DOI 10.1126/science.154.3748.503; Saenger W., 1984, PRINCIPLES NUCL ACID; SCHERER NF, 1990, J CHEM PHYS, V92, P5239, DOI 10.1063/1.458531; Schrader T, 2004, CHEM PHYS LETT, V392, P358, DOI 10.1016/j.cplett.2004.05.090; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P7; TRAMER Z, 1969, ACTA BIOCHIM POL, V16, P83; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; Vink AA, 2001, J PHOTOCH PHOTOBIO B, V65, P101, DOI 10.1016/S1011-1344(01)00245-7; WAGNER PJ, 1983, ACCOUNTS CHEM RES, V16, P461, DOI 10.1021/ar00096a006; Zhang SL, 1998, J PHYS CHEM A, V102, P461, DOI 10.1021/jp972385m	38	411	414	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 2	2007	315	5812					625	629		10.1126/science.1135428	http://dx.doi.org/10.1126/science.1135428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131YR	17272716	Green Accepted			2022-12-28	WOS:000243909400037
J	Janson, ME; Loughlin, R; Loiodice, I; Fu, CH; Brunner, D; Nedelec, FJ; Tran, PT				Janson, Marcel E.; Loughlin, Rose; Loiodice, Isabelle; Fu, Chuanhai; Brunner, Damian; Nedelec, Francois J.; Tran, Phong T.			Crosslinkers and motors organize dynamic microtubules to form stable bipolar arrays in fission yeast	CELL			English	Article							SPINDLE MIDZONE FORMATION; SELF-ORGANIZATION; INTERPHASE MICROTUBULES; POLARITY ORIENTATION; BUNDLING ACTIVITY; MITOTIC SPINDLES; ACTIN-FILAMENTS; GAMMA-TUBULIN; KINESIN; CELLS	Microtubule (MI) nucleation not only occurs from centrosomes, but also in large part from dispersed nucleation sites. The subsequent sorting of short MTs into networks like the mitotic spindle requires molecular motors that laterally slide overlapping MTs and bundling proteins that statically connect MTs. How bundling proteins interfere with MT sliding is unclear. In bipolar MT bundles in fission yeast, we found that the bundler ase1p localized all along the length of antiparallel MTs, whereas the motor klp2p (kinesin-14) accumulated only at MT plus ends. Consequently, sliding forces could only overcome resistant bundling forces for short, newly nucleated MTs, which were transported to their correct position within bundles. Ase1p thus regulated sliding forces based on polarity and overlap length, and computer simulations showed these mechanisms to be sufficient to generate stable bipolar bundles. By combining motor and bundling proteins, cells can thus dynamically organize stable regions of overlap between cytoskeletal filaments.	Univ Penn, Philadelphia, PA 19104 USA; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	University of Pennsylvania; European Molecular Biology Laboratory (EMBL)	Nedelec, FJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	nedelec@embl.de; tranp@mail.med.upenn.edu	Tran, Phong/GZA-8504-2022; Nedelec, Francois J/H-3317-2011; Tran, Phong/F-1357-2015; Nedelec, Francois/AAC-1673-2019; Brunner, Damian/F-2024-2011; Fu, Chuanhai/G-8303-2016; Fu, Chuanhai/E-1479-2011	Nedelec, Francois J/0000-0002-8141-5288; Tran, Phong/0000-0002-2410-2277; Nedelec, Francois/0000-0002-8141-5288; Fu, Chuanhai/0000-0003-4354-3796; Brunner, Damian/0000-0001-5250-492X				Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.e04-10-0935; Baas PW, 2006, TRAFFIC, V7, P490, DOI 10.1111/j.1600-0854.2006.00392.x; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Gruneberg U, 2006, J CELL BIOL, V172, P363, DOI 10.1083/jcb.200511061; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Hizlan D, 2006, J STRUCT BIOL, V153, P73, DOI 10.1016/j.jsb.2005.10.007; Janson ME, 2005, J CELL BIOL, V169, P297, DOI 10.1083/jcb.200410119; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Mahoney NM, 2006, CURR BIOL, V16, P564, DOI 10.1016/j.cub.2006.01.053; Maresca TJ, 2005, CURR BIOL, V15, P1755, DOI 10.1016/j.cub.2005.08.049; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Murata T, 2005, NAT CELL BIOL, V7, P961, DOI 10.1038/ncb1306; Nedelec F, 2002, J CELL BIOL, V158, P1005, DOI 10.1083/jcb.200202051; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Patel SR, 2005, BLOOD, V106, P4076, DOI 10.1182/blood-2005-06-2204; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sharp DJ, 1997, J CELL SCI, V110, P2373; Smertenko AP, 2004, PLANT CELL, V16, P2035, DOI 10.1105/tpc.104.023937; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; Tran PT, 1997, J CELL BIOL, V138, P105, DOI 10.1083/jcb.138.1.105; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	41	162	165	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					357	368		10.1016/j.cell.2006.12.030	http://dx.doi.org/10.1016/j.cell.2006.12.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254972	Bronze			2022-12-28	WOS:000244420500019
J	Yaswen, P; Campisi, J				Yaswen, Paul; Campisi, Judith			Oncogene-induced senescence pathways weave an intricate tapestry	CELL			English	Editorial Material								The induction of cellular senescence by activated oncogenes acts as a barrier to cell transformation. Now, Sun et al. (2007) identify a key component of a senescence pathway that prevents tumorigenesis in a mouse model of skin cancer. They show that the p38-regulated/activated protein kinase (PRAK) induces senescence downstream of oncogenic Ras by directly phosphorylating and activating the tumor-suppressor protein p53.	Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Buck Inst Age Res, Novato, CA 94945 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Buck Institute for Research on Aging	Yaswen, P (corresponding author), Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd, Berkeley, CA 94720 USA.	p_yaswen@lbl.gov; jcampisi@lbl.gov						Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; SUN P, 2007, CELL; Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	11	97	105	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 26	2007	128	2					233	234		10.1016/j.cell.2007.01.005	http://dx.doi.org/10.1016/j.cell.2007.01.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254959	Bronze, Green Submitted			2022-12-28	WOS:000244420500006
J	Johnston, SC; Rothwell, PM; Nguyen-Huynh, MN; Giles, MF; Elkins, JS; Bernstein, AL; Sidney, S				Johnston, S. Claiborne; Rothwell, Peter M.; Nguyen-Huynh, Mai N.; Giles, Matthew F.; Elkins, Jacob S.; Bernstein, Allan L.; Sidney, Stephen			Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack	LANCET			English	Article							SYMPTOMATIC CAROTID STENOSIS; SHORT-TERM PROGNOSIS; CLINICAL CHARACTERISTICS; MINOR STROKE; ABCD SCORE; MANAGEMENT; DIAGNOSIS; STRATIFICATION; ABNORMALITIES; INDIVIDUALS	Background We aimed to validate two similar existing prognostic scores for early risk of stroke after transient ischaemic attack (TIA) and to derive and validate a unified score optimised for prediction of 2-day stroke risk to inform emergency management. Methods The California and ABCD scores were validated in four independent groups of patients (n=2893) diagnosed with TIA in emergency departments and clinics in defined populations in the USA and UK. Prognostic value was quantified with c statistics. The two groups used to derive the original scores (n=1916) were used to derive a new unified score based on logistic regression. Findings The two existing scores predicted the risk of stroke similarly in each of the four validation cohorts, for stroke risks at 2 days, 7 days, and 90 days (c statistics 0.60-0.81). in both derivation groups, c: statistics were improved for a unified score based on five factors (age 60 years [1 point]; blood pressure >= 140/90 mm Hg [1]; clinical features: unilateral weakness [2], speech impairment without weakness [1]; duration >= 60 min [2] or 10-59 min [1]; and diabetes [1]). This score, ABCD(2), validated well (c statistics 0.62-0.83); overall, 1012 (21%) of patients were classified as high risk (score 6-7, 8.1% 2-day risk), 2169 (45%) as moderate risk (score 4-5, 4.1%), and 1628 (34%) as low risk (score 0-3, 1.0%). Implications Existing prognostic scores for stroke risk after TIA validate well on multiple independent cohorts, but the unified ABCD(2) score is likely to be most predictive. Patients at high risk need immediate evaluation to optimise stroke prevention.	Univ Calif San Francisco, Dept Neurol, Stroke Serv, San Francisco, CA 94143 USA; Radcliffe Infirm, Univ Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Kaiser Permanente No Calif, Div Res, Oakland, CA USA	University of California System; University of California San Francisco; Radcliffe Infirmary; University of Oxford; Kaiser Permanente	Johnston, SC (corresponding author), Univ Calif San Francisco, Dept Neurol, Stroke Serv, San Francisco, CA 94143 USA.	clay.johnston@ucsfmedctr.org	Rothwell, Peter/ABE-5913-2020; s, s/GYR-2278-2022; s, s/HIK-1178-2022; s, s/HHD-0404-2022	Rothwell, Peter/0000-0001-9739-9211; 	MRC [G0500987] Funding Source: UKRI; Medical Research Council [G0500987] Funding Source: Medline; NINDS NIH HHS [NS 02042] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Coutts SB, 2005, ANN NEUROL, V57, P848, DOI 10.1002/ana.20497; Crisostomo RA, 2003, STROKE, V34, P932, DOI 10.1161/01.STR.0000061496.00669.5E; Cucchiara BL, 2006, STROKE, V37, P1710, DOI 10.1161/01.STR.0000227195.46336.93; Daffertshofer M, 2004, STROKE, V35, P2453, DOI 10.1161/01.STR.0000144050.90132.8e; Douglas VC, 2003, STROKE, V34, P2894, DOI 10.1161/01.STR.0000102900.74360.D9; Fairhead JF, 2005, NEUROLOGY, V65, P371, DOI 10.1212/01.WNL.0000170368.82460.b4; Giles M, 2006, CEREBROVASC DIS, V21, P58; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Gladstone DJ, 2004, CAN MED ASSOC J, V170, P1099, DOI 10.1503/cmaj.1031349; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; HANKEY GJ, 1992, J NEUROL NEUROSUR PS, V55, P171, DOI 10.1136/jnnp.55.3.171; Hill MD, 2004, NEUROLOGY, V62, P2015, DOI 10.1212/01.WNL.0000129482.70315.2F; Inatomi Y, 2004, NEUROLOGY, V62, P376, DOI 10.1212/01.WNL.0000110303.57683.3A; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Johnston SC, 2003, NEUROLOGY, V60, P280; Johnston SC, 2002, NEW ENGL J MED, V347, P1687, DOI 10.1056/NEJMcp020891; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; KOUDSTAAL PJ, 1989, STROKE, V20, P300, DOI 10.1161/01.STR.20.2.300; KRAAIJEVELD CL, 1984, STROKE, V15, P723, DOI 10.1161/01.STR.15.4.723; Lennard NS, 2003, BRIT J SURG, V90, P166, DOI 10.1002/bjs.4030; Lisabeth LD, 2004, STROKE, V35, P1842, DOI 10.1161/01.STR.0000134416.89389.9d; Lovett JK, 2003, STROKE, V34, pE138, DOI 10.1161/01.STR.0000080935.01264.91; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Newby LK, 2001, CIRCULATION, V103, P1832; Nguyen-Huynh MN, 2005, NEUROLOGY, V65, P1799, DOI 10.1212/01.wnl.0000187067.93321.fa; Purroy F, 2004, STROKE, V35, P2313, DOI 10.1161/01.STR.0000141703.21173.91; Rao SV, 2003, AM J CARDIOL, V91, P936, DOI 10.1016/S0002-9149(03)00107-3; REDGRAVE J, 2006, CEREBROVAS DIS S4, V21, P34; REDGRAVE JN, IN PRESS STROKE; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2006, LANCET NEUROL, V5, P323, DOI 10.1016/S1474-4422(06)70408-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; ROTHWELL PM, IN PRESS LANCET; Smith WS, 2003, NEUROLOGY, V60, P1424, DOI 10.1212/01.WNL.0000063305.61050.E6; STREIFLER JY, 1995, ARCH NEUROL-CHICAGO, V52, P246, DOI 10.1001/archneur.1995.00540270034016; Tsivgoulis G, 2006, STROKE, V37, P2892, DOI 10.1161/01.STR.0000249007.12256.4a; *WHO MONICA PROJ P, 1988, J CLIN EPIDEMIOL, V41, P105, DOI [DOI 10.1016/0895-4356(88)90084-4, 10.1016/0895-4356(88)90084-4]; 1996, FED REG, V61, P46166	42	865	943	2	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2007	369	9558					283	292		10.1016/S0140-6736(07)60150-0	http://dx.doi.org/10.1016/S0140-6736(07)60150-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131ZR	17258668				2022-12-28	WOS:000243912000032
J	Collins, SR; Miller, KM; Maas, NL; Roguev, A; Fillingham, J; Chu, CS; Schuldiner, M; Gebbia, M; Recht, J; Shales, M; Ding, HM; Xu, H; Han, JH; Ingvarsdottir, K; Cheng, B; Andrews, B; Boone, C; Berger, SL; Hieter, P; Zhang, ZG; Brown, GW; Ingles, CJ; Emili, A; Allis, CD; Toczyski, DP; Weissman, JS; Greenblatt, JF; Krogan, NJ				Collins, Sean R.; Miller, Kyle M.; Maas, Nancy L.; Roguev, Assen; Fillingham, Jeffrey; Chu, Clement S.; Schuldiner, Maya; Gebbia, Marinella; Recht, Judith; Shales, Michael; Ding, Huiming; Xu, Hong; Han, Junhong; Ingvarsdottir, Kristin; Cheng, Benjamin; Andrews, Brenda; Boone, Charles; Berger, Shelley L.; Hieter, Phil; Zhang, Zhiguo; Brown, Grant W.; Ingles, C. James; Emili, Andrew; Allis, C. David; Toczyski, David P.; Weissman, Jonathan S.; Greenblatt, Jack F.; Krogan, Nevan J.			Functional dissection of protein complexes involved in yeast chromosome biology using a genetic interaction map	NATURE			English	Article							H3 LYSINE-56 ACETYLATION; HISTONE H3; H3K56 ACETYLATION; CELL-CYCLE; MEDIATOR; DNA; INTEGRITY; PATHWAY; HST3; ASF1	Defining the functional relationships between proteins is critical for understanding virtually all aspects of cell biology. Large-scale identification of protein complexes has provided one important step towards this goal; however, even knowledge of the stoichiometry, affinity and lifetime of every protein - protein interaction would not reveal the functional relationships between and within such complexes. Genetic interactions can provide functional information that is largely invisible to protein - protein interaction data sets. Here we present an epistatic miniarray profile (E-MAP)(1) consisting of quantitative pairwise measurements of the genetic interactions between 743 Saccharomyces cerevisiae genes involved in various aspects of chromosome biology ( including DNA replication/ repair, chromatid segregation and transcriptional regulation). This E-MAP reveals that physical interactions fall into two well-represented classes distinguished by whether or not the individual proteins act coherently to carry out a common function. Thus, genetic interaction data make it possible to dissect functionally multi-protein complexes, including Mediator, and to organize distinct protein complexes into pathways. In one pathway defined here, we show that Rtt109 is the founding member of a novel class of histone acetyltransferases responsible for Asf1-dependent acetylation of histone H3 on lysine 56. This modification, in turn, enables a ubiquitin ligase complex containing the cullin Rtt101 to ensure genomic integrity during DNA replication.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Canc Res Inst, San Francisco, CA 94115 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Rockefeller Univ, Lab Cromatin Biol, New York, NY 10021 USA; Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; Wistar Inst Anat & Biol, Gene Express & REgulat Program, Philadelphia, PA 19104 USA; Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; Rockefeller University; Mayo Clinic; The Wistar Institute; University of British Columbia; University of Toronto	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu; jack.greenblatt@utoronto.ca	Schuldiner, Maya/C-9488-2009; Han, Junhong/L-5264-2013	Schuldiner, Maya/0000-0001-9947-115X; Weissman, Jonathan/0000-0003-2445-670X; Miller, Kyle/0000-0002-4544-0013; Berger, Shelley/0000-0001-5398-4400; Brown, Grant/0000-0002-9002-5003; Recht, Judith/0000-0003-3572-0457; Collins, Sean/0000-0002-4276-5840; Han, Junhong/0000-0002-3371-8698; Ingvarsdottir, Kristin/0000-0001-9915-1164				Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Ozdemir A, 2005, J BIOL CHEM, V280, P25949, DOI 10.1074/jbc.C500181200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; [No title captured]	30	691	696	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2007	446	7137					806	810		10.1038/nature05649	http://dx.doi.org/10.1038/nature05649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	156CX	17314980				2022-12-28	WOS:000245626800043
J	Hevroni, A; Koplewitz, BZ				Hevroni, Avigdor; Koplewitz, Benjamin Z.			Bone within bone - Chronic osteomyelitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hadassah Univ Hosp, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Hevroni, A (corresponding author), Hadassah Univ Hosp, IL-91120 Jerusalem, Israel.	hevroni1@yahoo.com							0	0	2	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2007	356	8					E7	E7		10.1056/NEJMicm055247	http://dx.doi.org/10.1056/NEJMicm055247			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	137XQ	17314333				2022-12-28	WOS:000244326700011
J	Sakakura, A; Ukai, A; Ishihara, K				Sakakura, Akira; Ukai, Atsushi; Ishihara, Kazuaki			Enantioselective halocyclization of polyprenoids induced by nucleophilic phosphoramidites	NATURE			English	Article							MARINE NATURAL-PRODUCTS; CYCLIZATION; TERPENES	Polycyclic bio-active natural products that contain halogen atoms have been isolated from a number of different marine organisms(1). The biosynthesis of these natural products appears to be initiated by an electrophilic halogenation reaction at a carbon - carbon double bond(2-4) via a mechanism that is similar to a proton-induced olefin polycyclization(5-8). Enzymes such as haloperoxidases generate an electrophilic halonium ion ( or its equivalent), which reacts with the terminal carbon - carbon double bond of the polyprenoid, enantioselectively inducing a cyclization reaction that produces a halogenated polycyclic terpenoid. Use of an enantioselective halocyclization reaction is one possible way to chemically synthesize these halogenated cyclic terpenoids; although several brominated cyclic terpenoids have been synthesized via a diastereoselective halocyclization reaction that uses stoichiometric quantities of a brominating reagent(9-12), the enantioselective halocyclization of isoprenoids induced by a chiral promoter has not yet been reported. Here we report the enantioselective halocyclization of simple polyprenoids using a nucleophilic promoter. Achiral nucleophilic phosphorus compounds are able to promote the diastereoselective halocyclization reaction to give a halogenated cyclic product in excellent yields. Moreover, chiral phosphoramidites promote the enantioselective halocyclization of simple polyprenoids with N-iodosuccinimide to give iodinated cyclic products in up to 99% enantiomeric excess and diastereomeric excess. To the best of our knowledge, this is the first successful example of the enantioselective halopolycyclization of polyprenoids.	Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Nagoya University	Ishihara, K (corresponding author), Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	ishihara@cc.nagoya-u.ac.jp	Sakakura, Akira/A-6319-2013	Sakakura, Akira/0000-0002-2995-1251				Blunt JW, 2006, NAT PROD REP, V23, P26, DOI 10.1039/b502792f; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Carter-Franklin JN, 2003, J AM CHEM SOC, V125, P3688, DOI 10.1021/ja029271v; Cui XL, 2000, J ORG CHEM, V65, P5653, DOI 10.1021/jo000449a; Fukuzumi T, 2006, J FLUORINE CHEM, V127, P548, DOI 10.1016/j.jfluchem.2006.01.004; GONZALEZ AG, 1976, TETRAHEDRON LETT, V17, P137; Grossman RB, 1998, CAN J CHEM, V76, P1233, DOI 10.1139/cjc-76-9-1233; Haas J, 2002, ORG LETT, V4, P297, DOI 10.1021/ol0171113; Huang AX, 1999, J AM CHEM SOC, V121, P9999, DOI 10.1021/ja992411p; Ishibashi H, 2004, J AM CHEM SOC, V126, P11122, DOI 10.1021/ja0472026; JOHNSON WS, 1976, BIOORG CHEM, V5, P51, DOI 10.1016/0045-2068(76)90016-X; Kang SH, 2003, J AM CHEM SOC, V125, P15748, DOI 10.1021/ja0369921; WOLINSKY LE, 1976, J ORG CHEM, V41, P597, DOI 10.1021/jo00866a003; YAMAGUCHI Y, 1985, TETRAHEDRON LETT, V26, P343, DOI 10.1016/S0040-4039(01)80813-3; YAMAMURA S, 1977, TETRAHEDRON LETT, P2171; Yarnell A, 2006, CHEM ENG NEWS, V84, P12, DOI 10.1021/cen-v084n012.p012; Yoder RA, 2005, CHEM REV, V105, P4730, DOI 10.1021/cr040623l; Zhang Y, 2004, J AM CHEM SOC, V126, P15038, DOI 10.1021/ja0454485	18	324	324	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2007	445	7130					900	903		10.1038/nature05553	http://dx.doi.org/10.1038/nature05553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	138CR	17314976				2022-12-28	WOS:000244341200045
J	Leutgeb, JK; Leutgeb, S; Moser, MB; Moser, EI				Leutgeb, Jill K.; Leutgeb, Stefan; Moser, May-Britt; Moser, Edvard I.			Pattern separation in the dentate gyrus and CA3 of the hippocampus	SCIENCE			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; ENTORHINAL CORTEX; GRANULE CELLS; UNIT-ACTIVITY; SPATIAL MAP; REPRESENTATION; ENVIRONMENT; DISTINCT; RECALL	Theoretical models have long pointed to the dentate gyrus as a possible source of neuronal pattern separation. In agreement with predictions from these models, we show that minimal changes in the shape of the environment in which rats are exploring can substantially alter correlated activity patterns among place-modulated granule cells in the dentate gyrus. When the environments are made more different, new cell populations are recruited in CA3 but not in the dentate gyrus. These results imply a dual mechanism for pattern separation in which signals from the entorhinal cortex can be decorrelated both by changes in coincidence patterns in the dentate gyrus and by recruitment of nonoverlapping cell assemblies in CA3.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Leutgeb, Jill/0000-0002-2014-842X				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; FYHN MH, IN PRESS NATURE; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hayman RMA, 2003, EUR J NEUROSCI, V18, P2825, DOI 10.1111/j.1460-9568.2003.03035.x; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Rapp PR, 2002, CEREB CORTEX, V12, P1171, DOI 10.1093/cercor/12.11.1171; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	36	1031	1043	3	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 16	2007	315	5814					961	966		10.1126/science.1135801	http://dx.doi.org/10.1126/science.1135801			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136MW	17303747				2022-12-28	WOS:000244229800034
J	Chartrel, N; Alvear-Perez, R; Leprince, J; Iturrioz, X; Reaux-Le Goazigo, A; Audinot, V; Chomarat, P; Coge, F; Nosjean, O; Rodriguez, M; Galizzi, JP; Boutin, JA; Vaudry, H; Llorens-Cortes, C				Chartrel, N.; Alvear-Perez, R.; Leprince, J.; Iturrioz, X.; Reaux-Le Goazigo, A.; Audinot, V.; Chomarat, P.; Coge, F.; Nosjean, O.; Rodriguez, M.; Galizzi, J. P.; Boutin, J. A.; Vaudry, H.; Llorens-Cortes, C.			Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake"	SCIENCE			English	Editorial Material								Zhang et al. ( Research Articles, 11 November 2005, p. 996) reported that obestatin, a peptide derived from the ghrelin precursor, activated the orphan G protein-coupled receptor GPR39. However, we found that I-125-obestatin does not bind GPR39 and observed no effects of obestatin on GPR39-transfected cells in various functional assays ( cyclic adenosine monophosphate production, calcium mobilization, and GPR39 internalization). Our results indicate that obestatin is not the cognate ligand for GPR39.	Univ Rouen, Lab Cellular & Mol Neuroendocrinol, INSERM, U413, F-76821 Mont St Aignan, France; Univ Rouen, European Inst Peptide Res, IFRMP 23, F-76821 Mont St Aignan, France; INSERM, U691, F-75005 Paris, France; Coll France, F-75005 Paris, France; Ctr Rech Croissy, IdRS, F-78290 Croissy Sur Seine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Boutin, JA (corresponding author), Univ Rouen, Lab Cellular & Mol Neuroendocrinol, INSERM, U413, F-76821 Mont St Aignan, France.	jean.boutin@fr.netgrs.com; hubert.vaudry@univ-rouen.fr; c.llorens-cortes@college-de-france.fr	ITURRIOZ, Xavier/Q-4406-2017; Goazigo, Annabelle Reaux-Le/F-2753-2017; Leprince, Jerome/N-9083-2017; Llorens-Cortès, catherine/AAL-3893-2021; Llorens-Cortes, Catherine/E-5839-2016; chartrel, nicolas/E-5545-2016; Boutin, Jean Albert/W-9103-2019; Iturrioz, Xavier/AAS-3555-2020	ITURRIOZ, Xavier/0000-0001-7143-8323; Goazigo, Annabelle Reaux-Le/0000-0003-3855-9523; Llorens-Cortès, catherine/0000-0002-7667-0401; Llorens-Cortes, Catherine/0000-0002-7667-0401; Boutin, Jean Albert/0000-0003-0068-7204; Iturrioz, Xavier/0000-0001-7143-8323; Leprince, Jerome/0000-0002-7814-9927				Holst B, 2007, ENDOCRINOLOGY, V148, P13, DOI 10.1210/en.2006-0933; Lauwers E, 2006, BIOCHEM BIOPH RES CO, V351, P21, DOI 10.1016/j.bbrc.2006.09.141; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255	3	164	171	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 9	2007	315	5813								10.1126/science.1135047	http://dx.doi.org/10.1126/science.1135047			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134FN	17289961				2022-12-28	WOS:000244069000026
J	Shang, YH; Claridge-Chang, A; Sjulson, L; Pypaert, M; Miesenbock, G				Shang, Yuhua; Claridge-Chang, Adam; Sjulson, Lucas; Pypaert, Marc; Miesenbock, Gero			Excitatory local circuits and their implications for olfactory processing in the fly antennal lobe	CELL			English	Article							ODOR REPRESENTATIONS; MOLECULAR-BASIS; DROSOPHILA; MAP; TRANSMISSION; INFORMATION; DYNAMICS; BEHAVIOR; SYSTEM; NOISE	Conflicting views exist of how circuits of the antennal lobe, the insect equivalent of the olfactory bulb, translate input from olfactory receptor neurons (ORNs) into projection-neuron (PN) output. Synaptic connections between ORNs and PNs are one-to-one, yet PNs are more broadly tuned to odors than ORNs. The basis for this difference in receptive range remains unknown. Analyzing a Drosophila mutant lacking ORN input to one glomerulus, we show that some of the apparent complexity in the antennal lobe's output arises from lateral, inter-glomerular excitation of PNs. We describe a previously unidentified population of cholinergic local neurons (LNs) with multiglomerular processes. These excitatory LNs respond broadly to odors but exhibit little glomerular specificity in their synaptic output, suggesting that PNs are driven by a combination of glomerulus-specific ORN afferents and diffuse LN excitation. Lateral excitation may boost PN signals and enhance their transmission to third-order neurons in a mechanism akin to stochastic resonance.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University	Miesenbock, G (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	gero.miesenboeck@yale.edu		Miesenboeck, Gero/0000-0003-2940-3228; Claridge-Chang, Adam/0000-0002-4583-3650	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005810] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC005810, R01 DC005810-05] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BORST A, 1983, J COMP PHYSIOL, V152, P373, DOI 10.1007/BF00606242; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; KITAMOTO T, 1992, J NEUROSCI, V12, P1628; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LAURENT G, 1994, J NEUROSCI, V14, P2993; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; LONGTIN A, 1991, PHYS REV LETT, V67, P656, DOI 10.1103/PhysRevLett.67.656; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Schoppa NE, 2002, NAT NEUROSCI, V5, P1194, DOI 10.1038/nn953; STEMMLER M, 1995, SCIENCE, V269, P1877, DOI 10.1126/science.7569930; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	53	238	242	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 9	2007	128	3					601	612		10.1016/j.cell.2006.12.034	http://dx.doi.org/10.1016/j.cell.2006.12.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	145CK	17289577	Green Accepted, Bronze			2022-12-28	WOS:000244842700024
J	Dupont-Nivet, G; Krijgsman, W; Langereis, CG; Abels, HA; Dai, S; Fang, XM				Dupont-Nivet, Guillaume; Krijgsman, Wout; Langereis, Cor G.; Abels, Hemmo A.; Dai, Shuang; Fang, Xiaomin			Tibetan plateau aridification linked to global cooling at the Eocene-Oligocene transition	NATURE			English	Article							CLIMATE-CHANGE; ANTARCTIC GLACIATION; MYR AGO; MIOCENE; INITIATION; EVOLUTION; UPLIFT; ONSET; BASIN; RATES	Continental aridification and the intensification of the monsoons in Asia are generally attributed to uplift of the Tibetan plateau and to the land - sea redistributions associated with the continental collision of India and Asia(1-3), whereas some studies suggest that past changes in Asian environments are mainly governed by global climate(4-6). The most dramatic climate event since the onset of the collision of India and Asia is the Eocene - Oligocene transition, an abrupt cooling step associated with the onset of glaciation in Antarctica 34 million years ago(7-9). However, the influence of this global event on Asian environments is poorly understood. Here we use magnetostratigraphy and cyclostratigraphy to show that aridification, which is indicated by the disappearance of playa lake deposits in the northeastern Tibetan plateau, occurred precisely at the time of the Eocene - Oligocene transition. Our findings suggest that this global transition is linked to significant aridification and cooling in continental Asia recorded by palaeontological and palaeoenvironmental changes(10-12), and thus support the idea that global cooling is associated with the Eocene - Oligocene transition(13-15). We show that, with sufficient age control on the sedimentary records, global climate can be distinguished from tectonism and recognized as a major contributor to continental Asian environments.	Univ Utrecht, Dept Earth Sci, Paleomagnet Lab Ft Hoofddijk, NL-3584 CD Utrecht, Netherlands; Lanzhou Univ, Key Lab Western Chinas Environm Syst, Lanzhou 730000, Gansu, Peoples R China; Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100085, Peoples R China	Utrecht University; Lanzhou University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Dupont-Nivet, G (corresponding author), Univ Utrecht, Dept Earth Sci, Paleomagnet Lab Ft Hoofddijk, Budapestlaan 17, NL-3584 CD Utrecht, Netherlands.	gdn@geo.uu.nl	DUPONT-NIVET, Guillaume/HII-9066-2022	Krijgsman, Wout/0000-0002-1472-1074; Dupont-Nivet, Guillaume/0000-0001-9905-9739; Langereis, Cor/0000-0001-9232-2178; Abels, Hemmo/0000-0001-7648-3369				An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Clift PD, 2004, GEOPH MONOG SERIES, V149, P255, DOI 10.1029/149GM14; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Dai S, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004187; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Garzione CN, 2005, GEOL SOC AM BULL, V117, P1156, DOI 10.1130/B25743.1; Graham SA, 2005, AM J SCI, V305, P101, DOI 10.2475/ajs.305.2.101; Grimes ST, 2005, GEOLOGY, V33, P189, DOI 10.1130/G21019.1; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Gupta AK, 2004, GEOLOGY, V32, P753, DOI 10.1130/G20662.1; Harris N, 2006, PALAEOGEOGR PALAEOCL, V241, P4, DOI 10.1016/j.palaeo.2006.07.009; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Kohn MJ, 2004, GEOLOGY, V32, P621, DOI 10.1130/G20442.1; Krijgsman W., 2004, STRATIGRAPHY, V1, P87; Kutzbach JE, 2004, GLOBAL PLANET CHANGE, V41, P157, DOI 10.1016/j.gloplacha.2004.01.015; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; OGG JG, 2004, GEOLOGIC TIME SCALE, P63, DOI [DOI 10.1017/CBO9780511536045.006, DOI 10.2277/0511074050]; Popov SV., 2004, COUR FORSCH I SENCKE, V250, P1; PROTHERO DR, 2004, ENCY GEOLOGY, P472; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Ruddiman WF, 1997, TECTONIC UPLIFT CLIM, P203, DOI DOI 10.1007/978-1-4615-5935-1_9; TALBOT MR, 1996, SEDIMENTARY ENV PROC, P83; WANG DN, 1990, REV PALAEOBOT PALYNO, V65, P95; Yechieli Y, 2002, EARTH-SCI REV, V58, P343, DOI 10.1016/S0012-8252(02)00067-3; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	30	441	506	15	248	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 8	2007	445	7128					635	638		10.1038/nature05516	http://dx.doi.org/10.1038/nature05516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	133UM	17287807				2022-12-28	WOS:000244039400041
J	Mulgrew, AT; Fox, N; Ayas, NT; Ryan, CF				Mulgrew, Alan T.; Fox, Nurit; Ayas, Najib T.; Ryan, C. Frank			Diagnosis and initial management of obstructive sleep apnea without polysomnography - A randomized validation study	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; HYPOPNEA SYNDROME; HOME OXIMETRY; CPAP THERAPY; RISK; POPULATION; PREDICTION; QUESTIONNAIRE; HYPERTENSION; RECORDINGS	Background: Polysomnography (PSG), despite limited availability and high cost, is currently recommended for diagnosis of obstructive sleep apnea and titration of effective continuous positive airway pressure (CPAP). Objective: To test the utility of a diagnostic algorithm in conjunction with ambulatory CPAP titration in initial management of obstructive sleep apnea. Design: A randomized, controlled, open-label trial that compared standard PSG with ambulatory CPAP titration in high-risk patients identified by a diagnostic algorithm. Setting: A tertiary referral sleep disorders program in Vancouver, British Columbia, Canada. Patients: 68 patients with a high pretest probability of moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] > 15 episodes/h) identified by sequential application of the Epworth Sleepiness Scale (ESS) score, Sleep Apnea Clinical Score, and overnight oximetry. Intervention: Patients were randomly assigned to PSG or ambulatory titration by using a combination of auto-CPAP and overnight oximetry. They were observed for 3 months. Measurements: Apnea-hypopnea index on CPAP, ESS score, quality of life, and CPAP adherence. Results: The PSG and ambulatory groups had similar median BMI (38 kg/m(2)), age (55 years), ESS score (14 points), and respiratory disturbance index (31 episodes of respiratory disturbance/h). Each episode is determined by a computer algorithm based on analysis of oxygen saturation measured by pulse oximetry. After 3 months, there were no differences in the primary outcome, AHI on CPAP (median, 3.2 vs. 2.5; difference, 0.8/h [95% CI, -0.9 to 2.3]) (P = 0.31), between the PSG and ambulatory groups, or in the secondary outcomes, ESS score, Sleep Apnea Quality of Life Index, and CPAP. Adherence to CPAP therapy was better in the ambulatory group than in the PSG group (median, 5.4 vs. 6.0; difference, -1.12 h/night [CI, -2.0 to 0.2]) (P = 0.021). Conclusions: In the initial management of patients with a high probability of obstructive sleep apnea, PSG confers no advantage over the ambulatory approach in terms of diagnosis and CPAP titration. The ambulatory approach may improve adherence to treatment. When access to PSG is inadequate, the ambulatory approach can be used to expedite management of patients most in need of treatment.			Ryan, CF (corresponding author), Lung Ctr, 7th Floor,Diamond Hlth Care Ctr,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.	fryan@interchange.ubc.ca						Al-Alawi A, 2006, J CLIN SLEEP MED, V2, P281; Ayas NT, 2005, SLEEP, V28, P1211, DOI 10.1093/sleep/28.10.1211; Ayas NT, 2004, SLEEP, V27, P249, DOI 10.1093/sleep/27.2.249; Chervin RD, 1999, ANN INTERN MED, V130, P496, DOI 10.7326/0003-4819-130-6-199903160-00006; Chesson AL, 1997, SLEEP, V20, P406; Chiner E, 1999, THORAX, V54, P968, DOI 10.1136/thx.54.11.968; Engleman HM, 1996, CHEST, V109, P1470, DOI 10.1378/chest.109.6.1470; Ficker JH, 1998, THORAX, V53, P643, DOI 10.1136/thx.53.8.643; Ficker JH, 2000, EUR RESPIR J, V16, P914, DOI 10.1183/09031936.00.16591400; Fitzpatrick MF, 2003, AM J RESP CRIT CARE, V167, P716, DOI 10.1164/rccm.200204-360OC; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Flemons WW, 1998, AM J RESP CRIT CARE, V158, P494; Flemons WW, 2002, AM J RESP CRIT CARE, V165, P159, DOI 10.1164/ajrccm.165.2.2010008; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; FLEMONS WW, 1994, AM J RESP CRIT CARE, V150, P1279, DOI 10.1164/ajrccm.150.5.7952553; Gagnadoux F, 1999, SLEEP, V22, P1095, DOI 10.1093/sleep/22.8.1095; Golpe R, 2002, CHEST, V122, P1156, DOI 10.1378/chest.122.4.1156; Gurubhagavatula I, 2001, AM J RESP CRIT CARE, V164, P1904, DOI 10.1164/ajrccm.164.10.2103039; HLA KM, 1994, ANN INTERN MED, V120, P382, DOI 10.7326/0003-4819-120-5-199403010-00005; Kokturk O, 2005, INT HEART J, V46, P801, DOI 10.1536/ihj.46.801; Krieger J, 1998, EUR RESPIR J, V12, P776, DOI 10.1183/09031936.98.12040776; Kushida CA, 1997, ANN INTERN MED, V127, P581, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00001; Lam B, 2005, THORAX, V60, P504, DOI 10.1136/thx.2004.031591; Lewis KE, 2004, SLEEP, V27, P134, DOI 10.1093/sleep/27.1.134; MAISLIN G, 1995, SLEEP, V18, P158, DOI 10.1093/sleep/18.3.158; Masa JF, 2004, AM J RESP CRIT CARE, V170, P1218, DOI 10.1164/rccm.200312-1787OC; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Pittman SD, 2004, SLEEP, V27, P1394, DOI 10.1093/sleep/27.7.1394; Rowley JA, 2000, SLEEP, V23, P929, DOI 10.1093/sleep/23.7.929; Schafer H, 1997, RESPIRATION, V64, P194; SERIES F, 1993, ANN INTERN MED, V119, P449, DOI 10.7326/0003-4819-119-6-199309150-00001; SMITH PL, 1994, AM J RESP CRIT CARE, V150, P1738; Teschler H, 1996, AM J RESP CRIT CARE, V154, P734, DOI 10.1164/ajrccm.154.3.8810613; Vazquez JC, 2000, THORAX, V55, P302, DOI 10.1136/thorax.55.4.302; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Weaver TE, 1997, SLEEP, V20, P278, DOI 10.1093/sleep/20.4.278; West SD, 2006, THORAX, V61, P226, DOI 10.1136/thx.2005.046300; Whitelaw WA, 2005, AM J RESP CRIT CARE, V171, P188, DOI 10.1164/rccm.200310-1360OC; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	39	247	260	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2007	146	3					157	166		10.7326/0003-4819-146-3-200702060-00004	http://dx.doi.org/10.7326/0003-4819-146-3-200702060-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	132QN	17283346				2022-12-28	WOS:000243957400001
J	Daley, GQ; Ahrlund-Richter, L; Auerbach, JM; Benvenisty, N; Charo, RA; Chen, G; Deng, HK; Goldstein, LS; Hudson, KL; Hyun, I; Junn, SC; Love, J; Lee, EH; McLaren, A; Mummery, CL; Nakatsuji, N; Racowsky, C; Rooke, H; Rossant, J; Scholer, HR; Solbakk, JH; Taylor, P; Trounson, AO; Weissman, IL; Wilmut, I; Yu, J; Zoloth, L				Daley, George Q.; Ahrlund-Richter, Lars; Auerbach, Jonathan M.; Benvenisty, Nissim; Charo, R. Alta; Chen, Grace; Deng, Hong-kui; Goldstein, Lawrence S.; Hudson, Kathy L.; Hyun, Insoo; Junn, Sung Chull; Love, Jane; Lee, Eng Hin; McLaren, Anne; Mummery, Christine L.; Nakatsuji, Norio; Racowsky, Catherine; Rooke, Heather; Rossant, Janet; Schoeler, Hans R.; Solbakk, Jan Helge; Taylor, Patrick; Trounson, Alan O.; Weissman, Irving L.; Wilmut, Ian; Yu, John; Zoloth, Laurie			The ISSCR guidelines for human embryonic stem cell research	SCIENCE			English	Editorial Material							PARTICIPATION; PAYMENT		Childrens Hosp, Boston, MA 02115 USA; Karolinska Inst, S-10401 Stockholm, Sweden; Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel; Univ Wisconsin, Sch Law, Madison, WI 53706 USA; Bird & Bird, Beijing, Peoples R China; Peking Univ, Beijing 100871, Peoples R China; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Johns Hopkins Univ, Berman Bioeth Inst, Baltimore, MD 21218 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Inst Global Management, Seoul, South Korea; Wilmer Cutler Pickering Hale & Dorr LLP, Washington, DC USA; Natl Univ Singapore, Singapore 117548, Singapore; Univ Cambridge, Cambridge CB2 1TN, England; Univ Utrecht, Sch Med, NL-3508 TC Utrecht, Netherlands; Kyoto Univ, Kyoto, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Univ Toronto, Toronto, ON, Canada; Max Planck Inst Mol Biomed, Munster, Germany; Univ Oslo, N-0316 Oslo, Norway; Univ Bergen, N-5020 Bergen, Norway; Monash Univ, Clayton, Vic 3168, Australia; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA	Harvard University; Boston Children's Hospital; Karolinska Institutet; Hebrew University of Jerusalem; University of Wisconsin System; University of Wisconsin Madison; Peking University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Johns Hopkins University; Case Western Reserve University; National University of Singapore; University of Cambridge; Utrecht University; Kyoto University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; Max Planck Society; University of Oslo; University of Bergen; Monash University; Stanford University; University of Edinburgh; Academia Sinica - Taiwan; Northwestern University; Feinberg School of Medicine	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Lee, Eng Hin/I-3325-2019; , HS/AAB-4434-2019; yu, john/AAA-9255-2021; YU, JOHN/G-8954-2012; Ahrlund-Richter, Lars/C-6226-2012	, HS/0000-0003-2643-5136; Yu, John/0000-0002-3237-4272; Trounson, Alan/0000-0001-5469-0500; Mummery, Christine/0000-0002-4549-6535; Charo, Robin Alta/0000-0003-3710-1043				Bentley JP, 2004, J MED ETHICS, V30, P293, DOI 10.1136/jme.2002.001594; Ethics Comm Am Soc Reprod Med, 2000, FERTIL STERIL, V74, P216; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; *UK COMM HUM FERT, HUM FERT EMBR; Wendler D, 2002, J PEDIATR-US, V141, P166, DOI 10.1067/mpd.2002.124381	6	82	85	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 2	2007	315	5812					603	604		10.1126/science.1139337	http://dx.doi.org/10.1126/science.1139337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131YR	17272706				2022-12-28	WOS:000243909400027
J	Miller, KA; Siscovick, DS; Sheppard, L; Shepherd, K; Sullivan, JH; Anderson, GL; Kaufman, JD				Miller, Kristin A.; Siscovick, David S.; Sheppard, Lianne; Shepherd, Kristen; Sullivan, Jeffrey H.; Anderson, Garnet L.; Kaufman, Joel D.			Long-term exposure to air pollution and incidence of cardiovascular events in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; ASSOCIATION; PARTICLES; DISEASE; LINES	BACKGROUND: Fine particulate air pollution has been linked to cardiovascular disease, but previous studies have assessed only mortality and differences in exposure between cities. We examined the association of long-term exposure to particulate matter of less than 2.5 microm in aerodynamic diameter (PM(sub 2.5)) with cardiovascular events. METHODS: We studied 65,893 postmenopausal women without previous cardiovascular disease in 36 U.S. metropolitan areas from 1994 to 1998, with a median follow-up of 6 years. We assessed the women's exposure to air pollutants using the monitor located nearest to each woman's residence. Hazard ratios were estimated for the first cardiovascular event, adjusting for age, race or ethnic group, smoking status, educational level, household income, body-mass index, and presence or absence of diabetes, hypertension, or hypercholesterolemia. RESULTS: A total of 1816 women had one or more fatal or nonfatal cardiovascular events, as confirmed by a review of medical records, including death from coronary heart disease or cerebrovascular disease, coronary revascularization, myocardial infarction, and stroke. In 2000, levels of PM(sub 2.5) exposure varied from 3.4 to 28.3 microg per cubic meter (mean, 13.5). Each increase of 10 microg per cubic meter was associated with a 24% increase in the risk of a cardiovascular event (hazard ratio, 1.24; 95% confidence interval [CI], 1.09 to 1.41) and a 76% increase in the risk of death from cardiovascular disease (hazard ratio, 1.76; 95% CI, 1.25 to 2.47). For cardiovascular events, the between-city effect appeared to be smaller than the within-city effect. The risk of cerebrovascular events was also associated with increased levels of PM(sub 2.5) (hazard ratio, 1.35; 95% CI, 1.08 to 1.68). CONCLUSIONS: Long-term exposure to fine particulate air pollution is associated with the incidence of cardiovascular disease and death among postmenopausal women. Exposure differences within cities are associated with the risk of cardiovascular disease.	Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, Seattle, WA 98105 USA; Univ Washington, Dept Med, Seattle, WA 98105 USA; Univ Washington, Dept Biostat, Seattle, WA 98105 USA; Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98105 USA; Fred Hutchinson Canc Res Ctr, Initiat Clin Coordinating Ctr, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Kaufman, JD (corresponding author), Univ Washington, Occupat & Environm Med Program, Dept Epidemiol, 4225 Roosevelt Way NE,Suite 100, Seattle, WA 98105 USA.	joelk@u.washington.edu	Kaufman, Joel D/B-5761-2008; Sheppard, Lianne/AAF-6304-2021	Kaufman, Joel D/0000-0003-4174-9037; Sheppard, Lianne/0000-0003-1622-508X; Anderson, Garnet/0000-0001-5087-7837	NIEHS NIH HHS [K24ES013195, K23ES011139, K24 ES013195-02, P30ES07033, T32ES07262, K24 ES013195, K24 ES013195-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K23ES011139, K24ES013195, P30ES007033, T32ES007262] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abbey DE, 1999, AM J RESP CRIT CARE, V159, P373, DOI 10.1164/ajrccm.159.2.9806020; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Chen LH, 2005, ENVIRON HEALTH PERSP, V113, P1723, DOI 10.1289/ehp.8190; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Krewski D., 2000, REANALYSIS HARVARD 6; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Kunzli N, 2001, AM J EPIDEMIOL, V153, P1050, DOI 10.1093/aje/153.11.1050; McMichael AJ, 1998, INT J EPIDEMIOL, V27, P450, DOI 10.1093/ije/27.3.450; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Samet J M, 2000, Res Rep Health Eff Inst, V94, P5; Vedal S, 1997, J AIR WASTE MANAGE, V47, P551, DOI 10.1080/10473289.1997.10463922	18	1292	1361	4	395	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 1	2007	356	5					447	458		10.1056/NEJMoa054409	http://dx.doi.org/10.1056/NEJMoa054409			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	131HW	17267905				2022-12-28	WOS:000243860700005
J	Martin-Belmonte, F; Gassama, A; Datta, A; Yu, W; Rescher, U; Gerke, V; Mostov, K				Martin-Belmonte, Fernando; Gassama, Ama; Datta, Anirban; Yu, Wei; Rescher, Ursula; Gerke, Volker; Mostov, Keith			PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42	CELL			English	Article							BASOLATERAL PLASMA-MEMBRANE; CELL-POLARITY; BINDING-PROTEIN; EXCHANGE FACTOR; MDCK CELLS; IN-VIVO; COMPLEX; ACTIVATION; RAC1; DYNAMICS	Formation of the apical surface and lumen is a fundamental, yet poorly understood, step in epithelial organ development. We show that PTEN localizes to the apical plasma membrane during epithelial morphogenesis to mediate the enrichment of Ptdlns(4,5)P-2 at this domain during cyst development in three-dimensional culture. Ectopic Ptdlns(4,5)P-2 at the basolateral surface causes apical proteins to relocalize to the basolateral surface. Annexin 2 (Anx2) binds Ptdlns(4,5)P-2 and is recruited to the apical surface. Anx2 binds Cdc42, recruiting it to the apical surface. Cdc42 recruits aPKC to the apical surface. Loss of function of PTEN, Anx2, Cdc42, or aPKC prevents normal development of the apical surface and lumen. We conclude that the mechanism of PTEN, Ptdlns(4,5)P-2, Anx2, Cdc42, and aPKC controls apical plasma membrane and lumen formation.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Inst Med Biochem, D-48149 Munster, Germany	University of California System; University of California San Francisco	Martin-Belmonte, F (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	fernando.martin-belmonte@ucsf.edu	Gassama, Ama/M-8832-2017; Martin-Belmonte, Fernando/J-8029-2014	Martin-Belmonte, Fernando/0000-0002-2564-4430; mostov, keith/0000-0002-8123-6247	NIAID NIH HHS [P01 AI053194] Funding Source: Medline; NIDDK NIH HHS [R01 DK067153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Bayless KJ, 2002, J CELL SCI, V115, P1123; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fan SL, 2004, CURR BIOL, V14, P1451, DOI 10.1016/j.cub.2004.08.025; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Hansen MDH, 2002, J BIOL CHEM, V277, P45371, DOI 10.1074/jbc.M207747200; Hansen MDH, 2001, CURR BIOL, V11, P356, DOI 10.1016/S0960-9822(01)00091-4; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hurd TW, 2003, CURR BIOL, V13, P2082, DOI 10.1016/j.cub.2003.11.020; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kawakatsu T, 2002, J BIOL CHEM, V277, P50749, DOI 10.1074/jbc.M209846200; Kazmierczak BI, 2004, MOL BIOL CELL, V15, P411, DOI 10.1091/mbc.E03-08-0559; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Lacalle RA, 2004, J CELL SCI, V117, P6207, DOI 10.1242/jcs.01545; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malacombe M, 2006, EMBO J, V25, P3494, DOI 10.1038/sj.emboj.7601247; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Mertens AEE, 2005, J CELL BIOL, V170, P1029, DOI 10.1083/jcb.200502129; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Munro EM, 2006, CURR OPIN CELL BIOL, V18, P86, DOI 10.1016/j.ceb.2005.12.007; Musch A, 2001, EMBO J, V20, P2171, DOI 10.1093/emboj/20.9.2171; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; VEGASALAS DE, 1987, J CELL BIOL, V104, P1249, DOI 10.1083/jcb.104.5.1249; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350	47	533	541	1	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 26	2007	128	2					383	397		10.1016/j.cell.2006.11.051	http://dx.doi.org/10.1016/j.cell.2006.11.051			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	139GO	17254974	Bronze, Green Accepted			2022-12-28	WOS:000244420500021
J	Siripala, AD; Welch, MD				Siripala, Anosha D.; Welch, Matthew D.			SnapShot: Actin regulators II	CELL			English	Editorial Material														Siripala, Anosha/0000-0003-4073-9195	NIGMS NIH HHS [R01 GM059609, R01 GM059609-07] Funding Source: Medline; NIGMS NIH HHS [R01 GM059609-07, R01 GM059609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	23	23	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 9	2007	128	5					1014	1014		10.1016/j.cell.2007.02.021	http://dx.doi.org/10.1016/j.cell.2007.02.021			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	148KN	17350583	Bronze			2022-12-28	WOS:000245073400023
